<SEC-DOCUMENT>0001140361-20-024555.txt : 20201104
<SEC-HEADER>0001140361-20-024555.hdr.sgml : 20201104
<ACCEPTANCE-DATETIME>20201104164917
ACCESSION NUMBER:		0001140361-20-024555
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201104
DATE AS OF CHANGE:		20201104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aquestive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001398733
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208623253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38599
		FILM NUMBER:		201287342

	BUSINESS ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-941-1900

	MAIL ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MonoSol Rx, Inc.
		DATE OF NAME CHANGE:	20070507
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>brhc10016591_10q.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  <div>
    <div style="font-size: 14pt;">
      <div style="text-align: center; text-indent: -0.2pt; margin-right: 0.1pt; margin-left: 0.2pt; color: rgb(0, 0, 0); font-weight: bold;">UNITED STATES</div>
    </div>
    <div>
      <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div style="font-size: 18pt;">
      <div style="text-align: center; margin-right: 0.2pt; margin-left: 0.2pt; color: rgb(0, 0, 0); font-weight: bold;">FORM 10-Q</div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">(Mark One)</div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z244091b34e5441e4a510959929875cdc">

        <tr>
          <td style="width: 0.1pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">&#9746;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>
        </tr>

    </table>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: bold;">For the quarterly period ended September 30, 2020</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">OR</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z758df0029f4645e88122cff534b91ae8">

        <tr>
          <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">&#9744;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>
        </tr>

    </table>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0);"><font style="font-weight: bold;">For the transition period from _____ </font>&#160;<font style="font-weight: bold;">to _____</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Commission File Number: 001-38599</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">Aquestive Therapeutics, Inc.</div>
      <div style="text-align: center; color: rgb(0, 0, 0);">(Exact Name of Registrant as Specified in its Charter)</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="ze004322346194888ae8bccc1461dd5ee">

        <tr>
          <td style="width: 33%; vertical-align: middle;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">30 Technology Drive, Warren, NJ 07059</div>
          </td>
          <td style="width: 33%; vertical-align: middle;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">82-3827296</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: middle;">
            <div style="text-align: center; color: rgb(0, 0, 0);">(State or other jurisdiction of Incorporation or organization)</div>
          </td>
          <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">&#160;<font style="font-weight: bold;">(908) 941-1900</font></div>
          </td>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0);">(I.R.S. Employer Identification Number)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Address, Zip Code and Telephone Number of Registrant&#8217;s Principal Executive Offices)</div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0);">Securities registered pursuant to Section 12(b) of the Act:</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z49c5e1bdc47d4a5e9f4b16e921ae8101">

        <tr>
          <td style="width: 38%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of each class</div>
          </td>
          <td style="width: 24%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Trading Symbol(s)</div>
          </td>
          <td style="width: 38%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of each exchange on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">Common Stock, par value $0.001 per share</div>
          </td>
          <td style="width: 24%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">AQST</div>
          </td>
          <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">NASDAQ Global Market</div>
          </td>
        </tr>

    </table>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="color: rgb(0, 0, 0);">Securities registered pursuant to Section 12(g) of the Act:</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> </font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font style="color: rgb(0, 0, 0); font-weight: bold;">None</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
        such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; Yes&#160; &#9744; No</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter)
        during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746; Yes&#160; &#9744; No</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the
        definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Securities Exchange Act of 1934.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z93f414e161f54f88b7dc0c7a053b3f5f">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Large accelerated filer &#8201;&#9744;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Accelerated filer &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer &#9746;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Smaller reporting company &#9746;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Emerging growth company &#8201;&#9746;</div>
          </td>
        </tr>

    </table>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
        provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0);">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; &#9744; Yes&#160; &#9746; No</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0);">The number of outstanding shares of the registrant&#8217;s common stock, par value of $0.001 per share, as of the close of business on November 2, 2020 was 33,619,796.</div>
    <div><br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">QUARTERLY REPORT ON FORM 10-Q</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">FOR THE QUARTER ENDED SEPTEMBER 30, 2020</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><a name="TABLEOFCONTENTS"><!--Anchor--></a>TABLE OF CONTENTS</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z19c8e3a648384dd4aa0cb2631a181408">

        <tr>
          <td style="width: 10%; vertical-align: bottom;">&#160;</td>
          <td style="width: 82%; vertical-align: bottom;">&#160;</td>
          <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Page No.</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">PART I &#8211; FINANCIAL INFORMATION</div>
          </td>
          <td style="width: 8%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="width: 92%; vertical-align: top;">&#160;</td>
          <td style="width: 8%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 1.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);"><a href="#FINANCIALSTATEMENTSUnaudi">Financial Statements (Unaudited)</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#BalanceSheets">Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">3</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#OperationsandComprehensiv">Condensed Consolidated Statements of Operations and Comprehensive Loss for the three- and nine-month periods ended September 30, 2020 and 2019</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; text-align: center;">4</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#ChangesinStockholdersDefi">Condensed Consolidated Statements of Changes in Stockholders&#8217; Deficit for the three- and nine-month periods ended September 30, 2020 and 2019</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">5</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#CashFlows">Condensed Consolidated Statements of Cash Flows for the nine-month periods ended September 30, 2020 and 2019</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; text-align: center;">6</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#Notes">Notes to Unaudited Condensed Consolidated Financial Statements</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">7</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 2.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Management">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">25</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Item 3.</div>
          </td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#Quantitative">Quantitative and Qualitative Disclosures about Market Risk</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">41</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 4.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Controls">Controls and Procedures</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 82%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">PART II &#8211; OTHER INFORMATION</div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 1.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Legal">Legal Proceedings</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Item 1A.</div>
          </td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#Risk">Risk Factors</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 2.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Unregistered">Unregistered Sales of Equity Securities and Use of Proceeds</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Item 3.</div>
          </td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#Defaults">Defaults Upon Senior Securities</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 4.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Mine">Mine Safety Disclosures</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Item 5.</div>
          </td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="#OtherInformation">Other Information</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Item 6.</div>
          </td>
          <td style="width: 82%; vertical-align: top;">
            <div><a href="#Exhibits">Exhibits</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="width: 92%; vertical-align: top;">
            <div><a href="#SIGNATURES">SIGNATURES</a></div>
          </td>
          <td style="width: 8%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0);">48</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">PART I &#8211; FINANCIAL INFORMATION</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z7b76ba4b2547421db64d878ac056e235">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 1.</td>
          <td style="width: auto; vertical-align: top;"><a name="FINANCIALSTATEMENTSUnaudi"><!--Anchor--></a>
            <div style="color: rgb(0, 0, 0); font-weight: bold;">FINANCIAL STATEMENTS <font style="font-style: italic;">(Unaudited)</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">Condensed Consolidated <a name="BalanceSheets"><!--Anchor--></a>Balance Sheets</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(In thousands, except share and per share amounts)</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(Unaudited)</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z67645d680f6e455991d0654788223929" style="font-family: &#38;amp; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Assets</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Current assets:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">17,064</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">49,326</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Trade and other receivables, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">7,990</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">13,130</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Inventories, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">3,242</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">2,859</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Prepaid expenses and other current assets</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">3,388</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">2,999</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total current assets</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">31,684</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">68,314</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Property and equipment, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;"><br>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;"><br>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">7,728</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">9,726</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Right-of-use assets, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">3,609</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Intangible assets, net and other assets</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">7,402</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">439</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total assets</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">50,423</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">78,479</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Liabilities and stockholders&#8217; deficit</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Current liabilities:</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Accounts payable and accrued expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">15,237</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">17,749</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Lease liabilities, current</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">664</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Loans payable, current</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,750</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Deferred revenue, current</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">722</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">806</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total current liabilities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">18,373</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">18,555</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loans payable, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">60,346</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">60,338</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Lease liabilities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">3,047</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Deferred revenue, net of current portion</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">3,694</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">4,348</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Asset retirement obligations</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,482</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,360</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total liabilities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">86,942</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">84,601</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Contingencies (note 18)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stockholders&#8217; deficit:</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Common stock, $.001 par value. Authorized 250,000,000 shares; 33,619,796 and 33,562,885 shares issued and outstanding at September 30, 2020 and December 31, 2019,
              respectively</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Additional paid-in capital</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">129,336</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">124,318</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Accumulated deficit</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(165,889</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(130,474</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total stockholders&#8217; deficit</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(36,519</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(6,122</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total liabilities and stockholders&#8217; deficit</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">50,423</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">78,479</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">See accompanying notes to the condensed consolidated financial statements.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">Condensed Consolidated Statements of<a name="OperationsandComprehensiv"><!--Anchor--></a> Operations and Comprehensive Loss</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(In thousands, except share and per share data amounts)</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(Unaudited)</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z72fef61fed8448798c081e8f514a990f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenues</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">8,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">12,418</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">38,700</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">36,190</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Costs and expenses:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">2,978</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">4,643</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">10,176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">13,569</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Research and development</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">7,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">5,063</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">15,461</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">17,517</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">11,803</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">13,714</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">40,310</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">47,868</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total costs and expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">22,041</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">23,420</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">65,947</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">78,954</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Loss from operations</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(13,781</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(11,002</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(27,247</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(42,764</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other income/(expenses):</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Interest expense</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(2,778</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(2,652</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(8,296</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(6,515</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Interest income</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">8</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">138</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">128</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">565</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Loss on extinguishment of debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss before income taxes</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(35,415</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(53,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Income taxes</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(35,415</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(53,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Comprehensive loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(35,415</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(53,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss per share - basic and diluted</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(0.49</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(0.74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(1.05</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(2.15</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Weighted-average number of common shares outstanding - basic and diluted</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">33,619,379</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">25,031,478</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">33,592,846</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">24,992,229</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">See accompanying notes to the condensed consolidated financial statements.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">Condensed Consolidated Statements of <a name="ChangesinStockholdersDefi"><!--Anchor--></a>Changes in Stockholders&#8217; Deficit</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(In thousands, except share amounts)</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(Unaudited)</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z788f99431bca491285d52fa17d9165fa" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" rowspan="1" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Common Stock</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" rowspan="1" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Additional</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Paid-in</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" rowspan="1" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Accumulated</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" rowspan="1" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stockholders&#8217;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Shares</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Capital</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Deficit</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Equity/Deficit</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">For the periods ended September 30, 2020:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -16.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Balance at January 1, 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">33,562,885</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">124,318</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(130,474</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(6,122</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">19,811</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,823</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,823</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(16,530</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(16,530</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at March 31, 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">33,582,696</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">126,141</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(147,004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(20,829</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Shares issued under employee stock purchase plan</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">14,961</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">18,944</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(204, 238, 255);"><br>
            </div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,702</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,702</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(2,334</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(2,334</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at June 30, 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">33,616,601</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">127,916</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(149,338</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(21,388</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">3,195</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,420</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,420</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at September 30, 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">33,619,796</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">129,336</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(165,889</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(36,519</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z26b07691886948cdb3bb38b635b27e13" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">For the periods ended September 30, 2019:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at January 1, 2019</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">24,957,309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">71,431</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(61,376</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">10,080</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Adoption of ASU 2014-09, ASU 2018-07 (Note 3C)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">20</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(2,852</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(2,832</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">17,830</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,422</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,422</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(14,726</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(14,726</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at March 31, 2019</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">24,975,139</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">72,873</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(78,954</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(6,056</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Shares issued under employee stock purchase plan</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">31,393</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">132</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">132</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">16,128</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,739</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,739</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(20,472</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(20,472</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at June 30, 2019</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25,022,660</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">74,744</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(99,426</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(24,657</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">20,304</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,810</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,810</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Fair value of warrants issued</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">6,800</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">6,800</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Balance at September 30, 2019</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25,042,964</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">83,354</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(117,838</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(34,459</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">See accompanying notes to the condensed consolidated financial statements.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">Condensed Consolidated Statements of<a name="CashFlows"><!--Anchor--></a> Cash Flows</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(In thousands)</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(Unaudited)</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za0b254b9892c4e639d7c0bcfebfc22cc" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Cash flows used for operating activities:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(35,415</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(53,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Adjustments to reconcile net loss to net cash used for operating activities:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Depreciation and amortization</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">2,337</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">2,288</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">5,052</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">5,199</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Amortization of debt issuance costs and discounts</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,758</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,338</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Loss on extinguishment of debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">All other non-cash expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">76</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Changes in operating assets and liabilities:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Trade and other receivables</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">5,082</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(3,887</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Inventories, net</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(383</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,317</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Prepaid expenses and other assets</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(7,101</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(1,029</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Accounts payable and accrued expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(2,573</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(5,632</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Deferred revenue</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(738</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(591</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 34.2pt; color: rgb(0, 0, 0);">Net cash used for operating activities</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(31,947</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(49,635</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Cash flows used for investing activities:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Capital expenditures</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(281</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(577</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Net cash used for investing activities</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(281</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(577</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Cash flows used for financing activities:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Proceeds from shares issued under employee stock purchase plan</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">62</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">112</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Proceeds from issuance of long-term debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">70,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Debt repayment</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(50,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Payments for loan acquisition costs</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(3,918</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Premium paid to retire debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(2,944</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Payments for taxes on share-based compensation</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(96</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(2,723</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Net cash (used for)/provided by financing activities</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">10,527</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Net decrease in cash and cash equivalents</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(32,262</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">(39,685</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Cash and cash equivalents:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Beginning of period</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">49,326</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">60,599</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">End of period</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">17,064</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">20,914</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Supplemental disclosures of cash flow information:</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Cash payments for interest</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">6,562</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">5,153</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net decrease in capital expenditures included in accounts payable and accrued expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(152</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(290</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Net increase in offering costs included in accounts payable and accrued expenses</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">237</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">162</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Warrants issued in connection with long-term debt</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">6,800</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">See accompanying notes to the condensed consolidated financial statements.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0); font-weight: bold;">&#160;AQUESTIVE THERAPEUTICS, INC.</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);"><a name="Notes"><!--Anchor--></a>Notes to Condensed Consolidated Financial Statements</div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">(Unaudited, in thousands, except share and per share information)</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z2e088a308f2a42c78e7dbb53bc09df13">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Corporate Organization and Company Overview</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(A) Company Overview</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Aquestive Therapeutics, Inc. (&#8220;Aquestive&#8221; or the &#8220;Company&#8221;) is a pharmaceutical company focused on identifying, developing and commercializing differentiated products that address patients&#8217; unmet
      medical needs and solve therapeutic problems.&#160; The Company has commercialized one internally-developed proprietary product to date, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or
      CNS, and other unmet needs, and is developing orally administered complex molecules as alternatives to more invasive therapies. Aquestive is pursuing its business objectives through both in-licensing and out-licensing arrangements, as well as the
      commercialization of its own products. Production facilities are in Portage, Indiana, and corporate headquarters, sales and commercialization operations and primary research laboratory facilities are based in Warren, New Jersey.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Aquestive is subject to risks common to companies in similar industries and stages of development, including, but not limited to, competition from larger companies, reliance on revenue from a limited
      number of products and customers, adequacy of existing and availability of additional operating and growth capital as and when required, uncertainty of regulatory approval for marketing its product candidates, reliance on a single manufacturing site,
      new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, dependence on patent-protected proprietary technology, ongoing government regulatory compliance requirements, dependence
      on the clinical and commercial success of its drug candidates, and uncertainty of broad adoption of its approved products, if any, by physicians and consumers.&#160;&#160; Aquestive is also subject to risks and uncertainties associated with the COVID-19
      pandemic. See Note 4. Risks and Uncertainties for further discussion related to COVID-19.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-weight: bold;">(B)</font>&#160;<font style="font-weight: bold;">Equity Transaction</font></div>
    <div><br>
    </div>
    <div style="font-style: italic;">Equity Offering of Common Stock</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On December 17, 2019, Aquestive received net proceeds of $37,835 after deducting underwriting discounts of $2,415 for the sale of 8,050,000 shares of common stock, par value $0.001 per share of the
      Company (&#8220;common stock&#8221;) in a public offering.&#160; Professional fees and other costs of this offering totaled $540, in addition to the underwriting discounts.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z540cc10de16b4c9cb62b2d9bfe821e8e">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Presentation</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and
      with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have
      been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2019 included in the
      Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 11, 2020 (the &#8220;2019 Annual Report on Form 10-K&#8221;). As included herein, the condensed consolidated balance sheet as of December 31, 2019 is derived from the audited consolidated financial
      statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The accompanying financial
      statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited
      condensed financial statements.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards
      Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z737959741b4047e3a3208415218a09e6">

        <tr>
          <td style="width: 42.8pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Summary of Significant Accounting Policies</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(A) Principles of Consolidation and Significant Accounting Policies</div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The interim condensed consolidated financial statements presented herein include the accounts of Aquestive Therapeutics, Inc. and its wholly owned subsidiary, MonoSol Rx, Inc.
        Other than corporate formation activities, MonoSol Rx, Inc. has conducted no commercial, drug development or operational activities and has no customers or vendors. The results of operations and cash flows reported in these condensed consolidated
        financial statements should not be regarded as necessarily indicative of results that may be expected in any other interim period or for the entire fiscal year.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">
        <div>
          <div style="text-indent: 21.6pt; color: #000000;">The Company&#8217;s significant accounting policies are described in the audited consolidated financial statements included in the 2019&#160;Annual Report on Form 10-K.&#160; Subsequent to the date of those
            financial statements, there have been no significant changes to these policies other than those listed below.</div>
        </div>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"> <br>
      </div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(B) Use of Estimates</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities,
      including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#160;
      Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of share-based compensation and contingencies.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(C) Recent Accounting Pronouncements</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">As an emerging growth company, the Company has elected to take advantage of the extended transition period afforded by the Jumpstart Our Business Startups Act for
        the implementation of new or revised accounting standards and, as a result, the Company will comply with new or revised accounting standards no later than the relevant dates on which adoption of such standards is required for emerging growth
        companies. The Company believes that the impact of recently issued accounting standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption</font><font style="color: rgb(33, 37, 41);">.</font></div>
    <div><br>
    </div>
    <div style="font-style: italic;">Recently Adopted Accounting Pronouncements:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; font-weight: normal; color: rgb(0, 0, 0);">In February 2016, the Financial Accounting Standards Board issued ASU, 2016-02, <font style="font-style: italic;">Leases (Topic 842)</font>, and issued
      amendments in July 2018 provided by ASU 2018-10. This ASU, as amended, requires lessees to recognize lease assets, termed &#8220;right-of-use assets&#8221; and related lease liabilities on the balance sheet that had previously been classified as operating leases
      under prior authoritative guidance. For income statement purposes, leases are now required to be classified as either operating or financing leases under a dual model similar to that specified by ASC 840. Operating leases continue to result in
      straight-line expense while financing leases result in a front-loaded expense pattern in a manner similar to recognition of capital lease expenses under ASC 840.</div>
    <font style="color: rgb(0, 0, 0);"> <font style="font-weight: normal;"> </font> </font>
    <div><font style="font-weight: normal; color: rgb(0, 0, 0);"><br>
      </font> </div>
    <font style="color: rgb(0, 0, 0);"> <font style="font-weight: normal;"> </font> </font>
    <div style="text-align: justify; text-indent: 18pt; font-weight: normal; color: rgb(0, 0, 0);">The Company adopted and applied ASU 2016-02 on January 1, 2020 using the modified retrospective transition provisions of ASC 842 to leases in effect as of
      that date of adoption and recorded right-of-use assets totaling $4,048 and lease liabilities as adjusted for accrued lease payments, in the amount of $4,224 based on an estimated incremental borrowing rate of 16.9%, representing the present value of
      remaining minimum lease payments. The assets and liabilities thus recorded were primarily those related to the Company&#8217;s leased plant, laboratory and corporate administrative facilities. The Company elected to apply the ASU-specified practical
      expedients and accordingly did not re-assess (i) whether its contracts contained a lease under the new definition of a lease, (ii) the classification of those leases, and (iii) initial direct costs of existing leases. In addition, the Company elected
      not to apply the hindsight expedient in the assessment of lease renewals and resultant term of leases. The Company also elected not to recognize a right-of-use asset and lease liability for those leases with a remaining lease term of 12 months or
      less. The adoption of ASU 2016-02 did not require a cumulative-effect adjustment to the opening balance of the accumulated deficit at the time of adoption.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In May 2014, the FASB issued ASU 2014-09, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, and subsequently issued a number of amendments to this update.&#160; The new
      standard, as amended in Accounting Standards Codification, or ASC 606, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes previous revenue recognition guidance. The
      standard&#8217;s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods
      or services.&#160; In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this standard effective January 1, 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In August 2016, the FASB issued ASU 2016-15,<font style="font-style: italic;"> Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, </font>providing
      guidance on the classification of certain cash receipts and payments in the statement of cash flows intended to reduce diversity in practice, including cash flows related to debt prepayment or extinguishment costs and contingent consideration that
      may be paid following a business combination. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In August 2018, the FASB issued ASU 2018-13, <font style="font-style: italic;">Fair Value Measurement (Topic 820): Disclosure Framework. </font>The purpose of the update is to improve the
      effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In
      addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and
      (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position
      or results of operations.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">In November 2018, the FASB issued ASU 2018-18, C</font><font style="font-style: italic; color: rgb(0, 0, 0);">ollaborative Arrangements (Topic 808): Clarifying the
        Interaction Between Topic 808 and Topic 606,</font><font style="color: rgb(0, 0, 0);"> which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative
        arrangement participant is a customer for a promised good or service that is distinct within the collaborative arrangement. The guidance also precludes entities from presenting amounts related to transactions with a collaborative arrangement
        participant that is not a customer as revenue, unless those transactions are directly related to third-party sales.</font> The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial
      position or results of operations.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Recent Accounting Pronouncements Not Adopted as of September 30, 2020:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In June 2016, the FASB issued ASU 2016-13,<font style="font-style: italic;"> Financial Instruments &#8211; Credit Losses (Topic 326)</font>, amending existing guidance on the
      accounting for credit losses on financial instruments within its scope. The guidance provides for use of a forward-looking expected loss model for estimating credit losses, replacing the incurred loss model that is based on past events and current
      conditions. The new guidance also changes the impairment model for available-for-sale debt securities, requiring the use of an allowance to record estimated credit losses (and subsequent recoveries). The new guidance is effective for the Company
      beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">August 2018, the FASB issued ASU 2018-15, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Intangibles&#8212;Goodwill and Other Internal-Use Software
        (Subtopic 350-40: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</font><font style="color: rgb(0, 0, 0);">, which aligns the requirements for capitalizing implementation costs
        incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance distinguishing between capitalizable service
        contract implementation costs and contract costs required to be expensed. In addition, the update requires that the term of the hosting arrangement is to include the non-cancelable period of the arrangement plus periods covered by (i) an option to
        extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to
        terminate) the arrangement in which exercise of the option is in the control of the vendor. This standard will become effective for the Company beginning January 1, 2021. The amendments may be applied either retrospectively or prospectively to all
        implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 and does not expect to have a material impact on its consolidated financial statements.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">December 2019, the FASB issued ASU 2019-12, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Income Taxes (Topic 740), Simplifying the Accounting
        for Income Taxes, </font><font style="color: rgb(0, 0, 0);">which amends accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental
        approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the
        anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate
        computation from the date of enactment. The standard will be effective for the Company beginning January 1, 2022, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on
        its consolidated financial statements.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In August 2020, the FASB issued ASU 2020-06, <font style="font-style: italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and
        Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font>. This Accounting Standards Update was issued to address the complexity in accounting for certain
      financial instruments with characteristics of liabilities and equity.&#160; Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative
      scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the
      number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be
      classified in equity and requires expanded disclosures intended to increase transparency. These amendments will be effective for the Company beginning January 1, 2024, with early adoption of the amendments permitted. The Company is currently
      evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the
      condensed consolidated financial statements of the Company.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="za73a372708134f6ab1dbef5f4b2eb4d8">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Risks and Uncertainties</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s cash requirements for 2020 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory
      filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September
      30, 2020, working capital totaled $13,311, which included $17,064 of cash and cash equivalents.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">As of September 30, 2020, Aquestive has experienced a history of net losses and the Company&#8217;s accumulated deficits totaled $165,889 which have been partially funded by profits from manufacture and
      supply operations, licensing revenues and certain other services, with the balance of the related funding requirements met by the Company&#8217;s equity and debt offerings including its 12.5% Senior Secured Notes due 2025 (the &#8220;12.5% Notes&#8221;). In 2019, the
      Company raised funding totaling $52,226, consisting of net proceeds of $13,110 from the refinancing of its debt in July 2019, $37,295 from the public offering of 8,050,000 common shares in December 2019, and $1,821 from the exercise of warrants
      issued in connection with the debt refinancing.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The characteristics described above provide indications that the Company&#8217;s ability to execute its near-term business objectives and achieve profitability over the longer term cannot be assured.
      Further, management views the impact of COVID-19 on the economy, its industry, its customers and suppliers and its own operations as constantly evolving, the future effects of which continue to be highly uncertain and unpredictable.&#160; Due to current
      or future interruptions and possible disruptions in health services, operations of the United States Food and Drug Administration (&#8220;FDA&#8221;), freight and other transportation services, supply, manufacturing, workforce health, availability of acceptable
      capital, financial and asset monetization markets, and availability of essential human and business requirements, and unforeseeable financial difficulties of the Company&#8217;s customers or vendors, the severity, rapidity of the spread, and the duration
      of the COVID-19 pandemic may be expected to negatively affect a great number of businesses across various industries, including Aquestive. The Company may experience financial and operational adversity in such areas as pre-clinical, clinical trials,
      regulatory review and approval of various product candidates, customer demand for products and services, customers&#8217; ability to pay for goods and services, supply of pharmaceutical ingredients and other raw materials from approved vendors, ongoing
      availability of an appropriate labor force and skilled professionals, and additional capital or other funding from capital, financial or monetization markets.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Subject to and absent any material adverse effect of these and other possible COVID-19 effects, the Company <font style="color: rgb(0, 0, 0);">expect</font><font style="color: rgb(0, 0, 0);">s</font><font style="color: rgb(0, 0, 0);"> that its anticipated revenues from licensed and proprietary products, cash on hand</font><font style="color: rgb(0, 0, 0);">, expense management initiatives,</font><font style="color: rgb(0, 0, 0);">&#160;</font><font style="color: rgb(0, 0, 0);">monetization of certain revenue streams for its out-licensed apomorphine product (KYNMOBI&#8482;), </font><font style="color: rgb(0, 0, 0);">and </font><font style="color: rgb(0, 0, 0);">access to equity markets, including
        under its shelf registration statement </font><font style="color: rgb(0, 0, 0);"> would be adequate to meet expected operating, investing, and financing needs for the next twelve months.&#160; To the extent additional funds are necessary to meet
        operating</font><font style="color: rgb(0, 0, 0);"> needs as the Company continues to execute its business strategy, </font><font style="color: rgb(0, 0, 0);"> additional funding requirements would be obtained through </font><font style="color: rgb(0, 0, 0);">modification of the existing debt facility to extend the potential availability of the first and second re-openers, and </font><font style="color: rgb(0, 0, 0);">access to appropriate financial markets </font><font style="color: rgb(0, 0, 0);">for </font><font style="color: rgb(0, 0, 0);">debt or equity financings, or a combination of these potential sources of funds, although management</font><font style="color: rgb(0, 0, 0);"> can provide no assurance that any of these
        sources of funding, either individually or in combination, will be available on reasonable terms, if at all.</font><font style="color: rgb(0, 0, 0);">&#160; In addition, the Company may be required to utilize available financial resources sooner than
        expected.&#160; Management has based </font><font style="color: rgb(0, 0, 0);">its expectation on assumptions that could change or prove to be inaccurate, either due to the impact of COVID-19 or to unrelated factors including factors arising in the
        capital markets, asset monetization markets, regulatory approval process, regulatory oversight and other factors.</font></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z0c227b68a35e4d03875727c0b8dd182a">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Revenues and Trade Receivables, Net</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Revenue from Contracts with Customers</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s revenues are derived from four primary sources: manufactured products made to order for licensees, including Suboxone&#174; and Zuplenz&#174;, manufacture and sale of its self-developed,
      self-commercialized proprietary product, Sympazan&#174; (clobazam), intellectual property licensing arrangements, and product development services provided under contracts with customers.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Revenue Recognition and Performance Obligations</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Aquestive recognizes revenue pursuant to ASC 606, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, to reflect amounts expected to be collectible in exchange for the
      transfer of contractually promised goods or services to its customers, as discussed in additional detail in the Company&#8217;s 2019 Annual Report on Form 10-K.&#160; Accordingly, the value of contractually promised goods or services is assessed at contract
      inception to identify those that constitute distinct performance obligations. Contract revenues are allocated to those distinct performance obligations based on estimated standalone values or expected values, and these allocated revenues are
      recognized at the point in time, or over the period of time, that those distinct obligations are satisfied. The Company&#8217;s performance obligations consist primarily of transferring control of goods, services or intellectual property that are
      identified in the contracts, purchase orders or invoices. Variable or contingent revenues which may become due from customers, such as milestone payments due upon acceptance of a regulatory filing, regulatory approval, or sales-based milestone
      payments, are not recognized until contingencies are met, the customer&#8217;s obligation to meet its contractual payment commitments is fixed and collection of invoiced amounts is reasonably assured, thereby limiting any significant probability of a
      revenue reversal.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Revenues from the sale of products and services and from licensing arrangements and related payments are evidenced by a contract with the customer. For manufacturing and supply and proprietary
      product sales, invoices are generally issued upon the transfer of control. Co-development and research revenue is typically invoiced based on the contractual payment schedule, or upon completion of the service. Licensing revenue is generally invoiced
      at the inception of an agreement, with additional charges rendered as related contingencies, such as regulatory approvals or sales targets, are met. Invoices are typically payable 30 to 60 days after the invoice date, however some payment terms may
      reach 75 days depending on the customer. The Company performs a review of each specific customer&#8217;s creditworthiness and ability to pay prior to acceptance as a customer, as well as periodic prospective reviews.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Manufacture and supply revenue</font> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined
      specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Proprietary product sales, net</font> &#8211; this net revenue is recognized upon delivery and transfer of control of proprietary product to the Company&#8217;s customers, at
      which point the Company has no ongoing performance obligations and the customer has assumed all significant risks and rewards of ownership. These revenues are subject to payment discounts, wholesaler service fees, volume and prompt payment discounts,
      rebates and other chargebacks, which are estimated and recorded at the time the revenue is recognized. Once all related variable considerations are resolved and uncertainties as to collectible amounts are eliminated, estimates are adjusted to actual
      allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">License and royalty revenues</font> &#8211; <font style="color: rgb(0, 0, 0);">the Company may realize revenue from functional or from symbolic licenses. For functional
        licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject
        to contingencies or constraints, if any. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be met by the Company, such as manufactured products or development services, revenues may be
        deferred when advance payment is received and recognized over the term of the license agreement. </font>Royalty revenues are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based
      products are sold to the Company&#8217;s strategic partners.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Co-development and research fees </font>&#8211; this revenue is recognized as contractual services or performance obligations are performed. Invoicing for contractual
      services may occur in advance or arrears, may, or may not, coincide with completion of underlying performance obligations, and therefore may give rise to contract assets or contract liabilities when the value of services completed varies from amounts
      that may be invoiced to the customer.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Contract Assets</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In limited situations, certain customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer
      may be invoiced under such agreements.&#160; In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets
      are reflected as a component of other receivables within Trade and other receivables and as a component of intangible and other assets within the Condensed Consolidated Balance Sheet. As of September 30, 2020, and December 31, 2019, such current and
      non-current contract assets were $8,922 and $4,363, respectively, consisting primarily of minimum annual royalties due under a certain licensing agreement and completed but unshipped products manufactured to specific order by certain licensees.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Contract Liabilities</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In other limited situations, certain customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment
      may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as
      deferred revenue within the Condensed Consolidated Balance Sheet. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September 30, 2020, and December 31, 2019,
      such contract liabilities were $4,416 and $5,154, respectively.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">The Company&#8217;s revenues were comprised of the following:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za4215d79b7704585a08ef93434d73e8d" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply revenue</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">5,903</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">9,155</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">20,078</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">24,739</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">License and royalty revenue</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">328</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,356</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">13,682</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">6,402</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Co-development and research fees</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">341</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,073</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">870</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">2,862</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Proprietary product sales, net</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">1,688</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">4,070</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">2,187</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">8,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">12,418</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">38,700</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">36,190</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Disaggregation of Revenue</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table provides disaggregated net revenue by geographic area:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf3dccf0efefc4610bb506e7ad2c07cd2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">United States</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">6,567</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">11,022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">35,496</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">33,683</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Ex-United States</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">1,693</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">1,396</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">3,204</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">2,507</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">8,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">12,418</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">38,700</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">36,190</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">Non-United States revenues are derived primarily from products manufactured for the Australian and Malaysian markets.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Trade and other receivables, net consist of the following:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z6c7e97cfcb3a4f8f9128c4193178d88f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade receivables</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">6,659</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">9,094</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contract and other receivables</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,872</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">4,363</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: allowance for bad debts</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(124</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: sales-related allowances</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(277</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(203</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade and other receivables, net</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">7,990</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">13,130</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The current portion of contract and other receivables totaled $1,872 and $4,363 as of September 30, 2020 and December 31, 2019, respectively. The current period balance is comprised primarily of
      $1,000 of minimum royalty revenue due from a licensee and the remaining balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed
      services. The December 31, 2019 balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services. Sales-related allowances for both
      periods presented are estimated in relation to revenues recognized for sales of Sympazan.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table presents the changes in the allowance for bad debt:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z8b475f1c39284811809bf1a7c5b7570e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at beginning of year</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">124</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">58</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Additions charged to bad debt expense</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">140</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">66</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Write-downs charged against the allowance</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at end of the period</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">124</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Sales Related Allowances and Accruals</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on
      estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated
      amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The
      calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a
      quarterly basis.</div>
    <div><br>
    </div>
    <div style="text-indent: 18pt;">The<font style="color: rgb(0, 0, 0);"> following table provides a summary of activity with respect to sales related allowances and accruals for the nine months ended September 30, 2020:</font></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" id="zfa4a16e723ad443c8260087620f40bb8" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 68%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total Sales Related</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allowances and Accruals</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 68%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 68%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at December 31, 2019</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,377</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 68%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Provision</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">3,996</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Payments / credits</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(3,441</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at September 30, 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">1,932</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Total reductions of gross product sales from sales-related allowances and accruals were $3,996 for the nine months ended September 30, 2020.&#160; Accruals for returns allowances and prompt pay discounts
      are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other
      receivables, net and Accounts payable and accrued expenses were $277 and $1,655, respectively, as of September 30, 2020 and $203 and $1,174, respectively, as of December 31, 2019.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Concentration of Major Customers</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Customers are considered major customers when sales exceed 10% of total net sales for the period or outstanding receivable balances exceed 10% of total receivables. For the year ended December 31,
      2019, Indivior, Inc. (&#8220;Indivior&#8221;) provided 86% of the total revenues for the period, and as of that date, the Company&#8217;s outstanding receivable balance from Indivior represented approximately 80% of gross receivables. For the nine months ended
      September 30, 2020, there were two customers exceeding the 10% threshold for revenue while there were three customers exceeding the 10% threshold for outstanding accounts receivable. Revenues provided by Indivior, and Sunovion Pharmaceuticals, Inc.
      (&#8220;Sunovion&#8221;) represented approximately 54% and 31%, respectively of total revenue for the nine months ended September 30, 2020, and outstanding accounts receivable due from Indivior, Sunovion and AmerisourceBergen represented approximately 50%, 12%
      and 11%, respectively of gross receivables.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z94ec4d4ae5e24e089c9e8b7ee06ae912">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 6.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Material Agreements</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Commercial Exploitation Agreement with Indivior</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In August 2008, the Company entered into a Commercial Exploitation Agreement with Reckitt Benckiser Pharmaceuticals, Inc.&#160; (with subsequent amendments collectively, the &#8220;Indivior License Agreement&#8221;).
      Reckitt Benckiser Pharmaceuticals, Inc. was later succeeded to in interest by Indivior, Inc.&#160; Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone, a sublingual film
      formulation, both inside and outside the United States on an exclusive basis.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications
      and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain Active Pharmaceutical Ingredients (&#8220;API&#8221;) for the manufacture of Suboxone directly from Indivior. The
      Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the
      year.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Indivior License Agreement provides for payment by Indivior of a purchase price per unit that is subject to adjustment based on the Company&#8217;s ability to satisfy minimum product thresholds.
      Additionally, in the event Indivior purchases certain large quantities of Suboxone during a specified period, Indivior will be entitled to scaled rebates on its purchases.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior
      License Agreement) in each of the United States and in the rest of the world subject to annual maximum amounts and limited to the life of the related United States or international patents. In 2012, Indivior exercised its right to buy out its future
      royalty obligations in the United States under the Indivior License Agreement. Indivior remains obligated to pay royalties for all sales outside the United States.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual
      property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the
      Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the
      commencement date. Thereafter, the Indivior License Agreement automatically renews for successive one-year periods, unless either party provides the other with written notice of its intent not to renew at least one year prior to the expiration of the
      initial or renewal term.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Supplemental Agreement with Indivior</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior
      all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities
      to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company is entitled to receive certain payments from Indivior
      commencing on the date of the agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable.&#160; Through February 20, 2019, the at-risk launch date of the competing generic products of Dr.
      Reddy&#8217;s Labs and Alvogen, the Company received an aggregate of $40,750 from Indivior under the Indivior Supplemental Agreement, of which $4,250 was collected during the three months ended March 31, 2019.&#160; Further payments under the Indivior
      Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. If such litigation is successful, in addition to the amounts already received as described in the foregoing, the Company may receive up
      to an additional $34,250, consisting of (i) up to $33,000 in the aggregate from any combination of (a) performance or event-based milestone payments and (b) single digit percentage royalties on net revenue earned by Indivior on sales of Suboxone and
      (ii) an additional $1,250 that was earned through the issuance of additional process patent rights to the Company.&#160; The aggregate payments under this Indivior Supplemental Agreement are capped at $75,000.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement are in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the
      Indivior License Agreement. Indivior&#8217;s payment obligations under the Indivior Supplemental Agreement are subject to certain factors affecting the market for Suboxone and may terminate prior to January 1, 2023 in the event certain contingencies
      relating to such market <font style="color: rgb(0, 0, 0);">occur.</font></div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">License Agreement with Sunovion Pharmaceuticals Inc.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion Pharmaceuticals Inc.), referred to as the Sunovion
      License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing
      apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product, KYNMOBI&#8482;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s
      obligation to remit a payment of $4,000 (the &#8220;FDA Approval Milestone Payment&#8221;) due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of the FDA approval. This amount was received
      as of September 30, 2020 and is included in License and royalty revenues for the nine-months ended September 30, 2020.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In consideration for the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of
      $5,000, the Company also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;) The Company is also entitled to receive certain contingent
      one-time milestone payments related to product availability and regulatory approval in Europe, certain one-time milestone payments based on the achievement of specific annual net sales thresholds of KYNMOBI&#8482;, and ongoing mid-single digit percentage
      royalty payments related to the net sales of KYNMOBI&#8482; (subject to reduction to low-single digit percentage royalty payments in certain circumstances), subject to certain minimum payments. The maximum aggregate milestone payments that may be paid to
      the Company pursuant to the Sunovion License Agreement are equal to $45,000. There can be no guarantee that any future milestones will be met or that additional milestone payments will be payable. There are&#160; minimum annual guaranteed royalty payments
      under the contract.&#160;&#160; As of September 30, 2020, the Company recorded minimum royalty receivables of $8,000 in the aggregate, of which $1,000 is included in Trade and other receivables and $7,000 is included in Intangibles, net and other assets, with
      the total reflected in License and royalty revenues for the nine- months ended September 30, 2020.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Effective March 16, 2020, the Company entered into a first amendment (the &#8220;First Amendment&#8221;) to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the
      Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the European Union (EU) which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition
      triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31,
      2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provisions to reflect the Company&#8217;s waiver of the right
      to terminate the Sunovion License Agreement in the event that KYNMOBI&#8482; was not commercialized by January 1, 2020.&#160; This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the
      Amendment to the Sunovion License Agreement.&#160; The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents. Upon termination of the Sunovion License Agreement, all rights to
      intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company and Sunovion must continue to pay royalties to the Company on each sale of Sunovion&#8217;s remaining inventory of
      apomorphine-based products.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties&#8217; agreement with respect to certain provisions in the License Agreement, specifically the date after
      which Sunovion has the right to terminate the License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the License Agreement.&#160; See Note 19, (A), Subsequent
      Events. On November 3, 2020, the Company entered into a royalty monetization agreement (the &#8220;Monetization Agreement&#8221;) with an affiliate of Marathon Asset Management (&#8220;Marathon&#8221;) pursuant to which the Company conveyed to Marathon the right to all
      royalties and other payments due to the Company under the Sunovion License Agreement.&#160; See Note 19, (B), Subsequent Events.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Agreement to Terminate CLA with KemPharm</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In March 2012, the Company entered into an agreement with KemPharm, Inc. (&#8220;KemPharm&#8221;) to terminate a Collaboration and License Agreement entered into by the Company and KemPharm in April 2011. Under
      this termination arrangement, the Company has the right to participate in any and all value that KemPharm may derive from the commercialization or any other monetization of KemPharm&#8217;s KP-415 and KP-484 compounds or their derivatives. Among these
      monetization transactions are those related to any business combinations involving KemPharm and collaborations, royalty arrangements, or other transactions from which KemPharm may realize value from these compounds. During September 2019, the Company
      received $1,000 from its 10% share of milestone payments paid to KemPharm under its licensing of KP-415 and KP-484 to a third party.&#160; The Company has also received a payment of $500 under this arrangement during June 2020, which is included in
      License and royalty revenues for the nine-month period ended September 30, 2020, in connection with the FDA&#8217;s acceptance of a New Drug Application (&#8220;NDA&#8221;) filing for KP-415. A Prescription Drug User Fee Act (PDUFA) target date for completion of FDA
      review has been scheduled for early March 2021. The Company&#8217;s share of remaining milestone payments associated with KP-415 approval and certain targeted labeling goals within timeframes ending in July 2021 may reach $4,800. However, there can be no
      guarantee that approvals, goals or any such payments will be achieved or received in the future.</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7b741ebfa53d4cc9b4b53cb8c7a0b2f9" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 45pt;">
              <div style="text-align: left; font-weight: bold;">Note 7.</div>
            </td>
            <td style="vertical-align: top;">
              <div style="text-align: left; font-weight: bold;">Financial Instruments &#8211; Fair Value Measurements</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an
      exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable
      inputs and minimize the use of unobservable inputs.&#160; Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered
      observable and the last is considered unobservable:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zb1705a7c3b324567b12bdb560eecf6f3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z4eb5e70e8bbd45f6956668386b342821">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z8380b5a02eeb4856a041e00ae6f5858c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160; methodologies and similar techniques.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 18pt;">The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on
      the short-term maturity of these assets and liabilities.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company granted warrants to certain holders of the 12.5% Notes in connection with its debt refinancing in July 2019.&#160; These warrants were valued based primarily on Level 3 inputs and an
      independent third-party appraisal prepared as of the grant date consistent with generally-accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of
      Certified Public Accountants&#8217; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued Compensation.&#160; See Note 14 for further information on these warrants.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z7c5134e1911e436387a0532628cd6975">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 8.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Inventories, Net</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">The components of Inventory, net is as follows:</div>
    <div style="text-indent: 21.6pt; color: rgb(0, 0, 0);"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z83eb14efa1d140b8b78fd03c10b0c537" style="font-family: &#38;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Raw material</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,153</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,244</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Packaging material</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,231</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,096</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Finished goods</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">858</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">519</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total inventory, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">3,242</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">2,859</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The Company manufactures Suboxone exclusively to order for its major customer subject to strict quality standards and recognizes revenue upon completion of all customary quality
      control evaluations, which occurs prior to actual shipment.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zbfd760672c10419196a02631887245dc">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 9.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment, Net</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z3cd8af02e4cb46708312e3a733765f4d" style="font-family: &#38;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 67%;"><br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Useful</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lives</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Machinery</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">21,406</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">21,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Furniture and fixtures</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,209</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,150</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Leasehold improvements</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">(a)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">21,333</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">21,333</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Computer, network equipment and software</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%;">
            <div style="text-align: center; color: rgb(0, 0, 0);">3-7 yrs</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">2,886</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">2,787</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Construction in progress</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,065</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">47,899</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">47,770</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated depreciation and amortization</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(40,171</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">(38,044</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total property and equipment, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">7,728</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">9,726</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z9bfbb52903404817a30851eb928f93dd">

        <tr>
          <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Total depreciation and amortization related to property and equipment was $714 and $695 for the three-month periods ended September 30, 2020 and 2019, respectively. For the
      respective nine-month periods, these expenses totaled $2,127 and $2,143.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z4e0efd41dd82408580f9f3b504b4ab2c">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 10.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Right-of-Use Assets and Lease Obligations</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The Company leases all realty used as its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities.
      None of these three leases include the characteristics specified in ASC 842, <font style="font-style: italic; font-weight: normal;">Leases, </font><font style="font-weight: normal;">that require classification as financing leases and, accordingly,
        these leases are accounted for as operating leases</font>. These leases provide remaining terms between 2.5 years and 6.0 years, including renewal options expected to be exercised to extend the lease periods. Measurement of the operating lease
      liability reflects an estimated discount rate of 16.9% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s latest collateralized debt refinancing. Right-of-use assets
      recorded upon adoption of ASC 842 totaled $4,048. For the three- and nine-month periods ended September 30, 2020, total operating lease expenses under these leases totaled $409 and $1,228, respectively, including variable lease expenses such as
      common area maintenance and operating costs totaling $89 and $255, respectively. Total payments to these lessors during the nine-month period ended September 30, 2020 were $1,255.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-indent: 18pt;">Maturities of the Company&#8217;s operating lease liabilities are as follows:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z5871740adf3a430b944cda73737fc5f4" style="font-family: &#38;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">266</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">1,287</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">1,295</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">944</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">565</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">565</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2026</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">424</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total lease payments</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0);">5,346</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: imputed interest</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">(1,635</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total operating lease liabilities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">3,711</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" id="zada056a4c1324392bc8ab41fce9936ce" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 11.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Intangible Assets, Net and Other Assets</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 21.6pt; color: rgb(0, 0, 0); margin-left: 18pt;"> <br>
      The following table provides the components of identifiable intangible assets, all of which are finite lived:</div>
    <div style="color: rgb(0, 0, 0);"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z5775c5d5e56e49d58bee3fdd9323c010">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased technology-based intangible</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,358</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,358</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased patent</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">509</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">509</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,867</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,867</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated amortization</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(2,752</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(2,714</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Intangible assets, net</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">115</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">153</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Royalty receivable</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">7,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other assets, primarily security deposits</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">287</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">286</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total intangible assets, net and other assets</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">7,402</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">439</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Amortization expense was $13 for each of the three-month periods ended September 30, 2020 and 2019. For the corresponding nine-month periods, these expenses totaled $38 and $39,
      respectively. During the remaining life of the purchased patent, estimated annual amortization expense is $50 for each of the years from 2020 to 2022.&#160; Royalty receivable consists of seven annual $1,000 minimum royalty payments due from Sunovion, the
      last of which is due in March 2028.&#160; See Note 6 above.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z716fb763d77d46e8b51449439a72e382" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 12.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Accounts Payable and Accrued Expenses</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); text-indent: 18pt;">Accounts payable and accrued expenses consisted of the following:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zc406a0f0ec204707b684ee0624e1a713">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accounts payable</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">$</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">9,169</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">12,274</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued compensation</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">4,129</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">3,758</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued distribution expenses</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,655</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,174</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" colspan="1">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">284</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">543</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total accounts payable and accrued expenses</div>
          </td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">15,237</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">17,749</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zac17acdfe898435b92080b84f2053a0c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 13.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">12.5 % Senior Secured Notes and Loans Payable</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">12.5% Senior Secured Notes</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On July 15, 2019, the Company completed a private placement of up to $100 million aggregate principal of the 12.5% Notes and issued warrants for two million shares of common stock (the &#8220;Warrants&#8221;),
      $.001 par value per share, through the structuring agent, Morgan Stanley &amp; Co., LLC, and entered into a purchase agreement and related agreements including a Collateral Agreement with U.S. Bank National Association, as trustee and collateral
      agent, and a Lien Subordination and Intercreditor Agreement for the benefit of Madryn Health Partners, other institutional noteholders (the &#8220;Noteholders&#8221;) and U.S. Bank National Association in dual roles providing terms and governing an asset-based
      loan facility.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Upon closing of the Indenture for the 12.5% Notes (&#8220;Indenture&#8221;), the Company issued $70,000 of principal of the 12.5% Notes (the &#8220;Initial Notes&#8221;) along with the Warrants and rights of first offer
      (the &#8220;First Offer Rights&#8221;) to the lenders participating in this transaction for the 12.5% Notes and Warrants (the &#8220;Lenders&#8221;).&#160; Issuance of the Initial Notes and Warrants provided net proceeds of $66,082.&#160; In addition to the Initial Notes, the
      Indenture may provide access to further loans of up to $30,000 that may become available in two tranches of additional notes (the &#8220;Additional Notes&#8221;) tied to the NDA filing for and FDA U.S. marketing approval of Libervant&#8482;, an important part of the
      Company&#8217;s drug candidate pipeline. Subject to approval of the holder of a majority of the outstanding principal amount of the 12.5% Notes in its discretion, and provided that no events of default exist, the Company may offer to the Lenders
      participation in a $10,000 additional offering of the 12.5% Notes (the &#8220;First Additional Offering&#8221;) under terms similar to the Initial Notes, on or before March 31, 2021, upon the filing of the Libervant&#8482; NDA with the FDA.&#160; A second funding
      opportunity would allow the Company to obtain, on or before March 31, 2021, an additional $20,000 if the first option has been elected and funded, or, if not elected or funded, an additional $30,000 may be offered for issuance following FDA approval
      of Libervant&#8482; for marketing in the U.S.&#160; On November 3, 2020, this Indenture was amended and will be partially repaid from proceeds resulting from the monetization transaction.&#160; See Note 19 (C), Subsequent Events.&#160; There can be no assurance that any
      additional financing will be consummated.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Proceeds from the issuance of the Initial Notes and Warrants were used to fully repay the Company&#8217;s $56,340 outstanding indebtedness to Perceptive Credit Opportunities Fund, LP (the &#8220;Perceptive
      Loan&#8221;), related early repayment fees and legal and other fees incurred to obtain the loan.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The 12.5% Notes provide a stated fixed rate of 12.5%, payable quarterly in arrears, with the initial quarterly principal repayment of the Initial Notes due on September 30, 2021, and the final
      quarterly payment due at maturity on June 30, 2025. The Company has recorded $1,750 as Loans Payable, Current to reflect this obligation in its Condensed Consolidated Balance Sheet at September 30, 2020.&#160; Principal payments are scheduled to increase
      annually from 10% of the face amount of debt then outstanding during the first four quarters to 40% of the initial loan principal during the final four quarters.</div>
    <div><br>
    </div>
    <div style="text-indent: 18pt;">A debt maturity table is presented below:</div>
    <div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z822fa3322c0a4fbab5d56a005eafadea">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">3,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">10,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">17,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">24,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">14,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">70,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company may elect, at its option, to prepay the 12.5% Notes at any time at premiums that range from 101.56% of outstanding principal if prepayment occurs on or after the 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> anniversary of the issue date of the Initial Notes to 112.5% if payment occurs during the third year after the issuance of the Initial Notes.&#160; In the event that
      redemption occurs within the two years after the issuance of the 12.5% Notes, a make-whole fee is required, based on the present value of remaining interest payments using an agreed-upon discount rate linked to the then-current U.S. Treasury rate.
      The Indenture also includes a change of control provision under which the Company may be required to repurchase the 12.5% Notes at 101% of the remaining principal plus accrued interest at the election of the Lenders.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Collateral for the loan under the 12.5% Notes consists of a priority lien on substantially all property and assets, including intellectual property, of the Company.&#160; This secured obligation provides
      payment rights that are senior to all existing and future subordinated indebtedness of the Company and provides Lenders with perfected security interests in substantially all of the Company&#8217;s assets.&#160; In the event that asset-based loans of up to
      $10,000 (&#8220;ABL Facility&#8221;) may be obtained, subject receivables and inventory assets will provide a second priority lien to senior secured Noteholders. The Company&#8217;s license of its intellectual property to a third-party drug development enterprise
      (specifically, Sunovion&#8217;s KYNMOBI&#8482; product) is one of the various assets serving as collateral for the loan.&#160; The&#160; Indenture permits the Company to monetize this asset while specifying that a portion of the proceeds, up to $40,000 if the First
      Additional Offering has not been elected or funded, or, $50,000 if it has been elected and funded, must be applied to prepay the Initial Notes, at 112.5% of the principal amount of the 12.5% Notes being repurchased, plus accrued and unpaid interest,
      if any, thereon, to the date of the repurchase, to the extent elected by the Noteholders, assuming that such monetization, up to such $40,000 or $50,000 level, as applicable, equals or exceeds those levels and if such monetization does not equal or
      exceed such level, such prepayment would be pro-rated among the Noteholders.&#160; To the extent that Lenders do not elect repayment of the debt at the date of the monetization, the amount not elected up to $40,000 (or $50,000 if an additional tranche is
      issued) will be held in a collateral account until approval of Libervant&#8482; by the FDA for U.S. marketing, at which time this cash collateral is to be released to the Company.&#160; Proceeds of more than $40,000 (or $50,000 if an additional tranche is
      issued) can be used immediately for general corporate purposes. As of September 30, 2020, the Company complied with all of its covenants under the Indenture.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company capitalizes legal and other third-party costs incurred in connection with obtaining debt as deferred debt issuance costs and applies the unamortized portion as a reduction of the
      outstanding face amount of the related loan in accordance with ASU 2015-03, <font style="font-style: italic;">Interest &#8211; Imputation of Interest: Simplifying the Presentation of Debt Issuance Costs</font>.&#160; Similarly, the Company amortizes debt
      discounts, such as those represented by warrants issued to its holders, and offsets those as a direct reduction of its outstanding debt.&#160; Amortization expenses arising from deferred debt issuance costs and debt discounts related to the 12.5% Notes
      were $590 and $1,758 for the three- and nine-month periods ended September 30, 2020, respectively. Comparative amortization expenses derived from deferred debt issuance costs and debt discounts related to the Perceptive Loan and the 12.5% Notes for
      the three- and nine-month periods ended September 30, 2019 were $556 and $1,338, respectively.&#160; Unamortized deferred debt issuance costs and deferred debt discounts totaled $7,904 and $9,662 as of September 30, 2020 and December 31, 2019,
      respectively.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Loans Payable - Perceptive</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In August 2016, the Company entered into a Loan Agreement and Guaranty with Perceptive Credit Opportunities Fund, LP (&#8220;Perceptive&#8221;) under which the total available facility of $50,000 had been
      borrowed as of March 2017.&#160; At closing, Perceptive received a warrant to purchase senior common equity interests representing 4.5% of the fully diluted common units of the Company on an as converted basis, which was automatically exercised in full at
      the time of Aquestive&#8217;s IPO.&#160; In July 2019, the Perceptive Loan was paid in full in connection with the completion of the sale of the Initial Notes and Warrants described above.&#160; The early extinguishment of this debt resulted in a charge to third
      quarter 2019 earnings of an amount of $4,896, including an early retirement premium of $2,944 and the remaining balances of the unamortized loan discount and loan acquisition costs.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc529b43309a54b97b3e33fdd5f969362" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 14.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Warrant</font>s <font style="font-weight: bold;">Issued to 12.5% Senior Secured Noteholders</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Warrants that were issued in conjunction with the Initial Notes described above expire on June 30, 2025 and entitled the holders of the Initial Notes to purchase two million shares of the
      Company&#8217;s common stock at $4.25 per share and include specified registration rights.&#160; Management estimated the fair value of the Warrants to be $6,800, assisted by an independent third-party appraiser.&#160; The fair value of these Warrants is treated as
      a debt discount, amortizable over the term of the Warrants, with the unamortized loan portion applied to reduce the face amount of the Initial Notes in the Company&#8217;s balance sheet.&#160; Additionally, since the Warrants issued do not provide warrant
      redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the Warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value
      attributed to the Warrants is presented in Additional-paid in capital in the accompanying Condensed Consolidated Balance Sheets.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Certain holders of the Initial Notes exercised Warrants for the purchase of 428,571 shares of common stock and proceeds therefor totaling $1,821 were received on December 16, 2019. There were no
      Warrants exercised by the holders of the Initial Notes during the nine-month period ended September 30, 2020.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On November 3, 2020, the Indenture was amended, and additional at-the-money warrants will be issued at the time of purchase of additional Notes.&#160; See Note 19 (C), Subsequent Events.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9f8f5dbb05294674a4acbd842bf3c68c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 15.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Net Loss Per Share</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Basic net income or loss per share is calculated by dividing net income or loss by the weighted-average number of common share</font>s outstanding during the
      periods. Diluted net income or loss per common share is similarly computed and includes the effect of any additional dilutive potential common shares outstanding during the periods. These potential common shares are excluded from the computation of
      net loss per share to the extent that their effects are antidilutive, and <font style="color: rgb(0, 0, 0);">as a result of the Company&#8217;s net losses incurred for the three- and nine-month periods ended September 30, 2020 and 2019, respectively, no
        potentially dilutive securities have been included in the computation of diluted net loss per share for the periods presented below.</font></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z1ffa3dbbbf6e4e458e2a22bff83adc69">

        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top;" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Numerator:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(16,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(18,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(35,415</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(53,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Denominator:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Weighted-average number of common shares &#8211; basic</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">33,619,379</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">25,031,478</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">33,592,846</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">24,992,229</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loss per common share &#8211; basic and diluted</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(0.49</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(0.74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(1.05</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(2.15</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following outstanding stock options, restricted stock units and warrants are antidilutive and have been excluded from the computation of the loss per common share for the
      periods ended September 30:</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z4026e75e01544dcfa3ba30bb2f334e7d">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Options on common shares outstanding</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">3,075,942</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,256,092</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units unvested</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">13,489</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">107,144</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Warrants on common shares outstanding</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,571,429</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total potentially antidilutive derivatives excluded from losses per share</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,660,860</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,363,236</div>
            <div></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z5123289c333647d7973fa9eca045dd64" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 16.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Share-Based Compensation</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The Company recognized share-based compensation in its Condensed Consolidated Statements of Operations and Comprehensive Loss during 2020 and 2019 as follows:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z1af69f6b5e054b5ca52c8032935d46a2">

        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top;" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">60</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">208</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Research and development</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">178</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">188</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">543</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">536</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,622</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,301</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,480</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,427</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,870</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,052</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,200</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Share-based compensation from:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">16</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">473</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">789</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,403</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,411</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,397</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,252</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">3,777</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Employee stock purchase plan</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">20</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,427</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,870</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,052</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,200</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Share-Based Compensation Equity Awards</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine-month period ended September 30, 2020:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zb035d3a43f5d408b89118b14b7bf6be1">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Restricted Stock Unit Awards (RSUs):</u></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Units</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Grant Date Fair</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of December 31, 2019</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">14.64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">4</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">7.54</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">14.88</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Forfeited</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of September 30, 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">14</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">11.38</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Grant date fair value of shares vested during the period</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">958</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unrecognized compensation costs as of September 30, 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">140</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Unrecognized compensation costs related to awards of RSUs are expected to be recognized over a weighted-average period of less than two years.</div>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z2df8d10161d445d1b2c30e19efbd354b">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Stock Option Awards:</u></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted Average</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Exercise Price</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of December 31, 2019</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,231</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">10.42</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">981</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">2.68</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercised, Forfeited, Expired</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(136</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(4.39</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of September 30, 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">3,076</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">8.22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested or expected to vest as of September 30, 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,866</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">8.22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercisable as of September 30, 2020</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,014</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">11.87</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The fair values of stock options granted during 2020 were estimated using the Black-Scholes-Merton pricing model based on the following assumptions:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 60%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="zbbd65d3f61a442e3ae5d623bb47eadff">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected dividend yield</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: right; color: rgb(0, 0, 0);">None</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 48%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected volatility</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">100</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected term (years)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5.5 - 6.1</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 48%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Risk-free interest rate</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">0.4 &#8211; 1.7</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The weighted average grant date fair value of stock options granted during 2020 was $2.10 During the nine-month period ended September 30, 2020, stock options were granted with
      exercise prices ranging from $1.54 to $7.86, and accordingly, given the Company&#8217;s share price of $4.86 at September 30, 2020, certain shares granted during this period provided intrinsic value at that date totaling $2,474. No intrinsic value was
      provided by stock options granted during the nine-month period ended September 30, 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">As of September 30, 2020, $6,554 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a weighted average period of 1.8 years
      from the date of grant.</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);"><u>Employee Stock Purchase Plan</u></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The Aquestive Therapeutics, Inc. Employee Stock Purchase Plan, or ESPP, as amended and restated effective as of January 1, 2019, features two six-month offering periods per year,
      running from January 1 to June 30 and July 1 to December 31. Under the ESPP, employees may elect to purchase the Company&#8217;s common stock at the lower of 85% of the fair value of shares on either the first or last day of the offering period. During the
      nine-month periods ended September 30, 2020 and 2019, respectively, 14,961 and 31,393 shares were purchased and issued through the ESPP at total discounts of $11 and $20.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf13b0196b3e74f67babe8355e298c7a9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 17.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences
      attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits.&#160; Valuation allowances are provided
      if it is more likely than not that some portion or all of the deferred tax asset will not be realized.&#160; The Company has considered the impact of the CARES Act in relation to the 2020 income tax provision. However, due to the full valuation allowance
      and no ability or intent to carryback the 2020 net operating loss, no impact is expected.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended September 30, 2020 and 2019,
      the Company recorded no income tax benefit from its pretax losses of $16,551 and $18,412, respectively, and similarly for the nine months ended September 30, 2020 and 2019, the Company recorded no tax benefit from its pretax loss of $35,415 and
      $53,610, respectively, due to realization uncertainties.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s U.S. Federal statutory rate is 21%.&#160; The primary factor impacting the effective tax rate for the three- and nine-month periods ended September 30, 2020 is the anticipated full year
      operating loss which will require full valuation allowances against any associated net deferred tax assets.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc3698a8ad8874cd7a4a3442057bc34f4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 18.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Contingencies</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Litigation and Contingencies</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business, including product liability, intellectual
      property, commercial litigation, or environmental or other regulatory matters. Except as described below, Aquestive is not presently a party to any litigation or other legal proceeding that is believed to be material to its financial condition.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Patent-Related Litigation</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Beginning in August 2013, the Company was informed of abbreviated new drug application (&#8220;ANDA&#8221;) filings in the United States by Watson Laboratories, Inc. (now Actavis Laboratories, Inc., or
      &#8220;Actavis&#8221;), Par Pharmaceutical, Inc. (&#8220;Par&#8221;), Alvogen Pine Brook, Inc. (&#8220;Alvogen&#8221;), Teva Pharmaceuticals USA, Inc.&#160; (&#8220;Teva&#8221;), Sandoz Inc. (&#8220;Sandoz&#8221;), and Mylan Technologies Inc. (&#8220;Mylan&#8221;), for the approval by the FDA of generic versions of Suboxone
      Sublingual Film in the United States. Aquestive filed patent infringement lawsuits against all six generic companies in the United States District Court for the District of Delaware (the &#8220;Delaware District Court&#8221;). After the commencement of the ANDA
      patent litigation against Teva, Dr. Reddy&#8217;s Laboratories (&#8220;DRL&#8221;) acquired the ANDA filings for Teva&#8217;s buprenorphine and naloxone sublingual film that are at issue in these trials.</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 18pt;">Of these, cases against three of the six generic companies have been resolved.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9d094916431343868cabc354a461291b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div><font style="font-style: italic;">Mylan</font> and <font style="font-style: italic;">Sandoz</font> settled without a trial. Sandoz withdrew all challenges and became the distributor of the authorized generic products.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zab964e3a2395465ba6183fdf853d2089" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>All cases against <font style="font-style: italic;">Par </font>were resolved pursuant to a May 2018 settlement agreement among the Company, Indivior, and Par and certain of its affiliates.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf36c7468c8be4faf80d506430e43b331" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div><font style="font-style: italic;">Actavis</font> was found to infringe Patent No. 8,603,514, or the &#8217;514 patent, and cannot enter the market until the expiration of the patent in 2024, and the United States Court of Appeals for the Federal
              Circuit (&#8220;Federal Circuit&#8221;) affirmed that ruling on July 12, 2019.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z41a0a392ece64307a7a75c05b08154ec" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div><font style="font-style: italic;">DRL</font> and <font style="font-style: italic;">Alvogen</font> were found not to infringe under a different claim construction analysis, and the Federal Circuit affirmed that ruling on July 12, 2019. <font style="font-style: italic;">Teva</font> has agreed to be bound by all DRL adjudications.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Subsequent to the above, all potential generic competitors without a settlement agreement were also sued for infringement of two additional new patents that contain new claims not adjudicated in the
      original Delaware District Court case against DRL and Alvogen.&#160; On July 12, 2019, the Federal Circuit affirmed the decisions from the previously decided cases.&#160; The remaining case against Actavis was dismissed in light of the infringement ruling
      above, which prevents Actavis from entering the market until 2024.&#160; The case(s) against the remaining defendants regarding the additional asserted patents have not been finally resolved.&#160; A <font style="font-style: italic;">Markman </font>hearing
      in the cases against Dr. Reddy&#8217;s and Alvogen which is pending in the United States District Court for the District of new Jersey (the &#8220;New Jersey District Court&#8221;) was held on October 17, 2019.&#160; On November 5, 2019, District Judge McNulty of the New
      Jersey District Court issued a <font style="font-style: italic;">Markman</font> opinion construing the disputed terms of the asserted patents. On January 9, 2020, the New Jersey District Court entered a stipulated order of non-infringement of one of
      the patents, Patent No. 9,931,305, or the &#8217;305 patent, based on the Federal Circuit&#8217;s claim construction ruling, and the Company and Indivior preserved available rights to appeal the claim construction ruling. On November 19, 2019, Magistrate Judge
      Waldor of the New Jersey District Court issued an order granting DRL and Alvogen&#8217;s requests to file amended answers to add antitrust counterclaims against Aquestive and Indivior.&#160; Aquestive and Indivior appealed the Magistrate Judge&#8217;s decision to
      District Judge McNulty on December 4, 2019, and DRL and Alvogen opposed the appeal. On January 17, 2020, the Company filed a motion to dismiss DRL&#8217;s and Alvogen&#8217;s antitrust counterclaims for failure to state a claim, and DRL and Alvogen opposed the
      motion.&#160; <font style="color: rgb(0, 0, 0);">On August 24, 2020, Judge McNulty issued an Opinion and Order denying both the appeal of the Magistrate&#8217;s decision and Aquestive&#8217;s Motion to Dismiss. On June 3, 2020, the court issued an order setting a
        schedule for ongoing fact discovery, expert discovery, and dispositive motions.&#160; The schedule currently sets the close of fact discovery for October 20, 2020, with expert discovery continuing through the end of April 2021.&#160; The schedule also sets
        the deadline for filing dispositive motions for May 18, 2021. </font>No trial date has been set in those cases.&#160; Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of
      estimates, of the possible outcome or loss, if any, in this matter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On February 19, 2019, the Federal Circuit issued its mandate reversing the New Jersey District Court&#8217;s preliminary injunction against Dr. Reddy&#8217;s.&#160; Following issuance of the mandate, the New Jersey
      District Court vacated preliminary injunctions against both Dr. Reddy&#8217;s and Alvogen.&#160; Dr. Reddy&#8217;s, Alvogen, and Mylan all launched generic versions of Suboxone Sublingual Film, and the launches by Dr. Reddy&#8217;s and Alvogen are &#8220;at risk&#8221; because the
      products are the subject of the ongoing patent infringement litigations.</div>
    <div style="text-align: justify; text-indent: 22.3pt; margin-left: 0.2pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On March 22, 2019, Aquestive and Indivior brought suit against Aveva Drug Delivery Systems, Inc., Apotex Corp., and Apotex Inc.in the United States District Court for the Southern District of Florida
      (the &#8220;Southern District of Florida Court&#8221;) for infringement of the Company&#8217;s U. S. Patent Nos.&#160; 8,017,150, 9,687,454, the &#8217;514 patent and &#8217;305 patent, seeking an injunction and potential monetary damages.&#160; Following a negotiated settlement between
      all parties, on December 3, 2019, the parties submitted a Notice of Settlement and a Joint Motion to Approve Consent Judgment. The Southern District of Florida Court entered an order dismissing the suit on December 18, 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Company is also seeking to enforce its patent rights in multiple cases against BioDelivery Sciences International, Inc. (&#8220;BDSI&#8221;). Three cases are currently pending but stayed in the U.S. District
      Court for the Eastern District of North Carolina (the &#8220;Eastern District of North Carolina Court&#8221;):</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za39b7379ae28498a85476fbfdae2ab48" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="vertical-align: top; width: 18.3pt;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>The first, a declaratory judgment action brought by BDSI against Indivior and Aquestive, seeks declarations of invalidity and non-infringement of U.S. Patents Nos. 7,897,080, 8,652,378 and 8,475,832. This case is stayed.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb2a1d9e985034fde993963e2ae419f95" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="vertical-align: top; width: 18.3pt;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>The second was filed by Aquestive and Indivior related to BDSI&#8217;s infringing Bunavail product, and alleges infringement of Aquestive&#8217;s patent, U.S. Patent No. 8,765,167, or the &#8217;167 patent, and seeks an injunction and potential monetary
              damages. Shortly after the case was filed, BDSI filed four (4) IPR&#8217;s challenging the asserted &#8217;167 patent.&#160; On March 24, 2016, the United States Patent Trial and Appeal Board (&#8220;PTAB&#8221;), issued a final written decision finding that all claims
              of the &#8217;167 patent were valid. The case was stayed in May 2016 pending the final determination of the appeals on those decisions.&#160; Following the PTAB&#8217;s February 7, 2019 decisions on remand denying institution, Aquestive and Indivior submitted
              a notice to the Court on February 15, 2019 notifying the Court that the stay should be lifted as a result of the PTAB&#8217;s decisions. The parties in this matter are awaiting further action from the Court.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zd6faabd8464a40c2a7c0618e726cb9ee" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;">On January 13, 2017, the Company also sued BDSI asserting infringement of the &#8217;167 patent by BDSI&#8217;s Belbuca product and seeking an injunction and potential monetary damages.&#160; On
                August 7, 2019, the Eastern District of North Carolina Court granted BDSI&#8217;s motion to dismiss the Complaint without prejudice and denied BDSI&#8217;s motion to stay as moot.&#160; On November 11, 2019, Aquestive filed a new Complaint against BDSI in
                the Eastern District of North Carolina Court.&#160; On November 27, 2019, BDSI filed a motion to stay the case pending BDSI&#8217;s appeal of the PTAB&#8217;s remand decisions, and the Company opposed this motion. The Eastern District of North Carolina
                Court denied BDSI&#8217;s motion to stay on April 1, 2020. BDSI&#8217;s appeal of the PTAB&#8217;s remand decisions to the United States Court of Appeals for the Federal Circuit was docketed on March 13, 2019, and on March 20, 2019, and a motion was made to
                dismiss this appeal for lack of jurisdiction.&#160; On August 29, 2019, the Federal Circuit granted the motion to dismiss BDSI&#8217;s appeal.&#160; On September 30, 2019, BDSI filed a petition for rehearing in the Federal Circuit </font><font style="font-size: 10pt; font-style: italic;">en banc</font><font style="font-size: 10pt;">, which the Company opposed.&#160; The Federal Circuit denied BDSI&#8217;s petition for rehearing </font><font style="font-size: 10pt; font-style: italic;">en
                banc</font><font style="font-size: 10pt;"> on January 13, 2020.&#160; </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">On June 11, 2020, BDSI filed a petition for writ of certiorari at the Supreme Court of the United States.&#160; At the
                request of the Supreme Court, Aquestive filed an opposition to BDSI&#8217;s petition on August 17, 2020, and BDSI filed a reply on August 27, 2010.&#160; On October 5, 2020, the Supreme Court issued an order denying BDSI&#8217;s petition. </font><font style="font-size: 10pt;">After the Federal Circuit denied BDSI&#8217;s petition, on January 13, 2020, BDSI filed with the Eastern District of North Carolina Court a motion to dismiss the Complaint, and Aquestive opposed on February 2, 2020.&#160; The
                Eastern District of North Carolina Court denied BDSI&#8217;s motion to dismiss </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">and its motion to stay </font><font style="font-size: 10pt;">on April 1, 2020.&#160; On April 16, 2020, BDSI
                filed an Answer to the Complaint, including counterclaims for non-infringement, invalidity, and unenforceability of the &#8217;167 patent.&#160; </font><font style="font-size: 10pt; color: rgb(0, 0, 0);"> On May 7, 2020, Aquestive filed a motion to
                dismiss BDSI&#8217;s unenforceability counterclaim and a motion to strike BDSI&#8217;s corresponding affirmative defenses for failure to state a claim for inequitable conduct under the heightened pleading standard applicable to such claims and
                defenses.&#160; Rather than oppose Aquestive&#8217;s Motion to Dismiss, on May 28, 2020, BDSI amended its counterclaims and filed an Answer and Amended Counterclaims, which included additional allegations in support of BDSI&#8217;s unenforceability
                counterclaim.&#160; On June 25, 2020, Aquestive filed a Motion to Dismiss BDSI&#8217;s Amended Counterclaim for unenforceability and a Motion to Strike BDSI&#8217;s corresponding affirmative defense of unenforceability again for failure to state a claim
                under the applicable heightened pleading standard.&#160; BDSI&#8217;s filed its opposition to Aquestive&#8217;s Motion to Dismiss and Strike on July 16, 2020.&#160; Aquestive filed its Reply to BDSI&#8217;s Opposition on July 30, 2020.&#160; The parties are awaiting
                further action from the court on Aquestive&#8217;s motion.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="font-style: italic; font-weight: bold;">Antitrust Litigation</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On September 22, 2016, forty-one states and the District of Columbia, or the States, brought suit against Indivior and the Company in the U.S. District Court for the Eastern District of Pennsylvania,
      alleging violations of federal and state antitrust statutes and state unfair trade and consumer protection laws relating to Indivior&#8217;s launch of Suboxone Sublingual Film in 2010 and seeking an injunction, civil penalties, and disgorgement. After
      filing the suit, the case was consolidated for pre-trial purposes with the <font style="font-style: italic;">In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation</font>, MDL No. 2445, or the Suboxone MDL, a multidistrict
      litigation relating to putative class actions on behalf of various private plaintiffs against Indivior relating to its launch of Suboxone Sublingual Film. While Aquestive was not named as a defendant in the original Suboxone MDL cases, the action
      brought by the States alleges that the Company participated in an antitrust conspiracy with Indivior in connection with Indivior&#8217;s launch of Suboxone Sublingual Film and engaged in related conduct in violation of federal and state antitrust law.
      Aquestive moved to dismiss the States&#8217; conspiracy claims, but by order dated October 30, 2017, the Court denied the motion to dismiss. An answer was filed denying the States&#8217; claims on November 20, 2017. The fact discovery period closed July 27,
      2018, but the parties agreed to conduct certain fact depositions in August 2018.&#160; The expert discovery phase closed May 30, 2019, but additional reports and depositions were conducted through August 1, 2019.&#160; The remainder of the case schedule,
      including summary judgment briefing, is stayed pending resolution of Indivior&#8217;s appeal of the District Court&#8217;s class certification ruling in a co-pending multi-district litigation to which the Company is not a party. On July 28, 2020, the U.S. Court
      of Appeals for the Third Circuit issued its opinion affirming the District Court&#8217;s order certifying the class.&#160; On August 27, 2020, the district court issued a scheduling order, setting the deadline for filing remaining <font style="font-style: italic;">Daubert</font> challenges and summary judgment.&#160; Under the scheduling order, the remaining <font style="font-style: italic;">Daubert</font> motions were filed on September 28, 2020, and oppositions are due on October 19, 2020.&#160; The court
      will set oral argument on the motions, but the date for oral argument is not yet known.&#160; Summary judgment motions are due January 11, 2021, and responses to summary judgment motions are due February 11, 2021.&#160; No trial date has yet been set.
      Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-style: italic; font-weight: bold;">Humana and Centene Actions</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On September 18, 2020, Humana, Inc., a health insurance payer, filed a suit against Aquestive and Indivior in the Eastern District of Pennsylvania relating to Suboxone.&#160; The
      Humana action, which alleges facts similar to those at issue in the Antitrust Case and the Suboxone MDL described above, was assigned to the same judge that is presiding over those actions.&#160; Humana&#8217;s Complaint alleges five causes of action against
      Aquestive, including conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment.&#160; On September 21, 2020, Centene Corporation and other related insurance
      payers filed a similar suit against Aquestive and Indivior in the Eastern District of Missouri.&#160; The counsel representing Humana is also representing Centene.&#160; On September 21, 2020, the Centene action was provisionally transferred to the Eastern
      District of Pennsylvania by the United States Judicial Panel on Multidistrict Litigation.&#160; No other proceedings have occurred and the schedule is not yet known.&#160; Management is not able to determine or predict the ultimate outcome of this proceeding
      or provide a reasonable estimate, or range of estimate, of the possible outcome or loss, if any, in this matter.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">California Complaint</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On December 5, 2019, Neurelis Inc. (&#8220;Neurelis&#8221;) filed a complaint against Aquestive in the Superior Court of California, County of San Diego alleging Unfair Competition,
      Defamation, and Malicious Prosecution related to the Company&#8217;s pursuit of FDA approval for Libervant&#8482;. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action.&#160; The Company filed a Motion to Strike
      Neurelis&#8217;s Complaint under California&#8217;s anti-SLAPP (&#8220;strategic lawsuit against public participation&#8221;) statute on Friday, January 31, 2020, which Neurelis is expected to oppose.&#160; Neurelis filed a motion for leave to file a Supplemental Complaint on
      February 5, 2020, which will be opposed.&#160; On February 5, 2020, Neurelis filed a Motion for Leave to File a Supplemental Complaint (&#8220;Motion&#8221;).&#160; On June 5, 2020, Neurelis filed a Motion for Limited Discovery related to Aquestive&#8217;s anti-SLAPP motion.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">The court previously scheduled a hearing on both Aquestive&#8217;s anti-SLAPP Motion and on Neurelis&#8217;s Motion for April 24, 2020.&#160; However, on April 3, 2020, in response
        to the COVID-19 pandemic, the court issued an order continuing all hearings scheduled through April 30, 2020.&#160; The court ultimately held a telephonic status conference on June 25, 2020 to determine a schedule for hearing the pending motions.&#160;
        During that status conference, the court set Aquestive&#8217;s anti-SLAPP motion for hearing on July 24, 2020.&#160; The court also declined Neurelis&#8217;s request to hear its Motion and its Motion for Limited Discovery.&#160; Neurelis filed its response to
        Aquestive&#8217;s anti-SLAPP Motion on July 13, 2020, and we filed our reply on July 17, 2020.&#160; The court held a telephonic hearing on Aquestive&#8217;s anti-SLAPP motion on July 24, 2020. On August 6, 2020, the Court issued an order granting in part and
        denying in part Aquestive&#8217;s anti-SLAPP motion.&#160; Aquestive filed a notice of appeal to the California Court of Appeal on September 1, 2020, and Neurelis filed a notice of cross-appeal on October 5, 2020.&#160; </font>Management is not able to determine
      or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z1a343204c44247ceaba3b5e0e2b8f1dd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 19.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Events</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0);"><font style="font-weight: bold; font-style: italic;">(A)</font>&#160;<font style="font-weight: bold; font-style: italic;">Amendment to License Agreement with Sunovion Pharmaceuticals Inc.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Effective as of October 23, 2020, the Company entered into a Second Amendment to the Sunovion License Agreement whereby the parties to the Sunovion License Agreement agreed to
      clarify the continued rights and obligations of the parties with respect to the prosecution and maintenance of the Company&#8217;s patents covered under the Agreement and that, on and after March 31, 2028, in respect of any jurisdiction or jurisdictions
      covered under the License Agreement, Sunovion may terminate its rights with respect to the Licensed Patents under the License Agreement upon 180 days prior written notice to the Company.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(B) Monetization of Certain Rights under the Sunovion License Agreement</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On November 3, 2020, the Company entered into the Monetization Agreement&#160; that will result in proceeds to the Company of up to $125,000 in exchange for which the
        Company conveyed to Marathon the right to all royalties and other payments due to the Company under the Sunovion License Agreement (See Note 6).&#160; Under the terms of the Monetization Agreement, Aquestive will receive a $40,000 cash payment within 12
        business days of signing and is eligible to receive up to $85,000 </font>of contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain other commercial
      milestones.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(C) Amendment and Partial Repayment of the 12.5% Notes</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">With the proceeds paid to the Company at closing under the Monetization Agreement, the Company will repay $22,500 of the 12.5% Notes, and issue $4,000&#160; of new
        senior notes in lieu of paying a prepayment premium on the early repayment of the 12.5% Notes, reducing the balance of senior notes outstanding to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31,
        2021 the Company&#8217;s ability to access, at the Company&#8217;s option, $30,000 of senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at the option
        of the Company, contingent upon FDA approval of the Company&#8217;s product candidate Libervant</font> (diazepam) Buccal Film for the management of seizure clusters<font style="color: rgb(0, 0, 0);">.&#160; A second $20,000 senior notes re-opener represents a
        right, at the Company&#8217;s option, to market to current holders of the Company&#8217;s 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S. market access.&#160; If and to the extent that
        the Company accesses these re-openers, the Company will grant warrants to purchase up to 714,000 shares of common stock, with the strike price calculated based on the 30-day volume weighted average closing price of the Company&#8217;s common stock at the
        warrant grant date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of the Company&#8217;s common stock.</font></div>
    <div style="text-align: justify;"><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z65c098ad223f4073b581f98ac0caaca7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Management"><!--Anchor--></a>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0); font-style: italic;">You should read this section in conjunction with our unaudited condensed interim consolidated financial statements and related notes included in Part I Item 1
      of this Quarterly Report on Form 10-Q and our audited consolidated financial statements and related notes thereto and management&#8217;s discussion and analysis of financial condition and results of operations for the years ended December 31, 2019 and 2018
      included in our 2019 Annual Report on Form 10-K. All dollar amounts are stated in thousands except for share data.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Forward-Looking Statements</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 18pt;">This Quarterly Report on Form 10-Q and certain other communications made by us include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&#160;&#160; Words
        such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; or the negative of those terms, and similar expressions are intended to identify forward-looking statements.</div>
      <div style="text-align: justify; text-indent: 18pt;"> <br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 18pt;">These forward-looking statements include, but are not limited to, statements regarding therapeutic benefits and plans and objectives for regulatory approvals of AQST-108, Libervant&#8482;; ability to
        cure the deficiencies identified in the FDA&#8217;s Complete Response Letter dated September 25, 2020 regarding the New Drug Application for Libervant and obtain FDA approval of Libervant for U.S. market access; ability to obtain FDA approval and advance
        AQST-108, Libervant and our other product candidates to the market; about our growth and future financial and operating results and financial position, regulatory approval and pathways, clinical trial timing and plans, our and our competitors&#8217;
        orphan drug approval and resulting drug exclusivity for our products or products of our competitors; short-term and long-term liquidity and cash requirements, cash funding and cash burn, business strategies, market opportunities, and other
        statements that are not historical facts.&#160; These forward-looking statements are also subject to the uncertain impact of the COVID-19 global pandemic on our business including with respect to our clinical trials including site initiation, patient
        enrollment and timing and adequacy of clinical trials; on regulatory submissions and regulatory reviews and approvals of our product candidates; pharmaceutical ingredients and other raw materials; supply chain, manufacture, distribution and sale of
        and demand for our products; our liquidity and availability of capital resources; customer demand for our products and services; customers&#8217; ability to pay for goods and services; and ongoing availability of an appropriate labor force and skilled
        professionals. Given these uncertainties the Company is unable to provide assurance that operations can be maintained as planned prior to the COVID-19 pandemic.</div>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 18pt;">These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from
        those described in the forward-looking statements.&#160; Such risks and uncertainties include, but are not limited to, risks associated with the Company&#8217;s development work, including any delays or changes to the timing, cost and success of our product
        development activities and clinical trials and plans; risk of delays in FDA approval of Libervant and our other drug candidates or failure to receive approval; risk of our ability to demonstrate to the FDA &#8220;clinical superiority&#8221; within the meaning
        of the FDA regulations of our drug candidate Libervant relative to FDA-approved diazepam rectal gel and nasal spray products, including by establishing a major contribution to patient care within the meaning of FDA regulations relative to the
        approved products as well as risks related to other potential pathways or positions which are or may in the future be advanced to the FDA to overcome the seven year orphan drug exclusivity granted by the FDA for the approved nasal spray product of
        a competitor in the U.S. and there can be no assurance that we will be successful; risk that a competitor obtains FDA orphan drug exclusivity for a product with the same active moiety as any of our other drug products for which we are seeking FDA
        approval and that such earlier approved competitor orphan drug blocks such other product candidates in the U.S. for seven years for the same indication; risk inherent in commercializing a new product (including technology risks, financial risks,
        market risks and implementation risks and regulatory limitations); risks and uncertainties concerning the royalty and other revenue stream of KYNMOBI&#8482; (apomorphine), achievement of royalty targets worldwide or in any jurisdiction and certain other
        commercial targets required for contingent payments under the monetization transaction, and of sufficiency of net proceeds of the monetization transaction after satisfaction of and compliance with the 12.5% Notes, as applicable, and for funding the
        Company&#8217;s operations; risk of development of our sales and marketing capabilities; risk of legal costs associated with and the outcome of our patent litigation challenging third-party at risk generic sale of our proprietary products; risk of
        sufficient capital and cash resources, including access to available debt and equity financing and revenues from operations, to satisfy all of our short-term and longer-term cash requirements and other cash needs, at the times and in the amounts
        needed; risk of failure to satisfy all financial and other debt covenants and of any default; risk related to government claims against Indivior for which we license, manufacture and sell Suboxone&#174; and which accounts for the substantial part of our
        current operating revenues; risk associated with Indivior&#8217;s cessation of production of its authorized generic buprenorphine naloxone film product, including the impact from loss of orders for the authorized generic product and risk of eroding
        market share for Suboxone and risk of sunsetting product; risks related to the outsourcing of certain marketing and other operational and staff functions to third parties; risk of the rate and degree of market acceptance of our product and product
        candidates; the success of any competing products, including generics; risk of the size and growth of our product markets; risks of compliance with all FDA and other governmental and customer requirements for our manufacturing facilities; risks
        associated with intellectual property rights and infringement claims relating to the Company&#8217;s products; risk of unexpected patent developments; the impact of existing and future legislation and regulatory provisions on product exclusivity;
        legislation or regulatory actions affecting pharmaceutical product pricing, reimbursement or access; claims and risks that may arise regarding the safety or efficacy of the Company&#8217;s products and product candidates; risk of loss of significant
        customers; risks related to legal proceedings including patent infringement, investigative and antitrust litigation matters; changes in government laws and regulations; risk of product recalls and withdrawals; uncertainties related to general
        economic, political, business, industry, regulatory and market conditions and other unusual items; and other uncertainties affecting the Company described in the &#8220;Risk Factors&#8221; section and in other sections included in our Annual Report on Form
        10-K, in our Quarterly Reports on Form 10-Q, and in our Current Reports on Form 8-K filed with the Securities Exchange Commission (SEC).&#160; Given those uncertainties, you should not place undue reliance on these forward-looking statements, which
        speak only as of the date made.&#160; All subsequent forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement.&#160; The Company assumes no obligation to update
        forward-looking statements, or outlook or guidance, after the date of this Quarterly Report on Form 10-Q whether as a result of new information, future events or otherwise, except as may be required by applicable law.&#160; Readers should not rely on
        the forward-looking statements included in this Quarterly Report on Form 10-Q as representing our views as of any date after the date of the filing of this Quarterly Report on Form 10-Q.</div>
    </div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Overview</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We are a pharmaceutical company focused on developing and commercializing differentiated products which leverage our proprietary PharmFilm&#174; technology to meet patients&#8217; unmet medical needs and to
      solve patients&#8217; therapeutic problems. Following the Company&#8217;s Initial Public Offering (&#8220;IPO&#8221;) in July 2018, the Company&#8217;s common stock trades on the Nasdaq Global Market under ticker symbol &#8220;AQST&#8221;. We have three commercial products, including one
      proprietary product and two out-licensed products, another FDA-approved product that has been out-licensed for commercialization in European markets following applicable regulatory approvals, as well as a late-stage proprietary product pipeline
      focused on the treatment of central nervous system, or CNS, diseases and an earlier stage pipeline including treatment of anaphylaxis. We have also licensed certain intellectual property rights for use in development and commercialization of oral
      films containing apomorphine, which are used for the treatment of off episodes in patients suffering from Parkinson&#8217;s disease and, having received FDA approval on May 21, 2020, was commercially launched by our licensee in September 2020. We believe
      that our products address the characteristics of these patient populations and the shortcomings of available treatments create opportunities for the development and commercialization of meaningfully differentiated medicines.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Sympazan, an oral film for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut syndrome, or LGS, was approved by the FDA on November 1, 2018.&#160; The
      Company commercially launched Sympazan in December 2018.&#160; Sympazan was launched as a precursor and complement to our product candidate Libervant and continues to progress on key performance metrics including prescriber growth, repeat prescribers,
      quarterly growth in retail shipments, and covered lives.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Exse<font style="color: rgb(0, 0, 0);">rvan&#174; <font style="font-weight: normal;">(riluzole)</font>, util</font>izing our proprietary PharmFilm technology, has been developed for the treatment of
      amyotrophic lateral sclerosis (ALS).&#160; Exservan was approved by the FDA on November 22, 2019.&#160; During the fourth quarter of 2019, we announced the granting of a license to Zambon S.p.A. for the development and commercialization of Exservan Oral Film
      in the European Union (EU) for treatment of ALS.&#160; Zambon is exclusively responsible for obtaining regulatory approval and marketing Exservan in the EU and we have sole and exclusive manufacturing rights for the product in the EU.&#160; We are seeking an
      appropriate licensee for the commercialization rights for Exservan in the United States.&#160; There can be no assurance that we will be successful in licensing Exservan in the United States.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Libervant is our most advanced proprietary investigational product candidate, which we intend to self-commercialize, subject to FDA approval for market access in the U.S.&#160; Libervant is a buccally, or
      inside of the cheek, administered soluble film formulation of diazepam.&#160; Aquestive is developing Libervant as an alternative to the device-dependent rescue therapies currently available to patients with refractory epilepsy, which are a rectal gel and
      newly approved nasal sprays.&#160;&#160; We are seeking to demonstrate that Libervant will, if approved by the FDA for U.S. market access, represent a &#8220;major contribution to patient care&#8221; within the meaning of FDA regulations and guidance, as compared to
      available treatment options, as the first, non-device delivered, oral diazepam-based product available to manage seizure clusters in epilepsy patients.&#160; However, overcoming the orphan drug marketing exclusivity is difficult to establish, with limited
      precedent, and there can be no assurance that the FDA will agree with our position seeking to overcome such marketing exclusivity and approve Libervant for U.S. market access. The Company filed an NDA for Libervant in November 2019.&#160; On September 25,
      2020, the Company received a Complete Response Letter (CRL) from the FDA regarding our NDA for Libervant. The FDA issues a CRL to indicate that the review cycle for an application is complete but the application cannot be approved in its current
      form. In the CRL, the FDA cited that, in a study submitted by the Company with the NDA, certain weight groups showed a lower drug exposure level than desired.&#160; The Company has provided to the FDA additional information on PK modeling to demonstrate
      that dose adjustments will obtain the desired exposure levels. There were no other safety, clinical pharmacology/biopharmaceutics or CMC issues identified in the CRL. The FDA did cite a small number of protocol deviations in blood draws in one of the
      studies in the NDA.&#160; The Company believes, based on discussions with the FDA, that the Company will not need to conduct any further clinical studies in order to cure the concerns cited in the CRL. In October, we received confirmation that the FDA has
      agreed to have a Type A meeting for Libervant with us to be held on November 12, 2020.&#160; A Type A meeting is granted for candidate drugs on hold to discuss impeding issues and a path forward for approval.&#160; At that meeting, we expect to discuss the
      information submitted in the October meeting package and to seek to confirm the pathway for approval and propose the immediate resubmission of our NDA.&#160; If the FDA agrees with our proposal, we plan on resubmitting the NDA before the end of the
      year.&#160;&#160; Following resubmission of our NDA for Libervant, the Company plans to request a two-month review period for the NDA from the FDA, as is permissible, but we can provide no assurance that the FDA will grant this request, in which case the
      resubmitted NDA would be reviewed under the statutory six-month review cycle. The Agency did not include in the CRL any indication regarding approval of U.S. market access for Libervant.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We have also developed a proprietary pipeline of complex molecule-based products addressing market opportunities beyond CNS indications, which include:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za7d94e4e15a64fc8ae83b2fda61a0ec4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>AQST-108, a &#8220;first of its kind&#8221; oral sublingual film formulation delivering systemic epinephrine that is in development as a rescue medication for the treatment of anaphylaxis using Aquestive&#8217;s proprietary PharmFilm technologies.&#160;
              Epinephrine is the standard of care for the treatment of anaphylaxis and is currently administered via subcutaneous or intramuscular injection.&#160; The current market leader is EpiPen&#174;, a single-dose, pre-filled automatic injection device.&#160; As a
              result of its administration via subcutaneous or intra-muscular injection, many patients and their caregivers are reluctant to use currently available products, resulting in increased hospital visits and overall cost of care to treat
              anaphylactic events.&#160; The data from the previously completed Phase I dose escalation study demonstrated that AQST-108 achieved similar ranges of mean values of maximum concentration (Cmax) and time to reach maximum concentration (Tmax) to
              that reported for injectables EpiPen and another injection device, Auvi-Q&#174;, provided a greater total exposure (AUC0-t; area under the curve) than that reported for EpiPen and Auvi-Q, had less interpatient variability when compared to degree
              of variation (CV%) data reported for EpiPen and&#160; Auvi-Q, and was well tolerated, with no study participants discontinuing participation due to an adverse event.&#160; We believe that, as a result of its sublingual administration, AQST-108 will
              improve patient compliance and lower the total cost of care. After a constructive face-to-face pre-IND meeting with the FDA in early February 2020, the Company submitted an IND for AQST-108, as expected, to the FDA on June 26, 2020 and our
              IND was subsequently accepted by the FDA on July 23, 2020.&#160; The FDA confirmed that the drug candidate will be reviewed under the 505(b)(2) regulatory approval pathway, and that no additional studies will be necessary prior to opening the IND
              application. We expect that this pathway will provide the means to more expedient and less costly development and filing.&#160; We completed enrollment and dosing of 28 healthy volunteers in a Phase 1 pharmacokinetic (PK) trial for AQST-108 in
              October 2020. The trial features a four-treatment crossover design comparing the pharmacokinetics and pharmacodynamics of AQST-108, 0.3 mg of epinephrine subcutaneous injection (subQ), 0.3 mg of epinephrine intramuscular (IM) injection, and
              0.5 mg epinephrine subQ.&#160; The study includes secondary endpoints for changes in blood pressure and heart rate.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z0c3c90c9c68c4a8fa80887e3ef74af23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>AQST-305 is a sublingual film formulation of octreotide, a small peptide that has a similar pharmacological profile to natural somatostatin, for the treatment of acromegaly, as well as severe diarrhea and flushing associated with carcinoid
              syndrome.&#160; Acromegaly is a hormone disorder that results from the overproduction of growth hormone in middle-aged adults.&#160; Octreotide is the standard of care for the treatment of acromegaly.&#160; The current market leader, Sandostatin&#174;, is
              administered via deep subcutaneous or intramuscular injections once a month.&#160; This monthly treatment regimen can result in loss of efficacy toward the end of the monthly treatment cycle.&#160; We are developing AQST-305 as a non-invasive,
              pain-free alternative to Sandostatin to reduce treatment burden, healthcare costs and the potential loss of efficacy of the treatment cycle.&#160; AQST-305 has shown promising preclinical and human proof of concept results.&#160; While we focus our
              efforts on Libervant and AQST-108 this year, limited formulation work is being done to prepare AQST-305 for additional research trials.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The COVID-19 pandemic may adversely impact the expected timelines for our clinical trials and studies and could contribute to delay in obtaining regulatory review and approval for our product
      candidates.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In addition to these product candidates, we have a portfolio of commercialized and development-stage licensed products.&#160; Our largest commercialized licensed product to date is Suboxone, a sublingual
      film formulation of buprenorphine and naloxone, for the treatment of opioid dependence. We have a sole and exclusive worldwide agreement with Indivior to manufacture Suboxone.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In early 2019, certain third-party pharmaceutical companies launched, at risk, generic film products for buprenorphine-naloxone.&#160;&#160; As of mid-October 2020, Suboxone branded products retain
      approximately 40% of film market share as generic film-based products have penetrated this market.&#160; Indivior accounted for 54% and 83% of our total revenues for the nine- month periods ended September 30, 2020 and 2019, respectively. Our total
      revenue mix is expected to shift to a higher proportionate share of proprietary product sales in future years as we continue to grow Sympazan revenues and pursue the launch of other products in our pipeline, assuming FDA approvals.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We manufacture all our licensed and proprietary products at our FDA- and DEA-inspected facilities and anticipate that our current manufacturing capacity is sufficient for commercial quantities of our
      products and product candidates currently in development. We have produced over 2 billion doses of Suboxone since 2006.&#160; Not all collaborative or licensed products of the Company that may be commercially launched in the future will necessarily be
      manufactured by the Company, such as KYNMOBI&#8482;.&#160;&#160; Our products are developed using our proprietary PharmFilm technology and know-how.&#160; The COVID-19 pandemic could negatively impact our continued commercialization of Sympazan, impact demand for our
      approved products and development and commercialization of other products in our pipeline.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On July 15, 2019, we completed a private placement of $70,000 of 12.5% Senior Secured Notes due June 2025 (&#8220;12.5% Notes&#8221;) and warrants for the purchase of up to 2.0 million common shares, against
      which 428,571 common shares were issued in December 2019 upon exercise.&#160; This financing provided net proceeds of $66,056 after all offering expenses.&#160; A portion of the net proceeds of the financing were used to repay all outstanding obligations and
      early repayment premiums under the Company&#8217;s prior credit facility of $52,944.&#160; We used the remaining net cash proceeds of $13,110 for the continued commercialization and advancement of our proprietary products and pipeline candidates, and other
      general corporate purposes.&#160; The 12.5% Notes are discussed in Note 13, 12.5% Senior Secured Notes, to our condensed consolidated financial statements included herein and in Liquidity and Capital Resources.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On September 11, 2019, we filed with the SEC a Registration Statement on Form S-3, which was declared effective on September 17, 2019 (File No. 353-233716) (the &#8220;S-3 Registration Statement&#8221;).&#160; Under
      the S-3 Registration Statement we may sell up to $150 million of our securities including, without limitation, common stock, preferred stock, warrants, and debt securities.&#160; On September 11, 2019, we entered into an equity distribution agreement to
      offer shares of our common stock from time to time in an &#8220;at-the-market&#8221; offering.&#160; We may offer and sell shares of common stock for an aggregate offering price of $25.0 million.&#160; No shares have been sold pursuant to this &#8220;at-the-market&#8221; offering as
      of the date of this report.&#160; The equity distribution agreement does not have an expiration date but can be canceled by us at any time for convenience with 10 days written notice.&#160; On December 12, 2019, we sold 8,050,000 common shares for gross
      proceeds of $40,250 in an underwritten public offering under the S-3 Registration Statement that netted $37,295 after the underwriter discount and offering costs.&#160; The S-3 Registration Statement also covers the resale of up to an additional 4,222,082
      shares of our common stock for sale by our stockholders and shares issuable upon the exercise of warrants held by the holders of our Noteholders, of which 428,571 shares were acquired when exercised in December 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On November 3, 2020, we entered into the Monetization Agreement with Marathon, that will result in proceeds to us of up to $125,000 in exchange for which the
        Company conveyed to Marathon the right to all royalties and other payments due to us under the Sunovion License Agreement (See Note 6).&#160; Under the terms of the Monetization Agreement, we will receive a $40,000 cash payment within 12 business days
        of signing and we are eligible to receive up to $85,000 of </font>contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain other commercial
      milestones.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">With the upfront proceeds of the monetization, we will repay $22,500 of the 12.5% Notes, and issue $4,000 of new senior notes in lieu of paying a prepayment premium on the early
      repayment of the 12.5% Notes, reducing the balance of senior notes outstanding&#160; to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 our ability to access, at our option, $30,000 of senior notes
      re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at our option, contingent upon FDA approval of our product candidate Libervant.&#160; A second $20,000
      senior notes re-opener represents a right, at our option, to market to current holders of our 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S. market access.&#160; If and to
      the extent that we access these re-openers, we will grant warrants to purchase up to 714,000 shares of&#160; common stock, with the strike price calculated based on the 30-day volume weighted average closing price of our common stock at the warrant grant
      date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of our common stock.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We generated revenues of $38,700 and $36,190 for the respective nine-month periods ended September 30, 2020 and 2019. These revenues were derived primarily from manufacture and supply revenues from
      commercial products licensed to our collaboration or commercialization licensees. Total revenues also included licensing, royalty and co-development and research fees and our proprietary product sales.&#160; Our licensing and royalty revenue is subject to
      the normally uneven nature of the timing of licensing milestone payments and to the product volumes and sales revenues realized by our licensees from which we receive royalties. Suboxone, which was launched in 2010, was our first licensed
      pharmaceutical product to be commercialized, and we have other licensing relationships that contribute to our revenue and future revenue opportunities. Sympazan, which was launched in December 2018, is the first proprietary pharmaceutical product
      commercialized directly by the Company. As of September 30, 2020, we had $17,064 in cash and cash equivalents. As a result of our investments in product development, recent investments in commercialization initiatives, share-based compensation
      expenses surrounding the 2018 initial public offering, among other expenses and legal and other expenses related to patent procurement, protection and prosecution and other matters, as of September 30, 2020, we had an accumulated deficit of $165,889
      resulting in a net shareholders&#8217; deficit of $36,519 as of that date. For the nine-month periods ended September 30, 2020 and 2019, we incurred net losses of $35,415 and $53,610, respectively.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We expect to continue to incur net losses for at least the next few years as we pursue the development, commercialization and marketing of our proprietary product candidates. Our net losses may
      fluctuate significantly from period to period, depending on regulatory approval developments concerning both our late-stage and earlier stage product candidates, the timing of our planned clinical trials and expenditures on our other research and
      development, as well as our commercialization activities. We expect our expenses will continue to be substantial in 2020 and future periods over time as we continue to, subject to any delay as a result of the coronavirus pandemic:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z3f680665d59d4ed2bbbe658a1d7e6a08" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>focus on the approval of Libervant for marketing in the U.S. and, subsequently, if approved, which we cannot assure, its commercialization,</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zebe75befdcfa430ba3f4c3d02ed81585" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>continue clinical development of AQST-108 along the 505(b)(2) pathway, having begun PK clinical trials during the third quarter of 2020, subject to any delay from the coronavirus pandemic, and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z876ec10f181744d6963076f32cb0e3f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>continue to grow Sympazan revenues as a precursor and complement to an eventual launch of Libervant, if approved for U.S. market access.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We expect to continue to manage the timing and level of expenses in light of the declining Suboxone revenues, offset in part by increasing revenue contributions from Sympazan, while focusing on the
      development and regulatory approvals of Libervant and AQST-108 and their subsequent commercialization, if approved by the FDA for U.S. market access.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 17.9pt; margin-right: 0.1pt; margin-left: 0.1pt;">Our business has been financed through a combination of <font style="color: rgb(0, 0, 0);">revenue</font> from licensed product and proprietary product
      activities, proceeds from our IPO and other equity issuances and proceeds from our debt instruments and facilities. Significant additional funding is expected to be required in order to execute our business strategy and operations.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Until we become profitable, if ever, we expect to need to raise significant additional capital in the future through equity or debt issuances, or both, and to continue to manage our expenses to
      extend our capital runway, in order to further the development, regulatory approval, commercialization and marketing of our products and product candidates, and to conduct our business.&#160; We have no committed sources of additional capital and there
      can be no assurance that such needed capital will be available on favorable terms, or at all.&#160; We may seek to obtain additional capital in the future through the issuance of our common stock, through other public or private equity or debt financings,
      through potential non-dilutive capital raising events that may result from royalty streams that may be realizable from our licensed products or licensed intellectual property, and through collaborations or licensing arrangements with other companies
      or other means, if available. We may not be able to raise additional capital or other funding on terms acceptable to us, or at all, and any failure to raise capital as and when needed could compromise our ability to execute our business plan and
      cause us to delay or curtail our operations until such funding is received.&#160; To the extent that we raise additional funds by issuance of equity securities, our stockholders would experience dilution, and other debt financings, if available (and
      subject to all of the existing restrictions and conditions under the Indenture for the 12.5% Notes) may involve increased restrictive covenants and increased fixed payments or may otherwise further constrain our financial flexibility.&#160; To the extent
      that we raise additional funds through collaborative or licensing arrangements, it may be necessary to relinquish some rights to our intellectual property or grant licenses on terms that are not favorable to us.&#160; In addition, payments made by
      potential collaborators or licensors generally will depend upon our achievement of negotiated development and regulatory milestones.&#160; Failure to achieve these milestones may harm our future capital position.&#160; See &#8220;Funding Requirements&#8221; below for
      additional information regarding Aquestive&#8217;s cash needs.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="font-style: italic; font-weight: bold;">Business Update Regarding COVID-19</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The current COVID-19 pandemic has continued to present substantial health and economic risks, uncertainties and challenges to our business, the U.S. and global economies and financial markets.&#160; It is
      not currently possible to predict how long the pandemic will last or the time it will take for the economy to return to prior levels.&#160; The extent to which COVID-19 impacts our business, operations, clinical trials, regulatory approval process,
      capital, financial and monetization markets, financial results and financial condition, and those of our suppliers, distributors, customers and other third parties necessary to our business including those involved in the regulatory approval process,
      will depend on future developments, which are highly uncertain and cannot be predicted with certainty or clarity, including the duration and continuing severity of the outbreak, resurgence of the outbreak, continued or additional government actions
      to contain COVID-19, timing or efficacy of any vaccine, and new information that will emerge concerning the short-term and long-term impact of COVID-19.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">To date, we have been able to continue to manufacture and supply our products and currently do not anticipate any significant interruption in supply, although we continue to monitor this situation
      closely and there is no assurance that disruptions or delays may not occur as a result of COVID-19.&#160; We are also monitoring demand for our products, which could be negatively impacted during the COVID-19 pandemic, as well as the financial condition
      of our customers and licensees, one of whom delayed remittance of certain payments due the Company for development services provided but ultimately made such payments in later Q2 2020.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Our office-based employees have generally been working from home since mid-March 2020, while essential staffing levels in our operations remain on site, and personnel have continued in our
      laboratories and manufacturing locations. In Q1 2020 we suspended in-person interactions by our sales and marketing personnel and engaged remotely to support our commercialization efforts.&#160; Sales and marketing practices continue to evolve in
      accordance with changing local rules and regulations with predominately virtual interactions with healthcare providers.&#160; However, the landscape continues to change as new case rates are rising in certain states and localities and these jurisdictions
      have or are contemplating reestablishing restrictions.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">For additional information on various uncertainties and risks caused by the COVID-19 pandemic, see Part II, Item 1A, Risk Factors included in this report.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Critical Accounting Policies and Use of Estimates</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">See Note 3, <font style="font-style: italic;">Summary of Significant Accounting Policies</font>, to our condensed consolidated financial statements, included herein for a discussion of recently
      issued accounting pronouncements and their impact or future potential impact on our financial results, if determinable.&#160; For a discussion of critical accounting policies that affect our judgments and estimates used in the preparation of our
      consolidated financial statements, refer to &#8220;<font style="font-style: italic;">Critical Accounting Policies and Use of Estimates</font>&#8221; in<font style="font-weight: bold;">&#160;</font>our 2019 Annual Report on Form 10-K.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">JOBS Act</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On April 5, 2012, the Jumpstart Our Business Startups Act, or the JOBS Act, was enacted. The JOBS Act provides that, among other things, an emerging growth company can take advantage of an extended
      transition period for complying with new or revised accounting standards. As an emerging growth company, we have elected to take advantage of the extended transition period afforded by the JOBS Act for the implementation of new or revised accounting
      standards and, as a result, we will comply with new or revised accounting standards not later than on the relevant dates on which adoption of such standards is required for emerging growth companies.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In addition, we intend to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act, subject to certain conditions contained therein and, as a result, we are not
      required to, among other things, (i) provide an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002,&#160; (ii) provide all of the compensation disclosure
      that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or (iii) disclose certain executive compensation-related items such as the correlation between executive compensation
      and performance and comparisons of the Chief Executive Officer&#8217;s compensation to median employee compensation. These exemptions will apply for a period of five years following the consummation of our IPO or until we no longer meet the requirements of
      being an emerging growth company, whichever is earlier.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We are also a &#8220;smaller reporting company,&#8221; meaning that we are not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a &#8220;smaller reporting
      company,&#8221; and have either: (i) a public float of less than $250 million or (ii) annual revenues of less than $100 million during the most recently completed fiscal year and (A) no public float or (B) a public float of less than $700 million. As a
      &#8220;smaller reporting company,&#8221; we are subject to reduced disclosure obligations in our SEC filings compared to other issuers, including with respect to disclosure obligations regarding executive compensation in our periodic reports and proxy statements
      and certain reduced financial disclosures in our periodic reports.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Financial Operations Overview</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Revenues</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Our revenues to date have been earned from manufactured products made to order for licensees, including Suboxone and Zuplenz, as well as revenue from our self-developed, self-commercialized
      proprietary product, Sympazan. Revenues are also earned from our product development services provided under contracts with customers, and from arrangements for the licensing of our intellectual property.&#160; These activities generate revenues in four
      primary categories: manufacturing and supply revenue, co-development and research fees, license and royalty revenue, and proprietary product sales, net.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Manufacture and Supply Revenue</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Currently, we produce two licensed commercialized pharmaceutical products: Suboxone and Zuplenz. We are the exclusive manufacturer for these products. We manufacture based on receipt of purchase
      orders from our licensees, and our licensees have an obligation to accept these orders once quality assurance validates compliance of the manufactured product with agreed upon technical specifications. Under ASC 606, we record revenues once the
      manufactured product passes quality control inspections. Our licensees are responsible for all other aspects of commercialization of these products and the Company has no role, either direct or indirect, in our customers&#8217; commercialization
      activities, including those related to marketing, pricing, sales and regulatory operations.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We expect future manufacture and supply revenue from licensed products to be based on volume demand for existing licensed products, and for manufacturing and supply rights under license and supply
      agreements for existing or new agreements for successful product development collaborations.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Co-development and Research Fees</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We work with our licensees to co-develop pharmaceutical products. In this regard, we earn fees through performance of specific tasks, activities, or completion of stages of development defined within
      a contractual arrangement with the relevant licensee. The nature and extent of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as
      the complexity of the product and the specific regulatory approval path necessary for that product.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">License and Royalty Revenue</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We<font style="color: rgb(0, 0, 0);"> may realize licensing revenue from transfers of our licenses.&#160; For licenses that do not require further development or other ongoing activities by us, our
        licensee has acquired the right to use the licensed intellectual property for self-development of their product candidate, for manufacturing, commercialization or other specified purposes upon the effective transfer of those rights, and related
        revenues are generally recorded at a point in time, subject to contingencies or constraints, if any.&#160; For licenses that may provide substantial value only in conjunction with other performance obligations to be provided by us, such as development
        services or the manufacture of specific products, revenues are generally recorded over the term of the license agreement.&#160; </font>We also may earn royalties based on our licensees&#8217; sales of products that use our intellectual property that are
      marketed and sold in the countries where we have patented technology rights.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Proprietary Product Sales, net</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">As we commercialize FDA approved proprietary CNS product candidates, we may directly sell such products to distributors of wholesale medical products in the United States, resulting in an additional
      and growing source of revenue. We commercialized our first proprietary CNS product, Sympazan, in December 2018.&#160; We currently sell Sympazan through wholesalers for distribution through retail pharmacies. Additionally, we may choose to access
      non-domestic markets by contracting with a collaborator to commercialize our product candidates in certain foreign markets. To date, the only revenue generated from our self-developed and self-commercialized pharmaceutical products is from the sale
      of Sympazan in the United States.<br>
      <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Revenues from sales of proprietary product are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions, each of which are
      described in more detail in our 2019 Annual Report on Form 10-K. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a
      reduction of the transaction price at the time of the sale. The Company records these estimated amounts in connection with the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such
      transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other
      related information that may require adjustments in the future. The adequacy of these provisions is reviewed on a quarterly basis.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Costs and Expenses</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Our costs and expenses are primarily the result of the following activities: generation of manufacture and supply revenues; development of our pipeline of proprietary product candidates; and selling,
      general and administrative expenses, including pre-launch and post launch commercialization efforts related to our CNS product candidates, intellectual property procurement, protection, prosecution and litigation expenses, corporate management
      functions, medical and clinical affairs administration, public company costs, share-based compensation expenses and interest on our corporate borrowings. We primarily record our costs and expenses in the following categories:</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Manufacture and Supply Costs and Expenses</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Manufacture and supply costs and expenses are primarily incurred from the manufacture of our commercialized licensed pharmaceutical products and for our self-developed, self-commercialized approved
      proprietary product, including raw materials, direct labor and overhead costs, principally in our Portage, Indiana facilities.&#160; Our material costs include the costs of raw materials used in the production of our proprietary dissolving film and
      primary packaging materials. Direct labor costs consist of payroll costs (including taxes and benefits) of employees engaged in production activities.&#160; Overhead costs principally consist of indirect payroll, facilities rent, utilities and
      depreciation for leasehold improvements and production machinery and equipment. These costs can increase, or decrease based on the costs of materials, purchased at market pricing, and the amount of direct labor required to produce a product, along
      with the allocation of fixed overhead, which is dependent on production volume.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We expect to continue to seek to rationalize and manage costs to reflect the declining production volumes of Suboxone.&#160; Our unit production costs of manufacture and supply increased in late 2019,
      resulting from the declining volume of Suboxone that began in 2019 and that continues to decline in 2020.&#160; We expect our overall manufacture and supply expense levels to decrease over the next several years due to the effects of lower Suboxone volume
      caused by competing generic products, modestly offset by the costs to manufacture our proprietary products, which began with the launch of Sympazan in December 2018.&#160; In addition to our proprietary products coming online, we may add licensed products
      which may need additional resources to manufacture.&#160; If such growth should occur for higher volume product opportunities such as Suboxone, we would incur increased costs associated with hiring additional personnel to support the increased manufacture
      and supply costs arising from higher manufactured volumes from proprietary and licensed products.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">Research and Development Expenses</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Since our inception, we have focused significant resources on our research and development activities.&#160; Research and development expenses primarily consist of:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2dcd6b2749864681aa2f6d12bd916bfe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>employee-related expenses, including compensation, benefits, share-based compensation and travel expenses;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z099cdeb7bc324a92a03a688d15952381" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>external research and development expenses incurred under arrangements with third parties, such as contract research organizations, investigational sites and consultants, including costs associated with preclinical and clinical activities
              and regulatory operations;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z6e6e91dfc59a4dc1b20d3f59b877a41e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>the cost of acquiring, developing and manufacturing clinical study materials; and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z21cbe22c8c35474ca39b590faca52452" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>costs associated with preclinical and clinical activities and regulatory operations and activities.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We expect our research and development expenses to continue to be significant over the next several years as we continue to seek to obtain U.S. marketing access for our Libervant product candidate
      and continue to develop existing product candidates such as AQST-108, AQST-305 and others, and we identify and develop or acquire additional product candidates and technologies.&#160; We may hire or engage additional skilled colleagues or third parties to
      perform these activities, conduct clinical trials and ultimately seek regulatory approvals for any product candidate that successfully completes those clinical trials.</div>
    <div style="text-align: justify; text-indent: 18pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="font-style: italic;">Selling, General and Administrative Expenses</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Selling, general and administrative expenses consist primarily of salaries, benefits, share-based compensation, commercialization and marketing costs, and other related costs for executive, finance,
      selling and operational personnel. Other significant costs include facility and related costs not otherwise included in research and development expenses such as: professional fees for patent-related and other legal expenses, consulting, tax and
      accounting services; insurance, selling, market research, advisory board and key opinion leaders, depreciation, and general corporate expenses, inclusive of IT systems related costs.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">A significant portion of selling, general and administrative expenses relate to the sales and marketing of our proprietary product, at this time Sympazan.&#160; Sympazan is the precursor and compliment to
      the launch of Libervant, assuming that it is approved and granted U.S. marketing access.&#160; We believe there is a very high degree of overlap and correlation between prescribers of Sympazan and the likely prescribers of an approved Libervant.&#160; While
      Sympazan continues to grow, we will continue to rationalize its contribution to move towards profitability while continuing to introduce epilepsy prescribers and patients to Aquestive and PharmFilm technology in advance of the anticipated launch of
      Libervant.&#160; The current commercial organization would begin the launch of Libervant, subject to its approval for U.S. marketing access, which cannot be assured, shortly after its approval.&#160;&#160; Until any Libervant launch is certain, we do not plan to
      increase the costs of our commercial organization and will expect to continue to improve the efficiency of the Sympazan commercial investments.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Our general and administrative costs include costs related to accounting, audit, legal, regulatory and tax-related services required to maintain compliance with exchange listing and SEC regulations,
      director and officer insurance costs, and investor and public relations costs.&#160; We continue to incur significant costs in seeking to protect our intellectual property rights, including significant litigation costs in connection with seeking to
      enforce our rights concerning third parties&#8217; at-risk launch of generic products.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">We will continue to manage our costs to appropriately reflect the declining Suboxone revenue, the marketing and sales costs related to Sympazan and other external factors affecting our business
      including the continuing impact of the COVID-19 pandemic, as we continue to focus on our core business:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze8dba4b8257a47d2b272a357877089c1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>Seeking to obtain the approval and subsequent launch of Libervant, subject to approval by the FDA for marketing in the U.S., which cannot be assured.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcf0b7207e9174236bf24e2c6050c65a8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>Continuing the development of AQST-108 along the 505(b)(2) pathway having begun PK clinical trials during the third quarter of 2020, subject to any delays associated with the coronavirus pandemic; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zecc5494ca6194945aa6ea9a050ab286b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18.3pt; vertical-align: top;">&#8226;</td>
          <td style="vertical-align: top; text-align: justify;">
            <div>Growing the revenue contribution from Sympazan as a first step to position Aquestive in the epilepsy community.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="font-style: italic;">Interest Expense</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Interest expense consists of interest costs at a fixed rate of 12.5%, payable quarterly, related to our currently outstanding debt obligation at the face amount of $70,000, as well as amortization of
      related loan costs and the debt discount.&#160; The 12.5% Notes are discussed in Note 13, 12.5% Senior Secured Notes, and our planned reduction in the 12.5% Notes, resulting from the KYNMOBI&#8482; royalty monetization, is discussed in Note 19(C), Subsequent
      Event, to our Consolidated Financial Statements and in Liquidity and Capital Resources.&#160; Interest expense has increased based on the additional borrowings under the 12.5% Notes period over period but in the future interest expense is expected to
      decrease as a result of the November 2020 debt reduction described above.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-style: italic;">Interest Income</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Interest income consists of earnings derived from an interest-bearing account. There is no minimum amount to be maintained in the account nor any fixed length of period for which interest is earned.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Results of Operations</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Comparison of the Three-Month Periods Ended September 30, 2020 and 2019</div>
    <div><font style="font-weight: bold; font-style: italic; color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">We recorded revenue of $8,260 and $12,418 during the three-month periods ended September 30, 2020 and 2019, respectively, and incurred net losses of $16,551 and $18,412 for those
      three-month periods.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0);"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="color: rgb(0, 0, 0);"><font style="font-style: italic;">Revenues</font>:</div>
    <div style="color: #000000;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" id="z959ca3a087444d0d87b1b8320f023e0a">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6" rowspan="1">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6" rowspan="1">&#160; <br>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Change</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-style: italic;">(In thousands, except %)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -7pt;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">&#160;$</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: #000000; font-weight: bold;"><br>
            </div>
          </td>
          <td style="vertical-align: top; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">%</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,903</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">9,155</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(3,252</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(36</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">License and royalty revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">328</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,356</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(1,028</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(76</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Co-development and research fees</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">341</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,073</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(732</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(68</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Proprietary product sales, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,688</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">854</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">102</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">8,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">12,418</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(4,158</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(33</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">For the three-month period ended September 30, 2020, total revenues decreased 33% or $4,158 to $8,260 compared to revenues of $12,418 for the same period in 2019. </font>The





      change is primarily attributable to decreases in manufacture and supply revenue, license and royalty revenue and co-development and research fees, offset in part by an increase in proprietary product sales, net.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Manufacture and supply revenue decreased 36% or $3,252 to $5,903 for the three-month period ended September 30, 2020 compared to $9,155 recognized during the same period in the prior year. This
      decrease is attributable to lower volume in 2020 partially offset by increased pricing associated with our Suboxone product affecting the current period.&#160;&#160; We expect Suboxone to continue to experience market share erosion as generic competition
      continues to take more market share.&#160; We continue to plan for the further erosion of this sunsetting product over time.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">License and royalty revenue decreased 76% or $1,028 to $328 for the three-month period ended September 30, 2020 compared to revenues of $1,356 from the prior year period. This change was primarily
      related to the inclusion of $1,000 from our 10% share of milestone payments paid to KemPharm during September 2019, under its licensing of KP-415 and KP-484.&#160; There were no milestone payments received during the three months ended September 30, 2020
      and there is no assurance that any such payments will be made in the future.&#160; &#160; Royalty revenues earned on Suboxone and Zuplenz remained relatively flat year-over-year. License fees are generally driven by transfer of rights, patent performance
      contingencies, specific FDA or other regulatory achievements, sales levels achievements or other contingencies and milestones, and will likely fluctuate significantly from quarter-to-quarter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Co-development and research fees decreased 68% or $732 to $341 for the three-month period ended September 30, 2020 compared to $1,073 from the prior year period. The decrease was driven by the timing
      of the achievement of research and development performance obligations and are normally expected to fluctuate significantly from one reporting period to the next.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Proprietary product sales, net increased 102% or $854 to $1,688 for the three-month period ended September 30, 2020 compared to $834 during the prior year period due to increased Sympazan
      prescriptions written by CNS physicians and improved payor approval rates.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Expenses and Other:</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" id="z96b5f89b07be49cc86aea7fadbd3aa99">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Change</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-style: italic;">(In thousands, except %)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold;" colspan="2">$</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="1">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center;">%</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,978</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,643</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(1,665</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(36</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Research and development</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">7,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">5,063</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,197</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">43</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">11,803</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">13,714</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(1,911</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(14</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Interest expense</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,778</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,652</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">126</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">5</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Interest income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(8</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(138</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(130</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(94</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loss on extinguishment of debt</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right;" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right;" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: right; color: rgb(0, 0, 0);">NM</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Manufacture and supply costs and expenses decreased 36% or $1,665 to $2,978 for the three-month period ended September 30, 2020 compared to $4,643 for the same period in 2019.&#160;
      The decrease was primarily due to lower volumes of Suboxone in the 2020 period compared to 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Research and development expenses increased 43% or $2,197 to $7,260 for the three-month period ended September 30, 2020 compared to $5,063 recorded during the prior
        year period. </font>Research and development expenses are driven primarily by the timing of clinical trial and other product development activities associated with the Company&#8217;s pipeline<font style="color: rgb(0, 0, 0);">.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Selling, general and administrative expenses decreased 14% or $1,911 to $11,803 for the three-month period ended September 30, 2020 as compared to $13,714 for the
        prior year period. </font> The Company continues to tightly manage selling, general and administrative expenses to focus our investments on continued development of our key pipeline products, Libervant and AQST-108, and the continued commercial
      growth of Sympazan, our first commercialized proprietary product.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Interest expense increased 5% or $126 to $2,778 for the three-month period ended September 30, 2020 compared to $2,652 for the same period in 2019. This was the
        result of $20,000 of additional outstanding</font> debt and related higher loan acquisition and discount costs associated with the issuance of the 12.5% Notes on July 15, 2019.&#160; Prior to July 15, 2019, our interest expense was subject to
      fluctuations based on one-month LIBOR under the prior Perceptive Loan and was approximately 12% to 12.5%.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Interest income decreased 94% or $130 for the three-month period ended September 30, 2020, compared to the prior year period. </font>This decrease is a result of
      lower interest rates and investing lower net cash balances during 2020 compared to the same period in 2019<font style="color: rgb(0, 0, 0);">.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Loss on the extinguishment of debt during the three-month period ended September 30, 2019 represented the expenses incurred to prepay our loans payable to Perceptive Credit
      Opportunities Fund including the remaining unamortized debt discount and loan acquisition costs and a prepayment premium.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Comparison of the Nine-Month Periods Ended September 30, 2020 and 2019</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">We recorded revenue of $38,700 and $36,190 during the nine-month periods ended September 30, 2020 and 2019, respectively, and incurred&#160; net losses of $35,415 and $53,610 for
      those periods.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Revenues:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" id="zda9348b018f1401aa34dff7f795ca6d8">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Change</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-style: italic;">(In thousands, except %)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold;" colspan="2">$</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="1">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center;">%</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">20,078</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">24,739</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(4,661</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">License and royalty revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">13,682</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">6,402</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">7,280</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">114</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Co-development and research fees</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">870</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,862</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(1,992</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(70</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Proprietary product sales, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,070</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,187</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,883</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">86</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">38,700</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">36,190</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">2,510</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">7</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">For the nine-month period ended September 30, 2020, total revenues increased 7% or $2,510 to $38,700 compared to revenues of $36,190 for the same period in 2019. The change is
      primarily attributable to increases in license and royalty revenue and proprietary product sales revenue for Sympazan, offset in part by decreases in manufacture and supply revenue and in co-development and research fees.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Manufacture and supply revenue decreased 19% or $4,661 to $20,078 for the nine-month period ended September 30, 2020 compared to $24,739 recognized during the prior year period.
      This decrease is attributable to lower Suboxone volume in 2020 partially offset by increased pricing.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">License and royalty revenue increased 114% or $7,280 to $13,682 for the nine-month period ended September 30, 2020 compared to revenues of $6,402 realized during
        the comparable prior year period. License fees decreased $1,250 during these periods. The 2020 period included a $4,000 milestone payment earned </font>upon the FDA approval, in May, and commercial launch in September of Sunovion&#8217;s KYNMOBI&#8482;
      product whereas the 2019 period included $1,000 from our 10% share of milestone payments paid to KemPharm and $4,250 in license and new patent fees derived from our licensed product Suboxone.&#160; In the 2020 period, royalty revenue increased
      significantly due to $8,000 of KYNMOBI&#8482; royalties recognized upon the approval of KYNMOBI&#8482; while royalty revenues earned on Suboxone and Zuplenz slightly increased year-over-year. All further license fees due from Indivior related to Suboxone have
      been suspended pending the outcome of litigation related to infringement claims against the generic products that have launched &#8220;at risk.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Co-development and research fees decreased 70% or $1,992 to $870 for the nine-month period ended September 30, 2020 compared to $2,862 during the prior year period. The decrease
      was driven by the timing of the achievement of research and development performance obligations, which typically fluctuate significantly from one reporting period to the next.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Proprietary product sales, net increased 86% or $1,883 during the nine-month period ended September 30, 2020 to $4,070, compared to the same prior year period of $2,187.
      Acceptance within medical and patient communities has steadily continued to improve following Sympazan&#8217;s launch in December 2018.</div>
  </div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
  </div>
  <!--PROfilePageNumberReset%Num%3%%%-->Expenses and Other:
  <div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" id="z6a860bd84137467c9d7eceeab69bc274">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%;" rowspan="1"><br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div>
            <div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Change</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-style: italic;">(In thousands, except %)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-weight: bold; text-align: center; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">&#160;2020</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">&#160;$</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 1%;" colspan="1">
            <div style="color: #000000; font-weight: bold;"><br>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center;">%</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">10,176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">13,569</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(3,393</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(25</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Research and development</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">15,461</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">17,517</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(2,056</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">40,310</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">47,868</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(7,558</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(16</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Interest expense</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">8,296</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">6,515</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">1,781</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">27</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Interest income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(128</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(565</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(437</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">(77</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="color: rgb(0, 0, 0);">%)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loss on extinguishment of debt</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">(4,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: right; color: rgb(0, 0, 0);">NM</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Manufacture and supply costs and expenses decreased 25% or $3,393 to $10,176 for the nine-month period ended September 30, 2020 compared to $13,569 for the same period in 2019.
      The decrease primarily reflected lower volumes of Suboxone in the 2020 period compared to 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Research and development expenses decreased 12% or $2,056 to $15,461 for the nine-month period ended September 30, 2020 compared to $17,517 for the same prior year period.
      Research and development expenses are driven primarily by the timing of clinical trial and other product development activities associated with the Company&#8217;s pipeline.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Selling, general and administrative expenses decreased 16% or $7,558 to $40,310 for the nine-month period ended September 30, 2020 compared to $47,868 for the same prior year
      period. The decrease was driven by careful and prudent management of expenses primarily in sales and marketing as well as factory overhead costs.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Interest expense increased 27% or $1,781 to $8,296 for the nine-month period ended September 30, 2020 compared to $6,515 for the same period in 2019, primarily from higher debt
      balances starting in the third quarter 2019. Prior to July 15, 2019, our interest expense was subject to fluctuations based on one-month LIBOR.&#160; Our 12.5% Senior Secured Notes carry a 12.5% fixed interest rate per annum, with an increased principal
      amount outstanding thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Interest income decreased 77% or $437 for the nine-month period ended September 30, 2020, compared to the same prior year period. </font>This decrease is a result
      of lower interest rates and investing lower net cash balances during 2020 compared to the same period in 2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Loss on the extinguishment of debt during the three months ended September 30, 2019 represented the expenses incurred to prepay our loans payable to Perceptive Credit
      Opportunities Fund including the remaining unamortized debt discount and loan acquisition costs and a prepayment premium.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Liquidity and Capital Resources</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Sources of Liquidity</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Since our inception in January 2004, we have incurred significant losses and as of September 30, 2020, we have a net stockholders&#8217; deficit of $36,519. We have funded our operations primarily with
      equity and debt financings, with gross margins from sales of commercialized licensed and proprietary products, and with license fees, milestone and royalty payments from our commercial partners and co-development licensees. We had $17,064 in cash and
      cash equivalents as of September 30, 2020 and working capital of $13,311.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On November 3, 2020, we entered into the Monetization Agreement with Marathon, that will result in proceeds to us of up to $125,000 in exchange for which we
        conveyed to Marathon the right to all royalties and other payments due to us under the Sunovion License Agreement (See Note 6).&#160; Under the terms of the Monetization Agreement, we will receive a $40,000 cash payment within 12 business days of
        signing the Monetization Agreement and we are eligible to receive up to $85,000 of </font>contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain
      other commercial milestones.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">With the upfront proceeds paid to the Company under the Monetization Agreement, we will repay $22,500 of the 12.5% Notes, and issue $4,000 of new senior notes in lieu of paying a
      prepayment premium on the early repayment of the 12.5% Notes, reducing the balance of senior notes outstanding to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 our ability to access, at our
      option, $30,000 of senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at our option, contingent upon FDA approval of our product candidate
      Libervant.&#160; A second $20,000 senior notes re-opener represents a right, at our option, to market to current holders of our 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for
      U.S. market access.&#160; If and to the extent that we access these re-openers, we will grant warrants to purchase up to 714,000 shares of common stock, with the strike price calculated based on the 30-day volume weighted average closing price of our
      common stock at the warrant grant date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of our common stock.</div>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">We generate revenue from licensed products and proprietary product sales, certain product development and licensing agreements and related activities. We have invested the
      margins from product sales and our other revenue sources, as well as proceeds from debt and equity securities in the development of those marketed products as well as development of our proprietary CNS and complex molecule pipeline and in development
      and growth of our growing patent portfolio. We also invested those financial resources in the protection and prosecution of those patents, in developing the commercialization aspects of our organization, in bringing our first self-developed CNS
      product to market and in developing our organization from private ownership to publicly owned status. The costs of these initiatives and concurrent growth, along with interest expenses and other costs of funding resulted in the $165,889 deficit we
      have accumulated from inception.</div>
    <div style="text-align: justify; text-indent: 22.5pt; color: rgb(0, 0, 0);"> <br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law as the pandemic continued to affect our nation&#8217;s economy. Among the
      significant goals of the CARES Act was to provide increased liquidity for businesses through deferral of employer payroll taxes, a tax credit for retaining employees and other provisions. We currently expect to benefit from the provision to defer the
      payment of certain employer payroll taxes of approximately $0.5 million for calendar year 2020, of which approximately $0.3 million has been deferred as of September 30, 2020. It is currently expected that half of these deferrals will become due at
      each of December 31, 2021 and December 31, 2022, respectively.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Cash Flows</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Nine-Month Periods Ended September 30, 2020 and 2019</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z5b317ff088ef44cab9f7cc16a12ca388">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic;">(in thousands)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net cash (used for) operating activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>(31,947</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>(49,635</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net cash (used for) investing activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div>(281</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div>)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div>(577</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
            <div>)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net cash (used for)/provided by financing activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div>(34</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
            <div>)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div>10,527</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net decrease in cash and cash equivalents</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>(32,262</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div>)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
            <div>(39,685</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">
            <div>)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Net Cash (Used for) Operating Activities</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Net cash used for operating activities for the nine-month period ended September 30, 2020 was $31,947.&#160; The use of cash can be understood as represented by three major factors: (1) our net loss of
      $35,415, (2) incremented by a net decrease in operating assets and liabilities of $5,713 partially offset by (3) non-cash operating expenses. The non-cash operating expenses of $9,181 primarily resulted from $5,052 of share-based compensation expense
      recorded in the nine months ended September 30, 2020.&#160; Other significant components included non-cash charges of $4,129 related to depreciation and amortization of debt issuance costs.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Net cash used for operating activities for the nine-month period ended September 30, 2019 was $49,635.&#160; The use of cash is attributable to: (1) our net loss of $53,610, (2) a net decrease in
      operating assets and liabilities of $9,822 partially offset by (3) non-cash operating expenses.&#160; The non-cash operating expenses of $13,797 primarily resulted from $5,199 of share-based compensation expense and a $4,896 loss on early extinguishment
      of our debt to Perceptive Credit Opportunities Fund recorded during this period.&#160; Other significant components included non-cash charges of $3,702 related to fixed asset depreciation and amortization of debt issuance costs.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Cash used by operations improved in 2020 compared to 2019 comparable periods due to management of costs and expenses in 2020 to focus on key priorities as discussed above.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Net Cash (Used for) Investing Activities</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Net cash used for investing activities was $281 for the nine-month period ended September 30, 2020 compared to $577 for the comparative prior year period.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="font-style: italic; font-weight: bold;">Net Cash (Used for)/Provided by Financing Activities</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Net cash used for financing activities was $34 for the nine-month period ended September 30, 2020 compared to $10,527 net cash provided during the corresponding period in 2019.&#160; The cash used in 2020
      is a result of payment for withholding taxes on share-based compensation offset, in part, by proceeds received from employees participating in the Company&#8217;s Employee Stock Purchase Plan.&#160; The cash provided in 2019 results primarily from the excess of
      proceeds received from the issuance of the 12.5% Notes, described below, of $70,000 over cash used for the repayment of the $50,000 loan principal repaid to Perceptive, a related early repayment premium of $2,944 and $3,918 of loan acquisition costs
      associated with the 12.5% Notes. We also paid $2,723 for withholding taxes associated with tax reimbursements connected to certain share-based compensation incurred in 2018.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">12.5% Senior Secured Notes</div>
    <div style="text-align: justify; text-indent: 27pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">On July 15, 2019 we issued $70,000 aggregate principal amount of the 12.5% Notes and Warrants under the Indenture for the 12.5% Notes (&#8220;Indenture&#8221;).&#160; In addition, the Indenture provides opportunity
      to issue up to $30,000 of additional 12.5% Notes under certain conditions for a total possible issuance amount of $100,000. Also, in July 2019, in connection with our issuance of the12.5% Notes we repaid all outstanding amounts due under the Loan
      Agreement with Perceptive Credit Opportunities Fund dated August 16, 2016.</div>
    <div style="text-align: justify; text-indent: 27pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The net proceeds from the issuance of the12.5% Notes was $66,054, after deducting expenses of the transaction.&#160; We used a portion of the net proceeds to repay an aggregate amount of $52,092 of
      existing Perceptive indebtedness, comprised of the outstanding principal amount, all accrued and unpaid interest and applicable prepayment and end-of-term fees, owed to Perceptive under the Credit Agreement and Guaranty (described below). We used the
      remaining net cash proceeds of approximately $13,110 for the continued commercialization and advancement of our proprietary products and pipeline candidates, and other general corporate purposes.</div>
    <div style="text-align: justify; text-indent: 27pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The additional 12.5% Notes can be issued if we satisfy certain conditions and achieve certain milestones related to the filing and approval of our epilepsy product candidate, Libervant, and there are
      available purchasers for the additional 12.5% Notes.&#160; Specifically, on or prior to March 31, 2021, we may issue an additional $10,000 aggregate principal amount of the 12.5% Notes if we filed a new drug application for our candidate Libervant with
      the FDA prior to that date, provided we have obtained the written consent of the holders of a majority in aggregate principal amount outstanding under the 12.5% Notes in their discretion, which cannot be assured (first reopener) and, on or prior to
      March 31, 2021, up to an additional $30,000 (less the amount of any first reopener additional 12.5% Notes issued by us) if the Company obtains FDA approval of Libervant for U.S. market access prior to that date.&#160; There can be no assurance that FDA
      approval will be granted or that such additional financing will be consummated.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Interest on the 12.5% Notes accrues at a rate of 12.5% per annum and is payable quarterly in arrears on March 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>,
      June 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>, September 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> and December 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of each year commencing on September 30, 2019.&#160; On each payment date commencing on September 30, 2021, we will also pay an installment of principal of the 12.5% Notes pursuant to a fixed amortization
      schedule.&#160; The stated maturity date of the 12.5% Note is June 30, 2025.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Collateral for the loan consists of a priority lien on substantially all assets, including intellectual property, of the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Under the original terms of the Indenture, we have the right to monetize our royalty and milestone interests derived from an IP licensing agreement with Sunovion Pharmaceuticals Inc.in its recently
      launched apomorphine-based product, KYNMOBI&#8482;.&#160; Upon any such monetization we are required to offer to purchase each holder&#8217;s 12.5% Notes on a pro rata basis at a repurchase price in cash equal to 112.5% of the principal amount of such 12.5% Notes,
      plus accrued interest and unpaid interest, if any, thereon to the repurchase date.&#160; The maximum amount that can be offered for repurchase is $40,000, or $50,000 if the first reopener has been issued and funded.&#160; The amount of 12.5% Notes repurchased
      will be at the discretion of the holders of the 12.5% Notes.&#160; See Note 13, 12.5% Senior Secured Notes, to our Condensed Consolidated Financial Statements.&#160; To the extent that the holders of the Notes do not elect repayment of the debt in connection
      with any such monetization, the amount not elected up to $40 million (or $50 million if the first reopener has been funded) is required to be held in a collateral account until Libervant is approved by the FDA for U.S. market access. Certain aspects
      of this Indenture were modified in November 2020, as outlined below.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Indenture permits us, upon the continuing satisfaction of certain conditions, including that we have at least $75,000 of net revenues for the most recently completed twelve calendar month period,
      to enter into an asset-based borrowing facility (&#8220;ABL Facility&#8221;) not to exceed $10,000. The ABL Facility may be collateralized by assets constituting only inventory, accounts receivable and the proceeds thereof of the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Affirmative and negative covenants and restrictions specified in the Indenture are considered typical for loans of this nature, including, but not limited to, requirements relating to preservation of
      corporate existence, publicly traded status, intellectual property and business interests; limitations or prohibitions of dividend payments or other distributions, repurchases of shares, asset transfers or dispositions, creation or occurrence of
      additional liens and security interests, and entering into licensing or monetization arrangements other than as permitted under the Indenture.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">38</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">The Indenture also restricts additional indebtedness except only such indebtedness as is expressly permitted under the terms of the Indenture (which includes the ABL Facility) on the terms and
      conditions set forth in the Indenture and such indebtedness as may be permitted under limitations set forth in the Indenture.&#160; The Indenture also restricts the issuance of any &#8220;Disqualified Stock&#8221; including, generally, mandatorily redeemable
      securities or securities redeemable at the option of the holder or securities convertible or exchangeable at the option of the holder for indebtedness of the Company or for other Disqualified Stock.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">In connection with this financing, we issued Warrants to the initial holders of the 12.5% Notes. These Warrants provide rights to purchase up to an aggregate of 2,000,000 shares of common stock at a
      price of $4.25 per Warrant.&#160; Warrants for 428,571 of common shares were exercised in December 2019 generating proceeds of $1,829.&#160; The Company registered the Warrants and associated shares as part of our S-3 Registration Statement.&#160; There were no
      Warrants exercised in the nine-month period ended September 30, 2020.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">With the upfront net proceeds paid under the Monetization Agreement, we will repay $22,500 of the 12.5% Notes, and issue $4,000 of new senior notes in lieu of paying a prepayment
      premium on the early repayment of the 12.5% Notes,&#160; reducing the senior notes outstanding&#160; to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 our ability to access, at our option, $30,000 of
      senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at our option, contingent upon FDA approval of our product candidate Libervant. A second
      $20,000 senior notes re-opener represents a right, at our option, to market to current holders of our 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S. market access,
      which cannot be assured.&#160; If and to the extent that we access these re-openers, we will grant warrants to purchase up to 714,000 shares of&#160; common stock, with the strike price calculated based on the 30-day volume weighted average closing price of
      our common stock at the time warrant grant date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of our common stock.</div>
    <div><br>
    </div>
    <div style="font-style: italic; font-weight: bold;">Equity Offering</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">Our current cash balance is also incremented as a result of the December 17, 2019 completion of an equity offering of 8,050,000 shares of common stock pursuant to our S-3 Registration Statement,
      including exercise of the underwriter&#8217;s over-allotment option, resulting in gross proceeds of approximately $40,250 before underwriter discounts and other costs and expenses. Net proceeds were $37,835.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Future Capital Requirements</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">We believe that our existing cash and cash equivalents combined with ultimate and timely realization of expected recurring revenue streams and proceeds from potential debt or
      equity transactions will be adequate to fund our expected operating and capital costs and to service our debt costs for the next 12 months.&#160; We have based this expectation on an operating plan and related assumptions that depend on various
      forward-looking factors that could change, or prove to be inaccurate, and additionally, we could utilize our available financial resources sooner than we currently expect. Our existing cash resources are not alone sufficient to fund our expected
      development, commercialization and other operations and activities, and we expect to continue to require external sources of funding and capital to develop and seek regulatory approval of our product candidates and for the commercialization of our
      approved products. Key factors and assumptions inherent in our planned continued operations and anticipated growth include, without limitation, those related to the following:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zbe3ca4d0a0ce4d48b4a98de8936aba60" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">the effects of the COVID-19 pandemic on our operations, operations of our key suppliers and third-party clinical and other service providers, our employees and contractors and debt, equity and other capital
              markets;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z552450e3cd294e32ba1ddc6d031202d7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for our manufactured goods, Suboxone and Sympazan, including effects of generics and other
              competitive pressures as currently envisioned;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zdad663ba7e5d457a995001384482ce9d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for provided co-development and feasibility services, as well as regulatory support services
              for recently licensed products, such as Exservan;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9a517265af6d41be8c07412dc82e715f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">access to debt or equity capital markets if, and at the time, needed for any necessary future funding;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">39</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z4f0d79c6c0464bd489c4e44e7c11fd73" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">FDA approval of our key new drug candidate, Libervant, for U.S. market access. We submitted the NDA filing for Libervant in the fourth quarter of 2019 and received a PDUFA date of September 27, 2020. We
              received a Complete Response Letter on September 25, 2020 denying approval of the NDA in its current form.&#160; We are planning to resubmit the NDA to the FDA and to seek to demonstrate that Libervant is &#8220;clinically superior&#8221; as a major
              contribution to patient care to gain U.S. market access. There can be no assurance that we will obtain approval of Libervant for U.S. market access;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za4ec8dd103f94b84aeb740eb3adb276d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">our ability to issue additional lender committed debt in an aggregate amount of $10,000 of additional 12.5% Notes, which is contingent upon FDA product approval of Libervant, noted above;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="ze63bef7c32624469b7774bcde6b408a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">our ability to issue additional marketable debt in an aggregate amount of up to $20,000 of additional 12.5% Notes, which is contingent upon FDA product approval of Libervant for U.S. market access, noted above;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z634d2e6eb84b489288c73ca1ce52a3ff" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">continuing review and appropriate adjustment of our cost structure consistent with our anticipated revenues and funding;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="ze2102efb8a9542daa1169ff35a8f9cd3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">continued growth and market penetration of Sympazan within expected commercialization cost levels for this product, including anticipated patient and physician acceptance and our ability to obtain adequate
              price and payment support from government agencies and other private medical insurers;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z4febb93bdca8444ab7c524e4991b1e24" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">effective commercialization within anticipated cost levels and expected ramp-up timeframes of our product candidate Libervant, if approved for U.S. market access by the FDA;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z006e37bd19e64d26b941d2facf164dc2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">infrastructure and administrative costs at expected levels to support operations as an FDA and highly regulated public company;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z40af2e9f36b844259982c1216a68fbad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">a manageable level of costs for ongoing efforts to protect our intellectual property rights, including litigation costs in connection with seeking to enforce our rights concerning third parties&#8217; at-risk launch
              of generic products;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z1519332b34184c1aab2eccfdeeb1de31" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">continued compliance with all covenants under our 12.5% Notes; and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z450078301cdf401ea388127bfa9e55ea" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">absence of significant unforeseen cash requirements.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">We expect to continue to manage business costs to appropriately reflect the declining state of Suboxone revenues, the marketing and sales costs related to Sympazan, the proceeds
      from any KYNMOBI&#8482; monetization and other external resources or factors affecting our business including, if available, any future potential issuances of additional 12.5% Notes under the Indenture, net proceeds of future equity financing, or other
      future access to the capital markets under our shelf registration statement filed with the SEC and effective September 17, 2019 or other potential available sources of liquidity, as well as the uncertainties associated with the coronavirus pandemic.
      In doing so, we plan to continue to focus on the core drivers of value for our stockholders, including, most importantly continued investments in our ongoing product development and planned commercialization activities in support of Libervant and
      AQST-108. Until profitability is achieved, if at all, additional capital and/or other financing or funding will be required, which could be material, to further advance the development and commercialization of Libervant and AQST-108, if approved by
      the FDA for U.S. market access, both of which are subject to regulatory approval, and to meet our other cash requirements, including debt service. We plan to conservatively manage our pre-launch spending as to both timing and level relating to
      Libervant, including cost rationalization associated with marketing and selling Sympazan.&#160; In this regard, absent spending on launch activities for Libervant, we expect to spend less on commercialization in 2020 compared to 2019.&#160; Even as such, we
      expect to continue to incur losses and negative cash flows and therefore we expect to be dependent upon external financing and funding to achieve our operating plan.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On November 3, 2020, we entered into the Monetization Agreement with Marathon, that will result in proceeds to us of up to $125,000 in exchange for which we
        conveyed to Marathon the right to all royalties and other payments due to us under the Sunovion License Agreement (See Note 6).&#160; Under the terms of the Monetization Agreement, we will receive a $40,000 cash payment within 12 business days of
        signing and we are eligible to receive up to $85,000 of </font>contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain other commercial milestones.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">With the upfront proceeds paid to the Company under the Monetization Agreement, we will repay $22,500 of the 12.5% Notes, and issue $4,000 of new senior notes in lieu of paying a
      prepayment premium on the early repayment of the 12.5% Notes, bringing senior notes outstanding down to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 our ability to access, at our option,
      $30,000 of senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at our option, contingent upon FDA approval of our product candidate
      Libervant.&#160; A second $20,000 senior notes re-opener represents a right, at our option, to market to current holders of our 12.5% Notes, or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S.
      market access, which cannot be assured.&#160; If and to the extent that we access these re-openers, we will grant warrants to purchase up to 714,000 shares of common stock, with the strike price calculated based on the 30-day volume weighted average
      closing price of our common stock at the warrant grant date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of our common stock.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">40</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The sufficiency of our short-term and longer-term liquidity is expected to be directly impacted by our level of operating revenues and our ability to achieve our operating plan
      for revenues, regulatory approval in the time period planned of our late-stage proprietary products and our ability to monetize other royalty streams or other licensed rights within planned timeframes.&#160; Although we may also be entitled to further
      potential milestones, royalty and other payments under our Indivior Supplemental Agreement, which are currently suspended and may only be reinstated if Indivior successfully adjudicates the related patent infringement litigation, there can be no
      assurance when, or if, any such payments may be realized.&#160; Our operating revenues have fluctuated in the past and can be expected to fluctuate in the future.&#160; We expect to incur significant operating losses and negative cash flows for the foreseeable
      future, and we have a significant level of debt on which we have substantial ongoing principal repayment and debt service obligations.&#160; A substantial portion of our current and past revenues has been dependent upon our licensing, manufacturing and
      sales with one customer, Indivior, which is expected to continue while we commercialize our own proprietary products and it could take significantly longer than planned to achieve anticipated levels of cash flows to help fund our operations and cash
      needs from sales of our proprietary products other than Suboxone.</div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">To the extent we raise additional funds by issuance of equity securities, our stockholders would experience further dilution and the terms of these securities could include
      liquidation or other preferences (if and to the extent permitted under the Indenture) that would adversely affect our stockholders&#8217; rights.&#160; Our ability to secure additional equity financing could be significantly impacted by numerous factors
      including our operating performance and prospects, positive or negative developments in the regulatory approval process for our proprietary products, timely achievement of regulatory approval of our late-stage proprietary products, our existing level
      of debt which is secured by substantially all our assets, restriction under the Indenture, and general market conditions, and there can be no assurance that we will continue to be successful in raising capital or that any such needed financing will
      be available, available on favorable or acceptable terms or at the times or in the amounts needed.&#160; Additionally, while the potential economic impact brought on by and the duration of the coronavirus pandemic is difficult to assess or predict, the
      significant impact of the coronavirus pandemic on the global financial markets, and on our own stock trading price, may reduce our ability to access additional capital, which would negatively impact our short-term and longer-term liquidity.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">If adequate funds are not available for our short-term or longer-term liquidity needs and cash requirements as and when needed, we may be required to reduce staff, further delay,
      significantly scale back, or discontinue some or all of our current or planned research and development programs and clinical and other product development activities, or reduce our planned commercialization efforts and otherwise significantly reduce
      our other spend and adjust our operating plan, and we would need to seek to take other steps intended to improve our liquidity.&#160; We also may be required to evaluate additional licensing opportunities, if any become available, of our proprietary
      product candidate programs that we currently plan to self-commercialize or explore other potential liquidity opportunities or other alternative or options or strategic alternatives, although we cannot assure that any of these actions would be
      available or available on reasonable terms.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">See also Part II, Item 1A, Risk Factors below concerning the significant risks and uncertainties concerning the Company&#8217;s business, operations, financial results and capital
      resources associated with the impact of the global coronavirus pandemic.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">Off-Balance Sheet Arrangements</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">During the period presented, we did not have any material off balance sheet arrangements, nor do we have any relationships with unconsolidated entities or financial partnerships,
      such as entries often referred to as structured finance or special purpose entities.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z66b9471cf78f4dc2929b2edfdcedccc2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 3.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"><a name="Quantitative"><!--Anchor--></a>Quantitative and Qualitative Disclosures about Market Risk</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Prior to July 15, 2019, our exposure to market risk due to changes in interest rates related primarily to the increase or decrease in the amount of interest expense from
      fluctuations in one-month LIBOR associated with our debt facility.&#160; For each 1% increase in one-month LIBOR in excess of the floor of 2%, our annual interest expense would have increased by approximately $500,000.&#160; However, our 12.5% Notes carry a
      12.5% fixed interest rate per annum, thereby eliminating market risk due to changes in interest rates.&#160; Our cash and cash equivalents are maintained in FDIC protected accounts with no exposure to material changes in interest rates. At September 30,
      2020, our interest rate on deposited cash was 0.18%.&#160; We do not purchase, sell or hold derivatives or other market risk sensitive instruments to hedge interest rate risk or for trading purposes.&#160; Further, we do not invest in any common stock or debt
      instruments that have been affected by the global COVID-19 outbreak which has resulted in material market movements during the quarter ended September 30, 2020.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">41</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Our accounts receivables have historically been concentrated with Indivior and, as of September 30, 2020, includes significant amounts due from Sunovion for contractually
      specified minimum annual royalties.&#160; In addition, beginning with the launch of Sympazan in 2018, our receivables concentrations with three large national wholesalers of pharmaceutical products has been growing and now, taken together, comprise
      approximately 28% of gross receivables.&#160; These receivables for our proprietary product may become increasingly significant in future periods should Sympazan sales increase and should other pipeline products become approved by the FDA and become
      distributed through these three regional, or other, wholesalers, as anticipated. In the event of non-performance or non-payment by any of Indivior, Sunovion or said wholesalers, there may be a material adverse impact on our financial condition,
      results of operations or net cash flow.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z359b4d1692704863a514d60d50f3f976" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 4.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"><a name="Controls"><!--Anchor--></a>Controls and Procedures.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Management&#8217;s Evaluation of our Disclosure Controls and Procedures</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act
      is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and (2) accumulated and communicated to our management, including to our principal executive officer and principal financial officer,
      to allow timely decisions regarding required disclosure.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">As of September 30, 2020, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure
      controls and procedures (as defined in Rules 13a-15(b) and 13a-15(e) under the Exchange Act). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving
      their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.&#160; Our principal executive officer and principal financial officer have concluded based upon the
      evaluation described above that, as of September 30, 2020, our disclosure controls and procedures were effective at the reasonable assurance level.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">Internal Control Over Financial Reporting</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act), identified in connection with the
      evaluation of such internal control that occurred during our last fiscal quarter, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;">PART II &#8211; OTHER INFORMATION</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z4cea91469d2a47f49c41aa4bddddfd61" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Legal"><!--Anchor--></a>Legal Proceedings</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0);">From time to time, we have been and may again become involved in legal proceedings arising in the course of our business.</div>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Patent-Related Litigation</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Beginning in August 2013, we were informed of abbreviated new drug application (&#8220;ANDA&#8221;) filings in the United States by Watson Laboratories, Inc. (now Actavis Laboratories, Inc.,
      or &#8220;Actavis&#8221;), Par Pharmaceutical, Inc. (&#8220;Par&#8221;), Alvogen Pine Brook, Inc. (&#8220;Alvogen&#8221;), Teva Pharmaceuticals USA, Inc. (&#8220;Teva&#8221;), Sandoz Inc. (&#8220;Sandoz&#8221;), and Mylan Technologies Inc. (&#8220;Mylan&#8221;), for the approval by the FDA of generic versions of Suboxone
      Sublingual Film in the United States. We filed patent infringement lawsuits against all six generic companies in the United States District Court for the District of Delaware (the &#8220;Delaware District Court&#8221;). After the commencement of the ANDA patent
      litigation against Teva, Dr. Reddy&#8217;s Laboratories (&#8220;DRL&#8221;) acquired the ANDA filings for Teva&#8217;s buprenorphine and naloxone sublingual film that are at issue in these trials.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 27pt;">Of these, cases against three of the six generic companies have been resolved.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z89e874268fa64b818e3b6bf01a2b155e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);"><font style="font-style: italic;">Mylan</font> and <font style="font-style: italic;">Sandoz</font> settled without a trial.&#160; Sandoz withdrew all challenges and became the distributor of the authorized generic
              products.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z01b20f8937c94492bd7679e7a221252e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">All cases against <font style="font-style: italic;">Par </font>were resolved pursuant to a May 2018 settlement agreement between the Company, Indivior, and Par and certain of its affiliates.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt;"><font style="color: #000000;"> </font><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">42</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z59c85b5b9cb64a24bf51ebffdff91bdb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);"><font style="font-style: italic;">Actavis</font> was found to infringe Patent No. 6,603,514, or the &#8217;514 patent, and cannot enter the market until the expiration of the patent in 2024, and the United States
              Court of Appeals for the Federal Circuit (&#8220;Federal Circuit&#8221;) affirmed that ruling on July 12, 2019.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z81c24744ae7a4a3a8bb3f85c3db7ca85" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);"><font style="font-style: italic;">DRL</font> and <font style="font-style: italic;">Alvogen</font> were found not to infringe under a different claim construction analysis, and the Federal Circuit affirmed that
              ruling on July 12, 2019. <font style="font-style: italic;">Teva</font> has agreed to be bound by all DRL adjudications.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Subsequent to the above, all potential generic competitors without a settlement agreement were also sued for infringement of two additional new patents that contain new claims
      not adjudicated in the original Delaware District Court case against DRL and Alvogen.&#160; On July 12, 2019, the Federal Circuit affirmed the decisions from the previously decided cases.&#160; The remaining case against Actavis was dismissed in light of the
      infringement ruling above, which prevents Actavis from entering the market until 2024.&#160; The case(s) against the remaining defendants regarding the additional asserted patents have not been finally resolved.&#160; A <font style="font-style: italic;">Markman





      </font>hearing in the cases against Dr. Reddy&#8217;s and Alvogen, which is pending in the United States District Court for the District of New Jersey (the &#8220;New Jersey District Court&#8221;), was held on October 17, 2019.&#160; On November 5, 2019, District Judge
      McNulty of the New Jersey District Court issued a <font style="font-style: italic;">Markman</font> opinion construing the disputed terms of the asserted patents. On January 9, 2020, the New Jersey District Court entered a stipulated order of
      non-infringement of one of the patents, Patent No. 9,931,305, or the &#8217;305 patent, based on the Federal Circuit Court&#8217;s claim construction ruling, and we and Indivior preserved our rights to appeal the claim construction ruling. On November 19, 2019,
      Magistrate Judge Waldor of the New Jersey District Court issued an order granting DRL and Alvogen&#8217;s requests to file amended answers to add antitrust counterclaims against us and Indivior.&#160; We and Indivior appealed the Magistrate Judge&#8217;s decision to
      District Judge McNulty on December 4, 2019, and DRL and Alvogen opposed the appeal. On January 17, 2020, we filed a motion to dismiss DRL&#8217;s and Alvogen&#8217;s antitrust counterclaims for failure to state a claim and DRL and Alvogen opposed the motion. On
      August 24, 2020, Judge McNulty issued an Opinion and Order denying both the appeal of the Magistrate&#8217;s decision and our Motion to Dismiss. On June 3, 2020, the court issued an order setting a schedule for ongoing fact discovery, expert discovery, and
      dispositive motions.&#160; The schedule currently sets the close of fact discovery for October 20, 2020, with expert discovery continuing through the end of April 2021.&#160; The schedule also sets the deadline for filing dispositive motions for May 18, 2021.&#160;
      No trial date has been set in those cases.&#160; We are not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or losses, is any, in this matter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On February 19, 2019, the Federal Circuit issued its mandate reversing the District of New Jersey&#8217;s preliminary injunction against Dr. Reddy&#8217;s.&#160; Following issuance of the
      mandate, the District of New Jersey vacated preliminary injunctions against both Dr. Reddy&#8217;s and Alvogen.&#160; Dr. Reddy&#8217;s, Alvogen, and Mylan all launched generic versions of Suboxone Sublingual Film, and the launches by Dr. Reddy&#8217;s and Alvogen are &#8220;at
      risk&#8221; because the products are the subject of the ongoing patent infringement litigations.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On March 22, 2019, we and Indivior brought suit against Aveva Drug Delivery Systems, Inc., Apotex Corp., and Apotex Inc. in the United States District Court for the Southern
      District of Florida (the &#8220;Southern District of Florida Court&#8221;) for infringement of the Company&#8217;s U.S. Patents Nos.&#160; 8,017,150, 9,687,454, the &#8217;514 patent and the &#8217;305 patent, seeking an injunction and potential monetary damages.&#160; Following a
      negotiated settlement between all parties, on December 3, 2019, the parties submitted a Notice of Settlement and a Joint Motion to Approve Consent Judgment. The Southern District of Florida Court entered an order dismissing the suit on December 18,
      2019.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">We are also seeking to enforce our patent rights in multiple cases against BioDelivery Sciences International, Inc. (&#8220;BDSI&#8221;). Three cases are currently pending but stayed in the
      U.S. District Court for the Eastern District of North Carolina (the &#8220;Eastern District of North Carolina Court&#8221;):</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z29f038c7ceaf425aa75e00ebe44745e2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">The first, a declaratory judgment action brought by BDSI against Indivior and Aquestive, seeks declarations of invalidity and non-infringement of U.S. Patents Nos. 7,897,080 8,652,378 and 8,475,832. This case
              is stayed.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za64cf67e322447238424de741c89b1d4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">The second was filed by us and Indivior related to BDSI&#8217;s infringing Bunavail product, and alleges infringement of our patent, U.S. Patent No. 8,765,167, or the &#8217;167 patent, and seeks an injunction and
              potential monetary damages. Shortly after the case was filed, BDSI filed four (4) IPR&#8217;s challenging the asserted &#8217;167 patent.&#160; On March 24, 2016, the United States Patent Trial and Appeal Board (PTAB), issued a final written decision finding
              that all claims of the &#8217;167 patent were valid. The case was stayed in May 2016 pending the final determination of the appeals on those decisions.&#160; Following the PTAB&#8217;s February 7, 2019 decisions on remand denying institution, we and Indivior
              submitted a notice to the Court on February 15, 2019 notifying the Court that the stay should be lifted as result of the PTAB&#8217;s decisions. We are awaiting further action from the Court.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">43</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z37be4bed5b9747f28867d65f68398068" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">On January 13, 2017, we also sued BDSI asserting infringement of the &#8217;167 patent by BDSI&#8217;s Belbuca product and seeking an injunction and potential monetary damages.&#160; On August 7, 2019, the Eastern District of
              North Carolina Court granted BDSI&#8217;s motion to dismiss the Complaint without prejudice and denied BDSI&#8217;s motion to stay as moot.&#160; On November 11, 2019, we filed a new Complaint against BDSI in the Eastern District of North Carolina Court.&#160; On
              November 27, 2019, BDSI filed a motion to stay the case pending BDSI&#8217;s appeal of the PTAB&#8217;s remand decisions, and we opposed the motion.&#160;&#160; The Eastern District of North Carolina Court denied BDSI&#8217;s motion to stay on April 1, 2020.&#160; BDSI&#8217;s
              appeal of the PTAB&#8217;s remand decisions to the United State Court of Appeals for the Federal Circuit was docketed on March 13, 2019, and on March 20, 2019, we moved to dismiss the appeal for lack of jurisdiction.&#160; On August 29, 2019, the
              Federal Circuit granted the motion to dismiss BDSI&#8217;s appeal.&#160; On September 30, 2019, BDSI filed a petition for rehearing in the Federal Circuit <font style="font-style: italic;">en banc</font>, which we opposed.&#160; The Federal Circuit denied
              BDSI&#8217;s petition for rehearing <font style="font-style: italic;">en banc</font> on January 13, 2020. On June 11, 2020, BDSI filed a petition for writ of certiorari at the Supreme Court of the United States.&#160; At the request of the Supreme
              Court, we filed an opposition to BDSI&#8217;s petition on August 17, 2020, and BDSI filed a reply on August 27, 2010.&#160; On October 5, 2020, the Supreme Court issued an order denying BDSI&#8217;s petition. After the Federal Circuit denied BDSI&#8217;s petition,
              on January 13, 2020, BDSI filed with the Eastern District of North Carolina Court a motion to dismiss the Complaint, and we opposed the motion on February 2, 2020.&#160;&#160; The Eastern District of North Carolina Court denied BDSI&#8217;s motion to dismiss
              and its motion to stay on April 1, 2020.&#160; On April 16, 2020, BDSI filed an Answer to the Complaint, including counterclaims for non-infringement, invalidity, and unenforceability of the &#8217;167 patent.&#160;&#160; On May 7, 2020, Aquestive filed a motion
              to dismiss BDSI&#8217;s unenforceability counterclaim and a motion to strike BDSI&#8217;s corresponding affirmative defenses for failure to state a claim for inequitable conduct under the heightened pleading standard applicable to such claims and
              defenses.&#160; Rather than oppose Aquestive&#8217;s Motion to Dismiss, on May 28, 2020, BDSI amended its counterclaims and filed an Answer and Amended Counterclaims, which included additional allegations in support of BDSI&#8217;s unenforceability
              counterclaim.&#160; On June 25, 2020, Aquestive filed a Motion to Dismiss BDSI&#8217;s Amended Counterclaim for unenforceability and a Motion to Strike BDSI&#8217;s corresponding affirmative defense of unenforceability again for failure to state a claim under
              the applicable heightened pleading standard.&#160; BDSI&#8217;s filed its opposition to Aquestive&#8217;s Motion to Dismiss and Strike on July 16, 2020.&#160; Aquestive filed its Reply to BDSI&#8217;s Opposition on July 30, 2020. The parties are awaiting further action
              from the court on Aquestive&#8217;s motion.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Antitrust Litigation</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On September 22, 2016, forty-one states and the District of Columbia, or the States, brought suit against Indivior and us in the U.S. District Court for the Eastern
        District of Pennsylvania, alleging violations of federal and state antitrust statutes and state unfair trade and consumer protection laws relating to Indivior&#8217;s launch of Suboxone Sublingual Film in 2010 and seeking an injunction, civil penalties,
        and disgorgement. After filing the suit, the case was consolidated for pre-trial purposes with the </font><font style="font-style: italic; color: rgb(0, 0, 0);">In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation</font><font style="color: rgb(0, 0, 0);">, MDL No. 2445, or the Suboxone MDL, a multidistrict litigation relating to putative class actions on behalf of various private plaintiffs against Indivior relating to its launch of Suboxone Sublingual Film. While we
        were not named as a defendant in the original Suboxone MDL cases, the action brought by the States alleges that we participated in an antitrust conspiracy with Indivior in connection with Indivior&#8217;s launch of Suboxone Sublingual Film and engaged in
        related conduct in violation of federal and state antitrust law. We moved to dismiss the States&#8217; conspiracy claims, but by order dated October 30, 2017, the Court denied our motion to dismiss. We filed an answer denying the States&#8217; claims on
        November 20, 2017. The fact discovery period closed July 27, 2018, but the parties agreed to conduct certain fact depositions in August 2018.&#160; The expert discovery phase closed May 30, 2019, but additional reports and depositions were conducted
        through August 1, 2019.&#160; The remainder of the case schedule, including summary judgment briefing, is stayed pending resolution of Indivior&#8217;s appeal of the District Court&#8217;s class certification ruling in a co-pending multi-district litigation to
        which we are not a party. </font>On July 28, 2020, the U.S. Court of Appeals for the Third Circuit issued its opinion affirming the District Court&#8217;s order certifying the class.&#160; On August 27, 2020, the district court issued a scheduling order,
      setting the deadline for filing remaining <font style="font-style: italic;">Daubert</font> challenges and summary judgment.&#160; Under the scheduling order, the remaining <font style="font-style: italic;">Daubert</font> motions were filed on September
      28, 2020, and oppositions are due on October 19, 2020.&#160; The court will set oral argument on the motions, but the date for oral argument is not yet known.&#160; Summary judgment motions are due January 11, 2021, and responses to summary judgment motions
      are due February 11, 2021.&#160; No trial date has yet been set. <font style="color: rgb(0, 0, 0);">We are not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimate, of the possible
        outcome or loss, if any, in this matter.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-style: italic; font-weight: bold;">Humana and Centene Actions</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">On September 18, 2020, Humana, Inc., a health insurance payer, filed a suit against Aquestive and Indivior in the Eastern District of Pennsylvania relating to Suboxone.&#160; The
      Humana action, which alleges facts similar to those at issue in the Antitrust Case and the Suboxone MDL described above, was assigned to the same judge that is presiding over those actions.&#160; Humana&#8217;s Complaint alleges five causes of action against
      Aquestive, including conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment.&#160; On September 21, 2020, Centene Corporation and other related insurance
      payers filed a similar suit against Aquestive and Indivior in the Eastern District of Missouri.&#160; The counsel representing Humana is also representing Centene.&#160; On September 21, 2020, the Centene action was provisionally transferred to the Eastern
      District of Pennsylvania by the United States Judicial Panel on Multidistrict Litigation.&#160; No other proceedings have occurred, and the schedule is not yet known.&#160; We are not able to determine or predict the ultimate outcome of this proceeding or
      provide a reasonable estimate, or range of estimate, of the possible outcome or loss, if any, in this matter.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">44</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">California Complaint</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On December 5, 2019, Neurelis Inc. (&#8220;Neurelis&#8221;) filed a complaint against Aquestive in the Superior Court of California, County of San Diego alleging Unfair Competition,
      Defamation, and Malicious Prosecution related to the Company&#8217;s pursuit of FDA approval for Libervant. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action.&#160; The Company filed a Motion to Strike
      Neurelis&#8217;s Complaint under California&#8217;s anti-SLAPP (&#8220;strategic lawsuit against public participation&#8221;) statute on January 31, 2020, which Neurelis is expected to oppose.&#160; Neurelis filed a motion for leave to file a Supplemental Complaint on February
      5, 2020, which we will oppose.&#160; On February 5, 2020, Neurelis filed a Motion for Leave to File a Supplemental Complaint (&#8220;Motion&#8221;).&#160; On June 5, 2020, Neurelis filed a Motion for Limited Discovery related to Aquestive&#8217;s anti-SLAPP motion.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The court previously scheduled a hearing on both Aquestive&#8217;s anti-SLAPP Motion and on Neurelis&#8217;s Motion for April 24, 2020.&#160; However, on April 3, 2020, in response to the
      COVID-19 pandemic, the court issued an order continuing all hearings scheduled through April 30, 2020.&#160; The court held ultimately a telephonic status conference on June 25, 2020 to determine a schedule for hearing the pending motions.&#160; During that
      status conference, the court set Aquestive&#8217;s anti-SLAPP motion for hearing on July 24, 2020.&#160; The court also declined Neurelis&#8217;s request to hear its Motion and its Motion for Limited Discovery.&#160; Neurelis filed its response to Aquestive&#8217;s anti-SLAPP
      Motion on July 13, 2020, and we filed our reply on July 17, 2020.&#160;&#160; The court held a telephonic hearing on Aquestive&#8217;s anti-SLAPP motion on July 24, 2020. On August 6, 2020, the Court issued an order granting in part and denying in part Aquestive&#8217;s
      anti-SLAPP motion.&#160; Aquestive filed a notice of appeal to the California Court of Appeal on September 1, 2020, and Neurelis filed a notice of cross-appeal on October 5, 2020.&#160; We are not able to determine or predict the ultimate outcome of this
      proceeding or provide a reasonable estimate, or range of estimate, of the possible outcome or loss, if any, in this matter.</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf3cbf2bc5c2f436d8cf9f4c8ffb5b08f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 1A.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Risk"><!--Anchor--></a>Risk Factors</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In light of continuing developments relating to the COVID-19 global pandemic, the Company is supplementing the risk factors previously disclosed in Item 1A of its 2019 Annual
      Report on Form 10-K to include the following risk factor under the heading &#8220;Risks Related to our Business Operations and Industry&#8221;:</div>
    <div><br>
    </div>
    <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Our business may be adversely affected by the ongoing coronavirus pandemic.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Beginning in late 2019, the outbreak of COVID-19, has evolved into a global pandemic.&#160; Depending upon the length and severity of the pandemic or any resurgence, which cannot be
      predicted, we may experience disruptions that could materially and adversely impact our business including:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zeabf55511c964895994199a454bbbb4c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">Various aspects of our clinical trials, including delays or difficulties in enrolling patients in our clinical trials, in clinical trial site initiation, and&#160; in recruiting clinical site investigators and
              clinical site staff; increased rates of patients withdrawing from clinical trials; diversion of healthcare resources away from the conduct of clinical trials; interruption of key clinical trial activities such as clinical trials site data
              monitoring due to limitations on travel imposed or recommended by federal or state governments; impact on employees and others or interruption of clinical trial visits or study procedures which may impact the integrity of subject data and
              clinical study endpoints; and interruption or delays in the operations of the U.S.&#160; FDA, and comparable foreign regulatory agencies, which may impact regulatory review and approval timelines.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb5ff959b07e84de6a5864a6df0456f15" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">If any third-party in our supply chain for any materials, including active pharmaceutical ingredients and other raw materials supply, which we need for our product candidates for our clinical trials and for the
              approved products we manufacture and distribute, are adversely impacted by restrictions resulting from the coronavirus pandemic, including staffing shortages, production slowdowns, or disruptions in freight and other transportation services
              and delivery distribution systems, our supply chain may be disrupted, limiting our ability to manufacture our product candidates for our clinical trials, conduct our research, development and clinical operations, and manufacture, distribute
              and sell our approved products.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z44fa853479304c3090a800ed898e693d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">We have closed our business office and requested most of our colleagues located there to work from home, restricted full-time on-site staff generally to those colleagues who must perform essential activities
              on-site and implemented staggered schedules for full-time on-site staff in our research and development laboratory in order to reduce risk of transmission.&#160; Our increased reliance on colleagues and other third parties on whom we rely working
              from home or having health issues may negatively impact productivity and has limited our in-person commercialization activities for our existing approved proprietary product and would limit commercial launch activities for any new approved
              product, or disrupt, delay, or otherwise adversely impact our business.&#160; In addition, this could increase our cybersecurity risk, create data accessibility concerns, and make us more susceptible to communication disruptions, any of which
              could adversely impact our business operations.&#160; Our colleagues conducting research and development activities might not be able to access our laboratory or manufacturing facilities for an extended period of time as a result of any further
              closure of our facilities as well as the possibility of further governmental restrictions.&#160; As a result, this could delay timely completion of pre-clinical activities, including completing Investigational New Drug (IND)/Clinical Trial
              Application (CTA) enabling studies or our ability to select future development candidates, and initiation of clinical or other of our development programs and production and delivery of our products.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">45</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z555a2812e381434884e4bbce562c9c8b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">The FDA and comparable foreign regulatory agencies may experience disruptions, have slower response times or be under-resourced to continue to monitor our clinical trials or to conduct required activities and
              review of our product candidates seeking regulatory review and such disruptions could materially affect the development, timing and approval of our product candidates.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zadb67a9e477e485e839e6c46b480c9f2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="color: rgb(0, 0, 0);">The coronavirus pandemic may impact the requirements of our customers and growth of our approved products.&#160; For example, Indivior, our significant customer for Suboxone, had announced that it anticipated
                coronavirus impact on its product sales.&#160;&#160; Further, sales force expansion may not be as productive during a time when a significant number of interactions are virtual and such interactions may not be as effective as face-to-face
                interactions. Additionally, an increasing number of patient visits to their Healthcare Professionals have been virtual during the coronavirus pandemic which may reduce the likelihood that a change in medicine would occur which could impact
                Sympazan growth. </font><font style="color: rgb(0, 0, 0);">We cannot accurately predict the adverse impact the coronavirus pandemic will have on orders of our approved products Suboxone and Sympazan.</font>&#160;<font style="color: rgb(0, 0, 0);">We also have experienced in one instance, and could in the future experience, extended customer payment cycles.</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z1e52388ff29f48c3bffe95a36b793a4f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0);">As a result of concerns caused by the continuing effects of the coronavirus, we may face issues and investor concerns in raising capital through sales of our common stock or other securities, or in seeking to
              monetize our licensed royalty and milestone rights.&#160; In addition, a recession, depression or other sustained adverse market event could materially and adversely affect the financial markets, our business, the value of our common stock and our
              ability to obtain on favorable terms, or at all, equity or debt financing or any potential monetization of our royalty streams.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The coronavirus pandemic continues to rapidly evolve.&#160; The ultimate impact of the coronavirus pandemic on us is highly uncertain and subject to change and will depend on future
      developments, which cannot be accurately predicted.&#160; We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, the manufacturing, marketing, distribution and sale of our approved
      products, the healthcare system or the global economy.&#160; Given the uncertainties, the Company is unable to provide assurance that operations can be maintained as planned prior to the COVID-19 pandemic.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Please also refer to the complete Item 1A of the Company&#8217;s 2019 Annual Report on Form 10-K for additional risks and uncertainties facing the Company, any of which risks and
      uncertainties may be further heightened by the coronavirus pandemic and have a material adverse effect on the Company&#8217;s business prospects, financial condition, results of operations, liquidity and available capital resources.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zaf431b838bf2443da5b13f0fbcbdadb1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Unregistered"><!--Anchor--></a>Unregistered Sales of Equity Securities and Use of Proceeds</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">None.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2e77addfd1c24fb1ab4f9cf6f2e2f4e8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Defaults"><!--Anchor--></a>Defaults Upon Senior Securities</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">None.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z60adcfdc9a2b42eea5b73e3830c8c455" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Mine"><!--Anchor--></a>Mine Safety Disclosures</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">Not applicable.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zd13c3cd1cde44d7b9f2024836bf0d782" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="OtherInformation"><!--Anchor--></a>Other Information</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">None.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">46</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z1426a262c791460da41058882cdd0047" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 6.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;"><a name="Exhibits"><!--Anchor--></a>Exhibits</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">The exhibits listed below are filed or furnished as part of this report.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zcee26804ac7f49b1833625488ef3daae" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Number</div>
          </td>
          <td style="width: 0.96%; vertical-align: bottom;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Description</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">&#160;</td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="brhc10016591_ex31-1.htm">31.1</a></div>
          </td>
          <td style="width: 0.96%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
              2002 (filed herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">
            <div><a href="brhc10016591_ex31-2.htm">31.2</a></div>
          </td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
              2002 (filed herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="brhc10016591_ex32-1.htm">32.1</a></div>
          </td>
          <td style="width: 0.96%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">
            <div><a href="brhc10016591_ex32-2.htm">32.2</a></div>
          </td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">101.INS</div>
          </td>
          <td style="width: 0.96%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">XBRL Instance Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">101.SCH</div>
          </td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Schema Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">101.CAL</div>
          </td>
          <td style="width: 0.96%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Calculation Linkbase Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">101.DEF</div>
          </td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Definition Linkbase Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">101.LAB</div>
          </td>
          <td style="width: 0.96%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Label Linkbase Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">101.PRE</div>
          </td>
          <td style="width: 0.96%; vertical-align: top;">&#160;</td>
          <td style="width: 90%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Presentation Linkbase Document</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: rgb(0, 0, 0);">*Portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K.&#160; The omitted information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">47</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal; font-style: italic; font-size: 8pt;"> Table of Contents</font></a></div>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><a name="SIGNATURES"><!--Anchor--></a>SIGNATURES</div>
    <div><br>
    </div>
    <div style="text-indent: 18pt; color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the County of
      Somerset, State of New Jersey.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zc38cfb0b705f4b22a0e4740e59177135" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top;" colspan="2"><br>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Aquestive Therapeutics, Inc.</div>
            <div style="color: rgb(0, 0, 0);">(REGISTRANT)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: bottom;" colspan="2"><br>
          </td>
          <td style="width: 50%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Date:</div>
          </td>
          <td style="width: 40%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">November 4, 2020</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Keith J. Kendall</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">Keith J. Kendall</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">President and Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Principal Executive Officer)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Date:</div>
          </td>
          <td style="width: 40%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">November 4, 2020</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ John T. Maxwell</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">John T. Maxwell</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">48</font></div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>brhc10016591_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 31.1</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Certification of Principal Executive Officer of Aquestive Therapeutics, Inc.</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">I, Keith J. Kendall, certify that:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z2b6ddb1a4b6249a68eb5fcacd41ac594" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zca25857c89294395a510aac147ccc15e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
                statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z93ad67c0309c4947a4b85a207fbe96f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of
                operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z8c3d13cae4dc48b590d5735b12f47214" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
                over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd9e6c55651d94d04b67e368ce91ecdcc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
                its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd75cb092f6d844e2a72597fa08b1b827" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
                financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zda2b3e8a2e1b46e5885f17c608ebb48e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
                the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="za08408a5927641178034818a7fedf8e4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the
                case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9ca25ae04ba0444983b0c4145cf024a9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z2736ee60f58b4453b38f3c2b1edc2c2e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zbe304926d9384e7ea709f20a461ee5d1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: #000000;">Dated: November 4, 2020</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zd5387a612ae744a082048f19815168dc" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ KEITH J. KENDALL</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-top: #000000 2px solid;">
              <div style="color: #000000;">Keith J. Kendall</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-style: italic;">President and Chief Executive Officer</div>
              <div style="color: #000000; font-style: italic;">(Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>brhc10016591_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 31.2</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Certification of Principal Financial and Accounting Officer of Aquestive Therapeutics, Inc.</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">I, John T. Maxwell, certify that:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6a3ba55a868e491792e91c763504a8f5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd476e255ef2f40fba6f2aba5ab3645c8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
                statements were made, not misleading with respect to the period covered by this annual report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z3d4c4f1831f04a4080e645070784fc97" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of
                operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc5d64b31cc9247f2b06305d8c7a6b9b5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
                over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z72b1891e0b8a46e893492bcc87cb020e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
                its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z15c6ff70dbae439ba0ff753abe1148e7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
                financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1719f333493a4dddadac8e6b1926dff1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
                the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze6f98dc8088f41c9884446ad246b2990" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the
                case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7ca5993e5f304733b6c61f92509c1a65" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z95681da3ee644363974e6e676e7a5e69" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc49ef3fe2f46490c913613d5c0fb8150" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: #000000;">Dated: November 4, 2020</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc3fadde29f194581b6d3c0d0615f2db3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ JOHN T. MAXWELL</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-top: #000000 2px solid;">
              <div style="color: #000000;">John T. Maxwell</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-style: italic;">Chief Financial Officer</div>
              <div style="color: #000000; font-style: italic;">(Principal Financial Officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>brhc10016591_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 32.1</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Certification of Principal Executive Officer</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to 18 U.S.C. Section 1350, as Adopted</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the
        United States Code (18 U.S.C. &#167;1350), I, Keith J. Kendall, President and Chief Executive Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zad4b4e01d29648308fa63e73e621e75b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The Company&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 2020, to which this Certification is attached as Exhibit 32.1 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of
                Section 13(a) or Section 15(d) of the Exchange Act; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zcf3e87d97e834e10a0f4a88f534e7d12" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of
                operations of the Company for the period covered by the Quarterly Report.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: #000000;">Dated: November 4, 2020</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="za711a5e7898641319f0dc9c116eb1b41" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="color: #000000;">/s/ KEITH J. KENDALL</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-top: #000000 2px solid;">
              <div style="color: #000000;">Keith J. Kendall</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-style: italic;">President and Chief Executive Officer</div>
              <div style="color: #000000; font-style: italic;">(Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any
        filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</div>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>brhc10016591_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 32.2</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Certification of Principal Financial and Accounting Officer</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to 18 U.S.C. Section 1350, as Adopted</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the
        United States Code (18 U.S.C. &#167;1350), I, John T. Maxwell, Chief Financial Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z34c7e50a3b6a4870bc152007f1bcfd24" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The Company&#8217;s Quarterly Report on Form 10-Q for the period-ended September 30, 2020, to which this Certification is attached as Exhibit 32.2 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of
                Section 13(a) or Section 15(d) of the Exchange Act; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0c56f22b1db647d8931063d657dc9f50" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right; color: #000000;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of
                operations of the Company for the period covered by the Quarterly Report.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: #000000;">Dated: November 4, 2020</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z71b8e90c2d6d477c96ec55f8da0be3e9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">/s/ JOHN T. MAXWELL</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">John T. Maxwell</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic;">Chief Financial Officer</div>
              <div style="color: rgb(0, 0, 0); font-style: italic;">(Principal Financial Officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any
        filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</div>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>aqst-20200930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:aqst="http://aquestive.com/20200930" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="aqst-20200930.xsd" />
  <xbrli:context id="c20200101to20200930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20201102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-11-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20181231_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190401to20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200401to20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-01</xbrli:startDate>
      <xbrli:endDate>2020-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-01</xbrli:startDate>
      <xbrli:endDate>2020-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190401to20190630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190401to20190630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200401to20200630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-01</xbrli:startDate>
      <xbrli:endDate>2020-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200401to20200630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-04-01</xbrli:startDate>
      <xbrli:endDate>2020-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190331_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200331_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190331_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200331_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190930_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200331_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190331_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190930_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200331_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190930">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190331_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191217to20191217">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-12-17</xbrli:startDate>
      <xbrli:endDate>2019-12-17</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191217">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-17</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20191231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190731">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190731">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191201to20191231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-12-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ProductOrServiceAxis_ProprietaryProductSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_ProductOrServiceAxis_ProprietaryProductSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_ProductOrServiceAxis_ProprietaryProductSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_ProductOrServiceAxis_ProprietaryProductSalesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductSalesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_StatementGeographicalAxis_NonUsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_StatementGeographicalAxis_US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_StatementGeographicalAxis_NonUsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_StatementGeographicalAxis_US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_StatementGeographicalAxis_NonUsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_StatementGeographicalAxis_US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_StatementGeographicalAxis_NonUsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_StatementGeographicalAxis_US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20191231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithSunovionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithSunovionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithSunovionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithSunovionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CustomerOneMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CustomerOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20191231_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20191231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_TypeOfArrangementAxis_CommercialExploitationAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190220_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-02-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190331_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_RangeAxis_MaximumMember_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_ProductOrServiceAxis_RoyaltyMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190901to20190930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AgreementToTerminateCLAWithKemPharmMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-09-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AgreementToTerminateCLAWithKemPharmMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AgreementToTerminateCLAWithKemPharmMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_FiniteLivedIntangibleAssetsByMajorClassAxis_TechnologyBasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TechnologyBasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190715to20190715">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-15</xbrli:startDate>
      <xbrli:endDate>2019-07-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_DebtInstrumentAxis_FirstAdditionalOfferingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:FirstAdditionalOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_DebtInstrumentAxis_SecondAdditionalOfferingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SecondAdditionalOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190715to20190715_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-15</xbrli:startDate>
      <xbrli:endDate>2019-07-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190715to20190715_CreditFacilityAxis_LineOfCreditMember_LineOfCreditFacilityAxis_PerceptiveCreditOpportunitiesFundLPMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqst:PerceptiveCreditOpportunitiesFundLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-15</xbrli:startDate>
      <xbrli:endDate>2019-07-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_DebtInstrumentAxis_FirstAdditionalOfferingMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:FirstAdditionalOfferingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_DebtInstrumentAxis_SecondAdditionalOfferingMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SecondAdditionalOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_CreditFacilityAxis_LineOfCreditMember_LineOfCreditFacilityAxis_PerceptiveCreditOpportunitiesFundLPMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqst:PerceptiveCreditOpportunitiesFundLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191216to20191216_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-12-16</xbrli:startDate>
      <xbrli:endDate>2019-12-16</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191216to20191216">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-12-16</xbrli:startDate>
      <xbrli:endDate>2019-12-16</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_UnvestedRestrictedStockUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">aqst:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_UnvestedRestrictedStockUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">aqst:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200701to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-07-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190101to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20190701to20190930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20191231_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_AwardTypeAxis_EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200930_PlanNameAxis_EmployeeStockPurchasePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20130801to20130831">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-08-01</xbrli:startDate>
      <xbrli:endDate>2013-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_LitigationCaseAxis_CaliforniaComplaintMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:CaliforniaComplaintMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20200101to20200930_LitigationCaseAxis_HumanaAndCenteneActionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:HumanaAndCenteneActionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20201023to20201023_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-10-23</xbrli:startDate>
      <xbrli:endDate>2020-10-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20201103_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-11-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20201103to20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-11-03</xbrli:startDate>
      <xbrli:endDate>2020-11-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-11-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="U001">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U002">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U003">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="U004">
    <xbrli:measure>aqst:Product</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U005">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U006">
    <xbrli:measure>aqst:Sources</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U007">
    <xbrli:measure>aqst:Customer</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U008">
    <xbrli:measure>aqst:Lease</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U009">
    <xbrli:measure>aqst:Payment</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U010">
    <xbrli:measure>aqst:Tranche</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U011">
    <xbrli:measure>aqst:Period</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U012">
    <xbrli:measure>aqst:Company</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U013">
    <xbrli:measure>aqst:Case</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U014">
    <xbrli:measure>aqst:Patent</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U015">
    <xbrli:measure>aqst:States</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U016">
    <xbrli:measure>aqst:Cause</xbrli:measure>
  </xbrli:unit>
  <!--Accounts Payable, Current-->
  <us-gaap:AccountsPayableCurrent id="Fact_267988f104524360a0c6ad0227bb034c" contextRef="c20200930" unitRef="U002" decimals="-3">9169000</us-gaap:AccountsPayableCurrent>
  <!--Accounts Payable, Current-->
  <us-gaap:AccountsPayableCurrent id="Fact_b374f1f947344a49878f4a5a1893ae3d" contextRef="c20191231" unitRef="U002" decimals="-3">12274000</us-gaap:AccountsPayableCurrent>
  <!--Accounts Payable and Accrued Liabilities Disclosure [Text Block]-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock id="Fact_d5e80fef3ebc4dde844987e8aef13a9a" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 12.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Accounts Payable and Accrued Expenses&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Accounts payable and accrued expenses consisted of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accounts payable&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;9,169&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,274&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accrued compensation&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;4,129&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,758&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accrued distribution expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,655&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,174&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Other&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;284&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;543&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total accounts payable and accrued expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;15,237&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;17,749&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <!--Accounts payable and accrued expenses-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Fact_54d63dbcfdfe4abdb864826501e4d93d" contextRef="c20191231" unitRef="U002" decimals="-3">17749000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <!--Accounts payable and accrued expenses-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Fact_6ba409c348bb4a6eb59a2b6f00c88694" contextRef="c20200930" unitRef="U002" decimals="-3">15237000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <!--Trade receivables-->
  <us-gaap:AccountsReceivableGross id="Fact_200bbb945e4e417ca6a2e5c041b7b551" contextRef="c20191231" unitRef="U002" decimals="-3">9094000</us-gaap:AccountsReceivableGross>
  <!--Trade receivables-->
  <us-gaap:AccountsReceivableGross id="Fact_e95bee0f543c4a7193582c4fea4503a2" contextRef="c20200930" unitRef="U002" decimals="-3">6659000</us-gaap:AccountsReceivableGross>
  <!--Accrued Marketing Costs, Current-->
  <us-gaap:AccruedMarketingCostsCurrent id="Fact_2d54016ee47c42aba7d65e8b87a9f3fc" contextRef="c20191231" unitRef="U002" decimals="-3">1174000</us-gaap:AccruedMarketingCostsCurrent>
  <!--Accrued Marketing Costs, Current-->
  <us-gaap:AccruedMarketingCostsCurrent id="Fact_57b772ea7d6e4f8eb18bae6a4ddbb46c" contextRef="c20200930" unitRef="U002" decimals="-3">1655000</us-gaap:AccruedMarketingCostsCurrent>
  <!--Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Fact_a868c9323fb24d929c204c0d3c3b400f" contextRef="c20191231" unitRef="U002" decimals="-3">38044000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Fact_f2207df6ca49482bb1c794bf2d6ace50" contextRef="c20200930" unitRef="U002" decimals="-3">40171000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Additional Paid in Capital-->
  <us-gaap:AdditionalPaidInCapital id="Fact_22019aedde184952aa5530cb5119c81f" contextRef="c20200930" unitRef="U002" decimals="-3">129336000</us-gaap:AdditionalPaidInCapital>
  <!--Additional Paid in Capital-->
  <us-gaap:AdditionalPaidInCapital id="Fact_e8e4cd7bb36a42dabf462de2239c26b6" contextRef="c20191231" unitRef="U002" decimals="-3">124318000</us-gaap:AdditionalPaidInCapital>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_0ef715ad3d814948b42d70a6c495caf9" contextRef="c20200401to20200630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_1dcd936e60474a0a877c70e67e4ddede" contextRef="c20190401to20190630" unitRef="U002" decimals="-3">1739000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_28267b156fac4fc98eaff26c2e9456f3" contextRef="c20190101to20190331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_28836023f7f54d1dbd13ca04fad0095c" contextRef="c20190101to20190331" unitRef="U002" decimals="-3">1422000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_2f5794ef05b44a8fa78052a113cd3092" contextRef="c20200101to20200331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_359d8f772f4b48999ec7c87917274eab" contextRef="c20190101to20190331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1422000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_37edfd823b4e45839b928d9b22422bc0" contextRef="c20190401to20190630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_428f05c12b8a4b5dbfcc9cf580a7b812" contextRef="c20190401to20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1739000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_535e095987e448e0bf6ba77b385d2a3c" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">1810000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_57a042fcf74e4d82b667d3fa812b425f" contextRef="c20190701to20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1810000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_6760e1352029499d83b265a36f003b0e" contextRef="c20190701to20190930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_820553799a794ba696f64adaa3387eae" contextRef="c20190701to20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_908e4784e95140be915aae3b955d0c22" contextRef="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_9b77407e8133497f8ae4fb13742fbbf3" contextRef="c20190101to20190331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_9cab6ff24736425693a249fe76c540ce" contextRef="c20200101to20200331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_a9c7f1a816f047258ab9f6952885021b" contextRef="c20200701to20200930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_b25dcd589171414ca3d1cdababf96b2b" contextRef="c20200701to20200930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_b52210fbe9f740368ba92ee790fbac5e" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">1420000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_c2f8bdaa8fba4fd6a2b9de908a6bb6a8" contextRef="c20200401to20200630" unitRef="U002" decimals="-3">1702000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_c9940b9d79c54435960dd4c1f7d62bcc" contextRef="c20200101to20200331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1823000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_da01ac114d1b4f288848f3550b249574" contextRef="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_e41537097a9c4825a1d9c7aea26bf4fc" contextRef="c20200401to20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1702000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_ebb9c2ede03b4a70a05a3286a56a37ac" contextRef="c20200701to20200930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">1420000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--APIC, Share-based Payment Arrangement, Increase for Cost Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact_ee99a23e52dc4d70a82956e5086ecbad" contextRef="c20200101to20200331" unitRef="U002" decimals="-3">1823000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Warrant Issued-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Fact_082c45f65dcd46d79aa30047968fa24d" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">6800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <!--Adjustments to Additional Paid in Capital, Warrant Issued-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Fact_345d46786cd54d60b1ce07606f474db5" contextRef="c20190701to20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <!--Adjustments to Additional Paid in Capital, Warrant Issued-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Fact_972b632c755d48ceb812076443f4a1bd" contextRef="c20190701to20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">6800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <!--Adjustments to Additional Paid in Capital, Warrant Issued-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Fact_9b048284b96b4ec0a127df21664c5559" contextRef="c20190701to20190930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <!--Share-based Payment Arrangement, Expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_2fd841322b7740c5bbdf2003c2effe3f" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">5200000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_36c7df7bd78840daa36d10402d3b8896" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">1427000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Manufacturing and supply [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_3c3e86269e814a27ba096a001f4ac30d" contextRef="c20200101to20200930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember" unitRef="U002" decimals="-3">208000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_3d44413c68c04c2d9a6841cdccc73ccd" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">5052000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Restricted Stock Units [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_47256c9236d64ec7ac51c11ca658c1e8" contextRef="c20190101to20190930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">1403000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Selling, General and Administrative [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_51a5c9c752aa4f31964bf709c84a2b42" contextRef="c20200701to20200930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3">1176000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_567807176dac42f7b4e9716bb8648baa" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">1870000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Research and Development [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_5ffbf42217df4f7785c23e95fbd4356d" contextRef="c20190101to20190930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3">536000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Selling, General and Administrative [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_65e1e1854e0349abba5e81e7e50f3892" contextRef="c20190101to20190930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3">4480000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Manufacturing and supply [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_73d529e63cce4684aec8631d420362a0" contextRef="c20190101to20190930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember" unitRef="U002" decimals="-3">176000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Restricted Stock Units [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_868d817febec42f6a43db7ea7cb749a2" contextRef="c20200701to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">16000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_8818b2c217514e9ebcde8ea1bd473a5a" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">4252000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_8c0692b86019447b8ed33cb6fc84ddee" contextRef="c20190701to20190930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">1397000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Research and Development [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_8eb5b19cab4a407f961f0fb0960396f4" contextRef="c20200101to20200930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3">543000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Research and Development [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_90f98e84f62a4f4c8522e942c818a5c2" contextRef="c20190701to20190930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3">188000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Restricted Stock Units [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_95248770254446619740851f52519d64" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">789000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Research and Development [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_a5558344dd6e447084ab8ec4edd3a45d" contextRef="c20200701to20200930_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3">178000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Manufacturing and supply [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_aaa814da475a4b0eb7bed99dc7ae42f8" contextRef="c20200701to20200930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember" unitRef="U002" decimals="-3">73000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Restricted Stock Units [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_b08adf90651c4698878729580017530e" contextRef="c20190701to20190930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">473000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_b0f2c0aa092047b4a8ebd494dc616a7c" contextRef="c20200701to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">1411000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Employee Stock Purchase Plan [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_bb7ec730fb0d4e26b92e8938e89b6961" contextRef="c20200701to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">0</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Employee Stock Purchase Plan [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_bd04daeb9dbd438e93fc9efcebbed2d8" contextRef="c20190701to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">0</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_cc9de33fcf0c4123a7ad4cdc1076bcbd" contextRef="c20190101to20190930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">3777000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Employee Stock Purchase Plan [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_d2edf0defd1f4ed4831f406337bc9605" contextRef="c20200101to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">11000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Selling, General and Administrative [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_de0ba5cd5749476680f5817468d873d6" contextRef="c20200101to20200930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3">4301000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Employee Stock Purchase Plan [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_e2994d44f2234107a4f1b6d1bdfbd829" contextRef="c20190101to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">20000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Manufacturing and supply [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_f37812c9c9f74750bab56dabc9bf659c" contextRef="c20190701to20190930_IncomeStatementLocationAxis_ManufacturingAndSupplyMember" unitRef="U002" decimals="-3">60000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Share-based Payment Arrangement, Expense-Selling, General and Administrative [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact_fb5069169e8d4d1f88bde8754edec3c9" contextRef="c20190701to20190930_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3">1622000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Accounts Receivable, Allowance for Credit Loss-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivable id="Fact_10d41af89d2043a488540220a1e00906" contextRef="c20200930" unitRef="U002" decimals="-3">264000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <!--Accounts Receivable, Allowance for Credit Loss-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivable id="Fact_c92d7f73f7f44a31a5e8e5cc8ee63706" contextRef="c20191231" unitRef="U002" decimals="-3">124000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <!--Accounts Receivable, Allowance for Credit Loss-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivable id="Fact_8f661c4b05064479bc85309a15f7838a" contextRef="c20181231" unitRef="U002" decimals="-3">58000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <!--Write-downs charged against the allowance-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs id="Fact_065d698a48b24f7489c511222ba6f3e5" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
  <!--Write-downs charged against the allowance-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs id="Fact_e5ffced3a6c64b40b2f4fe84e72b6a14" contextRef="c20190101to20191231" unitRef="U002" decimals="-3">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets id="Fact_41d612055426420182fc0ca55f01b008" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">13000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets id="Fact_454d1541ab084d9aa77c36b0765246f6" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">13000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets id="Fact_8003899b4be8418baf806126356f8ac4" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">38000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets id="Fact_dbda48e11a6f43a19c8c421d8133e929" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">39000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of debt issuance costs and discounts-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_a21c1c50d3bb4b2fb1a3c17cad2b87c4" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">1338000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Amortization of debt issuance costs and discounts-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_c81a872271bd44fc9af655257e794048" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">1758000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Amortization of debt issuance costs and discounts-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_01fa977c5aa148dabc1362da5067b61b" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">1758000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Amortization of debt issuance costs and discounts-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_035c849ed2ec4705936df4a3a0e19b88" contextRef="c20190701to20190930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">556000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Amortization of debt issuance costs and discounts-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_4e904e86928846cbb90820db8045066c" contextRef="c20200701to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">590000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Amortization of debt issuance costs and discounts-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Fact_ef39c7d2f40d4d54b2b00d0b0cd4d6fb" contextRef="c20190101to20190930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">1338000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_062785fc1cb34ca392f3b2a57e3be3f2" contextRef="c20190101to20190930" unitRef="U001" decimals="INF">2363236</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_209859ec09c3426a8cd95eee8175ecda" contextRef="c20200101to20200930" unitRef="U001" decimals="INF">4660860</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_46a20ab849e948b2a2542f91e424983c" contextRef="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF">3075942</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Warrant [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_46d71b8d0af441a7809b77644021b2ce" contextRef="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="INF">1571429</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Unvested Restricted Stock Units [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_5423171d670248e99f04021b541257cf" contextRef="c20200101to20200930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_UnvestedRestrictedStockUnitsMember" unitRef="U001" decimals="INF">13489</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Options on Common Shares Outstanding [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_616fb528ee6f49809ccbd13aacc64d34" contextRef="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF">2256092</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Unvested Restricted Stock Units [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_e95b9a5e6020466a884267f37267246f" contextRef="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_UnvestedRestrictedStockUnitsMember" unitRef="U001" decimals="INF">107144</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-Warrant [Member]-->
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact_ea1d754306c740e5a13b928b3228886a" contextRef="c20190101to20190930_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <!--Asset Retirement Obligations, Noncurrent-->
  <us-gaap:AssetRetirementObligationsNoncurrent id="Fact_72590e8f4e32497b8b6c7e056722b057" contextRef="c20200930" unitRef="U002" decimals="-3">1482000</us-gaap:AssetRetirementObligationsNoncurrent>
  <!--Asset Retirement Obligations, Noncurrent-->
  <us-gaap:AssetRetirementObligationsNoncurrent id="Fact_cedf0453ea05462ca717cc0982c39809" contextRef="c20191231" unitRef="U002" decimals="-3">1360000</us-gaap:AssetRetirementObligationsNoncurrent>
  <!--Assets-->
  <us-gaap:Assets id="Fact_0e3d859a30c248b39d7ab73d68302f3d" contextRef="c20191231" unitRef="U002" decimals="-3">78479000</us-gaap:Assets>
  <!--Assets-->
  <us-gaap:Assets id="Fact_1b418d855170476aa11d110790f57b63" contextRef="c20200930" unitRef="U002" decimals="-3">50423000</us-gaap:Assets>
  <!--Assets, Current-->
  <us-gaap:AssetsCurrent id="Fact_870f14afa5df403fbaf60eb72f244fd1" contextRef="c20191231" unitRef="U002" decimals="-3">68314000</us-gaap:AssetsCurrent>
  <!--Assets, Current-->
  <us-gaap:AssetsCurrent id="Fact_b07ab0c6568e41e8b429670777b53d26" contextRef="c20200930" unitRef="U002" decimals="-3">31684000</us-gaap:AssetsCurrent>
  <!--Basis of Presentation-->
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="Fact_60f5f98daf9546a88715980346d718dc" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&amp;#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2019 included in the Company&amp;#8217;s Annual Report on Form 10-K filed with the SEC on March 11, 2020 (the &amp;#8220;2019 Annual Report on Form 10-K&amp;#8221;). As included herein, the condensed consolidated balance sheet as of December 31, 2019 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The accompanying financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;).&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <!--Basis of Accounting [Text Block]-->
  <us-gaap:BasisOfAccounting id="Fact_6d6bed3356414fbab1ded89cf88e33d6" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 2.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Basis of Presentation&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&amp;#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2019 included in the Company&amp;#8217;s Annual Report on Form 10-K filed with the SEC on March 11, 2020 (the &amp;#8220;2019 Annual Report on Form 10-K&amp;#8221;). As included herein, the condensed consolidated balance sheet as of December 31, 2019 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The accompanying financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;).&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
  <!--Cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact_193d7fe3654a4ebbbe848fd6447641c0" contextRef="c20191231" unitRef="U002" decimals="-3">49326000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact_b8b7f7c8d8784d8c969c57e1b8e2e331" contextRef="c20200930" unitRef="U002" decimals="-3">17064000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="Fact_06724203530340c98336b3032a26e002" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-32262000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="Fact_17c0cdb6196c4e019eea4f970bb2722c" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-39685000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact_263cd974cd5847dfa8c19eed1a8ae3fa" contextRef="c20191231" unitRef="U002" decimals="-3">49326000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact_9f53463fb6ad4527a0f6c79533273611" contextRef="c20181231" unitRef="U002" decimals="-3">60599000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact_9910d5ec1a5d4877b834ddaae012ad30" contextRef="c20200930" unitRef="U002" decimals="-3">17064000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <!--Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents-->
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact_fb4a0944594245e99416c8e0040c1da7" contextRef="c20190930" unitRef="U002" decimals="-3">20914000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <!--Warrant exercise price (in dollars per share)-->
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="Fact_187bb6486cca4cd097ed7ef41257e350" contextRef="c20200930" unitRef="U003" decimals="3">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <!--Warrant exercise price (in dollars per share)-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="Fact_68ce95173ae84c10bee412504a0b8acb" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U003" decimals="2">4.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <!--Number of shares received upon automatic exercise of warrant (in shares)-->
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Fact_ea76843846cf4d2c90717f2f87c07d99" contextRef="c20200930" unitRef="U001" decimals="-6">2000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <!--Number of shares received upon automatic exercise of warrant (in shares)-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Fact_1077c913423c4fa4a003fe0d9f06a10e" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U001" decimals="-6">2000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <!--Number of shares received upon automatic exercise of warrant (in shares)-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-Subsequent Event [Member]-->
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Fact_a1a0b8877ffc42b4a14d45e842a806de" contextRef="c20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="INF">714000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <!--Material Agreements-->
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="Fact_fdda50950a5f436b81fbc07fe4246617" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 6.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Material Agreements&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Commercial Exploitation Agreement with Indivior&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2008, the Company entered into a Commercial Exploitation Agreement with Reckitt Benckiser Pharmaceuticals, Inc.&amp;#160; (with subsequent amendments collectively, the &amp;#8220;Indivior License Agreement&amp;#8221;). Reckitt Benckiser Pharmaceuticals, Inc. was later succeeded to in interest by Indivior, Inc.&amp;#160; Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&amp;#8217;s requirements for Suboxone, a sublingual film formulation, both inside and outside the United States on an exclusive basis.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain Active Pharmaceutical Ingredients (&amp;#8220;API&amp;#8221;) for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Indivior License Agreement provides for payment by Indivior of a purchase price per unit that is subject to adjustment based on the Company&amp;#8217;s ability to satisfy minimum product thresholds. Additionally, in the event Indivior purchases certain large quantities of Suboxone during a specified period, Indivior will be entitled to scaled rebates on its purchases.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) in each of the United States and in the rest of the world subject to annual maximum amounts and limited to the life of the related United States or international patents. In 2012, Indivior exercised its right to buy out its future royalty obligations in the United States under the Indivior License Agreement. Indivior remains obligated to pay royalties for all sales outside the United States.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&amp;#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renews for successive one-year periods, unless either party provides the other with written notice of its intent not to renew at least one year prior to the expiration of the initial or renewal term.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic; font-weight: bold;"&gt;Supplemental Agreement with Indivior&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company is entitled to receive certain payments from Indivior commencing on the date of the agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable.&amp;#160; Through February 20, 2019, the at-risk launch date of the competing generic products of Dr. Reddy&amp;#8217;s Labs and Alvogen, the Company received an aggregate of $40,750 from Indivior under the Indivior Supplemental Agreement, of which $4,250 was collected during the three months ended March 31, 2019.&amp;#160; Further payments under the Indivior Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. If such litigation is successful, in addition to the amounts already received as described in the foregoing, the Company may receive up to an additional $34,250, consisting of (i) up to $33,000 in the aggregate from any combination of (a) performance or event-based milestone payments and (b) single digit percentage royalties on net revenue earned by Indivior on sales of Suboxone and (ii) an additional $1,250 that was earned through the issuance of additional process patent rights to the Company.&amp;#160; The aggregate payments under this Indivior Supplemental Agreement are capped at $75,000.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement are in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the Indivior License Agreement. Indivior&amp;#8217;s payment obligations under the Indivior Supplemental Agreement are subject to certain factors affecting the market for Suboxone and may terminate prior to January 1, 2023 in the event certain contingencies relating to such market &lt;font style="color: rgb(0, 0, 0);"&gt;occur.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;License Agreement with Sunovion Pharmaceuticals Inc.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion Pharmaceuticals Inc.), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&amp;#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product, KYNMOBI&amp;#8482;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&amp;#8217;s obligation to remit a payment of $4,000 (the &amp;#8220;FDA Approval Milestone Payment&amp;#8221;) due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of the FDA approval. This amount was received as of September 30, 2020 and is included in License and royalty revenues for the nine-months ended September 30, 2020.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In consideration for the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &amp;#8220;Initial Milestone Payments&amp;#8221;) The Company is also entitled to receive certain contingent one-time milestone payments related to product availability and regulatory approval in Europe, certain one-time milestone payments based on the achievement of specific annual net sales thresholds of KYNMOBI&amp;#8482;, and ongoing mid-single digit percentage royalty payments related to the net sales of KYNMOBI&amp;#8482; (subject to reduction to low-single digit percentage royalty payments in certain circumstances), subject to certain minimum payments. The maximum aggregate milestone payments that may be paid to the Company pursuant to the Sunovion License Agreement are equal to $45,000. There can be no guarantee that any future milestones will be met or that additional milestone payments will be payable. There are&amp;#160; minimum annual guaranteed royalty payments under the contract.&amp;#160;&amp;#160; As of September 30, 2020, the Company recorded minimum royalty receivables of $8,000 in the aggregate, of which $1,000 is included in Trade and other receivables and $7,000 is included in Intangibles, net and other assets, with the total reflected in License and royalty revenues for the nine- months ended September 30, 2020.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Effective March 16, 2020, the Company entered into a first amendment (the &amp;#8220;First Amendment&amp;#8221;) to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the European Union (EU) which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provisions to reflect the Company&amp;#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI&amp;#8482; was not commercialized by January 1, 2020.&amp;#160; This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the Amendment to the Sunovion License Agreement.&amp;#160; The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company and Sunovion must continue to pay royalties to the Company on each sale of Sunovion&amp;#8217;s remaining inventory of apomorphine-based products.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties&amp;#8217; agreement with respect to certain provisions in the License Agreement, specifically the date after which Sunovion has the right to terminate the License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&amp;#8217;s patents covered under the License Agreement.&amp;#160; See Note 19, (A), Subsequent Events. On November 3, 2020, the Company entered into a royalty monetization agreement (the &amp;#8220;Monetization Agreement&amp;#8221;) with an affiliate of Marathon Asset Management (&amp;#8220;Marathon&amp;#8221;) pursuant to which the Company conveyed to Marathon the right to all royalties and other payments due to the Company under the Sunovion License Agreement.&amp;#160; See Note 19, (B), Subsequent Events.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Agreement to Terminate CLA with KemPharm&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In March 2012, the Company entered into an agreement with KemPharm, Inc. (&amp;#8220;KemPharm&amp;#8221;) to terminate a Collaboration and License Agreement entered into by the Company and KemPharm in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that KemPharm may derive from the commercialization or any other monetization of KemPharm&amp;#8217;s KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving KemPharm and collaborations, royalty arrangements, or other transactions from which KemPharm may realize value from these compounds. During September 2019, the Company received $1,000 from its 10% share of milestone payments paid to KemPharm under its licensing of KP-415 and KP-484 to a third party.&amp;#160; The Company has also received a payment of $500 under this arrangement during June 2020, which is included in License and royalty revenues for the nine-month period ended September 30, 2020, in connection with the FDA&amp;#8217;s acceptance of a New Drug Application (&amp;#8220;NDA&amp;#8221;) filing for KP-415. A Prescription Drug User Fee Act (PDUFA) target date for completion of FDA review has been scheduled for early March 2021. The Company&amp;#8217;s share of remaining milestone payments associated with KP-415 approval and certain targeted labeling goals within timeframes ending in July 2021 may reach $4,800. However, there can be no guarantee that approvals, goals or any such payments will be achieved or received in the future.&lt;/div&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <!--Contingencies (note 18)-->
  <us-gaap:CommitmentsAndContingencies id="Fact_ef8fe856e4234a918657ecc8554a36fc" contextRef="c20191231" unitRef="U002" xsi:nil="true" />
  <!--Contingencies (note 18)-->
  <us-gaap:CommitmentsAndContingencies id="Fact_f5e54ccf67b14782a3a3012426247388" contextRef="c20200930" unitRef="U002" xsi:nil="true" />
  <!--Commitments and Contingencies Disclosure [Text Block]-->
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Fact_ba0e2ee1f0754c51846fdef36817595f" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 18.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Contingencies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Litigation and Contingencies&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business, including product liability, intellectual property, commercial litigation, or environmental or other regulatory matters. Except as described below, Aquestive is not presently a party to any litigation or other legal proceeding that is believed to be material to its financial condition.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Patent-Related Litigation&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Beginning in August 2013, the Company was informed of abbreviated new drug application (&amp;#8220;ANDA&amp;#8221;) filings in the United States by Watson Laboratories, Inc. (now Actavis Laboratories, Inc., or &amp;#8220;Actavis&amp;#8221;), Par Pharmaceutical, Inc. (&amp;#8220;Par&amp;#8221;), Alvogen Pine Brook, Inc. (&amp;#8220;Alvogen&amp;#8221;), Teva Pharmaceuticals USA, Inc.&amp;#160; (&amp;#8220;Teva&amp;#8221;), Sandoz Inc. (&amp;#8220;Sandoz&amp;#8221;), and Mylan Technologies Inc. (&amp;#8220;Mylan&amp;#8221;), for the approval by the FDA of generic versions of Suboxone Sublingual Film in the United States. Aquestive filed patent infringement lawsuits against all six generic companies in the United States District Court for the District of Delaware (the &amp;#8220;Delaware District Court&amp;#8221;). After the commencement of the ANDA patent litigation against Teva, Dr. Reddy&amp;#8217;s Laboratories (&amp;#8220;DRL&amp;#8221;) acquired the ANDA filings for Teva&amp;#8217;s buprenorphine and naloxone sublingual film that are at issue in these trials.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; margin-left: 18pt;"&gt;Of these, cases against three of the six generic companies have been resolved.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18.3pt; vertical-align: top;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;&lt;font style="font-style: italic;"&gt;Mylan&lt;/font&gt; and &lt;font style="font-style: italic;"&gt;Sandoz&lt;/font&gt; settled without a trial. Sandoz withdrew all challenges and became the distributor of the authorized generic products.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18.3pt; vertical-align: top;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;All cases against &lt;font style="font-style: italic;"&gt;Par &lt;/font&gt;were resolved pursuant to a May 2018 settlement agreement among the Company, Indivior, and Par and certain of its affiliates.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18.3pt; vertical-align: top;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;&lt;font style="font-style: italic;"&gt;Actavis&lt;/font&gt; was found to infringe Patent No. 8,603,514, or the &amp;#8217;514 patent, and cannot enter the market until the expiration of the patent in 2024, and the United States Court of Appeals for the Federal Circuit (&amp;#8220;Federal Circuit&amp;#8221;) affirmed that ruling on July 12, 2019.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18.3pt; vertical-align: top;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;&lt;font style="font-style: italic;"&gt;DRL&lt;/font&gt; and &lt;font style="font-style: italic;"&gt;Alvogen&lt;/font&gt; were found not to infringe under a different claim construction analysis, and the Federal Circuit affirmed that ruling on July 12, 2019. &lt;font style="font-style: italic;"&gt;Teva&lt;/font&gt; has agreed to be bound by all DRL adjudications.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Subsequent to the above, all potential generic competitors without a settlement agreement were also sued for infringement of two additional new patents that contain new claims not adjudicated in the original Delaware District Court case against DRL and Alvogen.&amp;#160; On July 12, 2019, the Federal Circuit affirmed the decisions from the previously decided cases.&amp;#160; The remaining case against Actavis was dismissed in light of the infringement ruling above, which prevents Actavis from entering the market until 2024.&amp;#160; The case(s) against the remaining defendants regarding the additional asserted patents have not been finally resolved.&amp;#160; A &lt;font style="font-style: italic;"&gt;Markman &lt;/font&gt;hearing in the cases against Dr. Reddy&amp;#8217;s and Alvogen which is pending in the United States District Court for the District of new Jersey (the &amp;#8220;New Jersey District Court&amp;#8221;) was held on October 17, 2019.&amp;#160; On November 5, 2019, District Judge McNulty of the New Jersey District Court issued a &lt;font style="font-style: italic;"&gt;Markman&lt;/font&gt; opinion construing the disputed terms of the asserted patents. On January 9, 2020, the New Jersey District Court entered a stipulated order of non-infringement of one of the patents, Patent No. 9,931,305, or the &amp;#8217;305 patent, based on the Federal Circuit&amp;#8217;s claim construction ruling, and the Company and Indivior preserved available rights to appeal the claim construction ruling. On November 19, 2019, Magistrate Judge Waldor of the New Jersey District Court issued an order granting DRL and Alvogen&amp;#8217;s requests to file amended answers to add antitrust counterclaims against Aquestive and Indivior.&amp;#160; Aquestive and Indivior appealed the Magistrate Judge&amp;#8217;s decision to District Judge McNulty on December 4, 2019, and DRL and Alvogen opposed the appeal. On January 17, 2020, the Company filed a motion to dismiss DRL&amp;#8217;s and Alvogen&amp;#8217;s antitrust counterclaims for failure to state a claim, and DRL and Alvogen opposed the motion.&amp;#160; &lt;font style="color: rgb(0, 0, 0);"&gt;On August 24, 2020, Judge McNulty issued an Opinion and Order denying both the appeal of the Magistrate&amp;#8217;s decision and Aquestive&amp;#8217;s Motion to Dismiss. On June 3, 2020, the court issued an order setting a schedule for ongoing fact discovery, expert discovery, and dispositive motions.&amp;#160; The schedule currently sets the close of fact discovery for October 20, 2020, with expert discovery continuing through the end of April 2021.&amp;#160; The schedule also sets the deadline for filing dispositive motions for May 18, 2021. &lt;/font&gt;No trial date has been set in those cases.&amp;#160; Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On February 19, 2019, the Federal Circuit issued its mandate reversing the New Jersey District Court&amp;#8217;s preliminary injunction against Dr. Reddy&amp;#8217;s.&amp;#160; Following issuance of the mandate, the New Jersey District Court vacated preliminary injunctions against both Dr. Reddy&amp;#8217;s and Alvogen.&amp;#160; Dr. Reddy&amp;#8217;s, Alvogen, and Mylan all launched generic versions of Suboxone Sublingual Film, and the launches by Dr. Reddy&amp;#8217;s and Alvogen are &amp;#8220;at risk&amp;#8221; because the products are the subject of the ongoing patent infringement litigations.&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 22.3pt; margin-left: 0.2pt;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On March 22, 2019, Aquestive and Indivior brought suit against Aveva Drug Delivery Systems, Inc., Apotex Corp., and Apotex Inc.in the United States District Court for the Southern District of Florida (the &amp;#8220;Southern District of Florida Court&amp;#8221;) for infringement of the Company&amp;#8217;s U. S. Patent Nos.&amp;#160; 8,017,150, 9,687,454, the &amp;#8217;514 patent and &amp;#8217;305 patent, seeking an injunction and potential monetary damages.&amp;#160; Following a negotiated settlement between all parties, on December 3, 2019, the parties submitted a Notice of Settlement and a Joint Motion to Approve Consent Judgment. The Southern District of Florida Court entered an order dismissing the suit on December 18, 2019.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company is also seeking to enforce its patent rights in multiple cases against BioDelivery Sciences International, Inc. (&amp;#8220;BDSI&amp;#8221;). Three cases are currently pending but stayed in the U.S. District Court for the Eastern District of North Carolina (the &amp;#8220;Eastern District of North Carolina Court&amp;#8221;):&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; width: 18.3pt;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;The first, a declaratory judgment action brought by BDSI against Indivior and Aquestive, seeks declarations of invalidity and non-infringement of U.S. Patents Nos. 7,897,080, 8,652,378 and 8,475,832. This case is stayed.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; width: 18.3pt;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div&gt;The second was filed by Aquestive and Indivior related to BDSI&amp;#8217;s infringing Bunavail product, and alleges infringement of Aquestive&amp;#8217;s patent, U.S. Patent No. 8,765,167, or the &amp;#8217;167 patent, and seeks an injunction and potential monetary damages. Shortly after the case was filed, BDSI filed four (4) IPR&amp;#8217;s challenging the asserted &amp;#8217;167 patent.&amp;#160; On March 24, 2016, the United States Patent Trial and Appeal Board (&amp;#8220;PTAB&amp;#8221;), issued a final written decision finding that all claims of the &amp;#8217;167 patent were valid. The case was stayed in May 2016 pending the final determination of the appeals on those decisions.&amp;#160; Following the PTAB&amp;#8217;s February 7, 2019 decisions on remand denying institution, Aquestive and Indivior submitted a notice to the Court on February 15, 2019 notifying the Court that the stay should be lifted as a result of the PTAB&amp;#8217;s decisions. The parties in this matter are awaiting further action from the Court.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18.3pt; vertical-align: top;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;div style="font-size: 12pt;"&gt;&lt;font style="font-size: 10pt;"&gt;On January 13, 2017, the Company also sued BDSI asserting infringement of the &amp;#8217;167 patent by BDSI&amp;#8217;s Belbuca product and seeking an injunction and potential monetary damages.&amp;#160; On August 7, 2019, the Eastern District of North Carolina Court granted BDSI&amp;#8217;s motion to dismiss the Complaint without prejudice and denied BDSI&amp;#8217;s motion to stay as moot.&amp;#160; On November 11, 2019, Aquestive filed a new Complaint against BDSI in the Eastern District of North Carolina Court.&amp;#160; On November 27, 2019, BDSI filed a motion to stay the case pending BDSI&amp;#8217;s appeal of the PTAB&amp;#8217;s remand decisions, and the Company opposed this motion. The Eastern District of North Carolina Court denied BDSI&amp;#8217;s motion to stay on April 1, 2020. BDSI&amp;#8217;s appeal of the PTAB&amp;#8217;s remand decisions to the United States Court of Appeals for the Federal Circuit was docketed on March 13, 2019, and on March 20, 2019, and a motion was made to dismiss this appeal for lack of jurisdiction.&amp;#160; On August 29, 2019, the Federal Circuit granted the motion to dismiss BDSI&amp;#8217;s appeal.&amp;#160; On September 30, 2019, BDSI filed a petition for rehearing in the Federal Circuit &lt;/font&gt;&lt;font style="font-size: 10pt; font-style: italic;"&gt;en banc&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;, which the Company opposed.&amp;#160; The Federal Circuit denied BDSI&amp;#8217;s petition for rehearing &lt;/font&gt;&lt;font style="font-size: 10pt; font-style: italic;"&gt;en banc&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt; on January 13, 2020.&amp;#160; &lt;/font&gt;&lt;font style="font-size: 10pt; color: rgb(0, 0, 0);"&gt;On June 11, 2020, BDSI filed a petition for writ of certiorari at the Supreme Court of the United States.&amp;#160; At the request of the Supreme Court, Aquestive filed an opposition to BDSI&amp;#8217;s petition on August 17, 2020, and BDSI filed a reply on August 27, 2010.&amp;#160; On October 5, 2020, the Supreme Court issued an order denying BDSI&amp;#8217;s petition. &lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;After the Federal Circuit denied BDSI&amp;#8217;s petition, on January 13, 2020, BDSI filed with the Eastern District of North Carolina Court a motion to dismiss the Complaint, and Aquestive opposed on February 2, 2020.&amp;#160; The Eastern District of North Carolina Court denied BDSI&amp;#8217;s motion to dismiss &lt;/font&gt;&lt;font style="font-size: 10pt; color: rgb(0, 0, 0);"&gt;and its motion to stay &lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;on April 1, 2020.&amp;#160; On April 16, 2020, BDSI filed an Answer to the Complaint, including counterclaims for non-infringement, invalidity, and unenforceability of the &amp;#8217;167 patent.&amp;#160; &lt;/font&gt;&lt;font style="font-size: 10pt; color: rgb(0, 0, 0);"&gt; On May 7, 2020, Aquestive filed a motion to dismiss BDSI&amp;#8217;s unenforceability counterclaim and a motion to strike BDSI&amp;#8217;s corresponding affirmative defenses for failure to state a claim for inequitable conduct under the heightened pleading standard applicable to such claims and defenses.&amp;#160; Rather than oppose Aquestive&amp;#8217;s Motion to Dismiss, on May 28, 2020, BDSI amended its counterclaims and filed an Answer and Amended Counterclaims, which included additional allegations in support of BDSI&amp;#8217;s unenforceability counterclaim.&amp;#160; On June 25, 2020, Aquestive filed a Motion to Dismiss BDSI&amp;#8217;s Amended Counterclaim for unenforceability and a Motion to Strike BDSI&amp;#8217;s corresponding affirmative defense of unenforceability again for failure to state a claim under the applicable heightened pleading standard.&amp;#160; BDSI&amp;#8217;s filed its opposition to Aquestive&amp;#8217;s Motion to Dismiss and Strike on July 16, 2020.&amp;#160; Aquestive filed its Reply to BDSI&amp;#8217;s Opposition on July 30, 2020.&amp;#160; The parties are awaiting further action from the court on Aquestive&amp;#8217;s motion.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic; font-weight: bold;"&gt;Antitrust Litigation&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On September 22, 2016, forty-one states and the District of Columbia, or the States, brought suit against Indivior and the Company in the U.S. District Court for the Eastern District of Pennsylvania, alleging violations of federal and state antitrust statutes and state unfair trade and consumer protection laws relating to Indivior&amp;#8217;s launch of Suboxone Sublingual Film in 2010 and seeking an injunction, civil penalties, and disgorgement. After filing the suit, the case was consolidated for pre-trial purposes with the &lt;font style="font-style: italic;"&gt;In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation&lt;/font&gt;, MDL No. 2445, or the Suboxone MDL, a multidistrict litigation relating to putative class actions on behalf of various private plaintiffs against Indivior relating to its launch of Suboxone Sublingual Film. While Aquestive was not named as a defendant in the original Suboxone MDL cases, the action brought by the States alleges that the Company participated in an antitrust conspiracy with Indivior in connection with Indivior&amp;#8217;s launch of Suboxone Sublingual Film and engaged in related conduct in violation of federal and state antitrust law. Aquestive moved to dismiss the States&amp;#8217; conspiracy claims, but by order dated October 30, 2017, the Court denied the motion to dismiss. An answer was filed denying the States&amp;#8217; claims on November 20, 2017. The fact discovery period closed July 27, 2018, but the parties agreed to conduct certain fact depositions in August 2018.&amp;#160; The expert discovery phase closed May 30, 2019, but additional reports and depositions were conducted through August 1, 2019.&amp;#160; The remainder of the case schedule, including summary judgment briefing, is stayed pending resolution of Indivior&amp;#8217;s appeal of the District Court&amp;#8217;s class certification ruling in a co-pending multi-district litigation to which the Company is not a party. On July 28, 2020, the U.S. Court of Appeals for the Third Circuit issued its opinion affirming the District Court&amp;#8217;s order certifying the class.&amp;#160; On August 27, 2020, the district court issued a scheduling order, setting the deadline for filing remaining &lt;font style="font-style: italic;"&gt;Daubert&lt;/font&gt; challenges and summary judgment.&amp;#160; Under the scheduling order, the remaining &lt;font style="font-style: italic;"&gt;Daubert&lt;/font&gt; motions were filed on September 28, 2020, and oppositions are due on October 19, 2020.&amp;#160; The court will set oral argument on the motions, but the date for oral argument is not yet known.&amp;#160; Summary judgment motions are due January 11, 2021, and responses to summary judgment motions are due February 11, 2021.&amp;#160; No trial date has yet been set. Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; font-style: italic; font-weight: bold;"&gt;Humana and Centene Actions&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;On September 18, 2020, Humana, Inc., a health insurance payer, filed a suit against Aquestive and Indivior in the Eastern District of Pennsylvania relating to Suboxone.&amp;#160; The Humana action, which alleges facts similar to those at issue in the Antitrust Case and the Suboxone MDL described above, was assigned to the same judge that is presiding over those actions.&amp;#160; Humana&amp;#8217;s Complaint alleges five causes of action against Aquestive, including conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment.&amp;#160; On September 21, 2020, Centene Corporation and other related insurance payers filed a similar suit against Aquestive and Indivior in the Eastern District of Missouri.&amp;#160; The counsel representing Humana is also representing Centene.&amp;#160; On September 21, 2020, the Centene action was provisionally transferred to the Eastern District of Pennsylvania by the United States Judicial Panel on Multidistrict Litigation.&amp;#160; No other proceedings have occurred and the schedule is not yet known.&amp;#160; Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimate, of the possible outcome or loss, if any, in this matter.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;California Complaint&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;On December 5, 2019, Neurelis Inc. (&amp;#8220;Neurelis&amp;#8221;) filed a complaint against Aquestive in the Superior Court of California, County of San Diego alleging Unfair Competition, Defamation, and Malicious Prosecution related to the Company&amp;#8217;s pursuit of FDA approval for Libervant&amp;#8482;. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action.&amp;#160; The Company filed a Motion to Strike Neurelis&amp;#8217;s Complaint under California&amp;#8217;s anti-SLAPP (&amp;#8220;strategic lawsuit against public participation&amp;#8221;) statute on Friday, January 31, 2020, which Neurelis is expected to oppose.&amp;#160; Neurelis filed a motion for leave to file a Supplemental Complaint on February 5, 2020, which will be opposed.&amp;#160; On February 5, 2020, Neurelis filed a Motion for Leave to File a Supplemental Complaint (&amp;#8220;Motion&amp;#8221;).&amp;#160; On June 5, 2020, Neurelis filed a Motion for Limited Discovery related to Aquestive&amp;#8217;s anti-SLAPP motion.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;The court previously scheduled a hearing on both Aquestive&amp;#8217;s anti-SLAPP Motion and on Neurelis&amp;#8217;s Motion for April 24, 2020.&amp;#160; However, on April 3, 2020, in response to the COVID-19 pandemic, the court issued an order continuing all hearings scheduled through April 30, 2020.&amp;#160; The court ultimately held a telephonic status conference on June 25, 2020 to determine a schedule for hearing the pending motions.&amp;#160; During that status conference, the court set Aquestive&amp;#8217;s anti-SLAPP motion for hearing on July 24, 2020.&amp;#160; The court also declined Neurelis&amp;#8217;s request to hear its Motion and its Motion for Limited Discovery.&amp;#160; Neurelis filed its response to Aquestive&amp;#8217;s anti-SLAPP Motion on July 13, 2020, and we filed our reply on July 17, 2020.&amp;#160; The court held a telephonic hearing on Aquestive&amp;#8217;s anti-SLAPP motion on July 24, 2020. On August 6, 2020, the Court issued an order granting in part and denying in part Aquestive&amp;#8217;s anti-SLAPP motion.&amp;#160; Aquestive filed a notice of appeal to the California Court of Appeal on September 1, 2020, and Neurelis filed a notice of cross-appeal on October 5, 2020.&amp;#160; &lt;/font&gt;Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <!--Common Stock, Par or Stated Value Per Share-->
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact_6243eb22ffd841deb8435e045ba01a47" contextRef="c20200930" unitRef="U003" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, Par or Stated Value Per Share-->
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact_cfd58a2012064c8abb983f1887c590c3" contextRef="c20191231" unitRef="U003" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, Par or Stated Value Per Share-->
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact_e80a0da92c4342c5b8f6f0469308e185" contextRef="c20191217" unitRef="U003" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, Shares, Issued-->
  <us-gaap:CommonStockSharesIssued id="Fact_16a3a039c18d4c279b3099b491971d53" contextRef="c20191231" unitRef="U001" decimals="INF">33562885</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, Shares, Issued-->
  <us-gaap:CommonStockSharesIssued id="Fact_61b0d9d4787a4dd2b42bde40cfb4566d" contextRef="c20200930" unitRef="U001" decimals="INF">33619796</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, Shares Authorized-->
  <us-gaap:CommonStockSharesAuthorized id="Fact_57bc9e329dc24e19a8416956cdb3021c" contextRef="c20200930" unitRef="U001" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, Shares Authorized-->
  <us-gaap:CommonStockSharesAuthorized id="Fact_a1fe6c6f627f46c187a5c5b07587a9b5" contextRef="c20191231" unitRef="U001" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, Shares, Outstanding-->
  <us-gaap:CommonStockSharesOutstanding id="Fact_1504a31824454255a00799c9ac44e5a0" contextRef="c20200930" unitRef="U001" decimals="INF">33619796</us-gaap:CommonStockSharesOutstanding>
  <!--Common Stock, Shares, Outstanding-->
  <us-gaap:CommonStockSharesOutstanding id="Fact_d8fdb6e195d047ee8a645be11907e5d8" contextRef="c20191231" unitRef="U001" decimals="INF">33562885</us-gaap:CommonStockSharesOutstanding>
  <!--Common Stock, Value, Issued-->
  <us-gaap:CommonStockValue id="Fact_053c60ff965342a09a3b43eee3cbd1b4" contextRef="c20191231" unitRef="U002" decimals="-3">34000</us-gaap:CommonStockValue>
  <!--Common Stock, Value, Issued-->
  <us-gaap:CommonStockValue id="Fact_10510264e13a414f928056048cad3651" contextRef="c20200930" unitRef="U002" decimals="-3">34000</us-gaap:CommonStockValue>
  <!--Comprehensive Income (Loss), Net of Tax, Attributable to Parent-->
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact_85f479d2d309432194b5850a8e37c07a" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">-18412000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Comprehensive Income (Loss), Net of Tax, Attributable to Parent-->
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact_aa75e10a1c9645838842fc8952ddce31" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">-16551000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Comprehensive Income (Loss), Net of Tax, Attributable to Parent-->
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact_cceed1fa83c44181b1f1b686716157b8" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-53610000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Comprehensive Income (Loss), Net of Tax, Attributable to Parent-->
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact_f834955fa59f4077950919a024425626" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-35415000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Concentration Risk Disclosure [Text Block]-->
  <us-gaap:ConcentrationRiskDisclosureTextBlock id="Fact_6fec03dc1f1848e58ffbd181a13000e3" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 4.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Risks and Uncertainties&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company&amp;#8217;s cash requirements for 2020 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September 30, 2020, working capital totaled $13,311, which included $17,064 of cash and cash equivalents.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;As of September 30, 2020, Aquestive has experienced a history of net losses and the Company&amp;#8217;s accumulated deficits totaled $165,889 which have been partially funded by profits from manufacture and supply operations, licensing revenues and certain other services, with the balance of the related funding requirements met by the Company&amp;#8217;s equity and debt offerings including its 12.5% Senior Secured Notes due 2025 (the &amp;#8220;12.5% Notes&amp;#8221;). In 2019, the Company raised funding totaling $52,226, consisting of net proceeds of $13,110 from the refinancing of its debt in July 2019, $37,295 from the public offering of 8,050,000 common shares in December 2019, and $1,821 from the exercise of warrants issued in connection with the debt refinancing.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The characteristics described above provide indications that the Company&amp;#8217;s ability to execute its near-term business objectives and achieve profitability over the longer term cannot be assured. Further, management views the impact of COVID-19 on the economy, its industry, its customers and suppliers and its own operations as constantly evolving, the future effects of which continue to be highly uncertain and unpredictable.&amp;#160; Due to current or future interruptions and possible disruptions in health services, operations of the United States Food and Drug Administration (&amp;#8220;FDA&amp;#8221;), freight and other transportation services, supply, manufacturing, workforce health, availability of acceptable capital, financial and asset monetization markets, and availability of essential human and business requirements, and unforeseeable financial difficulties of the Company&amp;#8217;s customers or vendors, the severity, rapidity of the spread, and the duration of the COVID-19 pandemic may be expected to negatively affect a great number of businesses across various industries, including Aquestive. The Company may experience financial and operational adversity in such areas as pre-clinical, clinical trials, regulatory review and approval of various product candidates, customer demand for products and services, customers&amp;#8217; ability to pay for goods and services, supply of pharmaceutical ingredients and other raw materials from approved vendors, ongoing availability of an appropriate labor force and skilled professionals, and additional capital or other funding from capital, financial or monetization markets.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Subject to and absent any material adverse effect of these and other possible COVID-19 effects, the Company &lt;font style="color: rgb(0, 0, 0);"&gt;expect&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;s&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; that its anticipated revenues from licensed and proprietary products, cash on hand&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;, expense management initiatives,&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;&amp;#160;&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;monetization of certain revenue streams for its out-licensed apomorphine product (KYNMOBI&amp;#8482;), &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;and &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;access to equity markets, including under its shelf registration statement &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; would be adequate to meet expected operating, investing, and financing needs for the next twelve months.&amp;#160; To the extent additional funds are necessary to meet operating&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; needs as the Company continues to execute its business strategy, &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; additional funding requirements would be obtained through &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;modification of the existing debt facility to extend the potential availability of the first and second re-openers, and &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;access to appropriate financial markets &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;for &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;debt or equity financings, or a combination of these potential sources of funds, although management&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; can provide no assurance that any of these sources of funding, either individually or in combination, will be available on reasonable terms, if at all.&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;&amp;#160; In addition, the Company may be required to utilize available financial resources sooner than expected.&amp;#160; Management has based &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;its expectation on assumptions that could change or prove to be inaccurate, either due to the impact of COVID-19 or to unrelated factors including factors arising in the capital markets, asset monetization markets, regulatory approval process, regulatory oversight and other factors.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
  <!--Concentration Risk, Percentage-Commercial Exploitation Agreement With Sunovion [Member]-Revenue Benchmark [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_05b954549f4444dcb0bbb49374a73794" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithSunovionMember" unitRef="U005" decimals="INF">0.31</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Accounts Receivable [Member]-Commercial Exploitation Agreement with Indivior [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_3556e40cb21d498598e4fbdc4ca10624" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember" unitRef="U005" decimals="INF">0.5</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Commercial Exploitation Agreement with Indivior [Member]-Revenue Benchmark [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_40f76b40166d4f1d8e4bf4d3549c4916" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember" unitRef="U005" decimals="INF">0.54</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Commercial Exploitation Agreement With Sunovion [Member]-Accounts Receivable [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_63f230abc2344cfd95fe4627a5e68431" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithSunovionMember" unitRef="U005" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Customer One [Member]-Accounts Receivable [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_6e080c2770654e1da6d26c5f4b48a3f9" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CustomerOneMember" unitRef="U005" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Commercial Exploitation Agreement with Indivior [Member]-Revenue Benchmark [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_cea1b4b4e8474a1095148d791390056e" contextRef="c20190101to20191231_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember" unitRef="U005" decimals="INF">0.86</us-gaap:ConcentrationRiskPercentage1>
  <!--Concentration Risk, Percentage-Accounts Receivable [Member]-Commercial Exploitation Agreement with Indivior [Member]-->
  <us-gaap:ConcentrationRiskPercentage1 id="Fact_e0f85cff6a9f4b86b8a26bbddc8943f7" contextRef="c20190101to20191231_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_MajorCustomersAxis_CommercialExploitationAgreementWithIndiviorMember" unitRef="U005" decimals="INF">0.8</us-gaap:ConcentrationRiskPercentage1>
  <!--Principles of Consolidation and Significant Accounting Policies-->
  <us-gaap:ConsolidationPolicyTextBlock id="Fact_a674c75c9c2e451b9a57972297ac676c" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(A) Principles of Consolidation and Significant Accounting Policies&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The interim condensed consolidated financial statements presented herein include the accounts of Aquestive Therapeutics, Inc. and its wholly owned subsidiary, MonoSol Rx, Inc. Other than corporate formation activities, MonoSol Rx, Inc. has conducted no commercial, drug development or operational activities and has no customers or vendors. The results of operations and cash flows reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected in any other interim period or for the entire fiscal year.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;&lt;div&gt;&lt;div style="text-align: justify; text-indent: 21.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company&amp;#8217;s significant accounting policies are described in the audited consolidated financial statements included in the &lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2019&lt;/font&gt;&amp;#160;&lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt;A&lt;/font&gt;nnual Report on Form 10-K.&amp;#160; Subsequent to the date of those financial statements, there have been no significant changes to these policies other than those listed below.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <!--Contract with Customer, Liability-->
  <us-gaap:ContractWithCustomerLiability id="Fact_99e65a0ab2fe4a87aabfbe61aa62b1e0" contextRef="c20191231" unitRef="U002" decimals="-3">5154000</us-gaap:ContractWithCustomerLiability>
  <!--Contract with Customer, Liability-->
  <us-gaap:ContractWithCustomerLiability id="Fact_f9f4a6c2f27a4b76895700326b0fadbd" contextRef="c20200930" unitRef="U002" decimals="-3">4416000</us-gaap:ContractWithCustomerLiability>
  <!--Deferred revenue, current-->
  <us-gaap:ContractWithCustomerLiabilityCurrent id="Fact_9a2f4dc974774531a1b69c5d3ae0b3bf" contextRef="c20191231" unitRef="U002" decimals="-3">806000</us-gaap:ContractWithCustomerLiabilityCurrent>
  <!--Deferred revenue, current-->
  <us-gaap:ContractWithCustomerLiabilityCurrent id="Fact_e5137df071bc4da6899c40b08831e3a5" contextRef="c20200930" unitRef="U002" decimals="-3">722000</us-gaap:ContractWithCustomerLiabilityCurrent>
  <!--Deferred revenue, net of current portion-->
  <us-gaap:ContractWithCustomerLiabilityNoncurrent id="Fact_4bf0e1d467fc46f8b43513b124d72752" contextRef="c20200930" unitRef="U002" decimals="-3">3694000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
  <!--Deferred revenue, net of current portion-->
  <us-gaap:ContractWithCustomerLiabilityNoncurrent id="Fact_faaeb319e7894dee83e339d9df7c1ab7" contextRef="c20191231" unitRef="U002" decimals="-3">4348000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
  <!--Current and non-current contract assets-->
  <us-gaap:ContractWithCustomerAssetNet id="Fact_a1b258d99dff40889596656de8c64147" contextRef="c20191231" unitRef="U002" decimals="-3">4363000</us-gaap:ContractWithCustomerAssetNet>
  <!--Current and non-current contract assets-->
  <us-gaap:ContractWithCustomerAssetNet id="Fact_e9a64a14eba94f82b73701c56ab5e0b3" contextRef="c20200930" unitRef="U002" decimals="-3">8922000</us-gaap:ContractWithCustomerAssetNet>
  <!--Cost of Goods and Services Sold-->
  <us-gaap:CostOfGoodsAndServicesSold id="Fact_7a4aa87d4b37499597452582d16e3d2d" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">4643000</us-gaap:CostOfGoodsAndServicesSold>
  <!--Cost of Goods and Services Sold-->
  <us-gaap:CostOfGoodsAndServicesSold id="Fact_a959137a3573475191234ab862206750" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">10176000</us-gaap:CostOfGoodsAndServicesSold>
  <!--Cost of Goods and Services Sold-->
  <us-gaap:CostOfGoodsAndServicesSold id="Fact_b136befd8476453d985fadc8cbcb2f38" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">2978000</us-gaap:CostOfGoodsAndServicesSold>
  <!--Cost of Goods and Services Sold-->
  <us-gaap:CostOfGoodsAndServicesSold id="Fact_eb71cb7ae2b14311a0594d869372fed5" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">13569000</us-gaap:CostOfGoodsAndServicesSold>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses id="Fact_62bf8b1a91c2436c9eba9422addbb9d1" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">22041000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses id="Fact_c0a0cbe03d6c41a58c601ae2916364c7" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">23420000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses id="Fact_d201b5af14d8496f8d7f87b259f0eabb" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">78954000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses id="Fact_daaf27286e9543c5ba2e8d7f397af36c" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">65947000</us-gaap:CostsAndExpenses>
  <!--Disaggregation of Revenue-->
  <us-gaap:DisaggregationOfRevenueTableTextBlock id="Fact_a3e5e17a1bce4c228134e37923b6e73c" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following table provides disaggregated net revenue by geographic area:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;United States&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,567&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11,022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;35,496&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,683&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Ex-United States&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,693&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,396&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,204&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,507&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total revenues&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8,260&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,418&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;38,700&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;36,190&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
  <!--Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet id="Fact_902bcc54744c40c197b0a6854c07ba2a" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">7904000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
  <!--Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet id="Fact_af0dbfbb5f2a4331aeeeb6c66c769679" contextRef="c20191231_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">9662000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
  <!--Debt Instrument, Interest Rate, Increase (Decrease)-ASU 2016-02 [Member]-->
  <us-gaap:DebtInstrumentInterestRateIncreaseDecrease id="Fact_6492bfa390cd4e6cba6749cd60084d34" contextRef="c20190101to20191231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U005" decimals="INF">0.1690</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
  <!--Principal amount-Maximum [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentFaceAmount id="Fact_3000b09687814ff0ac10d7e35224703b" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember" unitRef="U002" decimals="-6">100000000</us-gaap:DebtInstrumentFaceAmount>
  <!--Principal amount-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentFaceAmount id="Fact_e0953519fd4742c0820a1a6359357df4" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-6">70000000</us-gaap:DebtInstrumentFaceAmount>
  <!--Frequency of periodic principal payment-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment id="Fact_67c6cf394f9a48f796c812936edfc19d" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">quarterly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
  <!--Debt Disclosure [Text Block]-->
  <us-gaap:DebtDisclosureTextBlock id="Fact_6f3c45bf33a1464194854aa2783f26b6" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 13.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;12.5 % Senior Secured Notes and Loans Payable&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;12.5% Senior Secured Notes&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On July 15, 2019, the Company completed a private placement of up to $100 million aggregate principal of the 12.5% Notes and issued warrants for two million shares of common stock (the &amp;#8220;Warrants&amp;#8221;), $.001 par value per share, through the structuring agent, Morgan Stanley &amp;amp; Co., LLC, and entered into a purchase agreement and related agreements including a Collateral Agreement with U.S. Bank National Association, as trustee and collateral agent, and a Lien Subordination and Intercreditor Agreement for the benefit of Madryn Health Partners, other institutional noteholders (the &amp;#8220;Noteholders&amp;#8221;) and U.S. Bank National Association in dual roles providing terms and governing an asset-based loan facility.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Upon closing of the Indenture for the 12.5% Notes (&amp;#8220;Indenture&amp;#8221;), the Company issued $70,000 of principal of the 12.5% Notes (the &amp;#8220;Initial Notes&amp;#8221;) along with the Warrants and rights of first offer (the &amp;#8220;First Offer Rights&amp;#8221;) to the lenders participating in this transaction for the 12.5% Notes and Warrants (the &amp;#8220;Lenders&amp;#8221;).&amp;#160; Issuance of the Initial Notes and Warrants provided net proceeds of $66,082.&amp;#160; In addition to the Initial Notes, the Indenture may provide access to further loans of up to $30,000 that may become available in two tranches of additional notes (the &amp;#8220;Additional Notes&amp;#8221;) tied to the NDA filing for and FDA U.S. marketing approval of Libervant&amp;#8482;, an important part of the Company&amp;#8217;s drug candidate pipeline. Subject to approval of the holder of a majority of the outstanding principal amount of the 12.5% Notes in its discretion, and provided that no events of default exist, the Company may offer to the Lenders participation in a $10,000 additional offering of the 12.5% Notes (the &amp;#8220;First Additional Offering&amp;#8221;) under terms similar to the Initial Notes, on or before March 31, 2021, upon the filing of the Libervant&amp;#8482; NDA with the FDA.&amp;#160; A second funding opportunity would allow the Company to obtain, on or before March 31, 2021, an additional $20,000 if the first option has been elected and funded, or, if not elected or funded, an additional $30,000 may be offered for issuance following FDA approval of Libervant&amp;#8482; for marketing in the U.S.&amp;#160; On November 3, 2020, this Indenture was amended and will be partially repaid from proceeds resulting from the monetization transaction.&amp;#160; See Note 19 (C), Subsequent Events.&amp;#160; There can be no assurance that any additional financing will be consummated.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Proceeds from the issuance of the Initial Notes and Warrants were used to fully repay the Company&amp;#8217;s $56,340 outstanding indebtedness to Perceptive Credit Opportunities Fund, LP (the &amp;#8220;Perceptive Loan&amp;#8221;), related early repayment fees and legal and other fees incurred to obtain the loan.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The 12.5% Notes provide a stated fixed rate of 12.5%, payable quarterly in arrears, with the initial quarterly principal repayment of the Initial Notes due on September 30, 2021, and the final quarterly payment due at maturity on June 30, 2025. The Company has recorded $1,750 as Loans Payable, Current to reflect this obligation in its Condensed Consolidated Balance Sheet at September 30, 2020.&amp;#160; Principal payments are scheduled to increase annually from 10% of the face amount of debt then outstanding during the first four quarters to 40% of the initial loan principal during the final four quarters.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-indent: 18pt;"&gt;A debt maturity table is presented below:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Remainder of 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;10,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;17,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;70,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company may elect, at its option, to prepay the 12.5% Notes at any time at premiums that range from 101.56% of outstanding principal if prepayment occurs on or after the 5&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;th&lt;/sup&gt; anniversary of the issue date of the Initial Notes to 112.5% if payment occurs during the third year after the issuance of the Initial Notes.&amp;#160; In the event that redemption occurs within the two years after the issuance of the 12.5% Notes, a make-whole fee is required, based on the present value of remaining interest payments using an agreed-upon discount rate linked to the then-current U.S. Treasury rate. The Indenture also includes a change of control provision under which the Company may be required to repurchase the 12.5% Notes at 101% of the remaining principal plus accrued interest at the election of the Lenders.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Collateral for the loan under the 12.5% Notes consists of a priority lien on substantially all property and assets, including intellectual property, of the Company.&amp;#160; This secured obligation provides payment rights that are senior to all existing and future subordinated indebtedness of the Company and provides Lenders with perfected security interests in substantially all of the Company&amp;#8217;s assets.&amp;#160; In the event that asset-based loans of up to $10,000 (&amp;#8220;ABL Facility&amp;#8221;) may be obtained, subject receivables and inventory assets will provide a second priority lien to senior secured Noteholders. The Company&amp;#8217;s license of its intellectual property to a third-party drug development enterprise (specifically, Sunovion&amp;#8217;s KYNMOBI&amp;#8482; product) is one of the various assets serving as collateral for the loan.&amp;#160; The&amp;#160; Indenture permits the Company to monetize this asset while specifying that a portion of the proceeds, up to $40,000 if the First Additional Offering has not been elected or funded, or, $50,000 if it has been elected and funded, must be applied to prepay the Initial Notes, at 112.5% of the principal amount of the 12.5% Notes being repurchased, plus accrued and unpaid interest, if any, thereon, to the date of the repurchase, to the extent elected by the Noteholders, assuming that such monetization, up to such $40,000 or $50,000 level, as applicable, equals or exceeds those levels and if such monetization does not equal or exceed such level, such prepayment would be pro-rated among the Noteholders.&amp;#160; To the extent that Lenders do not elect repayment of the debt at the date of the monetization, the amount not elected up to $40,000 (or $50,000 if an additional tranche is issued) will be held in a collateral account until approval of Libervant&amp;#8482; by the FDA for U.S. marketing, at which time this cash collateral is to be released to the Company.&amp;#160; Proceeds of more than $40,000 (or $50,000 if an additional tranche is issued) can be used immediately for general corporate purposes. As of September 30, 2020, the Company complied with all of its covenants under the Indenture.&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company capitalizes legal and other third-party costs incurred in connection with obtaining debt as deferred debt issuance costs and applies the unamortized portion as a reduction of the outstanding face amount of the related loan in accordance with ASU 2015-03, &lt;font style="font-style: italic;"&gt;Interest &amp;#8211; Imputation of Interest: Simplifying the Presentation of Debt Issuance Costs&lt;/font&gt;.&amp;#160; Similarly, the Company amortizes debt discounts, such as those represented by warrants issued to its holders, and offsets those as a direct reduction of its outstanding debt.&amp;#160; Amortization expenses arising from deferred debt issuance costs and debt discounts related to the 12.5% Notes were $590 and $1,758 for the three- and nine-month periods ended September 30, 2020, respectively. Comparative amortization expenses derived from deferred debt issuance costs and debt discounts related to the Perceptive Loan and the 12.5% Notes for the three- and nine-month periods ended September 30, 2019 were $556 and $1,338, respectively.&amp;#160; Unamortized deferred debt issuance costs and deferred debt discounts totaled $7,904 and $9,662 as of September 30, 2020 and December 31, 2019, respectively.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic;"&gt;Loans Payable - Perceptive&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2016, the Company entered into a Loan Agreement and Guaranty with Perceptive Credit Opportunities Fund, LP (&amp;#8220;Perceptive&amp;#8221;) under which the total available facility of $50,000 had been borrowed as of March 2017.&amp;#160; At closing, Perceptive received a warrant to purchase senior common equity interests representing 4.5% of the fully diluted common units of the Company on an as converted basis, which was automatically exercised in full at the time of Aquestive&amp;#8217;s IPO.&amp;#160; In July 2019, the Perceptive Loan was paid in full in connection with the completion of the sale of the Initial Notes and Warrants described above.&amp;#160; The early extinguishment of this debt resulted in a charge to third quarter 2019 earnings of an amount of $4,896, including an early retirement premium of $2,944 and the remaining balances of the unamortized loan discount and loan acquisition costs.&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <!--Interest rate-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Fact_6e92b82d65214b319bc8f12984aa225d" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U005" decimals="INF">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <!--Interest rate-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <!--Debt maturity date-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:DebtInstrumentMaturityDate id="Fact_53185980a01c4a11b4f286af8aa1f9a5" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">2025-06-30</us-gaap:DebtInstrumentMaturityDate>
  <!--Depreciation, Depletion and Amortization, Nonproduction-->
  <us-gaap:DepreciationAndAmortization id="Fact_d1a9ca9409954728aad1b8dada7ad847" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">2288000</us-gaap:DepreciationAndAmortization>
  <!--Depreciation, Depletion and Amortization, Nonproduction-->
  <us-gaap:DepreciationAndAmortization id="Fact_e0329a49f0664eab83367e8ca591bb12" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">2337000</us-gaap:DepreciationAndAmortization>
  <!--Depreciation-->
  <us-gaap:Depreciation id="Fact_4ff430a7e7314ce0a0bb18a25ba1500c" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">695000</us-gaap:Depreciation>
  <!--Depreciation-->
  <us-gaap:Depreciation id="Fact_a7385ef33c2042b2b94cc1554e5d412c" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">2127000</us-gaap:Depreciation>
  <!--Depreciation-->
  <us-gaap:Depreciation id="Fact_cc6b8b7655ef4562984c9356b19a2306" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">2143000</us-gaap:Depreciation>
  <!--Depreciation-->
  <us-gaap:Depreciation id="Fact_e6f0aee2a5ec465282cf12464458d4e7" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">714000</us-gaap:Depreciation>
  <!--Share-based Payment Arrangement [Text Block]-->
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Fact_ffd756710f4445cbb48513239f52d670" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 16.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Share-Based Compensation&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The Company recognized share-based compensation in its Condensed Consolidated Statements of Operations and Comprehensive Loss during 2020 and 2019 as follows:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Manufacture and supply&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;73&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;176&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Research and development&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;178&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;188&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;543&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;536&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Selling, general and administrative&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,176&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,622&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,301&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,480&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total share-based compensation expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,427&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,052&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,200&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Share-based compensation from:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Restricted stock units&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;16&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;473&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;789&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,403&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Stock options&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,411&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,397&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,252&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,777&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Employee stock purchase plan&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;20&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total share-based compensation expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,427&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,052&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,200&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Share-Based Compensation Equity Awards&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following tables provide information about the Company&amp;#8217;s restricted stock unit and stock option activity during the nine-month period ended September 30, 2020:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;u&gt;Restricted Stock Unit Awards (RSUs):&lt;/u&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Number of&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Units&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Grant Date Fair&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unvested as of December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;74&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14.64&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7.54&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Vested&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(64&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14.88&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Forfeited&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unvested as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11.38&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Grant date fair value of shares vested during the period&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;958&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unrecognized compensation costs as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Unrecognized compensation costs related to awards of RSUs are expected to be recognized over a weighted-average period of less than two years.&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;u&gt;Stock Option Awards:&lt;/u&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Number of&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted Average&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Outstanding as of December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,231&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;10.42&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;981&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2.68&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Exercised, Forfeited, Expired&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(136&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(4.39&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Outstanding as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,076&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8.22&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Vested or expected to vest as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,866&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8.22&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Exercisable as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,014&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11.87&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The fair values of stock options granted during 2020 were estimated using the Black-Scholes-Merton pricing model based on the following assumptions:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 60%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: right; color: rgb(0, 0, 0);"&gt;None&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;100&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected term (years)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5.5 - 6.1&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Risk-free interest rate&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;0.4 &amp;#8211; 1.7&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;The weighted average grant date fair value of stock options granted during 2020 was $2.10 During the nine-month period ended September 30, 2020, stock options were granted with exercise prices ranging from $1.54 to $7.86, and accordingly, given the Company&amp;#8217;s share price of $4.86 at September 30, 2020, certain shares granted during this period provided intrinsic value at that date totaling $2,474. No intrinsic value was provided by stock options granted during the nine-month period ended September 30, 2019.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;As of September 30, 2020, $6,554 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a weighted average period of 1.8 years from the date of grant.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);"&gt;&lt;u&gt;Employee Stock Purchase Plan&lt;/u&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;The Aquestive Therapeutics, Inc. Employee Stock Purchase Plan, or ESPP, as amended and restated effective as of January 1, 2019, features two six-month offering periods per year, running from January 1 to June 30 and July 1 to December 31. Under the ESPP, employees may elect to purchase the Company&amp;#8217;s common stock at the lower of 85% of the fair value of shares on either the first or last day of the offering period. During the nine-month periods ended September 30, 2020 and 2019, respectively, 14,961 and 31,393 shares were purchased and issued through the ESPP at total discounts of $11 and $20.&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <!--Net Loss Per Share-->
  <us-gaap:EarningsPerShareTextBlock id="Fact_4abaf5bceb7543b2ad6e923f3595ccc9" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 15.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Net Loss Per Share&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;Basic net income or loss per share is calculated by dividing net income or loss by the weighted-average number of common share&lt;/font&gt;s outstanding during the periods. Diluted net income or loss per common share is similarly computed and includes the effect of any additional dilutive potential common shares outstanding during the periods. These potential common shares are excluded from the computation of net loss per share to the extent that their effects are antidilutive, and &lt;font style="color: rgb(0, 0, 0);"&gt;as a result of the Company&amp;#8217;s net losses incurred for the three- and nine-month periods ended September 30, 2020 and 2019, respectively, no potentially dilutive securities have been included in the computation of diluted net loss per share for the periods presented below.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Net loss&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(16,551&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(18,412&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(35,415&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(53,610&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Weighted-average number of common shares &amp;#8211; basic&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,619,379&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;25,031,478&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,592,846&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,992,229&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Loss per common share &amp;#8211; basic and diluted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(0.49&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(0.74&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(1.05&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2.15&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following outstanding stock options, restricted stock units and warrants are antidilutive and have been excluded from the computation of the loss per common share for the periods ended September 30:&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Options on common shares outstanding&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,075,942&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,256,092&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Restricted stock units unvested&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,489&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;107,144&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Warrants on common shares outstanding&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,571,429&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total potentially antidilutive derivatives excluded from losses per share&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,660,860&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,363,236&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <!--Net loss per share - basic and diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact_1c4706c71a62449a88dfcf9b7547a389" contextRef="c20190701to20190930" unitRef="U003" decimals="2">-0.74</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Net loss per share - basic and diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact_25df42d439784885928bbea6dfe453f8" contextRef="c20200101to20200930" unitRef="U003" decimals="2">-1.05</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Net loss per share - basic and diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact_2ce2b2e8afe14616bc6575c319d82bdb" contextRef="c20200701to20200930" unitRef="U003" decimals="2">-0.49</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Net loss per share - basic and diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact_5d0f68e1b49f4e889f30c342620b8d1f" contextRef="c20190101to20190930" unitRef="U003" decimals="2">-2.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Federal statutory tax rate-->
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Fact_0a0f996bae144c76a9321019199e6de0" contextRef="c20200101to20200930" unitRef="U005" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <!--Unrecognized compensation costs of RSU awards-Restricted Stock Units [Member]-->
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions id="Fact_77f60ac4cb9d415c8ab9513f241f1655" contextRef="c20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">140000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
  <!--Unrecognized compensation expense related to non-vested stock options-Options on Common Shares Outstanding [Member]-->
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions id="Fact_9daeea33a14e429e92595e466037e828" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">6554000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <!--Unrecognized compensation cost, recognition period-Options on Common Shares Outstanding [Member]-->
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Fact_29847469d1554d9d874c4d998ebae893" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <!--Unrecognized compensation cost, recognition period-Restricted Stock Units [Member]-->
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Fact_ef79641ed3b34cdfb6f0391fd57884dc" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <!--Accrued compensation-->
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Fact_2bbdfe6b1eb942a8b940e042c9439057" contextRef="c20191231" unitRef="U002" decimals="-3">3758000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <!--Accrued compensation-->
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Fact_3a91c114860148c49819ed8318ce96a4" contextRef="c20200930" unitRef="U002" decimals="-3">4129000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <!--Fair Value Disclosures [Text Block]-->
  <us-gaap:FairValueDisclosuresTextBlock id="Fact_ea6de0b160524a899107a6cebbc50db2" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="vertical-align: top; width: 45pt;"&gt;&lt;div style="text-align: left; font-weight: bold;"&gt;Note 7.&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="text-align: left; font-weight: bold;"&gt;Financial Instruments &amp;#8211; Fair Value Measurements&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&amp;#160; Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Level 1 &amp;#8212; Observable quoted prices in active markets for identical assets or liabilities.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Level 2 &amp;#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 18pt;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Level 3 &amp;#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&amp;#160; methodologies and similar techniques.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-indent: 18pt;"&gt;The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company granted warrants to certain holders of the 12.5% Notes in connection with its debt refinancing in July 2019.&amp;#160; These warrants were valued based primarily on Level 3 inputs and an independent third-party appraisal prepared as of the grant date consistent with generally-accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&amp;#8217; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued Compensation.&amp;#160; See Note 14 for further information on these warrants.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <!--2020-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear id="Fact_4a90b84614694def984eee105ccf8e4e" contextRef="c20200930" unitRef="U002" decimals="-3">50000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
  <!--2021-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="Fact_bec368d00a7a493c9ca1ae38f5ed1969" contextRef="c20200930" unitRef="U002" decimals="-3">50000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <!--Finite-Lived Intangible Assets, Net-->
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Fact_99bf0719b76246a5bd86d9f944fb614c" contextRef="c20191231" unitRef="U002" decimals="-3">153000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <!--Finite-Lived Intangible Assets, Net-->
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Fact_e1807d5e6510495a9720c4eebb857436" contextRef="c20200930" unitRef="U002" decimals="-3">115000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <!--Finite-Lived Intangible Assets, Gross-Purchased Technology-based Intangible [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_050b096aea474c5c9ea1bdd52a7919eb" contextRef="c20200930_FiniteLivedIntangibleAssetsByMajorClassAxis_TechnologyBasedIntangibleAssetsMember" unitRef="U002" decimals="-3">2358000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--Finite-Lived Intangible Assets, Gross-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_3fe3914676da4e5c856dcdaf5f7f6f61" contextRef="c20200930" unitRef="U002" decimals="-3">2867000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--Finite-Lived Intangible Assets, Gross-Purchased Technology-based Intangible [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_7587e70318bf401ba51da598ff203dd8" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TechnologyBasedIntangibleAssetsMember" unitRef="U002" decimals="-3">2358000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--Finite-Lived Intangible Assets, Gross-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_758aebf2b8a94d7cbef01d6f7951d133" contextRef="c20191231" unitRef="U002" decimals="-3">2867000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--Finite-Lived Intangible Assets, Gross-Patents [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_7a96823daf494b9d9f8645c23142074d" contextRef="c20200930_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U002" decimals="-3">509000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--Finite-Lived Intangible Assets, Gross-Patents [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Fact_ef53feba422b4f9dae9b5ff550cb91d1" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="U002" decimals="-3">509000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <!--2022-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="Fact_88b51cbc62a14c8a825113a37a9d2af6" contextRef="c20200930" unitRef="U002" decimals="-3">50000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Fact_0d6a945838554b9e80eb58af92001d76" contextRef="c20200930" unitRef="U002" decimals="-3">2752000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Fact_13d29c11a2e54099b6ba25067b94bace" contextRef="c20191231" unitRef="U002" decimals="-3">2714000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Loss on extinguishment of debt-->
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="Fact_41e4a07622604677b89901f76000de8c" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <!--Loss on extinguishment of debt-->
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="Fact_7be5278fcbc1468ab15899c20e0b929e" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-4896000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <!--Loss on extinguishment of debt-->
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="Fact_8c0ec52f220e49139054d295b3cbe192" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">-4896000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <!--Loss on extinguishment of debt-->
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="Fact_b88c557c0acf4cc18a1982ea6fef37ad" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <!--Intangible Assets, Net and Other Assets-->
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock id="Fact_3f36cfdec8e24a719d0c73ad61f899e3" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 11.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Intangible Assets, Net and Other Assets&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent: 21.6pt; color: rgb(0, 0, 0); margin-left: 18pt;"&gt;&lt;br /&gt; The following table provides the components of identifiable intangible assets, all of which are finite lived:&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Purchased technology-based intangible&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,358&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,358&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Purchased patent&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;509&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;509&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,867&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,867&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: accumulated amortization&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2,752&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2,714&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Intangible assets, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;115&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;153&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Royalty receivable&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Other assets, primarily security deposits&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;287&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;286&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total intangible assets, net and other assets&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,402&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;439&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;Amortization expense was $13 for each of the three-month periods ended September 30, 2020 and 2019. For the corresponding nine-month periods, these expenses totaled $38 and $39, respectively. During the remaining life of the purchased patent, estimated annual amortization expense is $50 for each of the years from 2020 to 2022.&amp;#160; Royalty receivable consists of seven annual $1,000 minimum royalty payments due from Sunovion, the last of which is due in March 2028.&amp;#160; See Note 6 above.&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <!--Net (loss)/income before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="Fact_59fbdf851b7744e59386252d9d854522" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-35415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Net (loss)/income before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="Fact_62c069f3384344a4961a87e274b186d9" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-53610000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Net (loss)/income before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="Fact_a698b5f9553846279e4d88f8202eee24" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">-16551000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Net (loss)/income before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="Fact_ee40d5ce3d754b2289b9f23ab2ed8bf4" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">-18412000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Income Tax Disclosure [Text Block]-->
  <us-gaap:IncomeTaxDisclosureTextBlock id="Fact_85d08788e6724988813f6b0ebb13ff3b" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 17.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Income Taxes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits.&amp;#160; Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.&amp;#160; The Company has considered the impact of the CARES Act in relation to the 2020 income tax provision. However, due to the full valuation allowance and no ability or intent to carryback the 2020 net operating loss, no impact is expected.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company&amp;#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended September 30, 2020 and 2019, the Company recorded no income tax benefit from its pretax losses of $16,551 and $18,412, respectively, and similarly for the nine months ended September 30, 2020 and 2019, the Company recorded no tax benefit from its pretax loss of $35,415 and $53,610, respectively, due to realization uncertainties.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company&amp;#8217;s U.S. Federal statutory rate is 21%.&amp;#160; The primary factor impacting the effective tax rate for the three- and nine-month periods ended September 30, 2020 is the anticipated full year operating loss which will require full valuation allowances against any associated net deferred tax assets.&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit id="Fact_2a6e206c2d374255b8832e88028b7371" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit id="Fact_347536a6b60c49d0984e0716a2211695" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit id="Fact_d8cb605d2fe0417891ad68cccd0d923a" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit id="Fact_fdbfcdaa5d744da39bd3bb21682513fd" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
  <!--Increase (Decrease) in Accounts Payable and Accrued Liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Fact_1055933e6e304c66aa1bd91f0882afd2" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-5632000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Increase (Decrease) in Accounts Payable and Accrued Liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Fact_73fba00d9d804ad396ad5fa83286cb0a" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-2573000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Increase (Decrease) in Accounts and Other Receivables-->
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="Fact_01caae904ac44c3e8a9ae1d4d67a50bf" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-5082000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <!--Increase (Decrease) in Accounts and Other Receivables-->
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="Fact_622a4f8380b04f30a564b968ce4ee8a3" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">3887000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <!--Increase (Decrease) in Deferred Revenue-->
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="Fact_1ef598c925ef4256a249200f4c8b1893" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-738000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <!--Increase (Decrease) in Deferred Revenue-->
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="Fact_426d6d1c17094424a6ddfbca7b3e8b28" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-591000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <!--Increase (Decrease) in Inventories-->
  <us-gaap:IncreaseDecreaseInInventories id="Fact_8b8e037f2ef9492586982fc01c0fcb02" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-1317000</us-gaap:IncreaseDecreaseInInventories>
  <!--Increase (Decrease) in Inventories-->
  <us-gaap:IncreaseDecreaseInInventories id="Fact_f21b55dda9ef4e3288237d9ec98446c7" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">383000</us-gaap:IncreaseDecreaseInInventories>
  <!--Increase (Decrease) in Prepaid Expense and Other Assets-->
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact_06c4977f6277461da764fb333ab3e4df" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">1029000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <!--Increase (Decrease) in Prepaid Expense and Other Assets-->
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact_d19921a0e6244aceb50d2501f9205b33" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">7101000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <!--Interest Expense-->
  <us-gaap:InterestExpense id="Fact_02c6dcc261374d33b764277d943b4137" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">2778000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense id="Fact_18f7f473387e4d94a85e84373739f328" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">6515000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense id="Fact_2ee5816894f941d6aee0faf8f7e45441" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">2652000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense id="Fact_e135ed9aaf314bb5bf4bb29d756a378f" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">8296000</us-gaap:InterestExpense>
  <!--Interest Paid, Excluding Capitalized Interest, Operating Activities-->
  <us-gaap:InterestPaidNet id="Fact_a60ec035a9c2427d958c474d68c70fe1" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">6562000</us-gaap:InterestPaidNet>
  <!--Interest Paid, Excluding Capitalized Interest, Operating Activities-->
  <us-gaap:InterestPaidNet id="Fact_d6e4460e20cc4d9e93c54e721753bdd2" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">5153000</us-gaap:InterestPaidNet>
  <!--Finished goods-->
  <us-gaap:InventoryFinishedGoods id="Fact_c13b0fb3199c4d658e1785f83d192d2d" contextRef="c20191231" unitRef="U002" decimals="-3">519000</us-gaap:InventoryFinishedGoods>
  <!--Finished goods-->
  <us-gaap:InventoryFinishedGoods id="Fact_d892601e351847de87a03a8377fdfe72" contextRef="c20200930" unitRef="U002" decimals="-3">858000</us-gaap:InventoryFinishedGoods>
  <!--Inventory Disclosure [Text Block]-->
  <us-gaap:InventoryDisclosureTextBlock id="Fact_dfebfc0c92b04aaba516eb6aeb3a0795" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 8.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Inventories, Net&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The components of Inventory, net is as follows:&lt;/div&gt;&lt;div style="text-indent: 21.6pt; color: rgb(0, 0, 0);"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Raw material&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,153&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,244&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Packaging material&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,231&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,096&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Finished goods&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;858&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;519&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total inventory, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,242&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,859&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;The Company manufactures Suboxone exclusively to order for its major customer subject to strict quality standards and recognizes revenue upon completion of all customary quality control evaluations, which occurs prior to actual shipment.&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <!--Raw material-->
  <us-gaap:InventoryRawMaterials id="Fact_0feb15b3de2d46e3b19ae437ebf1031c" contextRef="c20200930" unitRef="U002" decimals="-3">1153000</us-gaap:InventoryRawMaterials>
  <!--Raw material-->
  <us-gaap:InventoryRawMaterials id="Fact_fd52c993731041cabfe8db77878713a7" contextRef="c20191231" unitRef="U002" decimals="-3">1244000</us-gaap:InventoryRawMaterials>
  <!--Inventories, net-->
  <us-gaap:InventoryNet id="Fact_262936cfe8104c3eb0ee3a5d4f2dbd04" contextRef="c20200930" unitRef="U002" decimals="-3">3242000</us-gaap:InventoryNet>
  <!--Inventories, net-->
  <us-gaap:InventoryNet id="Fact_82273d82fecb4e5ea06dde8a1396328f" contextRef="c20191231" unitRef="U002" decimals="-3">2859000</us-gaap:InventoryNet>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest id="Fact_4bc33641f7404a77bdbfa7988ad61067" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">8000</us-gaap:InvestmentIncomeInterest>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest id="Fact_74967e4125484864a8f90ba4aab44bc9" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">128000</us-gaap:InvestmentIncomeInterest>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest id="Fact_81d6a3ffc7584f7d92ed9604c1b158ee" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">565000</us-gaap:InvestmentIncomeInterest>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest id="Fact_9b808b12908649979b86e31ba985a0f5" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">138000</us-gaap:InvestmentIncomeInterest>
  <!--Lessee, Operating Lease, Remaining Lease Term-Minimum [Member]-->
  <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm id="Fact_c88e0dbccffb4b799849c4c7b28620ca" contextRef="c20200930_RangeAxis_MinimumMember">P2Y6M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
  <!--Lessee, Operating Lease, Remaining Lease Term-Maximum [Member]-->
  <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm id="Fact_cf536bbc175d4532b8c1f4fb290def38" contextRef="c20200930_RangeAxis_MaximumMember">P6Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
  <!--2023-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree id="Fact_63a7b3fc502e4d00972949269b6f2b7a" contextRef="c20200930" unitRef="U002" decimals="-3">944000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
  <!--Lessee, Operating Lease, Liability, Undiscounted Excess Amount-->
  <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount id="Fact_d053d3a762c044cfa2bef00de37df781" contextRef="c20200930" unitRef="U002" decimals="-3">1635000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
  <!--2026-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive id="Fact_2a92fc84c266434bb747daed54cc883c" contextRef="c20200930" unitRef="U002" decimals="-3">424000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
  <!--Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear id="Fact_4c3a82b4cbc74853b8c6ae8a42aa1448" contextRef="c20200930" unitRef="U002" decimals="-3">266000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
  <!--2024-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour id="Fact_5c202d72a88c459cba91edeb3086d031" contextRef="c20200930" unitRef="U002" decimals="-3">565000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
  <!--Lessee, Operating Lease, Liability, to be Paid-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue id="Fact_c1d832c104004afc961e72a55b18a3b1" contextRef="c20200930" unitRef="U002" decimals="-3">5346000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
  <!--Operating Lease Liabilities-->
  <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock id="Fact_91f1a50a82994984888a2b58ab87aaad" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-indent: 18pt;"&gt;Maturities of the Company&amp;#8217;s operating lease liabilities are as follows:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Remainder of 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;266&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,287&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,295&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;944&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;565&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;565&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;424&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Total lease payments&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,346&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: imputed interest&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(1,635&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,711&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
  <!--Right-of-Use Assets and Lease Obligations-->
  <us-gaap:LesseeOperatingLeasesTextBlock id="Fact_10afba2ed3d04e4d99be3d78fc3bf0eb" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 10.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Right-of-Use Assets and Lease Obligations&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company leases all realty used as its p&lt;font style="color: rgb(0, 0, 0);"&gt;roduction and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, &lt;/font&gt;&lt;font style="font-style: italic; color: rgb(33, 37, 41);"&gt;Leases, &lt;/font&gt;&lt;font style="color: rgb(33, 37, 41);"&gt;that require classification as financing leases and, accordingly, these leases are accounted for as operating leases&lt;/font&gt;. These leases provide remaining terms between 2.5 years and 6.0 years, including renewal options expected to be exercised to extend the lease periods. Measurement of the operating lease liability reflects an estimated discount rate of 16.9% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&amp;#8217;s latest collateralized debt refinancing. Right-of-use assets recorded upon adoption of ASC 842 totaled $4,048. For the three- and nine-month periods ended September 30, 2020, total operating lease expenses under these leases totaled $409 and $1,228, respectively, including variable lease expenses such as common area maintenance and operating costs totaling $89 and $255, respectively. Total payments to these lessors during the nine-month period ended September 30, 2020 were $1,255.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-indent: 18pt;"&gt;Maturities of the Company&amp;#8217;s operating lease liabilities are as follows:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Remainder of 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;266&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,287&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,295&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;944&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;565&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;565&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;424&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Total lease payments&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,346&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: imputed interest&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(1,635&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,711&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
  <!--2025-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive id="Fact_36553a7fa9d445898ecf45d67a5b5fa3" contextRef="c20200930" unitRef="U002" decimals="-3">565000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
  <!--Lessee, Operating Lease, Liability, to be Paid, Year Two-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo id="Fact_5ab03dff60944fbf8368af55ffe810de" contextRef="c20200930" unitRef="U002" decimals="-3">1295000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
  <!--Lessee, Operating Lease, Liability, to be Paid, Year One-->
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths id="Fact_ac8a39edff2c4258a657dc110ae5ffc0" contextRef="c20200930" unitRef="U002" decimals="-3">1287000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
  <!--Liabilities and Equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity id="Fact_8c6bb43ce33a452c9f232dffb925838a" contextRef="c20191231" unitRef="U002" decimals="-3">78479000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Liabilities and Equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity id="Fact_96c65f6b8b924a8e940b68ed7f1a1e2f" contextRef="c20200930" unitRef="U002" decimals="-3">50423000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Liabilities-->
  <us-gaap:Liabilities id="Fact_42784e98b5b94cdfbbea66dc2d321cb6" contextRef="c20200930" unitRef="U002" decimals="-3">86942000</us-gaap:Liabilities>
  <!--Liabilities-->
  <us-gaap:Liabilities id="Fact_e35da616db3f4d56b292f1e51ccd5d59" contextRef="c20191231" unitRef="U002" decimals="-3">84601000</us-gaap:Liabilities>
  <!--Liabilities, Current-->
  <us-gaap:LiabilitiesCurrent id="Fact_16a42777526949da95dd96efe6036b32" contextRef="c20200930" unitRef="U002" decimals="-3">18373000</us-gaap:LiabilitiesCurrent>
  <!--Liabilities, Current-->
  <us-gaap:LiabilitiesCurrent id="Fact_7d4b6ee9aef24b469094d872a603a01e" contextRef="c20191231" unitRef="U002" decimals="-3">18555000</us-gaap:LiabilitiesCurrent>
  <!--Credit facility, maximum borrowing capacity-Perceptive Credit Opportunities Fund, LP [Member]-Line of Credit [Member]-->
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Fact_4e0adced611e4bdf8d0c974c0288b6fe" contextRef="c20200930_CreditFacilityAxis_LineOfCreditMember_LineOfCreditFacilityAxis_PerceptiveCreditOpportunitiesFundLPMember" unitRef="U002" decimals="-3">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <!--Notes payable outstanding-Subsequent Event [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:LoansPayable id="Fact_e61d1649feb7451a9130b430984fb40a" contextRef="c20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-3">51500000</us-gaap:LoansPayable>
  <!--Loans payable, current-->
  <us-gaap:LoansPayableCurrent id="Fact_8f4af03ab12b454396ee60416b2e0b4d" contextRef="c20191231" unitRef="U002" decimals="-3">0</us-gaap:LoansPayableCurrent>
  <!--Loans payable, current-->
  <us-gaap:LoansPayableCurrent id="Fact_c2f12ad9890c4b6e898257bf3f81ac52" contextRef="c20200930" unitRef="U002" decimals="-3">1750000</us-gaap:LoansPayableCurrent>
  <!--Remainder of 2020-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear id="Fact_d45c232961b440c0a2f7ba733566e38f" contextRef="c20200930" unitRef="U002" decimals="-3">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
  <!--Long-term Debt-->
  <us-gaap:LongTermDebt id="Fact_3350b03e03c7411c8d692c54d781303e" contextRef="c20200930" unitRef="U002" decimals="-3">70000000</us-gaap:LongTermDebt>
  <!--Long-Term Debt, Maturity, Year Five-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive id="Fact_ae7a6da938bf49ee96873c33bef46228" contextRef="c20200930" unitRef="U002" decimals="-3">14000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <!--Long-Term Debt, Maturity, Year Two-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="Fact_44b4d7d3d42d46e6ae64a0ad2ec06cd0" contextRef="c20200930" unitRef="U002" decimals="-3">10500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <!--Long-Term Debt, Maturity, Year Three-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="Fact_f9348ed1d9624ebeb840c544ef079820" contextRef="c20200930" unitRef="U002" decimals="-3">17500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <!--Long-Term Debt, Maturity, Year One-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="Fact_67acc0a9a49a4f35b65868c5222a9eb7" contextRef="c20200930" unitRef="U002" decimals="-3">3500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <!--Long-Term Debt, Maturity, Year Four-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour id="Fact_e887f701d3b6429f86cd80378f2b9faa" contextRef="c20200930" unitRef="U002" decimals="-3">24500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <!--Loans Payable, Noncurrent-->
  <us-gaap:LongTermLoansPayable id="Fact_1a9b463baab64b5ab3ae7e9398c4e609" contextRef="c20200930" unitRef="U002" decimals="-3">60346000</us-gaap:LongTermLoansPayable>
  <!--Loans Payable, Noncurrent-->
  <us-gaap:LongTermLoansPayable id="Fact_c1bd448d9e2d4b018e2a7bd03753cdb9" contextRef="c20191231" unitRef="U002" decimals="-3">60338000</us-gaap:LongTermLoansPayable>
  <!--Number of companies patent infringement lawsuits filed-->
  <us-gaap:LossContingencyNumberOfDefendants id="Fact_b4dcd1c389bc4e4283889013a2f62500" contextRef="c20130801to20130831" unitRef="U012" decimals="INF">6</us-gaap:LossContingencyNumberOfDefendants>
  <!--Loss Contingency, Claims Settled, Number-->
  <us-gaap:LossContingencyClaimsSettledNumber id="Fact_e050bc3a04694899b6ebce05ae96d496" contextRef="c20200101to20200930" unitRef="U013" decimals="INF">3</us-gaap:LossContingencyClaimsSettledNumber>
  <!--Loss Contingency, New Claims Filed, Number-->
  <us-gaap:LossContingencyNewClaimsFiledNumber id="Fact_706d82f2ba1c497a9a4401ca801ae3b1" contextRef="c20200101to20200930" unitRef="U013" decimals="INF">4</us-gaap:LossContingencyNewClaimsFiledNumber>
  <!--Loss Contingency, Pending Claims, Number-->
  <us-gaap:LossContingencyPendingClaimsNumber id="Fact_2a26795bab0842fc98a8d88e2478af7c" contextRef="c20200930" unitRef="U013" decimals="INF">3</us-gaap:LossContingencyPendingClaimsNumber>
  <!--Restricted Stock Units Awards-->
  <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock id="Fact_2ce027a14909454290a961d4e08c5acd" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following tables provide information about the Company&amp;#8217;s restricted stock unit and stock option activity during the nine-month period ended September 30, 2020:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;u&gt;Restricted Stock Unit Awards (RSUs):&lt;/u&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Number of&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Units&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Grant Date Fair&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unvested as of December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;74&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14.64&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7.54&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Vested&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(64&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14.88&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Forfeited&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unvested as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11.38&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Grant date fair value of shares vested during the period&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;958&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Unrecognized compensation costs as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
  <!--Net Cash Provided by (Used in) Operating Activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact_2cea372b03a34fdd9130257e14930e16" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-49635000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net Cash Provided by (Used in) Operating Activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact_9cad2a3bf8a94bfd867fe97998337ce5" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-31947000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_2c8a7975c8ad472aabad13e93e3f2af3" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">-16551000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_4446402e012047dd8a992fe04de0fb67" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-53610000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_bbef120d9a03403d97852976b527f5e7" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-35415000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_d082fc366a544f43abc26d396695c0b4" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">-18412000</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_006396b8034640e69d3816b0faae0241" contextRef="c20200401to20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_163fb00bd30b461db90747d30c004989" contextRef="c20190401to20190630" unitRef="U002" decimals="-3">-20472000</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_1e7e18f1791e432ba854064831b3d07e" contextRef="c20200401to20200630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-2334000</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_28fdd03b7b55403589e4c7be11d7bf58" contextRef="c20190701to20190930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-18412000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_498289ede96c4cc2a406ed6ee8257ce9" contextRef="c20200101to20200331" unitRef="U002" decimals="-3">-16530000</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_734b56f04d78402497e42967f0a4255c" contextRef="c20200101to20200331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_7e9880b9d56a415cb66c260fe1663253" contextRef="c20200401to20200630" unitRef="U002" decimals="-3">-2334000</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_93b3a3a4d01640fca6bd6b81d8cb11c6" contextRef="c20190101to20190331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_9968a3716a0940578aca4e1ece3e316f" contextRef="c20200701to20200930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_9c8849d6e1e34f539438e634d2833542" contextRef="c20190101to20190331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_9e132cc0201644cfa923e9df4093eb3b" contextRef="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_b33f754912bd4769b70b7a63f210c321" contextRef="c20190701to20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_b8a45bed5fc24722b4ef67566fa050df" contextRef="c20190101to20190331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-14726000</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_c531410ef6694cc79efd661ff303aa5d" contextRef="c20190401to20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Additional Paid-in Capital [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_c8bcb9f623b744ee8a829688d81fc720" contextRef="c20200101to20200331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_d2ace2a56f194aa78818a0453e457c4f" contextRef="c20200101to20200331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-16530000</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_d51b1fcc0c6e41158064667d14886b11" contextRef="c20190701to20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_dc649b841ff44c7b88f932e2af20bca3" contextRef="c20200701to20200930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-16551000</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_de1cc96a631e48b39d0bdff5e6fc4a5f" contextRef="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net loss-Retained Earnings [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_f4ef57f68b504d3489bf5cb3aff433d2" contextRef="c20190401to20190630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-20472000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss id="Fact_f75985a3ca314253bdc684af9d1decf4" contextRef="c20190101to20190331" unitRef="U002" decimals="-3">-14726000</us-gaap:NetIncomeLoss>
  <!--Net loss-Common Stock [Member]-->
  <us-gaap:NetIncomeLoss id="Fact_f91f4d96f8cd4ff0b0c2879f869c70ee" contextRef="c20200701to20200930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NetIncomeLoss>
  <!--Net Cash Provided by (Used in) Investing Activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact_059046390f8441d2b0b1de668dc8bb4d" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-577000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net Cash Provided by (Used in) Investing Activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact_8ebbfe188f4f4d97bc438b38d5699091" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-281000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net Cash Provided by (Used in) Financing Activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact_1eef9a522810499297501e312cc47ef2" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">10527000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net Cash Provided by (Used in) Financing Activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact_4621233d0b9d4d6299069a77904caec2" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-34000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Recent Accounting Pronouncements-->
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Fact_62666af9d00a4f8487744a3f686dbce0" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(C) Recent Accounting Pronouncements&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;As an emerging growth company, the Company has elected to take advantage of the extended transition period afforded by the Jumpstart Our Business Startups Act for the implementation of new or revised accounting standards and, as a result, the Company will comply with new or revised accounting standards no later than the relevant dates on which adoption of such standards is required for emerging growth companies. The Company believes that the impact of recently issued accounting standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption&lt;/font&gt;&lt;font style="color: rgb(33, 37, 41);"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic;"&gt;Recently Adopted Accounting Pronouncements:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In February 2016, the Financial Accounting Standards Board issued ASU, 2016-02, &lt;font style="font-style: italic; color: rgb(33, 37, 41);"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="color: rgb(33, 37, 41);"&gt;, and issued amendments in July 2018 provided by ASU 2018-10. This ASU, as amended, requires lessees to recognize lease assets, termed &amp;#8220;right-of-use assets&amp;#8221; and related lease liabilities on the balance sheet that had previously been classified as operating leases under prior authoritative guidance. For income statement purposes, leases are now required to be classified as either operating or financing leases under a dual model similar to that specified by ASC 840. Operating leases continue to result in straight-line expense while financing leases result in a front-loaded expense pattern in a manner similar to recognition of capital lease expenses under ASC 840.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company adopted and applied ASU 2016-02 on January 1, 20&lt;font style="color: rgb(33, 37, 41);"&gt;20 using the modified retrospective transition provisions of ASC 842 to leases in effect as of that date of adoption and recorded right-of-use assets totaling $4,048 and lease liabilities as adjusted for accrued lease payments, in the amount of $4,224 based on an estimated incremental borrowing rate of 16.9%, representing the present value of remaining minimum lease payments. The assets and liabilities thus recorded were primarily those related to the Company&amp;#8217;s leased plant, laboratory and corporate administrative facilities. The Company elected to apply the ASU-specified practical expedients and accordingly did not re-assess (i) whether its contracts contained a lease under the new definition of a lease, (ii) the classification of those leases, and (iii) initial direct costs of existing leases. In addition, the Company elected not to apply the hindsight expedient in the assessment of lease renewals and resultant term of leases. The Company also elected not to recognize a right-of-use asset and lease liability for those leases with a remaining lease term of 12 months or less. The adoption of ASU 2016-02 did not require a cumulative-effect adjustment to the opening balance of the accumulated deficit at the time of adoption.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In May 2014, the FASB issued ASU 2014-09, &lt;font style="font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, and subsequently issued a number of amendments to this update.&amp;#160; The new standard, as amended in Accounting Standards Codification, or ASC 606, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes previous revenue recognition guidance. The standard&amp;#8217;s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&amp;#160; In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this standard effective January 1, 2019.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2016, the FASB issued ASU 2016-15,&lt;font style="font-style: italic;"&gt; Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, &lt;/font&gt;providing guidance on the classification of certain cash receipts and payments in the statement of cash flows intended to reduce diversity in practice, including cash flows related to debt prepayment or extinguishment costs and contingent consideration that may be paid following a business combination. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;font style="font-style: italic;"&gt;Fair Value Measurement (Topic 820): Disclosure Framework. &lt;/font&gt;The purpose of the update is to improve the effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;In November 2018, the FASB issued ASU 2018-18, C&lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;ollaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606,&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer for a promised good or service that is distinct within the collaborative arrangement. The guidance also precludes entities from presenting amounts related to transactions with a collaborative arrangement participant that is not a customer as revenue, unless those transactions are directly related to third-party sales.&lt;/font&gt; The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic;"&gt;Recent Accounting Pronouncements Not Adopted as of September 30, 2020:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;In June 2016, the FASB issued ASU 2016-13,&lt;font style="font-style: italic;"&gt; Financial Instruments &amp;#8211; Credit Losses (Topic 326)&lt;/font&gt;, amending existing guidance on the accounting for credit losses on financial instruments within its scope. The guidance provides for use of a forward-looking expected loss model for estimating credit losses, replacing the incurred loss model that is based on past events and current conditions. The new guidance also changes the impairment model for available-for-sale debt securities, requiring the use of an allowance to record estimated credit losses (and subsequent recoveries). The new guidance is effective for the Company beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In &lt;font style="color: rgb(0, 0, 0);"&gt;August 2018, the FASB issued ASU 2018-15, &lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;Intangibles&amp;#8212;Goodwill and Other Internal-Use Software (Subtopic 350-40: Customer&amp;#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance distinguishing between capitalizable service contract implementation costs and contract costs required to be expensed. In addition, the update requires that the term of the hosting arrangement is to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. This standard will become effective for the Company beginning January 1, 2021. The amendments may be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 and does not expect to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In &lt;font style="color: rgb(0, 0, 0);"&gt;December 2019, the FASB issued ASU 2019-12, &lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;which amends accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. The standard will be effective for the Company beginning January 1, 2022, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;font style="font-style: italic;"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&amp;#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity&lt;/font&gt;. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity.&amp;#160; Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&amp;#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&amp;#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&amp;#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. These amendments will be effective for the Company beginning January 1, 2024, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the condensed consolidated financial statements of the Company.&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <!--Operating lease payments-->
  <us-gaap:OperatingLeasePayments id="Fact_1f0f3295c1ea42b8b74238addba88943" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">1255000</us-gaap:OperatingLeasePayments>
  <!--Estimated discount rate-->
  <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent id="Fact_4b2b2466eeec4838945862bdc9266f87" contextRef="c20200930" unitRef="U005" decimals="3">0.169</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
  <!--Lease liabilities-ASU 2016-02 [Member]-->
  <us-gaap:OperatingLeaseLiability id="Fact_d26ce229384f4f3c8bb2efce901f4164" contextRef="c20191231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U002" decimals="-3">4224000</us-gaap:OperatingLeaseLiability>
  <!--Lease liabilities-->
  <us-gaap:OperatingLeaseLiability id="Fact_d2641d828d42436ab08f4cccddc7ebf6" contextRef="c20200930" unitRef="U002" decimals="-3">3711000</us-gaap:OperatingLeaseLiability>
  <!--Operating Lease, Liability, Noncurrent-->
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="Fact_9d78ea2095224d5399be170a4ae53843" contextRef="c20200930" unitRef="U002" decimals="-3">3047000</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <!--Operating Lease, Liability, Noncurrent-->
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="Fact_c014925c291c4652af768115d3616eeb" contextRef="c20191231" unitRef="U002" decimals="-3">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <!--Lease liabilities, current-->
  <us-gaap:OperatingLeaseLiabilityCurrent id="Fact_c2a047b0f259447182deb44b02945518" contextRef="c20200930" unitRef="U002" decimals="-3">664000</us-gaap:OperatingLeaseLiabilityCurrent>
  <!--Lease liabilities, current-->
  <us-gaap:OperatingLeaseLiabilityCurrent id="Fact_fd819a737d9d479d99bf4a8648e32302" contextRef="c20191231" unitRef="U002" decimals="-3">0</us-gaap:OperatingLeaseLiabilityCurrent>
  <!--Operating lease expense-->
  <us-gaap:OperatingLeaseCost id="Fact_1d8a63073f6d4ca0b5df3590b8fad0ec" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">409000</us-gaap:OperatingLeaseCost>
  <!--Operating lease expense-->
  <us-gaap:OperatingLeaseCost id="Fact_c6d47af9ad184cc4894be60b57b5cf03" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">1228000</us-gaap:OperatingLeaseCost>
  <!--Right-of-use assets, net-->
  <us-gaap:OperatingLeaseRightOfUseAsset id="Fact_2120a11d6b2d48ff99cb0eb929c669b2" contextRef="c20191231" unitRef="U002" decimals="-3">0</us-gaap:OperatingLeaseRightOfUseAsset>
  <!--Right-of-use assets, net-->
  <us-gaap:OperatingLeaseRightOfUseAsset id="Fact_339ea441d43643a889b23be942415153" contextRef="c20200930" unitRef="U002" decimals="-3">3609000</us-gaap:OperatingLeaseRightOfUseAsset>
  <!--Right-of-use assets, net-ASU 2016-02 [Member]-->
  <us-gaap:OperatingLeaseRightOfUseAsset id="Fact_9e548c84707e4e099f51c0446842990d" contextRef="c20191231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U002" decimals="-3">4048000</us-gaap:OperatingLeaseRightOfUseAsset>
  <!--Right-of-use assets, net-ASU 2016-02 [Member]-->
  <us-gaap:OperatingLeaseRightOfUseAsset id="Fact_78bd20ddda98492cab3c2e82f572e901" contextRef="c20200930_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U002" decimals="-3">4048000</us-gaap:OperatingLeaseRightOfUseAsset>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss id="Fact_0a388b8804b543c7a19aa54493532aab" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-42764000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss id="Fact_63591d7b9ea44d4c9c257820fdd7ecf2" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">-11002000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss id="Fact_63d52f68ccfc47dcb40c780cc1f7c295" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-27247000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss id="Fact_f73c213fbca9454b965698bd2f0f0063" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">-13781000</us-gaap:OperatingIncomeLoss>
  <!--Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]-->
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock id="Fact_c5891022b9b049278e6cdff4aeb74901" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 1.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Corporate Organization and Company Overview&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(A) Company Overview&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Aquestive Therapeutics, Inc. (&amp;#8220;Aquestive&amp;#8221; or the &amp;#8220;Company&amp;#8221;) is a pharmaceutical company focused on identifying, developing and commercializing differentiated products that address patients&amp;#8217; unmet medical needs and solve therapeutic problems.&amp;#160; The Company has commercialized one internally-developed proprietary product to date, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules as alternatives to more invasive therapies. Aquestive is pursuing its business objectives through both in-licensing and out-licensing arrangements, as well as the commercialization of its own products. Production facilities are in Portage, Indiana, and corporate headquarters, sales and commercialization operations and primary research laboratory facilities are based in Warren, New Jersey.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Aquestive is subject to risks common to companies in similar industries and stages of development, including, but not limited to, competition from larger companies, reliance on revenue from a limited number of products and customers, adequacy of existing and availability of additional operating and growth capital as and when required, uncertainty of regulatory approval for marketing its product candidates, reliance on a single manufacturing site, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, dependence on patent-protected proprietary technology, ongoing government regulatory compliance requirements, dependence on the clinical and commercial success of its drug candidates, and uncertainty of broad adoption of its approved products, if any, by physicians and consumers.&amp;#160;&amp;#160; Aquestive is also subject to risks and uncertainties associated with the COVID-19 pandemic. See Note 4. Risks and Uncertainties for further discussion related to COVID-19.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic;"&gt;&lt;font style="font-weight: bold;"&gt;(B)&lt;/font&gt;&amp;#160;&lt;font style="font-weight: bold;"&gt;Equity Transaction&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic;"&gt;Equity Offering of Common Stock&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On December 17, 2019, Aquestive received net proceeds of $37,835 after deducting underwriting discounts of $2,415 for the sale of 8,050,000 shares of common stock, par value $0.001 per share of the Company (&amp;#8220;common stock&amp;#8221;) in a public offering.&amp;#160; Professional fees and other costs of this offering totaled $540, in addition to the underwriting discounts.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <!--Other Noncash Income (Expense)-->
  <us-gaap:OtherNoncashIncomeExpense id="Fact_16f7a2bf231545faadd4df839e601041" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">-76000</us-gaap:OtherNoncashIncomeExpense>
  <!--Other Noncash Income (Expense)-->
  <us-gaap:OtherNoncashIncomeExpense id="Fact_c95b2f5cf282424a892dbc55b94164a8" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">-34000</us-gaap:OtherNoncashIncomeExpense>
  <!--Contract and other receivables-->
  <us-gaap:OtherReceivablesGrossCurrent id="Fact_2ac522db4e70428ca449cf18bea98672" contextRef="c20200930" unitRef="U002" decimals="-3">1872000</us-gaap:OtherReceivablesGrossCurrent>
  <!--Contract and other receivables-->
  <us-gaap:OtherReceivablesGrossCurrent id="Fact_932324eb270b456e94640be7dc24aed5" contextRef="c20191231" unitRef="U002" decimals="-3">4363000</us-gaap:OtherReceivablesGrossCurrent>
  <!--Other assets, primarily security deposits-->
  <us-gaap:OtherAssetsNoncurrent id="Fact_e47c4627f7374c2990117cc736608b2c" contextRef="c20200930" unitRef="U002" decimals="-3">287000</us-gaap:OtherAssetsNoncurrent>
  <!--Other assets, primarily security deposits-->
  <us-gaap:OtherAssetsNoncurrent id="Fact_ef8828dd44cd4fea913fce89f65fd53e" contextRef="c20191231" unitRef="U002" decimals="-3">286000</us-gaap:OtherAssetsNoncurrent>
  <!--Other-->
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Fact_7c92a7d194c240c1bcf7ad9262de683e" contextRef="c20191231" unitRef="U002" decimals="-3">543000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <!--Other-->
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Fact_8a35085dcbb841a3a87183ab94c3d47c" contextRef="c20200930" unitRef="U002" decimals="-3">284000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <!--Prepayment premiums paid-->
  <us-gaap:PaymentsOfDebtExtinguishmentCosts id="Fact_1c3391f6f350494eb9acd663639917ab" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
  <!--Prepayment premiums paid-->
  <us-gaap:PaymentsOfDebtExtinguishmentCosts id="Fact_eea80a2cc3c64a8c973f97ba5a3e72bc" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">2944000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
  <!--Prepayment premiums paid-->
  <us-gaap:PaymentsOfDebtExtinguishmentCosts id="Fact_1753e70562f84642b57b5bf7de463006" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">2944000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
  <!--Payment, Tax Withholding, Share-based Payment Arrangement-->
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation id="Fact_6a3162c857a3427ba753d7aa57cc7fc6" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">96000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <!--Payment, Tax Withholding, Share-based Payment Arrangement-->
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation id="Fact_ea3af4a46e8c4318aa3b26c59a191582" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">2723000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <!--Payments for deferred offering costs-->
  <us-gaap:PaymentsOfStockIssuanceCosts id="Fact_3b0f5caa473a492bb1c05672b4451c3e" contextRef="c20191217to20191217" unitRef="U002" decimals="-3">2415000</us-gaap:PaymentsOfStockIssuanceCosts>
  <!--Payments of Financing Costs-->
  <us-gaap:PaymentsOfFinancingCosts id="Fact_0a56808089be4301a84949efe89548d1" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">3918000</us-gaap:PaymentsOfFinancingCosts>
  <!--Payments of Financing Costs-->
  <us-gaap:PaymentsOfFinancingCosts id="Fact_be10fd46de354184997209b432a904b6" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:PaymentsOfFinancingCosts>
  <!--Payments to Acquire Property, Plant, and Equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact_9b455f04835e4914bdeafe935424e4b1" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">281000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Payments to Acquire Property, Plant, and Equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact_9d45acbc1056445fb565d9c48af1b6c7" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">577000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Prepaid Expense and Other Assets, Current-->
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Fact_6414155af00e45779f097baef7072ba3" contextRef="c20200930" unitRef="U002" decimals="-3">3388000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <!--Prepaid Expense and Other Assets, Current-->
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Fact_edad41b610ae430b9c6c2073ea68c4ac" contextRef="c20191231" unitRef="U002" decimals="-3">2999000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <!--Proceeds from refinancing of debt-->
  <us-gaap:ProceedsFromIssuanceOfDebt id="Fact_4f072b409ae24c3d894a860080f4ac43" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">70000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <!--Proceeds from refinancing of debt-->
  <us-gaap:ProceedsFromIssuanceOfDebt id="Fact_d8bdd180fb3e4f90a1b64bc7cbef2983" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfDebt>
  <!--Proceeds from refinancing of debt-->
  <us-gaap:ProceedsFromIssuanceOfDebt id="Fact_2f38eefdb95141368c0bcc1b6b5d5620" contextRef="c20190701to20190731" unitRef="U002" decimals="-3">13110000</us-gaap:ProceedsFromIssuanceOfDebt>
  <!--Proceeds from refinancing of debt-Subsequent Event [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:ProceedsFromIssuanceOfDebt id="Fact_f5e44da515654b29a7df0f587d54e065" contextRef="c20201103to20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-3">4000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <!--Proceeds from Warrant Exercises-->
  <us-gaap:ProceedsFromWarrantExercises id="Fact_c11540c0ab864bc3b7fc5eb6d23e50e1" contextRef="c20191216to20191216" unitRef="U002" decimals="-3">1821000</us-gaap:ProceedsFromWarrantExercises>
  <!--Proceeds from shares issued under employee stock purchase plan-->
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans id="Fact_0e1006b29ce94d16aea56fef6b19a6d2" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">112000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
  <!--Proceeds from shares issued under employee stock purchase plan-->
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans id="Fact_def3e21748fb497ca8000fdfdecf2136" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">62000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
  <!--Net proceeds from initial public offering-->
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Fact_b7574d14388448f5ac73cb0943ab19de" contextRef="c20191201to20191231" unitRef="U002" decimals="-3">37295000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <!--Proceeds from Issuance Initial Public Offering-->
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="Fact_d35fb85b7a324782a0ff755db461d93b" contextRef="c20191217to20191217" unitRef="U002" decimals="-3">37835000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <!--Professional fees and other costs-->
  <us-gaap:ProfessionalFees id="Fact_f06202671c6e4b4db1a9bd746af14c2b" contextRef="c20191217to20191217" unitRef="U002" decimals="-3">540000</us-gaap:ProfessionalFees>
  <!--Property, Plant and Equipment, Useful Life-Minimum [Member]-Computer, Network Equipment and Software [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_17fb296d9a0a419180fbdfded4df520e" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Furniture and Fixtures [Member]-Maximum [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_18d198ccde4249398578fe345e889804" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Furniture and Fixtures [Member]-Minimum [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_4a2a2d72c2474d7b94448fb2bdae3668" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Machinery [Member]-Maximum [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_771437c872f24b358fd24020dc127baa" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember_RangeAxis_MaximumMember">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Minimum [Member]-Machinery [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_8747d2906c1341cfa52d7cecca5d24df" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Computer, Network Equipment and Software [Member]-Maximum [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Fact_e5b635aa75534a659160a72b8e497aa5" contextRef="c20200101to20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember_RangeAxis_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment Disclosure [Text Block]-->
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="Fact_6e020b733b464db98572557c23cc07c7" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 9.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Property and Equipment, Net&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 67%;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Useful&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Lives&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Machinery&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-15 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,406&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,088&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-15 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,209&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,150&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(a)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,333&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,333&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Computer, network equipment and software&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-7 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,886&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,787&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Construction in progress&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,412&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;47,899&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;47,770&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: accumulated depreciation and amortization&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(40,171&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(38,044&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,728&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,726&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;(a)&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Total depreciation and amortization related to property and equipment was $714 and $695 for the three-month periods ended September 30, 2020 and 2019, respectively. For the respective nine-month periods, these expenses totaled $2,127 and $2,143.&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <!--Property, Plant and Equipment [Table Text Block]-->
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="Fact_ece1fedd5eeb4ca5b332fb21bdf8ea08" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 67%;"&gt;&lt;br /&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Useful&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Lives&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Machinery&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-15 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,406&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,088&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-15 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,209&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,150&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(a)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,333&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;21,333&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Computer, network equipment and software&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;3-7 yrs&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,886&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,787&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Construction in progress&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,412&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;47,899&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;47,770&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: accumulated depreciation and amortization&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(40,171&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(38,044&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,728&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,726&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;(a)&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <!--Property, Plant and Equipment, Gross-Computer, Network Equipment and Software [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_1c362f087e7545f7866c2f70c2b28f4f" contextRef="c20200930_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember" unitRef="U002" decimals="-3">2886000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Machinery [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_20b0e2d031414fd98c800edd2e00079e" contextRef="c20200930_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember" unitRef="U002" decimals="-3">21406000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Construction in Progress [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_49177cbd6d6c46e0a7e7ae5bb603b17f" contextRef="c20200930_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember" unitRef="U002" decimals="-3">1065000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Leasehold Improvements [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_6702d5f39c14463e9b365e3def2afae3" contextRef="c20200930_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U002" decimals="-3">21333000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_88879954ad1f4825a142df6ea122b407" contextRef="c20200930" unitRef="U002" decimals="-3">47899000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Construction in Progress [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_8c8a2d120f0a440bacd5d96d8a618f2e" contextRef="c20191231_PropertyPlantAndEquipmentByTypeAxis_ConstructionInProgressMember" unitRef="U002" decimals="-3">1412000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Furniture and Fixtures [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_a6723e9e1a8148c88cae9da88936467b" contextRef="c20191231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U002" decimals="-3">1150000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_af44e3ff6bfd4fa1894bf85609a72b17" contextRef="c20191231" unitRef="U002" decimals="-3">47770000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Machinery [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_cd9aea5e393043169bc2ac522b42b713" contextRef="c20191231_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember" unitRef="U002" decimals="-3">21088000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Computer, Network Equipment and Software [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_ce98d5b47ac14a7bbb4140c45fa7c43d" contextRef="c20191231_PropertyPlantAndEquipmentByTypeAxis_ComputerNetworkEquipmentAndSoftwareMember" unitRef="U002" decimals="-3">2787000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Furniture and Fixtures [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_cf20408e1690493a9bea0f7f585ac476" contextRef="c20200930_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U002" decimals="-3">1209000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-Leasehold Improvements [Member]-->
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact_eae483f43a84443087c6891f4d9621d3" contextRef="c20191231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U002" decimals="-3">21333000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property and equipment, net-->
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact_ee323491d01b4f058443ed8fcd5d5e35" contextRef="c20200930" unitRef="U002" decimals="-3">7728000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Property and equipment, net-->
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact_ff32d81266be47b1bc4aabd114373cad" contextRef="c20191231" unitRef="U002" decimals="-3">9726000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Additions charged to bad debt expense-->
  <us-gaap:ProvisionForDoubtfulAccounts id="Fact_0e8587ec69024d47b5fb724bf1cb4e4b" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">140000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Additions charged to bad debt expense-->
  <us-gaap:ProvisionForDoubtfulAccounts id="Fact_250e0628a899410eac48c2c7b40effa0" contextRef="c20190101to20191231" unitRef="U002" decimals="-3">66000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Repayments of Long-term Debt-Perceptive Credit Opportunities Fund, LP [Member]-Line of Credit [Member]-->
  <us-gaap:RepaymentsOfLongTermDebt id="Fact_d22e9b99883d469b9a3ef4394010bffd" contextRef="c20190715to20190715_CreditFacilityAxis_LineOfCreditMember_LineOfCreditFacilityAxis_PerceptiveCreditOpportunitiesFundLPMember" unitRef="U002" decimals="-3">56340000</us-gaap:RepaymentsOfLongTermDebt>
  <!--Repayments of Debt-->
  <us-gaap:RepaymentsOfDebt id="Fact_61aee9b39236430dbc28ee91bd0b52f1" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</us-gaap:RepaymentsOfDebt>
  <!--Repayments of Debt-->
  <us-gaap:RepaymentsOfDebt id="Fact_b3d671cf835340d0946ce0d7212326ad" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">50000000</us-gaap:RepaymentsOfDebt>
  <!--Repayments of Debt-Subsequent Event [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:RepaymentsOfDebt id="Fact_560d0b4c37744be098893bdac1f461e9" contextRef="c20201103to20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-3">22500000</us-gaap:RepaymentsOfDebt>
  <!--Research and Development Expense-->
  <us-gaap:ResearchAndDevelopmentExpense id="Fact_528aed5160f04c5a932110d0b151f9c0" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">17517000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and Development Expense-->
  <us-gaap:ResearchAndDevelopmentExpense id="Fact_908a0aa871aa4e79ada05b48c84a1fdc" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">5063000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and Development Expense-->
  <us-gaap:ResearchAndDevelopmentExpense id="Fact_bfc6d02b16984a72a3ca63b9a2c08cd2" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">15461000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and Development Expense-->
  <us-gaap:ResearchAndDevelopmentExpense id="Fact_f44c177e75104e3e84eab7afa8d42f16" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">7260000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Accumulated deficit-->
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Fact_08955333b2134a13bf87179f55cfd962" contextRef="c20200930" unitRef="U002" decimals="-3">-165889000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Accumulated deficit-->
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Fact_7100137899704ed8821532f2cca2c452" contextRef="c20191231" unitRef="U002" decimals="-3">-130474000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Revenue from Contract with Customer [Policy Text Block]-->
  <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock id="Fact_2081f69b17c349ad9ca4ac22fc9a3ef5" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Aquestive recognizes revenue pursuant to ASC 606, &lt;font style="font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, to reflect amounts expected to be collectible in exchange for the transfer of contractually promised goods or services to its customers, as discussed in additional detail in the Company&amp;#8217;s 2019 Annual Report on Form 10-K.&amp;#160; Accordingly, the value of contractually promised goods or services is assessed at contract inception to identify those that constitute distinct performance obligations. Contract revenues are allocated to those distinct performance obligations based on estimated standalone values or expected values, and these allocated revenues are recognized at the point in time, or over the period of time, that those distinct obligations are satisfied. The Company&amp;#8217;s performance obligations consist primarily of transferring control of goods, services or intellectual property that are identified in the contracts, purchase orders or invoices. Variable or contingent revenues which may become due from customers, such as milestone payments due upon acceptance of a regulatory filing, regulatory approval, or sales-based milestone payments, are not recognized until contingencies are met, the customer&amp;#8217;s obligation to meet its contractual payment commitments is fixed and collection of invoiced amounts is reasonably assured, thereby limiting any significant probability of a revenue reversal.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Revenues from the sale of products and services and from licensing arrangements and related payments are evidenced by a contract with the customer. For manufacturing and supply and proprietary product sales, invoices are generally issued upon the transfer of control. Co-development and research revenue is typically invoiced based on the contractual payment schedule, or upon completion of the service. Licensing revenue is generally invoiced at the inception of an agreement, with additional charges rendered as related contingencies, such as regulatory approvals or sales targets, are met. Invoices are typically payable 30 to 60 days after the invoice date, however some payment terms may reach 75 days depending on the customer. The Company performs a review of each specific customer&amp;#8217;s creditworthiness and ability to pay prior to acceptance as a customer, as well as periodic prospective reviews.&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
  <!--Total revenues-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_21f9596f785c4c61be5e156ad706e40a" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">36190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_9848c38807a54de38a59db0bc1ba62fe" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">38700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_d70ddecc19ad451ba35b21c12640267f" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">12418000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_f5bd8fe3d8784cfd9c8fe96b5a1d4029" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">8260000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Co-Development and Research Fees [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_135503cb8b1041dc854512ee27960bb4" contextRef="c20190701to20190930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember" unitRef="U002" decimals="-3">1073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Manufacture and Supply Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_144fe8dbfbff4f35b3f929126e530f3e" contextRef="c20190101to20190930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember" unitRef="U002" decimals="-3">24739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-License and Royalty Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_158903d2d8054b53bb5a3944f2f822b7" contextRef="c20190101to20190930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember" unitRef="U002" decimals="-3">6402000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Co-Development and Research Fees [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_30d41aeb32f74721946783c60cc7a7bb" contextRef="c20200101to20200930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember" unitRef="U002" decimals="-3">870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-License and Royalty Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_3feafba58d474720aa5173524f84ceea" contextRef="c20200701to20200930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember" unitRef="U002" decimals="-3">328000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Co-Development and Research Fees [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_48fe3040a920465392bb2f18a14716ff" contextRef="c20190101to20190930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember" unitRef="U002" decimals="-3">2862000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Manufacture and Supply Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_6547b0cadf7a42538045d6d297238182" contextRef="c20200101to20200930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember" unitRef="U002" decimals="-3">20078000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Manufacture and Supply Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_77ce0751c683408f81ff27f3a5aef065" contextRef="c20200701to20200930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember" unitRef="U002" decimals="-3">5903000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Manufacture and Supply Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_844ad42ffbbb4a7aaa1e961485e1a1dd" contextRef="c20190701to20190930_ProductOrServiceAxis_ManufactureAndSupplyRevenueMember" unitRef="U002" decimals="-3">9155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-License and Royalty Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_91e84591f37b4689ab2dab2fc4199cc9" contextRef="c20200101to20200930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember" unitRef="U002" decimals="-3">13682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Proprietary Product Sales [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_ad19d99cae0741b5b3fe313a91afc8c4" contextRef="c20200101to20200930_ProductOrServiceAxis_ProprietaryProductSalesMember" unitRef="U002" decimals="-3">4070000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Proprietary Product Sales [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_b4c5d73aeafe45ef820d0396b3b2d778" contextRef="c20200701to20200930_ProductOrServiceAxis_ProprietaryProductSalesMember" unitRef="U002" decimals="-3">1688000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-License and Royalty Revenue [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_bb1a369af2e949888ef18b8b3f96493b" contextRef="c20190701to20190930_ProductOrServiceAxis_LicenseAndRoyaltyRevenueMember" unitRef="U002" decimals="-3">1356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Proprietary Product Sales [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_e01150dbccc9489294d4e88f088ef1c0" contextRef="c20190701to20190930_ProductOrServiceAxis_ProprietaryProductSalesMember" unitRef="U002" decimals="-3">834000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Co-Development and Research Fees [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_e4a88c6d4a394a01b67149cd30761d2e" contextRef="c20200701to20200930_ProductOrServiceAxis_CoDevelopmentAndResearchFeesMember" unitRef="U002" decimals="-3">341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Proprietary Product Sales [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_faf90ac68fa54f00990cca683918bcc8" contextRef="c20190101to20190930_ProductOrServiceAxis_ProprietaryProductSalesMember" unitRef="U002" decimals="-3">2187000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Ex-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_0156e09c95434c0ba37960728bc22b4c" contextRef="c20200101to20200930_StatementGeographicalAxis_NonUsMember" unitRef="U002" decimals="-3">3204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_0463965372a74f6fa840b362f44a0ccd" contextRef="c20190701to20190930_StatementGeographicalAxis_US" unitRef="U002" decimals="-3">11022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Ex-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_534e4216cf154f4b9ece5be08702253f" contextRef="c20200701to20200930_StatementGeographicalAxis_NonUsMember" unitRef="U002" decimals="-3">1693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_69d39fd1d1124700a1a7d4d74f85e765" contextRef="c20200701to20200930_StatementGeographicalAxis_US" unitRef="U002" decimals="-3">6567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Ex-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_71cd0f46806d495c9463ba9025b98903" contextRef="c20190701to20190930_StatementGeographicalAxis_NonUsMember" unitRef="U002" decimals="-3">1396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_7da6b0668a264242986c7c5dc275706b" contextRef="c20200101to20200930_StatementGeographicalAxis_US" unitRef="U002" decimals="-3">35496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-Ex-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_822d5b52ac5c47d0883afe0faf61ff37" contextRef="c20190101to20190930_StatementGeographicalAxis_NonUsMember" unitRef="U002" decimals="-3">2507000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Total revenues-United States [Member]-->
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact_cd2ec7a05d8d4803a3c7129d833c39fa" contextRef="c20190101to20190930_StatementGeographicalAxis_US" unitRef="U002" decimals="-3">33683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <!--Revenues-Supplemental Agreement with Indivior [Member]-->
  <us-gaap:Revenues id="Fact_856b509bc79e45edb4488f7995833011" contextRef="c20190101to20190331_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">4250000</us-gaap:Revenues>
  <!--Revenues-Royalty [Member]-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <us-gaap:Revenues id="Fact_2881767b72494d9f88762684f4b2535e" contextRef="c20200101to20200930_ProductOrServiceAxis_RoyaltyMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">8000000</us-gaap:Revenues>
  <!--Revenues-Agreement to Terminate CLA with KemPharm [Member]-->
  <us-gaap:Revenues id="Fact_2f739651c3824840b2f80a81f84a7f0a" contextRef="c20190901to20190930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember" unitRef="U002" decimals="-3">1000000</us-gaap:Revenues>
  <!--Revenues-Agreement to Terminate CLA with KemPharm [Member]-->
  <us-gaap:Revenues id="Fact_c2d975bbd9bb458499eea0cdbc9f5c2c" contextRef="c20200101to20200930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember" unitRef="U002" decimals="-3">500000</us-gaap:Revenues>
  <!--Expected term (years)-Options on Common Shares Outstanding [Member]-Maximum [Member]-->
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Fact_055061a3632642f5bba888a62ef30516" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <!--Expected term (years)-Options on Common Shares Outstanding [Member]-Minimum [Member]-->
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Fact_d0f1c4abc5ea40b98351ce8f10d1f177" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <!--Purchase price of common stock as percentage of fair market value-Employee Stock Purchase Plan [Member]-->
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="Fact_48d100302442420daca80a501191c00a" contextRef="c20200101to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U005" decimals="2">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <!--Schedule of Inventory, Current [Table Text Block]-->
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock id="Fact_f8cae09af4534455a771f348eabfa86b" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The components of Inventory, net is as follows:&lt;/div&gt;&lt;div style="text-indent: 21.6pt; color: rgb(0, 0, 0);"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Raw material&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,153&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,244&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Packaging material&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,231&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,096&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Finished goods&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;858&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;519&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total inventory, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,242&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,859&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <!--Valuation Assumptions for Determination of Fair Value of Options-->
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="Fact_4b508a97be1a496eadd9228b54eaf592" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The fair values of stock options granted during 2020 were estimated using the Black-Scholes-Merton pricing model based on the following assumptions:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 60%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-align: right; color: rgb(0, 0, 0);"&gt;None&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;100&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Expected term (years)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5.5 - 6.1&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 48%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Risk-free interest rate&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;0.4 &amp;#8211; 1.7&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <!--Stock Option Activity-->
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Fact_0f189fe94ae74560b9c396eec199b6d4" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Unrecognized compensation costs related to awards of RSUs are expected to be recognized over a weighted-average period of less than two years.&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;u&gt;Stock Option Awards:&lt;/u&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Number of&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted Average&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0);"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Outstanding as of December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,231&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;10.42&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;981&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2.68&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Exercised, Forfeited, Expired&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(136&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(4.39&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Outstanding as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,076&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8.22&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Vested or expected to vest as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,866&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8.22&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Exercisable as of September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,014&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11.87&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <!--Debt Maturity-->
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="Fact_aac439e6ebe644168a33f5e6720ce2e6" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-indent: 18pt;"&gt;A debt maturity table is presented below:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Remainder of 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;10,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;17,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,500&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;14,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;70,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <!--Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]-->
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock id="Fact_8807d64278e04378847510d9768916e1" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Accounts payable and accrued expenses consisted of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accounts payable&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;9,169&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,274&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accrued compensation&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;4,129&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,758&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Accrued distribution expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,655&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,174&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Other&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;284&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;543&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total accounts payable and accrued expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;15,237&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;17,749&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <!--Share-based Compensation Expense-->
  <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock id="Fact_eafff74db81848a4a6c903fe2e5c53d5" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The Company recognized share-based compensation in its Condensed Consolidated Statements of Operations and Comprehensive Loss during 2020 and 2019 as follows:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Manufacture and supply&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;73&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;176&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Research and development&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;178&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;188&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;543&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;536&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Selling, general and administrative&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,176&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,622&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,301&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,480&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total share-based compensation expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,427&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,052&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,200&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Share-based compensation from:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Restricted stock units&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;16&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;473&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;789&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,403&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Stock options&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,411&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,397&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,252&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,777&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Employee stock purchase plan&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;20&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total share-based compensation expenses&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,427&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,052&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,200&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
  <!--Basic and Diluted Net Loss Per Share-->
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock id="Fact_caf7b434d9a241488398de33084ce91d" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div&gt;These potential common shares are excluded from the computation of net loss per share to the extent that their effects are antidilutive, and &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Net loss&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(16,551&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(18,412&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(35,415&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(53,610&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Weighted-average number of common shares &amp;#8211; basic&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,619,379&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;25,031,478&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,592,846&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,992,229&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Loss per common share &amp;#8211; basic and diluted&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(0.49&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(0.74&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(1.05&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2.15&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <!--Components of Identifiable Intangible Assets-->
  <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock id="Fact_48b8ec1351fc45f5bb865f39fc630738" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div&gt;The following table provides the components of identifiable intangible assets, all of which are finite lived:&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Purchased technology-based intangible&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,358&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,358&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Purchased patent&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;509&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;509&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,867&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,867&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: accumulated amortization&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2,752&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(2,714&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Intangible assets, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;115&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;153&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Royalty receivable&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,000&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Other assets, primarily security deposits&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;287&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;286&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total intangible assets, net and other assets&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,402&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;439&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
  <!--Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]-->
  <us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock id="Fact_3ea2d591721a4f44b6a63b3f95f09989" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following table presents the changes in the allowance for bad debt:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Allowance for doubtful accounts at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;58&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Additions charged to bad debt expense&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;66&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Write-downs charged against the allowance&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Allowance for doubtful accounts at end of the period&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;264&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock>
  <!--Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]-->
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="Fact_ed6e583f870042ab9c82617d8f9443dd" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following outstanding stock options, restricted stock units and warrants are antidilutive and have been excluded from the computation of the loss per common share for the periods ended September 30:&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Options on common shares outstanding&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,075,942&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,256,092&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Restricted stock units unvested&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,489&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;107,144&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Warrants on common shares outstanding&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,571,429&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total potentially antidilutive derivatives excluded from losses per share&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,660,860&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,363,236&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <!--Revenue from External Customers by Products and Services [Table Text Block]-->
  <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock id="Fact_66eb9cd8974b47479b07e8b04de319e1" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The Company&amp;#8217;s revenues were comprised of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Manufacture and supply revenue&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,903&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,155&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;20,078&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,739&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;License and royalty revenue&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;328&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,356&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,682&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,402&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Co-development and research fees&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;341&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,073&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,862&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Proprietary product sales, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,688&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;834&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,070&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,187&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total revenues&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8,260&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,418&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;38,700&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;36,190&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
  <!--Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]-->
  <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock id="Fact_23e14fd0272f48498c5f830f16ce3aa6" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Trade and other receivables, net consist of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Trade receivables&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,659&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,094&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Contract and other receivables&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,872&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,363&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: allowance for bad debts&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(264&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: sales-related allowances&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(277&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(203&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Trade and other receivables, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,990&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,130&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense id="Fact_117db00582cd4f6bb4e7cbaeda8e86ef" contextRef="c20190701to20190930" unitRef="U002" decimals="-3">13714000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense id="Fact_a844eb54560e4b5bab2e9b377d7dd2a5" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">40310000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense id="Fact_aaa11fd143544b9d85b1814e0949728b" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">11803000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense id="Fact_f8d1fc6385df44648fe4adbbd55c4ab0" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">47868000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-Minimum [Member]-->
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact_5d9b93d9b79d45ababef7f386fe21a95" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" unitRef="U003" decimals="2">1.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <!--Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-Maximum [Member]-->
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact_7bb60da4a0bf4927adad6a8c857ec743" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" unitRef="U003" decimals="2">7.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <!--Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact_d269256503e2429287e6c0d173c38bf6" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">2.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <!--Share-based Payment Arrangement, Noncash Expense-->
  <us-gaap:ShareBasedCompensation id="Fact_0984d370822443b4929006fc079a2076" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">5052000</us-gaap:ShareBasedCompensation>
  <!--Share-based Payment Arrangement, Noncash Expense-->
  <us-gaap:ShareBasedCompensation id="Fact_69bec3412aa640f9811e4e24bc763ee1" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">5199000</us-gaap:ShareBasedCompensation>
  <!--Share Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:SharePrice id="Fact_375f31697e57410eb626e38f2167cf60" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">4.86</us-gaap:SharePrice>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Fact_e18f7615437e4b37a7addb60e21f578f" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">981000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <!--Forfeited (in dollars per share)-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="Fact_44a2e39df4494d12ab9bc4773932b471" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Fact_5991bea523d44d158214f23904a760b3" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <!--Expected dividend yield-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Fact_0d6b1e30efba493699c51930cd8fdcbc" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="Fact_17f3779e34eb49798ae1a94461c483e9" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="Fact_d3284a1b59ad4d7288dca9356c2090ce" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3">64000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Fact_ea0216fd22c94375b24e89bb09e72016" contextRef="c20191231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Fact_56aca2fb6a1244d7a46a0a984d291da1" contextRef="c20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Fact_7292834fe76f4db498aece5bebc02834" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2">7.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="Fact_73ecdd3d85a642c78cfc73b7e1ab3e27" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="0">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <!--Vested (in dollars per share)-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="Fact_c7c66caab6974a27a0ea1194b4941240" contextRef="c20200101to20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2">14.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Fact_d87a8bb5973142cc82e8885ddb1afaed" contextRef="c20191231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2">14.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value-Restricted Stock Units [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Fact_2602490cea9346649748d4acea9392c9" contextRef="c20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2">11.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Fact_1486ad0c39944c1899b51ceab7c6a75a" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">2.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="Fact_1eff8f2dc9ec4d54b2059ba1adecf4c3" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">1014000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate-Options on Common Shares Outstanding [Member]-Minimum [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Fact_239de3ee186d48109704d0bda4470d5e" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate-Options on Common Shares Outstanding [Member]-Maximum [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Fact_827c88586b314384b76529f0c1dbd22f" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact_6dec593366b740c381236ab5161dd601" contextRef="c20191231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">2231000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact_d139ad944cd64ccf9013af97f415ae4a" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">3076000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact_adc88c864c3c49cf820596c0b3b540d6" contextRef="c20191231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">10.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact_6023cdefbf754f3da6e92a5abca82f52" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">8.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice id="Fact_ccd983b7334b489ab54d245f7a363fd1" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">11.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <!--Vested or expected to vest at end of period (in shares)-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="Fact_78205b8913074112adc3352d6bc3b5f3" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">2866000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price-Options on Common Shares Outstanding [Member]-->
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="Fact_5253a7c49fca4e61aa09e410f748a559" contextRef="c20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">8.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_ec6f17a8608148bbace10a6820d8d0b8" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">33562885</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_f000b60893054065a1c018e3afc96150" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">24957309</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_024aa277cb5245449180f5275f050489" contextRef="c20200331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">33582696</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_1a77a570cca64605824f2f16df4fa78c" contextRef="c20200930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">33619796</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_357e324c16854e8d8f940a4118f4ebff" contextRef="c20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">25022660</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_cd845fca016d42f8a36cb03a75d55b4f" contextRef="c20190331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">24975139</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_dff5d93d0bdb4b05b21a3bf5b8b88705" contextRef="c20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">25042964</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding id="Fact_f1b66902b94e411496c76e0f3167d661" contextRef="c20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">33616601</us-gaap:SharesOutstanding>
  <!--Summary of Significant Accounting Policies-->
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Fact_d69adcd547544473ad1de0e3019479ec" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 42.8pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 3.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Summary of Significant Accounting Policies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(A) Principles of Consolidation and Significant Accounting Policies&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The interim condensed consolidated financial statements presented herein include the accounts of Aquestive Therapeutics, Inc. and its wholly owned subsidiary, MonoSol Rx, Inc. Other than corporate formation activities, MonoSol Rx, Inc. has conducted no commercial, drug development or operational activities and has no customers or vendors. The results of operations and cash flows reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected in any other interim period or for the entire fiscal year.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;&lt;div&gt;&lt;div style="text-align: justify; text-indent: 21.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company&amp;#8217;s significant accounting policies are described in the audited consolidated financial statements included in the &lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2019&lt;/font&gt;&amp;#160;&lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt;A&lt;/font&gt;nnual Report on Form 10-K.&amp;#160; Subsequent to the date of those financial statements, there have been no significant changes to these policies other than those listed below.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(B) Use of Estimates&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&amp;#160; Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of share-based compensation and contingencies.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(C) Recent Accounting Pronouncements&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;As an emerging growth company, the Company has elected to take advantage of the extended transition period afforded by the Jumpstart Our Business Startups Act for the implementation of new or revised accounting standards and, as a result, the Company will comply with new or revised accounting standards no later than the relevant dates on which adoption of such standards is required for emerging growth companies. The Company believes that the impact of recently issued accounting standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption&lt;/font&gt;&lt;font style="color: rgb(33, 37, 41);"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic;"&gt;Recently Adopted Accounting Pronouncements:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In February 2016, the Financial Accounting Standards Board issued ASU, 2016-02, &lt;font style="font-style: italic; color: rgb(33, 37, 41);"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="color: rgb(33, 37, 41);"&gt;, and issued amendments in July 2018 provided by ASU 2018-10. This ASU, as amended, requires lessees to recognize lease assets, termed &amp;#8220;right-of-use assets&amp;#8221; and related lease liabilities on the balance sheet that had previously been classified as operating leases under prior authoritative guidance. For income statement purposes, leases are now required to be classified as either operating or financing leases under a dual model similar to that specified by ASC 840. Operating leases continue to result in straight-line expense while financing leases result in a front-loaded expense pattern in a manner similar to recognition of capital lease expenses under ASC 840.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company adopted and applied ASU 2016-02 on January 1, 20&lt;font style="color: rgb(33, 37, 41);"&gt;20 using the modified retrospective transition provisions of ASC 842 to leases in effect as of that date of adoption and recorded right-of-use assets totaling $4,048 and lease liabilities as adjusted for accrued lease payments, in the amount of $4,224 based on an estimated incremental borrowing rate of 16.9%, representing the present value of remaining minimum lease payments. The assets and liabilities thus recorded were primarily those related to the Company&amp;#8217;s leased plant, laboratory and corporate administrative facilities. The Company elected to apply the ASU-specified practical expedients and accordingly did not re-assess (i) whether its contracts contained a lease under the new definition of a lease, (ii) the classification of those leases, and (iii) initial direct costs of existing leases. In addition, the Company elected not to apply the hindsight expedient in the assessment of lease renewals and resultant term of leases. The Company also elected not to recognize a right-of-use asset and lease liability for those leases with a remaining lease term of 12 months or less. The adoption of ASU 2016-02 did not require a cumulative-effect adjustment to the opening balance of the accumulated deficit at the time of adoption.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In May 2014, the FASB issued ASU 2014-09, &lt;font style="font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, and subsequently issued a number of amendments to this update.&amp;#160; The new standard, as amended in Accounting Standards Codification, or ASC 606, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes previous revenue recognition guidance. The standard&amp;#8217;s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&amp;#160; In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this standard effective January 1, 2019.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2016, the FASB issued ASU 2016-15,&lt;font style="font-style: italic;"&gt; Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, &lt;/font&gt;providing guidance on the classification of certain cash receipts and payments in the statement of cash flows intended to reduce diversity in practice, including cash flows related to debt prepayment or extinguishment costs and contingent consideration that may be paid following a business combination. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;font style="font-style: italic;"&gt;Fair Value Measurement (Topic 820): Disclosure Framework. &lt;/font&gt;The purpose of the update is to improve the effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;In November 2018, the FASB issued ASU 2018-18, C&lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;ollaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606,&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt; which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer for a promised good or service that is distinct within the collaborative arrangement. The guidance also precludes entities from presenting amounts related to transactions with a collaborative arrangement participant that is not a customer as revenue, unless those transactions are directly related to third-party sales.&lt;/font&gt; The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic;"&gt;Recent Accounting Pronouncements Not Adopted as of September 30, 2020:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;In June 2016, the FASB issued ASU 2016-13,&lt;font style="font-style: italic;"&gt; Financial Instruments &amp;#8211; Credit Losses (Topic 326)&lt;/font&gt;, amending existing guidance on the accounting for credit losses on financial instruments within its scope. The guidance provides for use of a forward-looking expected loss model for estimating credit losses, replacing the incurred loss model that is based on past events and current conditions. The new guidance also changes the impairment model for available-for-sale debt securities, requiring the use of an allowance to record estimated credit losses (and subsequent recoveries). The new guidance is effective for the Company beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In &lt;font style="color: rgb(0, 0, 0);"&gt;August 2018, the FASB issued ASU 2018-15, &lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;Intangibles&amp;#8212;Goodwill and Other Internal-Use Software (Subtopic 350-40: Customer&amp;#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance distinguishing between capitalizable service contract implementation costs and contract costs required to be expensed. In addition, the update requires that the term of the hosting arrangement is to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. This standard will become effective for the Company beginning January 1, 2021. The amendments may be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 and does not expect to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In &lt;font style="color: rgb(0, 0, 0);"&gt;December 2019, the FASB issued ASU 2019-12, &lt;/font&gt;&lt;font style="font-style: italic; color: rgb(0, 0, 0);"&gt;Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, &lt;/font&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;which amends accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. The standard will be effective for the Company beginning January 1, 2022, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;font style="font-style: italic;"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&amp;#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity&lt;/font&gt;. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity.&amp;#160; Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&amp;#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&amp;#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&amp;#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. These amendments will be effective for the Company beginning January 1, 2024, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the condensed consolidated financial statements of the Company.&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <!--Shares issued under employee stock purchase plan (in shares)-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Fact_2c58b359464d40efa9443558c98abee8" contextRef="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">14961</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <!--Shares issued under employee stock purchase plan (in shares)-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Fact_87484390682c411d9961c9fee405ed46" contextRef="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">31393</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <!--Shares issued under employee stock purchase plan (in shares)-Employee Stock Purchase Plan [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Fact_018cfa272deb4c6a9109e9496fe8dd6f" contextRef="c20200101to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U001" decimals="INF">14961</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <!--Shares issued under employee stock purchase plan (in shares)-Employee Stock Purchase Plan [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Fact_9045c598af5b466f932e692706ee4fcb" contextRef="c20190101to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U001" decimals="INF">31393</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <!--Number of common shares issued (in shares)-->
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact_725df05fc2ce4a9c8bc8adbd3fb5cb80" contextRef="c20191217to20191217" unitRef="U001" decimals="INF">8050000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <!--Number of common shares issued (in shares)-->
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact_4e46ff1de42d4cdd9ce18486f18cbffd" contextRef="c20191201to20191231" unitRef="U001" decimals="INF">8050000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_538d5dee5b964812a48feed45b3dc29c" contextRef="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">16128</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_59945645ebf247c3bee3fd96e09a02c7" contextRef="c20200101to20200331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">19811</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_66f2ff34ff9f48e4b404219523928cf1" contextRef="c20190101to20190331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">17830</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_b30221fb44854f83912cf9e76ceb2c32" contextRef="c20200701to20200930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">3195</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_c1e94f4ad86c43789d6da5732514ece0" contextRef="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">18944</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="Fact_f2addc1e42ea43ec85566c63d67f48fd" contextRef="c20190701to20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">20304</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Shares issued under employee stock purchase plan-Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_1691eec3d7e246978e9c5dc2b22e4cc4" contextRef="c20190401to20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">132000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_4fb42cb1bc2c4f4d86b706341385052d" contextRef="c20200401to20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">73000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_4fd440702d584a67844e5bb11045415f" contextRef="c20200401to20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-Retained Earnings [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_7eeb4a31c668464d9a200937e6c68412" contextRef="c20190401to20190630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_b6355d0cab8249c78464dc2a1b44f194" contextRef="c20190401to20190630" unitRef="U002" decimals="-3">132000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_b9c0b1dd22054ae98c62957d04da53f3" contextRef="c20190401to20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-Retained Earnings [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_bf9fae3ffcae4affa5f0ec3085763348" contextRef="c20200401to20200630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Shares issued under employee stock purchase plan-->
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Fact_ebf21f30de8d45e99319e18456801c60" contextRef="c20200401to20200630" unitRef="U002" decimals="-3">73000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_1c860e8436be4f1dbf2281c171b0e5cf" contextRef="c20200930" unitRef="U002" decimals="-3">-36519000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_3afa89dbcd504fc6ba82023f924159ec" contextRef="c20191231" unitRef="U002" decimals="-3">-6122000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Cumulative Effect, Period of Adoption, Adjustment [Member]-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_36d401deba51454aa33ab9331cc3600b" contextRef="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">20000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_59fa550ba39544ac99731eedefa02c04" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">34000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_5b4aa3193831443294eb2b107adeab54" contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-130474000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_5ffa5c9b824140479cc0c89703b32cf0" contextRef="c20181231" unitRef="U002" decimals="-3">10080000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Cumulative Effect, Period of Adoption, Adjustment [Member]-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_65bfcc4551eb4b10b0a53576aeedb520" contextRef="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_7d4fc1b03a1d449eb2e56be0543e7bbf" contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">124318000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_ba5963fda46648cba0f1c72eaf870b3b" contextRef="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-61376000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_c0b14427c04a4164aa128e9fab5cd94e" contextRef="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">71431000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Cumulative Effect, Period of Adoption, Adjustment [Member]-->
  <us-gaap:StockholdersEquity id="Fact_c6497093c02946db88a65ff3c5a3ac66" contextRef="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitRef="U002" decimals="-3">-2832000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-Cumulative Effect, Period of Adoption, Adjustment [Member]-->
  <us-gaap:StockholdersEquity id="Fact_d22109794cea4166a6faba9e5b5c9324" contextRef="c20181231_CumulativeEffectPeriodOfAdoptionAxis_CumulativeEffectPeriodOfAdoptionAdjustmentMember_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-2852000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_e7b224c6f2d74ee8b6d1defd89075f83" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">25000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_092ec92545724640af5da7ee20b063eb" contextRef="c20200630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">34000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_16c795bde3344f67a4541eeb60feaeb9" contextRef="c20200331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">126141000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_1e86038bf8d84c4e9732672fc8adec50" contextRef="c20200930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">129336000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_25a19c70ac1f4e17ac6bea0bf3f5dd6e" contextRef="c20190630" unitRef="U002" decimals="-3">-24657000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_29624ced996c4b56866d31a1ccb66cd6" contextRef="c20190930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">25000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_369ec743f1d24e75b7f47f5163810a50" contextRef="c20200331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">34000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_3f9d268aa3a04e6683c659603bb0427e" contextRef="c20190630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-99426000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_47dab35fb8184008a7d3f5448097cdaf" contextRef="c20200930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-165889000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_498d965cbb484d1e86b09b9a66dbab4e" contextRef="c20190331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-78954000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_4ae222c022dd4ffc95ded6becc71fcd3" contextRef="c20200630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-149338000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_67e3e900569349829077844a65bb91d7" contextRef="c20190331" unitRef="U002" decimals="-3">-6056000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_af0cbcd01228465caaeeffcabbbe7bf9" contextRef="c20190930_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-117838000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_b55c60a82e7a4b78982f6a130ca0745f" contextRef="c20190930_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">83354000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_b6da221a792b4c23b45573aa97b33092" contextRef="c20190630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">25000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquity id="Fact_b80b320c1ec74353a88a62b74efc30c7" contextRef="c20200331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">-147004000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_bc527dcca1534808acf8a6d33031a363" contextRef="c20190930" unitRef="U002" decimals="-3">-34459000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_c9d1dde486914227a45abfc6b6f97eab" contextRef="c20200331" unitRef="U002" decimals="-3">-20829000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_e1b89da7f33f4fbea622117dc15bb6a7" contextRef="c20200930_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">34000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_ec305cbb25064c81b9b58bfa40f13cad" contextRef="c20190630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">74744000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_f456e2731f4648c59f35d1522e5ccea2" contextRef="c20190331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">72873000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity id="Fact_f51e5b1659454d47b8d842c4af21dd28" contextRef="c20200630" unitRef="U002" decimals="-3">-21388000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity id="Fact_fcb7de4052574b408ba53357acedb1dc" contextRef="c20200630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">127916000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-Common Stock [Member]-->
  <us-gaap:StockholdersEquity id="Fact_ff46e1ccd2754dffb834e62809714865" contextRef="c20190331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">25000</us-gaap:StockholdersEquity>
  <!--Subsequent Events-->
  <us-gaap:SubsequentEventsTextBlock id="Fact_5e29fc92d3454d2f961784976baa159e" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 19.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Subsequent Events&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;font style="font-weight: bold; font-style: italic;"&gt;(A)&lt;/font&gt;&amp;#160;&lt;font style="font-weight: bold; font-style: italic;"&gt;Amendment to License Agreement with Sunovion Pharmaceuticals Inc.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);"&gt;Effective as of October 23, 2020, the Company entered into a Second Amendment to the Sunovion License Agreement whereby the parties to the Sunovion License Agreement agreed to clarify the continued rights and obligations of the parties with respect to the prosecution and maintenance of the Company&amp;#8217;s patents covered under the Agreement and that, on and after March 31, 2028, in respect of any jurisdiction or jurisdictions covered under the License Agreement, Sunovion may terminate its rights with respect to the Licensed Patents under the License Agreement upon 180 days prior written notice to the Company.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(B) Monetization of Certain Rights under the Sunovion License Agreement&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;On November 3, 2020, the Company entered into the Monetization Agreement&amp;#160; that will result in proceeds to the Company of up to $125,000 in exchange for which the Company conveyed to Marathon the right to all royalties and other payments due to the Company under the Sunovion License Agreement (See Note 6).&amp;#160; Under the terms of the Monetization Agreement, Aquestive will receive a $40,000 cash payment within 12 business days of signing and is eligible to receive up to $85,000 &lt;/font&gt;of contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain other commercial milestones.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(C) Amendment and Partial Repayment of the 12.5% Notes&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="color: rgb(0, 0, 0);"&gt;With the proceeds paid to the Company at closing under the Monetization Agreement, the Company will repay $22,500 of the 12.5% Notes, and issue $4,000&amp;#160; of new senior notes in lieu of paying a prepayment premium on the early repayment of the 12.5% Notes, reducing the balance of senior notes outstanding to $51,500 in the aggregate.&amp;#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 the Company&amp;#8217;s ability to access, at the Company&amp;#8217;s option, $30,000 of senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at the option of the Company, contingent upon FDA approval of the Company&amp;#8217;s product candidate Libervant&lt;/font&gt; (diazepam) Buccal Film for the management of seizure clusters&lt;font style="color: rgb(0, 0, 0);"&gt;.&amp;#160; A second $20,000 senior notes re-opener represents a right, at the Company&amp;#8217;s option, to market to current holders of the Company&amp;#8217;s 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S. market access.&amp;#160; If and to the extent that the Company accesses these re-openers, the Company will grant warrants to purchase up to 714,000 shares of common stock, with the strike price calculated based on the 30-day volume weighted average closing price of the Company&amp;#8217;s common stock at the warrant grant date.&amp;#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of the Company&amp;#8217;s common stock.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <!--Use of Estimates-->
  <us-gaap:UseOfEstimates id="Fact_b9089fbbf4334e8ab6472fc26e04a288" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;(B) Use of Estimates&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&amp;#160; Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of share-based compensation and contingencies.&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <!--Variable lease expense-->
  <us-gaap:VariableLeaseCost id="Fact_10931700c17e494b840782fd1a462389" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">255000</us-gaap:VariableLeaseCost>
  <!--Variable lease expense-->
  <us-gaap:VariableLeaseCost id="Fact_e58bfe831ce6477c8106643845bdd548" contextRef="c20200701to20200930" unitRef="U002" decimals="-3">89000</us-gaap:VariableLeaseCost>
  <!--Fair value of warrants-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure id="Fact_f60115f44441447ab4b9a1dd4f992619" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U002" decimals="-3">6800000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact_17debbbb68da4f93a534ff5dd352da91" contextRef="c20200101to20200930" unitRef="U001" decimals="0">33592846</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact_2ab8f53966d04ab19492e8bf7f1d0706" contextRef="c20200701to20200930" unitRef="U001" decimals="0">33619379</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact_5f5c2bf45a854a1e8f8a67eb83dace7c" contextRef="c20190101to20190930" unitRef="U001" decimals="INF">24992229</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact_d8bceb9f1b0a43a6993bd5101ea48d78" contextRef="c20190701to20190930" unitRef="U001" decimals="INF">25031478</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <!--Weighted-average number of common shares outstanding - basic and diluted (in shares)-->
  <!--Amendment Flag-->
  <dei:AmendmentFlag id="Fact_7abcc5c5f77041879ee2687fdc8d49e9" contextRef="c20200101to20200930">false</dei:AmendmentFlag>
  <!--Current Fiscal Year End Date-->
  <dei:CurrentFiscalYearEndDate id="Fact_3cd1803ca2e34f55b66c671cb23d4548" contextRef="c20200101to20200930">--12-31</dei:CurrentFiscalYearEndDate>
  <!--Document Period End Date-->
  <dei:DocumentPeriodEndDate id="Fact_e23b6b438aac41c19017f84cb63cd38f" contextRef="c20200101to20200930">2020-09-30</dei:DocumentPeriodEndDate>
  <!--Entity Address, State or Province-->
  <dei:EntityAddressStateOrProvince id="Fact_d7327148c06847ebba7951c38673e66c" contextRef="c20200101to20200930">NJ</dei:EntityAddressStateOrProvince>
  <!--Entity Current Reporting Status-->
  <dei:EntityCurrentReportingStatus id="Fact_7ca2cdf800094ae1b542ef6ad041d4a6" contextRef="c20200101to20200930">Yes</dei:EntityCurrentReportingStatus>
  <!--Entity Filer Category-->
  <dei:EntityFilerCategory id="Fact_e65f6ecd444b43eaa0cf234921e50e47" contextRef="c20200101to20200930">Non-accelerated Filer</dei:EntityFilerCategory>
  <!--Entity Registrant Name-->
  <dei:EntityRegistrantName id="Fact_3aca4697b3b54a0d8adc225ec62721c7" contextRef="c20200101to20200930">Aquestive Therapeutics, Inc.</dei:EntityRegistrantName>
  <!--Entity Central Index Key-->
  <dei:EntityCentralIndexKey id="Fact_8bd8fbd4529a463b8553d13ab4f53d21" contextRef="c20200101to20200930">0001398733</dei:EntityCentralIndexKey>
  <!--Entity Common Stock, Shares Outstanding-->
  <dei:EntityCommonStockSharesOutstanding id="Fact_bd892ba2b3ac47f898417e296a921456" contextRef="c20201102" unitRef="U001" decimals="INF">33619796</dei:EntityCommonStockSharesOutstanding>
  <!--Document Fiscal Year Focus-->
  <dei:DocumentFiscalYearFocus id="Fact_db44889d1cab4eb69e5cfa702244f581" contextRef="c20200101to20200930">2020</dei:DocumentFiscalYearFocus>
  <!--Document Fiscal Period Focus-->
  <dei:DocumentFiscalPeriodFocus id="Fact_35b9b5d35dd448b287c75483b4f540c4" contextRef="c20200101to20200930">Q3</dei:DocumentFiscalPeriodFocus>
  <!--Document Type-->
  <dei:DocumentType id="Fact_bdd28257f87d47eebc4daf737ba92b95" contextRef="c20200101to20200930">10-Q</dei:DocumentType>
  <!--Entity Interactive Data Current-->
  <dei:EntityInteractiveDataCurrent id="Fact_0b1f44753b394f2da5f5a552669a28bd" contextRef="c20200101to20200930">Yes</dei:EntityInteractiveDataCurrent>
  <!--Entity Shell Company-->
  <dei:EntityShellCompany id="Fact_e3f27d0d2a024680a04771712af63bd0" contextRef="c20200101to20200930">false</dei:EntityShellCompany>
  <!--Entity Emerging Growth Company-->
  <dei:EntityEmergingGrowthCompany id="Fact_7d1e9e9f0ff24b64beb7baf6b73889f8" contextRef="c20200101to20200930">true</dei:EntityEmergingGrowthCompany>
  <!--Entity Ex Transition Period-->
  <dei:EntityExTransitionPeriod id="Fact_dab22b973ffa45299e2cc0d382ed4ebc" contextRef="c20200101to20200930">false</dei:EntityExTransitionPeriod>
  <!--Entity Small Business-->
  <dei:EntitySmallBusiness id="Fact_0e42feae303a492fab69a30dd772fe04" contextRef="c20200101to20200930">true</dei:EntitySmallBusiness>
  <!--Revenues and Trade Receivables, Net [Text Block]-->
  <aqst:RevenuesAndTradeReceivablesNetTextBlock id="Fact_58d5d1a1ffd143ac892a7435fae895a1" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 5.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Revenues and Trade Receivables, Net&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic; font-weight: bold;"&gt;Revenue from Contracts with Customers&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Company&amp;#8217;s revenues are derived from four primary sources: manufactured products made to order for licensees, including Suboxone&amp;#174; and Zuplenz&amp;#174;, manufacture and sale of its self-developed, self-commercialized proprietary product, Sympazan&amp;#174; (clobazam), intellectual property licensing arrangements, and product development services provided under contracts with customers.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Revenue Recognition and Performance Obligations&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Aquestive recognizes revenue pursuant to ASC 606, &lt;font style="font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, to reflect amounts expected to be collectible in exchange for the transfer of contractually promised goods or services to its customers, as discussed in additional detail in the Company&amp;#8217;s 2019 Annual Report on Form 10-K.&amp;#160; Accordingly, the value of contractually promised goods or services is assessed at contract inception to identify those that constitute distinct performance obligations. Contract revenues are allocated to those distinct performance obligations based on estimated standalone values or expected values, and these allocated revenues are recognized at the point in time, or over the period of time, that those distinct obligations are satisfied. The Company&amp;#8217;s performance obligations consist primarily of transferring control of goods, services or intellectual property that are identified in the contracts, purchase orders or invoices. Variable or contingent revenues which may become due from customers, such as milestone payments due upon acceptance of a regulatory filing, regulatory approval, or sales-based milestone payments, are not recognized until contingencies are met, the customer&amp;#8217;s obligation to meet its contractual payment commitments is fixed and collection of invoiced amounts is reasonably assured, thereby limiting any significant probability of a revenue reversal.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Revenues from the sale of products and services and from licensing arrangements and related payments are evidenced by a contract with the customer. For manufacturing and supply and proprietary product sales, invoices are generally issued upon the transfer of control. Co-development and research revenue is typically invoiced based on the contractual payment schedule, or upon completion of the service. Licensing revenue is generally invoiced at the inception of an agreement, with additional charges rendered as related contingencies, such as regulatory approvals or sales targets, are met. Invoices are typically payable 30 to 60 days after the invoice date, however some payment terms may reach 75 days depending on the customer. The Company performs a review of each specific customer&amp;#8217;s creditworthiness and ability to pay prior to acceptance as a customer, as well as periodic prospective reviews.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="font-style: italic;"&gt;Manufacture and supply revenue&lt;/font&gt; &amp;#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="font-style: italic;"&gt;Proprietary product sales, net&lt;/font&gt; &amp;#8211; this net revenue is recognized upon delivery and transfer of control of proprietary product to the Company&amp;#8217;s customers, at which point the Company has no ongoing performance obligations and the customer has assumed all significant risks and rewards of ownership. These revenues are subject to payment discounts, wholesaler service fees, volume and prompt payment discounts, rebates and other chargebacks, which are estimated and recorded at the time the revenue is recognized. Once all related variable considerations are resolved and uncertainties as to collectible amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="font-style: italic;"&gt;License and royalty revenues&lt;/font&gt; &amp;#8211; &lt;font style="color: rgb(0, 0, 0);"&gt;the Company may realize revenue from functional or from symbolic licenses. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints, if any. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be met by the Company, such as manufactured products or development services, revenues may be deferred when advance payment is received and recognized over the term of the license agreement. &lt;/font&gt;Royalty revenues are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold to the Company&amp;#8217;s strategic partners.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;&lt;font style="font-style: italic;"&gt;Co-development and research fees &lt;/font&gt;&amp;#8211; this revenue is recognized as contractual services or performance obligations are performed. Invoicing for contractual services may occur in advance or arrears, may, or may not, coincide with completion of underlying performance obligations, and therefore may give rise to contract assets or contract liabilities when the value of services completed varies from amounts that may be invoiced to the customer.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic; font-weight: bold;"&gt;Contract Assets&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In limited situations, certain customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&amp;#160; In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables and as a component of intangible and other assets within the Condensed Consolidated Balance Sheet. As of September 30, 2020, and December 31, 2019, such current and non-current contract assets were $8,922 and $4,363, respectively, consisting primarily of minimum annual royalties due under a certain licensing agreement and completed but unshipped products manufactured to specific order by certain licensees.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic; font-weight: bold;"&gt;Contract Liabilities&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;In other limited situations, certain customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&amp;#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Consolidated Balance Sheet. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September 30, 2020, and December 31, 2019, such contract liabilities were $4,416 and $5,154, respectively.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The Company&amp;#8217;s revenues were comprised of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Manufacture and supply revenue&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;5,903&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,155&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;20,078&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;24,739&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;License and royalty revenue&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;328&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,356&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,682&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,402&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Co-development and research fees&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;341&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,073&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;870&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,862&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Proprietary product sales, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,688&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;834&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,070&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,187&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total revenues&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8,260&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,418&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;38,700&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;36,190&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic;"&gt;Disaggregation of Revenue&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following table provides disaggregated net revenue by geographic area:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Nine Months Ended&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;United States&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,567&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;11,022&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;35,496&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;33,683&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Ex-United States&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,693&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,396&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,204&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;2,507&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total revenues&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;8,260&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;12,418&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;38,700&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;36,190&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;Non-United States revenues are derived primarily from products manufactured for the Australian and Malaysian markets.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;Trade and other receivables, net consist of the following:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Trade receivables&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;6,659&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;9,094&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Contract and other receivables&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,872&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;4,363&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: allowance for bad debts&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(264&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Less: sales-related allowances&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(277&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(203&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Trade and other receivables, net&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;7,990&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;13,130&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The current portion of contract and other receivables totaled $1,872 and $4,363 as of September 30, 2020 and December 31, 2019, respectively. The current period balance is comprised primarily of $1,000 of minimum royalty revenue due from a licensee and the remaining balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services. The December 31, 2019 balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services. Sales-related allowances for both periods presented are estimated in relation to revenues recognized for sales of Sympazan.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); text-indent: 18pt;"&gt;The following table presents the changes in the allowance for bad debt:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;September 30,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Allowance for doubtful accounts at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;58&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Additions charged to bad debt expense&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;66&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Write-downs charged against the allowance&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Allowance for doubtful accounts at end of the period&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;264&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"&gt;Sales Related Allowances and Accruals&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-indent: 18pt;"&gt;The&lt;font style="color: rgb(0, 0, 0);"&gt; following table provides a summary of activity with respect to sales related allowances and accruals for the nine months ended September 30, 2020:&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 68%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total Sales Related&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allowances and Accruals&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;"&gt;Balance at December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,377&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Provision&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,996&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Payments / credits&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(3,441&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;"&gt;Balance at September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,932&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Total reductions of gross product sales from sales-related allowances and accruals were $3,996 for the nine months ended September 30, 2020.&amp;#160; Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and Accounts payable and accrued expenses were $277 and $1,655, respectively, as of September 30, 2020 and $203 and $1,174, respectively, as of December 31, 2019.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-style: italic;"&gt;Concentration of Major Customers&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Customers are considered major customers when sales exceed 10% of total net sales for the period or outstanding receivable balances exceed 10% of total receivables. For the year ended December 31, 2019, Indivior, Inc. (&amp;#8220;Indivior&amp;#8221;) provided 86% of the total revenues for the period, and as of that date, the Company&amp;#8217;s outstanding receivable balance from Indivior represented approximately 80% of gross receivables. For the nine months ended September 30, 2020, there were two customers exceeding the 10% threshold for revenue while there were three customers exceeding the 10% threshold for outstanding accounts receivable. Revenues provided by Indivior, and Sunovion Pharmaceuticals, Inc. (&amp;#8220;Sunovion&amp;#8221;) represented approximately 54% and 31%, respectively of total revenue for the nine months ended September 30, 2020, and outstanding accounts receivable due from Indivior, Sunovion and AmerisourceBergen represented approximately 50%, 12% and 11%, respectively of gross receivables.&lt;/div&gt;&lt;/div&gt;</aqst:RevenuesAndTradeReceivablesNetTextBlock>
  <!--Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net-->
  <aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet id="Fact_a75a384ba6ca48b587d96ca8822c2512" contextRef="c20200930" unitRef="U002" decimals="-3">277000</aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet>
  <!--Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net-->
  <aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet id="Fact_d707d44799c7458fa52ec6be27540012" contextRef="c20191231" unitRef="U002" decimals="-3">203000</aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet>
  <!--Accounts Receivable Allowances, Credits and payments-->
  <aqst:AccountsReceivableAllowancesCreditsAndPayments id="Fact_1d03956159e547b38e2c6c024910e589" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">3441000</aqst:AccountsReceivableAllowancesCreditsAndPayments>
  <!--Accounts Receivable Allowances and Accruals-->
  <aqst:AccountsReceivableAllowancesAndAccruals id="Fact_14a02021c93645eab564372bd480c6c2" contextRef="c20191231" unitRef="U002" decimals="-3">1377000</aqst:AccountsReceivableAllowancesAndAccruals>
  <!--Accounts Receivable Allowances and Accruals-->
  <aqst:AccountsReceivableAllowancesAndAccruals id="Fact_3483c6c9e41a49c2ba4733cfd4b4a6d7" contextRef="c20200930" unitRef="U002" decimals="-3">1932000</aqst:AccountsReceivableAllowancesAndAccruals>
  <!--Accounts Receivable Allowances, Provision Related to Sales-->
  <aqst:AccountsReceivableAllowancesProvisionRelatedToSales id="Fact_ce18da00e0e343aeb5edf78ba72936d2" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">3996000</aqst:AccountsReceivableAllowancesProvisionRelatedToSales>
  <!--Accounts Receivable Allowances and Accruals - Accounts Payable and Accrued Expenses-->
  <aqst:AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses id="Fact_39ba4b0f378c446eb63f92edbfd87721" contextRef="c20191231" unitRef="U002" decimals="-3">1174000</aqst:AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses>
  <!--Accounts Receivable Allowances and Accruals - Accounts Payable and Accrued Expenses-->
  <aqst:AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses id="Fact_52260004e2c14f23a9d9c81e148e7d5c" contextRef="c20200930" unitRef="U002" decimals="-3">1655000</aqst:AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses>
  <!--Sales Related Allowances and Accruals [Table Text Block]-->
  <aqst:SalesRelatedAllowancesAndAccrualsTableTextBlock id="Fact_76040d8ec81b4c7f82857bd68502489e" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="text-indent: 18pt;"&gt;The&lt;font style="color: rgb(0, 0, 0);"&gt; following table provides a summary of activity with respect to sales related allowances and accruals for the nine months ended September 30, 2020:&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 68%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total Sales Related&lt;/div&gt;&lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allowances and Accruals&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;"&gt;Balance at December 31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,377&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Provision&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;3,996&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Payments / credits&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;(3,441&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 4px;"&gt;&lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;"&gt;Balance at September 30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;1,932&lt;/div&gt;&lt;/td&gt;&lt;td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:SalesRelatedAllowancesAndAccrualsTableTextBlock>
  <!--Revenue from Contracts with Customers, Number of Sources of Revenue-->
  <aqst:RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue id="Fact_10f6f2099253424cb6afa779ba249669" contextRef="c20200930" unitRef="U006" decimals="INF">4</aqst:RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue>
  <!--Invoices Payable Term-Maximum [Member]-->
  <aqst:InvoicesPayableTerm id="Fact_212a353ffcd547e6b341e9e8a6278912" contextRef="c20200101to20200930_RangeAxis_MaximumMember">P60D</aqst:InvoicesPayableTerm>
  <!--Invoices Payable Term-->
  <aqst:InvoicesPayableTerm id="Fact_36d3371db7c7418bae8780bfaa25741f" contextRef="c20200101to20200930">P75D</aqst:InvoicesPayableTerm>
  <!--Invoices Payable Term-Minimum [Member]-->
  <aqst:InvoicesPayableTerm id="Fact_902cc0cc11204cb0a57aebced39356f7" contextRef="c20200101to20200930_RangeAxis_MinimumMember">P30D</aqst:InvoicesPayableTerm>
  <!--Warrants Disclosure [Text Block]-->
  <aqst:WarrantsDisclosureTextBlock id="Fact_03919b9fc67a4db19d4bfac83c42a554" contextRef="c20200101to20200930">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;&lt;tr&gt;&lt;td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;Note 14.&lt;/td&gt;&lt;td style="width: auto; vertical-align: top;"&gt;&lt;div style="color: rgb(0, 0, 0);"&gt;&lt;font style="font-weight: bold;"&gt;Warrant&lt;/font&gt;s &lt;font style="font-weight: bold;"&gt;Issued to 12.5% Senior Secured Noteholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;The Warrants that were issued in conjunction with the Initial Notes described above expire on June 30, 2025 and entitled the holders of the Initial Notes to purchase two million shares of the Company&amp;#8217;s common stock at $4.25 per share and include specified registration rights.&amp;#160; Management estimated the fair value of the Warrants to be $6,800, assisted by an independent third-party appraiser.&amp;#160; The fair value of these Warrants is treated as a debt discount, amortizable over the term of the Warrants, with the unamortized loan portion applied to reduce the face amount of the Initial Notes in the Company&amp;#8217;s balance sheet.&amp;#160; Additionally, since the Warrants issued do not provide warrant redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the Warrants, except in the case of a &amp;#8220;cash change in control&amp;#8221;, the fair value attributed to the Warrants is presented in Additional-paid in capital in the accompanying Condensed Consolidated Balance Sheets.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;Certain holders of the Initial Notes exercised Warrants for the purchase of 428,571 shares of common stock and proceeds therefor totaling $1,821 were received on December 16, 2019. There were no Warrants exercised by the holders of the Initial Notes during the nine-month period ended September 30, 2020.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: justify; text-indent: 18pt;"&gt;On November 3, 2020, the Indenture was amended, and additional at-the-money warrants will be issued at the time of purchase of additional Notes.&amp;#160; See Note 19 (C), Subsequent Events.&lt;/div&gt;&lt;/div&gt;</aqst:WarrantsDisclosureTextBlock>
  <!--Trade and other receivables, net-->
  <aqst:TradeAndOtherReceivablesNet id="Fact_8f54589ecd6a45f694d0d33f0e22a584" contextRef="c20200930" unitRef="U002" decimals="-3">7990000</aqst:TradeAndOtherReceivablesNet>
  <!--Trade and other receivables, net-->
  <aqst:TradeAndOtherReceivablesNet id="Fact_dd27816dd66e4880a6bd677dd8bb9053" contextRef="c20191231" unitRef="U002" decimals="-3">13130000</aqst:TradeAndOtherReceivablesNet>
  <!--Trade and other receivables, net-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:TradeAndOtherReceivablesNet id="Fact_e8930ed9ca2547dc9a36296820378722" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">1000000</aqst:TradeAndOtherReceivablesNet>
  <!--Guaranteed Royalty Revenue-Minimum [Member]-->
  <aqst:GuaranteedRoyaltyRevenue id="Fact_949fa1f9e7604ed79740134fa41c524c" contextRef="c20200930_RangeAxis_MinimumMember" unitRef="U002" decimals="-3">1000000</aqst:GuaranteedRoyaltyRevenue>
  <!--Maximum Amount of Upfront Payment Receivable-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-Subsequent Event [Member]-->
  <aqst:MaximumAmountOfUpfrontPaymentReceivable id="Fact_db6e53efb9c542a092fcdec49b0a1e76" contextRef="c20201103_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">40000000</aqst:MaximumAmountOfUpfrontPaymentReceivable>
  <!--Maximum Amount of Payments Receivable for Milestones-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-Subsequent Event [Member]-->
  <aqst:MaximumAmountOfPaymentsReceivableForMilestones id="Fact_ab30d139d92a458690d82d668daa884a" contextRef="c20201103_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">85000000</aqst:MaximumAmountOfPaymentsReceivableForMilestones>
  <!--Class Of Warrant Or Right Warrants Issued During Period-Subsequent Event [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod id="Fact_93595459f46d4ab789045609cbbdfa46" contextRef="c20201103to20201103_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="INF">143000</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
  <!--Notice Period for Not to Renew Agreement-Commercial Exploitation Agreement with Indivior [Member]-->
  <aqst:NoticePeriodForNotToRenewAgreement id="Fact_f2c84411bbc74a5a955f6eb1df16101f" contextRef="c20200101to20200930_TypeOfArrangementAxis_CommercialExploitationAgreementWithIndiviorMember">P1Y</aqst:NoticePeriodForNotToRenewAgreement>
  <!--Notice Period for Not to Renew Agreement-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-Subsequent Event [Member]-->
  <aqst:NoticePeriodForNotToRenewAgreement id="Fact_6c8d130250974bc194159ab6a6b8c578" contextRef="c20201023to20201023_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember">P180D</aqst:NoticePeriodForNotToRenewAgreement>
  <!--Maximum Amount Of Payments Receivable For License Fees And Substantive Milestones-Supplemental Agreement with Indivior [Member]-->
  <aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones id="Fact_60ddd818570d4100b66a3d94c78a972f" contextRef="c20200930_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">75000000</aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones>
  <!--Maximum Amount Of Payments Receivable For License Fees And Substantive Milestones-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones id="Fact_5e4f472794c3460aaf0289d3ce679a63" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">45000000</aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones>
  <!--Maximum Amount Of Payments Receivable For License Fees And Substantive Milestones-Agreement to Terminate CLA with KemPharm [Member]-->
  <aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones id="Fact_4619351f07aa41dda8465c11000c44fe" contextRef="c20200930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember" unitRef="U002" decimals="-3">4800000</aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones>
  <!--Maximum Amount Of Payments Receivable For License Fees And Substantive Milestones-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-Subsequent Event [Member]-->
  <aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones id="Fact_5fdf56a3c83747c488f6a7eeaa24ffca" contextRef="c20201103_SubsequentEventTypeAxis_SubsequentEventMember_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">125000000</aqst:MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones>
  <!--Debt Instrument Additional Borrowing Capacity-Maximum [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:DebtInstrumentAdditionalBorrowingCapacity id="Fact_43d77a36ae3d4168878f98dd860f9d38" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember" unitRef="U002" decimals="-3">30000000</aqst:DebtInstrumentAdditionalBorrowingCapacity>
  <!--Debt Instrument Additional Borrowing Capacity-First Additional Offering [Member]-->
  <aqst:DebtInstrumentAdditionalBorrowingCapacity id="Fact_a3aec66d42704a67a8af4db8636183c1" contextRef="c20200930_DebtInstrumentAxis_FirstAdditionalOfferingMember" unitRef="U002" decimals="-3">10000000</aqst:DebtInstrumentAdditionalBorrowingCapacity>
  <!--Debt Instrument Additional Borrowing Capacity-Second Additional Offering [Member]-->
  <aqst:DebtInstrumentAdditionalBorrowingCapacity id="Fact_bf83322d12c64eac878d92077ae5bec5" contextRef="c20200930_DebtInstrumentAxis_SecondAdditionalOfferingMember" unitRef="U002" decimals="-3">20000000</aqst:DebtInstrumentAdditionalBorrowingCapacity>
  <!--Finite-Lived Intangible Assets, Net and Other Assets-->
  <aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets id="Fact_638bd8797aaa4e06ac62035b6b3a6906" contextRef="c20200930" unitRef="U002" decimals="-3">7402000</aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets>
  <!--Finite-Lived Intangible Assets, Net and Other Assets-->
  <aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets id="Fact_c7be5d8fad1b4fc4b4b4f6940b49fa76" contextRef="c20191231" unitRef="U002" decimals="-3">439000</aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets>
  <!--Finite-Lived Intangible Assets, Net and Other Assets-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets id="Fact_94300ba5f04242ce93e9294db8b04273" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">7000000</aqst:FiniteLivedIntangibleAssetsNetAndOtherAssets>
  <!--Number Of Customers Exceeding Ten Percent Thresholds-Accounts Receivable [Member]-->
  <aqst:NumberOfCustomersExceedingTenPercentThresholds id="Fact_0607a02f4aee41f884108298c5980e6a" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember" unitRef="U007" decimals="INF">3</aqst:NumberOfCustomersExceedingTenPercentThresholds>
  <!--Number Of Customers Exceeding Ten Percent Thresholds-Revenue Benchmark [Member]-->
  <aqst:NumberOfCustomersExceedingTenPercentThresholds id="Fact_28775ac5b8684331801e92f4f5a753b3" contextRef="c20200101to20200930_ConcentrationRiskByBenchmarkAxis_SalesRevenueNetMember" unitRef="U007" decimals="INF">2</aqst:NumberOfCustomersExceedingTenPercentThresholds>
  <!--Warrants Issued in Connection with Long-term Debt-->
  <aqst:WarrantsIssuedInConnectionWithLongTermDebt id="Fact_b881d336af4d40ce86ea0535df2bbdde" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">6800000</aqst:WarrantsIssuedInConnectionWithLongTermDebt>
  <!--Warrants Issued in Connection with Long-term Debt-->
  <aqst:WarrantsIssuedInConnectionWithLongTermDebt id="Fact_dba013003d544d28b5c30ddefcf7bb7e" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">0</aqst:WarrantsIssuedInConnectionWithLongTermDebt>
  <!--Increase (Decrease) in Capital Expenditures Included in Accounts Payable and Accrued Expenses-->
  <aqst:IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses id="Fact_982ee8fd2be0482d8111e74ffdf341e6" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">152000</aqst:IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses>
  <!--Increase (Decrease) in Capital Expenditures Included in Accounts Payable and Accrued Expenses-->
  <aqst:IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses id="Fact_da021e1eefe649af9e7dd89d7fecf266" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">290000</aqst:IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses>
  <!--Increase (Decrease) in Offering Costs Included in Accounts Payable and Accrued Expenses-->
  <aqst:IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses id="Fact_217e3e3cfc5346c3b5633c93fb597568" contextRef="c20190101to20190930" unitRef="U002" decimals="-3">162000</aqst:IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses>
  <!--Increase (Decrease) in Offering Costs Included in Accounts Payable and Accrued Expenses-->
  <aqst:IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses id="Fact_28749bda46db41d48aa8344dc0c346e0" contextRef="c20200101to20200930" unitRef="U002" decimals="-3">237000</aqst:IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses>
  <!--Number of Annual Royalty Payments Receivable-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:NumberOfAnnualRoyaltyPaymentsReceivable id="Fact_9b71df3b8f004be3ae143f3f44bf4214" contextRef="c20200101to20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U009" decimals="INF">7</aqst:NumberOfAnnualRoyaltyPaymentsReceivable>
  <!--Cumulative Royalty Receivable-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:CumulativeRoyaltyReceivable id="Fact_5d5e0edf21054c6f9912a7f5f5048399" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">8000000</aqst:CumulativeRoyaltyReceivable>
  <!--Cumulative Royalty Receivable-->
  <aqst:CumulativeRoyaltyReceivable id="Fact_3f6a4f0cc0ce4eacad448a8daa33b6c5" contextRef="c20200930" unitRef="U002" decimals="-3">7000000</aqst:CumulativeRoyaltyReceivable>
  <!--Cumulative Royalty Receivable-->
  <aqst:CumulativeRoyaltyReceivable id="Fact_8a256f8f83c44792bc62459b5b1983a6" contextRef="c20191231" unitRef="U002" decimals="-3">0</aqst:CumulativeRoyaltyReceivable>
  <!--Minimum Annual Royalty Receivable-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:MinimumAnnualRoyaltyReceivable id="Fact_72246b46c5ea443493f8e3f316b5989c" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">1000000</aqst:MinimumAnnualRoyaltyReceivable>
  <!--Stock Issued During Period, Shares, Warrant Exercise-Common Stock [Member]-->
  <aqst:StockIssuedDuringPeriodSharesWarrantExercise id="Fact_6f60cf6304594c1683ff0a935b3e72ac" contextRef="c20191216to20191216_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="INF">428571</aqst:StockIssuedDuringPeriodSharesWarrantExercise>
  <!--Class of Warrant or Right, Warrants Exercised-->
  <aqst:ClassOfWarrantOrRightWarrantsExercised id="Fact_3060770a052d4cdcb45d53dd882838b4" contextRef="c20200101to20200930" unitRef="U001" decimals="INF">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
  <!--Contingent payments receivable in the future-Supplemental Agreement with Indivior [Member]-Maximum [Member]-->
  <aqst:ContingentPaymentsReceivableInTheFuture id="Fact_ba058c9f5977452f94d5f242416543b7" contextRef="c20200930_RangeAxis_MaximumMember_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">34250000</aqst:ContingentPaymentsReceivableInTheFuture>
  <!--Receivable, Process Patent Rights-Supplemental Agreement with Indivior [Member]-->
  <aqst:ReceivableProcessPatentRights id="Fact_b2a0f9a6e38148839136da471b8931a2" contextRef="c20200930_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">1250000</aqst:ReceivableProcessPatentRights>
  <!--Aggregate Receivable-Supplemental Agreement with Indivior [Member]-Maximum [Member]-->
  <aqst:AggregateReceivable id="Fact_1bfa6d9f741445c8be51ac6999446e02" contextRef="c20200930_RangeAxis_MaximumMember_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">33000000</aqst:AggregateReceivable>
  <!--Cumulative Payments Received-Supplemental Agreement with Indivior [Member]-->
  <aqst:CumulativePaymentsReceived id="Fact_184513c5b1a94d1cb126741e7019ca28" contextRef="c20190220_TypeOfArrangementAxis_SupplementalAgreementWithIndiviorMember" unitRef="U002" decimals="-3">40750000</aqst:CumulativePaymentsReceived>
  <!--Cumulative Payments Received-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:CumulativePaymentsReceived id="Fact_84569149c66043e2ac8b53976655c76d" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">22000000</aqst:CumulativePaymentsReceived>
  <!--Automatic Renewal Period of Agreement-Commercial Exploitation Agreement with Indivior [Member]-->
  <aqst:AutomaticRenewalPeriodOfAgreement id="Fact_5aa2836d2fe74c2882d97680b2159136" contextRef="c20200101to20200930_TypeOfArrangementAxis_CommercialExploitationAgreementWithIndiviorMember">P1Y</aqst:AutomaticRenewalPeriodOfAgreement>
  <!--License Agreement Term-Commercial Exploitation Agreement with Indivior [Member]-->
  <aqst:LicenseAgreementTerm id="Fact_71d1f25e1d084403832f0917857244d2" contextRef="c20200101to20200930_TypeOfArrangementAxis_CommercialExploitationAgreementWithIndiviorMember">P7Y</aqst:LicenseAgreementTerm>
  <!--Upfront Payment Received-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:UpfrontPaymentReceived id="Fact_573fa97704db449599349badf2f2d4a7" contextRef="c20200101to20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">5000000</aqst:UpfrontPaymentReceived>
  <!--Cumulative Milestone Payments Receivable-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:CumulativeMilestonePaymentsReceivable id="Fact_486fa619d4f243478cc4a6972e5fb510" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">17000000</aqst:CumulativeMilestonePaymentsReceivable>
  <!--Payment Receivable, Collaborative Agreement-License Agreement with Sunovion Pharmaceuticals, Inc. [Member]-->
  <aqst:PaymentReceivableCollaborativeAgreement id="Fact_e655d010a93a462db37f8caf6f16c275" contextRef="c20200930_TypeOfArrangementAxis_LicenseAgreementWithSunovionPharmaceuticalsIncMember" unitRef="U002" decimals="-3">4000000</aqst:PaymentReceivableCollaborativeAgreement>
  <!--Percentage Share of Milestone Payment-Agreement to Terminate CLA with KemPharm [Member]-->
  <aqst:PercentageShareOfMilestonePayment id="Fact_386d7fa5c7e14d8b8ecc3ef1e13b051f" contextRef="c20190901to20190930_TypeOfArrangementAxis_AgreementToTerminateCLAWithKemPharmMember" unitRef="U005" decimals="INF">0.1</aqst:PercentageShareOfMilestonePayment>
  <!--Warrant to purchase senior common equity interest ratio to fully diluted common units, percentage-Line of Credit [Member]-Perceptive Credit Opportunities Fund, LP [Member]-->
  <aqst:WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage id="Fact_b6c34514a9904e438a394c4e5bdad703" contextRef="c20200930_CreditFacilityAxis_LineOfCreditMember_LineOfCreditFacilityAxis_PerceptiveCreditOpportunitiesFundLPMember" unitRef="U005" decimals="4">0.0450</aqst:WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage>
  <!--Number of Proprietary Products, Internally-developed-->
  <aqst:NumberOfProprietaryProductsInternallyDeveloped id="Fact_1396f8f04a88426d932f69a946669f9f" contextRef="c20200930" unitRef="U004" decimals="INF">1</aqst:NumberOfProprietaryProductsInternallyDeveloped>
  <!--Debt Instrument, Number of Tranches-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:DebtInstrumentNumberOfTranches id="Fact_eefd9bd404724815abd4fc94a7e45c56" contextRef="c20190715to20190715_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U010" decimals="INF">2</aqst:DebtInstrumentNumberOfTranches>
  <!--Portion of Proceeds Amount to Monetize Assets, Condition One-First Additional Offering [Member]-Maximum [Member]-->
  <aqst:PortionOfProceedsAmountToMonetizeAssetsConditionOne id="Fact_5dfceb16334944a2b1a75676c5ec4386" contextRef="c20200101to20200930_DebtInstrumentAxis_FirstAdditionalOfferingMember_RangeAxis_MaximumMember" unitRef="U002" decimals="-3">40000000</aqst:PortionOfProceedsAmountToMonetizeAssetsConditionOne>
  <!--Annual Percentage Increase of Initial Loan Principal Payments During Final Four Quarters-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters id="Fact_7238b91e3b1d452ca8c3c8a5cbcbf6db" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U005" decimals="1">0.4</aqst:AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters>
  <!--Annual Percentage Increase in Principal Payments During First Four Quarters-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters id="Fact_2b691684eb714e16b577d62f0b9618c5" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U005" decimals="1">0.1</aqst:AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters>
  <!--Elective redemption percentage of debt-Minimum [Member]-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:ElectiveRedemptionPercentageOfDebt id="Fact_3fca5139e25a493a8d9509da6bb31113" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MinimumMember" unitRef="U005" decimals="INF">1.0156</aqst:ElectiveRedemptionPercentageOfDebt>
  <!--Elective redemption percentage of debt-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-Maximum [Member]-->
  <aqst:ElectiveRedemptionPercentageOfDebt id="Fact_5016fa4af56949b3bc30ec9df3dfef87" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember" unitRef="U005" decimals="INF">1.1250</aqst:ElectiveRedemptionPercentageOfDebt>
  <!--Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights-->
  <aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights id="Fact_97271bc45f234041ab7976bf3242b5d5" contextRef="c20190715to20190715" unitRef="U002" decimals="-3">66082000</aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights>
  <!--Redemption percentage of debt under change of control provisions-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-->
  <aqst:RedemptionPercentageOfDebtUnderChangeOfControlProvisions id="Fact_c08f13941ae042b49c1207133b966773" contextRef="c20200101to20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" unitRef="U005" decimals="2">1.01</aqst:RedemptionPercentageOfDebtUnderChangeOfControlProvisions>
  <!--Asset based loans secured on second priority lien by receivables and inventory assets-Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]-Maximum [Member]-->
  <aqst:AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets id="Fact_dac7949b79f54afeb621edaa7651f6ab" contextRef="c20200930_DebtInstrumentAxis_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_RangeAxis_MaximumMember" unitRef="U002" decimals="-3">10000000</aqst:AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets>
  <!--Portion of Proceeds Amount to Monetize Assets, Condition Two-Maximum [Member]-Second Additional Offering [Member]-->
  <aqst:PortionOfProceedsAmountToMonetizeAssetsConditionTwo id="Fact_a9862a4e2c4c45f0811129b4ca010288" contextRef="c20200101to20200930_DebtInstrumentAxis_SecondAdditionalOfferingMember_RangeAxis_MaximumMember" unitRef="U002" decimals="-3">50000000</aqst:PortionOfProceedsAmountToMonetizeAssetsConditionTwo>
  <!--Number of Operating Leases-->
  <aqst:NumberOfOperatingLeases id="Fact_45a6f7164bf44b7cbb1afecc6745902d" contextRef="c20200930" unitRef="U008" decimals="INF">3</aqst:NumberOfOperatingLeases>
  <!--Discount value on shares issued under employee stock purchase plan-Employee Stock Purchase Plan [Member]-->
  <aqst:DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan id="Fact_5070989ce3724fdba9d8dab0871f54da" contextRef="c20190101to20190930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">20000</aqst:DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan>
  <!--Discount value on shares issued under employee stock purchase plan-Employee Stock Purchase Plan [Member]-->
  <aqst:DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan id="Fact_d0eebc4534f44ec0b5dc145efa74a284" contextRef="c20200101to20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U002" decimals="-3">11000</aqst:DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan>
  <!--Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value-Restricted Stock Units [Member]-->
  <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue id="Fact_d31b729456ae48ee91078e0f59b1cadf" contextRef="c20200930_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3">958000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value, Granted-Options on Common Shares Outstanding [Member]-->
  <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted id="Fact_0ef8b040b2234188a3f685235cc96a28" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">2474000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value, Granted-Options on Common Shares Outstanding [Member]-->
  <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted id="Fact_3b0349e7277f4ce9a6d7236f9e11395c" contextRef="c20190101to20190930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3">0</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted>
  <!--Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised,Forfeitures and Expirations in Period-Options on Common Shares Outstanding [Member]-->
  <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod id="Fact_624ed01775bf474db1798fc0fe19959d" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3">136000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod>
  <!--Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period WeightedAverageExercisePrice-Options on Common Shares Outstanding [Member]-->
  <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice id="Fact_b4e1a4fecaad4503a06b2dab3bd42115" contextRef="c20200101to20200930_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2">-4.39</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <!--Share-based Payment Arrangement, Number of Offering Periods-Employee Stock Purchase Plan [Member]-->
  <aqst:ShareBasedPaymentArrangementNumberOfOfferingPeriods id="Fact_083586ffd3e54f189cc128d1ebdeef47" contextRef="c20200930_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U011" decimals="INF">2</aqst:ShareBasedPaymentArrangementNumberOfOfferingPeriods>
  <!--Working Capital (Deficit)-->
  <aqst:WorkingCapitalDeficit id="Fact_353d7d9d128042e0a7f0e879d22e8d19" contextRef="c20200930" unitRef="U002" decimals="-3">13311000</aqst:WorkingCapitalDeficit>
  <!--Additional Fund Amount-->
  <aqst:AdditionalFundAmount id="Fact_c9639c47e0ec49b69dd98fc37bf78305" contextRef="c20190731" unitRef="U002" decimals="-3">52226000</aqst:AdditionalFundAmount>
  <!--Adjustments to Additional Paid in Capital, Warrant Exercise-->
  <aqst:AdjustmentsToAdditionalPaidInCapitalWarrantExercise id="Fact_199913c675d74cf89348015cff50e56f" contextRef="c20191201to20191231" unitRef="U002" decimals="-3">1821000</aqst:AdjustmentsToAdditionalPaidInCapitalWarrantExercise>
  <!--Inventory Packing Material Gross-->
  <aqst:InventoryPackingMaterialGross id="Fact_348d229aa58c4fe68b1313dab479c1c1" contextRef="c20200930" unitRef="U002" decimals="-3">1231000</aqst:InventoryPackingMaterialGross>
  <!--Inventory Packing Material Gross-->
  <aqst:InventoryPackingMaterialGross id="Fact_d41e2724e9664fa998adeb982a87207a" contextRef="c20191231" unitRef="U002" decimals="-3">1096000</aqst:InventoryPackingMaterialGross>
  <!--Number of states in the antitrust litigation-->
  <aqst:NumberOfStatesInTheAntitrustLitigation id="Fact_f7ac9e8ed6634b2b91b0afef0c7989ea" contextRef="c20200930" unitRef="U015" decimals="0">41</aqst:NumberOfStatesInTheAntitrustLitigation>
  <!--Number of Patents-->
  <aqst:NumberOfPatents id="Fact_df970a0a782a44de95acd6aec991ea1e" contextRef="c20200101to20200930" unitRef="U014" decimals="INF">2</aqst:NumberOfPatents>
  <!--Cause of Action, Number-California Complaint [Member]-->
  <aqst:NumberOfCauses id="Fact_73444ee11358451cb976232824611cfa" contextRef="c20200101to20200930_LitigationCaseAxis_CaliforniaComplaintMember" unitRef="U016" decimals="INF">3</aqst:NumberOfCauses>
  <!--Cause of Action, Number-Humana and Centene Actions [Member]-->
  <aqst:NumberOfCauses id="Fact_81199a3a5dbc4736a729e167a2687656" contextRef="c20200101to20200930_LitigationCaseAxis_HumanaAndCenteneActionsMember" unitRef="U016" decimals="INF">5</aqst:NumberOfCauses>
  <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:footnote xlink:label="Footnote-Item-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</link:footnote>
    <link:loc xlink:href="#Fact_6702d5f39c14463e9b365e3def2afae3" xlink:label="Fact_6702d5f39c14463e9b365e3def2afae3_lbl" xlink:type="locator" />
    <link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact_6702d5f39c14463e9b365e3def2afae3_lbl" xlink:to="Footnote-Item-1" xlink:type="arc" />
    <link:loc xlink:href="#Fact_eae483f43a84443087c6891f4d9621d3" xlink:label="Fact_eae483f43a84443087c6891f4d9621d3_lbl" xlink:type="locator" />
    <link:footnoteArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact_eae483f43a84443087c6891f4d9621d3_lbl" xlink:to="Footnote-Item-1" xlink:type="arc" />
  </link:footnoteLink>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>aqst-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://aquestive.com/20200930" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:aqst="http://aquestive.com/20200930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://aquestive.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited" id="CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>010000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <!--Parent Role: Condensed Consolidated Balance Sheets (Unaudited)-->
        <link:definition>010100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" id="CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
        <link:definition>020000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" id="CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited">
        <link:definition>030000 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverview" id="CorporateOrganizationAndCompanyOverview">
        <link:definition>060100 - Disclosure - Corporate Organization and Company Overview</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/BasisOfPresentation" id="BasisOfPresentation">
        <link:definition>060200 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>060300 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RisksAndUncertainties" id="RisksAndUncertainties">
        <link:definition>060400 - Disclosure - Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNet" id="RevenuesAndTradeReceivablesNet">
        <link:definition>060500 - Disclosure - Revenues and Trade Receivables, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/MaterialAgreements" id="MaterialAgreements">
        <link:definition>060600 - Disclosure - Material Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" id="FinancialInstrumentsFairValueMeasurements">
        <link:definition>060700 - Disclosure - Financial Instruments - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/InventoriesNet" id="InventoriesNet">
        <link:definition>060800 - Disclosure - Inventories, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>060900 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligations" id="RightofuseAssetsAndLeaseObligations">
        <link:definition>061000 - Disclosure - Right-of-Use Assets and Lease Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets" id="IntangibleAssetsNetAndOtherAssets">
        <link:definition>061100 - Disclosure - Intangible Assets, Net and Other Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpenses" id="AccountsPayableAndAccruedExpenses">
        <link:definition>061200 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable" id="SeniorSecuredNotesAndLoansPayable">
        <link:definition>061300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders" id="WarrantsIssuedTo125SeniorSecuredNoteholders">
        <link:definition>061400 - Disclosure - Warrants Issued to 12.5% Senior Secured Noteholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/NetLossPerShare" id="NetLossPerShare">
        <link:definition>061500 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SharebasedCompensation" id="SharebasedCompensation">
        <link:definition>061600 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061700 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/Contingencies" id="Contingencies">
        <link:definition>061800 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>061900 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/BasisOfPresentationPolicies" id="BasisOfPresentationPolicies">
        <!--Parent Role: Basis of Presentation-->
        <link:definition>070200 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>070300 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies" id="RevenuesAndTradeReceivablesNetPolicies">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>070500 - Disclosure - Revenues and Trade Receivables, Net (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables" id="RevenuesAndTradeReceivablesNetTables">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>080500 - Disclosure - Revenues and Trade Receivables, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/InventoriesNetTables" id="InventoriesNetTables">
        <!--Parent Role: Inventories, Net-->
        <link:definition>080800 - Disclosure - Inventories, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <!--Parent Role: Property and Equipment, Net-->
        <link:definition>080900 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables" id="RightofuseAssetsAndLeaseObligationsTables">
        <!--Parent Role: Right-of-Use Assets and Lease Obligations-->
        <link:definition>081000 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables" id="IntangibleAssetsNetAndOtherAssetsTables">
        <!--Parent Role: Intangible Assets, Net and Other Assets-->
        <link:definition>081100 - Disclosure - Intangible Assets, Net and Other Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables" id="AccountsPayableAndAccruedExpensesTables">
        <!--Parent Role: Accounts Payable and Accrued Expenses-->
        <link:definition>081200 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables" id="SeniorSecuredNotesAndLoansPayableTables">
        <!--Parent Role: 12.5% Senior Secured Notes and Loans Payable-->
        <link:definition>081300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
        <!--Parent Role: Net Loss Per Share-->
        <link:definition>081500 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SharebasedCompensationTables" id="SharebasedCompensationTables">
        <!--Parent Role: Share-Based Compensation-->
        <link:definition>081600 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails" id="CorporateOrganizationAndCompanyOverviewDetails">
        <!--Parent Role: Corporate Organization and Company Overview-->
        <link:definition>090100 - Disclosure - Corporate Organization and Company Overview (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090300 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RisksAndUncertaintiesDetails" id="RisksAndUncertaintiesDetails">
        <!--Parent Role: Risks and Uncertainties-->
        <link:definition>090400 - Disclosure - Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails" id="RevenuesAndTradeReceivablesNetRevenueDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090500 - Disclosure - Revenues and Trade Receivables, Net, Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails" id="RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090502 - Disclosure - Revenues and Trade Receivables, Net, Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" id="RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090504 - Disclosure - Revenues and Trade Receivables, Net, Trade and other receivables, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" id="RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090506 - Disclosure - Revenues and Trade Receivables, Net, Changes in Allowance for Bad Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" id="RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090508 - Disclosure - Revenues and Trade Receivables, Net, Summary of Activity with Sales Related Allowances and Accruals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails" id="RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails">
        <!--Parent Role: Revenues and Trade Receivables, Net-->
        <link:definition>090510 - Disclosure - Revenues and Trade Receivables, Net, Concentration of Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails" id="MaterialAgreementsAgreementWithIndiviorDetails">
        <!--Parent Role: Material Agreements-->
        <link:definition>090600 - Disclosure - Material Agreements, Agreement with Indivior (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails" id="MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails">
        <!--Parent Role: Material Agreements-->
        <link:definition>090602 - Disclosure - Material Agreements, License Agreement with Sunovion Pharmaceuticals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails" id="MaterialAgreementsAgreementToTerminateClaWithKempharmDetails">
        <!--Parent Role: Material Agreements-->
        <link:definition>090604 - Disclosure - Material Agreements, Agreement to Terminate CLA with KemPharm (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" id="FinancialInstrumentsFairValueMeasurementsDetails">
        <!--Parent Role: Financial Instruments - Fair Value Measurements-->
        <link:definition>090700 - Disclosure - Financial Instruments - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/InventoriesNetDetails" id="InventoriesNetDetails">
        <!--Parent Role: Inventories, Net-->
        <link:definition>090800 - Disclosure - Inventories, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
        <!--Parent Role: Property and Equipment, Net-->
        <link:definition>090900 - Disclosure - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails" id="RightofuseAssetsAndLeaseObligationsDetails">
        <!--Parent Role: Right-of-Use Assets and Lease Obligations-->
        <link:definition>091000 - Disclosure - Right-of-Use Assets and Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" id="RightofuseAssetsAndLeaseObligationsDetailsCalc2">
        <!--Parent Role: Right-of-Use Assets and Lease Obligations (Details)-->
        <link:definition>091002 - Disclosure - Right-of-Use Assets and Lease Obligations (Details) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails" id="IntangibleAssetsNetAndOtherAssetsDetails">
        <!--Parent Role: Intangible Assets, Net and Other Assets-->
        <link:definition>091100 - Disclosure - Intangible Assets, Net and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails" id="AccountsPayableAndAccruedExpensesDetails">
        <!--Parent Role: Accounts Payable and Accrued Expenses-->
        <link:definition>091200 - Disclosure - Accounts Payable and Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" id="SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails">
        <!--Parent Role: 12.5% Senior Secured Notes and Loans Payable-->
        <link:definition>091300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable, 12.5% Senior Secured Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails" id="SeniorSecuredNotesAndLoansPayablePerceptiveDetails">
        <!--Parent Role: 12.5% Senior Secured Notes and Loans Payable-->
        <link:definition>091302 - Disclosure - 12.5% Senior Secured Notes and Loans Payable, Perceptive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails" id="WarrantsIssuedTo125SeniorSecuredNoteholdersDetails">
        <!--Parent Role: Warrants Issued to 12.5% Senior Secured Noteholders-->
        <link:definition>091400 - Disclosure - Warrants Issued to 12.5% Senior Secured Noteholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/NetLossPerShareDetails" id="NetLossPerShareDetails">
        <!--Parent Role: Net Loss Per Share-->
        <link:definition>091500 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SharebasedCompensationDetails" id="SharebasedCompensationDetails">
        <!--Parent Role: Share-Based Compensation-->
        <link:definition>091600 - Disclosure - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091700 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/ContingenciesDetails" id="ContingenciesDetails">
        <!--Parent Role: Contingencies-->
        <link:definition>091800 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://aquestive.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
        <!--Parent Role: Subsequent Events-->
        <link:definition>091900 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xs:element name="RevenuesAndTradeReceivablesNetAbstract" id="aqst_RevenuesAndTradeReceivablesNetAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RevenuesAndTradeReceivablesNetTextBlock" id="aqst_RevenuesAndTradeReceivablesNetTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccountsReceivableAllowancesCreditsAndPayments" id="aqst_AccountsReceivableAllowancesCreditsAndPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AccountsReceivableAllowancesAndAccruals" id="aqst_AccountsReceivableAllowancesAndAccruals" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccountsReceivableAllowancesProvisionRelatedToSales" id="aqst_AccountsReceivableAllowancesProvisionRelatedToSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" id="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="SalesRelatedAllowancesAndAccrualsTableTextBlock" id="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ManufactureAndSupplyRevenueMember" id="aqst_ManufactureAndSupplyRevenueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CoDevelopmentAndResearchFeesMember" id="aqst_CoDevelopmentAndResearchFeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProprietaryProductSalesMember" id="aqst_ProprietaryProductSalesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LicenseAndRoyaltyRevenueMember" id="aqst_LicenseAndRoyaltyRevenueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" id="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="InvoicesPayableTerm" id="aqst_InvoicesPayableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsDisclosureTextBlock" id="aqst_WarrantsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TradeAndOtherReceivablesNet" id="aqst_TradeAndOtherReceivablesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="GuaranteedRoyaltyRevenue" id="aqst_GuaranteedRoyaltyRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="MaximumAmountOfUpfrontPaymentReceivable" id="aqst_MaximumAmountOfUpfrontPaymentReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="LicenseAgreementWithSunovionPharmaceuticalsIncMember" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MaximumAmountOfPaymentsReceivableForMilestones" id="aqst_MaximumAmountOfPaymentsReceivableForMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AgreementsAbstract" id="aqst_AgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoticePeriodForNotToRenewAgreement" id="aqst_NoticePeriodForNotToRenewAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" id="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SeniorSecuredNotesAbstract" id="aqst_SeniorSecuredNotesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FirstAdditionalOfferingMember" id="aqst_FirstAdditionalOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SecondAdditionalOfferingMember" id="aqst_SecondAdditionalOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DebtInstrumentAdditionalBorrowingCapacity" id="aqst_DebtInstrumentAdditionalBorrowingCapacity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="FiniteLivedIntangibleAssetsNetAndOtherAssets" id="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CustomerOneMember" id="aqst_CustomerOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommercialExploitationAgreementWithIndiviorMember" id="aqst_CommercialExploitationAgreementWithIndiviorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommercialExploitationAgreementWithSunovionMember" id="aqst_CommercialExploitationAgreementWithSunovionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CustomerConcentrationAbstract" id="aqst_CustomerConcentrationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfCustomersExceedingTenPercentThresholds" id="aqst_NumberOfCustomersExceedingTenPercentThresholds" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsIssuedInConnectionWithLongTermDebt" id="aqst_WarrantsIssuedInConnectionWithLongTermDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" id="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" id="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfAnnualRoyaltyPaymentsReceivable" id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CumulativeRoyaltyReceivable" id="aqst_CumulativeRoyaltyReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="MinimumAnnualRoyaltyReceivable" id="aqst_MinimumAnnualRoyaltyReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="WarrantsLiabilityAbstract" id="aqst_WarrantsLiabilityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesWarrantExercise" id="aqst_StockIssuedDuringPeriodSharesWarrantExercise" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightWarrantsExercised" id="aqst_ClassOfWarrantOrRightWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ComputerNetworkEquipmentAndSoftwareMember" id="aqst_ComputerNetworkEquipmentAndSoftwareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MaterialAgreementsAbstract" id="aqst_MaterialAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalAgreementWithIndiviorMember" id="aqst_SupplementalAgreementWithIndiviorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalAgreementAbstract" id="aqst_SupplementalAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContingentPaymentsReceivableInTheFuture" id="aqst_ContingentPaymentsReceivableInTheFuture" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ReceivableProcessPatentRights" id="aqst_ReceivableProcessPatentRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AggregateReceivable" id="aqst_AggregateReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CumulativePaymentsReceived" id="aqst_CumulativePaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CommercialExploitationAgreementAbstract" id="aqst_CommercialExploitationAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AutomaticRenewalPeriodOfAgreement" id="aqst_AutomaticRenewalPeriodOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LicenseAgreementTerm" id="aqst_LicenseAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="UpfrontPaymentReceived" id="aqst_UpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CumulativeMilestonePaymentsReceivable" id="aqst_CumulativeMilestonePaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PaymentReceivableCollaborativeAgreement" id="aqst_PaymentReceivableCollaborativeAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AgreementToTerminateCLAWithKemPharmAbstract" id="aqst_AgreementToTerminateCLAWithKemPharmAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AgreementToTerminateCLAWithKemPharmMember" id="aqst_AgreementToTerminateCLAWithKemPharmMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageShareOfMilestonePayment" id="aqst_PercentageShareOfMilestonePayment" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" id="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PerceptiveCreditOpportunitiesFundLPMember" id="aqst_PerceptiveCreditOpportunitiesFundLPMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CompanyOverviewAbstract" id="aqst_CompanyOverviewAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfProprietaryProductsInternallyDeveloped" id="aqst_NumberOfProprietaryProductsInternallyDeveloped" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EquityOfferingOfCommonStockAbstract" id="aqst_EquityOfferingOfCommonStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BasisOfPresentationAbstract" id="aqst_BasisOfPresentationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DebtInstrumentNumberOfTranches" id="aqst_DebtInstrumentNumberOfTranches" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PortionOfProceedsAmountToMonetizeAssetsConditionOne" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" id="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" id="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ElectiveRedemptionPercentageOfDebt" id="aqst_ElectiveRedemptionPercentageOfDebt" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" id="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" id="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" id="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfOperatingLeases" id="aqst_NumberOfOperatingLeases" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmployeeStockPurchasePlanAbstract" id="aqst_EmployeeStockPurchasePlanAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" id="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ShareBasedCompensationEquityAwardsAbstract" id="aqst_ShareBasedCompensationEquityAwardsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlanMember" id="aqst_EmployeeStockPurchasePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManufacturingAndSupplyMember" id="aqst_ManufacturingAndSupplyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedPaymentArrangementNumberOfOfferingPeriods" id="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="WorkingCapitalDeficit" id="aqst_WorkingCapitalDeficit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AdditionalFundAmount" id="aqst_AdditionalFundAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" id="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UnvestedRestrictedStockUnitsMember" id="aqst_UnvestedRestrictedStockUnitsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DilutiveInstrumentsAbstract" id="aqst_DilutiveInstrumentsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InventoryPackingMaterialGross" id="aqst_InventoryPackingMaterialGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NumberOfStatesInTheAntitrustLitigation" id="aqst_NumberOfStatesInTheAntitrustLitigation" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfPatents" id="aqst_NumberOfPatents" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="HumanaAndCenteneActionsMember" id="aqst_HumanaAndCenteneActionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CaliforniaComplaintMember" id="aqst_CaliforniaComplaintMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfCauses" id="aqst_NumberOfCauses" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>aqst-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SubsequentEventsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpensesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssetsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetailsCalc2" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited" />
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="InventoryNet" xlink:title="calculation: AssetsCurrent to InventoryNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="TradeAndOtherReceivablesNet" xlink:title="calculation: AssetsCurrent to TradeAndOtherReceivablesNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="calculation: Assets to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableAndAccruedLiabilitiesCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="ContractWithCustomerLiabilityCurrent" xlink:title="ContractWithCustomerLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="ContractWithCustomerLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to ContractWithCustomerLiabilityCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LoansPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to LoansPayableCurrent" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="ContractWithCustomerLiabilityNoncurrent" xlink:title="ContractWithCustomerLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="ContractWithCustomerLiabilityNoncurrent" xlink:title="calculation: Liabilities to ContractWithCustomerLiabilityNoncurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="LongTermLoansPayable" xlink:title="LongTermLoansPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermLoansPayable" xlink:title="calculation: Liabilities to LongTermLoansPayable" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="AssetRetirementObligationsNoncurrent" xlink:title="AssetRetirementObligationsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="AssetRetirementObligationsNoncurrent" xlink:title="calculation: Liabilities to AssetRetirementObligationsNoncurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquity" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquity" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="calculation: OperatingIncomeLoss to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="CostOfGoodsAndServicesSold" xlink:title="CostOfGoodsAndServicesSold" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="CostOfGoodsAndServicesSold" xlink:title="calculation: CostsAndExpenses to CostOfGoodsAndServicesSold" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: CostsAndExpenses to SellingGeneralAndAdministrativeExpense" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="ResearchAndDevelopmentExpense" xlink:title="calculation: CostsAndExpenses to ResearchAndDevelopmentExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="CostsAndExpenses" xlink:title="calculation: OperatingIncomeLoss to CostsAndExpenses" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InterestExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InterestExpense" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="InvestmentIncomeInterest" xlink:title="InvestmentIncomeInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InvestmentIncomeInterest" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InvestmentIncomeInterest" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to GainsLossesOnExtinguishmentOfDebt" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: NetIncomeLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="NetIncomeLoss" xlink:title="calculation: ComprehensiveIncomeNetOfTax to NetIncomeLoss" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NetIncomeLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="OtherNoncashIncomeExpense" xlink:title="OtherNoncashIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OtherNoncashIncomeExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OtherNoncashIncomeExpense" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to AmortizationOfFinancingCostsAndDiscounts" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="8.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDeferredRevenue" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDeferredRevenue" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsAndOtherReceivables" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="IncreaseDecreaseInInventories" xlink:title="IncreaseDecreaseInInventories" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInInventories" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInInventories" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainsLossesOnExtinguishmentOfDebt" order="3.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:title="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfDebt" order="12.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfDebt" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="PaymentsOfFinancingCosts" xlink:title="PaymentsOfFinancingCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfFinancingCosts" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfFinancingCosts" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="PaymentsOfDebtExtinguishmentCosts" xlink:title="PaymentsOfDebtExtinguishmentCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDebtExtinguishmentCosts" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDebtExtinguishmentCosts" order="8.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:label="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TradeAndOtherReceivablesNet" xlink:to="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="calculation: TradeAndOtherReceivablesNet to AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TradeAndOtherReceivablesNet" xlink:to="AllowanceForDoubtfulAccountsReceivable" xlink:title="calculation: TradeAndOtherReceivablesNet to AllowanceForDoubtfulAccountsReceivable" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="OtherReceivablesGrossCurrent" xlink:title="OtherReceivablesGrossCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TradeAndOtherReceivablesNet" xlink:to="OtherReceivablesGrossCurrent" xlink:title="calculation: TradeAndOtherReceivablesNet to OtherReceivablesGrossCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="AccountsReceivableGross" xlink:title="AccountsReceivableGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TradeAndOtherReceivablesNet" xlink:to="AccountsReceivableGross" xlink:title="calculation: TradeAndOtherReceivablesNet to AccountsReceivableGross" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InventoryPackingMaterialGross" xlink:label="InventoryPackingMaterialGross" xlink:title="InventoryPackingMaterialGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="InventoryPackingMaterialGross" xlink:title="calculation: InventoryNet to InventoryPackingMaterialGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="InventoryRawMaterials" xlink:title="InventoryRawMaterials" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="InventoryRawMaterials" xlink:title="calculation: InventoryNet to InventoryRawMaterials" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="InventoryFinishedGoods" xlink:title="InventoryFinishedGoods" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="InventoryFinishedGoods" xlink:title="calculation: InventoryNet to InventoryFinishedGoods" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="calculation: FiniteLivedIntangibleAssetsNet to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="FiniteLivedIntangibleAssetsGross" xlink:title="calculation: FiniteLivedIntangibleAssetsNet to FiniteLivedIntangibleAssetsGross" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="FiniteLivedIntangibleAssetsNet" xlink:title="calculation: FiniteLivedIntangibleAssetsNetAndOtherAssets to FiniteLivedIntangibleAssetsNet" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: FiniteLivedIntangibleAssetsNetAndOtherAssets to OtherAssetsNoncurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="CumulativeRoyaltyReceivable" xlink:title="calculation: FiniteLivedIntangibleAssetsNetAndOtherAssets to CumulativeRoyaltyReceivable" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccountsPayableAndAccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="AccruedMarketingCostsCurrent" xlink:title="AccruedMarketingCostsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="AccruedMarketingCostsCurrent" xlink:title="calculation: AccountsPayableAndAccruedLiabilitiesCurrent to AccruedMarketingCostsCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccountsPayableAndAccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: AccountsPayableAndAccruedLiabilitiesCurrent to AccountsPayableCurrent" order="8.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="5.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfUpfrontPaymentReceivable" xlink:label="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="MaximumAmountOfUpfrontPaymentReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="calculation: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to MaximumAmountOfUpfrontPaymentReceivable" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForMilestones" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="calculation: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to MaximumAmountOfPaymentsReceivableForMilestones" order="1.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>aqst-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SubsequentEventsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#ContingenciesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#IncomeTaxesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensationDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensationDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShareDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#WarrantsIssuedTo125SeniorSecuredNoteholdersDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayablePerceptiveDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpensesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssetsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetailsCalc2" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#FinancialInstrumentsFairValueMeasurementsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsAgreementToTerminateClaWithKempharmDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsAgreementWithIndiviorDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetRevenueDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RisksAndUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RisksAndUncertaintiesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#CorporateOrganizationAndCompanyOverviewDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensationTables" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShareTables" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayableTables" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpensesTables" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssetsTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsTables" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/BasisOfPresentationPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#BasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEvents" xlink:type="simple" xlink:href="aqst-20200930.xsd#SubsequentEvents" />
  <link:roleRef roleURI="http://aquestive.com/role/Contingencies" xlink:type="simple" xlink:href="aqst-20200930.xsd#Contingencies" />
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aqst-20200930.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensation" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShare" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShare" />
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders" xlink:type="simple" xlink:href="aqst-20200930.xsd#WarrantsIssuedTo125SeniorSecuredNoteholders" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayable" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpenses" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpenses" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssets" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligations" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligations" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNet" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNet" />
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="simple" xlink:href="aqst-20200930.xsd#FinancialInstrumentsFairValueMeasurements" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreements" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreements" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNet" />
  <link:roleRef roleURI="http://aquestive.com/role/RisksAndUncertainties" xlink:type="simple" xlink:href="aqst-20200930.xsd#RisksAndUncertainties" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/BasisOfPresentation" xlink:type="simple" xlink:href="aqst-20200930.xsd#BasisOfPresentation" />
  <link:roleRef roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverview" xlink:type="simple" xlink:href="aqst-20200930.xsd#CorporateOrganizationAndCompanyOverview" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="aqst-20200930.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesShareBasedCompensation" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="CumulativeEffectPeriodOfAdoptionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="definition: StatementTable to CumulativeEffectPeriodOfAdoptionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="CumulativeEffectPeriodOfAdoptionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CumulativeEffectPeriodOfAdoptionAxis" xlink:to="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="definition: CumulativeEffectPeriodOfAdoptionAxis to CumulativeEffectPeriodOfAdoptionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="CumulativeEffectPeriodOfAdoptionDomain_2" xlink:title="CumulativeEffectPeriodOfAdoptionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CumulativeEffectPeriodOfAdoptionAxis" xlink:to="CumulativeEffectPeriodOfAdoptionDomain_2" xlink:title="definition: CumulativeEffectPeriodOfAdoptionAxis to CumulativeEffectPeriodOfAdoptionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:title="CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CumulativeEffectPeriodOfAdoptionDomain" xlink:to="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:title="definition: CumulativeEffectPeriodOfAdoptionDomain to CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CorporateOrganizationAndCompanyOverview" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/BasisOfPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RisksAndUncertainties" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/IncomeTaxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SubsequentEvents" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/BasisOfPresentationPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to OperatingLeaseRightOfUseAsset" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to OperatingLeaseLiability" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="DebtInstrumentInterestRateIncreaseDecrease" xlink:title="DebtInstrumentInterestRateIncreaseDecrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="DebtInstrumentInterestRateIncreaseDecrease" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to DebtInstrumentInterestRateIncreaseDecrease" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to AdjustmentsForNewAccountingPronouncementsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RisksAndUncertaintiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract" xlink:label="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:title="DebtInstrumentInterestRateStatedPercentageAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:title="definition: ConcentrationRiskLineItems to DebtInstrumentInterestRateStatedPercentageAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: ConcentrationRiskLineItems to DebtInstrumentInterestRateStatedPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: ConcentrationRiskLineItems to RetainedEarningsAccumulatedDeficit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdditionalFundAmount" xlink:label="AdditionalFundAmount" xlink:title="AdditionalFundAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="AdditionalFundAmount" xlink:title="definition: ConcentrationRiskLineItems to AdditionalFundAmount" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="definition: ConcentrationRiskLineItems to ProceedsFromIssuanceOfDebt" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="definition: ConcentrationRiskLineItems to ProceedsFromIssuanceOfCommonStock" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="definition: ConcentrationRiskLineItems to StockIssuedDuringPeriodSharesNewIssues" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:title="definition: ConcentrationRiskLineItems to AdjustmentsToAdditionalPaidInCapitalWarrantExercise" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ConcentrationRiskLineItems" xlink:to="ConcentrationRiskTable" xlink:title="definition: ConcentrationRiskLineItems to ConcentrationRiskTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConcentrationRiskTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: ConcentrationRiskTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="definition: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="ContractWithCustomerAssetAndLiabilityAbstract" xlink:title="ContractWithCustomerAssetAndLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerAssetAndLiabilityAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerAssetAndLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InvoicesPayableTerm" xlink:label="InvoicesPayableTerm" xlink:title="InvoicesPayableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="InvoicesPayableTerm" xlink:title="definition: DisaggregationOfRevenueLineItems to InvoicesPayableTerm" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerAssetNet" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerAssetNet" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerLiability" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerLiability" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufactureAndSupplyRevenueMember" xlink:label="ManufactureAndSupplyRevenueMember" xlink:title="ManufactureAndSupplyRevenueMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="ManufactureAndSupplyRevenueMember" xlink:title="definition: ProductsAndServicesDomain to ManufactureAndSupplyRevenueMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAndRoyaltyRevenueMember" xlink:label="LicenseAndRoyaltyRevenueMember" xlink:title="LicenseAndRoyaltyRevenueMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="LicenseAndRoyaltyRevenueMember" xlink:title="definition: ProductsAndServicesDomain to LicenseAndRoyaltyRevenueMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CoDevelopmentAndResearchFeesMember" xlink:label="CoDevelopmentAndResearchFeesMember" xlink:title="CoDevelopmentAndResearchFeesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="CoDevelopmentAndResearchFeesMember" xlink:title="definition: ProductsAndServicesDomain to CoDevelopmentAndResearchFeesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ProprietaryProductSalesMember" xlink:label="ProprietaryProductSalesMember" xlink:title="ProprietaryProductSalesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="ProprietaryProductSalesMember" xlink:title="definition: ProductsAndServicesDomain to ProprietaryProductSalesMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="definition: DisaggregationOfRevenueTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:label="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:title="GeographicAreasRevenuesFromExternalCustomersAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to GeographicAreasRevenuesFromExternalCustomersAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="StatementGeographicalAxis" xlink:title="StatementGeographicalAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementGeographicalAxis" xlink:title="definition: DisaggregationOfRevenueTable to StatementGeographicalAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="SegmentGeographicalDomain" xlink:title="SegmentGeographicalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementGeographicalAxis" xlink:to="SegmentGeographicalDomain" xlink:title="definition: StatementGeographicalAxis to SegmentGeographicalDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="SegmentGeographicalDomain_2" xlink:title="SegmentGeographicalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementGeographicalAxis" xlink:to="SegmentGeographicalDomain_2" xlink:title="definition: StatementGeographicalAxis to SegmentGeographicalDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="US" xlink:title="US" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentGeographicalDomain" xlink:to="US" xlink:title="definition: SegmentGeographicalDomain to US" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="NonUsMember" xlink:title="NonUsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentGeographicalDomain" xlink:to="NonUsMember" xlink:title="definition: SegmentGeographicalDomain to NonUsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="AccountsReceivableNetAbstract" xlink:title="AccountsReceivableNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AccountsReceivableNetAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to AccountsReceivableNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="AccountsReceivableGross" xlink:title="AccountsReceivableGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AccountsReceivableGross" xlink:title="definition: DisaggregationOfRevenueLineItems to AccountsReceivableGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="OtherReceivablesGrossCurrent" xlink:title="OtherReceivablesGrossCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="OtherReceivablesGrossCurrent" xlink:title="definition: DisaggregationOfRevenueLineItems to OtherReceivablesGrossCurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AllowanceForDoubtfulAccountsReceivable" xlink:title="definition: DisaggregationOfRevenueLineItems to AllowanceForDoubtfulAccountsReceivable" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:label="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="definition: DisaggregationOfRevenueLineItems to AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="TradeAndOtherReceivablesNet" xlink:title="definition: DisaggregationOfRevenueLineItems to TradeAndOtherReceivablesNet" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_GuaranteedRoyaltyRevenue" xlink:label="GuaranteedRoyaltyRevenue" xlink:title="GuaranteedRoyaltyRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="GuaranteedRoyaltyRevenue" xlink:title="definition: DisaggregationOfRevenueLineItems to GuaranteedRoyaltyRevenue" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="definition: DisaggregationOfRevenueTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerConcentrationAbstract" xlink:label="CustomerConcentrationAbstract" xlink:title="CustomerConcentrationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="CustomerConcentrationAbstract" xlink:title="definition: ConcentrationRiskLineItems to CustomerConcentrationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="ConcentrationRiskPercentage1" xlink:title="definition: ConcentrationRiskLineItems to ConcentrationRiskPercentage1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCustomersExceedingTenPercentThresholds" xlink:label="NumberOfCustomersExceedingTenPercentThresholds" xlink:title="NumberOfCustomersExceedingTenPercentThresholds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskLineItems" xlink:to="NumberOfCustomersExceedingTenPercentThresholds" xlink:title="definition: ConcentrationRiskLineItems to NumberOfCustomersExceedingTenPercentThresholds" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ConcentrationRiskLineItems" xlink:to="ConcentrationRiskTable" xlink:title="definition: ConcentrationRiskLineItems to ConcentrationRiskTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConcentrationRiskTable" xlink:to="ConcentrationRiskByBenchmarkAxis" xlink:title="definition: ConcentrationRiskTable to ConcentrationRiskByBenchmarkAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConcentrationRiskByBenchmarkAxis" xlink:to="ConcentrationRiskBenchmarkDomain" xlink:title="definition: ConcentrationRiskByBenchmarkAxis to ConcentrationRiskBenchmarkDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain_2" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConcentrationRiskByBenchmarkAxis" xlink:to="ConcentrationRiskBenchmarkDomain_2" xlink:title="definition: ConcentrationRiskByBenchmarkAxis to ConcentrationRiskBenchmarkDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="SalesRevenueNetMember" xlink:title="SalesRevenueNetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskBenchmarkDomain" xlink:to="SalesRevenueNetMember" xlink:title="definition: ConcentrationRiskBenchmarkDomain to SalesRevenueNetMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="AccountsReceivableMember" xlink:title="AccountsReceivableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConcentrationRiskBenchmarkDomain" xlink:to="AccountsReceivableMember" xlink:title="definition: ConcentrationRiskBenchmarkDomain to AccountsReceivableMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConcentrationRiskTable" xlink:to="MajorCustomersAxis" xlink:title="definition: ConcentrationRiskTable to MajorCustomersAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MajorCustomersAxis" xlink:to="NameOfMajorCustomerDomain" xlink:title="definition: MajorCustomersAxis to NameOfMajorCustomerDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain_2" xlink:title="NameOfMajorCustomerDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MajorCustomersAxis" xlink:to="NameOfMajorCustomerDomain_2" xlink:title="definition: MajorCustomersAxis to NameOfMajorCustomerDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:label="CommercialExploitationAgreementWithIndiviorMember" xlink:title="CommercialExploitationAgreementWithIndiviorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NameOfMajorCustomerDomain" xlink:to="CommercialExploitationAgreementWithIndiviorMember" xlink:title="definition: NameOfMajorCustomerDomain to CommercialExploitationAgreementWithIndiviorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithSunovionMember" xlink:label="CommercialExploitationAgreementWithSunovionMember" xlink:title="CommercialExploitationAgreementWithSunovionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NameOfMajorCustomerDomain" xlink:to="CommercialExploitationAgreementWithSunovionMember" xlink:title="definition: NameOfMajorCustomerDomain to CommercialExploitationAgreementWithSunovionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerOneMember" xlink:label="CustomerOneMember" xlink:title="CustomerOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NameOfMajorCustomerDomain" xlink:to="CustomerOneMember" xlink:title="definition: NameOfMajorCustomerDomain to CustomerOneMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementAbstract" xlink:label="CommercialExploitationAgreementAbstract" xlink:title="CommercialExploitationAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CommercialExploitationAgreementAbstract" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CommercialExploitationAgreementAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementAbstract" xlink:label="SupplementalAgreementAbstract" xlink:title="SupplementalAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SupplementalAgreementAbstract" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to SupplementalAgreementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativePaymentsReceived" xlink:label="CumulativePaymentsReceived" xlink:title="CumulativePaymentsReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CumulativePaymentsReceived" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CumulativePaymentsReceived" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="Revenues" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to Revenues" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ContingentPaymentsReceivableInTheFuture" xlink:label="ContingentPaymentsReceivableInTheFuture" xlink:title="ContingentPaymentsReceivableInTheFuture" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ContingentPaymentsReceivableInTheFuture" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ContingentPaymentsReceivableInTheFuture" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AggregateReceivable" xlink:label="AggregateReceivable" xlink:title="AggregateReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AggregateReceivable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to AggregateReceivable" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ReceivableProcessPatentRights" xlink:label="ReceivableProcessPatentRights" xlink:title="ReceivableProcessPatentRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ReceivableProcessPatentRights" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ReceivableProcessPatentRights" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="LicenseAgreementTerm" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to LicenseAgreementTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AutomaticRenewalPeriodOfAgreement" xlink:label="AutomaticRenewalPeriodOfAgreement" xlink:title="AutomaticRenewalPeriodOfAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AutomaticRenewalPeriodOfAgreement" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to AutomaticRenewalPeriodOfAgreement" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NoticePeriodForNotToRenewAgreement" xlink:label="NoticePeriodForNotToRenewAgreement" xlink:title="NoticePeriodForNotToRenewAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="NoticePeriodForNotToRenewAgreement" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to NoticePeriodForNotToRenewAgreement" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:label="CommercialExploitationAgreementWithIndiviorMember" xlink:title="CommercialExploitationAgreementWithIndiviorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CommercialExploitationAgreementWithIndiviorMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to CommercialExploitationAgreementWithIndiviorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementWithIndiviorMember" xlink:label="SupplementalAgreementWithIndiviorMember" xlink:title="SupplementalAgreementWithIndiviorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="SupplementalAgreementWithIndiviorMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to SupplementalAgreementWithIndiviorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PaymentReceivableCollaborativeAgreement" xlink:label="PaymentReceivableCollaborativeAgreement" xlink:title="PaymentReceivableCollaborativeAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PaymentReceivableCollaborativeAgreement" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to PaymentReceivableCollaborativeAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativePaymentsReceived" xlink:label="CumulativePaymentsReceived" xlink:title="CumulativePaymentsReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CumulativePaymentsReceived" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CumulativePaymentsReceived" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UpfrontPaymentReceived" xlink:label="UpfrontPaymentReceived" xlink:title="UpfrontPaymentReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="UpfrontPaymentReceived" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to UpfrontPaymentReceived" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeMilestonePaymentsReceivable" xlink:label="CumulativeMilestonePaymentsReceivable" xlink:title="CumulativeMilestonePaymentsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CumulativeMilestonePaymentsReceivable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CumulativeMilestonePaymentsReceivable" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="Revenues" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to Revenues" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CumulativeRoyaltyReceivable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CumulativeRoyaltyReceivable" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="TradeAndOtherReceivablesNet" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to TradeAndOtherReceivablesNet" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to ProductOrServiceAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="RoyaltyMember" xlink:title="RoyaltyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="RoyaltyMember" xlink:title="definition: ProductsAndServicesDomain to RoyaltyMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmAbstract" xlink:label="AgreementToTerminateCLAWithKemPharmAbstract" xlink:title="AgreementToTerminateCLAWithKemPharmAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AgreementToTerminateCLAWithKemPharmAbstract" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to AgreementToTerminateCLAWithKemPharmAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="Revenues" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to Revenues" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PercentageShareOfMilestonePayment" xlink:label="PercentageShareOfMilestonePayment" xlink:title="PercentageShareOfMilestonePayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="PercentageShareOfMilestonePayment" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to PercentageShareOfMilestonePayment" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmMember" xlink:label="AgreementToTerminateCLAWithKemPharmMember" xlink:title="AgreementToTerminateCLAWithKemPharmMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="AgreementToTerminateCLAWithKemPharmMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to AgreementToTerminateCLAWithKemPharmMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsLiabilityAbstract" xlink:label="WarrantsLiabilityAbstract" xlink:title="WarrantsLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsLiabilityAbstract" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: ClassOfWarrantOrRightLineItems to DebtInstrumentInterestRateStatedPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightTable" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: ClassOfWarrantOrRightTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="definition: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNetDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:title="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="Depreciation" xlink:title="definition: PropertyPlantAndEquipmentLineItems to Depreciation" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGross" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNet" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="MachineryAndEquipmentMember" xlink:title="MachineryAndEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="MachineryAndEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to MachineryAndEquipmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:label="ComputerNetworkEquipmentAndSoftwareMember" xlink:title="ComputerNetworkEquipmentAndSoftwareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerNetworkEquipmentAndSoftwareMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerNetworkEquipmentAndSoftwareMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ConstructionInProgressMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ConstructionInProgressMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="LesseeOperatingLeaseRemainingLeaseTerm" xlink:title="LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseRemainingLeaseTerm" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseRemainingLeaseTerm" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageDiscountRatePercent" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseRightOfUseAsset" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseCost" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="VariableLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to VariableLeaseCost" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasePayments" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasePayments" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: LesseeLeaseDescriptionTable to AdjustmentsForNewAccountingPronouncementsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:label="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:title="NumberOfAnnualRoyaltyPaymentsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to NumberOfAnnualRoyaltyPaymentsReceivable" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MinimumAnnualRoyaltyReceivable" xlink:label="MinimumAnnualRoyaltyReceivable" xlink:title="MinimumAnnualRoyaltyReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="MinimumAnnualRoyaltyReceivable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to MinimumAnnualRoyaltyReceivable" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsGross" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsGross" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNet" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNet" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="CumulativeRoyaltyReceivable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to CumulativeRoyaltyReceivable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="OtherAssetsNoncurrent" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to OtherAssetsNoncurrent" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="TechnologyBasedIntangibleAssetsMember" xlink:title="TechnologyBasedIntangibleAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TechnologyBasedIntangibleAssetsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TechnologyBasedIntangibleAssetsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="PatentsMember" xlink:title="PatentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="PatentsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to PatentsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to TypeOfArrangementAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SeniorSecuredNotesAbstract" xlink:label="SeniorSecuredNotesAbstract" xlink:title="SeniorSecuredNotesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="SeniorSecuredNotesAbstract" xlink:title="definition: DebtInstrumentLineItems to SeniorSecuredNotesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: DebtInstrumentLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: DebtInstrumentLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:label="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:title="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:title="definition: DebtInstrumentLineItems to NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentAdditionalBorrowingCapacity" xlink:label="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="DebtInstrumentAdditionalBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAdditionalBorrowingCapacity" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentNumberOfTranches" xlink:label="DebtInstrumentNumberOfTranches" xlink:title="DebtInstrumentNumberOfTranches" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentNumberOfTranches" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentNumberOfTranches" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="RepaymentsOfLongTermDebt" xlink:title="RepaymentsOfLongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="RepaymentsOfLongTermDebt" xlink:title="definition: DebtInstrumentLineItems to RepaymentsOfLongTermDebt" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="DebtInstrumentFrequencyOfPeriodicPayment" xlink:title="DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFrequencyOfPeriodicPayment" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFrequencyOfPeriodicPayment" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LoansPayableCurrent" xlink:title="definition: DebtInstrumentLineItems to LoansPayableCurrent" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:label="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:title="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:title="definition: DebtInstrumentLineItems to AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:label="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:title="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:title="definition: DebtInstrumentLineItems to AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="MaturitiesOfLongTermDebtAbstract" xlink:title="definition: DebtInstrumentLineItems to MaturitiesOfLongTermDebtAbstract" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ElectiveRedemptionPercentageOfDebt" xlink:label="ElectiveRedemptionPercentageOfDebt" xlink:title="ElectiveRedemptionPercentageOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ElectiveRedemptionPercentageOfDebt" xlink:title="definition: DebtInstrumentLineItems to ElectiveRedemptionPercentageOfDebt" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:label="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:title="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:title="definition: DebtInstrumentLineItems to RedemptionPercentageOfDebtUnderChangeOfControlProvisions" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:label="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:title="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:title="definition: DebtInstrumentLineItems to AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:title="definition: DebtInstrumentLineItems to PortionOfProceedsAmountToMonetizeAssetsConditionOne" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:title="definition: DebtInstrumentLineItems to PortionOfProceedsAmountToMonetizeAssetsConditionTwo" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="definition: DebtInstrumentLineItems to AmortizationOfFinancingCostsAndDiscounts" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="definition: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FirstAdditionalOfferingMember" xlink:label="FirstAdditionalOfferingMember" xlink:title="FirstAdditionalOfferingMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="FirstAdditionalOfferingMember" xlink:title="definition: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to FirstAdditionalOfferingMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SecondAdditionalOfferingMember" xlink:label="SecondAdditionalOfferingMember" xlink:title="SecondAdditionalOfferingMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="SecondAdditionalOfferingMember" xlink:title="definition: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to SecondAdditionalOfferingMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="LineOfCreditFacilityAxis" xlink:title="LineOfCreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="LineOfCreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to LineOfCreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain" xlink:title="definition: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain_2" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain_2" xlink:title="definition: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PerceptiveCreditOpportunitiesFundLPMember" xlink:label="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="PerceptiveCreditOpportunitiesFundLPMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLenderDomain" xlink:to="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="definition: LineOfCreditFacilityLenderDomain to PerceptiveCreditOpportunitiesFundLPMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="LineOfCreditMember" xlink:title="LineOfCreditMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="LineOfCreditMember" xlink:title="definition: CreditFacilityDomain to LineOfCreditMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="LineOfCreditFacilityLineItems" xlink:title="LineOfCreditFacilityLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="LineOfCreditFacilityAbstract" xlink:title="LineOfCreditFacilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLineItems" xlink:to="LineOfCreditFacilityAbstract" xlink:title="definition: LineOfCreditFacilityLineItems to LineOfCreditFacilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: LineOfCreditFacilityLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:label="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:title="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLineItems" xlink:to="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:title="definition: LineOfCreditFacilityLineItems to WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLineItems" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="definition: LineOfCreditFacilityLineItems to GainsLossesOnExtinguishmentOfDebt" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="PaymentsOfDebtExtinguishmentCosts" xlink:title="PaymentsOfDebtExtinguishmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLineItems" xlink:to="PaymentsOfDebtExtinguishmentCosts" xlink:title="definition: LineOfCreditFacilityLineItems to PaymentsOfDebtExtinguishmentCosts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="LineOfCreditFacilityTable" xlink:title="LineOfCreditFacilityTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LineOfCreditFacilityLineItems" xlink:to="LineOfCreditFacilityTable" xlink:title="definition: LineOfCreditFacilityLineItems to LineOfCreditFacilityTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="LineOfCreditFacilityAxis" xlink:title="LineOfCreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LineOfCreditFacilityTable" xlink:to="LineOfCreditFacilityAxis" xlink:title="definition: LineOfCreditFacilityTable to LineOfCreditFacilityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain" xlink:title="definition: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain_2" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain_2" xlink:title="definition: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PerceptiveCreditOpportunitiesFundLPMember" xlink:label="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="PerceptiveCreditOpportunitiesFundLPMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LineOfCreditFacilityLenderDomain" xlink:to="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="definition: LineOfCreditFacilityLenderDomain to PerceptiveCreditOpportunitiesFundLPMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LineOfCreditFacilityTable" xlink:to="CreditFacilityAxis" xlink:title="definition: LineOfCreditFacilityTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="LineOfCreditMember" xlink:title="LineOfCreditMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="LineOfCreditMember" xlink:title="definition: CreditFacilityDomain to LineOfCreditMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsLiabilityAbstract" xlink:label="WarrantsLiabilityAbstract" xlink:title="WarrantsLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsLiabilityAbstract" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: ClassOfWarrantOrRightLineItems to DebtInstrumentInterestRateStatedPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: ClassOfWarrantOrRightLineItems to DebtInstrumentMaturityDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="WarrantsNotSettleableInCashFairValueDisclosure" xlink:title="WarrantsNotSettleableInCashFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsNotSettleableInCashFairValueDisclosure" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsNotSettleableInCashFairValueDisclosure" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="StockIssuedDuringPeriodSharesWarrantExercise" xlink:title="StockIssuedDuringPeriodSharesWarrantExercise" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="StockIssuedDuringPeriodSharesWarrantExercise" xlink:title="definition: ClassOfWarrantOrRightLineItems to StockIssuedDuringPeriodSharesWarrantExercise" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ProceedsFromWarrantExercises" xlink:title="definition: ClassOfWarrantOrRightLineItems to ProceedsFromWarrantExercises" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:label="ClassOfWarrantOrRightWarrantsExercised" xlink:title="ClassOfWarrantOrRightWarrantsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightWarrantsExercised" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightWarrantsExercised" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightTable" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: ClassOfWarrantOrRightTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="definition: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ClassOfWarrantOrRightTable to StatementEquityComponentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DilutiveInstrumentsAbstract" xlink:label="DilutiveInstrumentsAbstract" xlink:title="DilutiveInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="DilutiveInstrumentsAbstract" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to DilutiveInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UnvestedRestrictedStockUnitsMember" xlink:label="UnvestedRestrictedStockUnitsMember" xlink:title="UnvestedRestrictedStockUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="UnvestedRestrictedStockUnitsMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to UnvestedRestrictedStockUnitsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationEquityAwardsAbstract" xlink:label="ShareBasedCompensationEquityAwardsAbstract" xlink:title="ShareBasedCompensationEquityAwardsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationEquityAwardsAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationEquityAwardsAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanAbstract" xlink:label="EmployeeStockPurchasePlanAbstract" xlink:title="EmployeeStockPurchasePlanAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:label="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:title="ShareBasedPaymentArrangementNumberOfOfferingPeriods" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementNumberOfOfferingPeriods" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:label="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:title="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharePrice" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" order="33.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="34.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="35.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="36.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="37.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="38.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="39.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="40.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="41.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="42.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="43.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="44.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="45.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlanMember" xlink:title="definition: PlanNameDomain to EmployeeStockPurchasePlanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufacturingAndSupplyMember" xlink:label="ManufacturingAndSupplyMember" xlink:title="ManufacturingAndSupplyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ManufacturingAndSupplyMember" xlink:title="definition: IncomeStatementLocationDomain to ManufacturingAndSupplyMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/IncomeTaxesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/ContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="LossContingencyInformationAboutLitigationMattersAbstract" xlink:title="LossContingencyInformationAboutLitigationMattersAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyInformationAboutLitigationMattersAbstract" xlink:title="definition: LossContingenciesLineItems to LossContingencyInformationAboutLitigationMattersAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNumberOfDefendants" xlink:title="definition: LossContingenciesLineItems to LossContingencyNumberOfDefendants" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber" xlink:label="LossContingencyClaimsSettledNumber" xlink:title="LossContingencyClaimsSettledNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyClaimsSettledNumber" xlink:title="definition: LossContingenciesLineItems to LossContingencyClaimsSettledNumber" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfPatents" xlink:label="NumberOfPatents" xlink:title="NumberOfPatents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="NumberOfPatents" xlink:title="definition: LossContingenciesLineItems to NumberOfPatents" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="LossContingencyPendingClaimsNumber" xlink:title="LossContingencyPendingClaimsNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyPendingClaimsNumber" xlink:title="definition: LossContingenciesLineItems to LossContingencyPendingClaimsNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="LossContingencyNewClaimsFiledNumber" xlink:title="LossContingencyNewClaimsFiledNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNewClaimsFiledNumber" xlink:title="definition: LossContingenciesLineItems to LossContingencyNewClaimsFiledNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfStatesInTheAntitrustLitigation" xlink:label="NumberOfStatesInTheAntitrustLitigation" xlink:title="NumberOfStatesInTheAntitrustLitigation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="NumberOfStatesInTheAntitrustLitigation" xlink:title="definition: LossContingenciesLineItems to NumberOfStatesInTheAntitrustLitigation" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCauses" xlink:label="NumberOfCauses" xlink:title="NumberOfCauses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="NumberOfCauses" xlink:title="definition: LossContingenciesLineItems to NumberOfCauses" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="LitigationCaseAxis" xlink:title="LitigationCaseAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="LitigationCaseAxis" xlink:title="definition: LossContingenciesTable to LitigationCaseAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="LitigationCaseTypeDomain" xlink:title="LitigationCaseTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LitigationCaseAxis" xlink:to="LitigationCaseTypeDomain" xlink:title="definition: LitigationCaseAxis to LitigationCaseTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="LitigationCaseTypeDomain_2" xlink:title="LitigationCaseTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LitigationCaseAxis" xlink:to="LitigationCaseTypeDomain_2" xlink:title="definition: LitigationCaseAxis to LitigationCaseTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_HumanaAndCenteneActionsMember" xlink:label="HumanaAndCenteneActionsMember" xlink:title="HumanaAndCenteneActionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LitigationCaseTypeDomain" xlink:to="HumanaAndCenteneActionsMember" xlink:title="definition: LitigationCaseTypeDomain to HumanaAndCenteneActionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CaliforniaComplaintMember" xlink:label="CaliforniaComplaintMember" xlink:title="CaliforniaComplaintMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LitigationCaseTypeDomain" xlink:to="CaliforniaComplaintMember" xlink:title="definition: LitigationCaseTypeDomain to CaliforniaComplaintMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://aquestive.com/role/SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementsAbstract" xlink:label="AgreementsAbstract" xlink:title="AgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="AgreementsAbstract" xlink:title="definition: SubsequentEventLineItems to AgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SeniorSecuredNotesAbstract" xlink:label="SeniorSecuredNotesAbstract" xlink:title="SeniorSecuredNotesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SeniorSecuredNotesAbstract" xlink:title="definition: SubsequentEventLineItems to SeniorSecuredNotesAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: SubsequentEventLineItems to DebtInstrumentInterestRateStatedPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="RepaymentsOfDebt" xlink:title="definition: SubsequentEventLineItems to RepaymentsOfDebt" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="definition: SubsequentEventLineItems to ProceedsFromIssuanceOfDebt" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="LoansPayable" xlink:title="LoansPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="LoansPayable" xlink:title="definition: SubsequentEventLineItems to LoansPayable" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentAdditionalBorrowingCapacity" xlink:label="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="DebtInstrumentAdditionalBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="definition: SubsequentEventLineItems to DebtInstrumentAdditionalBorrowingCapacity" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:label="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:title="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NoticePeriodForNotToRenewAgreement" xlink:label="NoticePeriodForNotToRenewAgreement" xlink:title="NoticePeriodForNotToRenewAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="NoticePeriodForNotToRenewAgreement" xlink:title="definition: SubsequentEventLineItems to NoticePeriodForNotToRenewAgreement" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="definition: SubsequentEventLineItems to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfUpfrontPaymentReceivable" xlink:label="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="MaximumAmountOfUpfrontPaymentReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="definition: SubsequentEventLineItems to MaximumAmountOfUpfrontPaymentReceivable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForMilestones" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="definition: SubsequentEventLineItems to MaximumAmountOfPaymentsReceivableForMilestones" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: SubsequentEventTable to TypeOfArrangementAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: SubsequentEventTable to DebtInstrumentAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="definition: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FirstAdditionalOfferingMember" xlink:label="FirstAdditionalOfferingMember" xlink:title="FirstAdditionalOfferingMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="FirstAdditionalOfferingMember" xlink:title="definition: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to FirstAdditionalOfferingMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SecondAdditionalOfferingMember" xlink:label="SecondAdditionalOfferingMember" xlink:title="SecondAdditionalOfferingMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="SecondAdditionalOfferingMember" xlink:title="definition: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to SecondAdditionalOfferingMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="RangeAxis" xlink:title="definition: SubsequentEventTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>aqst-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl1" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl1">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl1" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US" id="us-gaap_AccountingStandardsUpdate201602Member_lbl">ASU 2016-02 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:title="label: AccountingStandardsUpdate201602Member to us-gaap_AccountingStandardsUpdate201602Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="AccountsReceivableMember" xlink:title="AccountsReceivableMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableMember_lbl">Receivables [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:title="label: AccountsReceivableMember to us-gaap_AccountsReceivableMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableMember_lbl1" xml:lang="en-US" id="us-gaap_AccountsReceivableMember_lbl1">Accounts Receivable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl1" xlink:title="label: AccountsReceivableMember to us-gaap_AccountsReceivableMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrent to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl1">Total accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrent to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="AccountsReceivableNetAbstract" xlink:title="AccountsReceivableNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccountsReceivableNetAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableNetAbstract_lbl">Trade and other receivables, net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetAbstract" xlink:to="us-gaap_AccountsReceivableNetAbstract_lbl" xlink:title="label: AccountsReceivableNetAbstract to us-gaap_AccountsReceivableNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccountsReceivableNetAbstract_lbl1">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetAbstract" xlink:to="us-gaap_AccountsReceivableNetAbstract_lbl1" xlink:title="label: AccountsReceivableNetAbstract to us-gaap_AccountsReceivableNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="AccountsReceivableGross" xlink:title="AccountsReceivableGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableGross_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableGross_lbl">Trade receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableGross" xlink:to="us-gaap_AccountsReceivableGross_lbl" xlink:title="label: AccountsReceivableGross to us-gaap_AccountsReceivableGross_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="AccruedMarketingCostsCurrent" xlink:title="AccruedMarketingCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedMarketingCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedMarketingCostsCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedMarketingCostsCurrent_lbl">Accrued distribution expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedMarketingCostsCurrent" xlink:to="us-gaap_AccruedMarketingCostsCurrent_lbl" xlink:title="label: AccruedMarketingCostsCurrent to us-gaap_AccruedMarketingCostsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedMarketingCostsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedMarketingCostsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedMarketingCostsCurrent_lbl1">Accrued Marketing Costs, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedMarketingCostsCurrent" xlink:to="us-gaap_AccruedMarketingCostsCurrent_lbl1" xlink:title="label: AccruedMarketingCostsCurrent to us-gaap_AccruedMarketingCostsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less: accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net loss to net cash used for operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:title="label: AdjustmentsForNewAccountingPronouncementsAxis to us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl">Fair value of warrants issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantIssued to us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl1">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantIssued to us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Share-based compensation expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Share-based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:title="AllowanceForDoubtfulAccountsReceivableRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_lbl">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableRollforward to us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl">Less: allowance for bad debts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivable to us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl1" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl1">Allowance for doubtful accounts at beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl1" xlink:title="label: AllowanceForDoubtfulAccountsReceivable to us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl2" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl2">Allowance for doubtful accounts at end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl2" xlink:title="label: AllowanceForDoubtfulAccountsReceivable to us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl3" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl3">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl3" xlink:title="label: AllowanceForDoubtfulAccountsReceivable to us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:title="AllowanceForDoubtfulAccountsReceivableWriteOffs" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl">Write-downs charged against the allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableWriteOffs to us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl">Amortization expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl">Amortization of debt issuance costs and discounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:title="label: AmortizationOfFinancingCostsAndDiscounts to us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl1">Amortization expense, deferred debt issuance costs and debt discounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl1" xlink:title="label: AmortizationOfFinancingCostsAndDiscounts to us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl">Total potentially antidilutive derivatives excluded from losses per share (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="AssetRetirementObligationsNoncurrent" xlink:title="AssetRetirementObligationsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_AssetRetirementObligationsNoncurrent_lbl">Asset retirement obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xlink:title="label: AssetRetirementObligationsNoncurrent to us-gaap_AssetRetirementObligationsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetRetirementObligationsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetRetirementObligationsNoncurrent_lbl1">Asset Retirement Obligations, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_lbl1" xlink:title="label: AssetRetirementObligationsNoncurrent to us-gaap_AssetRetirementObligationsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="BasisOfAccounting" xlink:title="BasisOfAccounting" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccounting_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccounting_lbl">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:title="label: BasisOfAccounting to us-gaap_BasisOfAccounting_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccounting_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccounting_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccounting_lbl1">Basis of Accounting [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl1" xlink:title="label: BasisOfAccounting to us-gaap_BasisOfAccounting_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl">Net decrease in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="CashAndCashEquivalentsAbstract" xlink:title="CashAndCashEquivalentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAbstract_lbl">Cash and cash equivalents:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:title="label: CashAndCashEquivalentsAbstract to us-gaap_CashAndCashEquivalentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAbstract_lbl1">Cash and Cash Equivalents [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl1" xlink:title="label: CashAndCashEquivalentsAbstract to us-gaap_CashAndCashEquivalentsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">End of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightTable_lbl">Class of Warrant or Right [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:title="label: ClassOfWarrantOrRightTable to us-gaap_ClassOfWarrantOrRightTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightLineItems_lbl">Class of Warrant or Right [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:title="label: ClassOfWarrantOrRightLineItems to us-gaap_ClassOfWarrantOrRightLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl">Number of shares received upon automatic exercise of warrant (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1">Number of shares callable by warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2">Warrants issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="CollaborativeArrangementDisclosureTextBlock" xlink:title="CollaborativeArrangementDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl">Material Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:title="label: CollaborativeArrangementDisclosureTextBlock to us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" id="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Contingencies (note 18)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl1">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $.001 par value. Authorized 250,000,000 shares; 33,619,796 and 33,562,885 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl1" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTax_lbl">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:title="label: ComprehensiveIncomeNetOfTax to us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTax_lbl1">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xlink:title="label: ComprehensiveIncomeNetOfTax to us-gaap_ComprehensiveIncomeNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl">Concentration Risk Benchmark [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:title="label: ConcentrationRiskByBenchmarkAxis to us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="ConcentrationRiskDisclosureTextBlock" xlink:title="ConcentrationRiskDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl">Risks and Uncertainties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:title="label: ConcentrationRiskDisclosureTextBlock to us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl1">Concentration Risk Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl1" xlink:title="label: ConcentrationRiskDisclosureTextBlock to us-gaap_ConcentrationRiskDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskBenchmarkDomain_lbl">Concentration Risk Benchmark [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:title="label: ConcentrationRiskBenchmarkDomain to us-gaap_ConcentrationRiskBenchmarkDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskLineItems_lbl">Concentration Risk [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:title="label: ConcentrationRiskLineItems to us-gaap_ConcentrationRiskLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskTable_lbl">Concentration Risk [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:title="label: ConcentrationRiskTable to us-gaap_ConcentrationRiskTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskPercentage1_lbl">Concentrations of risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:title="label: ConcentrationRiskPercentage1 to us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskPercentage1_lbl1" xml:lang="en-US" id="us-gaap_ConcentrationRiskPercentage1_lbl1">Concentration Risk, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl1" xlink:title="label: ConcentrationRiskPercentage1 to us-gaap_ConcentrationRiskPercentage1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="ConsolidationPolicyTextBlock" xlink:title="ConsolidationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ConsolidationPolicyTextBlock_lbl">Principles of Consolidation and Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:title="label: ConsolidationPolicyTextBlock to us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" id="us-gaap_ConstructionInProgressMember_lbl">Construction in Progress [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" xlink:title="label: ConstructionInProgressMember to us-gaap_ConstructionInProgressMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="ContractWithCustomerAssetAndLiabilityAbstract" xlink:title="ContractWithCustomerAssetAndLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl">Contract with Customer, Asset and Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" xlink:title="label: ContractWithCustomerAssetAndLiabilityAbstract to us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiability_lbl">Contract liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" xlink:title="label: ContractWithCustomerLiability to us-gaap_ContractWithCustomerLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiability_lbl1" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiability_lbl1">Contract with Customer, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl1" xlink:title="label: ContractWithCustomerLiability to us-gaap_ContractWithCustomerLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="ContractWithCustomerLiabilityCurrent" xlink:title="ContractWithCustomerLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiabilityCurrent_lbl">Deferred revenue, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:title="label: ContractWithCustomerLiabilityCurrent to us-gaap_ContractWithCustomerLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="ContractWithCustomerLiabilityNoncurrent" xlink:title="ContractWithCustomerLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl">Deferred revenue, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:title="label: ContractWithCustomerLiabilityNoncurrent to us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetNet_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetNet_lbl">Current and non-current contract assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetNet" xlink:to="us-gaap_ContractWithCustomerAssetNet_lbl" xlink:title="label: ContractWithCustomerAssetNet to us-gaap_ContractWithCustomerAssetNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="CostOfGoodsAndServicesSold" xlink:title="CostOfGoodsAndServicesSold" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" id="us-gaap_CostOfGoodsAndServicesSold_lbl">Manufacture and supply</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:title="label: CostOfGoodsAndServicesSold to us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostOfGoodsAndServicesSold_lbl1" xml:lang="en-US" id="us-gaap_CostOfGoodsAndServicesSold_lbl1">Cost of Goods and Services Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl1" xlink:title="label: CostOfGoodsAndServicesSold to us-gaap_CostOfGoodsAndServicesSold_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl">Total costs and expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpenses_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl1" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTable_lbl">Disaggregation of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:title="label: DisaggregationOfRevenueTable to us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueLineItems_lbl">Disaggregation of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:title="label: DisaggregationOfRevenueLineItems to us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueAbstract_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueAbstract_lbl">Revenue [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:title="label: DisaggregationOfRevenueAbstract to us-gaap_DisaggregationOfRevenueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl">Disaggregation of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:title="label: DisaggregationOfRevenueTableTextBlock to us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl">Unamortized deferred debt issuance cost and deferred debt discounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:title="label: DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet to us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xlink:title="label: DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet to us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="DebtInstrumentInterestRateIncreaseDecrease" xlink:title="DebtInstrumentInterestRateIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl">Incremental borrowing rate on lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:title="label: DebtInstrumentInterestRateIncreaseDecrease to us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl1">Debt Instrument, Interest Rate, Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl1" xlink:title="label: DebtInstrumentInterestRateIncreaseDecrease to us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">12.5% Senior Secured Notes and Loans Payable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="DebtInstrumentFrequencyOfPeriodicPayment" xlink:title="DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl">Frequency of periodic principal payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:title="label: DebtInstrumentFrequencyOfPeriodicPayment to us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">12.5% Senior Secured Notes and Loans Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl">Debt maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract" xlink:label="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:title="DebtInstrumentInterestRateStatedPercentageAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract_lbl">Debt Instrument, Interest Rate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentageAbstract to us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:title="label: DepreciationAndAmortization to us-gaap_DepreciationAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl1">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl1" xlink:title="label: DepreciationAndAmortization to us-gaap_DepreciationAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_Depreciation_lbl" xml:lang="en-US" id="us-gaap_Depreciation_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:title="label: Depreciation to us-gaap_Depreciation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Depreciation_lbl1" xml:lang="en-US" id="us-gaap_Depreciation_lbl1">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation_lbl1" xlink:title="label: Depreciation to us-gaap_Depreciation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">Share-Based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">Share-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl">Net loss per share - basic and diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl1">Loss per common share - basic and diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">Net Loss Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">Federal statutory tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl">Unrecognized compensation costs of RSU awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl">Compensation Cost Not yet Recognized [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl">Unrecognized compensation expense related to non-vested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl">Unrecognized compensation cost, recognition period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember_lbl1" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl1">Options on Common Shares Outstanding [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl1" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">Financial Instruments - Fair Value Measurements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl">Financial Instruments - Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl">2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNet_lbl">Intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNet to us-gaap_FiniteLivedIntangibleAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1">Finite-Lived Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsNet to us-gaap_FiniteLivedIntangibleAssetsNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsGross_lbl">Intangible assets, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:title="label: FiniteLivedIntangibleAssetsGross to us-gaap_FiniteLivedIntangibleAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsGross_lbl1">Finite-Lived Intangible Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsGross to us-gaap_FiniteLivedIntangibleAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl">Less: accumulated amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl">Identifiable Intangible Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:title="label: FiniteLivedIntangibleAssetsLineItems to us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl">Estimated Annual Amortization Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl">Loss on extinguishment of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1">Loss on extinguishment of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl">Selling, General and Administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:label="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:title="GeographicAreasRevenuesFromExternalCustomersAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_lbl" xml:lang="en-US" id="us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_lbl">Revenues by Geographic Market [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_lbl" xlink:title="label: GeographicAreasRevenuesFromExternalCustomersAbstract to us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl">Intangible Assets, Net and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">Intangible Assets, Net and Other Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Net loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Net (loss)/income before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl">Trade and other receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xlink:title="label: IncreaseDecreaseInAccountsAndOtherReceivables to us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl1">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl1" xlink:title="label: IncreaseDecreaseInAccountsAndOtherReceivables to us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:title="label: IncreaseDecreaseInDeferredRevenue to us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1">Increase (Decrease) in Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xlink:title="label: IncreaseDecreaseInDeferredRevenue to us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="IncreaseDecreaseInInventories" xlink:title="IncreaseDecreaseInInventories" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInInventories_lbl">Inventories, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:title="label: IncreaseDecreaseInInventories to us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInInventories_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInInventories_lbl1">Increase (Decrease) in Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl1" xlink:title="label: IncreaseDecreaseInInventories to us-gaap_IncreaseDecreaseInInventories_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl">Prepaid expenses and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="us-gaap_InterestExpense_lbl">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:title="label: InterestExpense to us-gaap_InterestExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpense_lbl1" xml:lang="en-US" id="us-gaap_InterestExpense_lbl1">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense_lbl1" xlink:title="label: InterestExpense to us-gaap_InterestExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Cash payments for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="InventoryFinishedGoods" xlink:title="InventoryFinishedGoods" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US" id="us-gaap_InventoryFinishedGoods_lbl">Finished goods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:title="label: InventoryFinishedGoods to us-gaap_InventoryFinishedGoods_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" xlink:title="InventoryDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_InventoryDisclosureAbstract_lbl">Inventories, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:title="label: InventoryDisclosureAbstract to us-gaap_InventoryDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="InventoryDisclosureTextBlock" xlink:title="InventoryDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_InventoryDisclosureTextBlock_lbl">Inventories, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:title="label: InventoryDisclosureTextBlock to us-gaap_InventoryDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InventoryDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_InventoryDisclosureTextBlock_lbl1">Inventory Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl1" xlink:title="label: InventoryDisclosureTextBlock to us-gaap_InventoryDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="InventoryRawMaterials" xlink:title="InventoryRawMaterials" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US" id="us-gaap_InventoryRawMaterials_lbl">Raw material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:title="label: InventoryRawMaterials to us-gaap_InventoryRawMaterials_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InventoryNet_lbl" xml:lang="en-US" id="us-gaap_InventoryNet_lbl">Inventories, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:title="label: InventoryNet to us-gaap_InventoryNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_InventoryNet_lbl1" xml:lang="en-US" id="us-gaap_InventoryNet_lbl1">Total inventory, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryNet" xlink:to="us-gaap_InventoryNet_lbl1" xlink:title="label: InventoryNet to us-gaap_InventoryNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="InvestmentIncomeInterest" xlink:title="InvestmentIncomeInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" id="us-gaap_InvestmentIncomeInterest_lbl">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:title="label: InvestmentIncomeInterest to us-gaap_InvestmentIncomeInterest_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="LesseeOperatingLeaseRemainingLeaseTerm" xlink:title="LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl">Remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:title="label: LesseeOperatingLeaseRemainingLeaseTerm to us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl1">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl1" xlink:title="label: LesseeOperatingLeaseRemainingLeaseTerm to us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable_lbl">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl">Remainder of 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems_lbl">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">Right-of-Use Assets and Lease Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Lease, Cost [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">Right-of-Use Assets and Lease Obligations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities and stockholders' deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">Liabilities and stockholders' deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="LineOfCreditFacilityTable" xlink:title="LineOfCreditFacilityTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityTable_lbl">Line of Credit Facility [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:title="label: LineOfCreditFacilityTable to us-gaap_LineOfCreditFacilityTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="LineOfCreditFacilityLineItems" xlink:title="LineOfCreditFacilityLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityLineItems_lbl">Line of Credit Facility [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:title="label: LineOfCreditFacilityLineItems to us-gaap_LineOfCreditFacilityLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="LineOfCreditFacilityAbstract" xlink:title="LineOfCreditFacilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityAbstract_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityAbstract_lbl">Line of Credit Facility [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityAbstract" xlink:to="us-gaap_LineOfCreditFacilityAbstract_lbl" xlink:title="label: LineOfCreditFacilityAbstract to us-gaap_LineOfCreditFacilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="LineOfCreditMember" xlink:title="LineOfCreditMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditMember_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditMember_lbl">Line of Credit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl" xlink:title="label: LineOfCreditMember to us-gaap_LineOfCreditMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="LineOfCreditFacilityAxis" xlink:title="LineOfCreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityAxis_lbl">Lender Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:title="label: LineOfCreditFacilityAxis to us-gaap_LineOfCreditFacilityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl">Credit facility, maximum borrowing capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityLenderDomain_lbl">Line of Credit Facility, Lender [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityLenderDomain" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xlink:title="label: LineOfCreditFacilityLenderDomain to us-gaap_LineOfCreditFacilityLenderDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="LoansPayable" xlink:title="LoansPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LoansPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LoansPayable_lbl" xml:lang="en-US" id="us-gaap_LoansPayable_lbl">Notes payable outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:title="label: LoansPayable to us-gaap_LoansPayable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LoansPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_LoansPayableCurrent_lbl">Loans payable, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl" xlink:title="label: LoansPayableCurrent to us-gaap_LoansPayableCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl">Remainder of 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1">Long-Term Debt, Maturity, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">Long-Term Debt, Maturity, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1">Long-Term Debt, Maturity, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1">Long-Term Debt, Maturity, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1">Long-Term Debt, Maturity, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="LongTermLoansPayable" xlink:title="LongTermLoansPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLoansPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US" id="us-gaap_LongTermLoansPayable_lbl">Loans payable, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl" xlink:title="label: LongTermLoansPayable to us-gaap_LongTermLoansPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLoansPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermLoansPayable_lbl1" xml:lang="en-US" id="us-gaap_LongTermLoansPayable_lbl1">Loans Payable, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl1" xlink:title="label: LongTermLoansPayable to us-gaap_LongTermLoansPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyNumberOfDefendants_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyNumberOfDefendants_lbl" xml:lang="en-US" id="us-gaap_LossContingencyNumberOfDefendants_lbl">Number of companies patent infringement lawsuits filed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfDefendants" xlink:to="us-gaap_LossContingencyNumberOfDefendants_lbl" xlink:title="label: LossContingencyNumberOfDefendants to us-gaap_LossContingencyNumberOfDefendants_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesLineItems_lbl">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:title="label: LossContingenciesLineItems to us-gaap_LossContingenciesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber" xlink:label="LossContingencyClaimsSettledNumber" xlink:title="LossContingencyClaimsSettledNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyClaimsSettledNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LossContingencyClaimsSettledNumber_lbl" xml:lang="en-US" id="us-gaap_LossContingencyClaimsSettledNumber_lbl">Number of cases resolved</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyClaimsSettledNumber" xlink:to="us-gaap_LossContingencyClaimsSettledNumber_lbl" xlink:title="label: LossContingencyClaimsSettledNumber to us-gaap_LossContingencyClaimsSettledNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyClaimsSettledNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyClaimsSettledNumber_lbl1" xml:lang="en-US" id="us-gaap_LossContingencyClaimsSettledNumber_lbl1">Loss Contingency, Claims Settled, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyClaimsSettledNumber" xlink:to="us-gaap_LossContingencyClaimsSettledNumber_lbl1" xlink:title="label: LossContingencyClaimsSettledNumber to us-gaap_LossContingencyClaimsSettledNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesTable_lbl">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:title="label: LossContingenciesTable to us-gaap_LossContingenciesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="LossContingencyNewClaimsFiledNumber" xlink:title="LossContingencyNewClaimsFiledNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LossContingencyNewClaimsFiledNumber_lbl" xml:lang="en-US" id="us-gaap_LossContingencyNewClaimsFiledNumber_lbl">Number of cases filed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNewClaimsFiledNumber" xlink:to="us-gaap_LossContingencyNewClaimsFiledNumber_lbl" xlink:title="label: LossContingencyNewClaimsFiledNumber to us-gaap_LossContingencyNewClaimsFiledNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyNewClaimsFiledNumber_lbl1" xml:lang="en-US" id="us-gaap_LossContingencyNewClaimsFiledNumber_lbl1">Loss Contingency, New Claims Filed, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNewClaimsFiledNumber" xlink:to="us-gaap_LossContingencyNewClaimsFiledNumber_lbl1" xlink:title="label: LossContingencyNewClaimsFiledNumber to us-gaap_LossContingencyNewClaimsFiledNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="LossContingencyPendingClaimsNumber" xlink:title="LossContingencyPendingClaimsNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyPendingClaimsNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LossContingencyPendingClaimsNumber_lbl" xml:lang="en-US" id="us-gaap_LossContingencyPendingClaimsNumber_lbl">Number of cases pending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPendingClaimsNumber" xlink:to="us-gaap_LossContingencyPendingClaimsNumber_lbl" xlink:title="label: LossContingencyPendingClaimsNumber to us-gaap_LossContingencyPendingClaimsNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyPendingClaimsNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyPendingClaimsNumber_lbl1" xml:lang="en-US" id="us-gaap_LossContingencyPendingClaimsNumber_lbl1">Loss Contingency, Pending Claims, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPendingClaimsNumber" xlink:to="us-gaap_LossContingencyPendingClaimsNumber_lbl1" xlink:title="label: LossContingencyPendingClaimsNumber to us-gaap_LossContingencyPendingClaimsNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="LossContingencyInformationAboutLitigationMattersAbstract" xlink:title="LossContingencyInformationAboutLitigationMattersAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl" xml:lang="en-US" id="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl">Litigation and Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl" xlink:title="label: LossContingencyInformationAboutLitigationMattersAbstract to us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl1" xml:lang="en-US" id="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl1">Loss Contingency, Information about Litigation Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl1" xlink:title="label: LossContingencyInformationAboutLitigationMattersAbstract to us-gaap_LossContingencyInformationAboutLitigationMattersAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="MachineryAndEquipmentMember" xlink:title="MachineryAndEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US" id="us-gaap_MachineryAndEquipmentMember_lbl">Machinery [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:title="label: MachineryAndEquipmentMember to us-gaap_MachineryAndEquipmentMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl" xml:lang="en-US" id="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl">Debt Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl" xlink:title="label: MaturitiesOfLongTermDebtAbstract to us-gaap_MaturitiesOfLongTermDebtAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl">Restricted Stock Units Awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:title="label: NonvestedRestrictedStockSharesActivityTableTextBlock to us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="NetIncomeLossAbstract" xlink:title="NetIncomeLossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAbstract_lbl">Numerator [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl" xlink:title="label: NetIncomeLossAbstract to us-gaap_NetIncomeLossAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash used for operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">Cash flows used for investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Cash flows used for operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used for investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash (used for)/provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:title="label: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:title="label: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl">Recent Accounting Pronouncements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="NonUsMember" xlink:title="NonUsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonUsMember_lbl" xml:lang="en-US" id="us-gaap_NonUsMember_lbl">Ex-United States [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonUsMember" xlink:to="us-gaap_NonUsMember_lbl" xlink:title="label: NonUsMember to us-gaap_NonUsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="NonoperatingIncomeExpenseAbstract" xlink:title="NonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl">Other income/(expenses):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:title="label: NonoperatingIncomeExpenseAbstract to us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: NonoperatingIncomeExpenseAbstract to us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" id="us-gaap_OperatingLeasePayments_lbl">Operating lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:title="label: OperatingLeasePayments to us-gaap_OperatingLeasePayments_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Estimated discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1">Operating Lease, Liability, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Right-of-use assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl1">Right of use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl">Costs and expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl">Corporate Organization and Company Overview</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">Corporate Organization and Company Overview [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="OtherNoncashIncomeExpense" xlink:title="OtherNoncashIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_OtherNoncashIncomeExpense_lbl">All other non-cash expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:title="label: OtherNoncashIncomeExpense to us-gaap_OtherNoncashIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNoncashIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_OtherNoncashIncomeExpense_lbl1">Other Noncash Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl1" xlink:title="label: OtherNoncashIncomeExpense to us-gaap_OtherNoncashIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="OtherReceivablesGrossCurrent" xlink:title="OtherReceivablesGrossCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesGrossCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherReceivablesGrossCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherReceivablesGrossCurrent_lbl">Contract and other receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesGrossCurrent" xlink:to="us-gaap_OtherReceivablesGrossCurrent_lbl" xlink:title="label: OtherReceivablesGrossCurrent to us-gaap_OtherReceivablesGrossCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets, primarily security deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="PatentsMember" xlink:title="PatentsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PatentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PatentsMember_lbl" xml:lang="en-US" id="us-gaap_PatentsMember_lbl">Purchased Patent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:title="label: PatentsMember to us-gaap_PatentsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PatentsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PatentsMember_lbl1" xml:lang="en-US" id="us-gaap_PatentsMember_lbl1">Patents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatentsMember" xlink:to="us-gaap_PatentsMember_lbl1" xlink:title="label: PatentsMember to us-gaap_PatentsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">Accounts Payable and Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="PaymentsOfDebtExtinguishmentCosts" xlink:title="PaymentsOfDebtExtinguishmentCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl">Premium paid to retire debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDebtExtinguishmentCosts" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xlink:title="label: PaymentsOfDebtExtinguishmentCosts to us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl1">Prepayment premiums paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDebtExtinguishmentCosts" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl1" xlink:title="label: PaymentsOfDebtExtinguishmentCosts to us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl">Payments for taxes on share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="PaymentsOfStockIssuanceCosts" xlink:title="PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfStockIssuanceCosts_lbl">Payments for deferred offering costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:title="label: PaymentsOfStockIssuanceCosts to us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="PaymentsOfFinancingCosts" xlink:title="PaymentsOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfFinancingCosts_lbl">Payments for loan acquisition costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:title="label: PaymentsOfFinancingCosts to us-gaap_PaymentsOfFinancingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfFinancingCosts_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfFinancingCosts_lbl1">Payments of Financing Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl1" xlink:title="label: PaymentsOfFinancingCosts to us-gaap_PaymentsOfFinancingCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl">Capital expenditures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfDebt_lbl">Proceeds from issuance of long-term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:title="label: ProceedsFromIssuanceOfDebt to us-gaap_ProceedsFromIssuanceOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfDebt_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfDebt_lbl1">Proceeds from refinancing of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl1" xlink:title="label: ProceedsFromIssuanceOfDebt to us-gaap_ProceedsFromIssuanceOfDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfDebt_lbl2" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfDebt_lbl2">Proceeds from Issuance of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl2" xlink:title="label: ProceedsFromIssuanceOfDebt to us-gaap_ProceedsFromIssuanceOfDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl">Proceeds from warrant exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl1">Proceeds from Warrant Exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:title="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:title="label: ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans to us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl">Net proceeds from initial public offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="ProceedsFromIssuanceInitialPublicOffering" xlink:title="ProceedsFromIssuanceInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl">Net proceeds from initial public offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:title="label: ProceedsFromIssuanceInitialPublicOffering to us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1">Proceeds from Issuance Initial Public Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xlink:title="label: ProceedsFromIssuanceInitialPublicOffering to us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="ProfessionalFees" xlink:title="ProfessionalFees" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfessionalFees_lbl" xml:lang="en-US" id="us-gaap_ProfessionalFees_lbl">Professional fees and other costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:title="label: ProfessionalFees to us-gaap_ProfessionalFees_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems_lbl">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:title="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_lbl">Property Plant and Equipment Income Statement Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract to us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Property and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Total property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl">Property and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl">Additions charged to bad debt expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="RepaymentsOfLongTermDebt" xlink:title="RepaymentsOfLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfLongTermDebt_lbl">Payment of existing debt obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:title="label: RepaymentsOfLongTermDebt to us-gaap_RepaymentsOfLongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfLongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfLongTermDebt_lbl1">Repayments of Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl1" xlink:title="label: RepaymentsOfLongTermDebt to us-gaap_RepaymentsOfLongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfDebt_lbl">Repayment of Note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:title="label: RepaymentsOfDebt to us-gaap_RepaymentsOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfDebt_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfDebt_lbl1">Debt repayment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl1" xlink:title="label: RepaymentsOfDebt to us-gaap_RepaymentsOfDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfDebt_lbl2" xml:lang="en-US" id="us-gaap_RepaymentsOfDebt_lbl2">Repayments of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl2" xlink:title="label: RepaymentsOfDebt to us-gaap_RepaymentsOfDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl1">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl1" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl">Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl">Restricted Stock Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl">Revenue Recognition and Performance Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl">Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1">Total revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Revenues_lbl" xml:lang="en-US" id="us-gaap_Revenues_lbl">Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:title="label: Revenues to us-gaap_Revenues_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="RisksAndUncertaintiesAbstract" xlink:title="RisksAndUncertaintiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US" id="us-gaap_RisksAndUncertaintiesAbstract_lbl">Risks and Uncertainties [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:title="label: RisksAndUncertaintiesAbstract to us-gaap_RisksAndUncertaintiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="RoyaltyMember" xlink:title="RoyaltyMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RoyaltyMember_lbl" xml:lang="en-US" id="us-gaap_RoyaltyMember_lbl">Royalty [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl" xlink:title="label: RoyaltyMember to us-gaap_RoyaltyMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl">Expected term (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl">Purchase price of common stock as percentage of fair market value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="SalesRevenueNetMember" xlink:title="SalesRevenueNetMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US" id="us-gaap_SalesRevenueNetMember_lbl">Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:title="label: SalesRevenueNetMember to us-gaap_SalesRevenueNetMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SalesRevenueNetMember_lbl1" xml:lang="en-US" id="us-gaap_SalesRevenueNetMember_lbl1">Revenue Benchmark [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl1" xlink:title="label: SalesRevenueNetMember to us-gaap_SalesRevenueNetMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="ScheduleOfInventoryCurrentTableTextBlock" xlink:title="ScheduleOfInventoryCurrentTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl">Inventory, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:title="label: ScheduleOfInventoryCurrentTableTextBlock to us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl1">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl1" xlink:title="label: ScheduleOfInventoryCurrentTableTextBlock to us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl">Valuation Assumptions for Determination of Fair Value of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl">Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl">Debt Maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl">Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:title="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl">Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:title="label: ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock to us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTable to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl">Basic and Diluted Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:title="label: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl">Components of Identifiable Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:title="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl">Changes in Allowance for Bad Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xlink:title="label: ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock to us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl1">Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl1" xlink:title="label: ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock to us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl">Antidilutive Securities Excluded from Computation of Loss Per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:title="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:title="label: ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock to us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl1">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl1" xlink:title="label: ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock to us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:title="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl">Trade and Other Receivables, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:title="label: ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock to us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl1">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl1" xlink:title="label: ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock to us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">Selling, general and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl">Weighted Average Exercise Price [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl">Weighted Average Grant Date Fair Value Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAbstract_lbl">Share-based Compensation expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:title="label: ShareBasedCompensationAbstract to us-gaap_ShareBasedCompensationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharePrice_lbl" xml:lang="en-US" id="us-gaap_SharePrice_lbl">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharePrice_lbl1" xml:lang="en-US" id="us-gaap_SharePrice_lbl1">Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl1" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl">Forfeited (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl">Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Forfeited (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl">Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl">Number of Units [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl">Unvested, at end of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1">Unvested, at beginning of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl">Vested (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl">Fair Value Assumptions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl">Unvested, at beginning of period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1">Unvested, at end of period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl">Exercisable at end of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Outstanding at beginning of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Outstanding at end of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl">Outstanding at end of period (In dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl">Exercisable at end of period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl">Number of Options [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl">Vested or expected to vest at end of period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl">Vested or expected to vest at end of period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">Condensed Consolidated Balance Sheets (Unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">Condensed Consolidated Statements of Cash Flows (Unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl">Shares issued under employee stock purchase plan (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl">Number of common shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl">Share-based compensation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:title="label: StockIssuedDuringPeriodSharesShareBasedCompensation to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesShareBasedCompensation to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl">Shares issued under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:title="label: StockIssuedDuringPeriodValueEmployeeStockPurchasePlan to us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total stockholders' deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl3">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">Stockholders' deficit:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="TechnologyBasedIntangibleAssetsMember" xlink:title="TechnologyBasedIntangibleAssetsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" xml:lang="en-US" id="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl">Purchased Technology-based Intangible [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TechnologyBasedIntangibleAssetsMember" xlink:to="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" xlink:title="label: TechnologyBasedIntangibleAssetsMember to us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="us-gaap_TypeOfArrangementAxis_lbl">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:title="label: TypeOfArrangementAxis to us-gaap_TypeOfArrangementAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" id="us-gaap_TypeOfAdoptionMember_lbl">Type of Adoption [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xlink:title="label: TypeOfAdoptionMember to us-gaap_TypeOfAdoptionMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="us-gaap_WarrantMember_lbl">Warrants on Common Shares Outstanding [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember_lbl1" xml:lang="en-US" id="us-gaap_WarrantMember_lbl1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl1" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl">Warrants Issued to 12.5% Senior Secured Noteholders [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="WarrantsNotSettleableInCashFairValueDisclosure" xlink:title="WarrantsNotSettleableInCashFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl">Fair value of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:title="label: WarrantsNotSettleableInCashFairValueDisclosure to us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl">Weighted-average number of common shares outstanding - basic and diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1">Weighted-average number of common shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl">Denominator [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="CumulativeEffectPeriodOfAdoptionDomain" />
    <link:label xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xml:lang="en-US" id="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:title="label: CumulativeEffectPeriodOfAdoptionDomain to srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="CumulativeEffectPeriodOfAdoptionAxis" />
    <link:label xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xml:lang="en-US" id="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:title="label: CumulativeEffectPeriodOfAdoptionAxis to srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:title="CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:label xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xml:lang="en-US" id="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:title="label: CumulativeEffectPeriodOfAdoptionAdjustmentMember to srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="LitigationCaseAxis" xlink:title="LitigationCaseAxis" />
    <link:label xlink:type="resource" xlink:label="srt_LitigationCaseAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_LitigationCaseAxis_lbl" xml:lang="en-US" id="srt_LitigationCaseAxis_lbl">Litigation Case [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis_lbl" xlink:title="label: LitigationCaseAxis to srt_LitigationCaseAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="LitigationCaseTypeDomain" xlink:title="LitigationCaseTypeDomain" />
    <link:label xlink:type="resource" xlink:label="srt_LitigationCaseTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_LitigationCaseTypeDomain_lbl" xml:lang="en-US" id="srt_LitigationCaseTypeDomain_lbl">Litigation Case [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationCaseTypeDomain" xlink:to="srt_LitigationCaseTypeDomain_lbl" xlink:title="label: LitigationCaseTypeDomain to srt_LitigationCaseTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:label xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MajorCustomersAxis_lbl" xml:lang="en-US" id="srt_MajorCustomersAxis_lbl">Customer [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:title="label: MajorCustomersAxis to srt_MajorCustomersAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:label xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US" id="srt_NameOfMajorCustomerDomain_lbl">Customer [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" xlink:title="label: NameOfMajorCustomerDomain to srt_NameOfMajorCustomerDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="srt_ProductsAndServicesDomain_lbl">Product and Service [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" xlink:title="label: ProductsAndServicesDomain to srt_ProductsAndServicesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductOrServiceAxis_lbl" xml:lang="en-US" id="srt_ProductOrServiceAxis_lbl">Product and Service [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:title="label: ProductOrServiceAxis to srt_ProductOrServiceAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="SegmentGeographicalDomain" xlink:title="SegmentGeographicalDomain" />
    <link:label xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US" id="srt_SegmentGeographicalDomain_lbl">Geographical [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" xlink:title="label: SegmentGeographicalDomain to srt_SegmentGeographicalDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="StatementGeographicalAxis" xlink:title="StatementGeographicalAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementGeographicalAxis_lbl" xml:lang="en-US" id="srt_StatementGeographicalAxis_lbl">Geographical [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:title="label: StatementGeographicalAxis to srt_StatementGeographicalAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="US" xlink:title="US" />
    <link:label xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="country_US_lbl" xml:lang="en-US" id="country_US_lbl">United States [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="US" xlink:to="country_US_lbl" xlink:title="label: US to country_US_lbl" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenuesAndTradeReceivablesNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_RevenuesAndTradeReceivablesNetAbstract_lbl1" xml:lang="en-US" id="aqst_RevenuesAndTradeReceivablesNetAbstract_lbl1">Revenues and Trade Receivables, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="aqst_RevenuesAndTradeReceivablesNetAbstract_lbl1" xlink:title="label: RevenuesAndTradeReceivablesNetAbstract to aqst_RevenuesAndTradeReceivablesNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetTextBlock" xlink:label="RevenuesAndTradeReceivablesNetTextBlock" xlink:title="RevenuesAndTradeReceivablesNetTextBlock" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl" xml:lang="en-US" id="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl">The entire disclosure of revenues and trade receivables, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAndTradeReceivablesNetTextBlock" xlink:to="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl" xlink:title="label: RevenuesAndTradeReceivablesNetTextBlock to aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl1" xml:lang="en-US" id="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl1">Revenues and Trade Receivables, Net [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAndTradeReceivablesNetTextBlock" xlink:to="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl1" xlink:title="label: RevenuesAndTradeReceivablesNetTextBlock to aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl2" xml:lang="en-US" id="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl2">Revenues and Trade Receivables, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAndTradeReceivablesNetTextBlock" xlink:to="aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl2" xlink:title="label: RevenuesAndTradeReceivablesNetTextBlock to aqst_RevenuesAndTradeReceivablesNetTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:label="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl">For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl" xlink:title="label: AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet to aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl1" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl1">Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl1" xlink:title="label: AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet to aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl2" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl2">Accrued balances - Trade and other receivables, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl2" xlink:title="label: AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet to aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl3" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl3">Less: sales-related allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl3" xlink:title="label: AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet to aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesCreditsAndPayments" xlink:label="AccountsReceivableAllowancesCreditsAndPayments" xlink:title="AccountsReceivableAllowancesCreditsAndPayments" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl">For an unclassified balance sheet, a valuation of sales allowance for receivables related to credits due a company that are expected to be uncollectible.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesCreditsAndPayments" xlink:to="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl" xlink:title="label: AccountsReceivableAllowancesCreditsAndPayments to aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl1" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl1">Accounts Receivable Allowances, Credits and payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesCreditsAndPayments" xlink:to="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl1" xlink:title="label: AccountsReceivableAllowancesCreditsAndPayments to aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl2" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl2">Payments / credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesCreditsAndPayments" xlink:to="aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl2" xlink:title="label: AccountsReceivableAllowancesCreditsAndPayments to aqst_AccountsReceivableAllowancesCreditsAndPayments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccruals" xlink:label="AccountsReceivableAllowancesAndAccruals" xlink:title="AccountsReceivableAllowancesAndAccruals" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AccountsReceivableAllowancesAndAccruals_lbl" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccruals_lbl">For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible and accruals.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccruals" xlink:to="aqst_AccountsReceivableAllowancesAndAccruals_lbl" xlink:title="label: AccountsReceivableAllowancesAndAccruals to aqst_AccountsReceivableAllowancesAndAccruals_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccruals_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AccountsReceivableAllowancesAndAccruals_lbl1" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccruals_lbl1">Accounts Receivable Allowances and Accruals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccruals" xlink:to="aqst_AccountsReceivableAllowancesAndAccruals_lbl1" xlink:title="label: AccountsReceivableAllowancesAndAccruals to aqst_AccountsReceivableAllowancesAndAccruals_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccruals_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="aqst_AccountsReceivableAllowancesAndAccruals_lbl2" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccruals_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccruals" xlink:to="aqst_AccountsReceivableAllowancesAndAccruals_lbl2" xlink:title="label: AccountsReceivableAllowancesAndAccruals to aqst_AccountsReceivableAllowancesAndAccruals_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccruals_lbl3" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="aqst_AccountsReceivableAllowancesAndAccruals_lbl3" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccruals_lbl3">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccruals" xlink:to="aqst_AccountsReceivableAllowancesAndAccruals_lbl3" xlink:title="label: AccountsReceivableAllowancesAndAccruals to aqst_AccountsReceivableAllowancesAndAccruals_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesProvisionRelatedToSales" xlink:label="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:title="AccountsReceivableAllowancesProvisionRelatedToSales" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl">For an unclassified balance sheet, a valuation of sales allowance for receivables related to sales due a company that are expected to be uncollectible.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:to="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl" xlink:title="label: AccountsReceivableAllowancesProvisionRelatedToSales to aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl1" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl1">Accounts Receivable Allowances, Provision Related to Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:to="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl1" xlink:title="label: AccountsReceivableAllowancesProvisionRelatedToSales to aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl2" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl2">Provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:to="aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl2" xlink:title="label: AccountsReceivableAllowancesProvisionRelatedToSales to aqst_AccountsReceivableAllowancesProvisionRelatedToSales_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:label="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:title="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl">For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within Accounts payable and other accrued expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl" xlink:title="label: AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses to aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl1" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl1">Accounts Receivable Allowances and Accruals - Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl1" xlink:title="label: AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses to aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl2" xml:lang="en-US" id="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl2">Accrued balances - Accounts payable and accrued expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:to="aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl2" xlink:title="label: AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses to aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:label="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:title="SalesRelatedAllowancesAndAccrualsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl" xml:lang="en-US" id="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl">Tabular disclosure of valuation of sales allowance and accruals for receivables due a company that are expected to be uncollectible including a rollforward of the balance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:to="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl" xlink:title="label: SalesRelatedAllowancesAndAccrualsTableTextBlock to aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl1" xml:lang="en-US" id="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl1">Sales Related Allowances and Accruals [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:to="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl1" xlink:title="label: SalesRelatedAllowancesAndAccrualsTableTextBlock to aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl2" xml:lang="en-US" id="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl2">Sales Related Allowances and Accruals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:to="aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl2" xlink:title="label: SalesRelatedAllowancesAndAccrualsTableTextBlock to aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufactureAndSupplyRevenueMember" xlink:label="ManufactureAndSupplyRevenueMember" xlink:title="ManufactureAndSupplyRevenueMember" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufactureAndSupplyRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ManufactureAndSupplyRevenueMember_lbl" xml:lang="en-US" id="aqst_ManufactureAndSupplyRevenueMember_lbl">The aggregate revenue generated from manufacture and supply.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufactureAndSupplyRevenueMember" xlink:to="aqst_ManufactureAndSupplyRevenueMember_lbl" xlink:title="label: ManufactureAndSupplyRevenueMember to aqst_ManufactureAndSupplyRevenueMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufactureAndSupplyRevenueMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ManufactureAndSupplyRevenueMember_lbl1" xml:lang="en-US" id="aqst_ManufactureAndSupplyRevenueMember_lbl1">Manufacture and Supply Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufactureAndSupplyRevenueMember" xlink:to="aqst_ManufactureAndSupplyRevenueMember_lbl1" xlink:title="label: ManufactureAndSupplyRevenueMember to aqst_ManufactureAndSupplyRevenueMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufactureAndSupplyRevenueMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ManufactureAndSupplyRevenueMember_lbl2" xml:lang="en-US" id="aqst_ManufactureAndSupplyRevenueMember_lbl2">Manufacture and Supply Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufactureAndSupplyRevenueMember" xlink:to="aqst_ManufactureAndSupplyRevenueMember_lbl2" xlink:title="label: ManufactureAndSupplyRevenueMember to aqst_ManufactureAndSupplyRevenueMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CoDevelopmentAndResearchFeesMember" xlink:label="CoDevelopmentAndResearchFeesMember" xlink:title="CoDevelopmentAndResearchFeesMember" />
    <link:label xlink:type="resource" xlink:label="aqst_CoDevelopmentAndResearchFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CoDevelopmentAndResearchFeesMember_lbl" xml:lang="en-US" id="aqst_CoDevelopmentAndResearchFeesMember_lbl">The aggregate revenue generated from Co-development and research fees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoDevelopmentAndResearchFeesMember" xlink:to="aqst_CoDevelopmentAndResearchFeesMember_lbl" xlink:title="label: CoDevelopmentAndResearchFeesMember to aqst_CoDevelopmentAndResearchFeesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CoDevelopmentAndResearchFeesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CoDevelopmentAndResearchFeesMember_lbl1" xml:lang="en-US" id="aqst_CoDevelopmentAndResearchFeesMember_lbl1">Co-Development and Research Fees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoDevelopmentAndResearchFeesMember" xlink:to="aqst_CoDevelopmentAndResearchFeesMember_lbl1" xlink:title="label: CoDevelopmentAndResearchFeesMember to aqst_CoDevelopmentAndResearchFeesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CoDevelopmentAndResearchFeesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CoDevelopmentAndResearchFeesMember_lbl2" xml:lang="en-US" id="aqst_CoDevelopmentAndResearchFeesMember_lbl2">Co-Development and Research Fees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoDevelopmentAndResearchFeesMember" xlink:to="aqst_CoDevelopmentAndResearchFeesMember_lbl2" xlink:title="label: CoDevelopmentAndResearchFeesMember to aqst_CoDevelopmentAndResearchFeesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ProprietaryProductSalesMember" xlink:label="ProprietaryProductSalesMember" xlink:title="ProprietaryProductSalesMember" />
    <link:label xlink:type="resource" xlink:label="aqst_ProprietaryProductSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ProprietaryProductSalesMember_lbl" xml:lang="en-US" id="aqst_ProprietaryProductSalesMember_lbl">The aggregate revenue generated from proprietary product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProprietaryProductSalesMember" xlink:to="aqst_ProprietaryProductSalesMember_lbl" xlink:title="label: ProprietaryProductSalesMember to aqst_ProprietaryProductSalesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ProprietaryProductSalesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ProprietaryProductSalesMember_lbl1" xml:lang="en-US" id="aqst_ProprietaryProductSalesMember_lbl1">Proprietary Product Sales [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProprietaryProductSalesMember" xlink:to="aqst_ProprietaryProductSalesMember_lbl1" xlink:title="label: ProprietaryProductSalesMember to aqst_ProprietaryProductSalesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ProprietaryProductSalesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ProprietaryProductSalesMember_lbl2" xml:lang="en-US" id="aqst_ProprietaryProductSalesMember_lbl2">Proprietary Product Sales, Net [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProprietaryProductSalesMember" xlink:to="aqst_ProprietaryProductSalesMember_lbl2" xlink:title="label: ProprietaryProductSalesMember to aqst_ProprietaryProductSalesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAndRoyaltyRevenueMember" xlink:label="LicenseAndRoyaltyRevenueMember" xlink:title="LicenseAndRoyaltyRevenueMember" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAndRoyaltyRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_LicenseAndRoyaltyRevenueMember_lbl" xml:lang="en-US" id="aqst_LicenseAndRoyaltyRevenueMember_lbl">The aggregate revenue generated from licensing and royalties.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAndRoyaltyRevenueMember" xlink:to="aqst_LicenseAndRoyaltyRevenueMember_lbl" xlink:title="label: LicenseAndRoyaltyRevenueMember to aqst_LicenseAndRoyaltyRevenueMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAndRoyaltyRevenueMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_LicenseAndRoyaltyRevenueMember_lbl1" xml:lang="en-US" id="aqst_LicenseAndRoyaltyRevenueMember_lbl1">License and Royalty Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAndRoyaltyRevenueMember" xlink:to="aqst_LicenseAndRoyaltyRevenueMember_lbl1" xlink:title="label: LicenseAndRoyaltyRevenueMember to aqst_LicenseAndRoyaltyRevenueMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:label="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:title="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl" xml:lang="en-US" id="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl">The number of primary sources of revenue of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:to="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl" xlink:title="label: RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue to aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl1" xml:lang="en-US" id="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl1">Revenue from Contracts with Customers, Number of Sources of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:to="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl1" xlink:title="label: RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue to aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl2" xml:lang="en-US" id="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl2">Number of revenue sources</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:to="aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl2" xlink:title="label: RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue to aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InvoicesPayableTerm" xlink:label="InvoicesPayableTerm" xlink:title="InvoicesPayableTerm" />
    <link:label xlink:type="resource" xlink:label="aqst_InvoicesPayableTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_InvoicesPayableTerm_lbl" xml:lang="en-US" id="aqst_InvoicesPayableTerm_lbl">Invoices payable term of customer and type of invoice in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvoicesPayableTerm" xlink:to="aqst_InvoicesPayableTerm_lbl" xlink:title="label: InvoicesPayableTerm to aqst_InvoicesPayableTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_InvoicesPayableTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_InvoicesPayableTerm_lbl1" xml:lang="en-US" id="aqst_InvoicesPayableTerm_lbl1">Invoices Payable Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvoicesPayableTerm" xlink:to="aqst_InvoicesPayableTerm_lbl1" xlink:title="label: InvoicesPayableTerm to aqst_InvoicesPayableTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_InvoicesPayableTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_InvoicesPayableTerm_lbl2" xml:lang="en-US" id="aqst_InvoicesPayableTerm_lbl2">Invoices payable term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvoicesPayableTerm" xlink:to="aqst_InvoicesPayableTerm_lbl2" xlink:title="label: InvoicesPayableTerm to aqst_InvoicesPayableTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsDisclosureTextBlock" xlink:label="WarrantsDisclosureTextBlock" xlink:title="WarrantsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US" id="aqst_WarrantsDisclosureTextBlock_lbl">The entire disclosure for warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsDisclosureTextBlock" xlink:to="aqst_WarrantsDisclosureTextBlock_lbl" xlink:title="label: WarrantsDisclosureTextBlock to aqst_WarrantsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_WarrantsDisclosureTextBlock_lbl1" xml:lang="en-US" id="aqst_WarrantsDisclosureTextBlock_lbl1">Warrants Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsDisclosureTextBlock" xlink:to="aqst_WarrantsDisclosureTextBlock_lbl1" xlink:title="label: WarrantsDisclosureTextBlock to aqst_WarrantsDisclosureTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsDisclosureTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_WarrantsDisclosureTextBlock_lbl2" xml:lang="en-US" id="aqst_WarrantsDisclosureTextBlock_lbl2">Warrants Issued to 12.5% Senior Secured Noteholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsDisclosureTextBlock" xlink:to="aqst_WarrantsDisclosureTextBlock_lbl2" xlink:title="label: WarrantsDisclosureTextBlock to aqst_WarrantsDisclosureTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:label xlink:type="resource" xlink:label="aqst_TradeAndOtherReceivablesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_TradeAndOtherReceivablesNet_lbl" xml:lang="en-US" id="aqst_TradeAndOtherReceivablesNet_lbl">Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeAndOtherReceivablesNet" xlink:to="aqst_TradeAndOtherReceivablesNet_lbl" xlink:title="label: TradeAndOtherReceivablesNet to aqst_TradeAndOtherReceivablesNet_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_TradeAndOtherReceivablesNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_TradeAndOtherReceivablesNet_lbl1" xml:lang="en-US" id="aqst_TradeAndOtherReceivablesNet_lbl1">Trade and other receivables, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeAndOtherReceivablesNet" xlink:to="aqst_TradeAndOtherReceivablesNet_lbl1" xlink:title="label: TradeAndOtherReceivablesNet to aqst_TradeAndOtherReceivablesNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_TradeAndOtherReceivablesNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_TradeAndOtherReceivablesNet_lbl2" xml:lang="en-US" id="aqst_TradeAndOtherReceivablesNet_lbl2">Trade and other receivables, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeAndOtherReceivablesNet" xlink:to="aqst_TradeAndOtherReceivablesNet_lbl2" xlink:title="label: TradeAndOtherReceivablesNet to aqst_TradeAndOtherReceivablesNet_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_TradeAndOtherReceivablesNet_lbl3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="aqst_TradeAndOtherReceivablesNet_lbl3" xml:lang="en-US" id="aqst_TradeAndOtherReceivablesNet_lbl3">Trade and other receivables, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeAndOtherReceivablesNet" xlink:to="aqst_TradeAndOtherReceivablesNet_lbl3" xlink:title="label: TradeAndOtherReceivablesNet to aqst_TradeAndOtherReceivablesNet_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_GuaranteedRoyaltyRevenue" xlink:label="GuaranteedRoyaltyRevenue" xlink:title="GuaranteedRoyaltyRevenue" />
    <link:label xlink:type="resource" xlink:label="aqst_GuaranteedRoyaltyRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_GuaranteedRoyaltyRevenue_lbl" xml:lang="en-US" id="aqst_GuaranteedRoyaltyRevenue_lbl">Guaranteed royalty revenue under the collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GuaranteedRoyaltyRevenue" xlink:to="aqst_GuaranteedRoyaltyRevenue_lbl" xlink:title="label: GuaranteedRoyaltyRevenue to aqst_GuaranteedRoyaltyRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_GuaranteedRoyaltyRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_GuaranteedRoyaltyRevenue_lbl1" xml:lang="en-US" id="aqst_GuaranteedRoyaltyRevenue_lbl1">Guaranteed Royalty Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GuaranteedRoyaltyRevenue" xlink:to="aqst_GuaranteedRoyaltyRevenue_lbl1" xlink:title="label: GuaranteedRoyaltyRevenue to aqst_GuaranteedRoyaltyRevenue_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_GuaranteedRoyaltyRevenue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_GuaranteedRoyaltyRevenue_lbl2" xml:lang="en-US" id="aqst_GuaranteedRoyaltyRevenue_lbl2">Guaranteed royalty revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GuaranteedRoyaltyRevenue" xlink:to="aqst_GuaranteedRoyaltyRevenue_lbl2" xlink:title="label: GuaranteedRoyaltyRevenue to aqst_GuaranteedRoyaltyRevenue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfUpfrontPaymentReceivable" xlink:label="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="MaximumAmountOfUpfrontPaymentReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl" xml:lang="en-US" id="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl">The maximum amount of upfront payments receivable under the collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfUpfrontPaymentReceivable" xlink:to="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl" xlink:title="label: MaximumAmountOfUpfrontPaymentReceivable to aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl1" xml:lang="en-US" id="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl1">Maximum Amount of Upfront Payment Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfUpfrontPaymentReceivable" xlink:to="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl1" xlink:title="label: MaximumAmountOfUpfrontPaymentReceivable to aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl2" xml:lang="en-US" id="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl2">Cash payment receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfUpfrontPaymentReceivable" xlink:to="aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl2" xlink:title="label: MaximumAmountOfUpfrontPaymentReceivable to aqst_MaximumAmountOfUpfrontPaymentReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl">The license agreement made with sunovion pharmaceuticals, inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncMember to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl1" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl1">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl1" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncMember to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl2" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl2">Sunovion [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl2" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncMember to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl3" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl3">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl3" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncMember to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForMilestones" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl">The maximum amount of payments receivable for milestones under the collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl" xlink:title="label: MaximumAmountOfPaymentsReceivableForMilestones to aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl1" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl1">Maximum Amount of Payments Receivable for Milestones</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl1" xlink:title="label: MaximumAmountOfPaymentsReceivableForMilestones to aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl2" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl2">Contingent payments receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl2" xlink:title="label: MaximumAmountOfPaymentsReceivableForMilestones to aqst_MaximumAmountOfPaymentsReceivableForMilestones_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:label="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:title="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl">The number of warrants issued during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:to="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl" xlink:title="label: ClassOfWarrantOrRightWarrantsIssuedDuringPeriod to aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl1" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl1">Class Of Warrant Or Right Warrants Issued During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:to="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl1" xlink:title="label: ClassOfWarrantOrRightWarrantsIssuedDuringPeriod to aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl2" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl2">Warrants issued to purchase common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:to="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl2" xlink:title="label: ClassOfWarrantOrRightWarrantsIssuedDuringPeriod to aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementsAbstract" xlink:label="AgreementsAbstract" xlink:title="AgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AgreementsAbstract_lbl1" xml:lang="en-US" id="aqst_AgreementsAbstract_lbl1">Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementsAbstract" xlink:to="aqst_AgreementsAbstract_lbl1" xlink:title="label: AgreementsAbstract to aqst_AgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AgreementsAbstract_lbl2" xml:lang="en-US" id="aqst_AgreementsAbstract_lbl2">License Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementsAbstract" xlink:to="aqst_AgreementsAbstract_lbl2" xlink:title="label: AgreementsAbstract to aqst_AgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NoticePeriodForNotToRenewAgreement" xlink:label="NoticePeriodForNotToRenewAgreement" xlink:title="NoticePeriodForNotToRenewAgreement" />
    <link:label xlink:type="resource" xlink:label="aqst_NoticePeriodForNotToRenewAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NoticePeriodForNotToRenewAgreement_lbl" xml:lang="en-US" id="aqst_NoticePeriodForNotToRenewAgreement_lbl">Notice period of intent not to renew agreement, prior to the expiration of the initial or renewal term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForNotToRenewAgreement" xlink:to="aqst_NoticePeriodForNotToRenewAgreement_lbl" xlink:title="label: NoticePeriodForNotToRenewAgreement to aqst_NoticePeriodForNotToRenewAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NoticePeriodForNotToRenewAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NoticePeriodForNotToRenewAgreement_lbl1" xml:lang="en-US" id="aqst_NoticePeriodForNotToRenewAgreement_lbl1">Notice Period for Not to Renew Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForNotToRenewAgreement" xlink:to="aqst_NoticePeriodForNotToRenewAgreement_lbl1" xlink:title="label: NoticePeriodForNotToRenewAgreement to aqst_NoticePeriodForNotToRenewAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NoticePeriodForNotToRenewAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NoticePeriodForNotToRenewAgreement_lbl2" xml:lang="en-US" id="aqst_NoticePeriodForNotToRenewAgreement_lbl2">Notice period of intent not to renew agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForNotToRenewAgreement" xlink:to="aqst_NoticePeriodForNotToRenewAgreement_lbl2" xlink:title="label: NoticePeriodForNotToRenewAgreement to aqst_NoticePeriodForNotToRenewAgreement_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_NoticePeriodForNotToRenewAgreement_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_NoticePeriodForNotToRenewAgreement_lbl3" xml:lang="en-US" id="aqst_NoticePeriodForNotToRenewAgreement_lbl3">Notice period of intent to terminate agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForNotToRenewAgreement" xlink:to="aqst_NoticePeriodForNotToRenewAgreement_lbl3" xlink:title="label: NoticePeriodForNotToRenewAgreement to aqst_NoticePeriodForNotToRenewAgreement_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl">The maximum amount of payments receivable for license fees and substantive milestones under the collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl" xlink:title="label: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl1" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl1">Maximum Amount Of Payments Receivable For License Fees And Substantive Milestones</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl1" xlink:title="label: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl2" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl2">Maximum payments under agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl2" xlink:title="label: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl3" xml:lang="en-US" id="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl3">Maximum amount of payments receivable under agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:to="aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl3" xlink:title="label: MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones to aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SeniorSecuredNotesAbstract" xlink:label="SeniorSecuredNotesAbstract" xlink:title="SeniorSecuredNotesAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_SeniorSecuredNotesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_SeniorSecuredNotesAbstract_lbl1" xml:lang="en-US" id="aqst_SeniorSecuredNotesAbstract_lbl1">Senior Secured Notes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeniorSecuredNotesAbstract" xlink:to="aqst_SeniorSecuredNotesAbstract_lbl1" xlink:title="label: SeniorSecuredNotesAbstract to aqst_SeniorSecuredNotesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_SeniorSecuredNotesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_SeniorSecuredNotesAbstract_lbl2" xml:lang="en-US" id="aqst_SeniorSecuredNotesAbstract_lbl2">12.5% Senior Secured Notes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeniorSecuredNotesAbstract" xlink:to="aqst_SeniorSecuredNotesAbstract_lbl2" xlink:title="label: SeniorSecuredNotesAbstract to aqst_SeniorSecuredNotesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:label xlink:type="resource" xlink:label="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl" xml:lang="en-US" id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl">A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl" xlink:title="label: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl1" xml:lang="en-US" id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl1">Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl1" xlink:title="label: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl2" xml:lang="en-US" id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl2">Senior Secured Notes Due 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl2" xlink:title="label: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FirstAdditionalOfferingMember" xlink:label="FirstAdditionalOfferingMember" xlink:title="FirstAdditionalOfferingMember" />
    <link:label xlink:type="resource" xlink:label="aqst_FirstAdditionalOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_FirstAdditionalOfferingMember_lbl" xml:lang="en-US" id="aqst_FirstAdditionalOfferingMember_lbl">The first additional offering of the loan agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FirstAdditionalOfferingMember" xlink:to="aqst_FirstAdditionalOfferingMember_lbl" xlink:title="label: FirstAdditionalOfferingMember to aqst_FirstAdditionalOfferingMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_FirstAdditionalOfferingMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_FirstAdditionalOfferingMember_lbl1" xml:lang="en-US" id="aqst_FirstAdditionalOfferingMember_lbl1">First Additional Offering [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FirstAdditionalOfferingMember" xlink:to="aqst_FirstAdditionalOfferingMember_lbl1" xlink:title="label: FirstAdditionalOfferingMember to aqst_FirstAdditionalOfferingMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_FirstAdditionalOfferingMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_FirstAdditionalOfferingMember_lbl2" xml:lang="en-US" id="aqst_FirstAdditionalOfferingMember_lbl2">Senior Secured Notes Due 2025 - First Additional Offering [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FirstAdditionalOfferingMember" xlink:to="aqst_FirstAdditionalOfferingMember_lbl2" xlink:title="label: FirstAdditionalOfferingMember to aqst_FirstAdditionalOfferingMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SecondAdditionalOfferingMember" xlink:label="SecondAdditionalOfferingMember" xlink:title="SecondAdditionalOfferingMember" />
    <link:label xlink:type="resource" xlink:label="aqst_SecondAdditionalOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_SecondAdditionalOfferingMember_lbl" xml:lang="en-US" id="aqst_SecondAdditionalOfferingMember_lbl">The second additional offering of the loan agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecondAdditionalOfferingMember" xlink:to="aqst_SecondAdditionalOfferingMember_lbl" xlink:title="label: SecondAdditionalOfferingMember to aqst_SecondAdditionalOfferingMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_SecondAdditionalOfferingMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_SecondAdditionalOfferingMember_lbl1" xml:lang="en-US" id="aqst_SecondAdditionalOfferingMember_lbl1">Second Additional Offering [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecondAdditionalOfferingMember" xlink:to="aqst_SecondAdditionalOfferingMember_lbl1" xlink:title="label: SecondAdditionalOfferingMember to aqst_SecondAdditionalOfferingMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_SecondAdditionalOfferingMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_SecondAdditionalOfferingMember_lbl2" xml:lang="en-US" id="aqst_SecondAdditionalOfferingMember_lbl2">Senior Secured Notes Due 2025 - Second Additional Offering [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecondAdditionalOfferingMember" xlink:to="aqst_SecondAdditionalOfferingMember_lbl2" xlink:title="label: SecondAdditionalOfferingMember to aqst_SecondAdditionalOfferingMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentAdditionalBorrowingCapacity" xlink:label="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="DebtInstrumentAdditionalBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl" xml:lang="en-US" id="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl">Amount of debt that can be borrowed in addition to initial notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAdditionalBorrowingCapacity" xlink:to="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl" xlink:title="label: DebtInstrumentAdditionalBorrowingCapacity to aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl1" xml:lang="en-US" id="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl1">Debt Instrument Additional Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAdditionalBorrowingCapacity" xlink:to="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl1" xlink:title="label: DebtInstrumentAdditionalBorrowingCapacity to aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl2" xml:lang="en-US" id="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl2">Additional borrowing capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAdditionalBorrowingCapacity" xlink:to="aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl2" xlink:title="label: DebtInstrumentAdditionalBorrowingCapacity to aqst_DebtInstrumentAdditionalBorrowingCapacity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl" xml:lang="en-US" id="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl">Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and amount of noncurrent assets classified as other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNetAndOtherAssets to aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl1" xml:lang="en-US" id="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl1">Finite-Lived Intangible Assets, Net and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsNetAndOtherAssets to aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl2" xml:lang="en-US" id="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl2">Intangible assets, net and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsNetAndOtherAssets to aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl3" xml:lang="en-US" id="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl3">Total intangible assets, net and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:to="aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl3" xlink:title="label: FiniteLivedIntangibleAssetsNetAndOtherAssets to aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerOneMember" xlink:label="CustomerOneMember" xlink:title="CustomerOneMember" />
    <link:label xlink:type="resource" xlink:label="aqst_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CustomerOneMember_lbl" xml:lang="en-US" id="aqst_CustomerOneMember_lbl">Entity's established relationships with its customers through contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerOneMember" xlink:to="aqst_CustomerOneMember_lbl" xlink:title="label: CustomerOneMember to aqst_CustomerOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CustomerOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CustomerOneMember_lbl1" xml:lang="en-US" id="aqst_CustomerOneMember_lbl1">Customer One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerOneMember" xlink:to="aqst_CustomerOneMember_lbl1" xlink:title="label: CustomerOneMember to aqst_CustomerOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CustomerOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CustomerOneMember_lbl2" xml:lang="en-US" id="aqst_CustomerOneMember_lbl2">AmerisourceBergen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerOneMember" xlink:to="aqst_CustomerOneMember_lbl2" xlink:title="label: CustomerOneMember to aqst_CustomerOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:label="CommercialExploitationAgreementWithIndiviorMember" xlink:title="CommercialExploitationAgreementWithIndiviorMember" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl">The commercial exploitation agreement with Indivior.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithIndiviorMember" xlink:to="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl" xlink:title="label: CommercialExploitationAgreementWithIndiviorMember to aqst_CommercialExploitationAgreementWithIndiviorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl1" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl1">Commercial Exploitation Agreement with Indivior [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithIndiviorMember" xlink:to="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl1" xlink:title="label: CommercialExploitationAgreementWithIndiviorMember to aqst_CommercialExploitationAgreementWithIndiviorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl2" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl2">Indivior [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithIndiviorMember" xlink:to="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl2" xlink:title="label: CommercialExploitationAgreementWithIndiviorMember to aqst_CommercialExploitationAgreementWithIndiviorMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl3" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl3">Commercial Exploitation Agreement with Indivior [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithIndiviorMember" xlink:to="aqst_CommercialExploitationAgreementWithIndiviorMember_lbl3" xlink:title="label: CommercialExploitationAgreementWithIndiviorMember to aqst_CommercialExploitationAgreementWithIndiviorMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithSunovionMember" xlink:label="CommercialExploitationAgreementWithSunovionMember" xlink:title="CommercialExploitationAgreementWithSunovionMember" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithSunovionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CommercialExploitationAgreementWithSunovionMember_lbl" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithSunovionMember_lbl">The commercial exploitation agreement with sunovion.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithSunovionMember" xlink:to="aqst_CommercialExploitationAgreementWithSunovionMember_lbl" xlink:title="label: CommercialExploitationAgreementWithSunovionMember to aqst_CommercialExploitationAgreementWithSunovionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithSunovionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CommercialExploitationAgreementWithSunovionMember_lbl1" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithSunovionMember_lbl1">Commercial Exploitation Agreement With Sunovion [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithSunovionMember" xlink:to="aqst_CommercialExploitationAgreementWithSunovionMember_lbl1" xlink:title="label: CommercialExploitationAgreementWithSunovionMember to aqst_CommercialExploitationAgreementWithSunovionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementWithSunovionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CommercialExploitationAgreementWithSunovionMember_lbl2" xml:lang="en-US" id="aqst_CommercialExploitationAgreementWithSunovionMember_lbl2">Sunovion [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementWithSunovionMember" xlink:to="aqst_CommercialExploitationAgreementWithSunovionMember_lbl2" xlink:title="label: CommercialExploitationAgreementWithSunovionMember to aqst_CommercialExploitationAgreementWithSunovionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerConcentrationAbstract" xlink:label="CustomerConcentrationAbstract" xlink:title="CustomerConcentrationAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_CustomerConcentrationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CustomerConcentrationAbstract_lbl1" xml:lang="en-US" id="aqst_CustomerConcentrationAbstract_lbl1">Customer Concentration [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerConcentrationAbstract" xlink:to="aqst_CustomerConcentrationAbstract_lbl1" xlink:title="label: CustomerConcentrationAbstract to aqst_CustomerConcentrationAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CustomerConcentrationAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CustomerConcentrationAbstract_lbl2" xml:lang="en-US" id="aqst_CustomerConcentrationAbstract_lbl2">Customer Concentration [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerConcentrationAbstract" xlink:to="aqst_CustomerConcentrationAbstract_lbl2" xlink:title="label: CustomerConcentrationAbstract to aqst_CustomerConcentrationAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCustomersExceedingTenPercentThresholds" xlink:label="NumberOfCustomersExceedingTenPercentThresholds" xlink:title="NumberOfCustomersExceedingTenPercentThresholds" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl" xml:lang="en-US" id="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl">Represents the number of customer exceeding the 10% threshold.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCustomersExceedingTenPercentThresholds" xlink:to="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl" xlink:title="label: NumberOfCustomersExceedingTenPercentThresholds to aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl1" xml:lang="en-US" id="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl1">Number Of Customers Exceeding Ten Percent Thresholds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCustomersExceedingTenPercentThresholds" xlink:to="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl1" xlink:title="label: NumberOfCustomersExceedingTenPercentThresholds to aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl2" xml:lang="en-US" id="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl2">Number of customers exceeding 10% thresholds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCustomersExceedingTenPercentThresholds" xlink:to="aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl2" xlink:title="label: NumberOfCustomersExceedingTenPercentThresholds to aqst_NumberOfCustomersExceedingTenPercentThresholds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsIssuedInConnectionWithLongTermDebt" xlink:label="WarrantsIssuedInConnectionWithLongTermDebt" xlink:title="WarrantsIssuedInConnectionWithLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl" xml:lang="en-US" id="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl">The amount of warrants issued in connection with long-term debt as part of a noncash transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssuedInConnectionWithLongTermDebt" xlink:to="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl" xlink:title="label: WarrantsIssuedInConnectionWithLongTermDebt to aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl1" xml:lang="en-US" id="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl1">Warrants Issued in Connection with Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssuedInConnectionWithLongTermDebt" xlink:to="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl1" xlink:title="label: WarrantsIssuedInConnectionWithLongTermDebt to aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl2" xml:lang="en-US" id="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl2">Warrants issued in connection with long-term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssuedInConnectionWithLongTermDebt" xlink:to="aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl2" xlink:title="label: WarrantsIssuedInConnectionWithLongTermDebt to aqst_WarrantsIssuedInConnectionWithLongTermDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:label="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:title="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US" id="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl">Increase (decrease) in future cash outflow to pay for purchases of fixed assets that have occurred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:title="label: IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl1" xml:lang="en-US" id="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl1">Increase (Decrease) in Capital Expenditures Included in Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl1" xlink:title="label: IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl2" xml:lang="en-US" id="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl2">Net (decrease) in capital expenditures included in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl2" xlink:title="label: IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:title="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US" id="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl">Increase (decrease) in future cash outflow to pay for deferred offering costs that have occurred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:title="label: IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl1" xml:lang="en-US" id="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl1">Increase (Decrease) in Offering Costs Included in Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl1" xlink:title="label: IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl2" xml:lang="en-US" id="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl2">Net increase in offering costs included in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl2" xlink:title="label: IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses to aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:label="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:title="NumberOfAnnualRoyaltyPaymentsReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl" xml:lang="en-US" id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl">Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:to="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl" xlink:title="label: NumberOfAnnualRoyaltyPaymentsReceivable to aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl1" xml:lang="en-US" id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl1">Number of Annual Royalty Payments Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:to="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl1" xlink:title="label: NumberOfAnnualRoyaltyPaymentsReceivable to aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl2" xml:lang="en-US" id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl2">Number of annual royalty payments receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:to="aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl2" xlink:title="label: NumberOfAnnualRoyaltyPaymentsReceivable to aqst_NumberOfAnnualRoyaltyPaymentsReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeRoyaltyReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CumulativeRoyaltyReceivable_lbl" xml:lang="en-US" id="aqst_CumulativeRoyaltyReceivable_lbl">Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeRoyaltyReceivable" xlink:to="aqst_CumulativeRoyaltyReceivable_lbl" xlink:title="label: CumulativeRoyaltyReceivable to aqst_CumulativeRoyaltyReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeRoyaltyReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CumulativeRoyaltyReceivable_lbl1" xml:lang="en-US" id="aqst_CumulativeRoyaltyReceivable_lbl1">Cumulative Royalty Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeRoyaltyReceivable" xlink:to="aqst_CumulativeRoyaltyReceivable_lbl1" xlink:title="label: CumulativeRoyaltyReceivable to aqst_CumulativeRoyaltyReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeRoyaltyReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CumulativeRoyaltyReceivable_lbl2" xml:lang="en-US" id="aqst_CumulativeRoyaltyReceivable_lbl2">Royalty receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeRoyaltyReceivable" xlink:to="aqst_CumulativeRoyaltyReceivable_lbl2" xlink:title="label: CumulativeRoyaltyReceivable to aqst_CumulativeRoyaltyReceivable_lbl2" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeRoyaltyReceivable_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_CumulativeRoyaltyReceivable_lbl3" xml:lang="en-US" id="aqst_CumulativeRoyaltyReceivable_lbl3">Aggregate royalty receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeRoyaltyReceivable" xlink:to="aqst_CumulativeRoyaltyReceivable_lbl3" xlink:title="label: CumulativeRoyaltyReceivable to aqst_CumulativeRoyaltyReceivable_lbl3" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MinimumAnnualRoyaltyReceivable" xlink:label="MinimumAnnualRoyaltyReceivable" xlink:title="MinimumAnnualRoyaltyReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_MinimumAnnualRoyaltyReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_MinimumAnnualRoyaltyReceivable_lbl" xml:lang="en-US" id="aqst_MinimumAnnualRoyaltyReceivable_lbl">Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumAnnualRoyaltyReceivable" xlink:to="aqst_MinimumAnnualRoyaltyReceivable_lbl" xlink:title="label: MinimumAnnualRoyaltyReceivable to aqst_MinimumAnnualRoyaltyReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_MinimumAnnualRoyaltyReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_MinimumAnnualRoyaltyReceivable_lbl1" xml:lang="en-US" id="aqst_MinimumAnnualRoyaltyReceivable_lbl1">Minimum Annual Royalty Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumAnnualRoyaltyReceivable" xlink:to="aqst_MinimumAnnualRoyaltyReceivable_lbl1" xlink:title="label: MinimumAnnualRoyaltyReceivable to aqst_MinimumAnnualRoyaltyReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_MinimumAnnualRoyaltyReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_MinimumAnnualRoyaltyReceivable_lbl2" xml:lang="en-US" id="aqst_MinimumAnnualRoyaltyReceivable_lbl2">Minimum annual royalty receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumAnnualRoyaltyReceivable" xlink:to="aqst_MinimumAnnualRoyaltyReceivable_lbl2" xlink:title="label: MinimumAnnualRoyaltyReceivable to aqst_MinimumAnnualRoyaltyReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsLiabilityAbstract" xlink:label="WarrantsLiabilityAbstract" xlink:title="WarrantsLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsLiabilityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_WarrantsLiabilityAbstract_lbl1" xml:lang="en-US" id="aqst_WarrantsLiabilityAbstract_lbl1">Warrants Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsLiabilityAbstract" xlink:to="aqst_WarrantsLiabilityAbstract_lbl1" xlink:title="label: WarrantsLiabilityAbstract to aqst_WarrantsLiabilityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantsLiabilityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_WarrantsLiabilityAbstract_lbl2" xml:lang="en-US" id="aqst_WarrantsLiabilityAbstract_lbl2">Warrants [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsLiabilityAbstract" xlink:to="aqst_WarrantsLiabilityAbstract_lbl2" xlink:title="label: WarrantsLiabilityAbstract to aqst_WarrantsLiabilityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="StockIssuedDuringPeriodSharesWarrantExercise" xlink:title="StockIssuedDuringPeriodSharesWarrantExercise" />
    <link:label xlink:type="resource" xlink:label="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl" xml:lang="en-US" id="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl">Number of new stock issued upon the exercise of warrants during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesWarrantExercise" xlink:to="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl" xlink:title="label: StockIssuedDuringPeriodSharesWarrantExercise to aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl1" xml:lang="en-US" id="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl1">Stock Issued During Period, Shares, Warrant Exercise</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesWarrantExercise" xlink:to="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesWarrantExercise to aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl2" xml:lang="en-US" id="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl2">Common Stock issued upon warrant exercises (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesWarrantExercise" xlink:to="aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesWarrantExercise to aqst_StockIssuedDuringPeriodSharesWarrantExercise_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:label="ClassOfWarrantOrRightWarrantsExercised" xlink:title="ClassOfWarrantOrRightWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl">The number of class of warrant or right exercised.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsExercised" xlink:to="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl" xlink:title="label: ClassOfWarrantOrRightWarrantsExercised to aqst_ClassOfWarrantOrRightWarrantsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl1" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl1">Class of Warrant or Right, Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsExercised" xlink:to="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl1" xlink:title="label: ClassOfWarrantOrRightWarrantsExercised to aqst_ClassOfWarrantOrRightWarrantsExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl2" xml:lang="en-US" id="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl2">Exercise of warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightWarrantsExercised" xlink:to="aqst_ClassOfWarrantOrRightWarrantsExercised_lbl2" xlink:title="label: ClassOfWarrantOrRightWarrantsExercised to aqst_ClassOfWarrantOrRightWarrantsExercised_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:label="ComputerNetworkEquipmentAndSoftwareMember" xlink:title="ComputerNetworkEquipmentAndSoftwareMember" />
    <link:label xlink:type="resource" xlink:label="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl" xml:lang="en-US" id="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl">Assets which are related to computer, network equipment and software.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerNetworkEquipmentAndSoftwareMember" xlink:to="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl" xlink:title="label: ComputerNetworkEquipmentAndSoftwareMember to aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl1" xml:lang="en-US" id="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl1">Computer, Network Equipment and Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerNetworkEquipmentAndSoftwareMember" xlink:to="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl1" xlink:title="label: ComputerNetworkEquipmentAndSoftwareMember to aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl2" xml:lang="en-US" id="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl2">Computer, Network Equipment and Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerNetworkEquipmentAndSoftwareMember" xlink:to="aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl2" xlink:title="label: ComputerNetworkEquipmentAndSoftwareMember to aqst_ComputerNetworkEquipmentAndSoftwareMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaterialAgreementsAbstract" xlink:label="MaterialAgreementsAbstract" xlink:title="MaterialAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_MaterialAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_MaterialAgreementsAbstract_lbl1" xml:lang="en-US" id="aqst_MaterialAgreementsAbstract_lbl1">Material Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaterialAgreementsAbstract" xlink:to="aqst_MaterialAgreementsAbstract_lbl1" xlink:title="label: MaterialAgreementsAbstract to aqst_MaterialAgreementsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementWithIndiviorMember" xlink:label="SupplementalAgreementWithIndiviorMember" xlink:title="SupplementalAgreementWithIndiviorMember" />
    <link:label xlink:type="resource" xlink:label="aqst_SupplementalAgreementWithIndiviorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_SupplementalAgreementWithIndiviorMember_lbl" xml:lang="en-US" id="aqst_SupplementalAgreementWithIndiviorMember_lbl">The supplemental commercial exploitation agreement with Indivior.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalAgreementWithIndiviorMember" xlink:to="aqst_SupplementalAgreementWithIndiviorMember_lbl" xlink:title="label: SupplementalAgreementWithIndiviorMember to aqst_SupplementalAgreementWithIndiviorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_SupplementalAgreementWithIndiviorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_SupplementalAgreementWithIndiviorMember_lbl1" xml:lang="en-US" id="aqst_SupplementalAgreementWithIndiviorMember_lbl1">Supplemental Agreement with Indivior [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalAgreementWithIndiviorMember" xlink:to="aqst_SupplementalAgreementWithIndiviorMember_lbl1" xlink:title="label: SupplementalAgreementWithIndiviorMember to aqst_SupplementalAgreementWithIndiviorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_SupplementalAgreementWithIndiviorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_SupplementalAgreementWithIndiviorMember_lbl2" xml:lang="en-US" id="aqst_SupplementalAgreementWithIndiviorMember_lbl2">Supplemental Agreement with Indivior [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalAgreementWithIndiviorMember" xlink:to="aqst_SupplementalAgreementWithIndiviorMember_lbl2" xlink:title="label: SupplementalAgreementWithIndiviorMember to aqst_SupplementalAgreementWithIndiviorMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementAbstract" xlink:label="SupplementalAgreementAbstract" xlink:title="SupplementalAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_SupplementalAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_SupplementalAgreementAbstract_lbl1" xml:lang="en-US" id="aqst_SupplementalAgreementAbstract_lbl1">Supplemental Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalAgreementAbstract" xlink:to="aqst_SupplementalAgreementAbstract_lbl1" xlink:title="label: SupplementalAgreementAbstract to aqst_SupplementalAgreementAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ContingentPaymentsReceivableInTheFuture" xlink:label="ContingentPaymentsReceivableInTheFuture" xlink:title="ContingentPaymentsReceivableInTheFuture" />
    <link:label xlink:type="resource" xlink:label="aqst_ContingentPaymentsReceivableInTheFuture_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ContingentPaymentsReceivableInTheFuture_lbl" xml:lang="en-US" id="aqst_ContingentPaymentsReceivableInTheFuture_lbl">Potential additional payment receivable under the agreement as of the balance sheet date. These are the aggregate from any combination of (a) performance or event-based milestone payments and (b) single digit percentage royalties on net revenue earned by Indivior on sales of Suboxone and earnings through the issuance of additional process patent rights to the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentPaymentsReceivableInTheFuture" xlink:to="aqst_ContingentPaymentsReceivableInTheFuture_lbl" xlink:title="label: ContingentPaymentsReceivableInTheFuture to aqst_ContingentPaymentsReceivableInTheFuture_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ContingentPaymentsReceivableInTheFuture_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ContingentPaymentsReceivableInTheFuture_lbl1" xml:lang="en-US" id="aqst_ContingentPaymentsReceivableInTheFuture_lbl1">Contingent payments receivable in the future</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentPaymentsReceivableInTheFuture" xlink:to="aqst_ContingentPaymentsReceivableInTheFuture_lbl1" xlink:title="label: ContingentPaymentsReceivableInTheFuture to aqst_ContingentPaymentsReceivableInTheFuture_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ContingentPaymentsReceivableInTheFuture_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ContingentPaymentsReceivableInTheFuture_lbl2" xml:lang="en-US" id="aqst_ContingentPaymentsReceivableInTheFuture_lbl2">Contingent payments receivable in the future</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentPaymentsReceivableInTheFuture" xlink:to="aqst_ContingentPaymentsReceivableInTheFuture_lbl2" xlink:title="label: ContingentPaymentsReceivableInTheFuture to aqst_ContingentPaymentsReceivableInTheFuture_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ReceivableProcessPatentRights" xlink:label="ReceivableProcessPatentRights" xlink:title="ReceivableProcessPatentRights" />
    <link:label xlink:type="resource" xlink:label="aqst_ReceivableProcessPatentRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ReceivableProcessPatentRights_lbl" xml:lang="en-US" id="aqst_ReceivableProcessPatentRights_lbl">Amount receivable for process patent rights under the collaboration agreement as of the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivableProcessPatentRights" xlink:to="aqst_ReceivableProcessPatentRights_lbl" xlink:title="label: ReceivableProcessPatentRights to aqst_ReceivableProcessPatentRights_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ReceivableProcessPatentRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ReceivableProcessPatentRights_lbl1" xml:lang="en-US" id="aqst_ReceivableProcessPatentRights_lbl1">Receivable, Process Patent Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivableProcessPatentRights" xlink:to="aqst_ReceivableProcessPatentRights_lbl1" xlink:title="label: ReceivableProcessPatentRights to aqst_ReceivableProcessPatentRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ReceivableProcessPatentRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ReceivableProcessPatentRights_lbl2" xml:lang="en-US" id="aqst_ReceivableProcessPatentRights_lbl2">Receivable, process patent rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivableProcessPatentRights" xlink:to="aqst_ReceivableProcessPatentRights_lbl2" xlink:title="label: ReceivableProcessPatentRights to aqst_ReceivableProcessPatentRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AggregateReceivable" xlink:label="AggregateReceivable" xlink:title="AggregateReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_AggregateReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AggregateReceivable_lbl" xml:lang="en-US" id="aqst_AggregateReceivable_lbl">Aggregate amount receivable under the collaboration agreement as of the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateReceivable" xlink:to="aqst_AggregateReceivable_lbl" xlink:title="label: AggregateReceivable to aqst_AggregateReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AggregateReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AggregateReceivable_lbl1" xml:lang="en-US" id="aqst_AggregateReceivable_lbl1">Aggregate Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateReceivable" xlink:to="aqst_AggregateReceivable_lbl1" xlink:title="label: AggregateReceivable to aqst_AggregateReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AggregateReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AggregateReceivable_lbl2" xml:lang="en-US" id="aqst_AggregateReceivable_lbl2">Aggregate revenue receivable, milestone payments and royalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateReceivable" xlink:to="aqst_AggregateReceivable_lbl2" xlink:title="label: AggregateReceivable to aqst_AggregateReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativePaymentsReceived" xlink:label="CumulativePaymentsReceived" xlink:title="CumulativePaymentsReceived" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativePaymentsReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CumulativePaymentsReceived_lbl" xml:lang="en-US" id="aqst_CumulativePaymentsReceived_lbl">Cumulative amount of payments received under the collaboration agreement as of the end of the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativePaymentsReceived" xlink:to="aqst_CumulativePaymentsReceived_lbl" xlink:title="label: CumulativePaymentsReceived to aqst_CumulativePaymentsReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativePaymentsReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CumulativePaymentsReceived_lbl1" xml:lang="en-US" id="aqst_CumulativePaymentsReceived_lbl1">Cumulative Payments Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativePaymentsReceived" xlink:to="aqst_CumulativePaymentsReceived_lbl1" xlink:title="label: CumulativePaymentsReceived to aqst_CumulativePaymentsReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativePaymentsReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CumulativePaymentsReceived_lbl2" xml:lang="en-US" id="aqst_CumulativePaymentsReceived_lbl2">Aggregate payments received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativePaymentsReceived" xlink:to="aqst_CumulativePaymentsReceived_lbl2" xlink:title="label: CumulativePaymentsReceived to aqst_CumulativePaymentsReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementAbstract" xlink:label="CommercialExploitationAgreementAbstract" xlink:title="CommercialExploitationAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CommercialExploitationAgreementAbstract_lbl1" xml:lang="en-US" id="aqst_CommercialExploitationAgreementAbstract_lbl1">Commercial Exploitation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementAbstract" xlink:to="aqst_CommercialExploitationAgreementAbstract_lbl1" xlink:title="label: CommercialExploitationAgreementAbstract to aqst_CommercialExploitationAgreementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CommercialExploitationAgreementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CommercialExploitationAgreementAbstract_lbl2" xml:lang="en-US" id="aqst_CommercialExploitationAgreementAbstract_lbl2">Commercial Exploitation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommercialExploitationAgreementAbstract" xlink:to="aqst_CommercialExploitationAgreementAbstract_lbl2" xlink:title="label: CommercialExploitationAgreementAbstract to aqst_CommercialExploitationAgreementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AutomaticRenewalPeriodOfAgreement" xlink:label="AutomaticRenewalPeriodOfAgreement" xlink:title="AutomaticRenewalPeriodOfAgreement" />
    <link:label xlink:type="resource" xlink:label="aqst_AutomaticRenewalPeriodOfAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AutomaticRenewalPeriodOfAgreement_lbl" xml:lang="en-US" id="aqst_AutomaticRenewalPeriodOfAgreement_lbl">Period for which the agreement is renewed automatically.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AutomaticRenewalPeriodOfAgreement" xlink:to="aqst_AutomaticRenewalPeriodOfAgreement_lbl" xlink:title="label: AutomaticRenewalPeriodOfAgreement to aqst_AutomaticRenewalPeriodOfAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AutomaticRenewalPeriodOfAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AutomaticRenewalPeriodOfAgreement_lbl1" xml:lang="en-US" id="aqst_AutomaticRenewalPeriodOfAgreement_lbl1">Automatic Renewal Period of Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AutomaticRenewalPeriodOfAgreement" xlink:to="aqst_AutomaticRenewalPeriodOfAgreement_lbl1" xlink:title="label: AutomaticRenewalPeriodOfAgreement to aqst_AutomaticRenewalPeriodOfAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AutomaticRenewalPeriodOfAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AutomaticRenewalPeriodOfAgreement_lbl2" xml:lang="en-US" id="aqst_AutomaticRenewalPeriodOfAgreement_lbl2">Automatic renewal period of agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AutomaticRenewalPeriodOfAgreement" xlink:to="aqst_AutomaticRenewalPeriodOfAgreement_lbl2" xlink:title="label: AutomaticRenewalPeriodOfAgreement to aqst_AutomaticRenewalPeriodOfAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_LicenseAgreementTerm_lbl" xml:lang="en-US" id="aqst_LicenseAgreementTerm_lbl">License agreement term period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="aqst_LicenseAgreementTerm_lbl" xlink:title="label: LicenseAgreementTerm to aqst_LicenseAgreementTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_LicenseAgreementTerm_lbl1" xml:lang="en-US" id="aqst_LicenseAgreementTerm_lbl1">License Agreement Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="aqst_LicenseAgreementTerm_lbl1" xlink:title="label: LicenseAgreementTerm to aqst_LicenseAgreementTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_LicenseAgreementTerm_lbl2" xml:lang="en-US" id="aqst_LicenseAgreementTerm_lbl2">License agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="aqst_LicenseAgreementTerm_lbl2" xlink:title="label: LicenseAgreementTerm to aqst_LicenseAgreementTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl1" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl1">License Agreement with Sunovion Pharmaceuticals, Inc. [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl1" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl2" xml:lang="en-US" id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl2">License Agreement with Sunovion Pharmaceuticals, Inc. [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl2" xlink:title="label: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UpfrontPaymentReceived" xlink:label="UpfrontPaymentReceived" xlink:title="UpfrontPaymentReceived" />
    <link:label xlink:type="resource" xlink:label="aqst_UpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_UpfrontPaymentReceived_lbl" xml:lang="en-US" id="aqst_UpfrontPaymentReceived_lbl">Amount of payments to be received during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UpfrontPaymentReceived" xlink:to="aqst_UpfrontPaymentReceived_lbl" xlink:title="label: UpfrontPaymentReceived to aqst_UpfrontPaymentReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_UpfrontPaymentReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_UpfrontPaymentReceived_lbl1" xml:lang="en-US" id="aqst_UpfrontPaymentReceived_lbl1">Upfront Payment Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UpfrontPaymentReceived" xlink:to="aqst_UpfrontPaymentReceived_lbl1" xlink:title="label: UpfrontPaymentReceived to aqst_UpfrontPaymentReceived_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeMilestonePaymentsReceivable" xlink:label="CumulativeMilestonePaymentsReceivable" xlink:title="CumulativeMilestonePaymentsReceivable" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CumulativeMilestonePaymentsReceivable_lbl" xml:lang="en-US" id="aqst_CumulativeMilestonePaymentsReceivable_lbl">Cumulative amount of payments receivable under the collaboration agreement as of the end of the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeMilestonePaymentsReceivable" xlink:to="aqst_CumulativeMilestonePaymentsReceivable_lbl" xlink:title="label: CumulativeMilestonePaymentsReceivable to aqst_CumulativeMilestonePaymentsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeMilestonePaymentsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CumulativeMilestonePaymentsReceivable_lbl1" xml:lang="en-US" id="aqst_CumulativeMilestonePaymentsReceivable_lbl1">Cumulative Milestone Payments Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeMilestonePaymentsReceivable" xlink:to="aqst_CumulativeMilestonePaymentsReceivable_lbl1" xlink:title="label: CumulativeMilestonePaymentsReceivable to aqst_CumulativeMilestonePaymentsReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CumulativeMilestonePaymentsReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CumulativeMilestonePaymentsReceivable_lbl2" xml:lang="en-US" id="aqst_CumulativeMilestonePaymentsReceivable_lbl2">Aggregate milestone payments receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CumulativeMilestonePaymentsReceivable" xlink:to="aqst_CumulativeMilestonePaymentsReceivable_lbl2" xlink:title="label: CumulativeMilestonePaymentsReceivable to aqst_CumulativeMilestonePaymentsReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PaymentReceivableCollaborativeAgreement" xlink:label="PaymentReceivableCollaborativeAgreement" xlink:title="PaymentReceivableCollaborativeAgreement" />
    <link:label xlink:type="resource" xlink:label="aqst_PaymentReceivableCollaborativeAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_PaymentReceivableCollaborativeAgreement_lbl" xml:lang="en-US" id="aqst_PaymentReceivableCollaborativeAgreement_lbl">Amount of payments receivable under the under the collaboration agreement as of the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentReceivableCollaborativeAgreement" xlink:to="aqst_PaymentReceivableCollaborativeAgreement_lbl" xlink:title="label: PaymentReceivableCollaborativeAgreement to aqst_PaymentReceivableCollaborativeAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_PaymentReceivableCollaborativeAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_PaymentReceivableCollaborativeAgreement_lbl1" xml:lang="en-US" id="aqst_PaymentReceivableCollaborativeAgreement_lbl1">Payment Receivable, Collaborative Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentReceivableCollaborativeAgreement" xlink:to="aqst_PaymentReceivableCollaborativeAgreement_lbl1" xlink:title="label: PaymentReceivableCollaborativeAgreement to aqst_PaymentReceivableCollaborativeAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_PaymentReceivableCollaborativeAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_PaymentReceivableCollaborativeAgreement_lbl2" xml:lang="en-US" id="aqst_PaymentReceivableCollaborativeAgreement_lbl2">Payment receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentReceivableCollaborativeAgreement" xlink:to="aqst_PaymentReceivableCollaborativeAgreement_lbl2" xlink:title="label: PaymentReceivableCollaborativeAgreement to aqst_PaymentReceivableCollaborativeAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmAbstract" xlink:label="AgreementToTerminateCLAWithKemPharmAbstract" xlink:title="AgreementToTerminateCLAWithKemPharmAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl1" xml:lang="en-US" id="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl1">Agreement to Terminate CLA with KemPharm [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementToTerminateCLAWithKemPharmAbstract" xlink:to="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl1" xlink:title="label: AgreementToTerminateCLAWithKemPharmAbstract to aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl2" xml:lang="en-US" id="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl2">Agreement to Terminate CLA with KemPharm [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementToTerminateCLAWithKemPharmAbstract" xlink:to="aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl2" xlink:title="label: AgreementToTerminateCLAWithKemPharmAbstract to aqst_AgreementToTerminateCLAWithKemPharmAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmMember" xlink:label="AgreementToTerminateCLAWithKemPharmMember" xlink:title="AgreementToTerminateCLAWithKemPharmMember" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl" xml:lang="en-US" id="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl">The agreement to terminate CLA with KemPharm.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementToTerminateCLAWithKemPharmMember" xlink:to="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl" xlink:title="label: AgreementToTerminateCLAWithKemPharmMember to aqst_AgreementToTerminateCLAWithKemPharmMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl1" xml:lang="en-US" id="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl1">Agreement to Terminate CLA with KemPharm [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementToTerminateCLAWithKemPharmMember" xlink:to="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl1" xlink:title="label: AgreementToTerminateCLAWithKemPharmMember to aqst_AgreementToTerminateCLAWithKemPharmMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl2" xml:lang="en-US" id="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl2">Agreement to Terminate CLA with KemPharm [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementToTerminateCLAWithKemPharmMember" xlink:to="aqst_AgreementToTerminateCLAWithKemPharmMember_lbl2" xlink:title="label: AgreementToTerminateCLAWithKemPharmMember to aqst_AgreementToTerminateCLAWithKemPharmMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PercentageShareOfMilestonePayment" xlink:label="PercentageShareOfMilestonePayment" xlink:title="PercentageShareOfMilestonePayment" />
    <link:label xlink:type="resource" xlink:label="aqst_PercentageShareOfMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_PercentageShareOfMilestonePayment_lbl" xml:lang="en-US" id="aqst_PercentageShareOfMilestonePayment_lbl">Percentage share of milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageShareOfMilestonePayment" xlink:to="aqst_PercentageShareOfMilestonePayment_lbl" xlink:title="label: PercentageShareOfMilestonePayment to aqst_PercentageShareOfMilestonePayment_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_PercentageShareOfMilestonePayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_PercentageShareOfMilestonePayment_lbl1" xml:lang="en-US" id="aqst_PercentageShareOfMilestonePayment_lbl1">Percentage Share of Milestone Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageShareOfMilestonePayment" xlink:to="aqst_PercentageShareOfMilestonePayment_lbl1" xlink:title="label: PercentageShareOfMilestonePayment to aqst_PercentageShareOfMilestonePayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_PercentageShareOfMilestonePayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_PercentageShareOfMilestonePayment_lbl2" xml:lang="en-US" id="aqst_PercentageShareOfMilestonePayment_lbl2">Percentage share of milestone payments paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageShareOfMilestonePayment" xlink:to="aqst_PercentageShareOfMilestonePayment_lbl2" xlink:title="label: PercentageShareOfMilestonePayment to aqst_PercentageShareOfMilestonePayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:label="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:title="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl" xml:lang="en-US" id="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl">Warrant to purchase senior common equity interest ratio to fully diluted common units, on an as converted basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:to="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl" xlink:title="label: WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage to aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl1" xml:lang="en-US" id="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl1">Warrant to purchase senior common equity interest ratio to fully diluted common units, percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:to="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl1" xlink:title="label: WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage to aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl2" xml:lang="en-US" id="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl2">Warrant to purchase senior common equity interest ratio to fully diluted common units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:to="aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl2" xlink:title="label: WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage to aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PerceptiveCreditOpportunitiesFundLPMember" xlink:label="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="PerceptiveCreditOpportunitiesFundLPMember" />
    <link:label xlink:type="resource" xlink:label="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl" xml:lang="en-US" id="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl">A lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerceptiveCreditOpportunitiesFundLPMember" xlink:to="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl" xlink:title="label: PerceptiveCreditOpportunitiesFundLPMember to aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl1" xml:lang="en-US" id="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl1">Perceptive Credit Opportunities Fund, LP [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerceptiveCreditOpportunitiesFundLPMember" xlink:to="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl1" xlink:title="label: PerceptiveCreditOpportunitiesFundLPMember to aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl2" xml:lang="en-US" id="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl2">Perceptive Credit Opportunities Fund, LP [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerceptiveCreditOpportunitiesFundLPMember" xlink:to="aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl2" xlink:title="label: PerceptiveCreditOpportunitiesFundLPMember to aqst_PerceptiveCreditOpportunitiesFundLPMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CompanyOverviewAbstract" xlink:label="CompanyOverviewAbstract" xlink:title="CompanyOverviewAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_CompanyOverviewAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CompanyOverviewAbstract_lbl1" xml:lang="en-US" id="aqst_CompanyOverviewAbstract_lbl1">Company Overview [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompanyOverviewAbstract" xlink:to="aqst_CompanyOverviewAbstract_lbl1" xlink:title="label: CompanyOverviewAbstract to aqst_CompanyOverviewAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfProprietaryProductsInternallyDeveloped" xlink:label="NumberOfProprietaryProductsInternallyDeveloped" xlink:title="NumberOfProprietaryProductsInternallyDeveloped" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl" xml:lang="en-US" id="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl">The number of internally-developed commercialized proprietary products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfProprietaryProductsInternallyDeveloped" xlink:to="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl" xlink:title="label: NumberOfProprietaryProductsInternallyDeveloped to aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl1" xml:lang="en-US" id="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl1">Number of Proprietary Products, Internally-developed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfProprietaryProductsInternallyDeveloped" xlink:to="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl1" xlink:title="label: NumberOfProprietaryProductsInternallyDeveloped to aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl2" xml:lang="en-US" id="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl2">Number of internally-developed proprietary products</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfProprietaryProductsInternallyDeveloped" xlink:to="aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl2" xlink:title="label: NumberOfProprietaryProductsInternallyDeveloped to aqst_NumberOfProprietaryProductsInternallyDeveloped_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EquityOfferingOfCommonStockAbstract" xlink:label="EquityOfferingOfCommonStockAbstract" xlink:title="EquityOfferingOfCommonStockAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_EquityOfferingOfCommonStockAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_EquityOfferingOfCommonStockAbstract_lbl1" xml:lang="en-US" id="aqst_EquityOfferingOfCommonStockAbstract_lbl1">Equity Offering of Common Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="aqst_EquityOfferingOfCommonStockAbstract_lbl1" xlink:title="label: EquityOfferingOfCommonStockAbstract to aqst_EquityOfferingOfCommonStockAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_BasisOfPresentationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_BasisOfPresentationAbstract_lbl1" xml:lang="en-US" id="aqst_BasisOfPresentationAbstract_lbl1">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAbstract" xlink:to="aqst_BasisOfPresentationAbstract_lbl1" xlink:title="label: BasisOfPresentationAbstract to aqst_BasisOfPresentationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentNumberOfTranches" xlink:label="DebtInstrumentNumberOfTranches" xlink:title="DebtInstrumentNumberOfTranches" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentNumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_DebtInstrumentNumberOfTranches_lbl" xml:lang="en-US" id="aqst_DebtInstrumentNumberOfTranches_lbl">Number of Tranches in which additional loan may become available under the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNumberOfTranches" xlink:to="aqst_DebtInstrumentNumberOfTranches_lbl" xlink:title="label: DebtInstrumentNumberOfTranches to aqst_DebtInstrumentNumberOfTranches_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentNumberOfTranches_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_DebtInstrumentNumberOfTranches_lbl1" xml:lang="en-US" id="aqst_DebtInstrumentNumberOfTranches_lbl1">Debt Instrument, Number of Tranches</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNumberOfTranches" xlink:to="aqst_DebtInstrumentNumberOfTranches_lbl1" xlink:title="label: DebtInstrumentNumberOfTranches to aqst_DebtInstrumentNumberOfTranches_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_DebtInstrumentNumberOfTranches_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_DebtInstrumentNumberOfTranches_lbl2" xml:lang="en-US" id="aqst_DebtInstrumentNumberOfTranches_lbl2">Number of tranches</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNumberOfTranches" xlink:to="aqst_DebtInstrumentNumberOfTranches_lbl2" xlink:title="label: DebtInstrumentNumberOfTranches to aqst_DebtInstrumentNumberOfTranches_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionOne" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl">The portion of proceeds amount to monetize asset if the First Additional Offering has not been elected or funded.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionOne to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl1" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl1">Portion of Proceeds Amount to Monetize Assets, Condition One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl1" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionOne to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl2" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl2">Portion of proceeds used to monetize assets, if First Additional Offering has not been elected or funded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl2" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionOne to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:label="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:title="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl">The annual percentage increase of initial loan principal payments during final four quarters.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl" xlink:title="label: AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters to aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl1" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl1">Annual Percentage Increase of Initial Loan Principal Payments During Final Four Quarters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl1" xlink:title="label: AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters to aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl2" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl2">Annual percentage increase of initial loan principal payments during final four quarters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl2" xlink:title="label: AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters to aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:label="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:title="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl">The annual percentage increase in principal payments during first four quarters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl" xlink:title="label: AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters to aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl1" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl1">Annual Percentage Increase in Principal Payments During First Four Quarters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl1" xlink:title="label: AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters to aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl2" xml:lang="en-US" id="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl2">Annual percentage increase in principal payments during first four quarters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:to="aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl2" xlink:title="label: AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters to aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ElectiveRedemptionPercentageOfDebt" xlink:label="ElectiveRedemptionPercentageOfDebt" xlink:title="ElectiveRedemptionPercentageOfDebt" />
    <link:label xlink:type="resource" xlink:label="aqst_ElectiveRedemptionPercentageOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ElectiveRedemptionPercentageOfDebt_lbl" xml:lang="en-US" id="aqst_ElectiveRedemptionPercentageOfDebt_lbl">Elective redemption percentage of debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ElectiveRedemptionPercentageOfDebt" xlink:to="aqst_ElectiveRedemptionPercentageOfDebt_lbl" xlink:title="label: ElectiveRedemptionPercentageOfDebt to aqst_ElectiveRedemptionPercentageOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ElectiveRedemptionPercentageOfDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ElectiveRedemptionPercentageOfDebt_lbl1" xml:lang="en-US" id="aqst_ElectiveRedemptionPercentageOfDebt_lbl1">Elective redemption percentage of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ElectiveRedemptionPercentageOfDebt" xlink:to="aqst_ElectiveRedemptionPercentageOfDebt_lbl1" xlink:title="label: ElectiveRedemptionPercentageOfDebt to aqst_ElectiveRedemptionPercentageOfDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ElectiveRedemptionPercentageOfDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ElectiveRedemptionPercentageOfDebt_lbl2" xml:lang="en-US" id="aqst_ElectiveRedemptionPercentageOfDebt_lbl2">Elective redemption percentage of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ElectiveRedemptionPercentageOfDebt" xlink:to="aqst_ElectiveRedemptionPercentageOfDebt_lbl2" xlink:title="label: ElectiveRedemptionPercentageOfDebt to aqst_ElectiveRedemptionPercentageOfDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:label="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:title="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" />
    <link:label xlink:type="resource" xlink:label="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl" xml:lang="en-US" id="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl">The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:to="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl" xlink:title="label: NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights to aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl1" xml:lang="en-US" id="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl1">Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:to="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl1" xlink:title="label: NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights to aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl2" xml:lang="en-US" id="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl2">Net proceeds from issuance of initial notes, warrants and first offer rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:to="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl2" xlink:title="label: NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights to aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:label="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:title="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" />
    <link:label xlink:type="resource" xlink:label="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl" xml:lang="en-US" id="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl">Redemption percentage of debt under change of control provisions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:to="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl" xlink:title="label: RedemptionPercentageOfDebtUnderChangeOfControlProvisions to aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl1" xml:lang="en-US" id="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl1">Redemption percentage of debt under change of control provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:to="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl1" xlink:title="label: RedemptionPercentageOfDebtUnderChangeOfControlProvisions to aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl2" xml:lang="en-US" id="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl2">Redemption percentage of debt under change of control provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:to="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl2" xlink:title="label: RedemptionPercentageOfDebtUnderChangeOfControlProvisions to aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:label="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:title="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" />
    <link:label xlink:type="resource" xlink:label="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl" xml:lang="en-US" id="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl">Asset based loans secured on second priority lien by receivables and inventory assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:to="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl" xlink:title="label: AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets to aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl1" xml:lang="en-US" id="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl1">Asset based loans secured on second priority lien by receivables and inventory assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:to="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl1" xlink:title="label: AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets to aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl2" xml:lang="en-US" id="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl2">Asset based loans secured on second priority lien by receivables and inventory assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:to="aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl2" xlink:title="label: AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets to aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl">The portion of proceeds amount to monetize asset if the First Additional Offering has been elected and funded.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionTwo to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl1" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl1">Portion of Proceeds Amount to Monetize Assets, Condition Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl1" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionTwo to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl2" xml:lang="en-US" id="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl2">Portion of proceeds used to monetize assets, if First Additional Offering has been elected and funded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:to="aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl2" xlink:title="label: PortionOfProceedsAmountToMonetizeAssetsConditionTwo to aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfOperatingLeases" xlink:label="NumberOfOperatingLeases" xlink:title="NumberOfOperatingLeases" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfOperatingLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfOperatingLeases_lbl" xml:lang="en-US" id="aqst_NumberOfOperatingLeases_lbl">Number of operating leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingLeases" xlink:to="aqst_NumberOfOperatingLeases_lbl" xlink:title="label: NumberOfOperatingLeases to aqst_NumberOfOperatingLeases_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfOperatingLeases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfOperatingLeases_lbl1" xml:lang="en-US" id="aqst_NumberOfOperatingLeases_lbl1">Number of Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingLeases" xlink:to="aqst_NumberOfOperatingLeases_lbl1" xlink:title="label: NumberOfOperatingLeases to aqst_NumberOfOperatingLeases_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfOperatingLeases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfOperatingLeases_lbl2" xml:lang="en-US" id="aqst_NumberOfOperatingLeases_lbl2">Number of leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingLeases" xlink:to="aqst_NumberOfOperatingLeases_lbl2" xlink:title="label: NumberOfOperatingLeases to aqst_NumberOfOperatingLeases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanAbstract" xlink:label="EmployeeStockPurchasePlanAbstract" xlink:title="EmployeeStockPurchasePlanAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_EmployeeStockPurchasePlanAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_EmployeeStockPurchasePlanAbstract_lbl1" xml:lang="en-US" id="aqst_EmployeeStockPurchasePlanAbstract_lbl1">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanAbstract" xlink:to="aqst_EmployeeStockPurchasePlanAbstract_lbl1" xlink:title="label: EmployeeStockPurchasePlanAbstract to aqst_EmployeeStockPurchasePlanAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:label="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:title="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" />
    <link:label xlink:type="resource" xlink:label="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl">Discount value on shares issued under employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:to="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl" xlink:title="label: DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan to aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl1" xml:lang="en-US" id="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl1">Discount value on shares issued under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:to="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl1" xlink:title="label: DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan to aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl2" xml:lang="en-US" id="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl2">Discount value on shares issued under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:to="aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl2" xlink:title="label: DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan to aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationEquityAwardsAbstract" xlink:label="ShareBasedCompensationEquityAwardsAbstract" xlink:title="ShareBasedCompensationEquityAwardsAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl1" xml:lang="en-US" id="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl1">Share-Based Compensation Equity Awards [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl1" xlink:title="label: ShareBasedCompensationEquityAwardsAbstract to aqst_ShareBasedCompensationEquityAwardsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl2" xml:lang="en-US" id="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl2">Share-Based Compensation Equity Awards [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="aqst_ShareBasedCompensationEquityAwardsAbstract_lbl2" xlink:title="label: ShareBasedCompensationEquityAwardsAbstract to aqst_ShareBasedCompensationEquityAwardsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl">The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl1" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl2" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl2">Grant date fair value of shares vested during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl">The aggregate intrinsic value of stock options granted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl1" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl2" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl2">Intrinsic value of options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl">For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl1" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised,Forfeitures and Expirations in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl2" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl2">Exercised, Forfeited, Expired (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:label xlink:type="resource" xlink:label="aqst_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US" id="aqst_EmployeeStockPurchasePlanMember_lbl">The Employee Stock Purchase Plan (the "ESPP") allows eligible full-time employees to purchase shares of common stock at 90 percent of the lower of the fair market value of a share of common stock on the first or last day of the quarter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMember" xlink:to="aqst_EmployeeStockPurchasePlanMember_lbl" xlink:title="label: EmployeeStockPurchasePlanMember to aqst_EmployeeStockPurchasePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_EmployeeStockPurchasePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_EmployeeStockPurchasePlanMember_lbl1" xml:lang="en-US" id="aqst_EmployeeStockPurchasePlanMember_lbl1">Employee Stock Purchase Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMember" xlink:to="aqst_EmployeeStockPurchasePlanMember_lbl1" xlink:title="label: EmployeeStockPurchasePlanMember to aqst_EmployeeStockPurchasePlanMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufacturingAndSupplyMember" xlink:label="ManufacturingAndSupplyMember" xlink:title="ManufacturingAndSupplyMember" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufacturingAndSupplyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ManufacturingAndSupplyMember_lbl" xml:lang="en-US" id="aqst_ManufacturingAndSupplyMember_lbl">Primary financial statement caption encompassing Manufacturing and supply expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufacturingAndSupplyMember" xlink:to="aqst_ManufacturingAndSupplyMember_lbl" xlink:title="label: ManufacturingAndSupplyMember to aqst_ManufacturingAndSupplyMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufacturingAndSupplyMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ManufacturingAndSupplyMember_lbl1" xml:lang="en-US" id="aqst_ManufacturingAndSupplyMember_lbl1">Manufacturing and supply [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufacturingAndSupplyMember" xlink:to="aqst_ManufacturingAndSupplyMember_lbl1" xlink:title="label: ManufacturingAndSupplyMember to aqst_ManufacturingAndSupplyMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ManufacturingAndSupplyMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_ManufacturingAndSupplyMember_lbl2" xml:lang="en-US" id="aqst_ManufacturingAndSupplyMember_lbl2">Manufacture and Supply [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManufacturingAndSupplyMember" xlink:to="aqst_ManufacturingAndSupplyMember_lbl2" xlink:title="label: ManufacturingAndSupplyMember to aqst_ManufacturingAndSupplyMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl">Weighted average price of options that were either exercised, forfeited or expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl1">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period WeightedAverageExercisePrice</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl2">Exercised, Forfeited, Expired (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice to aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:label="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:title="ShareBasedPaymentArrangementNumberOfOfferingPeriods" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl" xml:lang="en-US" id="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl">Number of offering periods in a share-based payment arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:to="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl" xlink:title="label: ShareBasedPaymentArrangementNumberOfOfferingPeriods to aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl1" xml:lang="en-US" id="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl1">Share-based Payment Arrangement, Number of Offering Periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:to="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl1" xlink:title="label: ShareBasedPaymentArrangementNumberOfOfferingPeriods to aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl2" xml:lang="en-US" id="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl2">Number of offering periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:to="aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl2" xlink:title="label: ShareBasedPaymentArrangementNumberOfOfferingPeriods to aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WorkingCapitalDeficit" xlink:label="WorkingCapitalDeficit" xlink:title="WorkingCapitalDeficit" />
    <link:label xlink:type="resource" xlink:label="aqst_WorkingCapitalDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_WorkingCapitalDeficit_lbl" xml:lang="en-US" id="aqst_WorkingCapitalDeficit_lbl">Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WorkingCapitalDeficit" xlink:to="aqst_WorkingCapitalDeficit_lbl" xlink:title="label: WorkingCapitalDeficit to aqst_WorkingCapitalDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_WorkingCapitalDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_WorkingCapitalDeficit_lbl1" xml:lang="en-US" id="aqst_WorkingCapitalDeficit_lbl1">Working Capital (Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WorkingCapitalDeficit" xlink:to="aqst_WorkingCapitalDeficit_lbl1" xlink:title="label: WorkingCapitalDeficit to aqst_WorkingCapitalDeficit_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_WorkingCapitalDeficit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_WorkingCapitalDeficit_lbl2" xml:lang="en-US" id="aqst_WorkingCapitalDeficit_lbl2">Working capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WorkingCapitalDeficit" xlink:to="aqst_WorkingCapitalDeficit_lbl2" xlink:title="label: WorkingCapitalDeficit to aqst_WorkingCapitalDeficit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdditionalFundAmount" xlink:label="AdditionalFundAmount" xlink:title="AdditionalFundAmount" />
    <link:label xlink:type="resource" xlink:label="aqst_AdditionalFundAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AdditionalFundAmount_lbl" xml:lang="en-US" id="aqst_AdditionalFundAmount_lbl">Amount included in debt instrument face amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFundAmount" xlink:to="aqst_AdditionalFundAmount_lbl" xlink:title="label: AdditionalFundAmount to aqst_AdditionalFundAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AdditionalFundAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AdditionalFundAmount_lbl1" xml:lang="en-US" id="aqst_AdditionalFundAmount_lbl1">Additional Fund Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFundAmount" xlink:to="aqst_AdditionalFundAmount_lbl1" xlink:title="label: AdditionalFundAmount to aqst_AdditionalFundAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AdditionalFundAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_AdditionalFundAmount_lbl2" xml:lang="en-US" id="aqst_AdditionalFundAmount_lbl2">Additional fund amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFundAmount" xlink:to="aqst_AdditionalFundAmount_lbl2" xlink:title="label: AdditionalFundAmount to aqst_AdditionalFundAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" />
    <link:label xlink:type="resource" xlink:label="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl" xml:lang="en-US" id="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl">Amount of increase in additional paid in capital (APIC) resulting from the exercise of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:to="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantExercise to aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl1" xml:lang="en-US" id="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl1">Adjustments to Additional Paid in Capital, Warrant Exercise</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:to="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantExercise to aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl2" xml:lang="en-US" id="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl2">Common Stock issued upon warrant exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:to="aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl2" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantExercise to aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UnvestedRestrictedStockUnitsMember" xlink:label="UnvestedRestrictedStockUnitsMember" xlink:title="UnvestedRestrictedStockUnitsMember" />
    <link:label xlink:type="resource" xlink:label="aqst_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_UnvestedRestrictedStockUnitsMember_lbl" xml:lang="en-US" id="aqst_UnvestedRestrictedStockUnitsMember_lbl">Unvested share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnvestedRestrictedStockUnitsMember" xlink:to="aqst_UnvestedRestrictedStockUnitsMember_lbl" xlink:title="label: UnvestedRestrictedStockUnitsMember to aqst_UnvestedRestrictedStockUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_UnvestedRestrictedStockUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_UnvestedRestrictedStockUnitsMember_lbl1" xml:lang="en-US" id="aqst_UnvestedRestrictedStockUnitsMember_lbl1">Unvested Restricted Stock Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnvestedRestrictedStockUnitsMember" xlink:to="aqst_UnvestedRestrictedStockUnitsMember_lbl1" xlink:title="label: UnvestedRestrictedStockUnitsMember to aqst_UnvestedRestrictedStockUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_UnvestedRestrictedStockUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="aqst_UnvestedRestrictedStockUnitsMember_lbl2" xml:lang="en-US" id="aqst_UnvestedRestrictedStockUnitsMember_lbl2">Restricted Stock Units Unvested [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnvestedRestrictedStockUnitsMember" xlink:to="aqst_UnvestedRestrictedStockUnitsMember_lbl2" xlink:title="label: UnvestedRestrictedStockUnitsMember to aqst_UnvestedRestrictedStockUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DilutiveInstrumentsAbstract" xlink:label="DilutiveInstrumentsAbstract" xlink:title="DilutiveInstrumentsAbstract" />
    <link:label xlink:type="resource" xlink:label="aqst_DilutiveInstrumentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_DilutiveInstrumentsAbstract_lbl1" xml:lang="en-US" id="aqst_DilutiveInstrumentsAbstract_lbl1">Dilutive Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DilutiveInstrumentsAbstract" xlink:to="aqst_DilutiveInstrumentsAbstract_lbl1" xlink:title="label: DilutiveInstrumentsAbstract to aqst_DilutiveInstrumentsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_DilutiveInstrumentsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_DilutiveInstrumentsAbstract_lbl2" xml:lang="en-US" id="aqst_DilutiveInstrumentsAbstract_lbl2">Dilutive Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DilutiveInstrumentsAbstract" xlink:to="aqst_DilutiveInstrumentsAbstract_lbl2" xlink:title="label: DilutiveInstrumentsAbstract to aqst_DilutiveInstrumentsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InventoryPackingMaterialGross" xlink:label="InventoryPackingMaterialGross" xlink:title="InventoryPackingMaterialGross" />
    <link:label xlink:type="resource" xlink:label="aqst_InventoryPackingMaterialGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_InventoryPackingMaterialGross_lbl" xml:lang="en-US" id="aqst_InventoryPackingMaterialGross_lbl">Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryPackingMaterialGross" xlink:to="aqst_InventoryPackingMaterialGross_lbl" xlink:title="label: InventoryPackingMaterialGross to aqst_InventoryPackingMaterialGross_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_InventoryPackingMaterialGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_InventoryPackingMaterialGross_lbl1" xml:lang="en-US" id="aqst_InventoryPackingMaterialGross_lbl1">Inventory Packing Material Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryPackingMaterialGross" xlink:to="aqst_InventoryPackingMaterialGross_lbl1" xlink:title="label: InventoryPackingMaterialGross to aqst_InventoryPackingMaterialGross_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_InventoryPackingMaterialGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_InventoryPackingMaterialGross_lbl2" xml:lang="en-US" id="aqst_InventoryPackingMaterialGross_lbl2">Packaging material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InventoryPackingMaterialGross" xlink:to="aqst_InventoryPackingMaterialGross_lbl2" xlink:title="label: InventoryPackingMaterialGross to aqst_InventoryPackingMaterialGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfStatesInTheAntitrustLitigation" xlink:label="NumberOfStatesInTheAntitrustLitigation" xlink:title="NumberOfStatesInTheAntitrustLitigation" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfStatesInTheAntitrustLitigation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfStatesInTheAntitrustLitigation_lbl" xml:lang="en-US" id="aqst_NumberOfStatesInTheAntitrustLitigation_lbl">The number of states in the antitrust litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInTheAntitrustLitigation" xlink:to="aqst_NumberOfStatesInTheAntitrustLitigation_lbl" xlink:title="label: NumberOfStatesInTheAntitrustLitigation to aqst_NumberOfStatesInTheAntitrustLitigation_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfStatesInTheAntitrustLitigation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfStatesInTheAntitrustLitigation_lbl1" xml:lang="en-US" id="aqst_NumberOfStatesInTheAntitrustLitigation_lbl1">Number of states in the antitrust litigation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInTheAntitrustLitigation" xlink:to="aqst_NumberOfStatesInTheAntitrustLitigation_lbl1" xlink:title="label: NumberOfStatesInTheAntitrustLitigation to aqst_NumberOfStatesInTheAntitrustLitigation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfPatents" xlink:label="NumberOfPatents" xlink:title="NumberOfPatents" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfPatents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfPatents_lbl" xml:lang="en-US" id="aqst_NumberOfPatents_lbl">Number of patents that contain new claims.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPatents" xlink:to="aqst_NumberOfPatents_lbl" xlink:title="label: NumberOfPatents to aqst_NumberOfPatents_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfPatents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfPatents_lbl1" xml:lang="en-US" id="aqst_NumberOfPatents_lbl1">Number of Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPatents" xlink:to="aqst_NumberOfPatents_lbl1" xlink:title="label: NumberOfPatents to aqst_NumberOfPatents_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfPatents_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfPatents_lbl2" xml:lang="en-US" id="aqst_NumberOfPatents_lbl2">Number of additional infringement on patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPatents" xlink:to="aqst_NumberOfPatents_lbl2" xlink:title="label: NumberOfPatents to aqst_NumberOfPatents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_HumanaAndCenteneActionsMember" xlink:label="HumanaAndCenteneActionsMember" xlink:title="HumanaAndCenteneActionsMember" />
    <link:label xlink:type="resource" xlink:label="aqst_HumanaAndCenteneActionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_HumanaAndCenteneActionsMember_lbl" xml:lang="en-US" id="aqst_HumanaAndCenteneActionsMember_lbl">Information by type of judicial proceeding, alternative dispute resolution or claim.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HumanaAndCenteneActionsMember" xlink:to="aqst_HumanaAndCenteneActionsMember_lbl" xlink:title="label: HumanaAndCenteneActionsMember to aqst_HumanaAndCenteneActionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_HumanaAndCenteneActionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_HumanaAndCenteneActionsMember_lbl1" xml:lang="en-US" id="aqst_HumanaAndCenteneActionsMember_lbl1">Humana and Centene Actions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HumanaAndCenteneActionsMember" xlink:to="aqst_HumanaAndCenteneActionsMember_lbl1" xlink:title="label: HumanaAndCenteneActionsMember to aqst_HumanaAndCenteneActionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_HumanaAndCenteneActionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_HumanaAndCenteneActionsMember_lbl2" xml:lang="en-US" id="aqst_HumanaAndCenteneActionsMember_lbl2">Humana and Centene Actions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HumanaAndCenteneActionsMember" xlink:to="aqst_HumanaAndCenteneActionsMember_lbl2" xlink:title="label: HumanaAndCenteneActionsMember to aqst_HumanaAndCenteneActionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CaliforniaComplaintMember" xlink:label="CaliforniaComplaintMember" xlink:title="CaliforniaComplaintMember" />
    <link:label xlink:type="resource" xlink:label="aqst_CaliforniaComplaintMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_CaliforniaComplaintMember_lbl" xml:lang="en-US" id="aqst_CaliforniaComplaintMember_lbl">Information by type of judicial proceeding, alternative dispute resolution or claim.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CaliforniaComplaintMember" xlink:to="aqst_CaliforniaComplaintMember_lbl" xlink:title="label: CaliforniaComplaintMember to aqst_CaliforniaComplaintMember_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_CaliforniaComplaintMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_CaliforniaComplaintMember_lbl1" xml:lang="en-US" id="aqst_CaliforniaComplaintMember_lbl1">California Complaint [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CaliforniaComplaintMember" xlink:to="aqst_CaliforniaComplaintMember_lbl1" xlink:title="label: CaliforniaComplaintMember to aqst_CaliforniaComplaintMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_CaliforniaComplaintMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_CaliforniaComplaintMember_lbl2" xml:lang="en-US" id="aqst_CaliforniaComplaintMember_lbl2">California Complaint [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CaliforniaComplaintMember" xlink:to="aqst_CaliforniaComplaintMember_lbl2" xlink:title="label: CaliforniaComplaintMember to aqst_CaliforniaComplaintMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCauses" xlink:label="NumberOfCauses" xlink:title="NumberOfCauses" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCauses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="aqst_NumberOfCauses_lbl" xml:lang="en-US" id="aqst_NumberOfCauses_lbl">Number of causes of action.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCauses" xlink:to="aqst_NumberOfCauses_lbl" xlink:title="label: NumberOfCauses to aqst_NumberOfCauses_lbl" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCauses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="aqst_NumberOfCauses_lbl1" xml:lang="en-US" id="aqst_NumberOfCauses_lbl1">Cause of Action, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCauses" xlink:to="aqst_NumberOfCauses_lbl1" xlink:title="label: NumberOfCauses to aqst_NumberOfCauses_lbl1" />
    <link:label xlink:type="resource" xlink:label="aqst_NumberOfCauses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="aqst_NumberOfCauses_lbl2" xml:lang="en-US" id="aqst_NumberOfCauses_lbl2">Number of causes alleged</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfCauses" xlink:to="aqst_NumberOfCauses_lbl2" xlink:title="label: NumberOfCauses to aqst_NumberOfCauses_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>aqst-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SubsequentEventsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#ContingenciesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#IncomeTaxesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensationDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensationDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShareDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#WarrantsIssuedTo125SeniorSecuredNoteholdersDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayablePerceptiveDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpensesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssetsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetailsCalc2" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#FinancialInstrumentsFairValueMeasurementsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsAgreementToTerminateClaWithKempharmDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreementsAgreementWithIndiviorDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetRevenueDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/RisksAndUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#RisksAndUncertaintiesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails" xlink:type="simple" xlink:href="aqst-20200930.xsd#CorporateOrganizationAndCompanyOverviewDetails" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensationTables" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShareTables" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayableTables" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpensesTables" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssetsTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligationsTables" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetTables" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNetPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/BasisOfPresentationPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#BasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEvents" xlink:type="simple" xlink:href="aqst-20200930.xsd#SubsequentEvents" />
  <link:roleRef roleURI="http://aquestive.com/role/Contingencies" xlink:type="simple" xlink:href="aqst-20200930.xsd#Contingencies" />
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aqst-20200930.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://aquestive.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="aqst-20200930.xsd#SharebasedCompensation" />
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShare" xlink:type="simple" xlink:href="aqst-20200930.xsd#NetLossPerShare" />
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders" xlink:type="simple" xlink:href="aqst-20200930.xsd#WarrantsIssuedTo125SeniorSecuredNoteholders" />
  <link:roleRef roleURI="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable" xlink:type="simple" xlink:href="aqst-20200930.xsd#SeniorSecuredNotesAndLoansPayable" />
  <link:roleRef roleURI="http://aquestive.com/role/AccountsPayableAndAccruedExpenses" xlink:type="simple" xlink:href="aqst-20200930.xsd#AccountsPayableAndAccruedExpenses" />
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets" xlink:type="simple" xlink:href="aqst-20200930.xsd#IntangibleAssetsNetAndOtherAssets" />
  <link:roleRef roleURI="http://aquestive.com/role/RightofuseAssetsAndLeaseObligations" xlink:type="simple" xlink:href="aqst-20200930.xsd#RightofuseAssetsAndLeaseObligations" />
  <link:roleRef roleURI="http://aquestive.com/role/PropertyAndEquipmentNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#PropertyAndEquipmentNet" />
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#InventoriesNet" />
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="simple" xlink:href="aqst-20200930.xsd#FinancialInstrumentsFairValueMeasurements" />
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreements" xlink:type="simple" xlink:href="aqst-20200930.xsd#MaterialAgreements" />
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesAndTradeReceivablesNet" xlink:type="simple" xlink:href="aqst-20200930.xsd#RevenuesAndTradeReceivablesNet" />
  <link:roleRef roleURI="http://aquestive.com/role/RisksAndUncertainties" xlink:type="simple" xlink:href="aqst-20200930.xsd#RisksAndUncertainties" />
  <link:roleRef roleURI="http://aquestive.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="aqst-20200930.xsd#SummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://aquestive.com/role/BasisOfPresentation" xlink:type="simple" xlink:href="aqst-20200930.xsd#BasisOfPresentation" />
  <link:roleRef roleURI="http://aquestive.com/role/CorporateOrganizationAndCompanyOverview" xlink:type="simple" xlink:href="aqst-20200930.xsd#CorporateOrganizationAndCompanyOverview" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:roleRef roleURI="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="aqst-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited" />
  <link:roleRef roleURI="http://aquestive.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="aqst-20200930.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: CoverAbstract to EntityExTransitionPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="TradeAndOtherReceivablesNet" xlink:title="presentation: AssetsCurrentAbstract to TradeAndOtherReceivablesNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="InventoryNet" xlink:title="presentation: AssetsCurrentAbstract to InventoryNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="presentation: AssetsAbstract to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LoansPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LoansPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="ContractWithCustomerLiabilityCurrent" xlink:title="ContractWithCustomerLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="ContractWithCustomerLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to ContractWithCustomerLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="LongTermLoansPayable" xlink:title="LongTermLoansPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermLoansPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermLoansPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="ContractWithCustomerLiabilityNoncurrent" xlink:title="ContractWithCustomerLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="ContractWithCustomerLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to ContractWithCustomerLiabilityNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="AssetRetirementObligationsNoncurrent" xlink:title="AssetRetirementObligationsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="AssetRetirementObligationsNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to AssetRetirementObligationsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: IncomeStatementAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="CostOfGoodsAndServicesSold" xlink:title="CostOfGoodsAndServicesSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="CostOfGoodsAndServicesSold" xlink:title="presentation: OperatingExpensesAbstract to CostOfGoodsAndServicesSold" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to SellingGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="CostsAndExpenses" xlink:title="presentation: OperatingExpensesAbstract to CostsAndExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="NonoperatingIncomeExpenseAbstract" xlink:title="NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="InterestExpense" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to InterestExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="InvestmentIncomeInterest" xlink:title="InvestmentIncomeInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="InvestmentIncomeInterest" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to InvestmentIncomeInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to GainsLossesOnExtinguishmentOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NonoperatingIncomeExpenseAbstract" xlink:title="presentation: IncomeStatementAbstract to NonoperatingIncomeExpenseAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ComprehensiveIncomeNetOfTax" xlink:title="presentation: IncomeStatementAbstract to ComprehensiveIncomeNetOfTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasicAndDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="CumulativeEffectPeriodOfAdoptionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="CumulativeEffectPeriodOfAdoptionDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:title="CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CumulativeEffectPeriodOfAdoptionDomain" xlink:to="CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:title="presentation: CumulativeEffectPeriodOfAdoptionDomain to CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CumulativeEffectPeriodOfAdoptionAxis" xlink:to="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="presentation: CumulativeEffectPeriodOfAdoptionAxis to CumulativeEffectPeriodOfAdoptionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="presentation: StatementTable to CumulativeEffectPeriodOfAdoptionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesShareBasedCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_2" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AmortizationOfFinancingCostsAndDiscounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainsLossesOnExtinguishmentOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="OtherNoncashIncomeExpense" xlink:title="OtherNoncashIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OtherNoncashIncomeExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OtherNoncashIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsAndOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="IncreaseDecreaseInInventories" xlink:title="IncreaseDecreaseInInventories" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInInventories" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDeferredRevenue" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDeferredRevenue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:title="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="PaymentsOfFinancingCosts" xlink:title="PaymentsOfFinancingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfFinancingCosts" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfFinancingCosts" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="PaymentsOfDebtExtinguishmentCosts" xlink:title="PaymentsOfDebtExtinguishmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDebtExtinguishmentCosts" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDebtExtinguishmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="CashAndCashEquivalentsAbstract" xlink:title="CashAndCashEquivalentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: CashAndCashEquivalentsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: CashAndCashEquivalentsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: SupplementalCashFlowInformationAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:label="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:title="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" xlink:title="presentation: SupplementalCashFlowInformationAbstract to IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:title="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:title="presentation: SupplementalCashFlowInformationAbstract to IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsIssuedInConnectionWithLongTermDebt" xlink:label="WarrantsIssuedInConnectionWithLongTermDebt" xlink:title="WarrantsIssuedInConnectionWithLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="WarrantsIssuedInConnectionWithLongTermDebt" xlink:title="presentation: SupplementalCashFlowInformationAbstract to WarrantsIssuedInConnectionWithLongTermDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CorporateOrganizationAndCompanyOverview">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/BasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="BasisOfAccounting" xlink:title="BasisOfAccounting" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="BasisOfAccounting" xlink:title="presentation: BasisOfPresentationAbstract to BasisOfAccounting" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RisksAndUncertainties">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="RisksAndUncertaintiesAbstract" xlink:title="RisksAndUncertaintiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="ConcentrationRiskDisclosureTextBlock" xlink:title="ConcentrationRiskDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RisksAndUncertaintiesAbstract" xlink:to="ConcentrationRiskDisclosureTextBlock" xlink:title="presentation: RisksAndUncertaintiesAbstract to ConcentrationRiskDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNet">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetTextBlock" xlink:label="RevenuesAndTradeReceivablesNetTextBlock" xlink:title="RevenuesAndTradeReceivablesNetTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="RevenuesAndTradeReceivablesNetTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to RevenuesAndTradeReceivablesNetTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreements">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaterialAgreementsAbstract" xlink:label="MaterialAgreementsAbstract" xlink:title="MaterialAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="CollaborativeArrangementDisclosureTextBlock" xlink:title="CollaborativeArrangementDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaterialAgreementsAbstract" xlink:to="CollaborativeArrangementDisclosureTextBlock" xlink:title="presentation: MaterialAgreementsAbstract to CollaborativeArrangementDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" xlink:title="InventoryDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="InventoryDisclosureTextBlock" xlink:title="InventoryDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="InventoryDisclosureTextBlock" xlink:title="presentation: InventoryDisclosureAbstract to InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligations">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsDisclosureTextBlock" xlink:label="WarrantsDisclosureTextBlock" xlink:title="WarrantsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="WarrantsDisclosureTextBlock" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to WarrantsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShare">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/Contingencies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SubsequentEvents">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/BasisOfPresentationPolicies">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: BasisOfPresentationAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="ConsolidationPolicyTextBlock" xlink:title="ConsolidationPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConsolidationPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to RevenueFromContractWithCustomerPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:title="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="DisaggregationOfRevenueTableTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to DisaggregationOfRevenueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:title="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:title="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:label="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:title="SalesRelatedAllowancesAndAccrualsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="SalesRelatedAllowancesAndAccrualsTableTextBlock" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to SalesRelatedAllowancesAndAccrualsTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" xlink:title="InventoryDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="ScheduleOfInventoryCurrentTableTextBlock" xlink:title="ScheduleOfInventoryCurrentTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="ScheduleOfInventoryCurrentTableTextBlock" xlink:title="presentation: InventoryDisclosureAbstract to ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShareTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:title="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to NonvestedRestrictedStockSharesActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CompanyOverviewAbstract" xlink:label="CompanyOverviewAbstract" xlink:title="CompanyOverviewAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfProprietaryProductsInternallyDeveloped" xlink:label="NumberOfProprietaryProductsInternallyDeveloped" xlink:title="NumberOfProprietaryProductsInternallyDeveloped" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompanyOverviewAbstract" xlink:to="NumberOfProprietaryProductsInternallyDeveloped" xlink:title="presentation: CompanyOverviewAbstract to NumberOfProprietaryProductsInternallyDeveloped" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="CompanyOverviewAbstract" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to CompanyOverviewAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EquityOfferingOfCommonStockAbstract" xlink:label="EquityOfferingOfCommonStockAbstract" xlink:title="EquityOfferingOfCommonStockAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="ProceedsFromIssuanceInitialPublicOffering" xlink:title="ProceedsFromIssuanceInitialPublicOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="ProceedsFromIssuanceInitialPublicOffering" xlink:title="presentation: EquityOfferingOfCommonStockAbstract to ProceedsFromIssuanceInitialPublicOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="PaymentsOfStockIssuanceCosts" xlink:title="PaymentsOfStockIssuanceCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="PaymentsOfStockIssuanceCosts" xlink:title="presentation: EquityOfferingOfCommonStockAbstract to PaymentsOfStockIssuanceCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: EquityOfferingOfCommonStockAbstract to StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: EquityOfferingOfCommonStockAbstract to CommonStockParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="ProfessionalFees" xlink:title="ProfessionalFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityOfferingOfCommonStockAbstract" xlink:to="ProfessionalFees" xlink:title="presentation: EquityOfferingOfCommonStockAbstract to ProfessionalFees" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="EquityOfferingOfCommonStockAbstract" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to EquityOfferingOfCommonStockAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to AdjustmentsForNewAccountingPronouncementsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to OperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="DebtInstrumentInterestRateIncreaseDecrease" xlink:title="DebtInstrumentInterestRateIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="DebtInstrumentInterestRateIncreaseDecrease" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to DebtInstrumentInterestRateIncreaseDecrease" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RisksAndUncertaintiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="RisksAndUncertaintiesAbstract" xlink:title="RisksAndUncertaintiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WorkingCapitalDeficit" xlink:label="WorkingCapitalDeficit" xlink:title="WorkingCapitalDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RisksAndUncertaintiesAbstract" xlink:to="WorkingCapitalDeficit" xlink:title="presentation: RisksAndUncertaintiesAbstract to WorkingCapitalDeficit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RisksAndUncertaintiesAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: RisksAndUncertaintiesAbstract to CashAndCashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="presentation: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: ConcentrationRiskTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract" xlink:label="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:title="DebtInstrumentInterestRateStatedPercentageAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to DebtInstrumentInterestRateStatedPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdditionalFundAmount" xlink:label="AdditionalFundAmount" xlink:title="AdditionalFundAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="AdditionalFundAmount" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to AdditionalFundAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to ProceedsFromIssuanceOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to ProceedsFromIssuanceOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantExercise" xlink:title="presentation: DebtInstrumentInterestRateStatedPercentageAbstract to AdjustmentsToAdditionalPaidInCapitalWarrantExercise" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentageAbstract" xlink:title="presentation: ConcentrationRiskLineItems to DebtInstrumentInterestRateStatedPercentageAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskTable" xlink:to="ConcentrationRiskLineItems" xlink:title="presentation: ConcentrationRiskTable to ConcentrationRiskLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RisksAndUncertaintiesAbstract" xlink:to="ConcentrationRiskTable" xlink:title="presentation: RisksAndUncertaintiesAbstract to ConcentrationRiskTable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:label="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:title="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufactureAndSupplyRevenueMember" xlink:label="ManufactureAndSupplyRevenueMember" xlink:title="ManufactureAndSupplyRevenueMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="ManufactureAndSupplyRevenueMember" xlink:title="presentation: ProductsAndServicesDomain to ManufactureAndSupplyRevenueMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAndRoyaltyRevenueMember" xlink:label="LicenseAndRoyaltyRevenueMember" xlink:title="LicenseAndRoyaltyRevenueMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="LicenseAndRoyaltyRevenueMember" xlink:title="presentation: ProductsAndServicesDomain to LicenseAndRoyaltyRevenueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CoDevelopmentAndResearchFeesMember" xlink:label="CoDevelopmentAndResearchFeesMember" xlink:title="CoDevelopmentAndResearchFeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="CoDevelopmentAndResearchFeesMember" xlink:title="presentation: ProductsAndServicesDomain to CoDevelopmentAndResearchFeesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ProprietaryProductSalesMember" xlink:label="ProprietaryProductSalesMember" xlink:title="ProprietaryProductSalesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="ProprietaryProductSalesMember" xlink:title="presentation: ProductsAndServicesDomain to ProprietaryProductSalesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="ContractWithCustomerAssetAndLiabilityAbstract" xlink:title="ContractWithCustomerAssetAndLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InvoicesPayableTerm" xlink:label="InvoicesPayableTerm" xlink:title="InvoicesPayableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="InvoicesPayableTerm" xlink:title="presentation: ContractWithCustomerAssetAndLiabilityAbstract to InvoicesPayableTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="ContractWithCustomerAssetNet" xlink:title="presentation: ContractWithCustomerAssetAndLiabilityAbstract to ContractWithCustomerAssetNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="ContractWithCustomerLiability" xlink:title="presentation: ContractWithCustomerAssetAndLiabilityAbstract to ContractWithCustomerLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerAssetAndLiabilityAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to ContractWithCustomerAssetAndLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: DisaggregationOfRevenueAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to DisaggregationOfRevenueTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="StatementGeographicalAxis" xlink:title="StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="SegmentGeographicalDomain" xlink:title="SegmentGeographicalDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="US" xlink:title="US" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalDomain" xlink:to="US" xlink:title="presentation: SegmentGeographicalDomain to US" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="NonUsMember" xlink:title="NonUsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentGeographicalDomain" xlink:to="NonUsMember" xlink:title="presentation: SegmentGeographicalDomain to NonUsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementGeographicalAxis" xlink:to="SegmentGeographicalDomain" xlink:title="presentation: StatementGeographicalAxis to SegmentGeographicalDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementGeographicalAxis" xlink:title="presentation: DisaggregationOfRevenueTable to StatementGeographicalAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:label="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:title="GeographicAreasRevenuesFromExternalCustomersAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: GeographicAreasRevenuesFromExternalCustomersAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to GeographicAreasRevenuesFromExternalCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="AccountsReceivableNetAbstract" xlink:title="AccountsReceivableNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="AccountsReceivableGross" xlink:title="AccountsReceivableGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="AccountsReceivableGross" xlink:title="presentation: AccountsReceivableNetAbstract to AccountsReceivableGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="OtherReceivablesGrossCurrent" xlink:title="OtherReceivablesGrossCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="OtherReceivablesGrossCurrent" xlink:title="presentation: AccountsReceivableNetAbstract to OtherReceivablesGrossCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivable" xlink:title="presentation: AccountsReceivableNetAbstract to AllowanceForDoubtfulAccountsReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:label="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="presentation: AccountsReceivableNetAbstract to AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="TradeAndOtherReceivablesNet" xlink:title="presentation: AccountsReceivableNetAbstract to TradeAndOtherReceivablesNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_GuaranteedRoyaltyRevenue" xlink:label="GuaranteedRoyaltyRevenue" xlink:title="GuaranteedRoyaltyRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetAbstract" xlink:to="GuaranteedRoyaltyRevenue" xlink:title="presentation: AccountsReceivableNetAbstract to GuaranteedRoyaltyRevenue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AccountsReceivableNetAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to AccountsReceivableNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:title="AllowanceForDoubtfulAccountsReceivableRollforward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="AllowanceForDoubtfulAccountsReceivable" xlink:title="presentation: AllowanceForDoubtfulAccountsReceivableRollforward to AllowanceForDoubtfulAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: AllowanceForDoubtfulAccountsReceivableRollforward to ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:title="AllowanceForDoubtfulAccountsReceivableWriteOffs" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:title="presentation: AllowanceForDoubtfulAccountsReceivableRollforward to AllowanceForDoubtfulAccountsReceivableWriteOffs" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="AllowanceForDoubtfulAccountsReceivable_2" xlink:title="AllowanceForDoubtfulAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="AllowanceForDoubtfulAccountsReceivable_2" xlink:title="presentation: AllowanceForDoubtfulAccountsReceivableRollforward to AllowanceForDoubtfulAccountsReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivableRollforward" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AllowanceForDoubtfulAccountsReceivableRollforward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccruals" xlink:label="AccountsReceivableAllowancesAndAccruals" xlink:title="AccountsReceivableAllowancesAndAccruals" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesAndAccruals" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesAndAccruals" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesProvisionRelatedToSales" xlink:label="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:title="AccountsReceivableAllowancesProvisionRelatedToSales" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesProvisionRelatedToSales" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesProvisionRelatedToSales" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesCreditsAndPayments" xlink:label="AccountsReceivableAllowancesCreditsAndPayments" xlink:title="AccountsReceivableAllowancesCreditsAndPayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesCreditsAndPayments" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesCreditsAndPayments" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccruals" xlink:label="AccountsReceivableAllowancesAndAccruals_2" xlink:title="AccountsReceivableAllowancesAndAccruals" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesAndAccruals_2" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesAndAccruals" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:label="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:label="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:title="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RevenuesAndTradeReceivablesNetAbstract" xlink:label="RevenuesAndTradeReceivablesNetAbstract" xlink:title="RevenuesAndTradeReceivablesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="SalesRevenueNetMember" xlink:title="SalesRevenueNetMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskBenchmarkDomain" xlink:to="SalesRevenueNetMember" xlink:title="presentation: ConcentrationRiskBenchmarkDomain to SalesRevenueNetMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="AccountsReceivableMember" xlink:title="AccountsReceivableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskBenchmarkDomain" xlink:to="AccountsReceivableMember" xlink:title="presentation: ConcentrationRiskBenchmarkDomain to AccountsReceivableMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskByBenchmarkAxis" xlink:to="ConcentrationRiskBenchmarkDomain" xlink:title="presentation: ConcentrationRiskByBenchmarkAxis to ConcentrationRiskBenchmarkDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskTable" xlink:to="ConcentrationRiskByBenchmarkAxis" xlink:title="presentation: ConcentrationRiskTable to ConcentrationRiskByBenchmarkAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:label="CommercialExploitationAgreementWithIndiviorMember" xlink:title="CommercialExploitationAgreementWithIndiviorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NameOfMajorCustomerDomain" xlink:to="CommercialExploitationAgreementWithIndiviorMember" xlink:title="presentation: NameOfMajorCustomerDomain to CommercialExploitationAgreementWithIndiviorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithSunovionMember" xlink:label="CommercialExploitationAgreementWithSunovionMember" xlink:title="CommercialExploitationAgreementWithSunovionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NameOfMajorCustomerDomain" xlink:to="CommercialExploitationAgreementWithSunovionMember" xlink:title="presentation: NameOfMajorCustomerDomain to CommercialExploitationAgreementWithSunovionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerOneMember" xlink:label="CustomerOneMember" xlink:title="CustomerOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NameOfMajorCustomerDomain" xlink:to="CustomerOneMember" xlink:title="presentation: NameOfMajorCustomerDomain to CustomerOneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorCustomersAxis" xlink:to="NameOfMajorCustomerDomain" xlink:title="presentation: MajorCustomersAxis to NameOfMajorCustomerDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskTable" xlink:to="MajorCustomersAxis" xlink:title="presentation: ConcentrationRiskTable to MajorCustomersAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CustomerConcentrationAbstract" xlink:label="CustomerConcentrationAbstract" xlink:title="CustomerConcentrationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CustomerConcentrationAbstract" xlink:to="ConcentrationRiskPercentage1" xlink:title="presentation: CustomerConcentrationAbstract to ConcentrationRiskPercentage1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCustomersExceedingTenPercentThresholds" xlink:label="NumberOfCustomersExceedingTenPercentThresholds" xlink:title="NumberOfCustomersExceedingTenPercentThresholds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CustomerConcentrationAbstract" xlink:to="NumberOfCustomersExceedingTenPercentThresholds" xlink:title="presentation: CustomerConcentrationAbstract to NumberOfCustomersExceedingTenPercentThresholds" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskLineItems" xlink:to="CustomerConcentrationAbstract" xlink:title="presentation: ConcentrationRiskLineItems to CustomerConcentrationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConcentrationRiskTable" xlink:to="ConcentrationRiskLineItems" xlink:title="presentation: ConcentrationRiskTable to ConcentrationRiskLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAndTradeReceivablesNetAbstract" xlink:to="ConcentrationRiskTable" xlink:title="presentation: RevenuesAndTradeReceivablesNetAbstract to ConcentrationRiskTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaterialAgreementsAbstract" xlink:label="MaterialAgreementsAbstract" xlink:title="MaterialAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:label="CommercialExploitationAgreementWithIndiviorMember" xlink:title="CommercialExploitationAgreementWithIndiviorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CommercialExploitationAgreementWithIndiviorMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to CommercialExploitationAgreementWithIndiviorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementWithIndiviorMember" xlink:label="SupplementalAgreementWithIndiviorMember" xlink:title="SupplementalAgreementWithIndiviorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="SupplementalAgreementWithIndiviorMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to SupplementalAgreementWithIndiviorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CommercialExploitationAgreementAbstract" xlink:label="CommercialExploitationAgreementAbstract" xlink:title="CommercialExploitationAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommercialExploitationAgreementAbstract" xlink:to="LicenseAgreementTerm" xlink:title="presentation: CommercialExploitationAgreementAbstract to LicenseAgreementTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AutomaticRenewalPeriodOfAgreement" xlink:label="AutomaticRenewalPeriodOfAgreement" xlink:title="AutomaticRenewalPeriodOfAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommercialExploitationAgreementAbstract" xlink:to="AutomaticRenewalPeriodOfAgreement" xlink:title="presentation: CommercialExploitationAgreementAbstract to AutomaticRenewalPeriodOfAgreement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NoticePeriodForNotToRenewAgreement" xlink:label="NoticePeriodForNotToRenewAgreement" xlink:title="NoticePeriodForNotToRenewAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommercialExploitationAgreementAbstract" xlink:to="NoticePeriodForNotToRenewAgreement" xlink:title="presentation: CommercialExploitationAgreementAbstract to NoticePeriodForNotToRenewAgreement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="CommercialExploitationAgreementAbstract" xlink:title="presentation: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to CommercialExploitationAgreementAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SupplementalAgreementAbstract" xlink:label="SupplementalAgreementAbstract" xlink:title="SupplementalAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativePaymentsReceived" xlink:label="CumulativePaymentsReceived" xlink:title="CumulativePaymentsReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="CumulativePaymentsReceived" xlink:title="presentation: SupplementalAgreementAbstract to CumulativePaymentsReceived" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="Revenues" xlink:title="presentation: SupplementalAgreementAbstract to Revenues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ContingentPaymentsReceivableInTheFuture" xlink:label="ContingentPaymentsReceivableInTheFuture" xlink:title="ContingentPaymentsReceivableInTheFuture" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="ContingentPaymentsReceivableInTheFuture" xlink:title="presentation: SupplementalAgreementAbstract to ContingentPaymentsReceivableInTheFuture" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AggregateReceivable" xlink:label="AggregateReceivable" xlink:title="AggregateReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="AggregateReceivable" xlink:title="presentation: SupplementalAgreementAbstract to AggregateReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ReceivableProcessPatentRights" xlink:label="ReceivableProcessPatentRights" xlink:title="ReceivableProcessPatentRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="ReceivableProcessPatentRights" xlink:title="presentation: SupplementalAgreementAbstract to ReceivableProcessPatentRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalAgreementAbstract" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="presentation: SupplementalAgreementAbstract to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SupplementalAgreementAbstract" xlink:title="presentation: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to SupplementalAgreementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaterialAgreementsAbstract" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="presentation: MaterialAgreementsAbstract to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaterialAgreementsAbstract" xlink:label="MaterialAgreementsAbstract" xlink:title="MaterialAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="RoyaltyMember" xlink:title="RoyaltyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="RoyaltyMember" xlink:title="presentation: ProductsAndServicesDomain to RoyaltyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PaymentReceivableCollaborativeAgreement" xlink:label="PaymentReceivableCollaborativeAgreement" xlink:title="PaymentReceivableCollaborativeAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="PaymentReceivableCollaborativeAgreement" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to PaymentReceivableCollaborativeAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativePaymentsReceived" xlink:label="CumulativePaymentsReceived" xlink:title="CumulativePaymentsReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="CumulativePaymentsReceived" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to CumulativePaymentsReceived" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UpfrontPaymentReceived" xlink:label="UpfrontPaymentReceived" xlink:title="UpfrontPaymentReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="UpfrontPaymentReceived" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to UpfrontPaymentReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeMilestonePaymentsReceivable" xlink:label="CumulativeMilestonePaymentsReceivable" xlink:title="CumulativeMilestonePaymentsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="CumulativeMilestonePaymentsReceivable" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to CumulativeMilestonePaymentsReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="Revenues" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to Revenues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="CumulativeRoyaltyReceivable" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to CumulativeRoyaltyReceivable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TradeAndOtherReceivablesNet" xlink:label="TradeAndOtherReceivablesNet" xlink:title="TradeAndOtherReceivablesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="TradeAndOtherReceivablesNet" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to TradeAndOtherReceivablesNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="presentation: LicenseAgreementWithSunovionPharmaceuticalsIncAbstract to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" xlink:title="presentation: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to LicenseAgreementWithSunovionPharmaceuticalsIncAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaterialAgreementsAbstract" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="presentation: MaterialAgreementsAbstract to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails">
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaterialAgreementsAbstract" xlink:label="MaterialAgreementsAbstract" xlink:title="MaterialAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmMember" xlink:label="AgreementToTerminateCLAWithKemPharmMember" xlink:title="AgreementToTerminateCLAWithKemPharmMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="AgreementToTerminateCLAWithKemPharmMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to AgreementToTerminateCLAWithKemPharmMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementToTerminateCLAWithKemPharmAbstract" xlink:label="AgreementToTerminateCLAWithKemPharmAbstract" xlink:title="AgreementToTerminateCLAWithKemPharmAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementToTerminateCLAWithKemPharmAbstract" xlink:to="Revenues" xlink:title="presentation: AgreementToTerminateCLAWithKemPharmAbstract to Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PercentageShareOfMilestonePayment" xlink:label="PercentageShareOfMilestonePayment" xlink:title="PercentageShareOfMilestonePayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementToTerminateCLAWithKemPharmAbstract" xlink:to="PercentageShareOfMilestonePayment" xlink:title="presentation: AgreementToTerminateCLAWithKemPharmAbstract to PercentageShareOfMilestonePayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementToTerminateCLAWithKemPharmAbstract" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="presentation: AgreementToTerminateCLAWithKemPharmAbstract to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="AgreementToTerminateCLAWithKemPharmAbstract" xlink:title="presentation: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to AgreementToTerminateCLAWithKemPharmAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaterialAgreementsAbstract" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="presentation: MaterialAgreementsAbstract to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="presentation: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsLiabilityAbstract" xlink:label="WarrantsLiabilityAbstract" xlink:title="WarrantsLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: WarrantsLiabilityAbstract to DebtInstrumentInterestRateStatedPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsLiabilityAbstract" xlink:title="presentation: ClassOfWarrantOrRightLineItems to WarrantsLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightLineItems" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ClassOfWarrantOrRightTable" xlink:title="presentation: FairValueDisclosuresAbstract to ClassOfWarrantOrRightTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/InventoriesNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" xlink:title="InventoryDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="InventoryRawMaterials" xlink:title="InventoryRawMaterials" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="InventoryRawMaterials" xlink:title="presentation: InventoryDisclosureAbstract to InventoryRawMaterials" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_InventoryPackingMaterialGross" xlink:label="InventoryPackingMaterialGross" xlink:title="InventoryPackingMaterialGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="InventoryPackingMaterialGross" xlink:title="presentation: InventoryDisclosureAbstract to InventoryPackingMaterialGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="InventoryFinishedGoods" xlink:title="InventoryFinishedGoods" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="InventoryFinishedGoods" xlink:title="presentation: InventoryDisclosureAbstract to InventoryFinishedGoods" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="InventoryNet" xlink:title="presentation: InventoryDisclosureAbstract to InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/PropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="MachineryAndEquipmentMember" xlink:title="MachineryAndEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="MachineryAndEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to MachineryAndEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:label="ComputerNetworkEquipmentAndSoftwareMember" xlink:title="ComputerNetworkEquipmentAndSoftwareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerNetworkEquipmentAndSoftwareMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerNetworkEquipmentAndSoftwareMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ConstructionInProgressMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ConstructionInProgressMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:title="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:to="Depreciation" xlink:title="presentation: PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract to Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfOperatingLeases" xlink:label="NumberOfOperatingLeases" xlink:title="NumberOfOperatingLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="NumberOfOperatingLeases" xlink:title="presentation: LeasesAbstract to NumberOfOperatingLeases" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to AdjustmentsForNewAccountingPronouncementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="LesseeOperatingLeaseRemainingLeaseTerm" xlink:title="LesseeOperatingLeaseRemainingLeaseTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LesseeOperatingLeaseRemainingLeaseTerm" xlink:title="presentation: LeaseCostAbstract to LesseeOperatingLeaseRemainingLeaseTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeasePayments" xlink:title="presentation: LeaseCostAbstract to OperatingLeasePayments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetailsCalc2" />
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="TechnologyBasedIntangibleAssetsMember" xlink:title="TechnologyBasedIntangibleAssetsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TechnologyBasedIntangibleAssetsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TechnologyBasedIntangibleAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="PatentsMember" xlink:title="PatentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="PatentsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to PatentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to TypeOfArrangementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsGross" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsNet" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CumulativeRoyaltyReceivable" xlink:label="CumulativeRoyaltyReceivable" xlink:title="CumulativeRoyaltyReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="CumulativeRoyaltyReceivable" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to CumulativeRoyaltyReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to OtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:label="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="FiniteLivedIntangibleAssetsNetAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsNetAndOtherAssets" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsNetAndOtherAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:label="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:title="NumberOfAnnualRoyaltyPaymentsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="NumberOfAnnualRoyaltyPaymentsReceivable" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to NumberOfAnnualRoyaltyPaymentsReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MinimumAnnualRoyaltyReceivable" xlink:label="MinimumAnnualRoyaltyReceivable" xlink:title="MinimumAnnualRoyaltyReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="MinimumAnnualRoyaltyReceivable" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to MinimumAnnualRoyaltyReceivable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="AccruedMarketingCostsCurrent" xlink:title="AccruedMarketingCostsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedMarketingCostsCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedMarketingCostsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to OtherAccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FirstAdditionalOfferingMember" xlink:label="FirstAdditionalOfferingMember" xlink:title="FirstAdditionalOfferingMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="FirstAdditionalOfferingMember" xlink:title="presentation: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to FirstAdditionalOfferingMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SecondAdditionalOfferingMember" xlink:label="SecondAdditionalOfferingMember" xlink:title="SecondAdditionalOfferingMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="SecondAdditionalOfferingMember" xlink:title="presentation: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to SecondAdditionalOfferingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="presentation: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="LineOfCreditFacilityAxis" xlink:title="LineOfCreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PerceptiveCreditOpportunitiesFundLPMember" xlink:label="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="PerceptiveCreditOpportunitiesFundLPMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityLenderDomain" xlink:to="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="presentation: LineOfCreditFacilityLenderDomain to PerceptiveCreditOpportunitiesFundLPMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain" xlink:title="presentation: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="LineOfCreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to LineOfCreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="LineOfCreditMember" xlink:title="LineOfCreditMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="LineOfCreditMember" xlink:title="presentation: CreditFacilityDomain to LineOfCreditMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SeniorSecuredNotesAbstract" xlink:label="SeniorSecuredNotesAbstract" xlink:title="SeniorSecuredNotesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: SeniorSecuredNotesAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: SeniorSecuredNotesAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:label="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:title="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:title="presentation: SeniorSecuredNotesAbstract to NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentAdditionalBorrowingCapacity" xlink:label="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="DebtInstrumentAdditionalBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentAdditionalBorrowingCapacity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentNumberOfTranches" xlink:label="DebtInstrumentNumberOfTranches" xlink:title="DebtInstrumentNumberOfTranches" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentNumberOfTranches" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentNumberOfTranches" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="RepaymentsOfLongTermDebt" xlink:title="RepaymentsOfLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="RepaymentsOfLongTermDebt" xlink:title="presentation: SeniorSecuredNotesAbstract to RepaymentsOfLongTermDebt" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="DebtInstrumentFrequencyOfPeriodicPayment" xlink:title="DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentFrequencyOfPeriodicPayment" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentFrequencyOfPeriodicPayment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentMaturityDate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="LoansPayableCurrent" xlink:title="presentation: SeniorSecuredNotesAbstract to LoansPayableCurrent" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:label="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:title="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" xlink:title="presentation: SeniorSecuredNotesAbstract to AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:label="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:title="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" xlink:title="presentation: SeniorSecuredNotesAbstract to AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebt" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebt" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="MaturitiesOfLongTermDebtAbstract" xlink:title="presentation: SeniorSecuredNotesAbstract to MaturitiesOfLongTermDebtAbstract" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ElectiveRedemptionPercentageOfDebt" xlink:label="ElectiveRedemptionPercentageOfDebt" xlink:title="ElectiveRedemptionPercentageOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ElectiveRedemptionPercentageOfDebt" xlink:title="presentation: SeniorSecuredNotesAbstract to ElectiveRedemptionPercentageOfDebt" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:label="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:title="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:title="presentation: SeniorSecuredNotesAbstract to RedemptionPercentageOfDebtUnderChangeOfControlProvisions" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:label="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:title="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" xlink:title="presentation: SeniorSecuredNotesAbstract to AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="PortionOfProceedsAmountToMonetizeAssetsConditionOne" xlink:title="presentation: SeniorSecuredNotesAbstract to PortionOfProceedsAmountToMonetizeAssetsConditionOne" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:label="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:title="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="PortionOfProceedsAmountToMonetizeAssetsConditionTwo" xlink:title="presentation: SeniorSecuredNotesAbstract to PortionOfProceedsAmountToMonetizeAssetsConditionTwo" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: SeniorSecuredNotesAbstract to AmortizationOfFinancingCostsAndDiscounts" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="SeniorSecuredNotesAbstract" xlink:title="presentation: DebtInstrumentLineItems to SeniorSecuredNotesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="LineOfCreditFacilityTable" xlink:title="LineOfCreditFacilityTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="LineOfCreditFacilityAxis" xlink:title="LineOfCreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="LineOfCreditFacilityLenderDomain" xlink:title="LineOfCreditFacilityLenderDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_PerceptiveCreditOpportunitiesFundLPMember" xlink:label="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="PerceptiveCreditOpportunitiesFundLPMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityLenderDomain" xlink:to="PerceptiveCreditOpportunitiesFundLPMember" xlink:title="presentation: LineOfCreditFacilityLenderDomain to PerceptiveCreditOpportunitiesFundLPMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAxis" xlink:to="LineOfCreditFacilityLenderDomain" xlink:title="presentation: LineOfCreditFacilityAxis to LineOfCreditFacilityLenderDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityTable" xlink:to="LineOfCreditFacilityAxis" xlink:title="presentation: LineOfCreditFacilityTable to LineOfCreditFacilityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="LineOfCreditMember" xlink:title="LineOfCreditMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="LineOfCreditMember" xlink:title="presentation: CreditFacilityDomain to LineOfCreditMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: LineOfCreditFacilityTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="LineOfCreditFacilityLineItems" xlink:title="LineOfCreditFacilityLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="LineOfCreditFacilityAbstract" xlink:title="LineOfCreditFacilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAbstract" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: LineOfCreditFacilityAbstract to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:label="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:title="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAbstract" xlink:to="WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" xlink:title="presentation: LineOfCreditFacilityAbstract to WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAbstract" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="presentation: LineOfCreditFacilityAbstract to GainsLossesOnExtinguishmentOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="PaymentsOfDebtExtinguishmentCosts" xlink:title="PaymentsOfDebtExtinguishmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityAbstract" xlink:to="PaymentsOfDebtExtinguishmentCosts" xlink:title="presentation: LineOfCreditFacilityAbstract to PaymentsOfDebtExtinguishmentCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityLineItems" xlink:to="LineOfCreditFacilityAbstract" xlink:title="presentation: LineOfCreditFacilityLineItems to LineOfCreditFacilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LineOfCreditFacilityTable" xlink:to="LineOfCreditFacilityLineItems" xlink:title="presentation: LineOfCreditFacilityTable to LineOfCreditFacilityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="LineOfCreditFacilityTable" xlink:title="presentation: DebtDisclosureAbstract to LineOfCreditFacilityTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="presentation: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_WarrantsLiabilityAbstract" xlink:label="WarrantsLiabilityAbstract" xlink:title="WarrantsLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: WarrantsLiabilityAbstract to DebtInstrumentInterestRateStatedPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: WarrantsLiabilityAbstract to DebtInstrumentMaturityDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: WarrantsLiabilityAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: WarrantsLiabilityAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="WarrantsNotSettleableInCashFairValueDisclosure" xlink:title="WarrantsNotSettleableInCashFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="WarrantsNotSettleableInCashFairValueDisclosure" xlink:title="presentation: WarrantsLiabilityAbstract to WarrantsNotSettleableInCashFairValueDisclosure" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="StockIssuedDuringPeriodSharesWarrantExercise" xlink:title="StockIssuedDuringPeriodSharesWarrantExercise" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="StockIssuedDuringPeriodSharesWarrantExercise" xlink:title="presentation: WarrantsLiabilityAbstract to StockIssuedDuringPeriodSharesWarrantExercise" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="ProceedsFromWarrantExercises" xlink:title="presentation: WarrantsLiabilityAbstract to ProceedsFromWarrantExercises" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:label="ClassOfWarrantOrRightWarrantsExercised" xlink:title="ClassOfWarrantOrRightWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilityAbstract" xlink:to="ClassOfWarrantOrRightWarrantsExercised" xlink:title="presentation: WarrantsLiabilityAbstract to ClassOfWarrantOrRightWarrantsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsLiabilityAbstract" xlink:title="presentation: ClassOfWarrantOrRightLineItems to WarrantsLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightLineItems" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightTable" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/NetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="NetIncomeLossAbstract" xlink:title="NetIncomeLossAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetIncomeLossAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="NetIncomeLossAbstract" xlink:title="presentation: EarningsPerShareAbstract to NetIncomeLossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: EarningsPerShareAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareBasicAndDiluted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_UnvestedRestrictedStockUnitsMember" xlink:label="UnvestedRestrictedStockUnitsMember" xlink:title="UnvestedRestrictedStockUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="UnvestedRestrictedStockUnitsMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to UnvestedRestrictedStockUnitsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DilutiveInstrumentsAbstract" xlink:label="DilutiveInstrumentsAbstract" xlink:title="DilutiveInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DilutiveInstrumentsAbstract" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: DilutiveInstrumentsAbstract to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="DilutiveInstrumentsAbstract" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to DilutiveInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SharebasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlanMember" xlink:title="presentation: PlanNameDomain to EmployeeStockPurchasePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ManufacturingAndSupplyMember" xlink:label="ManufacturingAndSupplyMember" xlink:title="ManufacturingAndSupplyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ManufacturingAndSupplyMember" xlink:title="presentation: IncomeStatementLocationDomain to ManufacturingAndSupplyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationAbstract to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationEquityAwardsAbstract" xlink:label="ShareBasedCompensationEquityAwardsAbstract" xlink:title="ShareBasedCompensationEquityAwardsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="presentation: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationEquityAwardsAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:title="presentation: ShareBasedCompensationEquityAwardsAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationEquityAwardsAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationEquityAwardsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_EmployeeStockPurchasePlanAbstract" xlink:label="EmployeeStockPurchasePlanAbstract" xlink:title="EmployeeStockPurchasePlanAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:label="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:title="ShareBasedPaymentArrangementNumberOfOfferingPeriods" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockPurchasePlanAbstract" xlink:to="ShareBasedPaymentArrangementNumberOfOfferingPeriods" xlink:title="presentation: EmployeeStockPurchasePlanAbstract to ShareBasedPaymentArrangementNumberOfOfferingPeriods" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockPurchasePlanAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="presentation: EmployeeStockPurchasePlanAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockPurchasePlanAbstract" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="presentation: EmployeeStockPurchasePlanAbstract to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:label="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:title="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockPurchasePlanAbstract" xlink:to="DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" xlink:title="presentation: EmployeeStockPurchasePlanAbstract to DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/ContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="LitigationCaseAxis" xlink:title="LitigationCaseAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="LitigationCaseTypeDomain" xlink:title="LitigationCaseTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_HumanaAndCenteneActionsMember" xlink:label="HumanaAndCenteneActionsMember" xlink:title="HumanaAndCenteneActionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LitigationCaseTypeDomain" xlink:to="HumanaAndCenteneActionsMember" xlink:title="presentation: LitigationCaseTypeDomain to HumanaAndCenteneActionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_CaliforniaComplaintMember" xlink:label="CaliforniaComplaintMember" xlink:title="CaliforniaComplaintMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LitigationCaseTypeDomain" xlink:to="CaliforniaComplaintMember" xlink:title="presentation: LitigationCaseTypeDomain to CaliforniaComplaintMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LitigationCaseAxis" xlink:to="LitigationCaseTypeDomain" xlink:title="presentation: LitigationCaseAxis to LitigationCaseTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LitigationCaseAxis" xlink:title="presentation: LossContingenciesTable to LitigationCaseAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyInformationAboutLitigationMattersAbstract" xlink:label="LossContingencyInformationAboutLitigationMattersAbstract" xlink:title="LossContingencyInformationAboutLitigationMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="LossContingencyNumberOfDefendants" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to LossContingencyNumberOfDefendants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber" xlink:label="LossContingencyClaimsSettledNumber" xlink:title="LossContingencyClaimsSettledNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="LossContingencyClaimsSettledNumber" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to LossContingencyClaimsSettledNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfPatents" xlink:label="NumberOfPatents" xlink:title="NumberOfPatents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="NumberOfPatents" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to NumberOfPatents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="LossContingencyPendingClaimsNumber" xlink:title="LossContingencyPendingClaimsNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="LossContingencyPendingClaimsNumber" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to LossContingencyPendingClaimsNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="LossContingencyNewClaimsFiledNumber" xlink:title="LossContingencyNewClaimsFiledNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="LossContingencyNewClaimsFiledNumber" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to LossContingencyNewClaimsFiledNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfStatesInTheAntitrustLitigation" xlink:label="NumberOfStatesInTheAntitrustLitigation" xlink:title="NumberOfStatesInTheAntitrustLitigation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="NumberOfStatesInTheAntitrustLitigation" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to NumberOfStatesInTheAntitrustLitigation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NumberOfCauses" xlink:label="NumberOfCauses" xlink:title="NumberOfCauses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingencyInformationAboutLitigationMattersAbstract" xlink:to="NumberOfCauses" xlink:title="presentation: LossContingencyInformationAboutLitigationMattersAbstract to NumberOfCauses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyInformationAboutLitigationMattersAbstract" xlink:title="presentation: LossContingenciesLineItems to LossContingencyInformationAboutLitigationMattersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:label="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="LicenseAgreementWithSunovionPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to LicenseAgreementWithSunovionPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: SubsequentEventTable to TypeOfArrangementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:label="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_FirstAdditionalOfferingMember" xlink:label="FirstAdditionalOfferingMember" xlink:title="FirstAdditionalOfferingMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="FirstAdditionalOfferingMember" xlink:title="presentation: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to FirstAdditionalOfferingMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SecondAdditionalOfferingMember" xlink:label="SecondAdditionalOfferingMember" xlink:title="SecondAdditionalOfferingMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="SecondAdditionalOfferingMember" xlink:title="presentation: TwelvePointFiveSeniorSecuredNotesDueJune302025Member to SecondAdditionalOfferingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:title="presentation: DebtInstrumentNameDomain to TwelvePointFiveSeniorSecuredNotesDueJune302025Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: SubsequentEventTable to DebtInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="RangeAxis" xlink:title="presentation: SubsequentEventTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_AgreementsAbstract" xlink:label="AgreementsAbstract" xlink:title="AgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_NoticePeriodForNotToRenewAgreement" xlink:label="NoticePeriodForNotToRenewAgreement" xlink:title="NoticePeriodForNotToRenewAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsAbstract" xlink:to="NoticePeriodForNotToRenewAgreement" xlink:title="presentation: AgreementsAbstract to NoticePeriodForNotToRenewAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsAbstract" xlink:to="MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" xlink:title="presentation: AgreementsAbstract to MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfUpfrontPaymentReceivable" xlink:label="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="MaximumAmountOfUpfrontPaymentReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsAbstract" xlink:to="MaximumAmountOfUpfrontPaymentReceivable" xlink:title="presentation: AgreementsAbstract to MaximumAmountOfUpfrontPaymentReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_MaximumAmountOfPaymentsReceivableForMilestones" xlink:label="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="MaximumAmountOfPaymentsReceivableForMilestones" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsAbstract" xlink:to="MaximumAmountOfPaymentsReceivableForMilestones" xlink:title="presentation: AgreementsAbstract to MaximumAmountOfPaymentsReceivableForMilestones" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="AgreementsAbstract" xlink:title="presentation: SubsequentEventLineItems to AgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_SeniorSecuredNotesAbstract" xlink:label="SeniorSecuredNotesAbstract" xlink:title="SeniorSecuredNotesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentInterestRateStatedPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="RepaymentsOfDebt" xlink:title="presentation: SeniorSecuredNotesAbstract to RepaymentsOfDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ProceedsFromIssuanceOfDebt" xlink:title="presentation: SeniorSecuredNotesAbstract to ProceedsFromIssuanceOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="LoansPayable" xlink:title="LoansPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="LoansPayable" xlink:title="presentation: SeniorSecuredNotesAbstract to LoansPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_DebtInstrumentAdditionalBorrowingCapacity" xlink:label="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="DebtInstrumentAdditionalBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="DebtInstrumentAdditionalBorrowingCapacity" xlink:title="presentation: SeniorSecuredNotesAbstract to DebtInstrumentAdditionalBorrowingCapacity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: SeniorSecuredNotesAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="aqst-20200930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:label="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:title="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeniorSecuredNotesAbstract" xlink:to="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:title="presentation: SeniorSecuredNotesAbstract to ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="SeniorSecuredNotesAbstract" xlink:title="presentation: SubsequentEventLineItems to SeniorSecuredNotesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295721320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 02, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aquestive Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001398733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,619,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293296801832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 17,064<span></span>
</td>
<td class="nump">$ 49,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">7,990<span></span>
</td>
<td class="nump">13,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">3,242<span></span>
</td>
<td class="nump">2,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,388<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">31,684<span></span>
</td>
<td class="nump">68,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,728<span></span>
</td>
<td class="nump">9,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">3,609<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets', window );">Intangible assets, net and other assets</a></td>
<td class="nump">7,402<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">50,423<span></span>
</td>
<td class="nump">78,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">15,237<span></span>
</td>
<td class="nump">17,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans payable, current</a></td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">806<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">18,373<span></span>
</td>
<td class="nump">18,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Loans payable, net</a></td>
<td class="nump">60,346<span></span>
</td>
<td class="nump">60,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">3,047<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">3,694<span></span>
</td>
<td class="nump">4,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Asset retirement obligations</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">86,942<span></span>
</td>
<td class="nump">84,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (note 18)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value. Authorized 250,000,000 shares; 33,619,796 and 33,562,885 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">129,336<span></span>
</td>
<td class="nump">124,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(165,889)<span></span>
</td>
<td class="num">(130,474)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(36,519)<span></span>
</td>
<td class="num">(6,122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
<td class="nump">$ 50,423<span></span>
</td>
<td class="nump">$ 78,479<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302260840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">33,619,796<span></span>
</td>
<td class="nump">33,562,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">33,619,796<span></span>
</td>
<td class="nump">33,562,885<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295741304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 8,260<span></span>
</td>
<td class="nump">$ 12,418<span></span>
</td>
<td class="nump">$ 38,700<span></span>
</td>
<td class="nump">$ 36,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Manufacture and supply</a></td>
<td class="nump">2,978<span></span>
</td>
<td class="nump">4,643<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="nump">13,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">7,260<span></span>
</td>
<td class="nump">5,063<span></span>
</td>
<td class="nump">15,461<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">11,803<span></span>
</td>
<td class="nump">13,714<span></span>
</td>
<td class="nump">40,310<span></span>
</td>
<td class="nump">47,868<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">22,041<span></span>
</td>
<td class="nump">23,420<span></span>
</td>
<td class="nump">65,947<span></span>
</td>
<td class="nump">78,954<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(13,781)<span></span>
</td>
<td class="num">(11,002)<span></span>
</td>
<td class="num">(27,247)<span></span>
</td>
<td class="num">(42,764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income/(expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,778)<span></span>
</td>
<td class="num">(2,652)<span></span>
</td>
<td class="num">(8,296)<span></span>
</td>
<td class="num">(6,515)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,896)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,896)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(16,551)<span></span>
</td>
<td class="num">(18,412)<span></span>
</td>
<td class="num">(35,415)<span></span>
</td>
<td class="num">(53,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(16,551)<span></span>
</td>
<td class="num">(18,412)<span></span>
</td>
<td class="num">(35,415)<span></span>
</td>
<td class="num">(53,610)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (16,551)<span></span>
</td>
<td class="num">$ (18,412)<span></span>
</td>
<td class="num">$ (35,415)<span></span>
</td>
<td class="num">$ (53,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (2.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average number of common shares outstanding - basic and diluted (in shares)</a></td>
<td class="nump">33,619,379<span></span>
</td>
<td class="nump">25,031,478<span></span>
</td>
<td class="nump">33,592,846<span></span>
</td>
<td class="nump">24,992,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293290166776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th">
<div>Cumulative Effect, Period of Adoption, Adjustment [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Cumulative Effect, Period of Adoption, Adjustment [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Cumulative Effect, Period of Adoption, Adjustment [Member] </div>
<div>Accumulated Deficit [Member]</div>
</th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 71,431<span></span>
</td>
<td class="num">$ (61,376)<span></span>
</td>
<td class="nump">$ 10,080<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (2,852)<span></span>
</td>
<td class="num">$ (2,832)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">24,957,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">17,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,726)<span></span>
</td>
<td class="num">(14,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">72,873<span></span>
</td>
<td class="num">(78,954)<span></span>
</td>
<td class="num">(6,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2019</a></td>
<td class="nump">24,975,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">71,431<span></span>
</td>
<td class="num">(61,376)<span></span>
</td>
<td class="nump">10,080<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (2,852)<span></span>
</td>
<td class="num">$ (2,832)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">24,957,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2019</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">83,354<span></span>
</td>
<td class="num">(117,838)<span></span>
</td>
<td class="num">(34,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2019</a></td>
<td class="nump">25,042,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">72,873<span></span>
</td>
<td class="num">(78,954)<span></span>
</td>
<td class="num">(6,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2019</a></td>
<td class="nump">24,975,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">31,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,739<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">16,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,472)<span></span>
</td>
<td class="num">(20,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2019</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">74,744<span></span>
</td>
<td class="num">(99,426)<span></span>
</td>
<td class="num">(24,657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2019</a></td>
<td class="nump">25,022,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">20,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Fair value of warrants issued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,412)<span></span>
</td>
<td class="num">(18,412)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2019</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">83,354<span></span>
</td>
<td class="num">(117,838)<span></span>
</td>
<td class="num">(34,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2019</a></td>
<td class="nump">25,042,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">124,318<span></span>
</td>
<td class="num">(130,474)<span></span>
</td>
<td class="num">(6,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">33,562,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">19,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,530)<span></span>
</td>
<td class="num">(16,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">126,141<span></span>
</td>
<td class="num">(147,004)<span></span>
</td>
<td class="num">(20,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">33,582,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">124,318<span></span>
</td>
<td class="num">(130,474)<span></span>
</td>
<td class="num">(6,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">33,562,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">129,336<span></span>
</td>
<td class="num">(165,889)<span></span>
</td>
<td class="num">(36,519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">33,619,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">126,141<span></span>
</td>
<td class="num">(147,004)<span></span>
</td>
<td class="num">(20,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">33,582,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">14,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,702<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">18,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,334)<span></span>
</td>
<td class="num">(2,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">127,916<span></span>
</td>
<td class="num">(149,338)<span></span>
</td>
<td class="num">(21,388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="nump">33,616,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="nump">3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,551)<span></span>
</td>
<td class="num">(16,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 129,336<span></span>
</td>
<td class="num">$ (165,889)<span></span>
</td>
<td class="num">$ (36,519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">33,619,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295540104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (35,415)<span></span>
</td>
<td class="num">$ (53,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,337<span></span>
</td>
<td class="nump">2,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">5,052<span></span>
</td>
<td class="nump">5,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">All other non-cash expenses</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Trade and other receivables</a></td>
<td class="nump">5,082<span></span>
</td>
<td class="num">(3,887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(383)<span></span>
</td>
<td class="nump">1,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(7,101)<span></span>
</td>
<td class="num">(1,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,573)<span></span>
</td>
<td class="num">(5,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(738)<span></span>
</td>
<td class="num">(591)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used for operating activities</a></td>
<td class="num">(31,947)<span></span>
</td>
<td class="num">(49,635)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used for investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments for loan acquisition costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,918)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premium paid to retire debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,944)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes on share-based compensation</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(2,723)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used for)/provided by financing activities</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">10,527<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(32,262)<span></span>
</td>
<td class="num">(39,685)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">49,326<span></span>
</td>
<td class="nump">60,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">17,064<span></span>
</td>
<td class="nump">20,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">6,562<span></span>
</td>
<td class="nump">5,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses', window );">Net (decrease) in capital expenditures included in accounts payable and accrued expenses</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses', window );">Net increase in offering costs included in accounts payable and accrued expenses</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsIssuedInConnectionWithLongTermDebt', window );">Warrants issued in connection with long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in future cash outflow to pay for deferred offering costs that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsIssuedInConnectionWithLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of warrants issued in connection with long-term debt as part of a noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsIssuedInConnectionWithLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302155416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate Organization and Company Overview<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Corporate Organization and Company Overview [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Corporate Organization and Company Overview</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 1.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Corporate Organization and Company Overview</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(A) Company Overview</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Aquestive Therapeutics, Inc. (&#8220;Aquestive&#8221; or the &#8220;Company&#8221;) is a pharmaceutical company focused on identifying, developing and commercializing differentiated products that address patients&#8217; unmet medical needs and solve therapeutic problems.&#160; The Company has commercialized one internally-developed proprietary product to date, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules as alternatives to more invasive therapies. Aquestive is pursuing its business objectives through both in-licensing and out-licensing arrangements, as well as the commercialization of its own products. Production facilities are in Portage, Indiana, and corporate headquarters, sales and commercialization operations and primary research laboratory facilities are based in Warren, New Jersey.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Aquestive is subject to risks common to companies in similar industries and stages of development, including, but not limited to, competition from larger companies, reliance on revenue from a limited number of products and customers, adequacy of existing and availability of additional operating and growth capital as and when required, uncertainty of regulatory approval for marketing its product candidates, reliance on a single manufacturing site, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, dependence on patent-protected proprietary technology, ongoing government regulatory compliance requirements, dependence on the clinical and commercial success of its drug candidates, and uncertainty of broad adoption of its approved products, if any, by physicians and consumers.&#160;&#160; Aquestive is also subject to risks and uncertainties associated with the COVID-19 pandemic. See Note 4. Risks and Uncertainties for further discussion related to COVID-19.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-weight: bold;">(B)</font>&#160;<font style="font-weight: bold;">Equity Transaction</font></div><div><br /></div><div style="font-style: italic;">Equity Offering of Common Stock</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On December 17, 2019, Aquestive received net proceeds of $37,835 after deducting underwriting discounts of $2,415 for the sale of 8,050,000 shares of common stock, par value $0.001 per share of the Company (&#8220;common stock&#8221;) in a public offering.&#160; Professional fees and other costs of this offering totaled $540, in addition to the underwriting discounts.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295407224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 2.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Presentation</div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2019 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 11, 2020 (the &#8220;2019 Annual Report on Form 10-K&#8221;). As included herein, the condensed consolidated balance sheet as of December 31, 2019 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The accompanying financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298308040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 42.8pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 3.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Summary of Significant Accounting Policies</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(A) Principles of Consolidation and Significant Accounting Policies</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The interim condensed consolidated financial statements presented herein include the accounts of Aquestive Therapeutics, Inc. and its wholly owned subsidiary, MonoSol Rx, Inc. Other than corporate formation activities, MonoSol Rx, Inc. has conducted no commercial, drug development or operational activities and has no customers or vendors. The results of operations and cash flows reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected in any other interim period or for the entire fiscal year.</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"><div><div style="text-align: justify; text-indent: 21.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s significant accounting policies are described in the audited consolidated financial statements included in the <font style="font-size: 10pt; font-family: 'Times New Roman';">2019</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">A</font>nnual Report on Form 10-K.&#160; Subsequent to the date of those financial statements, there have been no significant changes to these policies other than those listed below.</div></div></div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(B) Use of Estimates</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#160; Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of share-based compensation and contingencies.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(C) Recent Accounting Pronouncements</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">As an emerging growth company, the Company has elected to take advantage of the extended transition period afforded by the Jumpstart Our Business Startups Act for the implementation of new or revised accounting standards and, as a result, the Company will comply with new or revised accounting standards no later than the relevant dates on which adoption of such standards is required for emerging growth companies. The Company believes that the impact of recently issued accounting standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption</font><font style="color: rgb(33, 37, 41);">.</font></div><div><br /></div><div style="font-style: italic;">Recently Adopted Accounting Pronouncements:</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In February 2016, the Financial Accounting Standards Board issued ASU, 2016-02, <font style="font-style: italic; color: rgb(33, 37, 41);">Leases (Topic 842)</font><font style="color: rgb(33, 37, 41);">, and issued amendments in July 2018 provided by ASU 2018-10. This ASU, as amended, requires lessees to recognize lease assets, termed &#8220;right-of-use assets&#8221; and related lease liabilities on the balance sheet that had previously been classified as operating leases under prior authoritative guidance. For income statement purposes, leases are now required to be classified as either operating or financing leases under a dual model similar to that specified by ASC 840. Operating leases continue to result in straight-line expense while financing leases result in a front-loaded expense pattern in a manner similar to recognition of capital lease expenses under ASC 840.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company adopted and applied ASU 2016-02 on January 1, 20<font style="color: rgb(33, 37, 41);">20 using the modified retrospective transition provisions of ASC 842 to leases in effect as of that date of adoption and recorded right-of-use assets totaling $4,048 and lease liabilities as adjusted for accrued lease payments, in the amount of $4,224 based on an estimated incremental borrowing rate of 16.9%, representing the present value of remaining minimum lease payments. The assets and liabilities thus recorded were primarily those related to the Company&#8217;s leased plant, laboratory and corporate administrative facilities. The Company elected to apply the ASU-specified practical expedients and accordingly did not re-assess (i) whether its contracts contained a lease under the new definition of a lease, (ii) the classification of those leases, and (iii) initial direct costs of existing leases. In addition, the Company elected not to apply the hindsight expedient in the assessment of lease renewals and resultant term of leases. The Company also elected not to recognize a right-of-use asset and lease liability for those leases with a remaining lease term of 12 months or less. The adoption of ASU 2016-02 did not require a cumulative-effect adjustment to the opening balance of the accumulated deficit at the time of adoption.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In May 2014, the FASB issued ASU 2014-09, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, and subsequently issued a number of amendments to this update.&#160; The new standard, as amended in Accounting Standards Codification, or ASC 606, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes previous revenue recognition guidance. The standard&#8217;s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#160; In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this standard effective January 1, 2019.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2016, the FASB issued ASU 2016-15,<font style="font-style: italic;"> Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, </font>providing guidance on the classification of certain cash receipts and payments in the statement of cash flows intended to reduce diversity in practice, including cash flows related to debt prepayment or extinguishment costs and contingent consideration that may be paid following a business combination. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2018, the FASB issued ASU 2018-13, <font style="font-style: italic;">Fair Value Measurement (Topic 820): Disclosure Framework. </font>The purpose of the update is to improve the effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">In November 2018, the FASB issued ASU 2018-18, C</font><font style="font-style: italic; color: rgb(0, 0, 0);">ollaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606,</font><font style="color: rgb(0, 0, 0);"> which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer for a promised good or service that is distinct within the collaborative arrangement. The guidance also precludes entities from presenting amounts related to transactions with a collaborative arrangement participant that is not a customer as revenue, unless those transactions are directly related to third-party sales.</font> The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic;">Recent Accounting Pronouncements Not Adopted as of September 30, 2020:</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In June 2016, the FASB issued ASU 2016-13,<font style="font-style: italic;"> Financial Instruments &#8211; Credit Losses (Topic 326)</font>, amending existing guidance on the accounting for credit losses on financial instruments within its scope. The guidance provides for use of a forward-looking expected loss model for estimating credit losses, replacing the incurred loss model that is based on past events and current conditions. The new guidance also changes the impairment model for available-for-sale debt securities, requiring the use of an allowance to record estimated credit losses (and subsequent recoveries). The new guidance is effective for the Company beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">August 2018, the FASB issued ASU 2018-15, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Intangibles&#8212;Goodwill and Other Internal-Use Software (Subtopic 350-40: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</font><font style="color: rgb(0, 0, 0);">, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance distinguishing between capitalizable service contract implementation costs and contract costs required to be expensed. In addition, the update requires that the term of the hosting arrangement is to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. This standard will become effective for the Company beginning January 1, 2021. The amendments may be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 and does not expect to have a material impact on its consolidated financial statements.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">December 2019, the FASB issued ASU 2019-12, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, </font><font style="color: rgb(0, 0, 0);">which amends accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. The standard will be effective for the Company beginning January 1, 2022, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on its consolidated financial statements.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In August 2020, the FASB issued ASU 2020-06, <font style="font-style: italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font>. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity.&#160; Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. These amendments will be effective for the Company beginning January 1, 2024, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the condensed consolidated financial statements of the Company.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298310840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 4.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Risks and Uncertainties</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s cash requirements for 2020 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September 30, 2020, working capital totaled $13,311, which included $17,064 of cash and cash equivalents.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">As of September 30, 2020, Aquestive has experienced a history of net losses and the Company&#8217;s accumulated deficits totaled $165,889 which have been partially funded by profits from manufacture and supply operations, licensing revenues and certain other services, with the balance of the related funding requirements met by the Company&#8217;s equity and debt offerings including its 12.5% Senior Secured Notes due 2025 (the &#8220;12.5% Notes&#8221;). In 2019, the Company raised funding totaling $52,226, consisting of net proceeds of $13,110 from the refinancing of its debt in July 2019, $37,295 from the public offering of 8,050,000 common shares in December 2019, and $1,821 from the exercise of warrants issued in connection with the debt refinancing.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The characteristics described above provide indications that the Company&#8217;s ability to execute its near-term business objectives and achieve profitability over the longer term cannot be assured. Further, management views the impact of COVID-19 on the economy, its industry, its customers and suppliers and its own operations as constantly evolving, the future effects of which continue to be highly uncertain and unpredictable.&#160; Due to current or future interruptions and possible disruptions in health services, operations of the United States Food and Drug Administration (&#8220;FDA&#8221;), freight and other transportation services, supply, manufacturing, workforce health, availability of acceptable capital, financial and asset monetization markets, and availability of essential human and business requirements, and unforeseeable financial difficulties of the Company&#8217;s customers or vendors, the severity, rapidity of the spread, and the duration of the COVID-19 pandemic may be expected to negatively affect a great number of businesses across various industries, including Aquestive. The Company may experience financial and operational adversity in such areas as pre-clinical, clinical trials, regulatory review and approval of various product candidates, customer demand for products and services, customers&#8217; ability to pay for goods and services, supply of pharmaceutical ingredients and other raw materials from approved vendors, ongoing availability of an appropriate labor force and skilled professionals, and additional capital or other funding from capital, financial or monetization markets.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Subject to and absent any material adverse effect of these and other possible COVID-19 effects, the Company <font style="color: rgb(0, 0, 0);">expect</font><font style="color: rgb(0, 0, 0);">s</font><font style="color: rgb(0, 0, 0);"> that its anticipated revenues from licensed and proprietary products, cash on hand</font><font style="color: rgb(0, 0, 0);">, expense management initiatives,</font><font style="color: rgb(0, 0, 0);">&#160;</font><font style="color: rgb(0, 0, 0);">monetization of certain revenue streams for its out-licensed apomorphine product (KYNMOBI&#8482;), </font><font style="color: rgb(0, 0, 0);">and </font><font style="color: rgb(0, 0, 0);">access to equity markets, including under its shelf registration statement </font><font style="color: rgb(0, 0, 0);"> would be adequate to meet expected operating, investing, and financing needs for the next twelve months.&#160; To the extent additional funds are necessary to meet operating</font><font style="color: rgb(0, 0, 0);"> needs as the Company continues to execute its business strategy, </font><font style="color: rgb(0, 0, 0);"> additional funding requirements would be obtained through </font><font style="color: rgb(0, 0, 0);">modification of the existing debt facility to extend the potential availability of the first and second re-openers, and </font><font style="color: rgb(0, 0, 0);">access to appropriate financial markets </font><font style="color: rgb(0, 0, 0);">for </font><font style="color: rgb(0, 0, 0);">debt or equity financings, or a combination of these potential sources of funds, although management</font><font style="color: rgb(0, 0, 0);"> can provide no assurance that any of these sources of funding, either individually or in combination, will be available on reasonable terms, if at all.</font><font style="color: rgb(0, 0, 0);">&#160; In addition, the Company may be required to utilize available financial resources sooner than expected.&#160; Management has based </font><font style="color: rgb(0, 0, 0);">its expectation on assumptions that could change or prove to be inaccurate, either due to the impact of COVID-19 or to unrelated factors including factors arising in the capital markets, asset monetization markets, regulatory approval process, regulatory oversight and other factors.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302607448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetAbstract', window );"><strong>Revenues and Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetTextBlock', window );">Revenues and Trade Receivables, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 5.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Revenues and Trade Receivables, Net</div></td></tr></table><div><br /></div><div style="font-style: italic; font-weight: bold;">Revenue from Contracts with Customers</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s revenues are derived from four primary sources: manufactured products made to order for licensees, including Suboxone&#174; and Zuplenz&#174;, manufacture and sale of its self-developed, self-commercialized proprietary product, Sympazan&#174; (clobazam), intellectual property licensing arrangements, and product development services provided under contracts with customers.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Revenue Recognition and Performance Obligations</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Aquestive recognizes revenue pursuant to ASC 606, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, to reflect amounts expected to be collectible in exchange for the transfer of contractually promised goods or services to its customers, as discussed in additional detail in the Company&#8217;s 2019 Annual Report on Form 10-K.&#160; Accordingly, the value of contractually promised goods or services is assessed at contract inception to identify those that constitute distinct performance obligations. Contract revenues are allocated to those distinct performance obligations based on estimated standalone values or expected values, and these allocated revenues are recognized at the point in time, or over the period of time, that those distinct obligations are satisfied. The Company&#8217;s performance obligations consist primarily of transferring control of goods, services or intellectual property that are identified in the contracts, purchase orders or invoices. Variable or contingent revenues which may become due from customers, such as milestone payments due upon acceptance of a regulatory filing, regulatory approval, or sales-based milestone payments, are not recognized until contingencies are met, the customer&#8217;s obligation to meet its contractual payment commitments is fixed and collection of invoiced amounts is reasonably assured, thereby limiting any significant probability of a revenue reversal.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Revenues from the sale of products and services and from licensing arrangements and related payments are evidenced by a contract with the customer. For manufacturing and supply and proprietary product sales, invoices are generally issued upon the transfer of control. Co-development and research revenue is typically invoiced based on the contractual payment schedule, or upon completion of the service. Licensing revenue is generally invoiced at the inception of an agreement, with additional charges rendered as related contingencies, such as regulatory approvals or sales targets, are met. Invoices are typically payable 30 to 60 days after the invoice date, however some payment terms may reach 75 days depending on the customer. The Company performs a review of each specific customer&#8217;s creditworthiness and ability to pay prior to acceptance as a customer, as well as periodic prospective reviews.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Manufacture and supply revenue</font> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Proprietary product sales, net</font> &#8211; this net revenue is recognized upon delivery and transfer of control of proprietary product to the Company&#8217;s customers, at which point the Company has no ongoing performance obligations and the customer has assumed all significant risks and rewards of ownership. These revenues are subject to payment discounts, wholesaler service fees, volume and prompt payment discounts, rebates and other chargebacks, which are estimated and recorded at the time the revenue is recognized. Once all related variable considerations are resolved and uncertainties as to collectible amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">License and royalty revenues</font> &#8211; <font style="color: rgb(0, 0, 0);">the Company may realize revenue from functional or from symbolic licenses. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints, if any. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be met by the Company, such as manufactured products or development services, revenues may be deferred when advance payment is received and recognized over the term of the license agreement. </font>Royalty revenues are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold to the Company&#8217;s strategic partners.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="font-style: italic;">Co-development and research fees </font>&#8211; this revenue is recognized as contractual services or performance obligations are performed. Invoicing for contractual services may occur in advance or arrears, may, or may not, coincide with completion of underlying performance obligations, and therefore may give rise to contract assets or contract liabilities when the value of services completed varies from amounts that may be invoiced to the customer.</div><div><br /></div><div style="font-style: italic; font-weight: bold;">Contract Assets</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In limited situations, certain customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160; In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables and as a component of intangible and other assets within the Condensed Consolidated Balance Sheet. As of September 30, 2020, and December 31, 2019, such current and non-current contract assets were $8,922 and $4,363, respectively, consisting primarily of minimum annual royalties due under a certain licensing agreement and completed but unshipped products manufactured to specific order by certain licensees.</div><div><br /></div><div style="font-style: italic; font-weight: bold;">Contract Liabilities</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In other limited situations, certain customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Consolidated Balance Sheet. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September 30, 2020, and December 31, 2019, such contract liabilities were $4,416 and $5,154, respectively.</div><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The Company&#8217;s revenues were comprised of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply revenue</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">5,903</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">9,155</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">20,078</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">24,739</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">License and royalty revenue</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">328</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,356</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">13,682</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">6,402</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Co-development and research fees</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">341</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,073</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,862</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Proprietary product sales, net</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,688</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">834</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">4,070</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,187</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8,260</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,418</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">38,700</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">36,190</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic;">Disaggregation of Revenue</div><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table provides disaggregated net revenue by geographic area:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">United States</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">6,567</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11,022</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">35,496</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">33,683</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Ex-United States</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,693</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,396</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,204</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,507</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8,260</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,418</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">38,700</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">36,190</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0);">Non-United States revenues are derived primarily from products manufactured for the Australian and Malaysian markets.</div><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">Trade and other receivables, net consist of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade receivables</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">6,659</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">9,094</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contract and other receivables</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,872</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4,363</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: allowance for bad debts</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(264</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: sales-related allowances</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(277</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(203</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade and other receivables, net</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">7,990</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">13,130</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The current portion of contract and other receivables totaled $1,872 and $4,363 as of September 30, 2020 and December 31, 2019, respectively. The current period balance is comprised primarily of $1,000 of minimum royalty revenue due from a licensee and the remaining balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services. The December 31, 2019 balance represents reimbursable costs incurred on behalf of customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services. Sales-related allowances for both periods presented are estimated in relation to revenues recognized for sales of Sympazan.</div><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table presents the changes in the allowance for bad debt:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at beginning of year</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">58</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Additions charged to bad debt expense</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">140</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">66</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Write-downs charged against the allowance</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at end of the period</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">264</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Sales Related Allowances and Accruals</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.</div><div><br /></div><div style="text-indent: 18pt;">The<font style="color: rgb(0, 0, 0);"> following table provides a summary of activity with respect to sales related allowances and accruals for the nine months ended September 30, 2020:</font></div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 68%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total Sales Related</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allowances and Accruals</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,377</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Provision</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,996</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Payments / credits</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(3,441</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,932</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Total reductions of gross product sales from sales-related allowances and accruals were $3,996 for the nine months ended September 30, 2020.&#160; Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and Accounts payable and accrued expenses were $277 and $1,655, respectively, as of September 30, 2020 and $203 and $1,174, respectively, as of December 31, 2019.</div><div><br /></div><div style="font-style: italic;">Concentration of Major Customers</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Customers are considered major customers when sales exceed 10% of total net sales for the period or outstanding receivable balances exceed 10% of total receivables. For the year ended December 31, 2019, Indivior, Inc. (&#8220;Indivior&#8221;) provided 86% of the total revenues for the period, and as of that date, the Company&#8217;s outstanding receivable balance from Indivior represented approximately 80% of gross receivables. For the nine months ended September 30, 2020, there were two customers exceeding the 10% threshold for revenue while there were three customers exceeding the 10% threshold for outstanding accounts receivable. Revenues provided by Indivior, and Sunovion Pharmaceuticals, Inc. (&#8220;Sunovion&#8221;) represented approximately 54% and 31%, respectively of total revenue for the nine months ended September 30, 2020, and outstanding accounts receivable due from Indivior, Sunovion and AmerisourceBergen represented approximately 50%, 12% and 11%, respectively of gross receivables.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenues and trade receivables, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293376053816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaterialAgreementsAbstract', window );"><strong>Material Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Material Agreements</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 6.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Material Agreements</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Commercial Exploitation Agreement with Indivior</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2008, the Company entered into a Commercial Exploitation Agreement with Reckitt Benckiser Pharmaceuticals, Inc.&#160; (with subsequent amendments collectively, the &#8220;Indivior License Agreement&#8221;). Reckitt Benckiser Pharmaceuticals, Inc. was later succeeded to in interest by Indivior, Inc.&#160; Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone, a sublingual film formulation, both inside and outside the United States on an exclusive basis.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain Active Pharmaceutical Ingredients (&#8220;API&#8221;) for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Indivior License Agreement provides for payment by Indivior of a purchase price per unit that is subject to adjustment based on the Company&#8217;s ability to satisfy minimum product thresholds. Additionally, in the event Indivior purchases certain large quantities of Suboxone during a specified period, Indivior will be entitled to scaled rebates on its purchases.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) in each of the United States and in the rest of the world subject to annual maximum amounts and limited to the life of the related United States or international patents. In 2012, Indivior exercised its right to buy out its future royalty obligations in the United States under the Indivior License Agreement. Indivior remains obligated to pay royalties for all sales outside the United States.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renews for successive one-year periods, unless either party provides the other with written notice of its intent not to renew at least one year prior to the expiration of the initial or renewal term.</div><div><br /></div><div style="font-style: italic; font-weight: bold;">Supplemental Agreement with Indivior</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company is entitled to receive certain payments from Indivior commencing on the date of the agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable.&#160; Through February 20, 2019, the at-risk launch date of the competing generic products of Dr. Reddy&#8217;s Labs and Alvogen, the Company received an aggregate of $40,750 from Indivior under the Indivior Supplemental Agreement, of which $4,250 was collected during the three months ended March 31, 2019.&#160; Further payments under the Indivior Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. If such litigation is successful, in addition to the amounts already received as described in the foregoing, the Company may receive up to an additional $34,250, consisting of (i) up to $33,000 in the aggregate from any combination of (a) performance or event-based milestone payments and (b) single digit percentage royalties on net revenue earned by Indivior on sales of Suboxone and (ii) an additional $1,250 that was earned through the issuance of additional process patent rights to the Company.&#160; The aggregate payments under this Indivior Supplemental Agreement are capped at $75,000.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement are in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the Indivior License Agreement. Indivior&#8217;s payment obligations under the Indivior Supplemental Agreement are subject to certain factors affecting the market for Suboxone and may terminate prior to January 1, 2023 in the event certain contingencies relating to such market <font style="color: rgb(0, 0, 0);">occur.</font></div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">License Agreement with Sunovion Pharmaceuticals Inc.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion Pharmaceuticals Inc.), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product, KYNMOBI&#8482;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s obligation to remit a payment of $4,000 (the &#8220;FDA Approval Milestone Payment&#8221;) due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of the FDA approval. This amount was received as of September 30, 2020 and is included in License and royalty revenues for the nine-months ended September 30, 2020.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In consideration for the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;) The Company is also entitled to receive certain contingent one-time milestone payments related to product availability and regulatory approval in Europe, certain one-time milestone payments based on the achievement of specific annual net sales thresholds of KYNMOBI&#8482;, and ongoing mid-single digit percentage royalty payments related to the net sales of KYNMOBI&#8482; (subject to reduction to low-single digit percentage royalty payments in certain circumstances), subject to certain minimum payments. The maximum aggregate milestone payments that may be paid to the Company pursuant to the Sunovion License Agreement are equal to $45,000. There can be no guarantee that any future milestones will be met or that additional milestone payments will be payable. There are&#160; minimum annual guaranteed royalty payments under the contract.&#160;&#160; As of September 30, 2020, the Company recorded minimum royalty receivables of $8,000 in the aggregate, of which $1,000 is included in Trade and other receivables and $7,000 is included in Intangibles, net and other assets, with the total reflected in License and royalty revenues for the nine- months ended September 30, 2020.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Effective March 16, 2020, the Company entered into a first amendment (the &#8220;First Amendment&#8221;) to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the European Union (EU) which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provisions to reflect the Company&#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI&#8482; was not commercialized by January 1, 2020.&#160; This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the Amendment to the Sunovion License Agreement.&#160; The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company and Sunovion must continue to pay royalties to the Company on each sale of Sunovion&#8217;s remaining inventory of apomorphine-based products.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties&#8217; agreement with respect to certain provisions in the License Agreement, specifically the date after which Sunovion has the right to terminate the License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the License Agreement.&#160; See Note 19, (A), Subsequent Events. On November 3, 2020, the Company entered into a royalty monetization agreement (the &#8220;Monetization Agreement&#8221;) with an affiliate of Marathon Asset Management (&#8220;Marathon&#8221;) pursuant to which the Company conveyed to Marathon the right to all royalties and other payments due to the Company under the Sunovion License Agreement.&#160; See Note 19, (B), Subsequent Events.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Agreement to Terminate CLA with KemPharm</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In March 2012, the Company entered into an agreement with KemPharm, Inc. (&#8220;KemPharm&#8221;) to terminate a Collaboration and License Agreement entered into by the Company and KemPharm in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that KemPharm may derive from the commercialization or any other monetization of KemPharm&#8217;s KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving KemPharm and collaborations, royalty arrangements, or other transactions from which KemPharm may realize value from these compounds. During September 2019, the Company received $1,000 from its 10% share of milestone payments paid to KemPharm under its licensing of KP-415 and KP-484 to a third party.&#160; The Company has also received a payment of $500 under this arrangement during June 2020, which is included in License and royalty revenues for the nine-month period ended September 30, 2020, in connection with the FDA&#8217;s acceptance of a New Drug Application (&#8220;NDA&#8221;) filing for KP-415. A Prescription Drug User Fee Act (PDUFA) target date for completion of FDA review has been scheduled for early March 2021. The Company&#8217;s share of remaining milestone payments associated with KP-415 approval and certain targeted labeling goals within timeframes ending in July 2021 may reach $4,800. However, there can be no guarantee that approvals, goals or any such payments will be achieved or received in the future.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaterialAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaterialAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293383507800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Financial Instruments - Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments - Fair Value Measurements</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"><tr style="vertical-align: top;"><td style="vertical-align: top; width: 45pt;"><div style="text-align: left; font-weight: bold;">Note 7.</div></td><td style="vertical-align: top;"><div style="text-align: left; font-weight: bold;">Financial Instruments &#8211; Fair Value Measurements</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160; Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: rgb(0, 0, 0);">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: rgb(0, 0, 0);">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">&#8226;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: rgb(0, 0, 0);">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160; methodologies and similar techniques.</div></td></tr></table><div><br /></div><div style="text-indent: 18pt;">The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company granted warrants to certain holders of the 12.5% Notes in connection with its debt refinancing in July 2019.&#160; These warrants were valued based primarily on Level 3 inputs and an independent third-party appraisal prepared as of the grant date consistent with generally-accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued Compensation.&#160; See Note 14 for further information on these warrants.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293376518792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 8.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Inventories, Net</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The components of Inventory, net is as follows:</div><div style="text-indent: 21.6pt; color: rgb(0, 0, 0);"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Raw material</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,153</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,244</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Packaging material</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,231</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,096</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Finished goods</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">858</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">519</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total inventory, net</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,242</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,859</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The Company manufactures Suboxone exclusively to order for its major customer subject to strict quality standards and recognizes revenue upon completion of all customary quality control evaluations, which occurs prior to actual shipment.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302064584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 9.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment, Net</div></td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 67%;"><br /></td><td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Useful</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lives</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Machinery</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"><div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,406</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,088</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Furniture and fixtures</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,209</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,150</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Leasehold improvements</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"><div style="text-align: center; color: rgb(0, 0, 0);">(a)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,333</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,333</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Computer, network equipment and software</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0);">3-7 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2,886</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2,787</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Construction in progress</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,065</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,412</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">47,899</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">47,770</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated depreciation and amortization</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(40,171</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(38,044</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total property and equipment, net</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">7,728</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">9,726</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0);">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Total depreciation and amortization related to property and equipment was $714 and $695 for the three-month periods ended September 30, 2020 and 2019, respectively. For the respective nine-month periods, these expenses totaled $2,127 and $2,143.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293383507800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Right-of-Use Assets and Lease Obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Right-of-Use Assets and Lease Obligations</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 10.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Right-of-Use Assets and Lease Obligations</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company leases all realty used as its p<font style="color: rgb(0, 0, 0);">roduction and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, </font><font style="font-style: italic; color: rgb(33, 37, 41);">Leases, </font><font style="color: rgb(33, 37, 41);">that require classification as financing leases and, accordingly, these leases are accounted for as operating leases</font>. These leases provide remaining terms between 2.5 years and 6.0 years, including renewal options expected to be exercised to extend the lease periods. Measurement of the operating lease liability reflects an estimated discount rate of 16.9% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s latest collateralized debt refinancing. Right-of-use assets recorded upon adoption of ASC 842 totaled $4,048. For the three- and nine-month periods ended September 30, 2020, total operating lease expenses under these leases totaled $409 and $1,228, respectively, including variable lease expenses such as common area maintenance and operating costs totaling $89 and $255, respectively. Total payments to these lessors during the nine-month period ended September 30, 2020 were $1,255.</div><div><br /></div><div style="text-indent: 18pt;">Maturities of the Company&#8217;s operating lease liabilities are as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">266</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,287</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,295</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">944</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">565</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">565</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2026</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">424</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total lease payments</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">5,346</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: imputed interest</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(1,635</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total operating lease liabilities</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,711</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295580856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Other Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net and Other Assets</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 11.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Intangible Assets, Net and Other Assets</div></td></tr></table><div style="text-indent: 21.6pt; color: rgb(0, 0, 0); margin-left: 18pt;"><br /> The following table provides the components of identifiable intangible assets, all of which are finite lived:</div><div style="color: rgb(0, 0, 0);"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased technology-based intangible</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,358</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,358</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased patent</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">509</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">509</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated amortization</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2,752</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2,714</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Intangible assets, net</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">115</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">153</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Royalty receivable</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">7,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other assets, primarily security deposits</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">287</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">286</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total intangible assets, net and other assets</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">7,402</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">439</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Amortization expense was $13 for each of the three-month periods ended September 30, 2020 and 2019. For the corresponding nine-month periods, these expenses totaled $38 and $39, respectively. During the remaining life of the purchased patent, estimated annual amortization expense is $50 for each of the years from 2020 to 2022.&#160; Royalty receivable consists of seven annual $1,000 minimum royalty payments due from Sunovion, the last of which is due in March 2028.&#160; See Note 6 above.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293381594296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accounts Payable and Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 12.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Accounts Payable and Accrued Expenses</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); text-indent: 18pt;">Accounts payable and accrued expenses consisted of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accounts payable</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">9,169</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,274</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued compensation</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">4,129</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,758</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued distribution expenses</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,655</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,174</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">284</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">543</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total accounts payable and accrued expenses</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">15,237</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">17,749</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298132248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12.5% Senior Secured Notes and Loans Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>12.5% Senior Secured Notes and Loans Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">12.5% Senior Secured Notes and Loans Payable</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 13.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">12.5 % Senior Secured Notes and Loans Payable</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">12.5% Senior Secured Notes</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On July 15, 2019, the Company completed a private placement of up to $100 million aggregate principal of the 12.5% Notes and issued warrants for two million shares of common stock (the &#8220;Warrants&#8221;), $.001 par value per share, through the structuring agent, Morgan Stanley &amp; Co., LLC, and entered into a purchase agreement and related agreements including a Collateral Agreement with U.S. Bank National Association, as trustee and collateral agent, and a Lien Subordination and Intercreditor Agreement for the benefit of Madryn Health Partners, other institutional noteholders (the &#8220;Noteholders&#8221;) and U.S. Bank National Association in dual roles providing terms and governing an asset-based loan facility.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Upon closing of the Indenture for the 12.5% Notes (&#8220;Indenture&#8221;), the Company issued $70,000 of principal of the 12.5% Notes (the &#8220;Initial Notes&#8221;) along with the Warrants and rights of first offer (the &#8220;First Offer Rights&#8221;) to the lenders participating in this transaction for the 12.5% Notes and Warrants (the &#8220;Lenders&#8221;).&#160; Issuance of the Initial Notes and Warrants provided net proceeds of $66,082.&#160; In addition to the Initial Notes, the Indenture may provide access to further loans of up to $30,000 that may become available in two tranches of additional notes (the &#8220;Additional Notes&#8221;) tied to the NDA filing for and FDA U.S. marketing approval of Libervant&#8482;, an important part of the Company&#8217;s drug candidate pipeline. Subject to approval of the holder of a majority of the outstanding principal amount of the 12.5% Notes in its discretion, and provided that no events of default exist, the Company may offer to the Lenders participation in a $10,000 additional offering of the 12.5% Notes (the &#8220;First Additional Offering&#8221;) under terms similar to the Initial Notes, on or before March 31, 2021, upon the filing of the Libervant&#8482; NDA with the FDA.&#160; A second funding opportunity would allow the Company to obtain, on or before March 31, 2021, an additional $20,000 if the first option has been elected and funded, or, if not elected or funded, an additional $30,000 may be offered for issuance following FDA approval of Libervant&#8482; for marketing in the U.S.&#160; On November 3, 2020, this Indenture was amended and will be partially repaid from proceeds resulting from the monetization transaction.&#160; See Note 19 (C), Subsequent Events.&#160; There can be no assurance that any additional financing will be consummated.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Proceeds from the issuance of the Initial Notes and Warrants were used to fully repay the Company&#8217;s $56,340 outstanding indebtedness to Perceptive Credit Opportunities Fund, LP (the &#8220;Perceptive Loan&#8221;), related early repayment fees and legal and other fees incurred to obtain the loan.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The 12.5% Notes provide a stated fixed rate of 12.5%, payable quarterly in arrears, with the initial quarterly principal repayment of the Initial Notes due on September 30, 2021, and the final quarterly payment due at maturity on June 30, 2025. The Company has recorded $1,750 as Loans Payable, Current to reflect this obligation in its Condensed Consolidated Balance Sheet at September 30, 2020.&#160; Principal payments are scheduled to increase annually from 10% of the face amount of debt then outstanding during the first four quarters to 40% of the initial loan principal during the final four quarters.</div><div><br /></div><div style="text-indent: 18pt;">A debt maturity table is presented below:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">10,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">17,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">24,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">14,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Total</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">70,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company may elect, at its option, to prepay the 12.5% Notes at any time at premiums that range from 101.56% of outstanding principal if prepayment occurs on or after the 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> anniversary of the issue date of the Initial Notes to 112.5% if payment occurs during the third year after the issuance of the Initial Notes.&#160; In the event that redemption occurs within the two years after the issuance of the 12.5% Notes, a make-whole fee is required, based on the present value of remaining interest payments using an agreed-upon discount rate linked to the then-current U.S. Treasury rate. The Indenture also includes a change of control provision under which the Company may be required to repurchase the 12.5% Notes at 101% of the remaining principal plus accrued interest at the election of the Lenders.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Collateral for the loan under the 12.5% Notes consists of a priority lien on substantially all property and assets, including intellectual property, of the Company.&#160; This secured obligation provides payment rights that are senior to all existing and future subordinated indebtedness of the Company and provides Lenders with perfected security interests in substantially all of the Company&#8217;s assets.&#160; In the event that asset-based loans of up to $10,000 (&#8220;ABL Facility&#8221;) may be obtained, subject receivables and inventory assets will provide a second priority lien to senior secured Noteholders. The Company&#8217;s license of its intellectual property to a third-party drug development enterprise (specifically, Sunovion&#8217;s KYNMOBI&#8482; product) is one of the various assets serving as collateral for the loan.&#160; The&#160; Indenture permits the Company to monetize this asset while specifying that a portion of the proceeds, up to $40,000 if the First Additional Offering has not been elected or funded, or, $50,000 if it has been elected and funded, must be applied to prepay the Initial Notes, at 112.5% of the principal amount of the 12.5% Notes being repurchased, plus accrued and unpaid interest, if any, thereon, to the date of the repurchase, to the extent elected by the Noteholders, assuming that such monetization, up to such $40,000 or $50,000 level, as applicable, equals or exceeds those levels and if such monetization does not equal or exceed such level, such prepayment would be pro-rated among the Noteholders.&#160; To the extent that Lenders do not elect repayment of the debt at the date of the monetization, the amount not elected up to $40,000 (or $50,000 if an additional tranche is issued) will be held in a collateral account until approval of Libervant&#8482; by the FDA for U.S. marketing, at which time this cash collateral is to be released to the Company.&#160; Proceeds of more than $40,000 (or $50,000 if an additional tranche is issued) can be used immediately for general corporate purposes. As of September 30, 2020, the Company complied with all of its covenants under the Indenture.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company capitalizes legal and other third-party costs incurred in connection with obtaining debt as deferred debt issuance costs and applies the unamortized portion as a reduction of the outstanding face amount of the related loan in accordance with ASU 2015-03, <font style="font-style: italic;">Interest &#8211; Imputation of Interest: Simplifying the Presentation of Debt Issuance Costs</font>.&#160; Similarly, the Company amortizes debt discounts, such as those represented by warrants issued to its holders, and offsets those as a direct reduction of its outstanding debt.&#160; Amortization expenses arising from deferred debt issuance costs and debt discounts related to the 12.5% Notes were $590 and $1,758 for the three- and nine-month periods ended September 30, 2020, respectively. Comparative amortization expenses derived from deferred debt issuance costs and debt discounts related to the Perceptive Loan and the 12.5% Notes for the three- and nine-month periods ended September 30, 2019 were $556 and $1,338, respectively.&#160; Unamortized deferred debt issuance costs and deferred debt discounts totaled $7,904 and $9,662 as of September 30, 2020 and December 31, 2019, respectively.</div><div><br /></div><div style="font-style: italic;">Loans Payable - Perceptive</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2016, the Company entered into a Loan Agreement and Guaranty with Perceptive Credit Opportunities Fund, LP (&#8220;Perceptive&#8221;) under which the total available facility of $50,000 had been borrowed as of March 2017.&#160; At closing, Perceptive received a warrant to purchase senior common equity interests representing 4.5% of the fully diluted common units of the Company on an as converted basis, which was automatically exercised in full at the time of Aquestive&#8217;s IPO.&#160; In July 2019, the Perceptive Loan was paid in full in connection with the completion of the sale of the Initial Notes and Warrants described above.&#160; The early extinguishment of this debt resulted in a charge to third quarter 2019 earnings of an amount of $4,896, including an early retirement premium of $2,944 and the remaining balances of the unamortized loan discount and loan acquisition costs.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298352136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Issued to 12.5% Senior Secured Noteholders<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants Issued to 12.5% Senior Secured Noteholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsDisclosureTextBlock', window );">Warrants Issued to 12.5% Senior Secured Noteholders</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 14.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Warrant</font>s <font style="font-weight: bold;">Issued to 12.5% Senior Secured Noteholders</font></div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Warrants that were issued in conjunction with the Initial Notes described above expire on June 30, 2025 and entitled the holders of the Initial Notes to purchase two million shares of the Company&#8217;s common stock at $4.25 per share and include specified registration rights.&#160; Management estimated the fair value of the Warrants to be $6,800, assisted by an independent third-party appraiser.&#160; The fair value of these Warrants is treated as a debt discount, amortizable over the term of the Warrants, with the unamortized loan portion applied to reduce the face amount of the Initial Notes in the Company&#8217;s balance sheet.&#160; Additionally, since the Warrants issued do not provide warrant redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the Warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value attributed to the Warrants is presented in Additional-paid in capital in the accompanying Condensed Consolidated Balance Sheets.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Certain holders of the Initial Notes exercised Warrants for the purchase of 428,571 shares of common stock and proceeds therefor totaling $1,821 were received on December 16, 2019. There were no Warrants exercised by the holders of the Initial Notes during the nine-month period ended September 30, 2020.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On November 3, 2020, the Indenture was amended, and additional at-the-money warrants will be issued at the time of purchase of additional Notes.&#160; See Note 19 (C), Subsequent Events.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293303004760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 15.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Net Loss Per Share</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">Basic net income or loss per share is calculated by dividing net income or loss by the weighted-average number of common share</font>s outstanding during the periods. Diluted net income or loss per common share is similarly computed and includes the effect of any additional dilutive potential common shares outstanding during the periods. These potential common shares are excluded from the computation of net loss per share to the extent that their effects are antidilutive, and <font style="color: rgb(0, 0, 0);">as a result of the Company&#8217;s net losses incurred for the three- and nine-month periods ended September 30, 2020 and 2019, respectively, no potentially dilutive securities have been included in the computation of diluted net loss per share for the periods presented below.</font></div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Numerator:</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(16,551</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(18,412</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(35,415</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(53,610</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Denominator:</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Weighted-average number of common shares &#8211; basic</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">33,619,379</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">25,031,478</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">33,592,846</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">24,992,229</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loss per common share &#8211; basic and diluted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(0.49</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(0.74</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(1.05</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2.15</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following outstanding stock options, restricted stock units and warrants are antidilutive and have been excluded from the computation of the loss per common share for the periods ended September 30:</div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Options on common shares outstanding</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">3,075,942</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,256,092</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units unvested</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">13,489</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">107,144</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Warrants on common shares outstanding</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,571,429</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total potentially antidilutive derivatives excluded from losses per share</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">4,660,860</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,363,236</div><div></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298319736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 16.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Share-Based Compensation</div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The Company recognized share-based compensation in its Condensed Consolidated Statements of Operations and Comprehensive Loss during 2020 and 2019 as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">73</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">60</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">208</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">176</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Research and development</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">178</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">188</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">543</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">536</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,176</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,622</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">4,301</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">4,480</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,427</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,052</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,200</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Share-based compensation from:</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">16</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">473</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">789</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,403</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,411</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,397</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4,252</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,777</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Employee stock purchase plan</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">20</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,427</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,052</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,200</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Share-Based Compensation Equity Awards</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine-month period ended September 30, 2020:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Restricted Stock Unit Awards (RSUs):</u></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Units</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Grant Date Fair</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">74</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14.64</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">7.54</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(64</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14.88</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Forfeited</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11.38</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Grant date fair value of shares vested during the period</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">958</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unrecognized compensation costs as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">140</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Unrecognized compensation costs related to awards of RSUs are expected to be recognized over a weighted-average period of less than two years.</div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Stock Option Awards:</u></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted Average</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Exercise Price</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,231</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">10.42</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">981</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2.68</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercised, Forfeited, Expired</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(136</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(4.39</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">3,076</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8.22</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested or expected to vest as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,866</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">8.22</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercisable as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,014</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11.87</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The fair values of stock options granted during 2020 were estimated using the Black-Scholes-Merton pricing model based on the following assumptions:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 60%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><tr><td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected dividend yield</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="text-align: right; color: rgb(0, 0, 0);">None</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected volatility</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">100</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"><div style="color: rgb(0, 0, 0);">%</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected term (years)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">5.5 - 6.1</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Risk-free interest rate</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">0.4 &#8211; 1.7</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"><div style="color: rgb(0, 0, 0);">%</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The weighted average grant date fair value of stock options granted during 2020 was $2.10 During the nine-month period ended September 30, 2020, stock options were granted with exercise prices ranging from $1.54 to $7.86, and accordingly, given the Company&#8217;s share price of $4.86 at September 30, 2020, certain shares granted during this period provided intrinsic value at that date totaling $2,474. No intrinsic value was provided by stock options granted during the nine-month period ended September 30, 2019.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">As of September 30, 2020, $6,554 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a weighted average period of 1.8 years from the date of grant.</div><div><br /></div><div style="text-align: justify; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);"><u>Employee Stock Purchase Plan</u></div><div>&#160;</div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">The Aquestive Therapeutics, Inc. Employee Stock Purchase Plan, or ESPP, as amended and restated effective as of January 1, 2019, features two six-month offering periods per year, running from January 1 to June 30 and July 1 to December 31. Under the ESPP, employees may elect to purchase the Company&#8217;s common stock at the lower of 85% of the fair value of shares on either the first or last day of the offering period. During the nine-month periods ended September 30, 2020 and 2019, respectively, 14,961 and 31,393 shares were purchased and issued through the ESPP at total discounts of $11 and $20.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302702824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 17.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits.&#160; Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.&#160; The Company has considered the impact of the CARES Act in relation to the 2020 income tax provision. However, due to the full valuation allowance and no ability or intent to carryback the 2020 net operating loss, no impact is expected.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended September 30, 2020 and 2019, the Company recorded no income tax benefit from its pretax losses of $16,551 and $18,412, respectively, and similarly for the nine months ended September 30, 2020 and 2019, the Company recorded no tax benefit from its pretax loss of $35,415 and $53,610, respectively, due to realization uncertainties.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company&#8217;s U.S. Federal statutory rate is 21%.&#160; The primary factor impacting the effective tax rate for the three- and nine-month periods ended September 30, 2020 is the anticipated full year operating loss which will require full valuation allowances against any associated net deferred tax assets.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298330952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 18.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Contingencies</div></td></tr></table><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Litigation and Contingencies</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business, including product liability, intellectual property, commercial litigation, or environmental or other regulatory matters. Except as described below, Aquestive is not presently a party to any litigation or other legal proceeding that is believed to be material to its financial condition.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Patent-Related Litigation</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Beginning in August 2013, the Company was informed of abbreviated new drug application (&#8220;ANDA&#8221;) filings in the United States by Watson Laboratories, Inc. (now Actavis Laboratories, Inc., or &#8220;Actavis&#8221;), Par Pharmaceutical, Inc. (&#8220;Par&#8221;), Alvogen Pine Brook, Inc. (&#8220;Alvogen&#8221;), Teva Pharmaceuticals USA, Inc.&#160; (&#8220;Teva&#8221;), Sandoz Inc. (&#8220;Sandoz&#8221;), and Mylan Technologies Inc. (&#8220;Mylan&#8221;), for the approval by the FDA of generic versions of Suboxone Sublingual Film in the United States. Aquestive filed patent infringement lawsuits against all six generic companies in the United States District Court for the District of Delaware (the &#8220;Delaware District Court&#8221;). After the commencement of the ANDA patent litigation against Teva, Dr. Reddy&#8217;s Laboratories (&#8220;DRL&#8221;) acquired the ANDA filings for Teva&#8217;s buprenorphine and naloxone sublingual film that are at issue in these trials.</div><div><br /></div><div style="text-align: justify; margin-left: 18pt;">Of these, cases against three of the six generic companies have been resolved.</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18.3pt; vertical-align: top;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div><font style="font-style: italic;">Mylan</font> and <font style="font-style: italic;">Sandoz</font> settled without a trial. Sandoz withdrew all challenges and became the distributor of the authorized generic products.</div></td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18.3pt; vertical-align: top;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div>All cases against <font style="font-style: italic;">Par </font>were resolved pursuant to a May 2018 settlement agreement among the Company, Indivior, and Par and certain of its affiliates.</div></td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18.3pt; vertical-align: top;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div><font style="font-style: italic;">Actavis</font> was found to infringe Patent No. 8,603,514, or the &#8217;514 patent, and cannot enter the market until the expiration of the patent in 2024, and the United States Court of Appeals for the Federal Circuit (&#8220;Federal Circuit&#8221;) affirmed that ruling on July 12, 2019.</div></td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18.3pt; vertical-align: top;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div><font style="font-style: italic;">DRL</font> and <font style="font-style: italic;">Alvogen</font> were found not to infringe under a different claim construction analysis, and the Federal Circuit affirmed that ruling on July 12, 2019. <font style="font-style: italic;">Teva</font> has agreed to be bound by all DRL adjudications.</div></td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Subsequent to the above, all potential generic competitors without a settlement agreement were also sued for infringement of two additional new patents that contain new claims not adjudicated in the original Delaware District Court case against DRL and Alvogen.&#160; On July 12, 2019, the Federal Circuit affirmed the decisions from the previously decided cases.&#160; The remaining case against Actavis was dismissed in light of the infringement ruling above, which prevents Actavis from entering the market until 2024.&#160; The case(s) against the remaining defendants regarding the additional asserted patents have not been finally resolved.&#160; A <font style="font-style: italic;">Markman </font>hearing in the cases against Dr. Reddy&#8217;s and Alvogen which is pending in the United States District Court for the District of new Jersey (the &#8220;New Jersey District Court&#8221;) was held on October 17, 2019.&#160; On November 5, 2019, District Judge McNulty of the New Jersey District Court issued a <font style="font-style: italic;">Markman</font> opinion construing the disputed terms of the asserted patents. On January 9, 2020, the New Jersey District Court entered a stipulated order of non-infringement of one of the patents, Patent No. 9,931,305, or the &#8217;305 patent, based on the Federal Circuit&#8217;s claim construction ruling, and the Company and Indivior preserved available rights to appeal the claim construction ruling. On November 19, 2019, Magistrate Judge Waldor of the New Jersey District Court issued an order granting DRL and Alvogen&#8217;s requests to file amended answers to add antitrust counterclaims against Aquestive and Indivior.&#160; Aquestive and Indivior appealed the Magistrate Judge&#8217;s decision to District Judge McNulty on December 4, 2019, and DRL and Alvogen opposed the appeal. On January 17, 2020, the Company filed a motion to dismiss DRL&#8217;s and Alvogen&#8217;s antitrust counterclaims for failure to state a claim, and DRL and Alvogen opposed the motion.&#160; <font style="color: rgb(0, 0, 0);">On August 24, 2020, Judge McNulty issued an Opinion and Order denying both the appeal of the Magistrate&#8217;s decision and Aquestive&#8217;s Motion to Dismiss. On June 3, 2020, the court issued an order setting a schedule for ongoing fact discovery, expert discovery, and dispositive motions.&#160; The schedule currently sets the close of fact discovery for October 20, 2020, with expert discovery continuing through the end of April 2021.&#160; The schedule also sets the deadline for filing dispositive motions for May 18, 2021. </font>No trial date has been set in those cases.&#160; Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On February 19, 2019, the Federal Circuit issued its mandate reversing the New Jersey District Court&#8217;s preliminary injunction against Dr. Reddy&#8217;s.&#160; Following issuance of the mandate, the New Jersey District Court vacated preliminary injunctions against both Dr. Reddy&#8217;s and Alvogen.&#160; Dr. Reddy&#8217;s, Alvogen, and Mylan all launched generic versions of Suboxone Sublingual Film, and the launches by Dr. Reddy&#8217;s and Alvogen are &#8220;at risk&#8221; because the products are the subject of the ongoing patent infringement litigations.</div><div style="text-align: justify; text-indent: 22.3pt; margin-left: 0.2pt;"><br /></div><div style="text-align: justify; text-indent: 18pt;">On March 22, 2019, Aquestive and Indivior brought suit against Aveva Drug Delivery Systems, Inc., Apotex Corp., and Apotex Inc.in the United States District Court for the Southern District of Florida (the &#8220;Southern District of Florida Court&#8221;) for infringement of the Company&#8217;s U. S. Patent Nos.&#160; 8,017,150, 9,687,454, the &#8217;514 patent and &#8217;305 patent, seeking an injunction and potential monetary damages.&#160; Following a negotiated settlement between all parties, on December 3, 2019, the parties submitted a Notice of Settlement and a Joint Motion to Approve Consent Judgment. The Southern District of Florida Court entered an order dismissing the suit on December 18, 2019.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company is also seeking to enforce its patent rights in multiple cases against BioDelivery Sciences International, Inc. (&#8220;BDSI&#8221;). Three cases are currently pending but stayed in the U.S. District Court for the Eastern District of North Carolina (the &#8220;Eastern District of North Carolina Court&#8221;):</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;">&#160;</td><td style="vertical-align: top; width: 18.3pt;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div>The first, a declaratory judgment action brought by BDSI against Indivior and Aquestive, seeks declarations of invalidity and non-infringement of U.S. Patents Nos. 7,897,080, 8,652,378 and 8,475,832. This case is stayed.</div></td></tr></table><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;">&#160;</td><td style="vertical-align: top; width: 18.3pt;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div>The second was filed by Aquestive and Indivior related to BDSI&#8217;s infringing Bunavail product, and alleges infringement of Aquestive&#8217;s patent, U.S. Patent No. 8,765,167, or the &#8217;167 patent, and seeks an injunction and potential monetary damages. Shortly after the case was filed, BDSI filed four (4) IPR&#8217;s challenging the asserted &#8217;167 patent.&#160; On March 24, 2016, the United States Patent Trial and Appeal Board (&#8220;PTAB&#8221;), issued a final written decision finding that all claims of the &#8217;167 patent were valid. The case was stayed in May 2016 pending the final determination of the appeals on those decisions.&#160; Following the PTAB&#8217;s February 7, 2019 decisions on remand denying institution, Aquestive and Indivior submitted a notice to the Court on February 15, 2019 notifying the Court that the stay should be lifted as a result of the PTAB&#8217;s decisions. The parties in this matter are awaiting further action from the Court.</div></td></tr></table><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18.3pt; vertical-align: top;">&#8226;</td><td style="vertical-align: top; text-align: justify;"><div style="font-size: 12pt;"><font style="font-size: 10pt;">On January 13, 2017, the Company also sued BDSI asserting infringement of the &#8217;167 patent by BDSI&#8217;s Belbuca product and seeking an injunction and potential monetary damages.&#160; On August 7, 2019, the Eastern District of North Carolina Court granted BDSI&#8217;s motion to dismiss the Complaint without prejudice and denied BDSI&#8217;s motion to stay as moot.&#160; On November 11, 2019, Aquestive filed a new Complaint against BDSI in the Eastern District of North Carolina Court.&#160; On November 27, 2019, BDSI filed a motion to stay the case pending BDSI&#8217;s appeal of the PTAB&#8217;s remand decisions, and the Company opposed this motion. The Eastern District of North Carolina Court denied BDSI&#8217;s motion to stay on April 1, 2020. BDSI&#8217;s appeal of the PTAB&#8217;s remand decisions to the United States Court of Appeals for the Federal Circuit was docketed on March 13, 2019, and on March 20, 2019, and a motion was made to dismiss this appeal for lack of jurisdiction.&#160; On August 29, 2019, the Federal Circuit granted the motion to dismiss BDSI&#8217;s appeal.&#160; On September 30, 2019, BDSI filed a petition for rehearing in the Federal Circuit </font><font style="font-size: 10pt; font-style: italic;">en banc</font><font style="font-size: 10pt;">, which the Company opposed.&#160; The Federal Circuit denied BDSI&#8217;s petition for rehearing </font><font style="font-size: 10pt; font-style: italic;">en banc</font><font style="font-size: 10pt;"> on January 13, 2020.&#160; </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">On June 11, 2020, BDSI filed a petition for writ of certiorari at the Supreme Court of the United States.&#160; At the request of the Supreme Court, Aquestive filed an opposition to BDSI&#8217;s petition on August 17, 2020, and BDSI filed a reply on August 27, 2010.&#160; On October 5, 2020, the Supreme Court issued an order denying BDSI&#8217;s petition. </font><font style="font-size: 10pt;">After the Federal Circuit denied BDSI&#8217;s petition, on January 13, 2020, BDSI filed with the Eastern District of North Carolina Court a motion to dismiss the Complaint, and Aquestive opposed on February 2, 2020.&#160; The Eastern District of North Carolina Court denied BDSI&#8217;s motion to dismiss </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">and its motion to stay </font><font style="font-size: 10pt;">on April 1, 2020.&#160; On April 16, 2020, BDSI filed an Answer to the Complaint, including counterclaims for non-infringement, invalidity, and unenforceability of the &#8217;167 patent.&#160; </font><font style="font-size: 10pt; color: rgb(0, 0, 0);"> On May 7, 2020, Aquestive filed a motion to dismiss BDSI&#8217;s unenforceability counterclaim and a motion to strike BDSI&#8217;s corresponding affirmative defenses for failure to state a claim for inequitable conduct under the heightened pleading standard applicable to such claims and defenses.&#160; Rather than oppose Aquestive&#8217;s Motion to Dismiss, on May 28, 2020, BDSI amended its counterclaims and filed an Answer and Amended Counterclaims, which included additional allegations in support of BDSI&#8217;s unenforceability counterclaim.&#160; On June 25, 2020, Aquestive filed a Motion to Dismiss BDSI&#8217;s Amended Counterclaim for unenforceability and a Motion to Strike BDSI&#8217;s corresponding affirmative defense of unenforceability again for failure to state a claim under the applicable heightened pleading standard.&#160; BDSI&#8217;s filed its opposition to Aquestive&#8217;s Motion to Dismiss and Strike on July 16, 2020.&#160; Aquestive filed its Reply to BDSI&#8217;s Opposition on July 30, 2020.&#160; The parties are awaiting further action from the court on Aquestive&#8217;s motion.</font></div></td></tr></table><div><br /></div><div style="font-style: italic; font-weight: bold;">Antitrust Litigation</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">On September 22, 2016, forty-one states and the District of Columbia, or the States, brought suit against Indivior and the Company in the U.S. District Court for the Eastern District of Pennsylvania, alleging violations of federal and state antitrust statutes and state unfair trade and consumer protection laws relating to Indivior&#8217;s launch of Suboxone Sublingual Film in 2010 and seeking an injunction, civil penalties, and disgorgement. After filing the suit, the case was consolidated for pre-trial purposes with the <font style="font-style: italic;">In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation</font>, MDL No. 2445, or the Suboxone MDL, a multidistrict litigation relating to putative class actions on behalf of various private plaintiffs against Indivior relating to its launch of Suboxone Sublingual Film. While Aquestive was not named as a defendant in the original Suboxone MDL cases, the action brought by the States alleges that the Company participated in an antitrust conspiracy with Indivior in connection with Indivior&#8217;s launch of Suboxone Sublingual Film and engaged in related conduct in violation of federal and state antitrust law. Aquestive moved to dismiss the States&#8217; conspiracy claims, but by order dated October 30, 2017, the Court denied the motion to dismiss. An answer was filed denying the States&#8217; claims on November 20, 2017. The fact discovery period closed July 27, 2018, but the parties agreed to conduct certain fact depositions in August 2018.&#160; The expert discovery phase closed May 30, 2019, but additional reports and depositions were conducted through August 1, 2019.&#160; The remainder of the case schedule, including summary judgment briefing, is stayed pending resolution of Indivior&#8217;s appeal of the District Court&#8217;s class certification ruling in a co-pending multi-district litigation to which the Company is not a party. On July 28, 2020, the U.S. Court of Appeals for the Third Circuit issued its opinion affirming the District Court&#8217;s order certifying the class.&#160; On August 27, 2020, the district court issued a scheduling order, setting the deadline for filing remaining <font style="font-style: italic;">Daubert</font> challenges and summary judgment.&#160; Under the scheduling order, the remaining <font style="font-style: italic;">Daubert</font> motions were filed on September 28, 2020, and oppositions are due on October 19, 2020.&#160; The court will set oral argument on the motions, but the date for oral argument is not yet known.&#160; Summary judgment motions are due January 11, 2021, and responses to summary judgment motions are due February 11, 2021.&#160; No trial date has yet been set. Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-weight: bold;">Humana and Centene Actions</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On September 18, 2020, Humana, Inc., a health insurance payer, filed a suit against Aquestive and Indivior in the Eastern District of Pennsylvania relating to Suboxone.&#160; The Humana action, which alleges facts similar to those at issue in the Antitrust Case and the Suboxone MDL described above, was assigned to the same judge that is presiding over those actions.&#160; Humana&#8217;s Complaint alleges five causes of action against Aquestive, including conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment.&#160; On September 21, 2020, Centene Corporation and other related insurance payers filed a similar suit against Aquestive and Indivior in the Eastern District of Missouri.&#160; The counsel representing Humana is also representing Centene.&#160; On September 21, 2020, the Centene action was provisionally transferred to the Eastern District of Pennsylvania by the United States Judicial Panel on Multidistrict Litigation.&#160; No other proceedings have occurred and the schedule is not yet known.&#160; Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimate, of the possible outcome or loss, if any, in this matter.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">California Complaint</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">On December 5, 2019, Neurelis Inc. (&#8220;Neurelis&#8221;) filed a complaint against Aquestive in the Superior Court of California, County of San Diego alleging Unfair Competition, Defamation, and Malicious Prosecution related to the Company&#8217;s pursuit of FDA approval for Libervant&#8482;. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action.&#160; The Company filed a Motion to Strike Neurelis&#8217;s Complaint under California&#8217;s anti-SLAPP (&#8220;strategic lawsuit against public participation&#8221;) statute on Friday, January 31, 2020, which Neurelis is expected to oppose.&#160; Neurelis filed a motion for leave to file a Supplemental Complaint on February 5, 2020, which will be opposed.&#160; On February 5, 2020, Neurelis filed a Motion for Leave to File a Supplemental Complaint (&#8220;Motion&#8221;).&#160; On June 5, 2020, Neurelis filed a Motion for Limited Discovery related to Aquestive&#8217;s anti-SLAPP motion.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">The court previously scheduled a hearing on both Aquestive&#8217;s anti-SLAPP Motion and on Neurelis&#8217;s Motion for April 24, 2020.&#160; However, on April 3, 2020, in response to the COVID-19 pandemic, the court issued an order continuing all hearings scheduled through April 30, 2020.&#160; The court ultimately held a telephonic status conference on June 25, 2020 to determine a schedule for hearing the pending motions.&#160; During that status conference, the court set Aquestive&#8217;s anti-SLAPP motion for hearing on July 24, 2020.&#160; The court also declined Neurelis&#8217;s request to hear its Motion and its Motion for Limited Discovery.&#160; Neurelis filed its response to Aquestive&#8217;s anti-SLAPP Motion on July 13, 2020, and we filed our reply on July 17, 2020.&#160; The court held a telephonic hearing on Aquestive&#8217;s anti-SLAPP motion on July 24, 2020. On August 6, 2020, the Court issued an order granting in part and denying in part Aquestive&#8217;s anti-SLAPP motion.&#160; Aquestive filed a notice of appeal to the California Court of Appeal on September 1, 2020, and Neurelis filed a notice of cross-appeal on October 5, 2020.&#160; </font>Management is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate, or range of estimates, of the possible outcome or loss, if any, in this matter.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298413560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 19.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Events</div></td></tr></table><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0);"><font style="font-weight: bold; font-style: italic;">(A)</font>&#160;<font style="font-weight: bold; font-style: italic;">Amendment to License Agreement with Sunovion Pharmaceuticals Inc.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Effective as of October 23, 2020, the Company entered into a Second Amendment to the Sunovion License Agreement whereby the parties to the Sunovion License Agreement agreed to clarify the continued rights and obligations of the parties with respect to the prosecution and maintenance of the Company&#8217;s patents covered under the Agreement and that, on and after March 31, 2028, in respect of any jurisdiction or jurisdictions covered under the License Agreement, Sunovion may terminate its rights with respect to the Licensed Patents under the License Agreement upon 180 days prior written notice to the Company.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(B) Monetization of Certain Rights under the Sunovion License Agreement</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">On November 3, 2020, the Company entered into the Monetization Agreement&#160; that will result in proceeds to the Company of up to $125,000 in exchange for which the Company conveyed to Marathon the right to all royalties and other payments due to the Company under the Sunovion License Agreement (See Note 6).&#160; Under the terms of the Monetization Agreement, Aquestive will receive a $40,000 cash payment within 12 business days of signing and is eligible to receive up to $85,000 </font>of contingent payments at various points, beginning as early as the fourth quarter of 2020, based on the achievement of worldwide royalty targets and certain other commercial milestones.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(C) Amendment and Partial Repayment of the 12.5% Notes</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">With the proceeds paid to the Company at closing under the Monetization Agreement, the Company will repay $22,500 of the 12.5% Notes, and issue $4,000&#160; of new senior notes in lieu of paying a prepayment premium on the early repayment of the 12.5% Notes, reducing the balance of senior notes outstanding to $51,500 in the aggregate.&#160; In addition, the holders of the 12.5% Notes have extended to December 31, 2021 the Company&#8217;s ability to access, at the Company&#8217;s option, $30,000 of senior notes re-openers under the Indenture. The first $10,000 senior notes re-opener represents a commitment of such amount by current holders of 12.5% Notes, at the option of the Company, contingent upon FDA approval of the Company&#8217;s product candidate Libervant</font> (diazepam) Buccal Film for the management of seizure clusters<font style="color: rgb(0, 0, 0);">.&#160; A second $20,000 senior notes re-opener represents a right, at the Company&#8217;s option, to market to current holders of the Company&#8217;s 12.5% Notes, and/or other lenders, additional senior notes up to such amount, contingent upon FDA approval of Libervant for U.S. market access.&#160; If and to the extent that the Company accesses these re-openers, the Company will grant warrants to purchase up to 714,000 shares of common stock, with the strike price calculated based on the 30-day volume weighted average closing price of the Company&#8217;s common stock at the warrant grant date.&#160; In addition, as of the closing of this transaction, the Company will issue to the holders of the 12.5% Notes warrants to purchase 143,000 shares of the Company&#8217;s common stock.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302666872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2019 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 11, 2020 (the &#8220;2019 Annual Report on Form 10-K&#8221;). As included herein, the condensed consolidated balance sheet as of December 31, 2019 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The accompanying financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298193432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation and Significant Accounting Policies</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(A) Principles of Consolidation and Significant Accounting Policies</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The interim condensed consolidated financial statements presented herein include the accounts of Aquestive Therapeutics, Inc. and its wholly owned subsidiary, MonoSol Rx, Inc. Other than corporate formation activities, MonoSol Rx, Inc. has conducted no commercial, drug development or operational activities and has no customers or vendors. The results of operations and cash flows reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected in any other interim period or for the entire fiscal year.</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"><div><div style="text-align: justify; text-indent: 21.6pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s significant accounting policies are described in the audited consolidated financial statements included in the <font style="font-size: 10pt; font-family: 'Times New Roman';">2019</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">A</font>nnual Report on Form 10-K.&#160; Subsequent to the date of those financial statements, there have been no significant changes to these policies other than those listed below.</div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(B) Use of Estimates</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#160; Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of share-based compensation and contingencies.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(C) Recent Accounting Pronouncements</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">As an emerging growth company, the Company has elected to take advantage of the extended transition period afforded by the Jumpstart Our Business Startups Act for the implementation of new or revised accounting standards and, as a result, the Company will comply with new or revised accounting standards no later than the relevant dates on which adoption of such standards is required for emerging growth companies. The Company believes that the impact of recently issued accounting standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption</font><font style="color: rgb(33, 37, 41);">.</font></div><div><br /></div><div style="font-style: italic;">Recently Adopted Accounting Pronouncements:</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In February 2016, the Financial Accounting Standards Board issued ASU, 2016-02, <font style="font-style: italic; color: rgb(33, 37, 41);">Leases (Topic 842)</font><font style="color: rgb(33, 37, 41);">, and issued amendments in July 2018 provided by ASU 2018-10. This ASU, as amended, requires lessees to recognize lease assets, termed &#8220;right-of-use assets&#8221; and related lease liabilities on the balance sheet that had previously been classified as operating leases under prior authoritative guidance. For income statement purposes, leases are now required to be classified as either operating or financing leases under a dual model similar to that specified by ASC 840. Operating leases continue to result in straight-line expense while financing leases result in a front-loaded expense pattern in a manner similar to recognition of capital lease expenses under ASC 840.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">The Company adopted and applied ASU 2016-02 on January 1, 20<font style="color: rgb(33, 37, 41);">20 using the modified retrospective transition provisions of ASC 842 to leases in effect as of that date of adoption and recorded right-of-use assets totaling $4,048 and lease liabilities as adjusted for accrued lease payments, in the amount of $4,224 based on an estimated incremental borrowing rate of 16.9%, representing the present value of remaining minimum lease payments. The assets and liabilities thus recorded were primarily those related to the Company&#8217;s leased plant, laboratory and corporate administrative facilities. The Company elected to apply the ASU-specified practical expedients and accordingly did not re-assess (i) whether its contracts contained a lease under the new definition of a lease, (ii) the classification of those leases, and (iii) initial direct costs of existing leases. In addition, the Company elected not to apply the hindsight expedient in the assessment of lease renewals and resultant term of leases. The Company also elected not to recognize a right-of-use asset and lease liability for those leases with a remaining lease term of 12 months or less. The adoption of ASU 2016-02 did not require a cumulative-effect adjustment to the opening balance of the accumulated deficit at the time of adoption.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In May 2014, the FASB issued ASU 2014-09, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, and subsequently issued a number of amendments to this update.&#160; The new standard, as amended in Accounting Standards Codification, or ASC 606, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes previous revenue recognition guidance. The standard&#8217;s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#160; In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this standard effective January 1, 2019.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2016, the FASB issued ASU 2016-15,<font style="font-style: italic;"> Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, </font>providing guidance on the classification of certain cash receipts and payments in the statement of cash flows intended to reduce diversity in practice, including cash flows related to debt prepayment or extinguishment costs and contingent consideration that may be paid following a business combination. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In August 2018, the FASB issued ASU 2018-13, <font style="font-style: italic;">Fair Value Measurement (Topic 820): Disclosure Framework. </font>The purpose of the update is to improve the effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;"><font style="color: rgb(0, 0, 0);">In November 2018, the FASB issued ASU 2018-18, C</font><font style="font-style: italic; color: rgb(0, 0, 0);">ollaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606,</font><font style="color: rgb(0, 0, 0);"> which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer for a promised good or service that is distinct within the collaborative arrangement. The guidance also precludes entities from presenting amounts related to transactions with a collaborative arrangement participant that is not a customer as revenue, unless those transactions are directly related to third-party sales.</font> The Company adopted this new guidance on January 1, 2020 without material impact on its condensed consolidated financial position or results of operations.</div><div><br /></div><div style="color: rgb(0, 0, 0); font-style: italic;">Recent Accounting Pronouncements Not Adopted as of September 30, 2020:</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In June 2016, the FASB issued ASU 2016-13,<font style="font-style: italic;"> Financial Instruments &#8211; Credit Losses (Topic 326)</font>, amending existing guidance on the accounting for credit losses on financial instruments within its scope. The guidance provides for use of a forward-looking expected loss model for estimating credit losses, replacing the incurred loss model that is based on past events and current conditions. The new guidance also changes the impairment model for available-for-sale debt securities, requiring the use of an allowance to record estimated credit losses (and subsequent recoveries). The new guidance is effective for the Company beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">August 2018, the FASB issued ASU 2018-15, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Intangibles&#8212;Goodwill and Other Internal-Use Software (Subtopic 350-40: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</font><font style="color: rgb(0, 0, 0);">, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance distinguishing between capitalizable service contract implementation costs and contract costs required to be expensed. In addition, the update requires that the term of the hosting arrangement is to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. This standard will become effective for the Company beginning January 1, 2021. The amendments may be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 and does not expect to have a material impact on its consolidated financial statements.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">In <font style="color: rgb(0, 0, 0);">December 2019, the FASB issued ASU 2019-12, </font><font style="font-style: italic; color: rgb(0, 0, 0);">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, </font><font style="color: rgb(0, 0, 0);">which amends accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. The standard will be effective for the Company beginning January 1, 2022, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on its consolidated financial statements.</font></div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">In August 2020, the FASB issued ASU 2020-06, <font style="font-style: italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font>. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity.&#160; Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. These amendments will be effective for the Company beginning January 1, 2024, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; color: rgb(0, 0, 0);">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the condensed consolidated financial statements of the Company.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295502856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetAbstract', window );"><strong>Revenues and Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Performance Obligations</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; text-indent: 18pt;">Aquestive recognizes revenue pursuant to ASC 606, <font style="font-style: italic;">Revenue from Contracts with Customers</font>, to reflect amounts expected to be collectible in exchange for the transfer of contractually promised goods or services to its customers, as discussed in additional detail in the Company&#8217;s 2019 Annual Report on Form 10-K.&#160; Accordingly, the value of contractually promised goods or services is assessed at contract inception to identify those that constitute distinct performance obligations. Contract revenues are allocated to those distinct performance obligations based on estimated standalone values or expected values, and these allocated revenues are recognized at the point in time, or over the period of time, that those distinct obligations are satisfied. The Company&#8217;s performance obligations consist primarily of transferring control of goods, services or intellectual property that are identified in the contracts, purchase orders or invoices. Variable or contingent revenues which may become due from customers, such as milestone payments due upon acceptance of a regulatory filing, regulatory approval, or sales-based milestone payments, are not recognized until contingencies are met, the customer&#8217;s obligation to meet its contractual payment commitments is fixed and collection of invoiced amounts is reasonably assured, thereby limiting any significant probability of a revenue reversal.</div><div><br /></div><div style="text-align: justify; text-indent: 18pt;">Revenues from the sale of products and services and from licensing arrangements and related payments are evidenced by a contract with the customer. For manufacturing and supply and proprietary product sales, invoices are generally issued upon the transfer of control. Co-development and research revenue is typically invoiced based on the contractual payment schedule, or upon completion of the service. Licensing revenue is generally invoiced at the inception of an agreement, with additional charges rendered as related contingencies, such as regulatory approvals or sales targets, are met. Invoices are typically payable 30 to 60 days after the invoice date, however some payment terms may reach 75 days depending on the customer. The Company performs a review of each specific customer&#8217;s creditworthiness and ability to pay prior to acceptance as a customer, as well as periodic prospective reviews.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293301882328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetAbstract', window );"><strong>Revenues and Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The Company&#8217;s revenues were comprised of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply revenue</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">5,903</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">9,155</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">20,078</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">24,739</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">License and royalty revenue</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">328</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,356</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">13,682</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">6,402</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Co-development and research fees</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">341</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,073</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,862</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Proprietary product sales, net</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,688</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">834</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">4,070</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,187</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8,260</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,418</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">38,700</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">36,190</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table provides disaggregated net revenue by geographic area:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">United States</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">6,567</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11,022</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">35,496</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">33,683</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Ex-United States</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,693</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,396</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,204</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,507</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total revenues</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8,260</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,418</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">38,700</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">36,190</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade and Other Receivables, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">Trade and other receivables, net consist of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade receivables</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">6,659</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">9,094</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contract and other receivables</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,872</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4,363</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: allowance for bad debts</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(264</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: sales-related allowances</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(277</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(203</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Trade and other receivables, net</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">7,990</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">13,130</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock', window );">Changes in Allowance for Bad Debt</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The following table presents the changes in the allowance for bad debt:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at beginning of year</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">58</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Additions charged to bad debt expense</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">140</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">66</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Write-downs charged against the allowance</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Allowance for doubtful accounts at end of the period</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">264</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">124</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock', window );">Sales Related Allowances and Accruals</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-indent: 18pt;">The<font style="color: rgb(0, 0, 0);"> following table provides a summary of activity with respect to sales related allowances and accruals for the nine months ended September 30, 2020:</font></div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 68%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total Sales Related</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allowances and Accruals</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,377</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Provision</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,996</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Payments / credits</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(3,441</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 68%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal;">Balance at September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,932</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation of sales allowance and accruals for receivables due a company that are expected to be uncollectible including a rollforward of the balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SalesRelatedAllowancesAndAccrualsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298120712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">The components of Inventory, net is as follows:</div><div style="text-indent: 21.6pt; color: rgb(0, 0, 0);"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Raw material</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,153</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,244</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Packaging material</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,231</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,096</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Finished goods</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">858</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">519</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total inventory, net</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,242</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,859</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298350008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 67%;"><br /></td><td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Useful</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lives</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Machinery</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"><div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,406</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,088</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Furniture and fixtures</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0);">3-15 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,209</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,150</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Leasehold improvements</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);"><div style="text-align: center; color: rgb(0, 0, 0);">(a)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,333</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">21,333</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Computer, network equipment and software</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%;"><div style="text-align: center; color: rgb(0, 0, 0);">3-7 yrs</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2,886</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2,787</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Construction in progress</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,065</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,412</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 9%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">47,899</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">47,770</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated depreciation and amortization</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(40,171</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(38,044</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 67%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total property and equipment, net</div></td><td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">7,728</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">9,726</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"><tr><td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0);">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293302530840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Right-of-Use Assets and Lease Obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Liabilities</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-indent: 18pt;">Maturities of the Company&#8217;s operating lease liabilities are as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: &amp;quot; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">266</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,287</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,295</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">944</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">565</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">565</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2026</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">424</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total lease payments</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">5,346</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: imputed interest</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(1,635</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total operating lease liabilities</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">3,711</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298400712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Other Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of Identifiable Intangible Assets</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>The following table provides the components of identifiable intangible assets, all of which are finite lived:</div><div style="color: rgb(0, 0, 0);"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased technology-based intangible</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,358</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,358</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Purchased patent</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">509</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">509</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Less: accumulated amortization</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2,752</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2,714</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Intangible assets, net</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">115</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">153</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Royalty receivable</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">7,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other assets, primarily security deposits</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">287</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">286</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total intangible assets, net and other assets</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">7,402</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">439</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295502856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accounts Payable and Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: rgb(0, 0, 0); text-indent: 18pt;">Accounts payable and accrued expenses consisted of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accounts payable</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">9,169</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">12,274</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued compensation</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">4,129</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,758</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Accrued distribution expenses</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,655</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,174</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">284</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">543</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total accounts payable and accrued expenses</div></td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">15,237</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">17,749</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293373573592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12.5% Senior Secured Notes and Loans Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>12.5% Senior Secured Notes and Loans Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Debt Maturity</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-indent: 18pt;">A debt maturity table is presented below:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Remainder of 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2021</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2022</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">10,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2023</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">17,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2024</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">24,500</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">2025</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">14,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold;">Total</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">70,000</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293303010680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>These potential common shares are excluded from the computation of net loss per share to the extent that their effects are antidilutive, and </div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Numerator:</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net loss</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(16,551</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(18,412</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(35,415</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(53,610</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Denominator:</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Weighted-average number of common shares &#8211; basic</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">33,619,379</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">25,031,478</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">33,592,846</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">24,992,229</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Loss per common share &#8211; basic and diluted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(0.49</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(0.74</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(1.05</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">(2.15</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;"><div style="color: rgb(0, 0, 0);">)</div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Antidilutive Securities Excluded from Computation of Loss Per Common Share</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following outstanding stock options, restricted stock units and warrants are antidilutive and have been excluded from the computation of the loss per common share for the periods ended September 30:</div><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;"><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Options on common shares outstanding</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">3,075,942</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,256,092</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units unvested</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">13,489</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">107,144</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Warrants on common shares outstanding</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,571,429</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total potentially antidilutive derivatives excluded from losses per share</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">4,660,860</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,363,236</div><div></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298212824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Compensation Expense</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The Company recognized share-based compensation in its Condensed Consolidated Statements of Operations and Comprehensive Loss during 2020 and 2019 as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nine Months Ended</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">September 30,</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2020</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2019</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Manufacture and supply</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">73</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">60</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">208</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">176</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Research and development</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">178</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">188</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">543</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">536</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Selling, general and administrative</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,176</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,622</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">4,301</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">4,480</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,427</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,052</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,200</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Share-based compensation from:</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Restricted stock units</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">16</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">473</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">789</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,403</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,411</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">1,397</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4,252</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">3,777</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Employee stock purchase plan</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">-</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">20</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total share-based compensation expenses</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,427</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">1,870</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,052</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">5,200</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Restricted Stock Units Awards</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine-month period ended September 30, 2020:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Restricted Stock Unit Awards (RSUs):</u></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Units</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Grant Date Fair</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">74</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14.64</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">4</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">7.54</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(64</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14.88</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Forfeited</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;"><div style="color: rgb(0, 0, 0);">&#8212;</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unvested as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">14</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11.38</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Grant date fair value of shares vested during the period</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">958</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Unrecognized compensation costs as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">140</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">Unrecognized compensation costs related to awards of RSUs are expected to be recognized over a weighted-average period of less than two years.</div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><u>Stock Option Awards:</u></div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted Average</div><div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Exercise Price</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; color: rgb(0, 0, 0);">(in thousands)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of December 31, 2019</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">2,231</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">10.42</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Granted</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">981</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">2.68</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercised, Forfeited, Expired</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(136</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">(4.39</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Outstanding as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">3,076</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">8.22</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Vested or expected to vest as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">2,866</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);"><div style="color: rgb(0, 0, 0);">8.22</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Exercisable as of September 30, 2020</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">1,014</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">11.87</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Valuation Assumptions for Determination of Fair Value of Options</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt;">The fair values of stock options granted during 2020 were estimated using the Black-Scholes-Merton pricing model based on the following assumptions:</div><div><br /></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 60%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><tr><td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected dividend yield</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="text-align: right; color: rgb(0, 0, 0);">None</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected volatility</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">100</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"><div style="color: rgb(0, 0, 0);">%</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255);"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Expected term (years)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><div style="color: rgb(0, 0, 0);">5.5 - 6.1</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 48%;"><div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Risk-free interest rate</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: rgb(0, 0, 0);">0.4 &#8211; 1.7</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;"><div style="color: rgb(0, 0, 0);">%</div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293361080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate Organization and Company Overview (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>Product </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CompanyOverviewAbstract', window );"><strong>Company Overview [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfProprietaryProductsInternallyDeveloped', window );">Number of internally-developed proprietary products | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_EquityOfferingOfCommonStockAbstract', window );"><strong>Equity Offering of Common Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from initial public offering</a></td>
<td class="nump">$ 37,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for deferred offering costs</a></td>
<td class="nump">$ 2,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued (in shares) | shares</a></td>
<td class="nump">8,050,000<span></span>
</td>
<td class="nump">8,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees and other costs</a></td>
<td class="nump">$ 540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CompanyOverviewAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CompanyOverviewAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_EquityOfferingOfCommonStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_EquityOfferingOfCommonStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfProprietaryProductsInternallyDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of internally-developed commercialized proprietary products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfProprietaryProductsInternallyDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118262090&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293563144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Recent Accounting Pronouncements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Recent Accounting Pronouncements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">4,048<span></span>
</td>
<td class="nump">$ 4,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">$ 4,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Incremental borrowing rate on lease payments</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293495464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WorkingCapitalDeficit', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract', window );"><strong>Debt Instrument, Interest Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165,889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AdditionalFundAmount', window );">Additional fund amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from refinancing of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,110<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued (in shares)</a></td>
<td class="nump">8,050,000<span></span>
</td>
<td class="nump">8,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise', window );">Common Stock issued upon warrant exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract', window );"><strong>Debt Instrument, Interest Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AdditionalFundAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in debt instrument face amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AdditionalFundAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AdjustmentsToAdditionalPaidInCapitalWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293885256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Sources</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Sources</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetAbstract', window );"><strong>Revenues and Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue', window );">Number of revenue sources | Sources</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract', window );"><strong>Contract with Customer, Asset and Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_InvoicesPayableTerm', window );">Invoices payable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">75 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Current and non-current contract assets</a></td>
<td class="nump">$ 8,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">4,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">8,260<span></span>
</td>
<td class="nump">$ 12,418<span></span>
</td>
<td class="nump">$ 38,700<span></span>
</td>
<td class="nump">$ 36,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract', window );"><strong>Contract with Customer, Asset and Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_InvoicesPayableTerm', window );">Invoices payable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract', window );"><strong>Contract with Customer, Asset and Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_InvoicesPayableTerm', window );">Invoices payable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember', window );">Manufacture and Supply Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">5,903<span></span>
</td>
<td class="nump">9,155<span></span>
</td>
<td class="nump">$ 20,078<span></span>
</td>
<td class="nump">24,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and Royalty Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">13,682<span></span>
</td>
<td class="nump">6,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember', window );">Co-Development and Research Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">2,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ProprietaryProductSalesMember', window );">Proprietary Product Sales, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,688<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="nump">$ 4,070<span></span>
</td>
<td class="nump">$ 2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InvoicesPayableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Invoices payable term of customer and type of invoice in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InvoicesPayableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of primary sources of revenue of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenueFromContractsWithCustomersNumberOfSourcesOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ProprietaryProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ProprietaryProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293296576568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Revenues by Geographic Market [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 8,260<span></span>
</td>
<td class="nump">$ 12,418<span></span>
</td>
<td class="nump">$ 38,700<span></span>
</td>
<td class="nump">$ 36,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Revenues by Geographic Market [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">6,567<span></span>
</td>
<td class="nump">11,022<span></span>
</td>
<td class="nump">35,496<span></span>
</td>
<td class="nump">33,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Ex-United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Revenues by Geographic Market [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,693<span></span>
</td>
<td class="nump">$ 1,396<span></span>
</td>
<td class="nump">$ 3,204<span></span>
</td>
<td class="nump">$ 2,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293360232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Trade and other receivables, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Trade and other receivables, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Trade receivables</a></td>
<td class="nump">$ 6,659<span></span>
</td>
<td class="nump">$ 9,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Contract and other receivables</a></td>
<td class="nump">1,872<span></span>
</td>
<td class="nump">4,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: allowance for bad debts</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet', window );">Less: sales-related allowances</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">7,990<span></span>
</td>
<td class="nump">$ 13,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Trade and other receivables, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_GuaranteedRoyaltyRevenue', window );">Guaranteed royalty revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_GuaranteedRoyaltyRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guaranteed royalty revenue under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_GuaranteedRoyaltyRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293383589432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Changes in Allowance for Bad Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at beginning of year</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Additions charged to bad debt expense</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-downs charged against the allowance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at end of the period</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293397520792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Summary of Activity with Sales Related Allowances and Accruals (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RevenuesAndTradeReceivablesNetAbstract', window );"><strong>Revenues and Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccruals', window );">Beginning balance</a></td>
<td class="nump">$ 1,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesProvisionRelatedToSales', window );">Provision</a></td>
<td class="nump">3,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesCreditsAndPayments', window );">Payments / credits</a></td>
<td class="num">(3,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccruals', window );">Ending balance</a></td>
<td class="nump">1,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet', window );">Accrued balances - Trade and other receivables, net</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses', window );">Accrued balances - Accounts payable and accrued expense</a></td>
<td class="nump">$ 1,655<span></span>
</td>
<td class="nump">$ 1,174<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within Accounts payable and other accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesCreditsAndPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables related to credits due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesCreditsAndPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesProvisionRelatedToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables related to sales due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesProvisionRelatedToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenuesAndTradeReceivablesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenuesAndTradeReceivablesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293417528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net, Concentration of Major Customers (Details) - Customer<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfCustomersExceedingTenPercentThresholds', window );">Number of customers exceeding 10% thresholds</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue [Member] | Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue [Member] | Sunovion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfCustomersExceedingTenPercentThresholds', window );">Number of customers exceeding 10% thresholds</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables [Member] | Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables [Member] | Sunovion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables [Member] | AmerisourceBergen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CustomerConcentrationAbstract', window );"><strong>Customer Concentration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CustomerConcentrationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CustomerConcentrationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfCustomersExceedingTenPercentThresholds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of customer exceeding the 10% threshold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfCustomersExceedingTenPercentThresholds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_CommercialExploitationAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_CommercialExploitationAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_CommercialExploitationAgreementWithSunovionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_CommercialExploitationAgreementWithSunovionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293294007336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements, Agreement with Indivior (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Feb. 20, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember', window );">Commercial Exploitation Agreement with Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CommercialExploitationAgreementAbstract', window );"><strong>Commercial Exploitation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_LicenseAgreementTerm', window );">License agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AutomaticRenewalPeriodOfAgreement', window );">Automatic renewal period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NoticePeriodForNotToRenewAgreement', window );">Notice period of intent not to renew agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember', window );">Supplemental Agreement with Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SupplementalAgreementAbstract', window );"><strong>Supplemental Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativePaymentsReceived', window );">Aggregate payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ReceivableProcessPatentRights', window );">Receivable, process patent rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones', window );">Maximum payments under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember', window );">Supplemental Agreement with Indivior [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SupplementalAgreementAbstract', window );"><strong>Supplemental Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ContingentPaymentsReceivableInTheFuture', window );">Contingent payments receivable in the future</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AggregateReceivable', window );">Aggregate revenue receivable, milestone payments and royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AggregateReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount receivable under the collaboration agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AggregateReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AutomaticRenewalPeriodOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which the agreement is renewed automatically.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AutomaticRenewalPeriodOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CommercialExploitationAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CommercialExploitationAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ContingentPaymentsReceivableInTheFuture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential additional payment receivable under the agreement as of the balance sheet date. These are the aggregate from any combination of (a) performance or event-based milestone payments and (b) single digit percentage royalties on net revenue earned by Indivior on sales of Suboxone and earnings through the issuance of additional process patent rights to the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ContingentPaymentsReceivableInTheFuture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative amount of payments received under the collaboration agreement as of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement term period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of payments receivable for license fees and substantive milestones under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NoticePeriodForNotToRenewAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notice period of intent not to renew agreement, prior to the expiration of the initial or renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NoticePeriodForNotToRenewAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ReceivableProcessPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount receivable for process patent rights under the collaboration agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ReceivableProcessPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SupplementalAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SupplementalAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293448664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements, License Agreement with Sunovion Pharmaceuticals (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract', window );"><strong>License Agreement with Sunovion Pharmaceuticals, Inc. [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Aggregate royalty receivable</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">7,990<span></span>
</td>
<td class="nump">13,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets', window );">Intangible assets, net and other assets</a></td>
<td class="nump">7,402<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract', window );"><strong>License Agreement with Sunovion Pharmaceuticals, Inc. [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_PaymentReceivableCollaborativeAgreement', window );">Payment receivable</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativePaymentsReceived', window );">Aggregate payments received</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_UpfrontPaymentReceived', window );">Upfront Payment Received</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativeMilestonePaymentsReceivable', window );">Aggregate milestone payments receivable</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones', window );">Maximum payments under agreement</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Aggregate royalty receivable</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets', window );">Intangible assets, net and other assets</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License Agreement with Sunovion Pharmaceuticals, Inc. [Member] | Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract', window );"><strong>License Agreement with Sunovion Pharmaceuticals, Inc. [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativeMilestonePaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative amount of payments receivable under the collaboration agreement as of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativeMilestonePaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative amount of payments received under the collaboration agreement as of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativeRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativeRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LicenseAgreementWithSunovionPharmaceuticalsIncAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of payments receivable for license fees and substantive milestones under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PaymentReceivableCollaborativeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payments receivable under the under the collaboration agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PaymentReceivableCollaborativeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_UpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payments to be received during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_UpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293298234008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements, Agreement to Terminate CLA with KemPharm (Details) - Agreement to Terminate CLA with KemPharm [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AgreementToTerminateCLAWithKemPharmAbstract', window );"><strong>Agreement to Terminate CLA with KemPharm [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_PercentageShareOfMilestonePayment', window );">Percentage share of milestone payments paid</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones', window );">Maximum payments under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AgreementToTerminateCLAWithKemPharmAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AgreementToTerminateCLAWithKemPharmAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of payments receivable for license fees and substantive milestones under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PercentageShareOfMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage share of milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PercentageShareOfMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_AgreementToTerminateCLAWithKemPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_AgreementToTerminateCLAWithKemPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295757048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Fair Value Measurements (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsLiabilityAbstract', window );"><strong>Warrants Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">12.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293295359688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw material</a></td>
<td class="nump">$ 1,153<span></span>
</td>
<td class="nump">$ 1,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_InventoryPackingMaterialGross', window );">Packaging material</a></td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory, net</a></td>
<td class="nump">$ 3,242<span></span>
</td>
<td class="nump">$ 2,859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InventoryPackingMaterialGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InventoryPackingMaterialGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293289648136">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 47,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40,171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,044)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract', window );"><strong>Property Plant and Equipment Income Statement Disclosures [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">714<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
<td class="nump">2,127<span></span>
</td>
<td class="nump">$ 2,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, Network Equipment and Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, Network Equipment and Software [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, Network Equipment and Software [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,412<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293726440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Lease</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Lease</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Right-of-Use Assets and Lease Obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfOperatingLeases', window );">Number of leases | Lease</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Estimated discount rate</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="nump">16.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 3,609<span></span>
</td>
<td class="nump">$ 3,609<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">944<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2026</a></td>
<td class="nump">424<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">5,346<span></span>
</td>
<td class="nump">5,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,635)<span></span>
</td>
<td class="num">(1,635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 4,048<span></span>
</td>
<td class="nump">$ 4,048<span></span>
</td>
<td class="nump">4,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293936600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net and Other Assets (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Payment</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Identifiable Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 2,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(2,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,714)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Royalty receivable</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, primarily security deposits</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets', window );">Total intangible assets, net and other assets</a></td>
<td class="nump">7,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated Annual Amortization Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">Sunovion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Identifiable Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Royalty receivable</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets', window );">Total intangible assets, net and other assets</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated Annual Amortization Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable', window );">Number of annual royalty payments receivable | Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MinimumAnnualRoyaltyReceivable', window );">Minimum annual royalty receivable</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Purchased Technology-based Intangible [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Identifiable Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Purchased Patent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Identifiable Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativeRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativeRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_FiniteLivedIntangibleAssetsNetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MinimumAnnualRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MinimumAnnualRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfAnnualRoyaltyPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293297023736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accounts Payable and Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 9,169<span></span>
</td>
<td class="nump">$ 12,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">4,129<span></span>
</td>
<td class="nump">3,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued distribution expenses</a></td>
<td class="nump">1,655<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued expenses</a></td>
<td class="nump">$ 15,237<span></span>
</td>
<td class="nump">$ 17,749<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293058136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12.5% Senior Secured Notes and Loans Payable, 12.5% Senior Secured Notes (Details)<br> $ / shares in Units, $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 15, 2019 </div>
<div>USD ($) </div>
<div>Tranche</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights', window );">Net proceeds from issuance of initial notes, warrants and first offer rights</a></td>
<td class="nump">$ 66,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans payable, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization expense, deferred debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
<td class="nump">$ 1,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember', window );">Perceptive Credit Opportunities Fund, LP [Member] | Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of existing debt obligation</a></td>
<td class="num">$ (56,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentNumberOfTranches', window );">Number of tranches | Tranche</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Frequency of periodic principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">quarterly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters', window );">Annual percentage increase in principal payments during first four quarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters', window );">Annual percentage increase of initial loan principal payments during final four quarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions', window );">Redemption percentage of debt under change of control provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization expense, deferred debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 556<span></span>
</td>
<td class="nump">$ 1,758<span></span>
</td>
<td class="nump">$ 1,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred debt issuance cost and deferred debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ElectiveRedemptionPercentageOfDebt', window );">Elective redemption percentage of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ElectiveRedemptionPercentageOfDebt', window );">Elective redemption percentage of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets', window );">Asset based loans secured on second priority lien by receivables and inventory assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - First Additional Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - First Additional Offering [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne', window );">Portion of proceeds used to monetize assets, if First Additional Offering has not been elected or funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - Second Additional Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>12.5% Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - Second Additional Offering [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo', window );">Portion of proceeds used to monetize assets, if First Additional Offering has been elected and funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The annual percentage increase in principal payments during first four quarters</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AnnualPercentageIncreaseInPrincipalPaymentsDuringFirstFourQuarters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The annual percentage increase of initial loan principal payments during final four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AnnualPercentageIncreaseOfInitialLoanPrincipalPaymentsDuringFinalFourQuarters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset based loans secured on second priority lien by receivables and inventory assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AssetBasedLoansSecuredOnSecondPriorityLienByReceivablesAndInventoryAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt that can be borrowed in addition to initial notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Tranches in which additional loan may become available under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ElectiveRedemptionPercentageOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Elective redemption percentage of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ElectiveRedemptionPercentageOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of proceeds amount to monetize asset if the First Additional Offering has not been elected or funded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PortionOfProceedsAmountToMonetizeAssetsConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of proceeds amount to monetize asset if the First Additional Offering has been elected and funded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PortionOfProceedsAmountToMonetizeAssetsConditionTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption percentage of debt under change of control provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SeniorSecuredNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SeniorSecuredNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293296596984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12.5% Senior Secured Notes and Loans Payable, Perceptive (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (4,896)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (4,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Prepayment premiums paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,944<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember', window );">Perceptive Credit Opportunities Fund, LP [Member] | Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage', window );">Warrant to purchase senior common equity interest ratio to fully diluted common units</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant to purchase senior common equity interest ratio to fully diluted common units, on an as converted basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantToPurchaseSeniorCommonEquityInterestRatioToFullyDilutedCommonUnitsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=aqst_PerceptiveCreditOpportunitiesFundLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293486168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Issued to 12.5% Senior Secured Noteholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 16, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsLiabilityAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares received upon automatic exercise of warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="nump">$ 1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsExercised', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsLiabilityAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_StockIssuedDuringPeriodSharesWarrantExercise', window );">Common Stock issued upon warrant exercises (in shares)</a></td>
<td class="nump">428,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_WarrantsLiabilityAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares received upon automatic exercise of warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_StockIssuedDuringPeriodSharesWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued upon the exercise of warrants during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_StockIssuedDuringPeriodSharesWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293878904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (16,551)<span></span>
</td>
<td class="num">$ (2,334)<span></span>
</td>
<td class="num">$ (16,530)<span></span>
</td>
<td class="num">$ (18,412)<span></span>
</td>
<td class="num">$ (20,472)<span></span>
</td>
<td class="num">$ (14,726)<span></span>
</td>
<td class="num">$ (35,415)<span></span>
</td>
<td class="num">$ (53,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">33,619,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,031,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,592,846<span></span>
</td>
<td class="nump">24,992,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share - basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (2.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DilutiveInstrumentsAbstract', window );"><strong>Dilutive Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially antidilutive derivatives excluded from losses per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,660,860<span></span>
</td>
<td class="nump">2,363,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options on Common Shares Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DilutiveInstrumentsAbstract', window );"><strong>Dilutive Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially antidilutive derivatives excluded from losses per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,075,942<span></span>
</td>
<td class="nump">2,256,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=aqst_UnvestedRestrictedStockUnitsMember', window );">Restricted Stock Units Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DilutiveInstrumentsAbstract', window );"><strong>Dilutive Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially antidilutive derivatives excluded from losses per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,489<span></span>
</td>
<td class="nump">107,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants on Common Shares Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DilutiveInstrumentsAbstract', window );"><strong>Dilutive Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially antidilutive derivatives excluded from losses per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DilutiveInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DilutiveInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=aqst_UnvestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=aqst_UnvestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293292681880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Period </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Period </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">$ 1,427<span></span>
</td>
<td class="nump">$ 1,870<span></span>
</td>
<td class="nump">$ 5,052<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember', window );">Manufacture and Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">Selling, General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">1,622<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">$ 789<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at beginning of period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at end of period (in shares) | shares</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at beginning of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at end of period (in dollars per share)</a></td>
<td class="nump">$ 11.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue', window );">Grant date fair value of shares vested during the period | $</a></td>
<td class="nump">$ 958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs of RSU awards | $</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Compensation Cost Not yet Recognized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">$ 1,411<span></span>
</td>
<td class="nump">1,397<span></span>
</td>
<td class="nump">$ 4,252<span></span>
</td>
<td class="nump">3,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,231,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod', window );">Exercised, Forfeited, Expired (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">3,076,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,076,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">2,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares) | shares</a></td>
<td class="nump">1,014,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercised, Forfeited, Expired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (In dollars per share)</a></td>
<td class="nump">$ 8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested or expected to vest at end of period (in dollars per share)</a></td>
<td class="nump">8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in dollars per share)</a></td>
<td class="nump">11.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted', window );">Intrinsic value of options granted | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,474<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Compensation Cost Not yet Recognized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to non-vested stock options | $</a></td>
<td class="nump">$ 6,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=aqst_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods', window );">Number of offering periods | Period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock as percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,961<span></span>
</td>
<td class="nump">31,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan', window );">Discount value on shares issued under employee stock purchase plan | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount value on shares issued under employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DiscountValueOnSharesIssuedUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate intrinsic value of stock options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either exercised, forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of offering periods in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedPaymentArrangementNumberOfOfferingPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293383589304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net (loss)/income before income taxes</a></td>
<td class="num">$ (16,551)<span></span>
</td>
<td class="num">$ (18,412)<span></span>
</td>
<td class="num">$ (35,415)<span></span>
</td>
<td class="num">$ (53,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293296612328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2013 </div>
<div>Company</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>Case </div>
<div>Patent </div>
<div>States </div>
<div>Cause</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract', window );"><strong>Litigation and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of companies patent infringement lawsuits filed | Company</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Number of cases resolved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfPatents', window );">Number of additional infringement on patents | Patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of cases filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfStatesInTheAntitrustLitigation', window );">Number of states in the antitrust litigation | States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_HumanaAndCenteneActionsMember', window );">Humana and Centene Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract', window );"><strong>Litigation and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfCauses', window );">Number of causes alleged | Cause</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_CaliforniaComplaintMember', window );">California Complaint [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract', window );"><strong>Litigation and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NumberOfCauses', window );">Number of causes alleged | Cause</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfCauses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of causes of action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfCauses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patents that contain new claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfStatesInTheAntitrustLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states in the antitrust litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfStatesInTheAntitrustLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyInformationAboutLitigationMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyInformationAboutLitigationMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=aqst_HumanaAndCenteneActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=aqst_HumanaAndCenteneActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=aqst_CaliforniaComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=aqst_CaliforniaComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140293293265848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,110<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares callable by warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares callable by warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior Secured Notes Due 2025 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - First Additional Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember', window );">Senior Secured Notes Due 2025 - Second Additional Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AgreementsAbstract', window );"><strong>License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones', window );">Maximum amount of payments receivable under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Senior Secured Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_SeniorSecuredNotesAbstract', window );"><strong>Senior Secured Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of Note</a></td>
<td class="nump">$ 22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Notes payable outstanding</a></td>
<td class="nump">$ 51,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares callable by warrants (in shares)</a></td>
<td class="nump">714,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_AgreementsAbstract', window );"><strong>License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_NoticePeriodForNotToRenewAgreement', window );">Notice period of intent to terminate agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones', window );">Maximum amount of payments receivable under agreement</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfUpfrontPaymentReceivable', window );">Cash payment receivable</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqst_MaximumAmountOfPaymentsReceivableForMilestones', window );">Contingent payments receivable</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt that can be borrowed in addition to initial notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of payments receivable for license fees and substantive milestones under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfPaymentsReceivableForLicenseFeesAndSubstantiveMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfPaymentsReceivableForMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of payments receivable for milestones under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfPaymentsReceivableForMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MaximumAmountOfUpfrontPaymentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of upfront payments receivable under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MaximumAmountOfUpfrontPaymentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NoticePeriodForNotToRenewAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notice period of intent not to renew agreement, prior to the expiration of the initial or renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NoticePeriodForNotToRenewAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SeniorSecuredNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SeniorSecuredNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_FirstAdditionalOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SecondAdditionalOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ":&9%$'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  FAF11D#5T-^\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NNG&!%&7"]-.("$Q"<0M2KPMHDFCQ*C=V].&K1."!^ 8^\_G
MSY(;'83N(C['+F DB^EF<*U/0H<U.Q(% 9#T$9U*Y9CP8W/?1:=H?,8#!*4_
MU &AKJH5."1E%"F8@$68B4PV1@L=45$7SWBC9WSXC&V&&0W8HD-/"7C)@<EI
M8C@-;0-7P 0CC"Y]%]#,Q%S]$YL[P,[)(=DYU?=]V2]R;MR!P]O3XTM>M[ ^
MD?(:QU_)"CH%7+/+Y-?%PV:W9;*NZJK@O*B6.[X2RSMQ>_\^N?[PNPJ[SMB]
M_<?&%T'9P*^[D%]02P,$%     @ )H9D49E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MJNF'(C=%-/:&I7H8=TK@6X9Q:O&%!SF.BB(T#<G75#'U1N[3<GKH- ^(C*@
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M*+O+/:- K0W@_4[ Y-K?Z#/ X<QW\R]02P,$%     @ )H9D4:$G5,2! @
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M_PZ]G\3R%9)K]T_V7>YL[I&BU4;6/1@5U$QT3_K8U^$($$Y/ *(>$+T7$/>
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MQ]^=T<GIFLW \]=?K;]I@Q?!?(RK9%YDOZ?K>GLY"2?>.MG$AZQ^5SR\3;J
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MYG4WU#K=.EC5J@&03+$O"@)UPIVZ?HB2T7@PHW\^Y'8\X0&,QCI3 QI0E=&
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MMC/BC&@3[M3U0Y0\)\,ZU/UN0],I!4+64:XG&Z 0QAQ1M2$,Z)HG#+ZO)1M
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MZ&6BM'[IBH=F9/>*AQJ3PDVPQ:VX,N(-%12;;WK$=ZWIRVPK<(=-Q= 9S S
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MM.AE Z_+4;)[$0?=_7GV+U!+ P04    "  FAF119?%9_A8.   ')@  &
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M@;^![^G>]^KD>QI$<A,R;Y>="I1N<]M\D_C1X[J=L^GI$S57#RZ/U:? POX
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MML1NAZLO4&Q#KZ$MVAN*NE*J::E=4LBSD]\M?/DP!#C"'GFMT$MJ4QS,+I5
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M%FD!WF\M"B#=D(+\6??JOU!+ P04    "  FAF11]76%^S<.  #=*   &0
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M'@#=NOCLK P/< 0\,C.B-#7(?FDTI%@VT!TLV0TL;#=\TY0KP^%-:H"/@@;
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M=MX?COK8UYL.Q6P*/I/99/"M<K@/^C,Q&X[$"!MI4W\V%9],3; 85'PN9LD
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MKA6@MJ(%>+XTI@X7=$#\HO'-OP%02P,$%     @ )H9D473LMI2[$0  7S4
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M$BJ\GX)Q2O L;9HVR,<CX)30T.>F! *$-0;349ES FW-(5,N<ES\<' R'+#
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MKFW!']=:(7;H!7R_M*B(_@]B$']3]>K_4$L#!!0    ( ":&9%&"6.I4GP4
M . ,   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;+57VV[<-A#]%6*+
M%BVPWHMLY^8+8+M)DZ)IC;A)'XH^4-+LB@A%RB1E>?OU/4-J)36._=2^V"(Y
MES,S9X;<T\ZZS[XB"N*^UL:?S:H0FE?+I2\JJJ5?V(8,3C;6U3)@Z;9+WSB2
M952J]3);K9XM:ZG,[/PT[EV[\U/;!JT,73OAV[J6;G=)VG9GL_5LO_%!;:O
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M ?'G10XQL.FO)YP?#<Z/HO.C_R_]3SOXU082SQ?BZXZ^^^9%MEZ?/!KK%;F
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MT:5232")]SR<)1FMLWP)VRD-?*;N:1!.C-32'*B+ K*R!K4'@J!'(UXW[J9
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M1/,B -W/EOY@5>O[^4Y9F@Y^6],X1NT4Z/M>4;3#P3D8!_SF+U!+ P04
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M"?S<7E=$[5-.Y_F)-RPF+Y;+;J;W/ C2OE4:F+M(#O&"2YVN6OE8OOB@)[)
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M5M<-4V\_?#=)XO&5]4$(FEN*U1J#2> UXFU=93B_ *9*4%B)BYHFB%(7NK3
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M- ''%Q*/B?Z%#/1_YUS]!5!+ P04    "  FAF11YLMI18T$  " "@  &0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;*U;V6X;.9=^%<(##-*
M(EORFLX"R'8'G48<&W'R_Q>#N:"J*(E)J:@FJZQHGGZ^<[@42Y(=IV> ():J
MN)SU.PNI-VMCO[N%4HWXL:QJ]_9@T32KWP\/7;%02^F&9J5JO)D9NY0-OMKY
MH5M9)4N>M*P.QT='9X=+J>N#=V_XV9U]]\:T3:5K=6>%:Y=+:3>7JC+KMP>C
M@_C@LYXO&GIP^.[-2L[5O6J^KNXLOAVF54J]5+73IA96S=X>3$:_7Y[0>![P
M+ZW6+OLLB).I,=_IRX?R[<$1$:0J532T@L2?!W6EJHH6 AE_AS4/TI8T,?\<
M5W_/O(.7J73JRE3_UF6S>'MP<2!*-9-MU7PVZS]5X.>4UBM,Y?A_L?9CQZ<'
MHFA=8Y9A,BA8ZMK_E3^"'+()%T>/3!B'"6.FVV_$5%[+1KY[8\U:6!J-U>@#
ML\JS09RN22GWC<5;C7G-NRM3-[J>J[K0RKTY;+ DO3@LPO1+/WW\R/17X@8+
M+)SXHRY5V9]_"%(2/>-(S^7XR07OU6HHCH\&8GPT/GIBO>/$WS&O=_P<_L1_
M3::NL;"$_WYBZ9.T] DO??)/1??D=/*VW]U*%NKM =S)*?N@#MY],HT2HXNA
MZ-/]43=Z+KT9U^76R_?6+$4#3Q&-X;\#T2P4!BU7LMZ(A71BJI2?N90;(>?P
M53PJ#*;H^L%4#ZK$!U&IN:S$RII"J1+K.R&M=OA +VE)8_$8KBL*TUJ'[S,Q
M;3% .3? F*)J:1JM4+9%(RHMI[K2S89>-G \>&+K=U@I2X]!PE+90N-AE5@<
M8!^AZ@=M30WW;_ 2#PP(L("!>5O)QH &>&2CK!N*/WX4:M4(L%DJ5U@]!3=3
M0IN!F/S=*D=N+[03M6D$2[IN*DA!K"1H()F1E+KMN\VVY0$9R(96PNI:D= P
M>:J($F6)!WS5C1,S"*EFI@I3EYH6'8H[#*J;EY\5R,?,3*.7:J[K.HAYTL[A
M]+#^T7%?C6OPIVM"8<R&X.5T:M6#YL5J@%]IV[F0JU6E"[_LB__\CXOQ^.CU
MY-/UA#^.7O\&TBI6;%#HUUK3_/L&RX"MC?@W(!YS/\JIL21FV-= ?*B+H7A1
MPSLF12,?((#=]ZRTN*,?%3<=@'<K[A82(%JHM@&!55PTS," ;O2D>C"P;7$'
MPQ*7%H"^-3H,Z&9\40]R:P,GOMY/MN;1L&[2/?S!_$]_A'_6C2&7N=E4LL86
MQ:(VE9F3Q_7F\/MN"C3$HH4JK'F #4"J]/W]]834!KIA*X5X@.E"2XZ>W;=3
M\\. 67P@]9"/O-?5<J^6AIE10YMXOF++(N.P! KD,J*2:]>2+;*SPZ!D50FG
M?Z3]"S8K8F:O*5QKX*2&#U_!TYO$5'H,JJ]AR6MIE7A!;X(PTL/^ E$\('X&
M7^&UV/?KPM.+]>@9V6KD)_/(R 0I<""N[5!\5F6YH55'YZ_[YICT<OWY8S)[
M6?S=:DL.&S>)CD"<1;O@M:8M,*(V=K4@\R,#J&7EU>,Z]<Q(/0P'Q"RC@FM5
MD"60L2$\@*YN9_X!H ZI0Z>.9F&5BESOU\M"0L,,W, LQNBAE_+9ZV"3P8+C
MPPE4W-^%_"Z]#:X;OT,\R=/8?V!\3L&T('J*(V3"4_, RLET5H9T0I"6$ZH:
M#:$[I"S- @D?,-6IIJF\2N4<+/*GM2(95<Y @M !B;QGK"2&-6"X]%B)30C0
MO!DX+V4 :4-1BUX4E=1+#^>R_(:04S (IABE :=8XQ%39!$E"9$42,=!$E!8
M+?YJ$1Y&8TI!1J\\"+]7I;)8\TK; FXEY&RF&8CI9:D*[7UYQI$8CU8$S:9U
M6(C>(C7RFAF*+WAK%67+!/@]6J*&".E+[98PJ1"7*;.,QM*3G&W)(*.BU@M=
M+'AO%EQ<CZG"$V5]#*. 9;\CWV^AT8H2K1-/%U'SPOV6&6E.*U)=59>25D84
MEK:,JV5ZDR#9-@F3@A&3IMB0*3!6D$EGT!-Q UJ6,.;X][:+@2<^"QQ (^5<
MB9OB$U+MC7>U4M#8%4@+.=&MA8I 9+TANJ:(X!&&%2407G@W<D[& .*2OT?M
M>3.(T)I>WQA&('C$M5=),!' P7$DSZ,9V59'FF%RR!U808*JJ;*M%%N_J>>&
M'L^0B9*J"ZC/(AU2/R@ORI\04?BZ,DXSXB^9G&!':<VBM=9G-=C0>7HJXQ.T
M_AZ\_6W1F"FH&Q]%#LB!=W9GI]-UZ_5L33OW(H45T,*3E?76,]JBQGMZ)*1$
MI4BI+^_L47<?1_SZ!MGIZ&(0%H6<WZNI;2GA)$=\W!V#V"G>P81*J%>0$U@7
M3?038.,O?%>;/8&)]0ROJ?329[>Z_M;612_R[,2<H7AO*N28G+9A>R1\"<\#
M#8.GMQ8/T@/7_JT[%&=;W@UZ/=C:>9W2J#R)(22O)#: IGXI$_&+$#MA.B>+
M3]+$@3&$8@ X"HGO(1Q3Z2%;"I*,E%PK.![.P;"=?E-%@KOH*GN3G)0A>*\$
MA #_Q@FYNT2)Z/J 5!R@C"*>3;D1CI$\@N\#Q<!K2J(1.#3;__W&-6J9$MP)
M!<$?4)Y=#;U PA-Z_2M9U#UB)>J+NI=.O:\0N4K9RZ:>'-A+K/8'U:Y\2!KZ
M.A3WL1@1GPP$=S$X&IT/1J> @5>#LXOSP<GIB3?=,.ET=!+%3TR'I\='I^'I
M ,ZNOC/,U3W?P> N;UC"K!HR\5(NY5SU'$@BKL^! ^P.60HQ5<V:*U?*0%"M
M<;6!E:\5TD9"L.,<%<((LJ"E;F@I"0Y1#;!CWF>924VO_H)=-1F^3SAA)XG5
M5")RT*'A'MU^K@H?8G/T#T$\@A#;6TZ]A[K1*[]#+/00L0.">J&"-$5U']@@
M@ N:L)03</*^1%#4JTIMY7Z7VG2&7&C*M*EP 8FU]-%ZJSJZO+[_T.7I7SA!
M#4O:/,2L@/\<8I'PN49NNM3KZQ"F]8C-_R%=LRV^3\8"V:ZD-<":ON4_8WC/
M_G]/>2V)$LF9@UE*"NZ5M+Y?\"WHDQN!4$.$ 0 9L9X$EW"BEQ!X(W=IQ8B8
MND:-IY$ ;7RM8.J7VV[(8KD+"1&[W/G@XM7YX.@"+G<Q.#L=#X[/+WCZQ>#D
M_'1P<3PF!< 0.#_$7R_G88])IZB[P-FBKP/!R".(9T/3 :84M<Q@$"@E;5ZV
MM7R0NHJ [ $.CJ?FRNT@RVZ>%*$@8Q:\$KJ<GYT.1F?GW"#(4 6/TB3:RHOW
MUQ#D?@&3H%Y.5U22P))(!EZS7CPSV(MX<?*;^'#W.9%=+(A%+P).%V,"NT-E
M'F$X,1V=#?9 ?F#]"_>#?(S@!/32(&/N^AU?)I==RR!FC3X_%FM+Z%5WF2D>
M=^TGPL)0 06(WR'5%UQLEUUBSU+I_)52+>(AN7/#?D/[EPK2I'S$=\-F61[M
M"+]0Z[FLZLF!G$9&WEB^*8$[]U"7%4O<U%]R@AN2=G(_W;2^!_B(*>?@7GMP
M#]6JQQN3)XVG85,:.-M$ OU %B;#,F0B'.K7BMJ&2"IFO#ILD>H4@&L408^Q
MC/TO6>QA)-0N-"=]<V M-1<!,VQ+;<6 /ZE89'HZWZ;R0M:> 1_?SON=P*Z2
M]KC%)NOEMQO_=XTCX%WBY%)5T[:0J6L;G?'7 WI7NIWG<?FY6"[F%M5E8"N1
MMTP!.H33) LX =EZZ#T@B^9>@+<7F)1^?"56N:0GQOOU)P1^'Y)'N\FCAP_)
MO8=NWQ1G20<A #Z7T_Z>XR2M#*WD-KD)W:+#]GCKE[D]2TU.%@RVR^6C09D5
MJC%N9N@H)6_5S];<,\2-C[YB'/FB<_B/&8@.WP?>X/ZS +@N91[;Q2*W5TSQ
M7=%D$S%]E%))VBL]]B5R?)R40FLL9:GZ9JD3&[1W)8OO1,^W%K4/#-.+-6MO
M/%G21E_@>G+'!?:(CI>^5ZLF9,9'>XV*6W:,/IP6+)2TV?G.-A$(0E,4MB*V
MEO88C3>4[8G[[.&1K>,>9AOVR$1BJV4TBIV*Q[FAL$GR+@@-C<7J(B#\/;5T
MEZHSD7U-]=CN8K>/@WHS]V!"[<6@HW[V,VR2SD?GD0\RIQXO5JVJ338TH((7
M0NS8G.8MISY;VZVG&%3WDI3WX7]%=X-]:NHIA3M)OX3Z\F<0/^AGX@FN\E _
MCA;S_PA;D1C:G5M+/P.TV_3D;)^YXFWMUB1UL\U@=W9:F)9JM)#AD5UOEQ2#
MK.;PHH&'^ (Q'+<^&OM##ANR,:)O-\K]!&QV]LH)[H,D"\KJ[ZJ_0F%02;J5
M\5',=](ED\ =9BHXN56(8J2U*HB[05CW:6_H=,!/=2.G5/9B)<I;VKH,%KW@
MJQBJIMY:I23O@S7JDE+P<$1*,VGI%K 6A.V#C"=A*#Y+3M:0)@8G5\_I#@]\
MZ(!!7O1,0$)S96A1]E5,NVX;"-M[F'&5CXY [.V%YF2]=ZK50F$*/'<MB/9P
M]WP%=H@[/GW<1':X[N^PCW+6VL[6WERZY>[_B;D0A[LK\QV')^VHLY?,))XR
MG:V,Q4N#%-J/ <^P$F8\,&OB@=-9A)%M@=,6GSDZ;$>8VV[CN$R\.M,O2YY5
MAQ2Q@-KE(":%$Z3^C:7PE-U?Z.4=H?MZQ@?AS>8EGYOZ#"VFG3DL7YFJ74ZU
M3-T!'X\'^YNTO=9,GHS\PP;4G:IKMZD>9$T4L .1@+!%U75X9B$^<EWD+2A)
M@;ZWD3?_LJUA<=C24GI(CX%/KEU"-"BPFG 7C8[G?5<F=/@B9TGBOL_^L]L!
ME" \7K -1(%%*ZH89.6;I^$\:6ZL#R8Q$0@',[%-.>@W4X@%Q,V2FT@D4"0>
M+_F(6ZQ:2]CHNL#_@>KZCNH7E[T#]3\WI37%@ANG7CZ?PO'Z;_NMZUJV4SJ6
MBG__;%$-2'\-BCJN6',2#DQZACA* .QGQ"Z^A(]#&H2AKK5\;+.2&V4'"=[Z
MYP+[VQ!/%'RY4?5T'$7B73/R$33E<3WVV^C0S@FGE[J2(5^@ +1USR 3V!4?
M) >O2+*_N?Z8W8F*I\34VG!.SVO?$62=(SYQ@U2E.TYT4THS_M%A8"2@"*<M
MGOIDK5E9'#D@D?$Q#SN1[!^G96W5//6IW4I;63#0>2?T9T*?/US=DI:A(RO;
M,D"W]S>XTB Z72@380.TNW?!%5WWT]3\WIG560 O&Y.I;R1054.?BV5,FC*
M2Z5(-#\Z$#*VNYT7;ZI5X5I"S\Q<9V9!N_]'<[N!10#H=.CT(>8Z55$UX6^Z
MD6"#J<6#A=Z[P,2C3#+*!D:#$LF Z*B$JW$^SX>D:S=3UG86]5//"->B^D7\
M7]3!(5BYDS6XH%R*3C?*N$B'"T-D]$'2^85%OF]@"CZM*)-#I*/I< MPHQKQ
MO39KK'(#R82.67@94\/8!J4K)>0-5,+S:D017?D3IFWX#B6GV^PRZ:8@3X&(
M".,@<.D@*5J7E+ODLV$J@B52>IJ=/?69.R#5:1J?MK"B,GS+<D;7%0=;C<8A
M *#20&:2;.>,M]EATVGL!WQ2+1TX;]UBBT_SFX)LIL5.QRN[5%G'0E19,M-4
M8'?4#'P:R#7)O21[4'/3A=JOWG&OPF4BAL)K-9/+<!.4SZZQ6$&W:<2=!0@5
MW"#.SS3VG7,B+OGSMAG?O$NW\2AZ?00<6E@AG1Z=7(Q?#SN91*[?TPE2ELE&
M&>3'=ZE_D[A)4-J$T[,^_/7/^7:SZ9 1YJK80E</89UTLX/W1K^\_SBYNTL:
M]?=<YKJ(EP&3 E>42!0^.2STBD6=]!Y2&JZNZ7 3MA8+_N.$"CY:):GA'UT>
M*8(^?+FT1ZJA,.3NF")/Q6!Z)^CV&9)P%:[[]N2=:OS3_NYK7574L$^-J-M]
M8W=HN.EH^!AI>/\D#>FBI\D%U95*S]L+:$_BN4ZW:S(#WDVX,WWF#5F?HF>W
MRR*RE3ZOX8X:G6W2E9$G5PVDA6;GCLEEE(=[/B>QKOC3K.ENS:!K@*0^D.:[
MBBLZ0$]^>?NO#]<O1Z]@;;#=I2Z>NBZ573BB8Z[ D,NXC/>0PL:]8L>O&=$9
MPEFHBN2"SVJU,#5,GHV;\UE$*\57=K;JW3[R;]W;BA)FB YM^'0CZ[JUZ9!N
M9Y^<:Z>:YVB\MV,L[SHU=!QS4*=S:4T9W8XJ8TL3C-%J7$YFVL^^[K73'3?6
M? &PT_)SS"P5N<=Y_W,=*UPZF4W]3S_P?)?/775FTGF.0'>%V'7CSWH)SU[K
MY)9\Z)83=L:#IDW^[%FNO.=L*=U3"2<(T7WRL-X[X"!NLFHGE^L.#G6K%XB@
M[J5,*VPUEH=BW^]B#K.?%Z&0G?./J$(?R__2*#U-O].:^)\G=</]C[QNI$6D
M1'FK9IAZ-#P_/?!76>*7QJSXQTI L,8L^2.T#/'3 +R?&131X0MMD'Z]]NY_
M 5!+ P04    "  FAF11^B'!)_L%  !?#P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6RE5VUOVS80_BN$EPTIX-JRG+1IEP1PTA8MT)<@6=</PS[0
MTMGB(HDJ2=GQ?OV>(R793APGP+[8XLO=/??<"\G3I3:W-B-RXJ[(2WO6RYRK
MW@Z'-LFHD':@*RJQ,M.FD Y#,Q_:RI!,O5"1#^,H>C4LI"I[YZ=^[LJ<G^K:
MY:JD*R-L7132K"XHU\NSWJC73ERK>>9X8GA^6LDYW9#[7ET9C(:=EE055%JE
M2V%H=M:;C-Y>'/%^O^%/14N[\2W8DZG6MSSXE)[U(@9$.26.-4C\+>B2\IP5
M <;/1F>O,\F"F]^M]@_>=_@RE98N=?Y#I2X[ZYWT1$HS6>?N6B\_4N//,>M+
M=&[]KUB&O?&;GDAJZW31" -!H<KP+^\:'C8$3J)'!.)&(/:X@R&/\IUT\OS4
MZ*4PO!O:^,.[ZJ4!3I4<E!MGL*H@Y\YOZJFEGS653KQ?X->>#AW4\N(P:51<
M!!7Q(RK>B"^Z=)D5[\N4TFWY(>!TF.(6TT6\5^$-50,QCOHBCN)HC[YQY^/8
MZQL_UT?QUV1JG4%&_+U'_5&G_LBK/_H_%.Y7\54[$J,W _$0ZN'DA9B@"M*"
M)YT6GU6"FB QF1LB/[E4+H-DJ1><YU>91+8F5#N5R-R*3V4R$.]G,_+Y+Z05
M>B:^)4Y/R8AX'%CN"Y>1N-1%)<N5@%(RE I5PIX4-Y3H,MU&P=L[DSL@95 P
M7?EME31.D7V&E.2OE#<FN31J%N1AW*FRQH+A$K-" HR>YFHNN;"]/YMV/!V&
M; 6/6Z.5T9:2.C0"B'.[<E3*,J%6O''^MU].XM'KWRW4.1^ 1"\\&36RV_B=
M&X"ARF72]46C5\[ G/@B39*)\<AS>]('CQT>&&.&_ZF-LJD*G4F;K?$NDP^X
MZJ]Y+"1X(H/F ,1" 7+#TRXB&D6IN&K<VV-#U!74CTXBD<H5"#$*2)=&.4B*
M4B._J%7;D#<0AQ<ON!V04__*X-Q,7))QX%M<!UAKBWM2X5LIOH*%@I/TZ1SE
MA2VK:T4<'C"1Y\P$6C4' ]F0(-'L/?2,M:YX\F 4'_>C*.+-=)=DLIR3F+'W
MF4)D-V60G0M:A:Q%W*7+8)XW^"#PK&3;>B5SGYT^>;%ND&"KPH<@K>_S^#R.
M#F^(A&\=KUX,Q/=.A).AJXK=M/3%!%W&^H[0D).0;P_BX"CRKB?29BU&GTK@
M8A2+:6W1O*P-.0$C5LU+5<Z]8\H*0EVJ:>X]:I4VI)X$3@\O-SL:BUUQY<I<
M7%-KKP$_B@?'OWH7K?C!V=S4<HA>)55ZGS@$.\FU94!K#A_C8%.P80$ Q$$<
M]X\!]"&(?N.E1<0.CKPWV%3B[F&IY.HH/50PE2NJ>0WZ/#E W3F'ST+5A6@2
MA:3)5\+L\;V/U;1.6!&O3&7>-JXML[AS60> ?A_X/AYY-U0P(^=P'"V3!C@2
MA$Q3Q70$$C*=@RN[B_9,(H!TAY)/0Y*_0U!#68;^-MK9/>54Y<JM?/XG"?*E
MSZ'9M5-7 <?!.&H)W?+*T$N^@C*\=40_X:MTM8$S?V X4\8Z5&W0L%N<&48+
M\!4G4;9%H5S+MZU1U;+0-88XM9+:&%[9H&4["8(G ?F]\Z/?G%?SKH%^>#<1
MLD+6+I#BCQTV1B/ R%T.7\I]_+,"QPL))0,Q@4O^"#Z(G^^A[S]/LH[XX#)^
M2[Y3[?![E^S]@A@"2FAI.6>)X=DFO>#Q%M;0"3;H?IJN-1'<@+\/;@8MXI!8
M2.=9.(A#)_"YVO3]K<[@=_,]) -'&VFUHP_,#=M;2L/__IBH:ASIN/TW'KP>
MA>JWN&R1)XH3"NAQ84]N^^'H9;6X9JI;[EE\6.(^EM0YHIOZET3:=H!Q]!+=
M5"QT7A?HQ_XE@554GL'#J&MH0<DC0=FTWP:]<:!Q)WU8^[*+<6O##]'&<3LN
MK4S6+6*+G] !&\+W-(^=#(Z.QO>X>\J?P:Y;^G#CT5.0F?NG'<LAJ\+[IYOM
M7H^3\&A:;P]/3YS;<X5[5TXSB$:#U\>]4#[MP.G*/Z&FVN%!YC\SO(#)\ :L
MSS3<;09LH'M3G_\'4$L#!!0    ( ":&9%'A2OJ[GP0  #@+   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;)56VVX;-Q#]E8$*%#;@Z.HT3BP+D)1+
M@R* 8-5M@:(/U.Y(RX1+;CBD%?]]9TAI)0.R [](NTO.F3-G+N1XZ_PWJA #
M_*B-I9M.%4+SKM>CHL):4=<U:'EE[7RM K_Z38\:CZI,1K7I#?O]WWJUTK8S
M&:=O"S\9NQB,MKCP0+&NE7^8H7';F\Z@L_]PJS=5D ^]R;A1&UQBN&L6GM]Z
M+4JI:[2DG06/ZYO.=/!N=BG[TX:_-&[IZ!DDDI5SW^3E<WG3Z0LA-%@$05#\
M=X]S-$: F,;W'6:G=2F&Q\][](\I=HYEI0CGSORMRU#==*XZ4.):11-NW?9W
MW,7S6O *9RC]PC;O'8TZ4$0*KMX9,X-:V_RO?NQT.#*XZC]A,-P9#!/O["BQ
M?*^"FHR]VX*7W8PF#RG49,WDM)6D+(/G5<UV83)3I G<&A8>"6U02:NSA3.Z
MT$CGXUY@+[*W5^P09QEQ^ 3B6_CB;*@(/M@2R\?V/6;74ASN*<Z&SP(NL>G"
MJ'\!P_ZP_PS>J UYE/!&+PKYW^F*@N<B^>\9%Y>MB\ODXO(E+DY)^3S,GQ5R
MV1:N;I1]T'8#V@;TNH9H52QUP!(*QRI;RD_$62N5?%YKJVRAE0%BY\A=% BV
MZ!&X=1OE>8NV8B)MK<,#5UVHX*Z[[,(&+7IES(.XQD;0A$.T01@T7C-N8Y#@
M[-=?KH;#_G6R^C2=+M+[X/H<E"TSX-0'71B$05_$N,5--%GMY:M_@%VW 1WX
M,CWGQ547/@O#NC&:ES #ALH1@H_L_P(*](''#H/DX92ZG%VOG0O6!8124V$<
M14X"6-DB43%_$\LL@+(VLL^?2W>LFJCARP.G-GZHU#W""M$>I86#=*PP(W>!
M\\GL7Y(RJEPT)6."3-Q=SKY&FT?:3A*$>2X12<#@S37!477\Q('HY=&D#:(9
MI;0(YIK%X[T/J#R@M#*\QP+K%7H8#:09!V\?:7F*QS3K>YMR"LQ8)BE7PZL_
M&-Y@>8A@^6$NZU^4+RH8#'*SPYDL[<HL.7P:<%]\79C2@5?%):_M17+QA.XK
M95(N\QFH4MN>B)1XUGL^0%A'[^H$^ *5$VJH5 #9E4I;$%RCK222%VME^1"4
M[1? =0JJ_,K3/YN?B0=-J0&=Y1KF_;F>.7=%]%X6C@S.$R7-A"6K' L1'[@I
MLPK62OL#M\Q+RHOX'$LT]SW9\*\KZ:BJ][*F2GX\F4Z&S0>LG+YMHS)9HXCT
M6A>I6REKR<UUKUTD:4ZB^)2(P>T'ECRFC'+H$D-S-&4SMUTA,G<"O%<FIMQ0
M7!%^CV*"]PE3)#E,"0;U+FYR14JBDAQ,*17(3JE'89\:Q*?(<U4R&]:#4R)8
MN5]X&.2>XWA4PX.N4"N>EINH\WA)^VD?K8H\_;R6,#DAAZFC)(QHVR:<'J;U
M,G!_*\])G+NRE;V=W-/E_-',/FEYUX@2=&1TUQKM)/G81GP28>;XK[7_.%W.
MVF8]==;VCFXS-?I-NK,1).!\L6F_MM?":;X-';;G.R6/DXWF,C.X9M-^]\WK
M#OA\3\LOP37I;K1R@6]:Z;'B08M>-O"Z'"7[%W'07I8G_P-02P,$%     @
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M0Z=\^[JF:Q4J7D#_5U*:_80-#!>U^9]02P,$%     @ )H9D4>\XS[)C @
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M5CN:2D'LZ#> QAO0]U9K=SQX@NG'LOD-4$L#!!0    ( ":&9%$)Z"B4F (
M )P%   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;*54VV[;, S]%<(K
MAA9(ZWN29DF I-NP 2U:]+(]#'M08CH6*EN>)#?MWX^2'3<#VKSLQ:8H\IQ#
MVN1T*]6C+A -/)>BTC.O,*:>^+Y>%U@R?29KK.@FEZIDAHYJX^M:(<M<4BG\
M* B&?LEXY<VGSG>CYE/9&,$KO%&@F[)DZF6)0FYG7NCM'+=\4QCK\.?3FFWP
M#LU#?:/HY/<H&2^QTEQ6H#"?>8MPLDQLO OXP7&K]VRPE:RD?+2'[]G,"ZP@
M%+@V%H'1ZPDO4 @+1#+^=)A>3VD3]^T=^E=7.]6R8AHOI/C),U/,O+$'&>:L
M$>96;K]A5T]J\=92:/>$;1N;QAZL&VUDV263@I)7[9L]=WW82Q@'[R1$74+D
M=+=$3N5G9MA\JN06E(TF-&NX4ETVB>.5_2AW1M$MISPS=U_A5.:G#QIAH34:
M#:S*X!*I5+A>";YAMGT:CN_92J ^F?J&>&VVO^XXEBU'] ['.5S)RA0:OE09
M9O_F^Z2W%QWM1"^C@X!W6)]!' P@"J+@ %[<-R%V>/%_-^'78J6-HE_I]P':
MI*=-'&WR#NUUC8IPJTU'=,G9B@MN..JWFGP0S [O1-=LC3./IE.C>D)O?L5,
MHQP@R!Q,@7 ARYI5+Q\_C*-P](G<O0;A-(A7#< 4 M.02T&CJR=PBW;*,U06
MS+8>CB :#JT90CB(QB-K1M8\3ZT9PWF26".!=.@\Z<X80D+>>VF8Z)AK]D+#
M3IU/!W$RI)9HHN1EW1C,@%<&J2H#Q^%@&*=PTJ4>DG\$\6 4AO#6E_+W)J9$
MM7%[0<-:-I5IAZ?W]JMGT4[<:WB[MZZ8VG#Z-03FE!J<C5(/5+L+VH.1M9N_
ME30TS<XL:'VBL@%TGTMI=@=+T"_D^5]02P,$%     @ )H9D40ITL33V @
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M8:7WBR .#ANW<E>2VPC3>2-VN$'ZUJP->^' 4L@:E95:@<'M(EC&L]7$Q?N
M[Q+W]L@&5TFF];US/A>+('()884Y.0;!RP->854Y(D[C=\\9#)(.>&P?V#_Z
MVKF63%B\TM4/65"Y""X#*' KVHIN]?X3]O5,'5^N*^N_L.]BI^<!Y*TE7?=@
MSJ"6JEO%8]^'(\!E] (@Z0&)S[L3\EE>"Q+IW.@]&!?-;,[PI7HT)R>5^RD;
M,GPJ&4=IG(RFKV&#2FK#2]X:+."K)K0@5 %?M% 6UN))9!7"FSNWV+?SD%C:
M$81Y+[/J9)(79-[#C5946OB@"BS^Q8><\I!W<LA[E9PDW& S@G%T!DF41"?X
MQD,?QIYO_#_Z\'.963)\H7Z=4)X,RA.O/'E!^1HS@AM!K9'T]%QG3\+=T,YL
M(W)<!#R5%LT#!NF2+R:SUCTKD$];6O ABKBVS,WC#&[136Z!!O36]Q)>P3MG
MQ# ^FT:1,Q.(HX,]AOCB8$\@F1SL*<23LXCM.TVB8I*+R+O/-2@\NJXUFIT?
M2@NY;A5U-W?8'>9^V5WWO^'=HW$CS$[RGZEPR]!H=#$-P'2#V#FD&W_Y,TT\
M2MXL^>U"XP+X?*OY'_>.$QA>P_0/4$L#!!0    ( ":&9%&[;6QJUP,   T)
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;(U6VV[C-A#]E8%:%+L
M:]UM*VL;B),M6J";#9*T>2CZ0$MCBX@DJB1E9_]^AY2CVHGC]D4:D9S#,S.'
M',UV4CWI$M' <UTU>NZ5QK07OJ_S$FNN1[+%AF;64M7<T*?:^+I5R OG5%=^
M% 1CO^:B\18S-W:K%C/9F4HT>*M =W7-U;<E5G(W]T+O9>!.;$IC!_S%K.4;
MO$?S1WNKZ,L?4 I18Z.%;$#A>NY=AA?+U*YW"_X4N-,'-MA(5E(^V8_?BKD7
M6$)886XL J?7%J^PJBP0T?AGC^D-6UK'0_L%_1<7.\6RXAJO9/4H"E/.O:D'
M!:YY5YD[N?L5]_$X@KFLM'O"KE\[23W(.VUDO7<F!K5H^C=_WN?AP&$:O.,0
M[1TBQ[O?R+&\YH8O9DKN0-G5A&8-%ZKS)G*BL46Y-XIF!?F9Q0W5_7>I-=RB
M@ON2*X0/#WQ5H?XX\PUM8)?Y^1YLV8-%[X!E\$4VIM3PN2FP./;WB=C +GIA
MMXS. MYC.X(X8! %47 &+QZBC1U>_/^C_>MRI8TB<?Q]!C\9\!.'G[R#O^1:
MY,"; JY%U1DLX.V.I])Z'O6A1(W02H.-$;R"7-8U"5I;- TV"'S.JXY2#FLE
M:S EVC5M9[A3OEQ#0S0J2Z,E&LX1C'0+\=G"DLGM X4"7*_IR/3 G'8L;"AT
M=)@+[*%4B$=U!JJ2P7I%R+94-\3^W+PM)3W"[,"ZZ6I4W$AUX1+FF/X('\(Q
M2],0/CI[RI(PZNTX)3OM[31FXS @^QH;20>D1WETIQ&+G_F6@#<(3><(4"J.
ML_?3#],H##_9DTV5BRU8QN()D4M9$(<LF4SM:)I%;)J,(4I81F8497U5;3H/
M 5_AV805>R40UV"49#WK8#1)]G&-@GTDT<C&=$:%Z:#"]*Q>+@^*1LG/.R6,
MH%@_'ZGDZE@A@TBO^G#>U>K9O6T/N= MSW'N49/0J+;H60'#6E;4 $2S 6H-
MVE!FK$WW6_X$LK4L-*-;GLZBR&VZ^IFN$5:)E,8=5XK4^%:6;K:D.L,*L?GO
MHV"'JI.UHQ;G9FE"R$(#OE'OQ2DMOQXB/7_M P*"/I;;8>PQ"R8IRY((2%#I
MF 59!'>G$] U6YJ@P3!FR32#,)BP,$G@\24I9S<*63HA)9-FG3JC3_ @#=TC
MPXU2?3O.:$$)V')KZE?YM(G#PULD8>-QP*9C.L@L'L<LBL=P2L+^08NBL[YQ
MC5@3Z:XQ?;<:1H=>?]FWN'^7]S\*7[C:"$INA6MRI9-$BE1]\^T_C&Q=PUM)
M0^W3F27]KZ"R"VA^+2GP_8?=8/@#6GP'4$L#!!0    ( ":&9%'BK8%IN 4
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M(9)D8E'QO\BBVK.>[5OG]-.*1*@XE?.M4J+@.=/T,M5T(\[1#C&'AQJEE5+
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M.:]8><95W@B:%F<R:RKDFT)QN25RW\OR /G[AE)QO,D+U">-DW\!4$L#!!0
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M1LM<WXG59Z@*ZEJ^1.3*_:)5]6X4H*146A05V"@H&%__TZ?*B"V X6D'D I
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M:&.>&V;F^@?2OF">SX30FXG=H+Y0CO\"4$L#!!0    ( ":&9%&]0D5UK ,
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M+!+8C6T7D*W#J.PM\>"%9<DW'= G\/G!<I/[P$_?\._(7@%02P,$%     @
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MM&D8;EB9E@[2!IC]M1#Z;6*[QO GD?\'4$L#!!0    ( ":&9%&PX3K&@@4
M (H<   9    >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;+59VV[;.!#]%<+H
M0PNTL4C*DAPD!AH[]@9H%D'3[#X$?6!LVB8JB2Y)Q4FQ'[_4):(O#"4W]4LB
MT7-F.&>H,Y1XMN;BAUQ2JL!3$J?RO+-4:G7:[<KIDB9$GO 53?4O<RX2HO2M
M6'3E2E R*T!)W$6>%W03PM+.X*P8NQ&#,YZIF*7T1@"9)0D1SQ<TYNOS#NR\
M#'QEBZ7*![J#LQ59T%NJ[E8W0M]U:R\SEM!4,IX"0>?GG<_P=.+C'%!8_,/H
M6FY<@SR5!\Y_Y#=7L_..E\^(QG2J<A=$_WND0QK'N2<]CY^5TTX=,P=N7K]X
M'Q?)ZV0>B*1#'O_+9FIYWHDZ8$;G)(O55[[^BU8)]7)_4Q[+XB]8E[9!OP.F
MF50\J<!Z!@E+R__DJ2)B Q!YKP!0!4 [ !W8#L 5 .\"_%< ?@7PVT;H58!>
MVPA!!0C: L(*$!;%*MDM2C,BB@S.!%\#D5MK;_E%4=\"K2O"TGPIWBJA?V4:
MIP8W0J]JH9X!26?@\F?&5GJ=J8_@;_T4O!]115@L/X!/X.YV!-Z_^P#> 9:"
M;TN>20V09UVEYY![ZDZK>,,R'GHE'@;7/%5+"2[3&9U9\)=N?-^![^K<:P+0
M"P%#Y'1X2U<G 'L? ?*09YG/J#4<]FWIO"WZ^&W1)V[XB$XU'-K@6USB>C'A
MPA_^C<5T__E!*J&5Y[LCD%\'\HM ?IM U 1:""ZMB[)T%Q3N<G5^'/AAU-<Y
M/V[6JI75Q&85AEYMM951K\ZHY\SH"Y7R5 OS-$NRF"@ZTWJJ>\N4D5*Q=9XD
MX4*Q7\6 +<<R0&]C7I]\#X9P)\EV9A.+&8X\W[>G&=1I!LXTOW%%8K!ZI7PI
M5;;$@KVIA"&*=M)J8S39-^J'*+"G%-8IA>T6_4U,4K6]],%5.N4)!;=*E[08
M&#$YC;G,!)7M'HFHGD;D9'9TZ'*)]@F#_C9?HVAOJ0?]W@[Q^WX01.&VT7C?
M$8(^MA/?KS/N.S.^)M.E'A+/X/Z:)@]4N&B$GFF(WG%%#&[T7OAG9:SRMTVV
M[P4[):G, K?9Q.K-BR)[62 R::$#"P/^ ]<L94F6M*J5Z3?PR T'FHX#W2WG
M3M)Y%H-8;YQMI;EL@&/P3(F0KJF85@'=O<+.+WEJS:]1:Q@<F5^CHC!\&[]N
M..PU$VRD%+JU=)R)E"FMT47>8_:D2KUN0:T1+]@_+K7(*!KR_JS,5/XVA0$B
M;W>W5%D%3JN)S1?LO;);0D8ZD5LZ&TITF. @(VT(';EJ1ML0?M,#T0!O%AQD
MM ^YQ:L%V>W5!QF=0[TCDVV$#KGWI8UDN^$MU <9)41N*?M"B:1+'L_ 5:)W
MRH_%QK&5^B"C<"@Z,K5&Z)![FW:H^EPT^+N'WZV:U;=L9C#&NZ+5MVR-]LPF
MC=ZVWX^-%&.W% ]YLLH4%073^4>ZC7>%G)];/E=KHA^T%M7&1BPQ/&ZUL1%(
M[-[['=QK*G];3$?1[HZVL@J<5A.;KS *7RG:QE<-MY0>7+3#N@\V.HS](]?1
M:"]V[S&;!+$!WMQ]L-%F[!;7WZ*_?3_"1IAQRS?]WZ;?Z#-V[T ;Z7?#PV;Z
MC7YCM]X.>:HSR\J3 Y8"S<)"=_]6#<DWPN@?^:W;-VKH_^&W;G__=1IZP>YW
MD%96$YN5#Y%=HOQ<=K='C&CY;M&RM\F+!I39>[#-O4?^=%7?D^@,Z&$!U)("
MN=1#^IK/B]LX!P,]D !>&# !J%0L*;YG9AM+^L16R.[&*49"Q:(XH))@RK-4
ME1]2Z]'Z$.RB./K9&1_"TQ&TC%_"T[%M_+./3L>^S9.F2_]2G!9US93*4[IK
M(A8LE3KKN9Z>=Q)J113EP5=YH_BJ.'=YX$KQI+A<4C*C(C?0O\\Y5R\W>8#Z
M^''P/U!+ P04    "  FAF11%7F4Q-8$  "X%0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6RU6&UOVS80_BN$T0$MD$0B]6([< PD<8<5J->@:;H/
MQ3[0%FT3E41/I.,$V(\?22FB9=&4TG9?;$F^>^ZY.^KAF9,]*[[S#2$"/&5I
MSJ\&&R&VEY['EQN287[!MB27OZQ8D6$A;XNUQ[<%P8EVRE(/^7[L99CF@^E$
M/[LKIA.V$RG-R5T!^"[+</%\0U*VOQK P<N#SW2]$>J!-YUL\9K<$_&PO2OD
MG5>C)#0C.:<L!P5970VNX>4L0,I!6WRE9,\/KH%*9<'8=W7S(;D:^(H12<E2
M* @LOQ[)+4E3A21Y_%.!#NJ8RO'P^@7]=YV\3&:!.;EEZ5\T$9NKP6@ $K+"
MNU1\9OL_2)50I/"6+.7Z$^Q+VW@X ,L=%RRKG"6#C.;E-WZJ"G'@@.(3#JAR
M0'T=@LHA.': )QS"RB'4E2E3T76888&GDX+M0:&L)9JZT,74WC)]FJN^WXM"
M_DJEGYCJ1I^SU?D#)^":<R(XP'D"/A)93/!ID=(U5@WBX.V,"$Q3_@Z\ 30'
M7S9LQZ4EGWA"\E!HWK**>5/&1"=B!F#.<K'AX'V>D,3B?^OV'SO\/9E_703T
M4H0;Y 2\)]L+$/AG /G(?[B?@;=OWND"V+C].JB9&VI&EA(**B@XKJ <R09U
MQP,-&_QTQ[]=+[@HY)OYMR-L6(<-==CP1-@_=]F"%("M0*H"<? O.%67FQ(I
MTDA*N!ZGP<1[/&R"RZ)!+ZKI1<ZJ:"YGX)9QT2_ON :.G7F_YX)*>2()2"A?
MLETN0"%O;6F[@6!\,?9_LZW(U_LU,AG6F0R=0'KAJ ;NY#K!>N'8LBA!XL/6
MQ/[XJ']]C&9M(]_>Y%&=P<B9P:<MD;6G^;I<@X \R>W3O@1'K046MI)HVT"$
M1G:*XYKBV$GQ*RXH7J2DF^&X%7UT3+!M@J+(S@_Z9L/P7U7$+7Z6<X!U+=Q6
M4,T2G:1PL&?!CI=5KC[YMAHJU>O[4=:.IE0\GX&[DM89F.U(OS<:(A,?N=\$
MHB:JI)0S)?36/1"UJQ_'1QWJ,&KR,PH/ R<_20E:*066=HR&QYPZK)JDC/Y#
M]P8@22$KJ;:60S2.CDEU6#5)&=6'41>IP$HJ:H4;A^$Q)[=1DY+9+Z!;KR6E
MT$HI;D6+XE:9W$9-2D;XH5OY):7(2FG8AY+;J$G)*#ET2[FD%%LI680;M1KG
M-FI2,LH-W=+]A0F<=HOB#6S+<A2$+67HL&H.ND:]D5N]E71> IIM=VHDH;D@
M!>'"1A.UM?L<QL%Q>SO-FD2-QB/8HYKL:+-)*X&GQ%K:"K,Q%PXA/*;<8=5D
M;'8%Y-X5KN\?U*@>G_L(?)L3->ZZMAMDY!RY)_97SZ;(B#)RBW+/F:Y".1S%
M0C\<'=>UC]4,M96\8=7,Q"@YZAK@_X^9 !G91F[9_I'U.JLP&Q5#IY0(&;U&
M;KV>TYQFNZS7*C2*BT:_>!4:Y41NY2SG*5,U*4J9=1FZ81!X)KC@( :9/A^P
M_GO_&8CF_VVCN8%;<^?XJ6\[ J./0=<,_,IV!$;(@C[C;7<[.F#BLI:V+OR(
M9YF,=W#4E9%BK8\,.=!_K,M3K_II?2QYK0_C/&->GFG.<;&F.9=)KJ2K?S&4
M E.4QX3EC6!;?7"V8$*P3%]N")9COS*0OZ\8$R\W*D!]6#O]#U!+ P04
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MQ&Y^)TU %<"8I:+ZBVX:6V>"XE)(EC6# 4%&\_H_OFT2T1K@S0<&>,T ;V.
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M=6&U.@%W#)9OA.7VYYL98(V9=6%I(7"],5B!$9;7)]C  &O,K M+ZX9K%PZ
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MIKK\AUTMZSD0%=K(K :3!1D7U9,]U'$X !!/.\"O ?XI('@&,*@!@]=J"&I
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MH-^ON3['3<=<IMK+\^PW4$L#!!0    ( ":&9%%>80&SB00  !,2   9
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M41O \SD'KLL;':#Z#C3\'U!+ P04    "  FAF11#! 1N;H)  " -   &0
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M2(X9 ->7 BPT/S$OVHIWO>-_ 5!+ P04    "  FAF115L$?N3@"  " "@
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MZ#59FN?@#K_)SZ$@+=.+(9C@K?T#<MKRJR'KWC:BS]K:W^WRHKDKN'USIG\
M4$L#!!0    ( ":&9%&7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKEN
MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MEW\</SSSUM3=(9\-_W::O0%02P$"% ,4    "  FAF11!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M ":&9%&0-70W[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( ":&9%&97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ )H9D44:@
M5;3B P  / X  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( ":&9%$7/?'-J04  /\5   8
M  " @28,  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  F
MAF11H2=4Q($"  #0!@  &               @($%$@  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ )H9D4?F]CI-5!0  8Q4  !@
M         ("!O!0  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( ":&9%$F!J,0J@@  (,U   8              " @4<:  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  FAF11Z4LDML(&  #?&@
M&               @($G(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ )H9D4=']^=M8!@  . X  !@              ("!'RH  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( ":&9%%KLO6^G00
M $L+   8              " @:TP  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    "  FAF119?%9_A8.   ')@  &               @(&
M-0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ )H9D4889
M["LX"0  XA4  !D              ("!S$,  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    "  FAF11]76%^S<.  #=*   &0
M    @($[30  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M ":&9%%T[+:4NQ$  %\U   9              " @:E;  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ )H9D48)8ZE2?!0  X P  !D
M             ("!FVT  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    "  FAF11][39<-X"   /!@  &0              @(%Q<P  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( ":&9%$EUK]D7 ,
M '4'   9              " @89V  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ )H9D48/?'+)1 P  4@<  !D              ("!
M&7H  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  FAF11
MOWZWGX #  #L!P  &0              @(&A?0  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( ":&9%$U/7(;? (  -\%   9
M      " @5B!  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ )H9D4;$)!5[!#   U"   !D              ("!"X0  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  FAF11^!%1\<D$  #_"@
M&0              @($#D0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( ":&9%'>:@+Y"@0  %@)   9              " @0.6  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ )H9D474\_74@
M!P  VA$  !D              ("!1)H  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    "  FAF11YLMI18T$  " "@  &0
M@(&;H0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( ":&
M9%%-D);EA!(  ,DV   9              " @5^F  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ )H9D4?HAP2?[!0  7P\  !D
M         ("!&KD  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    "  FAF11X4KZNY\$   X"P  &0              @(%,OP  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( ":&9%$,%S/_/0X   PG
M   9              " @2+$  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ )H9D48C(1(#N P  <0@  !D              ("!EM(
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  FAF114F:N
MK0P%  "T#0  &0              @(&[U@  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( ":&9%'O.,^R8P(  "4%   9
M  " @?[;  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M)H9D4?=G6A7] @  9 8  !D              ("!F-X  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    "  FAF11">@HE)@"  "<!0  &0
M            @(',X0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( ":&9%$*=+$T]@(  &L&   9              " @9OD  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ )H9D4;563@5] @
MN04  !D              ("!R.<  'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    "  FAF11W>HV,U8"   9!0  &0              @(%\
MZ@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( ":&9%&[
M;6QJUP,   T)   9              " @0GM  !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ )H9D4>*M@6FX!0  90X  !D
M     ("!%_$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ":&9%&0JVW:#@,  !P*   9              "
M@6L& 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ )H9D
M4;X@58SS @  *@D  !D              ("!L D! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    "  FAF11>22)MN@"  "[!P  &0
M        @(':# $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( ":&9%'<Y),R^P(   T(   9              " @?D/ 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ )H9D4:\-!RA3 P  7 X
M !D              ("!*Q,! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    "  FAF11O4)%=:P#  "1#   &0              @(&U%@$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( ":&9%%;S&5)
ME0,  (0-   9              " @9@: 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ )H9D4:#$GR*3 @  Q08  !D
M ("!9!X! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  F
MAF11I13^00,"  !'!   &0              @($N(0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( ":&9%&E1@QV80(  # &   9
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M970U-2YX;6Q02P$"% ,4    "  FAF115L\/3^4'  #%)@  &0
M    @(&'. $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M ":&9%'B#!/H:@,  #0*   9              " @:-  0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ )H9D40>7'V%I P  2 L  !D
M             ("!1$0! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    "  FAF117F$!LXD$   3$@  &0              @('D1P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( ":&9%$,$!&YN@D
M ( T   9              " @:1, 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ )H9D40!Z@_BB @   @@  !D              ("!
ME58! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  FAF11
M-9Q+ES #  "6"@  &0              @(%N60$ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( ":&9%'DG0'"X 0  /<5   9
M      " @=5< 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ )H9D45;!'[DX @  @ H   T              ( ![&$! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  FAF11EXJ[',     3 @  "P
M@ %/9 $ 7W)E;',O+G)E;'-02P$"% ,4    "  FAF11'(9V9?\$  #_*0
M#P              @ $X90$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M)H9D42=EU:4, @  A"4  !H              ( !9&H! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ )H9D4>[5[1CF 0  ]20  !,
M             ( !J&P! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $<
,1P!H$P  OVX!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>203</ContextCount>
  <ElementCount>369</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>47</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - Corporate Organization and Company Overview</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CorporateOrganizationAndCompanyOverview</Role>
      <ShortName>Corporate Organization and Company Overview</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksAndUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - Revenues and Trade Receivables, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNet</Role>
      <ShortName>Revenues and Trade Receivables, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - Material Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreements</Role>
      <ShortName>Material Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - Financial Instruments - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</Role>
      <ShortName>Financial Instruments - Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - Inventories, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNet</Role>
      <ShortName>Inventories, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - Right-of-Use Assets and Lease Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofuseAssetsAndLeaseObligations</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - Intangible Assets, Net and Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets</Role>
      <ShortName>Intangible Assets, Net and Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccountsPayableAndAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable</Role>
      <ShortName>12.5% Senior Secured Notes and Loans Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - Warrants Issued to 12.5% Senior Secured Noteholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders</Role>
      <ShortName>Warrants Issued to 12.5% Senior Secured Noteholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>061500 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>061600 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SharebasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>061700 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>061800 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>061900 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>070200 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/BasisOfPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>070300 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>070500 - Disclosure - Revenues and Trade Receivables, Net (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetPolicies</Role>
      <ShortName>Revenues and Trade Receivables, Net (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>080500 - Disclosure - Revenues and Trade Receivables, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetTables</Role>
      <ShortName>Revenues and Trade Receivables, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RevenuesAndTradeReceivablesNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>080800 - Disclosure - Inventories, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNetTables</Role>
      <ShortName>Inventories, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/InventoriesNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>080900 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>081000 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RightofuseAssetsAndLeaseObligations</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>081100 - Disclosure - Intangible Assets, Net and Other Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables</Role>
      <ShortName>Intangible Assets, Net and Other Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/IntangibleAssetsNetAndOtherAssets</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>081200 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/AccountsPayableAndAccruedExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>081300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/SeniorSecuredNotesAndLoansPayableTables</Role>
      <ShortName>12.5% Senior Secured Notes and Loans Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>081500 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossPerShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>081600 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/SharebasedCompensation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090100 - Disclosure - Corporate Organization and Company Overview (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CorporateOrganizationAndCompanyOverviewDetails</Role>
      <ShortName>Corporate Organization and Company Overview (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/CorporateOrganizationAndCompanyOverview</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090300 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090400 - Disclosure - Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksAndUncertaintiesDetails</Role>
      <ShortName>Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/RisksAndUncertainties</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090500 - Disclosure - Revenues and Trade Receivables, Net, Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090502 - Disclosure - Revenues and Trade Receivables, Net, Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090504 - Disclosure - Revenues and Trade Receivables, Net, Trade and other receivables, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetTradeAndOtherReceivablesNetDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Trade and other receivables, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090506 - Disclosure - Revenues and Trade Receivables, Net, Changes in Allowance for Bad Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetChangesInAllowanceForBadDebtDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Changes in Allowance for Bad Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090508 - Disclosure - Revenues and Trade Receivables, Net, Summary of Activity with Sales Related Allowances and Accruals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetSummaryOfActivityWithSalesRelatedAllowancesAndAccrualsDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Summary of Activity with Sales Related Allowances and Accruals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090510 - Disclosure - Revenues and Trade Receivables, Net, Concentration of Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesAndTradeReceivablesNetConcentrationOfMajorCustomersDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net, Concentration of Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090600 - Disclosure - Material Agreements, Agreement with Indivior (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreementsAgreementWithIndiviorDetails</Role>
      <ShortName>Material Agreements, Agreement with Indivior (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090602 - Disclosure - Material Agreements, License Agreement with Sunovion Pharmaceuticals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreementsLicenseAgreementWithSunovionPharmaceuticalsDetails</Role>
      <ShortName>Material Agreements, License Agreement with Sunovion Pharmaceuticals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090604 - Disclosure - Material Agreements, Agreement to Terminate CLA with KemPharm (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreementsAgreementToTerminateClaWithKempharmDetails</Role>
      <ShortName>Material Agreements, Agreement to Terminate CLA with KemPharm (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090700 - Disclosure - Financial Instruments - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails</Role>
      <ShortName>Financial Instruments - Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>090800 - Disclosure - Inventories, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNetDetails</Role>
      <ShortName>Inventories, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/InventoriesNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>090900 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>091000 - Disclosure - Right-of-Use Assets and Lease Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsDetails</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/RightofuseAssetsAndLeaseObligationsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>091100 - Disclosure - Intangible Assets, Net and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsDetails</Role>
      <ShortName>Intangible Assets, Net and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/IntangibleAssetsNetAndOtherAssetsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>091200 - Disclosure - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccountsPayableAndAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/AccountsPayableAndAccruedExpensesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>091300 - Disclosure - 12.5% Senior Secured Notes and Loans Payable, 12.5% Senior Secured Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/SeniorSecuredNotesAndLoansPayable125SeniorSecuredNotesDetails</Role>
      <ShortName>12.5% Senior Secured Notes and Loans Payable, 12.5% Senior Secured Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>091302 - Disclosure - 12.5% Senior Secured Notes and Loans Payable, Perceptive (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/SeniorSecuredNotesAndLoansPayablePerceptiveDetails</Role>
      <ShortName>12.5% Senior Secured Notes and Loans Payable, Perceptive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>091400 - Disclosure - Warrants Issued to 12.5% Senior Secured Noteholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholdersDetails</Role>
      <ShortName>Warrants Issued to 12.5% Senior Secured Noteholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/WarrantsIssuedTo125SeniorSecuredNoteholders</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>091500 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossPerShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>091600 - Disclosure - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SharebasedCompensationDetails</Role>
      <ShortName>Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/SharebasedCompensationTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>091700 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/IncomeTaxes</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>091800 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/Contingencies</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="aqst-20200930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>091900 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/SubsequentEvents</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aqst-20200930.xml</File>
    <File>aqst-20200930.xsd</File>
    <File>aqst-20200930_cal.xml</File>
    <File>aqst-20200930_def.xml</File>
    <File>aqst-20200930_lab.xml</File>
    <File>aqst-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001140361-20-024555-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-20-024555-xbrl.zip
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MJ HXE)."7@!07_-+/LW%=+N?AZ8VV/\HI[:BJ%%.':R<.F*J&@WM0S"T#XN
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M)@'S/1[&84"BQ$F6>P$VXT1KN79^Y6)VO$,OB(/ YK@Q[B8ACZTP)MPG+F/
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M85;PJ;@@$]D'1 T^-P$ PK77G!0&SQ!HKSD5UHWA6)B7L*(./%>MY53"^8O
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MX=,%=C(;7U 4O4D2D*5#<.VMOGFSVEWWB]:5<AEZ%7H-]0+T^_'U\NWMZLW
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M>7M&:$T6[11L@<'X0J7.,,T%NB'_D6>@7PD"$Z=A8CHU2:<S_'VF4O43($L
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M<OTX_9!OLN:BV1+CTJ/5BY,U$3)*WD0Q,ZW7I36J+^Y:GYCJE?'!M&A'EM"
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ML[?IAH-K@[Y2>HA]QI;CQ_^/O3?_;1Q)%@9_7V#_!VYO#5 -R%XFF;QZOC>
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MG+34PT^9G@7<1RV$I@%M%8"W>NG.H.7VK*/ZI*#9EQ8MNBN;9B!B?<2R[T_
M9^XLNQRA5./867FRP@387;<>);6<Q)7H0;V*<<N6CG7U/K?Z\H)2;,]@0LJ!
M\D3"\6NM-EO3S[)>+KA:?F&=$1:I'O>$S[Q_>67&R*O=0!J]AC\IN=7SBI3L
MM2:(ODW!O?P.1&R-^$.EA..4<*8MM@!D13U0LK<IKFJYW$P>M>;I7 ($\M)J
MCZULO1+7T1I&(0^ _7=>M*:HY=4"QP\KU3%?B<'Z9 :[5B]4'QC0E$;KZMF/
MFB?47F2YA<>56BJ$3%@U7>B1;^MSM+2X&)*^7>=_K>H8&E2UV:W]:\_@OD^V
MM?RU]O:#>;BSO7JPH5:A90HVEQ4;V!9[!A7 <#B[%\P!V#G+)2HF@O]6<S,I
MVK"'@:]O^Q47-8H%^*<M/5?U:+MZ3E\^1S[!*/'6C.ECV*BG0U2 5P_NNP=(
MEK5I^<S1Y$W;P_5R-2Q,CR+#)L!RJGM>,P.2%#A\3LU<PX;:]<=YT7RZ\A(C
ML*:'MMH_J8?EIK7^6;8>0F&Z3WK4LTMA,ZV<401;9 2'[CW80MWB0Z%O3[1&
M72J>&QP2/$/VT^C5T^84)ZJ1=(6<LU3HN:>-UM.MP9N!MOCRSMRRELKN]&0&
M#T7'#I'U_ 58L5:3YE=*<CK3*54O9IRR%V\:L->>Z=A,P*QQP%[8U0RGUXHC
M6ON/-8T:RJ3;VY@;Q+@JM;)-JIK^MQOUXC//G[C4[N@SA"D&I#-C1M1@A[GJ
MZOY"N7G6AT:>L'7U:V!:<&8_KBF/UH,83W4=D-J;E:RHH=1NHS1(3<'UG[;'
MT$FE1U534+$45S.QGF5'W*,O*UJS,;VZ%SAV3O^!_6I-PW#UU0F>&BGKVAR3
M* T-V##T@1MEEIKM77YM:6"69.KE!3QG NGI=.9IU)8P&BKKKFW6PT>5.X !
M#-JYK'MBU1TLCJJM !VKA@ \(Y/ LS&*Z$3-$ZONYPI[5<ADJLPLJH\\!C(W
M-@KMXHMF%,&+=@/ZW]E4,?[G:QP<"^"M86:W!?[CZ@&=;G9?@@\CJJEFFK2^
M%&"J"SQ00,D9L?_2#$AE.*J[L>1J@"C\/>O(B-!AWE+G)WE5U&154D.7*]8[
MJ@*(Y69VUE JJ+W&/MAYG7.O-#[--NMCJ;0]9$-UG#^C)G3-%(5]]Y^K%PS#
MTS9^^"1G+,V,*[I;9Y6QYG-@62%[Q^3B%(D>@ROW1!$]C/"A]3R"O!U'DDY6
M:[)CF9)WDCR_8S/L*6V*LU,3CI_.C)RD'&O_F>7VB23I)S,0.]2%#U)UGYN!
M(,%H(8YA(7:H%3YCK3PD6(YM(1PZ6HBVO!VO8PR>J1U#O,;Z]V/6OQ.*%S6G
MD*=3%\#WBL\)"^ W3DO FOA3"-Y8DW7ZT[>38:PS:X:@%PY>DW786[=V"H2Z
M-Y_@M1!>(>E+]PE>O<R7=YZ=/!]]Y[M(9^JJ:ZZK3,Q\Z@)3]NN[('+I^>KV
MIC_-(TW,*_1-'.<5#N5620,L64B=8:2L>UG--^V50E)ESF(BRL6UT52D<_51
MSMAT*@N-_^):$1+6Q-_P BN%14M6-%DI*I&K-:=X]7X0:$,T11"%+ORMVZC%
M=5H(-6R[A<^=M] KN4MJ<O=W=?6G:"N%G.F<"/,RO.PT5[>8:(2O*N]X5VL7
M)RH9YP]Y@7/<)5X*X^T5YI6G!69.Z%0]DT=B+K5,VJ8:28Y7*?J2V]0*-5>%
M55GG_&$*H[A0V2BBKA)3=[FP4W\L$YGP4K"94:G2E[[@U6(%^X'?UC>FRU0)
M-BWS>GHV(&MF0>N4U&Q1Y%-]C5PBF71"S<UURJ_7,G_4_'6-KKY9;=)%>Q@>
M>+FYAEPBWZIDF%8E9HP5E4X_U31A"[V%*&!FS%<KS>B(%^VMG-8Z<T]=HIJ$
MHQ5\,6$C+77ZE,HRUBE;4\Q;Q93?*D9A-GDI\!\D^!S$\E8GN*KAHI-63BW2
M8XHTP(31^KN3E32S;L8)\&)ITJ];M]S-'+!:YDSRH\Y#P2MJG;F-26@ EDKY
MTLR("4.*>\HF[U9M5"M#HPM..ZVL;!+#5'(!@)_H3",%HAIB;79<):BMT^>.
MA#I-K;OE?C5YMIV#:-+2VIFJ5[^_M5Z;]-I.>EF=]Z3R/5#(2Y.T5T@NT^]H
M?4P6>(8OST$ -7@ZE:>5G:'3PKJ< = 8\I>MQ'F37MQ)>^@08)IRS%A E%)%
MOQY>41NJU>D%9D3=ZCQ$ 32:YG/%"2KU&P#",L5R+KF:% _TQ]RF#.#.L\Y;
M_]]_O7_WX?<W[50N>)FH^.)7U(-YUNC,[PRPK.J- MR*[XJERG9^=UNH5E*G
M.CM;ZS# :I8JQNTDSIG<+:G3.]0;47F!?M8HW6K+@BQ1#VNNP:Q3PB8U8]!.
M0MW&_$.5@H+9<YT,NU8*'2;8/?.:Q=+%W?EX,]!$R&1L/I^:9-66&[&2Q8B*
M52N>!HO[4T!CB6 OU36\M*-]$9HJ4\ERM5BJ%$&@L4K_+*1Q;W#AMHU?+ME\
M#-I4,9=!--98M/AZHK+A9LV^E!58FG8*7KT?ZH-Z4X"\-4FGR,.J=$!1C.N,
M'[!+8.;P>_*'SF);7.>EU-\V,IJLOPS<<*EW4RVP?%Y_U;Q+_=QRO'0F9ZQX
MZ*+0I1&SW/@P;1EN,W:'/@KU6D>*?)F-N9YHI=)FC%UL$[]+,_R+X8!V9F>7
MM9^WR*CVMYV&:'*N49AU6OZO33[BM<31N9C4VZ[0T(7 %A8#3^_/^S2<@#FB
M*/O=I&O%V,;I0"=923-GY77[A:ER(Y43,I6L7+I#/?;P8RO+?8;)M$#P[,%T
M,)F<*KTQG<VD2 $D3.""=;[)3$''\P(4C$KQKN"G$EQ3ZTJ]?SUUK*= "25?
MV4IC_5#7\1R,BLJN7'H=C4;L\X7N<G1^.4)LQ-E<E8O]#\C4:A)EVQ;Q7!M^
MDU$)G 76,3,NGZ*"MK@JWTVQ?XE9Z5)]6_VA\=-Y,]U6ZT]M(:I6NX5:[:/"
MP("@ZGB6[3AK)?].:SB=*ZI\/Y0 CJF'ZLT*3E/5[UW8[L1"*F((U<DTZY;1
M*9(UW0(: PNQUYO9O%HTLVWKK_QF?4Z1.VI#)H&S5631?+.G;83:67PYOJR3
MQ:PSY*>W70:L:55JVM:11VD4'ZMU*:BF9:[>[;+DS53Q8(XC_+;4\[CW2:*<
M +V V@(!\8/2<ZV=4&%T.\D1X.CDU6L(-=*R'E,,?D;99'+?RQ]=W)J=-3JD
M;2]5+O,S+[+5<RK)-&P<E@4./;U0GV08/L]PYJ4IU2XMG8_>)_% N3ER.!B4
MVTM->M 6F*',>I$#&L*'8B_(K:1#-RFY;:0?@Q^):IIY?DTS%X]S.DBW]K/=
M#F4+W-I?6"*YP -553TVB6RJWQM-?-]!/NO5NZ;/"C=_)76Y:!?,1\68FV2^
MDZ!L7;2VY'@Q+<1)5]4W=#>Q5T=7!ZP4@BHVN>H4@?Z]8BCNMUKQ;9^:WYN6
MWU/$LSQS4!O;*@JK*Q]5R9HQV]=,:)<:@M,BOT$/K-2%GE@T _@%'?VQJ,L8
M)VW(=12G*H.-,E/>=WVJ88(S4[>+)Q^=P+51AZB#:,LGU^4/(IU6*(/F<23,
M6LBL"EEU9)3A,1TJ5E:FF)2OJ*&*7*I%/F,+'9R!?@#PTU);37Q1[1HJOPF6
MO_JS NA:)%;1VYN/'U8B9E4QO:R67E41^&83$>C7]!AI?,Y45[<L:@E"N47!
MB) E+\!1!.+'X.>LQ("F. /X&(A;I>7UTB-.C9G2E3RR=DRO6?%-:H6'9X@F
MF5TK)U@,?0E]/).U3/PS.@DCOWWR A_7=2$+,%3JM>:\5CW@3")*&P6Z/-B*
M=<% L\-M#T0Y#\UYGJHP45J8 T>5NM12:;LUU=/39:R_\433Q*)Q+= 3/7B7
MD':C'C5^1"@V N_D6[M#D8R<.'2$[SF$QBZ)8AXFQ(E";(CA>+U]0@[6I*6W
M%Y'C;=.*:!7#@Q.];DK2U$R(8VSJ._.VEQC+-)OHN23THM!F-N&4$1+3Q E]
MEH2,D21BWA&;O>#/%[9_X6YLK--&H45*D..F\P#\9M06RF/;OYP _3)SM 6_
MKA-KN<Q5)CJ>:4,M05C$643M*/)HX "1!(E#P00+F AI<&=3+M7^Y>[.9HX3
MABN-A39"=1("2-MU(D:CQ/9]*ED<NJX?R) S+R)Q3)S[^]_<0P#7#1Y%@+NP
M6J)!DX2Z-@MDX!+*)7 _ !\RQXL9\6R;]^UCL,,^^I&W$8M'@,T"-_1DXKH
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MO!HRP 3(614%8I%K&P9V0<H+]=I]6*8L7Q)Q>KO<EU+">V&W (1KX#+P)R'
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M/Y1!KA+00K@)K['53:L_2^0D/*3<\7WJTC@.:""8%![EH"C<![J>U'D8DW2
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M6E *6'9DX5)W4:05K[F>#1&)M%T>4$)X*/S(X1X500BR[#XP'@G655_K[5V
MO]0 3ZRZPM7$%:@''K&O;[+U\)3)@/G@2KAAG- (++,?!BYWW5@FU'><!\Y^
M(/0N=+<&<UNZ],6CN[ZO$Y12\$U$(%Q!U3 [GTF?,K"]CN2VS\5#8RU[7:'N
M#N761%&%68\F2W<>3Q*Y%$(3 GZG0V4LXQ T@$>I3.P E-Y#"1,\GC#=L3QW
MDZ8O/M_EA9N#=#]@'#1BQ"C\7^)ZL>^%?@@FP'%8!#[! T?Q/8H\FR/U>[1-
M7JV/F]E9C#LC5V08!DE@$^'&/G6B) 1A"FTW"!,GCA+VP'%.#GTT^W0GKRB/
MX&/M$;S/LXU.@7Y-OR\(WA]$.&[,&" ;>RQV0=G*R(U"3L&]Z9VK=S^R$"BM
M3E3I@6+?N' 2"TI#$>%TS]@FH718$ O8.L_E(GY@V RXK,R=NQ.7]Y4JC 0'
MAZOZQ%2% 0OEBF4)EE;J*M\INRDK+%!/TJE<GXR3E^4+ !:_GO%;O>B'Y"7$
MT9E@6+?98 U&@ O"W3"*8<NH$[HAN'C$!8_'=X#GUK%V[=!,W8.?5O G'?S?
MO'\-!&AC?@]8K2TM2ZOU50C$IRR=E1#*+!: ,.RR>O@>Q/5#YAE#VJ6@@JF*
M.83D$*+3,(K J8TY_)&!@R!HU'NDLWDF)''7,'<W8MX#UQVH8X<*@_[K='OD
MX3']E'IH%?O ]G$XJ1,SPFD4H#JG-N$,]I;)#:.0=L*>;M[W'L#N0/^C5)&O
M(<&6R)N']#.KN#O,\8/(BUELA]1)>!2R4(0@[S0(61)L-4QMI_WN@:85U>AA
MRU@8C>>5UM<,Y?KJ!N<MKV()N@V'5DJQ?$H]]/F:%;*\PBKM.\8_.<#>3L (
MQ2,I#XP36'$(YJFTP7PS?LKQ3ZN-.WKKE^_HYJ'+LE7E.2*_[,T 6C,O9J9'
M1)Q7BXW%W\5R(TJU$;C;ZO1;_VKZ!3!#Y(=5NA^W;GR;%C<;:\?_;QW?[+%L
MO+X,/5[N$"Y8X0^]4F:$S'K^Z?/7\E>]-57?#ASL6OAQB4+.H]__\ R:-MOH
M#C4[]BZJ'9T>@=C7.Y0F/9.]//7[SYF7_JG^ J)]0%ZZ K39-WG -_R] !?8
M>HG=<%ZSM#C@F_Z+3:LU3 ;$EX_,0S,O/J+L'5','B,_.L-1M5?*JQ(\F_*N
M;, 34>C\-F, 6.U'8FI/+_!/6Q[[U00YJA];8KV4W#C1!)UH$ATL"W%(M:E#
M@N78=;+!<$N.?I8M'[M);=</A%[ZY\JL^S<:AS$'RC&6X@A:?RQV:]5]GH"K
MSY_^Y[;+P:4WO(U^6M[L?RE?=O19G[C/^GSP?L"6B.QP)G#&[#$D6$[@M(;A
MP)GUB+;A>-=1K_,BD>F1K,$IB]"'7EZ^_\+QYBK9.=[MX3 V^R=Z]=U<]>C:
M_+/CH2,H8ZR.'M!9]'I&QRE4^:Y$&4JS@=/#O)<^ P=QR88@\8/CJR</X, /
MS(^$'B&7[DD"DD/QUUE'*3H116 B2L+2 H&N5,%OJ;),+6,06_F/.NEQ#&K.
MM)_./E")O$$(\!,./LXP[CE.XN/00QCGY"$,CK[[EJE9>5A6)+-2)\3KN6]#
MBFQVI=5 M/X3<OE.AC"A.W#<857&H#AP!/!(-NL , ^?37?H+?B0XK-E8:M<
M6"]8>6U]U(59PHIOK>=?2]72]]=6[SFS3D^S*U@"5Z@7^/T6GWZ3-8\NG^R4
MO#$W<&+;92Y-A,!F-8X72$(CUY9DO<B31'7)&_QT?ZGR!8U\M]N7:7LP3TV<
MB#/A,#=.0A;1.!&A'R0R"J(H=-V 2V^W&M >XK@DHL$^B#/-RSZ,WV3@SDA5
M,MK:\9 %4>#!/X(&#F,Q$\25D2O=Q&%);S/*8!>DB.]Y9!6I)20/A9M2ZE/;
MD38!^0V$@#V)G$3:5$@[B?WUM@J[<JKG^L3>/]QQ+!, 643,=JGMBB@(/2<*
M_-AS@L23O>T@=F,BCY(U"7L\W,(.G82[OL\\2A/JLI@[OG CWX\\;L>TC][!
M+O0F(27.+G!?@89'MYQ-5:--</I!*<QQLOK&#ET;<+-M'Q")0^RC0&WI1\(-
MB1_;"6/2=FAO<3=M]L1W[7]_7K"%ZC2@^R9BO6R>85L)U6IK"2D"^B8S8&[5
M<FO?^TA\-XEM.Q;8A<PG(H9M OEQ;0XX16%?VX8:5_C)OW\?41QWVL=/<L'2
M#'3W*U;@5/ARU^TC$@Q4F) @(I*Z3LQ"C]H^#5T2N\(.>OLS[;)]-8 U?%OM
MVX7CNO2H9'!",-BV&P>Q!_B[7AA)RH-8$B*"./'6^S:M2NA!R+"S6&^I_J/0
M 02%C'Q..7<8[+@4OI389HW+WDXJ2S7JWMN'!,V6NY/Z?Z%'Q^MRZ1VW+G!I
M[/F)C2W%P*C1*)#4B<"]L!D%I[2WPT('FWNV3L.F0#N)T@ED%(9V' G/9V"=
M>.S[8#WL!#Q*WW6\7B>C(Z'[%K;]V8[(C<%79E38!&Q'PID?"S E1(0\)H3?
MXS'?OW7'L1U[I$?DAQ!"$)_9$;6](&2<44DDE^!1$K^W%6#'GQP$/1XCS!$/
M0QJ!+B(28BC/C:@;2M^EPH$XP:/KK1]WY(C#"?.CL);$=3C'[J4^I3QAD0-1
MA$@H[*F,W?BQ1OAP6.^/]V/730*/1L2)(9;RHSBPXX"!P^40F[O.NA^YHP4^
M#N\_VA&)0T:]6 HOX0[X@DY,9>('GN\GS/9LL:X"=A2 !SHB (I_&AO!/9=0
M8@,5_ B<E2"2B?!]DB2N[3+F]36S[?K<@^"+/=(CC'D<);X#SBJEX+.Q$+R=
M,!0A27C0WS)R%W?G3.1$.(Q+AX'C1R+*6!"&)&0V]5Q)P8>EO:9R%S(\4$Z.
MZ?@*C\2PY]SFOJ2$>"'$;;X?"$+#T ?_Z;$:\W!6X_&[SWT:Q1 =)0G%."T,
MD\AU@!\2QXYY_Q2871RE!^_^;J=UC]I]23B/?+"0$+B'L1L).Q9)XDD_X91Y
MO89B%[TXX-U/P"9Z0>*'L0=1GTO#"$)T#J$$<(/KBEXG<1?4'WAFL>O9S9;(
M!EX4>LP%KB80S[HQ\'Y(61()(G#VT;T.P=YM^V.X-HE(0D7D)R$7-$GLV.9.
M&&#GVH@'MNP];MI%< _"M7=<E[Q1UU0/NBYI'NV[+K$]8%G?C>PDI)0()[9C
MV&[?#P78__X6_CN>T =;79;T 'EJTH0RCA-)0.539*4@YA CQFXH/#\"U'?L
M)MHGR.&:$M\S:5ZG&<OX@TC3/-I'&B)E$C'/00QH%#E1X-D02!.(+6D@DWNB
MYZTZKCM;L4T/E*>F#?4=XH!UP),T*GP'>,6/6!" G'$F>>]0B=WNCM8.T7:E
MS">)';4 ;YY7JI\KDBB#G[E2>#UDN%E^M_O5C_DTY;?ZOSW=67W']WVT(;;-
M**B8,(!8@KE@4GV!C8E/TYUU<U\Y]87?+ Q$4KZQU]SS%[]:]]%P->UGBYZH
M]_6/W= J%A]%0.]-1KK"N6<6@(=Y=M^L;T5^L[@V/;EQ'-ZRAZQUS4I+3J7J
M+;K(K07[0UI,?&?9@GU3:=/X90!'MX1=%"PK53!7MXH%#PE3KI3(X5?_4<WF
MY8(5"^M#55B_5R6X/6"N/^.?JGF)(@C$+M1WT]E\JFBH\_G@91GL+WQ8R.\I
M2B];TER-$%+]3AE.= *H&?:\K::++CXWZ72J,)WBSX#U-DMFN34%'P"A8IE:
MK@":?*\3R4L+H+NY3ODUD,8TTL6$\@K^L%PDQ2:\X$'@K"+$L)_\()V7UI<6
MP+&<IA+T/KY[49,%) K?4"C6 TS2LJPV :^>8X4$+!;6+:A"F222JY%8BACX
MYVL&OS%KADBF;-J\(K-T%W:E0>#O\]SLKJ(84E=E5YK1M'E66M4<NP@;*BB^
M1HZ\ASM==V*YP<2BQ##HY=J3#Y>@'G%6[_A4$^\*H07J;93@A[0U?J (O\FL
MUS(N*E;<8C,X7S/OZV8#6C!^;G;X]QS^J7G@ZO-7U4?.O["=B;5*]#[==M=&
MZ!&KUO,O^3SE5DB=7Q^\IQ/5;;KF5""L4,0%$PQ*8:K0#>O&UDI= ";JCQ?$
M1I$ ^5&XH6C/E+J9U )56E,U]+)$%=6D YLYR0P^691 2%G,L(NJ*4-U[+^J
MQ+F+/+FHFJ\UGY*_*G!!SAGRQMK(990-W)J836%KI%5>2[G0LG;-!. !^B2O
MRBD*L,PL/H7UTR0UI9;=4<X@-6KPT[S >6:L6ESG18I*#X3R6Y4*?,&E]1H^
M2U6X@,*M(Q)K7A4@DSC+SZRD!?UFJ6KT;-/N^R4H/FQ/W( !2R>-%]2!B5FB
M KZ;Y4).K3(%:\L*90@0TW(.#HE:5&W7"V 0V*H/J]AQU2N^DGIW4&O@II=@
M+-0&3''BGOR!B=L2U>A4K@.S?(Q928%,/,T9\DG]W)PM8(,S_0UP #* O06N
M88I:-7-S$JJWU:Q1HUPCLD<=M(L*:"M_9E03LB*;SZ>I%O!:OI$)_\$RI2U4
M]\A=Y-&Q+;2^NL8)]E=O9"$718[[JKBO;<]1,DNEXX& FD8.DM;L$!!>&Q:3
M<:\81)59P2^-6=0RQ;5+T"-_L"!J)8#J&9W8-%0/K L?Z@"!A#2V% Q?435B
M6@^)F5BI%E(V0Z6)@,"JCD-!:M'6*W@L#*EF2LA!N@KM;TQ;LR0+@P/Q+Z._
MH,H!V2ZEUL&J/$S_NBPD*]1(,_QX!O_@8,HN6-J^&WP5?BW,%M=5N:30C2SP
M!0!? 6XN=K8M9:.3E!3V=_M7+P0M!+H)_)\I VS8(@<NP=?!VO-<8<4$0HB"
MJ';;3-1<<T%:_A\RH7;D@ TOEO(_+W!R  ?"H3")5&EVQ;4<40%BP&,B%<K;
M*.0%8@]NW_/T5Y!XJ;01>AJH*7 E_9,^LV.&?%HXU4 "<-F$!!W1R+/YS@06
MA!7Q.[7"XXWOJ(FGN57;(O@R?%LM X +4)? O;IJ!+XO?Z1E2XM=6F_0L=%7
M%5V?LJ8/XM:AT35(=XE,OJ1*PY** $J'P[LTAH4$S""\,U*"&@]=3#7_KO[2
MRM; M_/5]R\-(.L1L1Z)NC4>]Y(^VC5F+5;63]2@$,>:Z<%9\"#:7L/3+>^W
MK::6&Z^,$BS,JUDU55QW46L-)<^*((:QP3RI5]<FU@0;P%'Z8:S2!"[@.,="
M>\8@R!UU<RH5#ISRCBF/AAH'[NKS[RT'37UR84=;^6?&6?TNT8*"[9NI 3):
M2M0VO0!HP"LHR@ZVFL7+9FQH*TJPLF8.4\L/4U1/T8-'K7VYS*E76XLR5\<4
M;1\,^;G7*7VA+(H6OPFR"9H,WP:/UOAX&*&A_<'I'\#-A;P&(XQJ2/L:VF^I
M]"%-.[))=+2FR %J49DP11;>)0NOR6(( 5X)+*:&IVC?K%FE[1PL_2W$NL:X
MHUQ!H2FEC./'<,16'6*!*0$(09K*Z[R:BI8<UB\"G(0$1]IP*QK71.\#T&2F
MXL]O>2Z45)6R^)YR[=(N44F5R3+V3+VVD F*?ZFU'IAG(*T.QO!)'96J&%W#
MAHJ(Z]V.S1^GFL3R!X?H]IML*8,U8-I<L:8.:V(MO7*1EGR:EU71"&^&L]Q
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MQ3H"^(X.[G,SUD>3S\>[$J&[IX+LA?95);,1P;].)V:X3Z@H_<@T_&4Z!C6
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M")8*;1@+!5<F)?JTHZ2=MW!K\,YC.@>\YN W@*]P!UZ"<Q_* /X'' 8U7FC
M#]90!?-;X_R)Q=R[$U,;3 !O8\3;#/#F7@SF4_<@; 0^"S]*_!^3%X&QUJBY
M_["$%37B*_]B1NXD'I)XZ\=AZ//!&7W[I8:ASWV;]'MQA+"RU&&/9QCZ?(A@
MU6N=(GKV@<##I-B7?\:]'A/;I_4O>QKPP,JOXIA[S<V',0>.<S7UZ^+.%'(.
M?^R'Z710DNREP3X@\'*6&A X(/"P/MW.+1I.F*;P:Q4U/%J8?M="O+->@&P%
MX(NZ)CG;CK\E\2B*SI*F=U@>W+C#[P:>&GCJQ#PE1IR<Y<9\X*F!IUXF3[$(
M>"H:>&K@J8&G#L53$1O%Y"RI-#W@J4MI)O*CF4SO\LF.@<)>UHGWIAJ]7RTH
M+P&IP]%=+%*'H[M8I Y']UH#PO]P-ZU&7TF 7GXVP63A$JVF]D%2:E-B3G 3
M9:X&-^(X1G5O!VD<Q3=@Z!JD(Y;TM[%E_^FK]P .#+"1 6@T"AD9\40,#/!R
M 1P8X#$-$*5T)'A_&\;WG[YZ#^#  )LU !^EP "4OB@3Z**[>?Q<%]:U?:!U
M%\B5SVE??'@*=V@H%CX,JQ_CCB.\YF?AW\NX#QPHM\^4F_"!<@?*O3S*)=?A
M63(U!LH=*'<_RJ77Y\DQ.E6FP_9=2';JZ='T$<&N(],)=B7!FXJ?T-3/;>ZZ
M4OPTF<O)YQQ_O"E+,R\W]Q-YET_RN?DY_V+T\BW_TJ9>(EQDPBC"(F(5CVR4
M92*.+$NMBEF8,'&67B+PS'@\_0IH#'QGCEDQ_9)K^%#=.&2)J[R-JWR)*^FV
M/0KD>(R/?;W-U:UK&&(=DH(Q8FDM,62KYL3CU]-(9*@0/5N%Z*--(H:"XX&<
M=COF'XVJJ(D<EYI>35US#RK\7F;=XH# 7A5^)O%Y9W-_J&;J:+!_U.T$'OM\
M7_6D7MI[>SM3'4[3H6X;^G1Q=1DNZN$[RX]8U-^$A$,0R$"_ _WVDWZ/H(TV
M&W['4SXSB6U(SZ1G]O:;#A;[?-1EZ>^TDIVX+0I[<?5YJ$,>2&X@N8,=\GE]
MB\%&ZO?DJ",8/B(^RX29@2C[AZJ!*%^Y-?ZS*<OO ZG4XFXQECAN0=Y- <#_
M<6,$!MO\%1A*W])1TH^I.IO(_(A9,@.!7@:!DEXD(!Z40%_6G<)/ZXDB$W.N
MX,[9[:<^P7)J6X[TN#G6X%[T I:3DV3$+I0D#Z\DCB/^/T[OY7A^'Q1&F?R+
M/-O]\6DXZ&R\L1/5)Z/P+.,)SR9DA\-?'OY5[P[^7/;N":,I[^>WIFCLWUF1
MP]OY^#XHC5H4.8A';6;3,I_OWUW]B$;(6;W;Y]18]\\'/O@NM@VCBOX&47MV
M&3NPPDMGA0OJ%G*62^+3-4OX;3J7XZY2(AQ1C!T2IBV]V9.0[E +V9M:R&3$
MPU[<3QR*)@8*?6$4REDO<HUVZKFS?0'NUD6P3?$MO"$G6)P9?&SB0:/@S:(H
M0(F,@ANL184'L"RU"-X41N?SP'74^:?[8(!?#-PG_]_FVES_'KYFRG?3HEES
MN619K;BI5)<92764DH02R2WG62QCEC&;1C9,4Y&>ME3W,2H+5I0P$?6KW:6]
MIG2UO*ZT]Q;."X#()^Z?<@7SF=3@D6;SKJ+=^L>>U>6N8F4HSGTQU91#<6[O
MUK]D<AJ*<P_G-?:F"O-EUI8."!R*<UN"<-4X1M=D;A=C3-$$<,"JD_,@,_ Y
M[(F#?5CNC2R.YDKU*6E@*&S<+M>!GB55[D+)HT^PO#I2'0IPCYR5<P,&(^;Q
MEQ@'*#YCPX=IX_4'YL^9F93[)^H,B1D[R6=^J3DYKV&5PYUS?([[Q[-?(J)/
M>D[K^1]%/C=7>OJU)?/D9YE/ROEJ /04)O.^R.E),<GY03Y$R<D1[)>FW3]=
M"X^?JSKE_&=U20 .]#_0_PO+M=DB?&0PX\8Z=3@S13X=)I.\[NP%&O>BN/*$
M%#$08V^)\4SARQ.ETCPW9Z7)K*D_A0+\9C+/W6RI_(L)/OD2@]R4P=L_U7BA
MP?&QQ?0NP$;XB[EKYX OU=WT@P^F"%P__9V2;MIK+I>L5WP'"[;66^_=WY&$
M8W1L(L&L2,*04YFE2M"8)%K8E'.F]7F2<-J$_U^+<I[;^PTWPUMEYDP7\W(N
M)TABL +N?SIS@;E14)AR7N0*6V_XORPF.>II4-)?95%(I[3AE&3[M/&OMQ)^
MR(R9!&;EP.N._JU#QU^-.R>6H9&P- 1*M W@.^UDC,<Z^N^-)?Q>SS*,AL[_
M+R\;9$@NZMWZ SD-V46]RKMX[Q5R *JQK2'+MNX^A:-\]F!3GV Y]8TT&X5)
M-$KY6<I-SH[M 99^4"$=T2@>A>FE4N&EI$=\[':]%I,O\(>3#&P>+LQ;D1\V
MXN(<=527?P@7=]1A,B+\'(&^L]_\G#U!HHXIG=O.'2Z'7_;E,!E%"1EQVHO*
MV-X15^\!'*A_2(UX8:D1O@W);(I3AW(Y'M^OWJD H>1?)/Y8/KA1&;O[.G=Y
MXG3E.=1C7Z^H>\#5AVGA,(KC<"3B<R1G#ZD0KX?.Z(C%;$396G9XF^1Z3W[/
M2GXX5.Y DPSQT7PQDX7Q0OKMGW-33$# OUF4L M3E$%V'WPHIGJAJOOT3Z;X
MDBNS6YN1MP#U_/X?N38_3>RTN'/052LCS/6ZS;(_W->+WDQTO61'XD,<FRQ5
M6J0)SWC"DS0+$R.RD&O#2&K(970?P2.3D_O&WDG^6@:%QTX9?#6%ST4H<ASX
M5V4B-&D10]^1BAE[4TK=7BI^]E+SZ>PH]ZZ_W1;&!+_ 'V_+X"UFJG00T$DN
M><]_.A=!""M+'?9X?LTGKYD4#N2(O=8<$I109TP@&?*$7L,9]SIYIT_K7W(N
MV,#*K^28>\W-AXW+1O2\J7B_R,G"@HN\*'RF>[F8S<;WM5MYBNCKV:\UA@XR
MVW60&:7AI8YV&HCUE1%K.B+1RQZ-]W)A>77$2L-1F%QJ?ZZ!6E\;M?)1<IX>
M_+U+JD#C_3AF^<^YPGYQSB0OFGF/I[+)A_S95ID*/8=DOOP3N+1S)B,6]:^-
MW"6<P<6=-!O%XASU/I=_")=VU/&9QEF]I@CBF^F5!LMD/)W=P4>\Q6)*(PMU
M&UAC]A\R]W)]AY=10LDXN5!OX.6<>9]@.7D7_E&8#('I 9;S4:!(SI+*?G8\
M#[#T@_[H2,1# X/&&-Y\IW]HV_=#,9T5N9G+XCZ8^4STH)1CX^<MG\+R/>?4
M]+[/0S_\I',RBL59+FK.>,P#A9V2P@3K14_6@;Y>*'UQ<)9Z47<Y4-@+I3 Z
M(B*Y# H[@>W)S]R#QA?BUU6"Y[!(=\5 7VJA7U(2R-EV+$:T/V7^O:+"W@,X
ML,GI=DSHB)->.):](\/> SCPR>EV#&\EX:!/+A+ @4].R"?QB*0OBD^>U07G
MP/UDNB<#5=/>1L&OTSD&_G^>RHGO@=.,' J6,X=VFP!4?=M]V7T7P.H89-31
M\88R0[C5(4VHY8*G0D56L-"26!DF97P!'6\*J7T"]'1^:PKP89NY3>YV!3=0
MYN5\:'4SU##WKH9YF(+3N_4OF9Q^!-GGJ8D,0W#VE(HGI-@3$F<O=S4@\'SM
MIGHRZLE;<2W;[117$+UR>U^..WOPG<2C.+K42M*!6%\9L::C,#U+;D[ODBR/
M-R7J#=BEA53S;K?_!*IC*)YK)SN*I'_%<Y=P!I=VTAP;I??NI%^6(?RS*<OO
M XDQ2CE1?AIX)G6@338?C.*77J'Q+8W[;CMLN9/O!EI]Z;1*Z"N@U1/-'SRF
M,G&51E>%&4L<J]JHEK-D>0XYU<?,J?Z6)CU+J>Z3MAAH\;2T>)XVL$>EQ1,-
MVSM_)'YS/L4Y.'5(4CM_H/1L.TY&Z<O*41O89&"3(]0&L!%A+XI/GC?1<-=<
MR&6VIAF/X9%1\#<S,84<.QUXH^_R25[."S>%-GC[YPS[K:ZE8OI7JQ=AP=77
MJK>669>$)#H+PTA0I;F-LXR;1&72:"F,B(U=R[HD:9CXK$OX";,N@\4D]W_]
M/0SI-X$V*K^3X_+?O[EBW_P'80GA81BV$+05A.? A12<FRSB41P:GD69S*A)
M,Y8D.M&:RNCI#-3'<<%#1L)+P864A%A-.(LXSU(MHHP(PDV8\C2A(NO"1;(#
M+@@1(;L07%BAB54Q$Y&VG,=<6,.ESC(=18K++.SB$;(#C_!$Q&(O7. $U*M,
MXAA-'+D)?W2)X\%-4<C)9X-M#MW T_:#'^2]:W]X\U46>A2\G^$;8%C_#5Z!
MI_-)\,$4^13^] ^7=@>OW( (EI\1KZ90.:#H0Y$K<U6]&L""L/H=_,>M4P;O
M%_-R#N>"">7__,7E _Z_JU]@(W>+N^4O'IX.OOL#@MC>2GLG/]POGZEVX391
MP>$W\-/$@U\#7\%>@^X@7QYQI-,L9? _2:IY)('UC4TL$[$UE,CT:=;_EX/@
MM_N9N?DS+__U]FXVGMX;\VD.<MW#Y;?[KX^X#?=,A0C_^U4286T2H< MUQ%O
M4<?I,'2A)";_[!^))5D6AUIR&6:6IS216NI8"B6BQ*B$LZ.0F$?$-B267(MX
M(+&M2:P/%*5IG-(HCD)F**<I%8F)5:A)PA03F7VZ8F9;BGJ<<NAU+/I#.0U!
M+%?$0J>)DN7M1H.@$^8EHL-4<,V24%#*.<N >],PC*T*DU32,-FB-.EQ R *
M([JJ_SL!.ME^XS0SBG%"I8QY:%-!B.% 8YE*8F8ZAH_O:/!$)$UWWN_!V/0!
M%[$DLHS$:6*BA)/09#&-#1.6DCA1-EZW[@[).WQ=ZNXN%)\O$_]63,ORR))O
M)W9W "W/QA!ADYA$G"7@D;%$@M;4H$;!*+-1(M:]T\-(./*08($#MJ#7O3;=
MG/B[:6%-CHKJ6S@I/1V/95$&,U,$)7[RNZN/!OR 7.$3;A_![P!Z>?@#>OO?
MBWQ^_],$5ELXP?T>H_"_W<I)M8L*T@60R@,Q[?;WHYR;=S(O_B['BQ:_<2ZI
M82FZ4BG7(&.R-%,\25C*:,:3=>'RQ)DNT>&PX9#Q\=/O3W)?^,U_'.)$#XJE
M0[*]!RQH018XT((YP+99*/2'O%:9I.6KI2G)C(PHTQP(*!*4<$M9&G*9Q&&V
MLR&] P&M"09^&+&P(RX:,D'][DY*YU]R;28ZN,_-6)])HC=D?%.6BSL/0@WA
MCQ6 'X'<6X:5CC-B6&AL)GG*XC158!NP4&EAM<K4D>1[U#Y&.,7P^C#'N"T"
MSL#F2ZW20TYO@%MG=I)8EB2I8=R W9VD0AHB4\YCHKA@)CTELY]272QQ<09B
M^3L@J9^4XB%;)Q/-J."29%$J-=<)%4(KF;(H!HI(0V5.22;QJ93"*C+.0"?@
M9GYQ,,"/"\1,?PBE <T#UG(I9 B>G=64JA3<BBBCW(@TR\+4)."^KOOR)"64
MD0/21W(J^GB @X% MB*0*)9*4IO%DE"P+Q/)8QE*C #1E&C9Z9\<5H \O#!]
MP02R19C6/1*@FQ2@?14X ZL_=/1HN/(Q/SC!B"WCUB2QY1J,&S!ME(DRDZD0
M_W J/]C%_G>Z7CH5K@Y)CTO2"5K&^2AH/*B_3\?PS3$2+9KH/72AEA"N.E$)
M,TIKID4D8TY5(I15"<L2,)0S9FAR"B<J!*EU9 =J=?L-;52V:M]C9:NVV@YB
M0B4JCI6469PF7-)$AD82DG(0&!P45&=X^DAB@O!KL<M-SZF0=5[#YM(45@/Z
M#D2H12)%!MY5P@B(&"6H$4)$6F=$6FGTP8WF#M*+3Z*BML?.0'7'ICH:AY2C
M]PZ>/(]C#@)0:"[=OU-PWPYNB:]1';EF)Q%XYZ&Z_:WP'MT<[D!7A(M8ZE"Q
M-.5<$9&F642 JC)0M3*)Y,GR)LC1KA3/0T=5=@8F-3<._UE)I 700S>?&&N%
MI5JE1G$=\8R&49I)(N&,+%>=MTB'NU &<CJ0D[]IIZ=PGC[FY1_!N\(8T%QS
M X<Z?X[OM'="Z"[>!(*,$-< K[I2E*7:8(:+B#47)$R3D.LPTY+S)-31SF'D
M/=- N^ZI#F$%;8N8"Z*A?3,^#T=#@B8*;&,19V K,\&S)(YH:D-%=*8I/5S.
MRG9YGATT1)(+I:%&T;1HH!^*IK7&0T43 _JCE+$XSA(.1H< SRB68''$1.LX
M[$JFZ_"=GJMH*&6'35U:V^FK/V!-6"HUFI(ZYDK9-"1,VC2QG$32\$YS\G"6
M! N3^-(/^+RIV=OC8[NT;*E!_BL!M, 43Y45:%G&*LQ8%O%0;WG#^$RG@H37
MG!Z%& Z6PS^0R+_BD#*EC<UL$G'+M(Q-2F4D,R4%M1$]:LZQN*8OA$*JV#]6
M_C7W./.I^_4#9[37Y..W<3/1]29^F^*O6AO8CJJ4TJE@6<(8S[A(P<;@FO+(
M)I+%S.HM;ZZ?*WC(M3B$77D0G#R\'9H6@6D1",;: CD/,&%R:O&^").)\ K)
M71N5W_62'AXQ01+4,9E("5@#G! **HBQB.HX4Z!T[)&#&53$AS5!MD7 Z87*
MY>BDIW&X964LC9A,P)"Q2G(3$RG#U' 2VH0+&45;!N%[H:KV0\DJL:W:)U?U
M^;H[ED>/M*TP6UEI*K8DD2(.!>$BRZ0R))0QL+46.LS$)IOQTQQ<;-RGOV)
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M"WXO'4[> KF#7.R%C@%],9->"B)H&Z@821V%.>8C?\WGM\'OUY^N@[_=W'P
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M ;&Z,1G^<S%VVQ6H6+#-C1,7L!/WRRL2(DL _[B](6O?.7$S6EH4H&U*XPU
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M^[;9%]CFZ52^LBVVTR^6*H-_42(Y<)_R$+.SAE+2,) \7<W(>OWTZV4S!+>
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M*.9O>3;?DSM@]S5A\!WPFHL_SJIR,94G'48%/FPW YK _X3A-:QVF\63^%F
M&ZL)QZM6)[BG^M&SWZT](]T 1[.1&&XW>K+=X#><>3NAY>:MO'[NZ8.QL#O-
M]%%P,Y+T0482CE*?[FQ>/GX%.21:OCEE34<D#(_*^BAI^>:4%;,:Q\E16Q\E
M+=^>MK)13'?GH-^OAMR_\_XP;ODUR,@=^.2[F64/V<NUDV(K=:?!/BSSXY?
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M^)'7A/8;5!UL!DPVJ4UYT31A6_A<FJ/XAB]"D41RWU>^HHQRE85*YG&2\3@
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MIS)D3 9)%@KJ RMRD<=9%F^02>5ZEMR!&6!E*X70D>]?*?/I!\T0"X72*6G
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MH-/.!> TB0*.%809&E<?KQD$:<8$QQPWR> ][!MG\_4W5F\IQ?!N&T88]4"
MZ3T898X $^\=^J3U8!BI><@\TSFM"'F4QR1"I"[+8I'!;CM70D0Q"U,_6'<
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M^W2$YB1%BHGQ]J32D*6IXBNG.:R,C=^[-'4UFL:OF0X.&^!TDNX8M.=($*$
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M7X D&#QP$PB D6$S5JT,.ASN\ ^  W X_OZ?+]ODS1/(\ABFO[S]^,.'MV]
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MJ)Z3=09JCNU?]_ >9%LD2 %.D^"WN-C\-]@^(H=@.T&Q:?494_(J#O&@W/Z
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MMXZZ<GE'T[6X,\/IS='%"+/"VFU7KLA.QE<)0>[*%")!4ET T<O+ VA8?N8
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M<(=?U!O$S0]W0F3IR7Z(F/[ 0*+:0E;O\XEEL7,KZW@58OY /EZ%T+V*=@P
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M^N*AU1S(T'B+<V_?%3@ K<G ':R'![#J!:F0X!><"T@4U->"#9^_%P_X5MM
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M05: ;)2VT1A#$I1@@*&_H#'>7)(8,U&OI8N$+-':Y3'N'TPIT=)( YV3> N
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MH-#M*T+*TN/#W*D@[/+0Q6#-XX @2&D46PBLJR( =/O^C[KP\=/D4;#+0QN
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M\3%<K1D,WY0]+R69KH]4S.KKR.DDM^R;0_E5_!S?K>GI-LMX\I7S1R'4Y<Y
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M+ZZ/2*U.SKYJ$DR82\5E@=?R>%T:I\MRRO9-?\JV/HNPGQ*ME)H\"%2:&A%
M;EQLGK=QK T <$/*U[JA;#RS PJ;THT]%H/T.]2U\#@;1O%2E95+''@>=_$I
M?8=8B[]\F*JRC4.<^LXKY0D+?'SXEFWOBM5V/=PX?<W6:SYD%]>;25+,*/U6
MMK'41R"UE4?4:9B1SDU$M[<9=<_6:!1W&^L[!_T)9?*^TO8])S,:< P) \/
M8&6J'R-&M"/P:#$J1(R*"S,% Q>;4FT<3V=_9T-IA_AWL=A6>E<$4(%:@,2:
MRU,);,]:M H4YLJJ GU4W5L\%J208A1JJ9>9EDUFVIT2&!?DCMXG:2I>&[ 5
M>:9Q]O+1JRE,7<%W6)BZP^]K>_P.+@T?B][7:.A]#4(O%<?JK4CQ0$GU35X^
M>E_/C][7,Z+WEWD'"(U+'-#^HCB#3WGZWLN'ZR_SP_67X.OZ/[.DH)>KU6#Y
MQ3AMJTJ_I3T+J7?^YA_]]UU/)WG78E3^\]62?4YSLGB(LWNZ)/%]G*1Y4>:D
MW0#A$'@^A)4UX:5]/8;X.T/V$:#7!G^1H'6>Q>7J+"TX\A)Q:'2>TV) ?)!P
MPW.#\%1::\WCKYR N-,RUVP@:LLT;XH\<Q+6XVQ,O_08I]7K$ S@P3FX\%X
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MT6>+2J?+%;UEIQ!"G!@PN1F/GW)*("\KG5*D>AE:"Q$A]7*0I)P*F XEOY,
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MPV.-T5A4?BI$XS6Y8UG&/HLC#S(N3_A@8"T$R6/\+"2"RM<@%"D#!+1_=:%
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M#IU-=QA"G94=>?F75K6J?8*\X0L',9HIT_&0\3T9N@_^YZHEY7HI:=5SCK>
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MS!E8>L%FNO%.7,)JJ[\0MGE<LV=*Z^M9]Q,V[2F="Y8^T9P7(B>?XVR9E[>
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M971X"J-28!AK=@)XZ*Q-NHP\71= N+:5ZCBTJ#X*,A[UNTZ.9,F/K<1S+:N
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M9+U=[^J8;[:D9C^T%8%$@%UB *7Z9U!6?W:4P)_=Y^KGT6GYN<G HO1=[U-
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M9PSV.P_@WY'LH5QBQ2>6Y2MO/^9TM5V?)ZL^["PT]H@W:TPG@<F'BU(*Z-/
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M)#9JO#5A5&4U=@I]A"3*1?GI4W -8T'6TG"6$7<^9J'@P-VXC-BU ALAA7$
ME@4Z0.E0VGW0=+A3AN7#GJ_P2%G>$@[E8T?81,5:V!4+2_/SC8G:[D81<&^@
MFP+IGG3W0B10LG6['L*S00<!*5;J@=C5\N <9>Y'/AU7TR!F7G_U^\N$FNWH
M9@36@AS5\.(9&L-;HJ8(7HJZ8A8W/DOYM/<SBE.-NC)HI\%.8+5[&L*B7H\
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M'76TJLW-1^)(5?HER<65\Q5CV-TZN0_@<FYC)S.[#NF21:71)HK>JD,,H15
M)B=CX<,+G?UC :'SW=GA_L_GQ0*.HGZ9BAR?=4J[78:X:HBGZ''4T5GZ"A=0
MX._CY>Y3 ?<+5G@N*91=I0 W/!KJL.PD^ME%O7&I<TS0:P6[\C?)FF>'V?.
M< ;I^NG'U,NL6AU.#\UXT-/HY3J]#!=67K/I>,49\[8=[_,\^6N:4_X+/?#A
M_UOZ1->LG "H;[<9)#& ["ZC:64G UUC'7T&%N)-SP*3?M2(E+-:R[V0;UY
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M@ZESP3"21C";#E:%'9,->:R >0Z X,U)<U=T%\R2A3A[.EEOQ8846'TYRLJ
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MFNU0XT48%1QOY2/-BG)O3\&;^NZ?V^1QT[R-419D,+5!?6520XN@>D=N7B*
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MW22BVOP,>:'K:428;AM0#V-H?4%DZ&&R#P)SU))T%2B(U'H 3G<\!$8Q$+5
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M[&1()10".0P]S.QZ0D8.N5:7'#K+\Y+C?;*FV2GGZ#W+GJ6<D$ITJ-"3F,R
MCCU<X,M,Z_$^U&A@7CXAS:,0P"WO*@;Z;650[@AW$2RQ,R]PK^E](J9JTD*L
M:Y(B5R[2@6Y?9#)VNP9QP2NUK4>O1*6![_Y1N70L!/PJ.HS!?F 9@KO270C+
M+,U<F? <D,7KLW1)O_QO*@^_"IEN+=*7F5Z$="TB5Q]2XX:R0Z*SJS>J9Z1\
M2/C3$+"LZC<&_)FEI457O%=3R&S-C.?RG*V;@BW^&ISE(@<W0*&+=*W"=-AK
MS"-SP.S)0 B3@1T[ZB/:A>21Y*3V(,@"P0$;TU-2&FET>YPR>IE[YG(_@?J>
M?](?Q1JD>K.7 RF$^<N>3>P93+EYTQRF3&L_B]F>IB^?AS&/J>I#!O[!Y7.9
M/87^;*;4GA^45Q.K9IQ+Y*1([\BA8;UEU0W:APY@>._K#1!?3]\'AWE9?TI1
MK_CI=;AOJ<B1/[ Y-_;%KG$%W-N/>@BO'B& 6AC"QG'+I@FZ.]$]6L5'8<"S
M\_LS_>\F!Z&0ZN-NKSEOM7Z6%E0L=4F>Z-NXB.LY26F=KA?M5.@JT<FUN=PP
M;E6N]:&OQS6J327>$A'O2^-FHCR$"MS0P\RN)V15MURK6V_K+,]+CIL'NE[S
M\O\Q3N7S,C*!#A&Z I/AWS:'"WJ)93W4!PH-P,L'I'X2 JJEG<0@/ZL,P6W9
M+FZ'5N9%Z[L-S>[YF/3WC'TN'G2PU4IV\*N0G QDJ5U<1.M<Z*&MUFPPWDB0
M2B0DM.O[EEEU@@S_4J4N$31V9V;$E_(F[T2<Q525]'(Z*,6Z7)"(32?"P"@R
M"U3V#120J^WP_X7LG]=#R"# K^Y)!O_5I; ?:/0PK[ X<\&RB=?K-]L\26DN
M7]PBE>B6+%V)Z35+VQYRT2(Q;:A:!AJ[LD4\(<VC$, L[RH&^FVEE4M;N%>Z
M#.U@ 7?!MFF1/5<[S>I_]#>:U1__0_17!T7[#^HO)#X8B<B]$PP0#JS)<-<3
MBCZFB;@,I5P.EP=RIE+K)V:J'ZF+IH\W CQ]R1%XB?^95WL.?_[UEY]+((A/
M_G%-GVBZI>*$#AY3E_2:+FCR)&YURR]HH=B89:=4?R&HTDC$67P;\1M.ON)W
MA#\9:JW-1(UP>1!'*4Y:\D>$:P2S<\P2*&Q\-W99 S,@F&7O;R[NW=(OQ1MN
M[B\K\@VT0.QK:;FCW\Z);4I8UM.VY3&O]C3L^QU)PZZ9Z/:!$MZF)*-DN;\J
MDZU(UN9G4?(S:_,SI<6/(;-RB" 8+:7=:T/+G0$@+WL.9P+N'(ECX! #LM#4
M(91(J15T\D"!Z:CT,0FGPP3B"JBO;8"JO()RC%<,M+X&H?7% _3U[ !]C5GA
MG"S*D4N^]W>R7K//,?])15OXXVP;K_.R3?S?E\4#S;IMZY$ SV#]@V(8G$+H
MZ?[1JRFT)BGC )*'Z#W+>' @VW2QCO,\625\O'\7KX4=DC]06AR1N+P%_O^T
M]VW-C>/(FG\%T1$GNBO"-3M6Q3S,/BC"[:J:X]VJMK=<O1TGYHFF((NG*4)#
M4G9Y?OW!E3<1)"[)BRXO,]46,A,2O@0R$XE,T3"!&F=9$+,-14E#:\JA8IVA
MU1Y3DE %VC=!C@)JUN$?.QS*UJI/F DD<4S_$E&B*U21_AKE&U9;B.]6;-\B
M;.YS,P !M8@,@N/Z;N?/N]@(H:8YO<K#V*%P<QE8V:GUJAA5K !4LN+:IIBA
M]])@8'_D'&=F.LQ6 S46\>Q4T-..AID$H(D--Z&!%7'!%3'=ET=M7=O:#[R+
MMG4#:.;:=N@43*!M'XRT[>]"VQ+\'%"#;6!]^S"\OGWX:?D%9]G_%J;K^Q3'
M['N5)NS$MZ>S5:T/1Z):'\;RMV]3O(IX*?Z'X(TY@,V<!3=B S^ZC7BH[>10
MUJC^L5:\TRZAX3: WZNV%7;7+(2ZN,(S=FL[ &RR[W3#RGR+.>1CM)WHQ(^K
M1<.[G'JY@/K3ZTI>(4G(#=J=)#TS;#LX@J#@'M#!:Q=HYLP!F)=Z\8 @IVY:
ML0C_2^WI9P9A!^\*%,)37*6XW9>X78J,XA1.=;T!=(<QHXL*?IH%<EXS-M7:
M<&GI&WK?)=@Z>:/="HP>^H>*[]L'\4\>H7ZQ=A>(CA,UMPZ-[_@;CL<\2'/?
M@!U4%%S:4+_BYRA)V.,SN5V?/"C]0M(NH!PGN&P>0:Z!\E/B'4.&"A3+:/ G
M437I7/#H%\=UP>-H$5E>HCFC!M\W$7W[3AZ9U6=APO=P,##GM1R&4DF-P%'-
M_.XY..EI%\MAX[5BZ&E%:_MP;;*/& #-?$O1,#/:7CHG,H&:#>\^] B'5C"#
M@&Y!C;Z5FL,9G*T2.'@? VG!@%Y)A]21DG=Z9@"M"PO>J%M\>K;0=O!A!H+V
M%"%@->PA>.-CY"=X]8D: TEF96"ZL+4+(ANP'<$[[)W%5&%HTXGY.I=F<N81
MR&[+N"\,@)WX I5<Q$"F*V+Y369L]SJIFZ53;05U)Z>[5X*M5VXXY;GL$Z/&
MYXUG-,H.89VF7XQ^J.BM9(P4YXO"FF/NB#1VG-L(HZF,G\EO/*U1]+8]J[_U
M4&T<IQ?=- ?7$>DFJ./"W2'I'+7G2+.)Z J>.%++']N:VF=+LA0&[E2XR=?N
M,"[LEO1O^SA(&U51.GV":F(*2*9+1/V3/;\F"Q#]Y6+*\S5(5TPV=0G4%C>Q
M(^"*:^(/MOI&9,FHV&^<)C"R>L'8XHZ"(16+6M8B(J4"V#J;^I^<%LVFC,L$
M,-<8PR/BW-.T=9 (:,$Z2H=$^\(0[6<';8TM.2*T02W#KT&R7P=A3JT$*O1Q
MO]O%;[)8C2C8V= .X_'RYS$8[Z.GO>S!+3Q3B5IE-&/ R]L%S\\I?^>@:MJA
M9YS@E.LC4P"T+7EQK<PXMXG-*G.($)=5K.M=+VFA:89"!D<CC$%D+,H/A]3H
M^=K F!BI*F#-I*[O0)C3V#' H/.T58QD %HGQO+\H+<X;^AI[ Q@Z(':$K?D
M(^4?DQT[0*G,;SC#] ?<?,8X:S4FS GDCV!"X*-*_?S![0ECD5IM,N1@9E'<
MDO>KDAO7NE3R0VL\^=VM!6*(TYK6M:V?ME W4S'#PQ/&P#"7Y0E,:F)0T'UL
M@$Z-16SP3';ZP<"G,3/ T>=I:)@) ;0TS 5Z8G!QP:#&W@#'(*C%\9"271KA
M/$C?Z#]7^S#G\9168\-HK/SR/6-]E*B3-;AU82)-JSO]Q&8VQ:[DP_[-&(D;
MJ(F-"3-$$-N%JRM0)UFA.P;,!P4=C,U@),8=;M<\M;J DAPD0J\SV9Z!(:4Q
M#( PY6D.]/('M 2,9+DC:]&!+-F5X13AI3GS@> %>M)_B4*6&L/,"O(6Q'GG
M)8798/FE^P;[J$@W;_#3WDB<5DL,J,W.^Y@SXLD?+'S F463G_:&H"#62U=7
MGFZZ0GM,V ^+/)@CWTR.!^;HH2\'"9],#)M9#!@<6YJ#'PQ<0[11^TQ_BEN2
M\%9MV1]1OKG=9SG9TG/]MSV3>[]^Y'#-[M>2H@%<;S[U5FLN? !: ]F+!3\'
M?&?2US_(D3$_/1(^@B4"4NMARZPM\8MFE=9M*DT0\W:M\VC6YH%* @F0UCY$
M]BR;G8E<)S69PH"V@7.?PC"J4K:*4[<RD@-_;8<*'M0W*=3IL50C27O1&_U)
M.K'BP'2A<Y,-WY?.?1[#J ]UYTN]4&>*/&8N2J%W_"=6"M" P5WR0B)6&T \
MLOF.TVU#DSI&R)^E=82/WK8P!#?^]#*TRJ8C6:H/BO=G=#O8,J4*Y7J*'KOT
M>[,_1F(T_7_T\T/R7\G7Y./WY#_I_SW^S!Z5;(/\BC\NP3^"[8Z](O_YX?J_
M_O;U^L/'GZF6[EB> :_WNV&1A1U)>4"!M8FFO$F"T1L.4LHA>L%H2\&UH<<?
M%[^)Z%"<H%7P-G60H0M3Q P$=95L&5PHFY;1 !"%,;<ZF-N"\[J"3O5TF7UV
MM.NO,50< .!I7&BX IH-'1)L8;#0;%)'"P/-T>P  ]#C](\@30.Z.W\L'A7J
M7HL:C)1?K7.D#X([&(,?M_VRM)#N(]6TN&='Z*LDG?BX,UEK8K<H==AW$!7P
M[V4\()1@CD4#(:X@HL>D&H'*(3-J,@\((<T)"H ASQ.UASO@R6H@R15)BPJ2
M[K)L+UY^7R_^\K?_0(\XB>BN](A#2K5"OY$<;TB\HE,]&7!ISF4 <(&>T^:=
MW,U;M _6>WW,INH>W=)[VZ#?;%D]#UXH@8=KE7><(:H481PQM_9*%4I3GFRC
M%H*HWD9]V!RC7R@9^RAA3G.,R([=KK/[]/ M9'[SZR8*-_B%NM]1AF*2/./T
MG7"MGPE9<:D93E^X4?Q+68JAHRGZNXD-"9OVE$XMS$WZ20[:='R4;N(^;<+[
M^W_/N\<P((0TA@0 ACP-B?':8?OTN>YO8'TV2-)8#0!(\FS: =+J62&)Y$'L
MBJ3.QAS]K9G/!DF:-AP 2 )MM_&/?<!L78P;J4<-#/8-DU]2/\P'^SJNX#9G
MCR M[#OIEN6G,K?RK;CCW"<K+$Q'5HPK>"*I*/D5/*<8LZE.;.;U+CNQ6**Z
M(N@H"BWH9CD4GF#LNCX)3DBZKD&ID5AY CC16'%>0/&TW[I8 QIO?6*<X++H
MVGE. "X:4\T++L"EFGY$V_U6!!ONU[_OZ)=/<MGOMCS6&[BSI"K*-AE2^14N
M,1("?BS;R>VH8F+.AE_E; 4!"D2XB*S17M 4+<XKYNOLSW);8!'W56^60#%B
M4"F$8B%P)#Q#%8&R$@B!9%X02L#XIH"Q)$"2HE)X_N0AJJT0-1A&O:M%&4L"
MK1EE)14"J:RF0Y!MU-Y:V5I/'I3:VE&#@7*0MY[JH&,)I(_[A+S0X^]A$Z3;
M(,3[/ J#.+M+PLX7H"XL&N]"[5A O-FSD3C8&U*'2?2^\K/FR<VF6#W_4^34
MD%IA\1(BDUS0KL[FBE4@G\F#4R<,-I\*NF*B_?V@#;>#5X7V4YE"*6"?M[I(
M!U>'RE/8@E:H@:)&#TTUH S^,K-'LI/H0\^#VE$5PM."<Q5K9<Z]X/2)=!AT
M/I, 5PQ6K%QIP 7K.O-O$JQ[7E.ZBK6[O^QT77RF ([T#Y<CP!\3,U +T#O7
MAI\F';1*%ZK/)/T:Q3C+27+0?-:-N#U,W$L,&+CHD35TT-A,O&D<PX2;)H3<
M%CIFF8#;@OK8(LFF$-0$1BR T1D>Z>&CBY(8B1]7#P8)-AO*!=2 UM"SHJLV
M.V7P+TG/#-MF >GAP T;GC80.%R4VE X(,1Y'>*$I7KC]EO!,P.S62![.###
MMD=@/=/OU_(UR'WZ+7K>Y.IMB'A1\W&?TK5_P&E$5@WM<*16C1-LJ;WJA-L)
M S?5W.3K2X@[L&N4NE+/-5$D'DZM^'ANDNTXT=1M%1S!1?Q7O%%NW(Y167O<
M90(C8QRH+X.;8$ATLXX-C K=K]7[-W2?(DY9/(A3;P0%,1+49X=R76>'\6#N
MV_/!7B)D P@WZ9!@KSY[C8IGKSOZ>VV"C'G4VRUUI:G)$/[)WMJA;!/0W_/=
MV2%=US]B/*2#&FM%1"^[><IX':N&=N@'R!^@;8"/)A[R@SM4]+RUJJ0C698?
MH'^JCR8..W>L%3'[=>N@/AQ<X%;+!W[I ?=9O0#+]5^TW$^<  XTFYLU#D"W
MJ-](3G]JL?]1SY7^YW?R#2?XM9#=P)(Y@?R:)@0^N.[G#^X;&HO4 M^0PU*,
MD_Z=*(^7LZA.0CA*4D92AN"O6#EDPB^6>.7C'[M(1NEEF8 HB?*(%0-(!2G]
M)ZMS-;'C: $IXK3H=87KIRT4T%3,\/B%.:+-97DB][J KC3)6#C]-P%:/KK<
M]DX4>YI3'QQ\GE:!F1! *\%<H"<$%[:[YXD"46-V@ /1,TG'3(A52DY?^IFY
M2$\H?M!#D1W5] 2.$E:RY]2AJ$F> 8?BZ(DQTEUA32IYFVQJK0=)'KU@KXP9
M"ZX6J31&7(>^?368Q"3)-^;S\KJP-15CF:ZC'CFP'MN\G$E6<CZU7!X;Y;"Y
M.[9$IOV=LH$ J\MFXPG/1*?'2R2RF- 8VGR8>G3?GGI$6:J$4M$UFG)%%;9'
ME9<TL9YZ9#)-I*@CY#X9SF3DI"B+68VAKHM278OS5AR<,S'3CT#[/%*O)M(^
M3R\6<": U?. 9S6&]GTHM:_;[KVHI".LCD8E0;UY461<UAAG)<9U5_/] ^4/
MV#709RO1\X6SHOME:'6]CW394LY]/I>X!JM+[-:AKDYZHD)#>OD.!QY PZY?
MD"."J/FE;0MP@CC26$K>.(+M"_"*XQ?\0*(D_TRWZ4/)'_?X_^P3_(%2+O[6
M6E/%AX7J).#$PJO.L8-$\/"EQR3TI9%=>2YOT H_Y8CGTCV+&/TF>&%)ND%2
MI!GP1G^BM0#*-T&U;4&*GO ;X8WW]"T*HK6DGKJQ@ ]H"1"(&B6;';B5M9R=
MIS*%%@%U-?"0#JX_K \")T6<%C'BJ_:3CO4#82S0A[]>(<9E)J_P)]4)76^%
M*93"MQN#HUC(-@T>4P!7C87&<Z##+_#OKLTR"?Q!#<S/49KE-ZM5Q(R@(+Y?
MKS%+SV^U)(W&RA^H9ZR/_G:R!C<"3:1I5;*?F-\WK]DP%!3C$)$#519I3(+Y
MW!6;P8#8KE9=LSK)"A4R8#XHTF ,)2,Q[ABCI@\?@\I!2(V:R=X.#"F-L0*$
M*4_SHY<_H)UA),L=6;V6PWMT9LC3V E R ,]^>F2D61E>/2;#2[B\]V#_<*L
M7;S!3W\C<1WQUEYJ?OYG?-S1& "&8"#62]:,Q';15:*Q_>R'11S4S9")' ^L
M\1LB#K3Y;L?@T-+>%@%AR_O6J$\ Z,V1B3 /A!G8 ^>'0.T]$Q "08V"C_@I
MOTNR/.7'8BGV5Y*FY)7*O0UV01CE;PTP6]/)'\."SD?-C,6 &Q"VDK7:9\=(
M];:FY@._-<HW08Y":D,\8?3$*:AR1DEA<C"\J3NDA.GLQ":&/9Z(SU+75=.8
M1:&EED)'@S*,96(M$@;$U%YAXU%)4#TV"A*D:,X"L1I[9F#(>EHY5K( #1YK
MN3# I690!:A/!5##<P*JQNP9&*C =R/T1,1?HA>\NJ-'?/(</<7X)LMPSGHP
MJ\[,X@\'5R7VI,7-B0VI7R327-( ]RK6PCL"E9:\E'D4K'.6RKPE:1[]NZC;
M$?"!5PC_"./]BFGN.DJ")&3&D?B,/_5[)F3U&L7Q%8J#\$\V;+=YRUC1>/4*
M,)3MC@+&@,X0Q=%:=#TO,ZP3JJG[-&6GF^0=LAI:T3JB%EJ0B?[HD]_X.*"9
M>**L&4$UYU()J-J*'E.=H"Z/[*6"*1*_6F(D[SD-*HG0C50BUM&>(9Y3RK^>
M$9JU5U$CP-G[HLI.'.B]E;UH,%!3\ZV"8W48)!+'?#^6?STC'&LOMD; L><+
M,5MQ@,_ 7$2#X?C#3\OO;':L\,D%S>U+/ &:01]7W>ZSG&QQ>I_@UGM;[>>J
MP/SAYUYEAYOLP-T&G01][>!6@N6GA')]^SE#F!KJ3W&4;:CYDN*8"\XVT2X3
MIGO$#'+)@J[Y)B7[YPVB..;O/:8.D^J7EYBL2*/F;W-H6=6WG0DX4H!*K>M8
MVV&$E4N7?T?T@YE<3SFNN*Z@N=V2^Q8E;^,)679<Q]]NX5GXCOXM$E_D5YP^
MX[GTIW1<?5V1;[O5A^VJ0K:4/PNI?/JQBTDD=OQ:0[Z[9!6]1"1M/]A<Z=7!
M9T_O!7U;<? 'I^,,]+KCQ)#G.X4%*:N86]!66H7SLU>13WW(.D.-0*Q^0V=M
M694Z[3:)T5$/9 2XBH;%.S,B2K!7"9N-8!7M7$Z::4"OLU/&1;VOG>,B$[3-
MM_,,8-'/(VD76.L-L'%A[1E'<Y()V-';63XLJ#]<MG0W!$R*?=BH6_\,5#=Q
M5^>EG=[<>6G2#ZSX=7%3."^M,_#1_!:&-LY+)LGG[[QHH&:A]/K5M];Y.BL;
MG6^;Q.BH'\UY:1<-BW<CYX61(D5[/"?=$*!W=UX@43^\\W(H$S*(ZRH?%OOL
M*<L%U%ZN"R2H86//,KI]RWYL=I'')]!>E-)H;.,R53,6XNJDE37\U5FGF-[;
ME [J\DJM-F@VU07-EKMYV=*_*NT7+ZUT!Y<P7=P'Q=0 5W.=LMR!M3@W8/7<
MZ'D""[;?Y9YMXO=K)37[]"/$F*55?\?) ST)Z!2^4P[9AL2K9AZ]&['J@VE)
M[-5,RTH6N(/L)%[?8\N>V_(;WM$_L(K3HL D9\$2W%7V#$NG%TSX@.N__@=+
MIQ$\IFZ'Z88RXKWVC:Y<5GS*#ET.XL>%.E K32>Y@"!G+38%K._7Q5:;H8(.
M44(D*5%)>F;8UK7A' O<ONTYK05"MNIT$@X(\44!\<K.G56V[MJV?6[0UC7V
M' O:H';9'[R2=)[=9=F>I2Y3:S#!(3,PF O^A;!II%OV^K*A)O:$\N>R(?11
M87,YX':8M6BM[EIRXE<3Y:O"5TF-(D[.2CV$!0-Q0<'J?+_G]<)%7?$,[8*4
M$P?\46*0;1#U")(LX$03FV@.H"-><*BKN#F/0KUMQ8Z'>!ASS%XF$-:I&:8(
MT%T![]L&O+\4\&9T9P)>C>TU.'H];2X[88#VEKU@( PO*A@VW:+/!,,:(VMP
M#(,:5W=)F.(@PQ^Q^'\J/-A%.;_SP,DJRO=4'^B@>+]B,[L)0W9R9P_!&^O4
M=9.LZ%]2.FD^/#OH93T4>_F3P[/WV1V@9P-N] TT0>U6,XB\I>**?EE)ON_8
MGK3>,W:(FX-DGZ]C\LH4;!>\\0;8.[IJ&SHV8X;C.OK!BU:(]Y&LY-@F>,&(
MA+S"Q=11OL&4AHP U/IF""VIV#*'^0ISTWX8 WBHF8VJ]]=5Q?]857S)&U69
M(\6=#5#\D13 'Y1+$4C)N*B\.SJ/6.<]'8(AIF3F-OQ=*'V"GX,<K[2.PU 3
M'%7W6; 7YXWS/I1JCZMJ'U74/E!JOZNH?2#5'E_4WAN?1ZSV _M0JOCQ+<ER
M4._)E['6;W)G#+M]NLYC!%_)<VH6.Z:7)$?_:(6I3%8)O>CH$#+IQ^ =>2N%
M?K>$@&/?-NDJHV.#])OV?#1Z*/_'=TXCZ;+>YREZ$7"VQ^_MS%2%C3V<F>DP
MN%?C,QG :Q#XB8VDR=*#B90V1TGSG#UZSV6F*FSLK<Q,A0=);;Y)DGT0?R-O
M09R_4?', LZ^X1!'+VPFFIQF0ZI&,G,O%43R6X^0P=*7S>3VYKN9L*GDN05\
M.$K%>+8[< *4%A3HZ8TG+6->-9 ;]NP_]W3+H?2L1F :/6]D7?!=2G8XI<,H
M49"("ILLM>9M)EG.IKAKYLE9@*(]/ZZ'P4%BG)' D> .F\)L*! "Z-=5I(OQ
M2!(@18%*DI.':$]Z\@ 8!4I(-I T0":RH50(I"[L]N231VI/MO$ 2 5^9;O=
MLW*Z+UC*U!I$!B.+%[8=(_W>0FH9PQ<SZ975\1"RFW19#D#9?JNZQX9!FKXQ
MGT@D"/-<#:59%2,GR!3!4Q#S[B79!E/W:A7D>.HR)@80(79KV7PYJ26JO)OL
M83P@ J'>=_<*<<7>=0U\RL*8BV$!B!_MFVYO 'F_Y^[D#OJ:NU>2*XRH$?#M
M8&<Z&>QHGVU[8\>WME\W=ZLJ?KW%*?MEN:+GPT_+F^?GE"=OM)QP)X,C74T]
M?QR!ULG[&B71=K^M69Y:*]!LL/S"?8-]=*&;-[@Y:"1.JQ &U$LYINE3G5AX
MRQ _Q'J5ZSK635>HF0G[84$*8S&:R?& YW6)ST9T:BZV(SBP-!8D&+(\[<A^
M 8"FI)DP#WPM#/:_$\.7QLH$P]<@S]"_1,%3%-/C1U.(K7=<XY%YRSB()XH'
M;.$?U&I%]+X]U%"63PV+ ;.IB]6_K,U7A-TKT/YH\(#FX(V@CNM@F!G@%:M6
MCAMPJF]43PPN/6],'>$"NB\^YB3\4[Q<_;AGV0X/.(W(ZG$34,C):7SZP0II
M9DWPN9#*'\*.U$<Y;"2!^UP.PK4Z9,VK<LN5X%>4,7KU"'R_(XEPQ21%K9C'
MBO/GG^^XD(E=+B>@$4\ U%76ADNAQ?:BQT0ZC#7A(A4,X]3FX"2J/H<@0H+J
M"@FZ*[7?(D5Z1FC6&"RCP-G3K+$5!]K9R$4X&*P7HB ^W:(?#S9MN4D7&W>&
M?HD2E'%6[\X(V!K3:A1@P^8OQ$&6W:^EF/OT&PN!*OM/25TU4QFLB%16@R&1
MUP6/D0SX7 <;L?I;'W,NO Y:I?@LHZS84(BD(I9=Z.G4-I0E8HCS>C:NBHSH
MRULC"W'CP!0H(<)*'@! 69J$PN0?)28Y06$0985%M#IQ<.J2*89"IV^*A;$@
MR&P+*Z$ &*5F3G$45]W/V1@T@\-2EZ<Q%"RA6VOO]A12O^'\E:1_?OK7/MJQ
M0_HF63V2=4Z7$^NZTMG1E=WH3.D\&Q.9B8$W8BPE=W4BLF"TO!&%M%XW4;A!
M]#.4XIA5)6$ "R6K*Y0(9@@K;OR6/I/\IK9NK#%%?);[H$>1&8MJ;R(;H:/!
M&:RMG)U(&""+-G(2K9("?:JA51'-I]76&*C5]XL;$K;^_>',9<'VA;.3"P/>
MQ06\/4L[*GA!#:6O]#!-HR N>L]EFMR#_H$J+;%CH%=*CI8O8*97KPQ]%DX/
MZ5(-*/N&SN=*V6!QB=TR--)NM$1ERDT?7\!KY?UN%W,9%7'ZUM_J1MF.2ETF
MFU)YW4:8"8&_0K:2J[^"L&##8YM9A<"T%[7B-?5UL26*B/L2-RX?S!B4]PXV
M D<"+]"ML)U "-BRN^ J9F_:L3D3ZVD$C.JN?H<#J>^%K[DD0(/?4BH$5!<7
MJ&J6<S2HPN;0M<G5V/A&8[L,&QA+OY/UP.> L;UO0*U3I+E8_6;+W:DR!K9_
M)UVW>@SF =R2)(^29RKBL C$74)-S,^\HNG!Y8 557$U8$CE%Y$R$C+ M8"-
MW(YPE#F;Y0/)Z0AF[P>K5<1F1O\IBZ-4'_3MDQ46C_A*5Z"SO .B@C+,;QD$
ME7I%R]0%!<D;\S6>HD3X%Y3/+\$[EH2Z)NF6\Z+'(GZA8MX_!>P.;!O%.,M)
M@LO2+2Q6]LO3.Y31;TNGN(J>HYRQ8'T.@V?U7C=BK402=JM!OP]EN,<(!VE"
M63Z]E2<P'9$%L>@Z\KA_(C^8)": C:7\68'=E.R?-_S;L#PM,<EU[7=+28@S
M5@XPYS^?>.-(M9+7S"#;'?W:D]^?V*D=<=>)9AS/B$$EBF<A<"1MA[HUL1((
MH>?\QD2-;JU'%XDL<5%\^N0AJKTH&0RCWI<DQI) KTBLI$(@=7%!:OMJCH94
M4(>IE/(@SL8'?C3RQ)5F%P6CL?)GZ!GKHVJ=K,%M/A-I6KWJ)U[>B Z^%?WA
M3=9:#972Q@M)3'\2DC:#OS,NZ&6&'F*[R'6UZR0KE,V ^:  A3%3C,2X0Y.:
M).68*R1'(3%,I*].7#H;&%$:FP,(4I[V12]_0*O"2)8[L!9U8+5N=2<%+(V)
M  0L4'.@J*6E+=K4,4)^O=81/MAO80A^S.ME:(&N(ZD4) L.#O>C/L*[UIZ8
M+59=!5H&%\#7,AH 2C '<@=S6Q!=5U$TE[)('LNO.5L=UM_S'-5P!3P].R38
MHF!1*VXH8Z-IY>S4Q%R+N.K1XD5S9#K@9: *UW4O_?!5:._ @_K6AP-ARGLV
M^<+?BO2),JCMV4I9+2\L3U)Z,C9"3NPUML69BI.5^F>*=R1E09=YE-8P@,QA
MK="NQ=55"FW2M!0*;6<['!ZA:UWK9#@BL5[INM%#8_(7FU"XZ2US[0@<L"+7
M;<P'J7&M$^0(G]HQ?K!]G0AZ>@M=.Z('^J&DS)[]5$F>[4L4LJ0J'TF:47F^
MS3$1 OJBS$9@UY,<<S[+<C2J#I]AEI$M5HC'0AZ\PS'A4'V%8R%Q))#"/A^S
MD0J!U,4%J>VK.1I288.A^YQLJ:SP&T[P:Q"+6D3WZT)R,S1J.EX%2OO'>X4Z
M^MC#!U$-)>KC($8,EN+/_*)4/)6OI[U%S+BB]-3&"!3#((ZGSNPRAP=Q6<%&
MI*2/M(R;F D9'(E ,5A347X89/%9-0[)@;+8(>^ZJ,:>).)TP5Q8R/D&>DUD
M0(9]3>7Y 6]1!5XJ@;<K@!><-/!T46%8X(':$%^BD'6B+@1\Q^FV =>N(?*+
MM@_Q48\VCN#V0(<0K19H:9;RD\I!3S5R.X_@;><:$L/?O([JMM$%D/6LA@ %
MS-'<Q=T:#M<E'DHU9Q\>,0XTYZH3$#Q/3QU;P .S2X0U'!:Z[>&(X: Y[9S@
M,.B9QMYU/NX3\D*/@8=-D&Z#$.^YSY7=):$FJ.K'1',NFC*!5 TSF<-MHW;R
MC37+AFW+5LR?3RMZU&!PA2B+O\PF$N8)19T>.P"C6]/-&&KW JOY3*,A QXO
M=I,80$T6%S6!0L=,U 3T4/U]1W_EXO6/)JVH>Y#\672#?%2ZG2>XP]@I1JN3
M'53J>4TU;X@N_!,NLX?FUF*G9XV)\8K4M:1]?*$%7>R& 0Z,-=3-WP$RU)J1
M'ZI$GYGD^7CC0F-E. ,#MD9%D03R5>6T'CZ$;.9EV- <Y%MVTL D+'6(&# +
MLU^J01Y3'Q.CW$SK%P_'D)UI@K7#E"E#*.B2ISK(6_*H>H6- F_HI$X#<?[
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M2M1HYI)A!QQ+3A:GRRR:BXR$6G<CR0>VPQM(@W3$L98+ UXKT^B<P.MN%/F
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MAF*&QQ_0HR!C69[(NS:%WHDB3_<8"!IZGA:5F1! B\E<H"< %V<.0(TQ @Y
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MK[=\?>P!GY&:BM(_XC/CL%3C9!LY-1*QH;-IFF4.!.*T5HTG?'VTY0L^0RF
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M5GG1HLA!'.-GO#JR9>Z)Z/8N<W&&5+_W%_HO^D?U)_H_K#K>\G\ 4$L#!!0
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M<9* -7:*"^;>X -9DHP_'TNM I^<5X%:A2M&[A'9M-#='O4 BXP]^X6@?2/
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M?,*(IY[)<<YU6TKU75\U"L>8&RH]Y@6?D'<0&([9VJEY#WT/4'"%A%OH7O8
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M"O$)Q1N/(. *C^89";@*R7G^!AGEE_X_/8MZ">+*F!+>HI#8./KA+%GV?^A
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M%UC=XED"$*R 71=F.VC$L!JO_1DNHD#GN 2SQ\MTYQD6/6?;5&IGU8U=Y]B
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MES<-U1KQJMYP&GE7"@?"_+3Z.!P*?DY@6+V<4]V<0[GIG9IIXED/ =U7SA"
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MAR#FJ L(=K]TBF#=5A(51A7T0X)VCOJ8AY<LVT7$<*>+*= >UEJ6/&S^QL]
MVP<,\L8'460!XHXT!PB=R88".?_W]*(@8^LR^KT)&^Q_/WP_F?:5\:7;5],E
MYD"]_1(ET:;8L'<BK&_-KJ/_S5Z@A2%3+.[Z($*R1U#N&/H-_9HB7X(W_F"R
MOK5;R#>G!U/0=?%@]AMZ?%XPLG%89$X80FG6U5ZCXU])>8N#VO+9P>+OY40.
MDS><6Q%0<'&X\\:!&Q)-.+L;S2Z+91'?LBU<Q'V<3:/M_KJ(2EMS>[[KY 53
MA_DNV%7O)*:; 5L"B+KS3 B;!\\:PX AC(X.HN&$J&E@$O#\0(0KA-M1@4 (
MJ&PZW%HM#ZBM6@JL3]0Q,25_5R067[R*?R!8@::Y4/W/J*K!JOT9T;5Q=3]?
M:Z"!G1K1_ 8L_2#W\J:;2*9(S9E]J2DWE'<Y%08M=D(=N';*R*[HCO3E6Q@7
MRRA9TR$G_UL^!F_R;!HH!GX>C1R#:U,5F#JC*!K0?)5DR\A)'MUVFVDWU::L
MNJ64XO<WS .-:BCNS=6"'7+DAM\7=#HM3R'C2S?S3DS"S_>WQ-QS.#YEZ9Z2
M'+7//MHG[GY%>)T&V^<H#&+&<:$4KKUCQX4[+%]H/>P%,^=1"M?PQ8?3Y"MK
M&,M0^/T:OWPH*[FFNXJW^A]#UNJ??__Z,.!C_T/=8?J#M05#+E7,Z')_)>#B
MH,:?MO5W,W>+DZ_L7"+&E^;UE.X7MP>6SX3""/>0^.N;RNTFAANA@?AXJ,L[
MN7R41[>?&CGZT,5*S<,78/77%+W;X\W]()[1ARH:3Y2&)BZ)UYXF0=S>X>&X
MO%-0U +20W&*QWD3CYND(S,$Z73Z<XK<"2-W!LR >CA/C^C1#8BC,3X/'55_
M8WR^/7$BY+[\B7Q:Y,\H'83_3G&^4YSO= W@= W H-'WZAK *7/<??]KKLSQ
M4VC%G]!*_2A=ME_E^>X$"+8IF">&=8C?7U.<#<=7 L7EL8:R_4JB9(0PE,&^
M(1 B+TOV\9#Z:Q>&KGW)T'F1T@$8Z P$M'FU6PCJOO8HL*JH0F+,_N:!G\4Q
M?J6E@*]P>H&+IWQ5Q&-A#*V04J/&* $;N:]E6NRKFBP@#8U\L%\JS4OHJE_#
M&JV*.^IERPO=NI//:1'$F2!&(5WS=!%RET=UA!YHJ6FQ35YTU>EKE.V86;OA
M:@L7K.>*-IL&051#HU9]CO,@-JX8OQ8!+?F,T*"6U?"X5P+6'.ERP=S7!R"+
MBLK QZI?$=Z[>U$J&UWUXT )=OW-DB,US$_'?Z?CO_=P_'?^3".?V772W41\
M#I:T8/[I_,_V7OH>Q_$*IZ]!NAQ(1;N]T@Z[U]YQ6;V/N(/VL!N*1:C2UXA/
M:-C7;?7^3QZDN>VB''<I?HDR(BP&LP,5A8#NRW@*0/U41P7V#2BAF-JQ!V5_
M2Z,<+5:KT1F17FLE<]EI[:>B3A/2P0QHIP.&;_XZI\Y:6OS[I]-J+Q?*X==[
MC4++U7I_F;!CMD[O8J<Z[KI;6PVZQ[C??2@VFR#=+59G(6D6Y3MZJ: L_WV/
MRC>_F0</IYVP^4,]O9,[O>,YORR$EB2T[0*4FN7=F8:RM2Y_/;4?<3G1%11/
M@@&@A%P,1Z*0, G-H9Q<ROI[N7F>]A Q<4ZZ%N54$G?!KGPG5D$[^8T!BLEJ
M?"0Z*97+'.K((NIMPHW>VCS>8+W?U5FRKYIO?3:^FSKE=SF;WS6;]NJFZ1A7
MZ[G2>@Z^T'=X:L#J4N3-%[2\?-O2)^XTK2\8K9KF ] >G_ZKRG+F60#HCLG$
M)J<"-KU7T!>K+\&_<-H6&CC%96:M^BYXTGY?[EW^[CT/R!W6/N\^HR1\W@3I
M'XPKRU!P'KLC<(<8;SK&K%4(!><R/@2WQG@=X2VG')E>S/O30IBF*B,;QN93
M!; 1PC#^1J\2"+&71<K86#U_6F6\,#-51@;&=;6\4AP@E^JZPT<\1PS/JG0Y
M*P96-K(R*?<)U4]62 CX6R5 XG\PQ2M<O"7B;5.SY6B=N2\,?)*RZU<SG" ^
M0/LXY1C@H"S<!ALTV" PO1HI7%, EP]G\JWX#<$;1D%,]G(QCNI9LTY16?F3
MGDY?)\OH)<(IY^EXS?:MSZ;<WMIDEP\<GBZ0O@'@DJQL@#*I>>[%S*R #T6"
M"1.)K@*RV\,5<-C>>P44"L2L @Y)N78XVC"U2-@>-O=[HS[C[XZKAX0AE>$?
MH_+\W3>!DX'A"W=?A&.<9;5W/JYC]H:E7AS4_V4A\C>)?L3G#:=FEAR0%PN[
MF50G2V(]>]1X3R1#8 =6E0/KSCC=D>6/JNL:?92-% .4-U8]4'NS&31@K"TN
MG]7!]!918.YR>YBMQ?@XL^&VH(O@8M6:I<NW$"%:)/P1)77/'PF&[!G'R^',
MUFO<;!45&[NO4Y/$H:AEJK2.+3@X7D.PFKF6+-HWO0=LQ7CGF--.>4#@%5P[
M$GCS/E]@!!T%ZR9*\)#[>47E2T F"]FUMSOUC!DT,I[=P*#+]A7E@&W0EP]H
M[[ W?$;+(B;[NW,<$XXP59L7=):FM-9%U<MD>4M4BO.9*&.2$1[(6&>LK(?Y
M"#3'S#,0L#8<CX3 8M7I'.-T00C3E#YCP]@[(QZ-1L > /;1L5[KYD19M?7I
MQ,+*!5[-039^CJ'8D8.?;LRS(7PHMMNX[&UGA9(JJ&*KQF1#6_FHC'HBF:R"
M8+*>[PC%JQ^>NECTQX%)K,S&427B;Z!\1@<.PYR9_IB8[T]9$Y7=#[\24^Y/
M[PC-DN[SQG]'B/6MW>^].?V.D*#KC"=S.N\(]1OZ:]G&T^*=OR,TKZGG6:%#
MF/<.;9]/7B<+9!3 ;3>:YE&W>U"3J ^V-^>=#*NU@NW#YZ@L<Q.%]+I;2^,1
MI9L!+R*0NN-L$(M'%FK2QR FAZ<7(!K4JK!QN[:S/RMRO"%,A/<H0:]!?%=>
M82?.;M/M8;0-"M_$U^3P/BF,*OO:V@,@Y%H&XBTFW4551Z]P2O[YB,O>\W0)
MWJ#)#@ T\$F;E 6@K4X02IZG/,[BI<CCQ\!, G-] X24Y\U",!Y(YGA3(%A1
MT'@.S^F\V!1Q.4Y-=:+JK'U_9MUF"<H VQ1!/J"]S1Y(]EB!S<%&3H2_RJ[A
MX_7\2FR3K#&,;@U^'I0W\$$9."PH#OT>BXW=.'=#F.01,<M)WM='&D.X3AZ?
MT561%RFCJH-*JWT:+:R5^QJA)P!56P$E,H>',VGS53^1T\G7&FZW^!#-!HL%
MX;YBR!E35 (F0OU2;O,,^+YO=RD.49;=D0XG^7VT?AX5K 3!MHN$$-9]=5!A
M5GDY$:)VK?99?8!RMJ$%'1:KL44CV[<ZM'2%RHS/AX)P&R345_H2Q2C+<3)R
M+@QC[1]B3<?JOH+.(T!%53;6"<]?;YQKJZ^RXYQW@R_IB;^O%<Y[BCCC2=4A
M#B+-=M_?.Q. K'E\@.3QX?5G7J?*"3M#9X[E3L;P)*Q;3N'N.4@W08B*/ KG
M>!_D=%/C=%/C=%/C=%/#:+J$P(!=)R&3]RDH..D6,!0^9LD;$-;DE'F]/GA^
MZ_>4/W]4VZ%3_KS!3.^[%"^+,%^D#RA](<:!L:2+0/;O#S- ;#!2AH>J3F3,
M\HY2N#Y++#A[9ZQX%\3YCGV-@/6M":3WOUFS"W+98S$C_6G-15<&R/MH_#6F
MPNF'X0K-E%T/:_T.-@^;OR*<=ST"V,=#+$?L;CB3^G^ZS67O-E>4\&]SL;XU
M,:'^-^=N<PFZ+K[-U6_HKUT;3XO3;:YW<YO+U G(Z3:7I[>YU&(YG .":4BT
M8GAS)##720/[G('^H'&N:BBV:G:&T%;6S.#$0<6ZDND;0KU>E*XLE+IK%P'>
M21[]=/W23+#75RE YKTS5\Z^;HF8V[1?C@:)@6KI\8 \UAP0WZ:TAD?,A@LF
M-3EM*MPX@XYK?0!M1H9(V,9CS=*1BGGS)*3M6N;W*:W7+Q4_1+ZO_B0PG0A\
M^.SW=WJ5;KIB@N[8Z6O6Z/*=1H[XC"MW?58%6*^YD*-5F@'IL7[ )6!^1690
MK+7H9W?>:7ND!=*)15SDSRCM%TH?9NC)(9L\/1&DQ\H$EX I91)2K)7I+ZXX
M=5=1$N7HANYTK@GOR3HB73W+,I279?=K+JH?!KJET[06M5I3C[5O@HQ,J:-:
M%VK]_*NGV7]S7:LR$CF?][Z5;A<]S_<\W<8Z]&TLC8"$[:/BTVVLH[J-M2](
MB&E)PB@A$.=Q0"W>?Z+-EAJ[TRVLTRVLTRVLTRTLMVYA,0W7S5EMN$HOC<VP
M:KNVL@ZXG8^7K'3%,OEFE0)AS]WKTW6JH]K/G*Y3G;(=NR<(CF8[ NPKQ_O6
M: E?*QWPS[T[+M09$.@9H0)NYL'@0>T,+YFU?47]@?27&,5A3L@PC14*WR2P
MRN%]TPU5$4Q2&@ QUU(*3XDZ'BCQ(;)S%%7==$K.J0Q__Q!)WS>9]^1(J5^>
M[V=/QT6'/B[RL,+CZ;C(X^.B*V*_$OJNR'5"Q%.4K%\%4?K/("[0%Q1D15K)
M0_^(R,Q6KNW4192%,:;]XITI04";U!HAJ+WX2!QDV6+U6QFWRQ=I6;N:=3XD
M!VQB%P) :VQ>H*=\KW>,PQH^0,T6"\ 1=FZ##6*6V9&!,5GK@AE,C7Q%\0NZ
MPU&27Q&S\("2"*</*"33@%B_'&47!?I'D: ?2<M//S$/6Z:@:([;M%!86^^D
MXX>-2*6_GO&(EN%A+6*>NZ8"TX#!<TPDX^8TA8_*WV,3P+(Q$J+T[(./="Q&
M[P\P6+QRCR1 P**%>I9C@YH$V80$3U$<Y3N..R6%JWLN@'-D2;Y.B.DB'O ]
MV1P\$+5%RWV\4KA(0QHREVUQ0VOS7SZDH^FO((*^6>#2&EL%,8TC,[?,H!=T
MK@$L;R]H)<![9&(=1YE4K*_*BB9#[&]$![2!YHE6'IL1H><*UNLHRW7R0G#A
M-"KO-=D.I32]V>WESUGZ 9#U" LAK2W_;:_N@]<F(CCTSH0P0^[Z,-8F*&1<
M,(RU_M04(*8SDX/0H02!MH=W0?A'E*R;7OZ:XHP[\B+8H0:P8;W1! "K>AK!
M1FSML-^P_:#7 K-GM/P5XR57C9A 0_T9 'FC."+F]#1F@-'?VHTM1^,;Y:Q/
M0XVP>V=<50]D-\&AH]^]WZU3M ?G07QCT:6[2_$6I60CE2PO_RRB;1D<M._;
M-=VZBXGKW.T;Q\,#P^]K_\O@';B-Q>VE^(X5K-GHYI2LF36!<#OV>4=3RMD/
M6D!;R!2BV\(]"="^\1[!@+:02:#;PIH$O@3$Z"<H[1DJ=KUS.62;ABB M/D:
M!'CDL J[H^<A9&2J]$ !>G\//JZ*-(ERNJ@GRZOHC?Z-?>M0#MBD8 @ ?=$E
M,+-:JB3"[LPC%LJ:=(."##WC>'F]V:;XI<HR8C^E)X=LJFV+('U1)CB[6MHD
M1.]2]5:\V18Y2HE3_8K3/_:.9K)\P*O\E8B;J2W*[=K;7>!VOFB2KBBT]$J!
MF+5:K:9N+Y8GEF7VYW5"Q+,F\F*;+@AHJW\B4']4#LRPII:)\.M7-[5]Y*:R
M\<(ZNQ2@M/?DZH>SY&3\/4!6WOF+),_=(?/N(HAI"L7?I>7,7N+TC-GI&;-W
M\8S9W(-972SDQ&@8W_J70YT=3$'7Q8/9;^AO6LW8QIW>I%->?WD+A?XJV\'H
M;S2%R^8-)RD9WD 6YKZ9E)P\,_NT:*_BR1>CB4P$O2;N">%KAE9%?!.MAD=?
M"BUD(NBV<&\7Q1I3D3//Y1^XC>K0$SKR73K67FR;6?M8J5<P8)G.V4Z^,J9N
M\C2LR9IV' E99V%8/3Z!EA>(]#^,2OF0O\>H'/!D>;;!:1[]N_R=*XV!.II&
MVQ3),H;6&Q6?29)ZD\%<9S3.17ZIIDV"UI2^[8DC$IF"8Z3@$'FDM H<&[;*
MQK/@7)+V>"<AD37HLI.<G$SB\Y;G<6%27R<AWE17Z.@_Y24S#&"2F00()HOW
M1/?+PT TK$_M7<_N)_<FH,+@82&CP!DHIU?=^>S2T9^"HO?"7)"^FOE3GFA&
MK2*$NK^!5Z/G?+SXV S'?#>CRZ2F$G-<F!_B*F%*N=C N< N 2:CY.>5T_+2
M+%X56?UZ&6&LS/Q:/,71NB1AO:17V1^>1\+^V,WSF^8W<++.;@MZJ+)8+8A*
M$"DEZXK4H',2J+J77"A[3_2QA8JA'/7G61\;G51<+)X[VC>(S"%4,G.!LC"-
MME0"K,LD ,A6AP60IYR,4TZ&H\?XIYR,4T[&*2?C:',R( L8. U#@(R=>6'?
M'*@?22W_561Y>8OB"J>WZ/4L#&E)>.+]D)U%0OX:UA6%QRNL5MOF<$FMK>U'
M^9:X''MV#5$!2/])O@&(S7/(6M8/>9 L@W29?=TN@QQ]^N'CSS]\8C]+I])F
M?X((:6/[P3/VR&$]GOLFA$6A/MN#8/;7$.O9!@R:37T1*U'JO$<VH."OJ(%K
MWA1KK;0N*A+R-VN1+8=1A%6XM^;%8Z70=F^^GN.,EYG(_=Z-?O6_6Q[!?KSG
M'M&+0<V_Z",IS(&$-NJ-I[R1W> :<]BP)LN,<%L7?W6;%X;7\P!<G\'?$ UN
MH^79"_EU79:1I.:1EHVM"\8.%$ZW>3T.ZLW=5,*)8@"HHSH%?Q>OP:2CK"Y6
M7^OS%J$"<F"9VC:"]4&UQ PJZ]$(W1Q/IEG3',J[4%VZ $P=J0!\4 P&*\K:
M4.'03YJS;3?^&:01]?1Y@\_]7@N,\=W-H9<Q AAY!@K#=_RM3?OFP4CAU!\"
M,:?_'LA-/0"QI&P&]GAJC?CI6 (/XQTMEF\*(0&&FVXN& .AOT'XOFHTKQQ$
M*&NTY*+@U3C7:<J<AK*F3NW1VX<@]N_6TDWCDF9O7!$_/8C_"P7C0EQ3$0GV
M\E!$UB:KEJ)PMOY:4NM/<97N\"(%T&YX'CT L4[$=8O>\NHQM2\XR9_9\4=]
M-"K*ST1SG*HOE]@!%)_9"<\O2T(9IW/\\15K:ON@M:*2MZV/5K?9\CF,2K>T
M/0^8*/%+"+.S,C7:ZVASU?ZX]9DAHP-J=$7=WPB0"K-7N-!RPQG--92Y:G[4
MNLR0T.%4N2+N;TA+B=?H98I=[C;7T>2R^7%K\EA"!]3DDKCA4)R#FGRV(A[1
M1'5FXE#4Z0&.HU5LD:P.H]V#'M0J_O/QJKBF5FLJ\A'KKA5U;37T+R;KB;BB
MIE^399U%@I:7;R$!/=O0?ZGHK P'1('Y.(Y+FX&RFE&U^3VH]?ROWA9EXG ,
M.J#:#4: "^6=/L+XG:9Q7!JU3OUB,E#FYH'RA'-/Y;-F-5K^WB8$7B102V17
MNCH@1>UO(9&2*6;Q OBE>UD! R$F0WKI;"&0\R ./[6]--^3:X(H64=$EE5/
M:"FV9+G(GU%:_6"[( E]B?@UBF/2JV%?^:_CUJNT5MM:*Q7;.O# *GV[.2>&
M_ 6->BQ^8A7:</3(JKRAO3<1^5W[O/L2_ NGYW&0L>[_:K1L7DU4:>FB9/9]
MO TV[*=8-5O+)<1N;>^&- J?$QSC]>XSL<OCWC*O3*NT:>Y0P]I86^!UQQOK
MB:/O"R@2+Z_!PHCZFU5Y1S;)O$<YF=^:&J#];SXJE(B]R8HS0#Y'FI$;4N8N
M8GBJ=0>/P; +Y8.ZJJ3]O=JNX7F)QT;BE_"J8,JH2X9E3-5?JUI73TA36OVF
M+$LY=@R%,/V2*$,8>S51]CVAF\Q;G 3[7Q[)W[*@?+:3O9YHMF[JI*BV-E<Q
M\B8*44(VU^L4E=1^B_+GAR+!+_1%@><@W00A*O(H#.+L.@G9#UQ/0-$<5FBA
ML%?<1'.TL1%A#<J?J/6E#!-I]<'[4M=BJX2G3F)FX9\^L;(ZBBJ1][9Z0Q:/
M*>LT![^_-_D%3(^"\O+8!"^.#VOBHA#XC^BI-9(+PHV'] 0=9#UF!@67LV_[
M03/%X13O%.2/FL'(2;8&_8?-?+VB)F"P\XI5][4JN!)*$,C5DHO@.!05)I\9
M5)=+6&,I=2NS12P>I45$:?$X%I64/3QF1/UN)Y;2F98LR-E.GU<S@O3W'N^"
M.-_=HQ!%+XQ#10!D+3LAI$<* ^=85UN$%":\4^?"$MM)-"![QK!(Z< ,<^U$
M,$VF'1O&(SV"<*FK01S<-JXX<2R,A)=>1HK:=H?9%+;I&33U2)DFR&2>-6U(
M4O].DA//:RI%&N3C <GHA) $C,,1U!7JNN6+U9#)X1$&"+@YL9  >Z-O2ESK
MZ9F,A.=U.@1BN"IRFOK7X?_R;5L>/2C'X\"HY L6 )6+PF1T&%+URB!&0*@%
MC-%% P'7,4E$1D^N8.LB[:<L< /NG[]+GQK[DM)99I!I31^'RFC9F3E*Q;4.
M.VE,EMSR:[ZP:VY-PJ$U.^S7W[(S*2!5N0X[%PS4ZK*=KF!PJZKJK1K?P (Z
M8'B@3#Q;?)8D11#7L=M]44].!%VQU>!98VDK;_103PYZ*@>F92W:SE&Q^OW6
M7K^YF@4#[K]XRP7V1H^4N-93'QD)_3B[$W<)C*>KC\=IUCSUFV.X:*UWE15/
MN.;9'PTE^G1 5.@:VI ?^!)W_0 @K9= V2"2(;^D!:V(4CHEUJ].UQW+FIX%
M\>BF?GMQ3 K97B,30-I^^K49BG/F.;(8J/^XZPC(VL2'# T&,M>?T@+,G<=<
M1Q@]3^J[W&QCO$/H'I4Y7IVZ)VRM </7,@; NZY+JBPKJ14 N;_QIGH!^!*D
M?R!:6H<^Y<+1*PCHWB8)0%W7)@5&5>V3 *_GQ=6K9(F*0ZF)@@'W,J7XP*ZK
MDQ*S2@HEP^QO;7.NIRI5+8V6;$=*W-)UI=,7PQ272TQF0E1AE$)UX)W3 THB
MG#Z@D.P9E[<X+P5R@X.DX?SCIY_&,+:W4Q?H*9>6G!(#U4K! [)F(&B'KA/2
MC:*\K\D('@H@.DR-(!SAB'&;GP_ Y,?R/?Y^9[C5F61@3-8FUEOBA*:K(^0[
M'"4YK='-F,X%^D>1H!])RT\_L>LI34#1U&/00F$RKSG-\K/E,J)V,X@7*V*F
MB:_*9!<$VQXH"V'MW4:?,F1830:#J^D:E*O L9"BM6@'1Z$(1YBX!3"-@@$W
M9?TDP-[JE)(4S"B5C*3GU:6DRPPV8KS[8\$C6E8_T"(VQ]RV-@K#LA] 5T D
MXZ:X!Q^5OU4\1/[L2'K26AT,;&/!^5XCBVS[T&)U3KH;Y5=!6!9G9SC6,K"V
M.!(/S"D&;^C&-F4ZVU!P <-]<'->PAU*0[2EF^Z*WF*[Q6E>)&4$X:H@F^T[
M=@%)U7;-J2"\G;U2Y=#APOIR&)0REU LRT["*7F^7$GM E:>4G)Q-TN8'/'1
M+F5 >PQ:T/BX_#VSDRYH4M$YM8CU.\-<N$0@3):L5^/NZAVG6B,/@+'Z6E^*
MA .  =ST)RL+W7"V^E]W3[QR '1:)+1FG6"C\5=HDK7!S*H@6 \.FH?/M#59
MFG?L#/G7T,:0GWZ_IU43&:9_]'LMEL[OA^\GTP ROG3[.B&RK=_;.B^:V5_F
MMW[NN74SS9(I%G>]/U\Z"#IYXLZ]00 ;S."-/YBL;\U@]K\Y-YB"KHL'L]_0
MW_?1QC8.B\P)0RC-XMEK=+1K)F]- "V5G<;^IA/U>;OA5..50#&/HCM0)H_,
M1MDF[-P-.6![5,8'=&14B#>&F*_PRL"8X](%LW</23X\H\@]E[_!72,NZG$8
MOXO2F25\HK9<)SDB LGO@QP]Y#0ONXQ+$OFLQ8E D(9,C1(W]$K'%&2@KW5B
M(AY'W^CK,8O5;^5S ?DB+5_&;.[CEJ*ILAZ#.$;+S[L:+JL!1Z$Z,]B:(-A4
M;(ZKL5EIJ>CV9,J>I_<S^;]\(S,ZRM!=&H6H_=@R_1&BZU <(@V7X_!1KQ4E
M,UF;Y?1L; !XI2I0?I?B$*%E=D4$?9UE19#0;E_3@\@@+EEN6#A+EF727)G4
MQ#3#IM UQ2TFHW-<80W+2T5WIY.>H[K!%%T>)-VT.7B?<9KB5WI1+-@&893O
MA(XMH!T[3US4SG$UU)6 OE<KI#&A1O !%*OQ5NCC5N$S$D<_>,#L?/P1L%=Z
M(^%57UG&B&L-^=E3+_ >;>L:0XO5#4[6CRC=4):'1SL2L.:<APOFN/H ^5-1
M'#[*6F7^XNTK+H-@5(K^+% 2[A:K.Y1&>!F%==TJ<=A/VHP=!A0T<US)-/F?
M$"84D*B5\*_^A6OZ/'X)<KI3WUV0B2'4-Q8@4\/Z@%[IE(!'?2WJ(ZWUYA?_
M]*9[N9=]TUP T:1PL2 <5Q$Y5RJZP<36Q'X/>@C!<9&K$GC[R/1U$J8HR,B?
M=VF4A-&6?*P7YHN"7H@JMY-7N$C_;Q&DU"D;:(4YA$U9 @,('=<YXS)345$3
MQ!N-/OS;$8IJW49)Z,3D\D=VMQH:/@FW1-DU<7NJ]R8D:6(*:/:CF0V^GG74
M+DR$!GLQ3A(&%+Q-+Y.!6_1Y]MW9=[.[-6V5 /+DB2ETK3<U%9TU<P!6$6Q<
M:GT[(.M(Y;--[8"_228*O%\GDM=*C.!2UWT6KF-3?*F\9M5Z%G7/'P]3XI[]
MZL@4%#I:;O_-D=F4&_*LB'&=-O!RB*>J3*@/@X'3D&BK<X7D2!6:(:%#J'1%
MUO-7IY79ICNRJ3K=Q:&KTA6.X]1HAGP.H- 556LY++;T.7J9;*.[.+3UN<1Q
MI/H\EL\A]+FD:BUUQKP^"]14H'T>*I5179F4&^/""^NPD*]BL% EBBM'W6Q2
M74C@O8Q12(L(W:,EVFPI?_OX\V+%F$?P!LV[%H &CFN+,L\J^@)!WFB,,[FR
M_,Y^I7'(\V=Z776Q.L=)3GIQE^*7*"/ HS()$]&T&6RZ:!Q7/$/R4<N TR79
M**DS>;?E4V&?@PQ5)>)KCA=)5625^#^89LC<1"CYW'EV+RM?*GLAG.-T5[TV
M-CQY-8VW.74UA]=QO9Y+@DJGK>;ZT&C^X?.)>64<Z4.W.*%.?G5%H[IW_(B_
MX 3ET;_K5_3()*[2Z!?)<%<W 4-3VE$'@^-Z.UTJ*AJJ1:W1195$9:=T<7RD
M,0&#IB[:/="81Q=E)QEF=;%[A/%1(U_9B7!"]\'P\CG2( F;!\/(.D!?8BF?
MW1GZ!XK-FN4?W,QQS=3D7VGQ!I-H=% C]]D)'>RG=7]-@HISU/)XEZ)-1!^1
M7I:@]3W,4A*W2'R;0QL;,P5? YOCBFQ66OK)_!J4F]-C7XL^RXI 886J2Z("
M6S?=]]A%&#TOHJWT;,%8W-IO%]R,WE#7B&&Y4-A-_%BZ2+P\V;&?/V=B\O.=
M<\9TZK_6MZ]A?WJB[Z"/4[ >ZI/""9ZCL/UH'ZM/IQ=&3B^,H-,+(Z<71O3D
M?WIA9";!FGEGA(L9]-J(AU<B3J^-G%X;.?#L/;TV<GIMQ*%UPN0*<5PO43%=
M"$YU=1"L:%\PJ=+ZC-L]]IX= BK:]KFY?Z_?D)!5)M1I*A &OZE3AH.9+ZLO
M"8 GW\VE52)DPQWE[,OK4IV/^*Y(P^<@J]]"/L>;#4XN_RQ(?SNEQ"/\B*^*
M.-Y=1'&1HV4%]I7L#3-N ?@9*=1#-0L%YW5[?KFJ38%9^N/YQ=Y?B8.6W> L
M0]DBN7S+B14HHNR9AOB96=9@^'J$ /#.Z[$JSVI:"<#NS--SRNIUU][JH9ST
MN2O/A(?!5"A\$T25PSNO7JH\JZD7 +OALNVVX].L(WD%;QL0C^X>S8LQ'_G.
M5V7/-C%,VD%KV!PZ=5XO%[O:J;T GY]G]TWE?II9A):/^..GGT;'^<\X)JQE
MML_N.X\,5$\+T+Y)#_,56_5W&/)6;KT0PSKOEP.*WGJQ?>(_> Y@?!S"!V _
MOV#W.&10L#[8(.:1B R,_2Q !\Q<O*"JNW2'HR2G5\?'N3X7!?I'D: ?2<M/
M/S%/0Z:@J#G50^%(%AYC_+ 1J8CR]/9$Z;JE1\SSXWZ!:1@_2L&;8R(9-\<T
M?%3^.JR 96/\(HSLK(:/E/'TB^<'^>4CC)21*A1VCC=;G-"M(V,1 \$V;\N*
M8:WQ.^@.<UT3PC1U!-@P]ARM,E#YD./P#^;JQOW>N%7C[]8FM5C^6,Y,?SHS
MT97'KF,T_EI"V.3$,.T>7 X1H2Z+1K!1^BM,V+*B8@]55A@)7G\S YALCT)'
MHATA+\XD S9^,IG=1,&3Z*A?"C?8PS/@'-G_G5[5KJV"?$C-/:K-I:7YIK:'
MKND[>:1)0ZO ;S0I:!'SB:9C66-.+[$?0DGG?(A=J,D6WV%W4MU/3[#/J-"3
M7F!75V,W'V W>U9VB_,'E!-QT1W0=7(>9,]7093^,XB+SG$6Q\%6:SSPNJ&-
MW=;32:)04%!5.H;OV$_9MI51GNKXN'JBJGK-].&92+YY&+Z9:J.PIWK3-@JJ
MTM1M)9L@!@454Z.B7R#Z!:5/V'XF9E._ZHJ,PX"[498< +1)D!."NJUF"FPJ
MJ)48JWZ1Z<EJQ#%73%>@X;#I^1+BQW$;B1PW1B.WM4:+]:FN&0._QKOL+IU%
M V.N&![>!,2];[J9E0*\GI_SP\X4E*+>*H<*,L3^YE>JYL[QI"S/N 12XHK;
MZQS,6Y33"PO$'RN=,=MYEI=!FA#WL.T/YQA&!M8<YW/!K+F&1-[7"9$^HE+G
M<">$J5GCP+C!EX@?$1\6S8U8YEC,1-^>,%%1ZS% X>]!NG3Z#>4%<B-X6$>B
MF^U.QB&#9(@N'6AY1O8:P1JU8>UR1[PH\BP/DB61!N\<6K-Y$RA3;NZDH#H]
M_1QD45A6Y2UO>"J(2XX$(#01$GLNE*Z28$,2&_A9BMTI-PZ:W?!\5P$QL!--
M -SVJA/R]YQY* >Q60%"<[Q1=PP%1-W4>(5KEQ2O_A;6D6CP0_B,ED6,%JNS
M)(^6E*_R&D1S@'WY%L8%V;+1*";-"BSRNN3\4#2L&U;S(&\..@PCM_?(PK3N
M?]ZQ$3"RZ0] J7G*84Y*CHT4][(:%%PHLXF7UPRM/)MMC'<(E4=EB_)Q-&;*
MOQ2N66WX<-;6&?!H83B?_95&1J%<<?B8':J5]#5Y01E9 ._)?],H)'\K^UL6
MK6$J!KQ!+3E( R]419ES=9V!D-#W>AUQ5.JP-E.[F-_Z:3=>Z8R('W7U&&#3
M=UF=V'T>PH?!RFLW9%2,]+%\^TG:-W^CMS-M&;@C.H?S.[C*9I0C_O@;XL3?
MJ/5$L=QP+H691FMFAW0SQT6SB[H_^RL:O%-  &1S 48$Z:NN5&\_FE64/DXS
M6M+@M%=I J GTVTS4W2#^A3\CA@PJ4T'](VGR,OVQ[L:&SNL8BN,>E$WW1PO
M81\\/X]QUF7B+7V.^T<WHPPU4V=%CIV:S!J>AQ^RF.Z&H<M)AWXKD'+P%&1E
M >@M2K(2K>V4MWVFX6+5[=<]BH.R5G669_N>-S5@N4ZC"62M7SD-F0,G;LV1
M8G_(SVBT9ET6X\@^[_8P-0MGKT&Z%!^V&<([.F>;C-?>G9<X2&A\A'$FQOK4
MW&GI?;+>>>89$_OC@ 'SQ0][QQ1-F7M*3GXLQ(=F'0ZQH*TMJAQA#P^$I!SV
MU\8^UM$A$ N;O_$]YG3#$CUFRZL)APZ;^BL<\R8<"PT<SQ&?2+T[*-X'%4NN
M"!56.@7K6Q.XZ7^SYVUH#^6>@V0I7(+F)-'X(+.0L#8HK(/:^X>OS+43!%N+
M20)KSZ[-J2%8348#FS=#SZCYD_3(7WOX'C*!YE97O>RAN515GG%D],VI0P:S
MF>LS/LB*-0AE=WM2QKQFZ<')\^V'KP7^V8RN[X"LO_<-JDMM;6G8&TJ)"F/L
M"0,@:[D+(5WCE.GN@F#%W)J/QWP)DF(5A'E9OX98AH=BNXUWS)49 EIW7PQJ
MS5C 1@ KL=JW!T(*=(Z+,<]S#'S8#0HBX_!,K[J@%Q3C;5D;^HT:1,3;ID!;
M[#<K\A;NZY@ZXXJJ!B+@[R+S*TI0&L2$N[/E)DHB>CY#3\9$RJ;4IGD@%-;&
M?87385Y1Y8 D_*W? O%7L-I2#Q)QX_Y+$)_\> 08AL-Z]<)..%/,-TOSCNDE
M_QJ:7?+3[_>4:X87/_J]6:GWOQ^^GVQO8_REVU>V,9^YMU^(H=P4&[;/S?K6
M.-G];]:F+DNF6-SU_G3K("A=Y'Y#9T*>L,$,WOB#R?K6[IC>G!Y,0=?%@]EO
MZ&]>W-C&89$Y80BE6<-[C4XK-AH)]+#K<X>DO]7)I7+@B>&&<WG%'$+H22P
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M(D%2E%2$?%2&-_^'%)YXH1X)D+'^#43'1#@67X7(WZC)B,_140+/%>*=.8@
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M/%#MB/H+_0]]<.]___]02P$"% ,4    "  FAF11)V)3&NEA 0 B9PT $0
M            @ $     87%S="TR,#(P,#DS,"YX;6Q02P$"% ,4    "  F
MAF11&-3>QW04  !FZP  $0              @ $88@$ 87%S="TR,#(P,#DS
M,"YX<V102P$"% ,4    "  FAF11JHZB#]H0  !=[@  %0
M@ &[=@$ 87%S="TR,#(P,#DS,%]C86PN>&UL4$L! A0#%     @ )H9D49EO
M?FA&0   ?$D$ !4              ( !R(<! &%Q<W0M,C R,# Y,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( ":&9%',S.2$<K(  ,H,"P 5              "
M 4'( 0!A<7-T+3(P,C P.3,P7VQA8BYX;6Q02P$"% ,4    "  FAF11G"MZ
M\0A@   9E08 %0              @ 'F>@( 87%S="TR,#(P,#DS,%]P<F4N
9>&UL4$L%!@     &  8 B@$  "'; @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
